data_2enq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2enq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.562 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 46.3 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.26 135.3 55.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.096 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.554 HD12 ' CH2' ' A' ' 156' ' ' TRP . 6.7 tp -97.54 128.92 44.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.412 ' NH2' ' CE3' ' A' ' 63' ' ' TRP . 0.3 OUTLIER -127.35 123.6 36.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.531 HD12 ' CE1' ' A' ' 66' ' ' TYR . 11.3 mt -124.57 137.09 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.175 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -113.96 135.41 54.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 mm -94.78 142.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.136 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.87 -69.19 0.78 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 p -172.3 173.85 4.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.5 161.07 21.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 149' ' ' CYS . 2.1 t -128.34 158.37 38.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 39.47 52.16 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.962 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.825 0.345 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.407 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 29.4 t70 -82.85 -55.91 4.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.407 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 25.9 mmtt -146.32 -177.12 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 pt -145.52 170.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 3.7 p90 -158.57 166.23 32.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.422 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 99.0 t -122.27 139.6 48.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.126 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -115.72 121.2 41.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.812 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.9 p -118.91 154.16 33.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.08 169.26 41.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.536 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.456 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 4.1 mp -122.98 137.24 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.806 0.336 . . . . 0.0 111.124 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.532 ' CD2' ' HA ' ' A' ' 43' ' ' PRO . 2.9 m-85 -137.03 150.22 47.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.463 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 2.4 t-160 -113.01 99.36 7.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.84 32.55 61.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.478 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.31 -22.45 34.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.58 140.04 29.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.605 0.716 . . . . 0.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 53.8 Cg_endo -69.74 156.09 64.31 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.367 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 39' ' ' HIS . 9.1 mp -120.51 -38.01 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.2 m -154.98 168.21 27.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -51.9 152.65 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -93.94 163.44 13.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.453 HG11 ' CD1' ' A' ' 64' ' ' LEU . 25.4 t -116.73 145.06 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -125.33 141.68 51.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.5 p -85.86 160.66 19.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -52.75 170.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -95.88 115.22 27.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.439 HG13 ' NE1' ' A' ' 60' ' ' TRP . 1.5 m -116.96 152.16 48.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.593 0.711 . . . . 0.0 111.11 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 137.74 36.24 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.35 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 24.6 p -47.85 -44.88 29.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 t -53.16 -31.33 42.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -134.39 84.78 39.87 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.62 0.724 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.447 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.75 3.31 2.84 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.717 2.278 . . . . 0.0 112.37 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -62.81 127.15 29.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.447 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 5.6 m-90 -106.22 -63.46 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 58.67 45.05 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 63' ' ' TRP . 5.5 tp10 -127.55 147.47 50.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.412 ' CE3' ' NH2' ' A' ' 12' ' ' ARG . 77.9 m95 -88.66 117.71 27.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.453 ' CD1' HG11 ' A' ' 48' ' ' VAL . 9.2 tp -101.0 123.25 44.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -99.59 136.63 39.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' CE1' HD12 ' A' ' 13' ' ' ILE . 34.8 m-85 -106.35 138.36 42.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.49 38.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.427 ' C ' HD12 ' A' ' 68' ' ' ILE . 1.8 pp -108.05 161.53 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.588 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.62 124.86 49.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -55.84 -55.27 42.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 0.0 111.173 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.588 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.9 Cg_endo -69.74 2.94 3.07 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 112.346 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.486 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.1 t0 -127.72 1.46 6.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.89 115.71 62.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.643 0.735 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.452 ' HG2' ' CB ' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.78 145.64 57.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.456 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 25.3 mmt85 -59.69 -35.9 75.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . . . -62.73 -32.92 74.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.452 ' CB ' ' HG2' ' A' ' 74' ' ' PRO . . . -68.35 165.0 19.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.093 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -163.09 176.36 10.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.857 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.3 tp -98.97 136.69 38.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.76 132.11 40.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.66 158.62 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.8 p -159.57 135.89 8.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.829 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.7 mt -86.58 136.57 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . 30.3 m -132.53 151.29 51.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 83.6 p -112.97 122.76 48.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 96' ' ' HIS . 8.9 p -106.19 125.85 61.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.0 tptt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.93 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.842 0.354 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -130.27 122.98 29.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.52 ' CD2' HG21 ' A' ' 86' ' ' VAL . 5.7 m170 -100.95 128.79 46.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.2 t -131.82 129.01 21.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 110.872 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 143.18 49.65 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 0.0 112.282 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.1 mt -118.45 -56.83 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.19 178.68 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.469 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 64.8 p-90 -161.42 144.07 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.96 132.46 4.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.412 ' CB ' HG23 ' A' ' 139' ' ' THR . 6.6 m120 -111.93 120.26 41.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 0.0 110.909 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.7 mt -112.24 127.27 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -68.87 98.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.3 mt -43.15 -34.32 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.456 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 63.3 m-85 -107.9 110.43 22.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -51.65 170.22 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.65 ' CE1' ' CG2' ' A' ' 110' ' ' THR . 0.6 OUTLIER -55.48 -20.25 12.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.984 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.65 ' CG2' ' CE1' ' A' ' 109' ' ' TYR . 41.5 p -102.64 28.46 6.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.113 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 110' ' ' THR . 4.3 p30 46.71 40.34 8.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 113' ' ' LEU . 93.1 m -126.23 109.24 12.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 112' ' ' THR . 34.0 mt -34.2 132.95 0.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.1 m -66.2 163.31 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.5 p -160.42 175.6 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.54 134.9 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.484 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.414 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 5.9 ttpt -43.01 150.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.803 0.335 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 34.8 ttp -158.79 148.72 19.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.7 114.44 9.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.79 160.94 27.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.68 150.23 29.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.5 mt -106.52 153.35 22.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.536 ' CH2' ' OD1' ' A' ' 142' ' ' ASN . 54.7 m95 -85.94 144.81 39.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.514 0.673 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 132.61 23.71 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.646 2.231 . . . . 0.0 112.363 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.675 0.75 . . . . 0.0 111.123 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 40.3 mt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.81 0.338 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 21.7 tp -106.32 133.05 51.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.914 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -107.08 91.37 6.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.636 0.731 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -17.12 38.01 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.67 2.247 . . . . 0.0 112.381 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 mm -88.89 -20.69 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -41.93 150.75 0.27 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.3 m -66.46 164.2 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.963 0.411 . . . . 0.0 111.086 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.412 HG23 ' CB ' ' A' ' 103' ' ' ASN . 28.4 p -108.15 161.11 15.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.133 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.32 167.51 18.62 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.462 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.6 p -93.5 118.73 31.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 110.885 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.536 ' OD1' ' CH2' ' A' ' 123' ' ' TRP . 31.6 t30 -61.35 123.62 77.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.665 0.745 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -8.73 24.36 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.722 2.282 . . . . 0.0 112.333 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -73.44 138.98 45.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -90.21 -49.5 6.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -44.69 -38.42 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.8 p -63.77 151.24 89.34 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.583 0.706 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 166.4 27.7 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 0.0 112.356 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.402 ' HB3' ' CG2' ' A' ' 19' ' ' THR . 4.2 t -146.1 135.88 23.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.8 mt -113.84 138.49 50.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.967 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.414 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 18.3 tt0 -106.93 132.08 53.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.528 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -134.84 161.74 34.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -116.41 120.84 40.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.517 ' CE2' HD21 ' A' ' 152' ' ' LEU . 25.9 m-85 -90.15 113.94 25.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.63 136.65 46.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.554 ' CH2' HD12 ' A' ' 11' ' ' LEU . 2.7 m95 -134.58 98.96 4.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.564 ' CG ' ' N ' ' A' ' 158' ' ' SER . 15.5 p90 -103.83 -51.76 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.564 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 4.0 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.521 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 5.6 m . . . . . 0 C--O 1.229 0.025 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.52 147.07 44.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.093 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.2 tp -93.25 130.28 39.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.47 ' HD2' ' CE3' ' A' ' 63' ' ' TRP . 6.2 ttp180 -127.97 127.61 43.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.948 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.449 ' CD1' HD21 ' A' ' 79' ' ' LEU . 51.4 mt -130.75 156.3 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -140.65 128.01 21.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.5 mm -90.29 143.33 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.23 -73.66 0.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 t -162.49 172.17 15.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.23 162.9 17.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' TYR . 9.5 t -130.69 156.08 45.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' THR . 4.9 m-85 35.59 45.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.863 0.364 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -79.56 -57.32 3.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -146.15 177.49 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 pt -139.64 173.72 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -165.98 160.57 16.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.529 HG22 ' CZ2' ' A' ' 60' ' ' TRP . 37.6 t -116.74 146.84 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.145 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -119.68 136.14 54.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 63.0 p -130.59 157.65 42.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.11 141.58 3.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -93.59 133.66 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 111.111 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.52 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 17.5 m-85 -127.86 158.69 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.551 ' CD2' ' HB1' ' A' ' 76' ' ' ALA . 12.0 t-160 -134.57 95.43 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.69 32.07 28.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.48 -17.81 46.27 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -96.97 141.8 23.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.625 0.726 . . . . 0.0 110.938 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.477 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.77 160.88 48.08 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.643 2.229 . . . . 0.0 112.358 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mp -119.9 -26.4 5.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.5 p -158.38 168.24 27.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -57.04 131.23 49.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.428 ' ND2' ' OH ' ' A' ' 38' ' ' TYR . 6.4 m120 -64.09 148.52 49.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.15 147.16 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -130.16 145.24 51.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 51' ' ' GLN . 3.2 t -87.59 176.12 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.402 ' N ' ' OG1' ' A' ' 50' ' ' THR . 11.6 pt20 -63.52 167.9 5.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.1 mtm-85 -92.13 140.61 29.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.38 152.12 49.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.662 0.744 . . . . 0.0 111.153 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.67 36.08 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.686 2.257 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.1 p -47.78 -45.75 29.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.4 m -52.3 -28.34 18.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -134.5 87.38 32.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.668 0.747 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.75 3.73 2.6 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.351 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -55.69 134.4 51.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.529 ' CZ2' HG22 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -120.88 -68.45 0.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 53.55 52.72 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -127.56 143.39 51.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.47 ' CE3' ' HD2' ' A' ' 12' ' ' ARG . 90.0 m95 -87.38 104.35 16.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -93.39 120.69 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -95.96 151.95 18.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -118.03 140.21 50.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -84.33 30.29 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 pp -106.63 159.42 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.594 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -110.88 139.97 45.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.967 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.522 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.5 mp -64.64 -58.06 14.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.699 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.594 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.0 Cg_endo -69.73 2.43 3.53 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.679 2.252 . . . . 0.0 112.322 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.477 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.0 t70 -120.67 -0.74 10.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.52 117.13 68.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 138.37 37.49 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.622 2.215 . . . . 0.0 112.344 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -56.45 -26.47 53.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB1' ' CD2' ' A' ' 39' ' ' HIS . . . -70.31 -27.41 64.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.087 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.43 165.52 23.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -157.89 174.13 15.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.449 HD21 ' CD1' ' A' ' 13' ' ' ILE . 33.2 tp -97.01 143.64 27.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.9 m -133.58 154.65 50.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.66 137.84 14.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.42 154.37 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.812 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.9 mt -98.75 128.68 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.193 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 18.6 m -128.52 142.58 51.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.8 p -108.37 130.96 55.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.542 HG23 ' CD2' ' A' ' 96' ' ' HIS . 9.9 p -110.64 129.21 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.115 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 tptm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.902 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.84 0.352 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -137.52 121.61 17.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.542 ' CD2' HG23 ' A' ' 86' ' ' VAL . 9.1 m170 -97.46 141.46 30.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.7 t -148.6 132.34 8.47 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.582 0.706 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 152.51 69.38 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.24 . . . . 0.0 112.397 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.6 mt -128.48 -47.21 1.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.87 155.47 46.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.112 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -135.68 126.2 26.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.4 130.07 5.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 1.0 OUTLIER -104.6 161.49 14.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 88.6 mt -151.17 118.03 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -64.83 105.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 70.9 mt -44.32 -54.73 5.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.407 ' CE1' ' HG ' ' A' ' 113' ' ' LEU . 65.0 m-85 -94.28 120.34 34.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -56.75 -176.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.09 -0.9 12.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 p -108.86 11.39 26.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.117 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 64.33 48.56 2.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.4 m -147.33 125.64 12.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.432 ' CD2' ' CH2' ' A' ' 156' ' ' TRP . 15.0 mt -45.27 142.12 2.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.487 HG23 ' CZ ' ' A' ' 154' ' ' PHE . 2.4 m -64.24 176.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.4 p -168.51 173.69 7.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.34 139.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.476 ' HD3' ' CG ' ' A' ' 151' ' ' GLU . 0.7 OUTLIER -48.51 146.11 3.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.861 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 32.0 ttp -147.86 152.49 37.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.4 116.68 11.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 pp -128.85 160.41 32.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 147' ' ' THR . 5.4 m120 -87.3 146.95 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 mt -104.63 150.05 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -83.09 151.68 63.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.539 0.685 . . . . 0.0 110.951 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 160.63 48.98 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 0.0 112.365 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.2 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.639 0.733 . . . . 0.0 111.128 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.845 0.355 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.6 tp -110.49 145.3 37.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.441 ' ND2' ' CA ' ' A' ' 137' ' ' GLY . 64.2 t30 -119.18 93.87 47.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 110.911 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.52 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.3 Cg_endo -69.83 -47.3 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.716 2.277 . . . . 0.0 112.31 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 137' ' ' GLY . 0.4 OUTLIER -64.36 -30.14 49.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.137 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.441 ' CA ' ' ND2' ' A' ' 134' ' ' ASN . . . -35.14 151.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.468 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 m -56.85 176.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.401 . . . . 0.0 111.125 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.2 p -129.48 161.73 29.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.122 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.57 159.17 20.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.0 p -78.18 130.87 36.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.855 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -64.37 119.81 59.63 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.644 0.735 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -7.2 20.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.673 2.249 . . . . 0.0 112.354 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -85.94 145.49 27.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -92.97 -37.15 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.69 -14.67 3.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.485 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 65.0 p -88.85 151.39 47.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.581 0.705 . . . . 0.0 111.154 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 169.39 19.07 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.342 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 t -150.79 137.83 19.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.2 mt -114.42 139.59 49.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.476 ' CG ' ' HD3' ' A' ' 117' ' ' LYS . 5.5 tt0 -107.09 123.17 47.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.506 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -131.08 162.54 29.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -119.15 131.72 55.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 114' ' ' VAL . 24.5 m-85 -95.98 119.74 35.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.822 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.94 137.43 44.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.432 ' CH2' ' CD2' ' A' ' 113' ' ' LEU . 15.9 m95 -130.02 91.24 3.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.958 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.562 ' CG ' ' N ' ' A' ' 158' ' ' SER . 22.3 p90 -96.95 -52.62 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.562 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 30.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.882 0.373 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.45 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . . . -119.55 128.42 53.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.6 tp -97.83 131.66 44.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -139.21 136.57 35.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.1 mt -129.5 135.94 60.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 21.2 tttt -113.59 113.26 24.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.28 143.77 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.35 -73.22 0.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.5 p -170.52 171.0 6.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.94 154.23 25.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.415 HG21 ' CD2' ' A' ' 20' ' ' TYR . 8.1 t -134.64 143.25 47.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CD2' HG21 ' A' ' 19' ' ' THR . 1.6 m-85 63.73 41.29 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.143 179.876 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.804 0.335 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -72.06 -62.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -144.74 177.08 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -137.69 158.12 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -152.37 140.38 20.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 95.8 t -89.82 149.07 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.163 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.405 ' N ' HG13 ' A' ' 33' ' ' VAL . 37.3 ttt85 -131.53 119.35 21.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.4 p -117.04 179.33 4.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.64 140.57 3.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.493 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.7 mp -90.07 142.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.165 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.507 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 22.0 m-85 -137.23 143.68 42.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.563 ' CD2' ' HB1' ' A' ' 76' ' ' ALA . 13.3 t-160 -122.14 99.01 6.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.13 36.58 31.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.44 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.92 35.41 50.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -148.53 140.39 14.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.728 . . . . 0.0 110.88 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 143.45 51.09 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 0.0 112.345 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.3 mp -97.67 -41.83 7.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.8 m -150.36 162.54 40.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -44.02 120.3 2.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -60.52 162.25 6.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.32 147.46 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.163 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -126.86 148.89 49.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.1 t -98.13 163.82 12.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.174 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -49.95 179.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -107.02 127.71 53.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 m -129.95 152.13 79.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.6 0.714 . . . . 0.0 111.161 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 141.55 45.57 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.704 2.269 . . . . 0.0 112.343 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.3 p -50.13 -45.36 52.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.8 p -53.64 -30.85 44.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -134.2 86.3 36.8 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.581 0.705 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.572 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.6 Cg_endo -69.75 3.63 2.66 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.723 2.282 . . . . 0.0 112.322 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.81 135.4 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.572 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -128.93 -56.35 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.5 p30 38.37 37.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -104.29 142.7 34.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.465 ' NE1' ' HD2' ' A' ' 14' ' ' LYS . 45.4 m95 -85.38 104.4 15.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -96.32 121.43 38.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -99.74 141.92 31.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -110.86 128.95 55.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -81.34 47.66 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 69' ' ' TYR . 2.1 pp -114.0 167.25 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.16 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.599 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.55 123.72 46.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.606 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -58.49 -53.2 68.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.634 0.731 . . . . 0.0 111.143 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.82 3.11 2.99 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.268 . . . . 0.0 112.329 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.486 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 3.5 t70 -124.82 -4.42 7.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.01 111.85 30.45 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.94 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 135.9 31.65 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.365 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.47 ' NE ' ' OD1' ' A' ' 111' ' ' ASP . 62.0 mmt-85 -45.27 -43.63 10.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.563 ' HB1' ' CD2' ' A' ' 39' ' ' HIS . . . -50.18 -47.98 54.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.51 160.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 -156.13 173.15 17.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.4 tp -98.62 131.02 45.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -125.98 132.34 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.95 147.05 41.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 88.6 p -155.24 130.32 9.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.6 mt -80.5 131.72 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 55.7 m -123.37 143.38 50.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.7 m -106.98 128.05 54.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.414 ' CG2' ' HB3' ' A' ' 94' ' ' GLU . 6.9 p -109.05 137.71 39.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.169 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.936 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 24.3 mt-10 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.825 0.345 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -124.74 115.33 20.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.949 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.441 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 5.1 m170 -97.07 141.33 30.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.38 124.79 2.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.635 0.731 . . . . 0.0 110.855 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 147.14 61.89 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.706 2.271 . . . . 0.0 112.298 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 mt -113.2 -47.62 3.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.84 156.91 44.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.434 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 67.2 p-90 -137.21 138.91 40.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.07 124.21 3.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.53 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -101.75 129.16 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.892 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.452 ' CD1' HD21 ' A' ' 120' ' ' LEU . 85.0 mt -124.0 126.8 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.076 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 106' ' ' LEU . 8.2 t-20 -73.43 95.24 2.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 105' ' ' ASN . 51.4 mt -35.08 -34.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 105' ' ' ASN . 88.7 m-85 -103.56 112.7 25.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.92 -178.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.829 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 109' ' ' TYR . 1.3 p90 -62.06 -30.53 71.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.947 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t -93.99 33.86 1.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.181 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.47 ' OD1' ' NE ' ' A' ' 75' ' ' ARG . 14.5 t0 43.0 44.73 4.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 69.7 m -131.52 109.66 10.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.17 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 112' ' ' THR . 60.3 mt -34.66 140.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' A' ' 154' ' ' PHE . 27.6 m -67.66 165.44 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 p -164.94 158.1 16.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.864 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.94 141.05 1.23 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -40.01 149.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.917 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.7 ttp -159.76 148.46 17.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.71 123.36 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.47 ' HB2' ' CB ' ' A' ' 141' ' ' SER . 4.6 pp -135.34 156.55 48.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -77.95 158.72 29.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.852 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.429 HD13 ' CD1' ' A' ' 150' ' ' LEU . 10.3 mt -118.87 158.64 25.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -91.46 152.04 43.23 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.576 0.703 . . . . 0.0 110.909 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 170.37 16.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.346 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.548 0.69 . . . . 0.0 111.164 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.1 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.873 0.368 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.3 tp -88.64 135.73 33.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -108.06 91.36 7.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.653 0.74 . . . . 0.0 110.897 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.507 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.76 -10.41 28.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.8 mm -95.61 -16.62 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.434 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -41.46 148.17 0.36 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 m -65.3 166.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 66.6 p -108.96 154.67 21.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.139 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.02 135.93 8.27 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.47 ' CB ' ' HB2' ' A' ' 120' ' ' LEU . 88.2 p -51.12 120.41 4.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.377 . . . . 0.0 110.837 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER -50.05 132.15 22.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.644 0.735 . . . . 0.0 110.881 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.0 11.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.688 2.259 . . . . 0.0 112.363 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 146' ' ' GLU . 23.4 t-20 -49.25 143.89 5.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -97.6 -32.49 11.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.447 ' N ' ' OD1' ' A' ' 144' ' ' ASN . 11.9 pt-20 -84.3 34.56 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.5 p -118.26 155.2 51.91 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.516 0.674 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 137.19 34.7 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.308 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 8.3 t -120.69 131.68 54.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.429 ' CD1' HD13 ' A' ' 122' ' ' LEU . 6.4 mt -107.23 140.06 40.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -109.12 123.91 49.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.559 HD23 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -135.08 161.21 35.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -121.18 123.88 43.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 152' ' ' LEU . 25.6 m-85 -91.23 116.13 28.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.61 152.21 51.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.424 ' CZ2' ' HB3' ' A' ' 113' ' ' LEU . 5.3 m95 -137.47 107.97 6.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.497 ' CG ' ' N ' ' A' ' 158' ' ' SER . 16.2 p90 -90.28 -46.65 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.497 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 26.9 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.406 ' C ' HD12 ' A' ' 70' ' ' ILE . 5.4 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.77 126.15 51.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.498 HD12 ' CZ3' ' A' ' 156' ' ' TRP . 12.4 tp -84.15 144.1 29.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -146.95 139.07 24.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.6 mt -141.28 127.65 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.409 ' HB2' ' CD2' ' A' ' 63' ' ' TRP . 25.8 tttp -103.24 120.35 40.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 mm -83.08 145.99 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.06 -73.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.1 p -172.96 169.17 4.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.446 ' CB ' HD21 ' A' ' 150' ' ' LEU . . . -113.97 158.1 21.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.463 HG23 ' CD2' ' A' ' 20' ' ' TYR . 14.6 t -137.04 151.99 49.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.463 ' CD2' HG23 ' A' ' 19' ' ' THR . 9.7 m-85 58.85 32.76 22.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.136 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.6 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -85.27 -56.38 3.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -148.09 179.69 7.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 55' ' ' CYS . 7.7 pt -139.79 170.15 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.151 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -170.79 150.64 3.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.568 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 9.3 t -102.49 151.94 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -130.86 116.65 18.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.8 p -104.57 170.31 7.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.185 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.98 146.5 4.96 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.47 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 38' ' ' TYR . 3.6 mp -104.12 135.95 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.86 0.362 . . . . 0.0 111.127 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.453 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 35.4 m-85 -129.07 149.18 51.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.467 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.8 t-160 -123.05 98.45 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.74 44.29 39.42 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.446 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.92 29.68 72.47 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.442 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -139.48 140.78 26.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 142.78 48.78 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.712 2.275 . . . . 0.0 112.323 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 39' ' ' HIS . 9.1 mp -110.49 -34.91 6.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 p -152.72 163.09 40.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -47.84 151.49 0.89 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -80.21 140.25 36.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.44 HG11 ' CG ' ' A' ' 64' ' ' LEU . 74.4 t -104.7 132.67 50.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -118.81 161.31 20.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.405 HG22 ' CD1' ' A' ' 60' ' ' TRP . 8.8 t -107.4 160.49 15.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -46.85 154.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.05 136.72 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.413 ' CG2' ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -144.23 152.12 53.4 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.663 0.745 . . . . 0.0 111.086 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 139.89 41.26 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.696 2.264 . . . . 0.0 112.37 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 31' ' ' ILE . 24.9 p -51.03 -44.15 60.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.1 m -53.49 -35.52 60.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -132.53 83.96 52.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.719 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.539 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.79 3.27 2.88 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.688 2.259 . . . . 0.0 112.342 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -49.94 113.15 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.568 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 6.2 m-90 -106.41 -48.83 3.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 60' ' ' TRP . 6.8 m-80 36.61 49.72 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -121.38 146.54 46.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.409 ' CD2' ' HB2' ' A' ' 14' ' ' LYS . 59.5 m95 -87.71 100.05 12.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.44 ' CG ' HG11 ' A' ' 48' ' ' VAL . 12.2 tp -84.39 119.27 24.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -95.07 137.79 33.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -107.75 127.56 53.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.4 50.41 1.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 pp -118.5 163.4 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.57 112.23 22.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.626 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.5 mp -48.68 -52.42 45.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.661 0.743 . . . . 0.0 111.148 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.3 Cg_endo -69.8 2.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.498 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.1 t70 -129.29 1.82 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.6 118.61 71.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.627 0.727 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 136.92 34.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.65 2.233 . . . . 0.0 112.341 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 23.2 mmt85 -54.47 -36.1 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -59.39 -35.61 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.26 166.25 8.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.106 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -162.18 174.46 12.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.0 tp -94.87 134.35 37.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.0 m -132.28 132.66 43.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.56 155.15 50.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.6 m -157.62 127.42 6.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mt -83.48 140.03 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 63.7 m -136.11 149.68 48.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.9 p -106.6 120.44 41.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 86' ' ' VAL . 7.6 p -102.55 115.43 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.143 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HD2' ' C ' ' A' ' 87' ' ' LYS . 1.4 tmmt? . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.829 0.347 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -136.07 120.94 18.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.863 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -96.98 135.98 38.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.2 t -137.03 131.94 18.04 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.576 0.703 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 151.93 69.04 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.682 2.255 . . . . 0.0 112.319 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.5 mt -127.82 -53.36 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.923 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.04 164.89 32.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.084 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.532 ' O ' ' CE3' ' A' ' 101' ' ' TRP . 58.9 p-90 -146.94 129.2 15.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.33 129.29 5.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.469 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -106.75 126.84 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 0.0 110.862 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.2 mt -118.51 124.03 72.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.21 96.12 0.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.5 mt -37.92 -45.49 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 67.7 m-85 -94.42 114.81 26.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -48.06 174.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -60.67 -19.03 57.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 t -94.57 12.45 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.131 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 65.97 37.75 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 113' ' ' LEU . 4.5 m -136.77 121.68 18.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.576 ' CD2' ' CH2' ' A' ' 156' ' ' TRP . 23.2 mt -34.69 146.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.505 HG21 ' CG ' ' A' ' 154' ' ' PHE . 23.4 m -75.31 175.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.144 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.6 p -167.15 161.42 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.795 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.1 136.6 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.407 ' HE2' ' CD ' ' A' ' 151' ' ' GLU . 38.7 tttt -42.77 146.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.727 0.298 . . . . 0.0 110.917 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.3 ttp -154.61 148.21 25.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.63 117.17 11.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.126 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.425 ' CD1' ' O ' ' A' ' 121' ' ' ASN . 4.3 pp -129.72 161.88 29.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.425 ' O ' ' CD1' ' A' ' 120' ' ' LEU . 10.8 m120 -82.05 158.48 23.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.5 mt -117.31 144.85 44.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.467 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 49.8 m95 -70.35 152.01 95.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 0.0 110.943 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 170.27 16.9 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 0.0 112.352 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.9 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.656 0.741 . . . . 0.0 111.104 179.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.2 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.842 0.354 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.3 tp -99.32 128.64 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -108.48 91.51 8.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.679 0.752 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.453 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.76 -43.92 2.38 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.711 2.274 . . . . 0.0 112.391 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 137' ' ' GLY . 45.2 mt -65.11 -28.72 45.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -35.01 151.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -60.68 176.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.7 p -122.05 169.11 11.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.112 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.79 166.32 24.28 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 142' ' ' ASN . 6.3 p -88.32 94.19 9.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.628 HD22 ' ND2' ' A' ' 144' ' ' ASN . 10.3 t30 -37.09 133.33 0.71 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.657 0.742 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' ASN . 54.0 Cg_endo -69.66 -48.67 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.361 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.628 ' ND2' HD22 ' A' ' 142' ' ' ASN . 2.3 m-20 -37.12 126.38 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -86.69 -27.22 23.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -60.46 -34.74 74.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.5 p -66.36 151.02 96.58 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.591 0.71 . . . . 0.0 111.168 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 159.48 53.24 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.726 2.284 . . . . 0.0 112.324 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 t -135.51 137.36 42.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.446 HD21 ' CB ' ' A' ' 18' ' ' ALA . 10.4 mt -109.21 138.12 46.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.407 ' CD ' ' HE2' ' A' ' 117' ' ' LYS . 34.7 tt0 -105.67 126.46 52.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.478 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -136.09 159.52 41.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -115.61 123.96 49.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.505 ' CG ' HG21 ' A' ' 114' ' ' VAL . 35.4 m-85 -92.13 118.17 30.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.599 ' C ' ' CD1' ' A' ' 156' ' ' TRP . 1.3 m-20 -143.48 158.23 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.599 ' CD1' ' C ' ' A' ' 155' ' ' ASP . 0.9 OUTLIER -153.16 112.78 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.524 ' CG ' ' N ' ' A' ' 158' ' ' SER . 28.9 p90 -101.28 -53.27 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 1.9 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.889 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.421 ' C ' HD12 ' A' ' 70' ' ' ILE . 28.1 m . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.19 139.45 49.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.09 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.508 HD11 ' CZ3' ' A' ' 156' ' ' TRP . 6.0 tp -95.89 137.15 35.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.453 ' N ' HD12 ' A' ' 11' ' ' LEU . 9.1 ttp180 -136.71 132.42 34.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.0 mt -138.28 137.31 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.193 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -116.85 128.84 55.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 mm -91.34 140.14 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -98.04 -71.19 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.4 p -171.06 -179.54 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.35 164.57 18.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 t -135.5 150.87 49.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 50.83 52.41 15.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 179.863 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.0 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.819 0.342 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.54 -64.93 0.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -142.06 179.85 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 53' ' ' VAL . 6.2 pt -136.81 178.25 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 2.3 p90 -172.95 159.55 4.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -118.53 148.98 21.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -124.82 120.69 32.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.8 p -113.7 166.43 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.141 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.74 154.98 8.97 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -102.49 144.73 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.867 0.365 . . . . 0.0 111.13 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.481 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 53.4 m-85 -139.16 153.13 47.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 76' ' ' ALA . 2.8 t-160 -130.18 101.84 5.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.87 24.26 76.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.13 -35.49 4.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.519 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.34 138.93 55.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.718 . . . . 0.0 110.885 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 53.8 Cg_endo -69.81 165.31 31.46 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.629 2.219 . . . . 0.0 112.328 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mp -122.83 -39.88 2.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.0 p -146.84 161.18 41.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -47.84 155.13 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.73 142.84 29.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.465 ' CG1' HD12 ' A' ' 64' ' ' LEU . 83.5 t -99.78 134.56 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -119.84 140.59 50.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 t -97.82 163.55 12.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -51.12 162.39 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.52 123.01 35.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.448 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 2.3 m -119.6 152.29 53.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 132.79 24.14 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.341 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 4.5 p -44.58 -46.9 10.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -49.75 -34.9 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.883 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -134.72 87.42 31.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.579 0.704 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.583 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.8 Cg_endo -69.77 3.57 2.7 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.681 2.254 . . . . 0.0 112.334 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -54.1 110.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.882 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.583 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.0 m-90 -97.91 -60.58 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 48.07 50.38 16.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -121.58 141.08 51.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -82.95 101.2 10.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.465 HD12 ' CG1' ' A' ' 48' ' ' VAL . 10.0 tp -92.29 114.86 27.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -97.91 139.65 33.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.928 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -105.96 138.66 41.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.8 32.5 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 69' ' ' TYR . 1.9 pp -99.8 164.25 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.26 123.63 47.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.602 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -56.92 -53.8 61.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.6 0.714 . . . . 0.0 111.112 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.79 2.14 3.82 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.641 2.227 . . . . 0.0 112.323 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.499 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 7.0 t0 -124.99 -9.58 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.34 114.46 35.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.697 . . . . 0.0 110.94 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 145.42 57.0 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.692 2.261 . . . . 0.0 112.31 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -57.01 -45.74 82.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.542 ' HB2' ' CE1' ' A' ' 39' ' ' HIS . . . -52.27 -35.53 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.419 ' C ' ' HG3' ' A' ' 78' ' ' ARG . . . -65.75 156.32 33.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.419 ' HG3' ' C ' ' A' ' 77' ' ' ALA . 88.0 mtt180 -152.76 172.47 16.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.4 tp -93.74 133.04 37.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.5 m -127.64 134.51 49.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.26 154.72 46.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 99.8 p -158.86 131.33 6.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.431 HG21 ' N ' ' A' ' 84' ' ' CYS . 22.6 mt -80.59 141.98 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.431 ' N ' HG21 ' A' ' 83' ' ' ILE . 87.7 m -135.77 149.16 49.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.9 m -115.02 120.32 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 96' ' ' HIS . 6.1 p -105.21 137.8 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 tptt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.917 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.497 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 24.1 mt-10 . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.803 0.335 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -120.2 120.29 35.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.569 ' CD2' HG21 ' A' ' 86' ' ' VAL . 5.0 m170 -93.81 145.5 24.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.7 t -152.53 126.34 4.35 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.585 0.707 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 155.0 67.05 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.294 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.4 mt -128.51 -53.09 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.16 152.35 49.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.483 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 64.1 p-90 -134.06 127.37 32.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.48 129.45 6.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -112.53 124.75 53.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.7 mt -119.39 132.5 69.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.181 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -74.84 96.89 3.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.9 mt -36.49 -39.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -99.84 117.36 34.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -57.02 -174.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -76.2 6.39 5.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.95 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.1 p -126.54 18.6 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 58.45 30.05 19.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 94.4 m -117.49 103.52 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 112' ' ' THR . 24.0 mt -34.7 135.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.403 HG21 ' CE2' ' A' ' 154' ' ' PHE . 15.4 m -70.05 157.46 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.6 t -156.15 173.46 16.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.89 142.99 0.18 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.485 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.46 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 9.3 ttpt -44.6 148.75 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 31.8 ttp -159.69 147.86 17.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.73 122.23 16.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.3 155.37 48.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -75.66 152.17 37.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.6 mt -115.81 148.87 39.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.483 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 21.0 m95 -78.38 147.44 72.2 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.553 0.692 . . . . 0.0 110.943 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.44 ' O ' ' NE1' ' A' ' 101' ' ' TRP . 53.0 Cg_endo -69.8 173.57 10.81 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.682 2.255 . . . . 0.0 112.324 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 85.4 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.581 0.705 . . . . 0.0 111.123 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 25.7 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.842 0.354 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.59 135.66 38.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.958 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -105.84 91.39 5.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.639 0.733 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.481 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.77 -33.28 16.85 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.349 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.41 -20.81 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -42.75 153.86 0.19 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.503 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.3 m -62.95 158.17 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.371 . . . . 0.0 111.129 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 20.0 p -104.19 165.39 11.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.67 169.37 25.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.48 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 142' ' ' ASN . 24.4 p -88.08 102.35 14.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 141' ' ' SER . 56.5 t-20 -34.4 120.48 0.54 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -1.93 9.35 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.709 2.273 . . . . 0.0 112.379 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -85.34 135.02 34.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -85.49 -50.5 7.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -42.82 -52.64 4.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 45.7 p -48.28 150.22 2.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.622 0.725 . . . . 0.0 111.113 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 158.87 55.38 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.656 2.237 . . . . 0.0 112.299 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 7.7 t -135.54 138.39 43.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.1 mt -109.28 142.02 40.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.419 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 9.9 tt0 -110.02 123.54 49.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.521 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -131.06 164.44 25.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.46 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 59.6 mt-10 -123.85 117.69 25.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.403 ' CE2' HG21 ' A' ' 114' ' ' VAL . 31.6 m-85 -82.39 104.35 12.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.844 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -112.35 143.78 42.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.508 ' CZ3' HD11 ' A' ' 11' ' ' LEU . 12.8 m95 -134.67 88.05 2.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 158' ' ' SER . 11.8 p90 -90.05 -41.53 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.466 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 30.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.431 ' H ' ' CB ' ' A' ' 158' ' ' SER . 1.7 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.894 0.378 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.403 ' H ' ' CB ' ' A' ' 158' ' ' SER . . . -120.56 135.09 55.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.554 HD11 ' CH2' ' A' ' 156' ' ' TRP . 12.4 tp -94.42 145.3 24.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.419 ' C ' HG13 ' A' ' 13' ' ' ILE . 27.4 ptt180 -147.53 141.69 26.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.419 HG13 ' C ' ' A' ' 12' ' ' ARG . 21.7 mt -141.13 140.82 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -115.24 136.81 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 16' ' ' LEU . 43.5 mm -98.58 141.69 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.435 ' N ' HG23 ' A' ' 15' ' ' ILE . 4.1 mm? -98.44 -71.99 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.9 p -169.1 172.95 7.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.427 ' CB ' HD21 ' A' ' 150' ' ' LEU . . . -121.53 164.09 17.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.072 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -145.35 156.31 43.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 58.87 35.07 24.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.7 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 179.915 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.4 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.829 0.347 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -68.26 -61.75 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.892 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -148.18 174.52 11.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -132.49 -179.72 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.098 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -169.74 173.58 6.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.562 HG22 ' CZ2' ' A' ' 60' ' ' TRP . 94.0 t -124.97 146.2 31.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.401 ' NH1' HD11 ' A' ' 132' ' ' LEU . 17.9 ttt180 -129.67 117.31 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.1 p -115.8 175.67 5.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.104 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.44 146.34 4.5 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.516 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.406 ' CG1' HD13 ' A' ' 106' ' ' LEU . 2.3 mp -90.04 140.82 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 111.173 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.556 ' CE1' HD21 ' A' ' 133' ' ' LEU . 37.8 m-85 -137.64 134.04 35.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.541 ' CD2' ' HB2' ' A' ' 76' ' ' ALA . 8.0 t-160 -127.19 105.39 8.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.1 56.16 3.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.489 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.75 37.84 28.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.466 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -154.12 142.71 14.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.678 0.751 . . . . 0.0 110.886 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.472 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 53.3 Cg_endo -69.8 165.96 29.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.654 2.236 . . . . 0.0 112.33 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.6 mp -119.96 -40.25 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 16.2 p -145.94 165.3 29.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -51.06 128.17 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -59.9 143.55 51.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.458 HG12 ' CD1' ' A' ' 64' ' ' LEU . 56.3 t -104.14 133.41 48.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.155 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.31 140.34 49.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -96.58 153.13 18.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -41.72 161.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.1 mtm-85 -89.33 146.09 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.81 152.14 64.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.635 0.731 . . . . 0.0 111.155 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 135.88 31.47 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.719 2.279 . . . . 0.0 112.338 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 8.0 p -46.2 -48.53 17.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -47.76 -36.53 11.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -132.93 87.05 41.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.63 0.728 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.597 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 54.0 Cg_endo -69.74 3.09 2.96 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.68 2.253 . . . . 0.0 112.359 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -57.18 125.82 24.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.832 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.597 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 5.2 m-90 -108.83 -57.42 2.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.937 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 49.28 53.19 13.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -128.23 143.54 51.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -87.64 104.68 16.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.458 ' CD1' HG12 ' A' ' 48' ' ' VAL . 11.6 tp -90.06 121.08 31.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -97.47 136.73 37.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -106.2 129.28 54.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.08 44.25 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.891 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 pp -111.29 164.17 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.119 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.605 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.95 120.07 38.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.616 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -55.61 -52.8 68.97 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.614 0.721 . . . . 0.0 111.153 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.82 2.98 3.07 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.726 2.284 . . . . 0.0 112.325 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.496 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 1.8 t70 -126.08 -7.15 6.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.43 ' C ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -77.99 114.84 45.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.588 0.709 . . . . 0.0 110.917 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.72 139.25 39.9 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.725 2.283 . . . . 0.0 112.331 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.49 ' NE ' ' OD1' ' A' ' 111' ' ' ASP . 74.6 mmt-85 -50.23 -40.39 47.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . . . -54.71 -43.67 72.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.068 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.419 ' CB ' HD11 ' A' ' 73' ' ' LEU . . . -53.13 154.22 3.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -151.25 170.75 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.7 tp -93.94 133.23 37.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m -132.73 142.73 49.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.71 157.6 43.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.3 p -157.92 131.1 7.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.47 ' CD1' HD11 ' A' ' 150' ' ' LEU . 29.0 mt -85.65 126.22 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 28.6 m -124.22 151.03 44.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 p -107.54 127.7 53.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.411 HG21 ' NE2' ' A' ' 96' ' ' HIS . 2.6 p -105.58 132.53 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.0 tptp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.8 0.334 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -138.85 114.5 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 4.5 m170 -94.34 130.62 40.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.9 t -131.94 127.3 21.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.583 0.706 . . . . 0.0 110.887 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 150.4 67.86 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.633 2.222 . . . . 0.0 112.336 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.0 mt -123.87 -50.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.88 179.36 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.514 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 64.6 p-90 -158.22 130.79 7.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.954 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.33 133.43 6.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -115.39 132.55 56.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.771 0.32 . . . . 0.0 110.914 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.31 124.84 73.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 106' ' ' LEU . 4.9 m120 -64.66 89.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 105' ' ' ASN . 16.0 mt -34.66 -40.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -105.25 112.51 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -52.13 173.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -55.33 -35.59 65.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 t -87.78 27.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.49 ' OD1' ' NE ' ' A' ' 75' ' ' ARG . 8.4 t0 47.83 52.46 12.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 97.2 m -139.16 108.71 6.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.133 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.469 ' HB3' ' CZ2' ' A' ' 156' ' ' TRP . 20.3 mt -34.94 133.21 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.527 HG21 ' CE2' ' A' ' 154' ' ' PHE . 26.4 m -63.43 171.71 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.7 m -162.85 175.53 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.04 153.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.496 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.423 ' HE3' ' CG ' ' A' ' 153' ' ' GLU . 20.0 ttmt -58.73 148.07 30.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.76 0.314 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 41.1 ttp -154.67 151.86 29.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.908 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.84 128.5 26.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.117 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 pp -139.87 162.48 35.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -87.52 150.52 23.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 mt -108.17 155.41 20.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.539 ' CH2' ' HD2' ' A' ' 143' ' ' PRO . 7.3 m95 -90.94 141.54 26.72 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.61 0.719 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 136.01 31.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.353 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.619 0.723 . . . . 0.0 111.111 179.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.401 HD11 ' NH1' ' A' ' 34' ' ' ARG . 12.1 mt . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.843 0.354 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.556 HD21 ' CE1' ' A' ' 38' ' ' TYR . 9.7 tp -97.38 145.93 25.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -114.38 93.05 30.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.638 0.733 . . . . 0.0 110.857 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.79 -38.68 7.39 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.663 2.242 . . . . 0.0 112.317 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.2 mt -73.02 -20.12 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.405 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -45.67 148.36 1.89 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.3 m -62.35 178.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.141 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 82.4 p -123.79 157.65 33.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.151 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.25 170.91 19.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 p -84.07 128.93 34.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 144' ' ' ASN . 5.9 t-20 -65.6 132.45 94.99 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.672 0.749 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.539 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.79 -50.82 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.689 2.259 . . . . 0.0 112.329 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 69.1 m-80 -39.01 135.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -89.19 -25.95 21.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -85.19 41.39 0.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.8 p -129.55 152.82 80.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.582 0.706 . . . . 0.0 111.145 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 137.15 34.66 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.325 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.37 146.46 48.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.47 HD11 ' CD1' ' A' ' 83' ' ' ILE . 5.7 mt -120.95 156.21 32.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -121.62 120.25 34.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.563 HD22 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -127.43 163.65 23.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.423 ' CG ' ' HE3' ' A' ' 117' ' ' LYS . 49.5 mt-10 -124.59 120.99 33.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.563 ' CE2' HD22 ' A' ' 152' ' ' LEU . 39.2 m-85 -89.31 102.12 14.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -122.6 134.78 54.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.554 ' CH2' HD11 ' A' ' 11' ' ' LEU . 15.7 m95 -120.89 98.01 5.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.597 ' CG ' ' N ' ' A' ' 158' ' ' SER . 12.4 p90 -79.53 -53.38 6.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.597 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 61.6 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.88 0.371 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.71 125.19 49.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.564 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 21.0 tp -88.42 142.44 27.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.422 ' HD2' ' CD1' ' A' ' 157' ' ' PHE . 7.7 ptm180 -149.34 127.56 12.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.9 mt -129.52 138.7 53.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.496 ' HD3' ' CE2' ' A' ' 63' ' ' TRP . 3.3 ttpm? -114.02 129.91 56.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mm -89.51 145.34 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.89 -72.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.1 p -169.72 174.8 5.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.99 156.74 34.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.519 HG23 ' CE2' ' A' ' 20' ' ' TYR . 9.8 t -127.1 163.19 24.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.519 ' CE2' HG23 ' A' ' 19' ' ' THR . 7.8 m-85 53.3 30.81 10.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.126 179.873 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.82 0.343 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.436 ' N ' ' HD3' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -83.34 -52.22 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -147.52 178.6 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.432 ' CG1' ' O ' ' A' ' 53' ' ' VAL . 6.9 pt -138.46 174.83 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -169.51 155.57 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.523 HG21 ' CZ2' ' A' ' 60' ' ' TRP . 58.1 t -111.6 140.28 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -113.42 127.53 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.5 p -123.67 169.73 11.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.54 135.54 1.97 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -81.9 146.51 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.515 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 44.8 m-85 -140.6 162.89 34.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.459 ' CB ' HD11 ' A' ' 44' ' ' LEU . 3.1 t-160 -132.65 94.3 3.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.53 -32.98 4.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.541 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.45 -30.52 0.29 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -91.44 152.64 43.84 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.679 0.752 . . . . 0.0 110.841 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 156.34 63.56 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.737 2.292 . . . . 0.0 112.343 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' N ' HD13 ' A' ' 44' ' ' LEU . 8.9 mp -106.22 -41.39 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.9 m -133.8 -67.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -173.42 171.96 3.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.34 144.51 32.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.461 HG13 ' CD1' ' A' ' 64' ' ' LEU . 43.2 t -110.76 140.24 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -120.73 144.01 48.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.7 p -94.85 159.68 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -49.92 172.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -100.98 131.79 46.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 1.5 m -136.02 152.17 75.07 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.592 0.71 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 140.18 41.93 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.0 p -50.03 -32.77 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 m -63.13 -31.29 72.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -133.32 81.43 55.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.738 . . . . 0.0 110.902 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 3.17 2.91 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.692 2.261 . . . . 0.0 112.343 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -61.42 106.74 0.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.523 ' CZ2' HG21 ' A' ' 33' ' ' VAL . 3.9 m-90 -90.68 -47.24 7.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 39.3 41.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' C ' ' HG3' ' A' ' 14' ' ' LYS . 5.3 tp10 -114.03 135.82 53.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.496 ' CE2' ' HD3' ' A' ' 14' ' ' LYS . 52.7 m95 -83.73 107.88 16.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.461 ' CD1' HG13 ' A' ' 48' ' ' VAL . 10.0 tp -95.2 121.02 36.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.84 140.12 31.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -107.39 125.43 51.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -78.05 45.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.0 164.17 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.59 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.62 124.86 48.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.947 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.559 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -51.89 -55.47 30.09 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.607 0.718 . . . . 0.0 111.134 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.59 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.5 Cg_endo -69.71 2.42 3.52 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.691 2.261 . . . . 0.0 112.401 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.488 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.6 t70 -123.04 -5.69 8.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.422 HD13 ' C ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -83.6 114.7 55.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.633 0.73 . . . . 0.0 110.939 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.413 ' N ' HD13 ' A' ' 73' ' ' LEU . 53.9 Cg_endo -69.7 136.04 32.14 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.694 2.263 . . . . 0.0 112.369 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.433 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -49.75 -44.34 48.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.64 -39.17 61.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.43 157.84 25.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -153.02 177.56 10.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -93.77 139.38 30.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.9 m -129.74 145.94 51.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.87 136.83 14.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.7 m -143.84 139.58 29.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.453 ' CG1' HD12 ' A' ' 150' ' ' LEU . 59.5 mt -88.76 146.84 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.15 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 81.3 m -146.18 153.56 40.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.8 m -114.72 122.3 46.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.65 127.53 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 29' ' ' ASP . 21.9 tptm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -126.98 134.29 50.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -107.71 125.39 51.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.3 t -129.25 125.89 22.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.719 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 152.23 69.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.643 2.229 . . . . 0.0 112.352 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.2 mt -123.91 -49.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.73 174.25 11.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.464 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 68.6 p-90 -151.18 134.33 15.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.918 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.8 133.11 5.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -120.48 130.68 54.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.432 HG12 ' CD2' ' A' ' 120' ' ' LEU . 14.6 mt -114.22 130.55 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 106' ' ' LEU . 40.5 m-20 -67.28 95.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.7 mt -34.81 -43.15 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.433 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 77.8 m-85 -107.24 111.05 23.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 34.6 p30 -52.19 -177.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.876 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -56.49 -37.88 70.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.436 ' O ' ' C ' ' A' ' 111' ' ' ASP . 8.9 t -88.73 34.7 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.138 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 110' ' ' THR . 6.7 m-20 35.62 54.75 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 113' ' ' LEU . 98.1 m -134.28 109.29 8.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.172 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 112' ' ' THR . 56.7 mt -34.36 138.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.526 HG22 ' CZ ' ' A' ' 154' ' ' PHE . 12.8 m -68.02 165.49 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 p -159.73 162.86 35.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.1 142.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.424 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 7.8 ttpt -47.21 148.71 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.7 ttp -156.1 151.94 27.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.3 132.56 29.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.432 ' CD2' HG12 ' A' ' 104' ' ' ILE . 3.6 pp -141.16 154.41 45.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.35 152.13 39.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 mt -111.45 141.35 45.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.464 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 23.5 m95 -75.88 152.01 84.55 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.53 0.681 . . . . 0.0 110.925 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 154.0 68.46 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.3 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.628 0.727 . . . . 0.0 111.12 179.886 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.807 0.337 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.8 tp -80.42 135.83 36.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -106.11 91.27 5.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.616 0.722 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.515 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.2 Cg_endo -69.73 -44.81 1.88 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.237 . . . . 0.0 112.366 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 137' ' ' GLY . 44.3 mt -67.61 -28.38 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -36.65 149.13 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.502 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -51.73 168.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 111.155 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.454 HG22 ' CZ ' ' A' ' 78' ' ' ARG . 12.7 p -115.14 168.14 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.78 -168.81 30.65 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.451 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.8 p -96.14 148.53 22.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.893 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 142' ' ' ASN . 0.4 OUTLIER -84.45 138.72 38.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.62 0.724 . . . . 0.0 110.88 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -48.2 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.252 . . . . 0.0 112.383 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -40.74 142.14 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -98.2 -31.72 11.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -82.16 40.39 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.0 p -124.21 151.96 66.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.583 0.706 . . . . 0.0 111.115 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 117.23 4.96 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.67 2.247 . . . . 0.0 112.311 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 13.4 t -105.68 137.78 42.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.453 HD12 ' CG1' ' A' ' 83' ' ' ILE . 3.4 mt -105.51 162.18 13.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.424 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 27.5 tt0 -129.81 112.43 13.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.569 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -118.35 162.87 17.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.457 ' N ' HD21 ' A' ' 152' ' ' LEU . 14.9 mt-10 -118.74 119.1 33.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.526 ' CZ ' HG22 ' A' ' 114' ' ' VAL . 50.2 m-85 -87.58 107.46 18.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.26 155.56 48.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.564 ' CZ3' HD13 ' A' ' 11' ' ' LEU . 4.9 m95 -142.48 120.32 11.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.515 ' CG ' ' N ' ' A' ' 158' ' ' SER . 10.1 p90 -110.28 -47.83 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.515 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 8.6 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.871 0.367 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.14 151.21 38.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.086 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.526 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 14.3 tp -110.79 138.95 46.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -148.34 140.07 23.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.466 ' CD1' HD22 ' A' ' 79' ' ' LEU . 85.0 mt -135.93 137.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.159 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttt -110.71 120.81 43.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.6 mm -82.42 141.11 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.26 -72.29 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -172.07 176.79 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.7 163.07 20.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.2 t -134.78 163.39 29.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 39.54 44.6 1.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.3 mt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.835 0.35 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.418 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 21.5 t0 -72.98 -60.56 2.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.418 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 26.3 mmtp -147.91 166.56 27.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 pt -119.44 169.9 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.505 ' CZ ' ' SG ' ' A' ' 84' ' ' CYS . 6.3 p90 -163.82 144.56 8.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.568 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 63.2 t -103.03 143.92 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.423 ' N ' HG12 ' A' ' 33' ' ' VAL . 52.3 ttm-85 -121.03 122.25 39.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.6 p -116.1 166.91 11.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.73 149.42 6.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.59 134.89 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 111.148 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.463 ' CD2' ' HA ' ' A' ' 43' ' ' PRO . 47.7 m-85 -133.72 158.33 43.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.466 ' C ' ' CD2' ' A' ' 39' ' ' HIS . 6.9 t-160 -131.85 103.37 6.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.858 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.94 17.15 78.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.483 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.5 -35.48 4.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.457 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.33 142.88 59.17 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.668 0.747 . . . . 0.0 110.885 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.463 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.77 166.02 29.02 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.689 2.259 . . . . 0.0 112.338 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mp -124.89 -41.25 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.0 m -154.39 160.06 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -41.36 151.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -88.82 165.48 14.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.459 HG11 ' CD1' ' A' ' 64' ' ' LEU . 64.2 t -119.96 133.59 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -115.38 138.2 51.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.416 HG23 ' NE1' ' A' ' 60' ' ' TRP . 15.2 t -90.37 159.12 16.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -49.67 174.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -101.89 133.48 46.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -137.36 152.11 72.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.641 0.734 . . . . 0.0 111.164 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 134.23 27.4 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.353 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.6 p -45.48 -44.93 12.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.866 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.8 t -48.66 -40.58 28.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -130.32 86.65 53.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.533 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.3 Cg_endo -69.8 2.97 3.07 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.746 2.297 . . . . 0.0 112.298 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -50.8 109.55 0.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.568 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 1.5 m-90 -99.54 -47.62 5.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 60' ' ' TRP . 3.9 p30 35.25 41.05 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.839 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.12 138.19 50.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -83.05 112.33 19.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.459 ' CD1' HG11 ' A' ' 48' ' ' VAL . 11.1 tp -97.15 119.25 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -93.07 140.13 29.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -112.47 128.71 56.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -82.21 40.5 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.0 pp -106.93 164.01 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.595 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.0 127.02 53.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -60.01 -54.46 55.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.663 0.744 . . . . 0.0 111.165 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.595 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.74 3.49 2.73 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 0.0 112.355 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.7 t70 -125.46 -7.12 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.417 HD11 ' C ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -82.12 115.72 59.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.608 0.718 . . . . 0.0 110.926 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 132.75 23.96 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.322 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 1.6 mpp_? -47.63 -43.62 26.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.38 58.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.58 167.12 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.1 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -162.21 170.87 18.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.466 HD22 ' CD1' ' A' ' 13' ' ' ILE . 49.3 tp -94.64 133.73 37.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 33.6 m -120.26 150.33 40.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.69 137.17 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 86.5 p -143.61 133.27 23.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.46 ' CG1' HD13 ' A' ' 150' ' ' LEU . 71.7 mt -84.69 140.78 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.505 ' SG ' ' CZ ' ' A' ' 32' ' ' TYR . 1.4 p -151.18 160.24 43.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.3 p -117.23 156.48 27.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.445 HG22 ' CD2' ' A' ' 96' ' ' HIS . 14.8 p -133.77 122.39 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.163 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.0 tptt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.908 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.828 0.347 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -122.57 126.08 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.445 ' CD2' HG22 ' A' ' 86' ' ' VAL . 7.1 m170 -99.59 134.74 42.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.0 t -135.65 120.31 13.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.611 0.72 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 142.01 46.65 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.664 2.243 . . . . 0.0 112.338 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.8 mt -111.65 -55.65 2.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.02 176.52 8.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.074 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.489 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 61.9 p-90 -152.76 145.09 23.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -151.83 139.78 7.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -117.83 150.3 39.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.784 0.326 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.0 mt -138.27 117.91 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 106' ' ' LEU . 12.4 m120 -62.41 96.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.0 mt -35.15 -40.5 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 98.1 m-85 -108.56 115.37 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -55.64 -176.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.475 ' CD1' HG23 ' A' ' 110' ' ' THR . 13.2 p90 -68.41 -4.41 14.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.475 HG23 ' CD1' ' A' ' 109' ' ' TYR . 10.0 p -109.36 22.47 15.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.154 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 110' ' ' THR . 6.0 p-10 46.61 54.43 8.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.3 m -149.9 120.83 7.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.8 mt -40.32 140.81 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.481 HG22 ' CE2' ' A' ' 154' ' ' PHE . 20.3 m -71.3 169.82 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.081 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.6 p -162.86 161.18 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.45 132.73 0.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.415 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 15.6 ttpt -39.63 148.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.738 0.304 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.9 ttp -156.2 149.22 24.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.7 113.66 8.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.89 157.81 29.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -77.67 154.51 32.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.449 ' CD1' HD11 ' A' ' 83' ' ' ILE . 4.4 mt -114.06 134.12 55.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.489 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 10.7 m95 -74.57 147.37 84.63 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.567 0.699 . . . . 0.0 110.935 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 133.93 26.88 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.251 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.7 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 179.913 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.1 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.784 0.326 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.7 tp -105.59 131.72 52.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -110.3 91.81 12.35 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.647 0.737 . . . . 0.0 110.902 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.435 ' HB3' ' CD1' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.79 -28.36 25.2 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.656 2.237 . . . . 0.0 112.335 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.2 mm -77.21 -23.58 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.416 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -36.5 147.77 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.32 174.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 111.159 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 42.2 p -117.28 172.47 7.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.163 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.33 169.63 42.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.529 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.4 p -87.68 135.99 33.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 110.833 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -76.2 122.36 86.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.657 0.742 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -1.33 8.25 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.677 2.252 . . . . 0.0 112.365 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -82.62 129.05 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -84.39 -53.53 5.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -40.6 -35.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.7 p -69.39 151.37 96.85 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 160.1 50.96 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.731 2.287 . . . . 0.0 112.348 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 14.5 t -140.09 136.4 33.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.46 HD13 ' CG1' ' A' ' 83' ' ' ILE . 8.7 mt -106.47 152.18 23.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.411 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 14.8 tt0 -120.71 115.66 23.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.572 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -121.06 159.42 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.958 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.415 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 63.5 mt-10 -116.09 122.55 45.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.481 ' CE2' HG22 ' A' ' 114' ' ' VAL . 28.9 m-85 -90.82 112.53 24.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.553 ' C ' ' CD1' ' A' ' 156' ' ' TRP . 6.6 t0 -132.61 159.07 40.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.553 ' CD1' ' C ' ' A' ' 155' ' ' ASP . 3.6 m95 -152.17 108.18 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.498 ' CG ' ' N ' ' A' ' 158' ' ' SER . 31.5 p90 -102.22 -53.76 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.498 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 16.1 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.62 133.62 54.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.566 HD12 ' CZ3' ' A' ' 156' ' ' TRP . 15.8 tp -83.53 126.96 33.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.575 ' NE ' ' CE3' ' A' ' 63' ' ' TRP . 7.0 ttt180 -124.64 120.38 31.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 mt -131.14 141.07 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 34.8 tttt -122.26 128.66 51.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.0 mm -89.76 149.27 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.47 -70.63 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 p -172.45 -176.82 1.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.951 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.61 146.07 50.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 t -120.15 138.09 53.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 67.11 45.25 1.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.934 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 29' ' ' ASP . 18.7 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.861 0.363 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.456 ' N ' HG22 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -80.52 -57.4 3.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -147.47 -178.7 6.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 53' ' ' VAL . 7.2 pt -139.86 178.02 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 1.2 p90 -173.22 156.61 3.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.562 HG21 ' CZ2' ' A' ' 60' ' ' TRP . 87.3 t -113.75 149.7 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.121 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -122.35 132.78 54.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.1 p -128.52 162.02 28.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.44 143.32 3.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.442 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.72 140.82 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.37 . . . . 0.0 111.136 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.511 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 54.1 m-85 -136.4 145.28 45.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.458 ' CB ' HD13 ' A' ' 44' ' ' LEU . 4.5 t-160 -117.56 94.55 4.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.94 20.95 77.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.15 -26.84 19.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -85.02 141.89 38.11 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.623 0.725 . . . . 0.0 110.85 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 159.87 51.82 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.704 2.269 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.458 HD13 ' CB ' ' A' ' 39' ' ' HIS . 8.9 mp -120.64 -33.54 3.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.94 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.2 m -154.06 165.79 35.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.64 131.29 29.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.815 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -65.65 153.1 42.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.16 140.34 35.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -121.74 137.75 54.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.1 p -83.88 176.35 8.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -63.99 174.7 1.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -102.43 125.98 49.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.428 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 1.4 m -130.28 152.14 79.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.619 0.723 . . . . 0.0 111.101 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 142.28 47.46 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.689 2.259 . . . . 0.0 112.347 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 23.4 p -50.58 -48.16 57.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.8 t -47.34 -38.52 13.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -132.03 87.29 44.63 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.552 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.5 Cg_endo -69.78 3.66 2.65 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.709 2.272 . . . . 0.0 112.312 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -55.64 108.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.562 ' CZ2' HG21 ' A' ' 33' ' ' VAL . 2.3 m-90 -93.56 -52.95 4.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 43.31 49.75 5.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -121.19 138.09 54.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.575 ' CE3' ' NE ' ' A' ' 12' ' ' ARG . 77.8 m95 -84.09 108.39 16.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 tp -98.2 122.68 41.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -100.87 145.25 28.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -113.5 131.02 56.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -82.71 47.61 1.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.26 168.13 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -115.07 129.86 56.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.594 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -62.84 -53.63 54.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 111.164 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.1 Cg_endo -69.69 -0.95 7.59 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.362 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.5 t70 -117.64 -13.47 10.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.6 114.97 32.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.556 0.693 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 146.37 59.82 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.637 2.225 . . . . 0.0 112.353 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.445 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 21.1 mmt85 -59.22 -41.84 89.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.64 -31.41 62.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.77 167.35 15.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.097 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -163.23 173.73 13.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.5 tp -95.37 142.8 27.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.0 m -129.82 148.52 51.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.32 137.08 14.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 95.3 p -148.92 146.22 27.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.4 mt -93.16 143.37 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.176 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 74.7 m -137.85 145.78 42.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.8 p -109.76 122.56 47.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.443 HG21 ' CD2' ' A' ' 96' ' ' HIS . 12.0 p -105.79 121.63 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.7 tttm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.925 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 9.9 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.776 0.322 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -126.61 119.16 26.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.443 ' CD2' HG21 ' A' ' 86' ' ' VAL . 8.1 m170 -98.77 124.16 43.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.74 123.21 15.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.866 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 143.03 49.42 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.662 2.241 . . . . 0.0 112.351 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.0 mt -107.63 -45.8 3.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.38 178.18 7.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.503 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 70.0 p-90 -154.33 137.89 15.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.03 138.5 7.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.473 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -122.25 140.55 52.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.465 ' CG1' HD22 ' A' ' 120' ' ' LEU . 56.5 mt -120.97 139.69 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.46 ' N ' HG22 ' A' ' 104' ' ' ILE . 77.7 m-20 -76.69 87.91 3.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 105' ' ' ASN . 21.9 mt -34.49 -36.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 59.0 m-85 -109.67 119.34 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -53.1 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.85 6.47 5.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 p -128.76 18.19 6.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.181 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 65.06 29.84 11.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 113' ' ' LEU . 88.2 m -118.68 105.76 11.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 112' ' ' THR . 31.4 mt -36.07 141.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.5 m -70.45 170.35 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.1 m -168.9 164.28 11.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.17 140.72 1.01 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.452 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 38.3 tttt -44.6 149.15 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.783 0.325 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.4 ttp -159.89 154.03 23.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.95 126.67 20.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.465 HD22 ' CG1' ' A' ' 104' ' ' ILE . 4.1 pp -136.15 153.78 51.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -79.25 158.52 27.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.455 ' CD1' HD11 ' A' ' 150' ' ' LEU . 1.9 mt -116.4 148.09 41.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.566 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 8.1 m95 -85.51 150.53 54.22 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.571 0.7 . . . . 0.0 110.944 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 138.82 38.71 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.663 2.242 . . . . 0.0 112.391 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.625 0.726 . . . . 0.0 111.124 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.867 0.365 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.8 tp -102.98 139.34 38.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -105.41 91.52 4.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.679 0.752 . . . . 0.0 110.87 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.511 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.9 Cg_endo -69.73 -22.76 31.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.723 2.282 . . . . 0.0 112.366 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.413 ' O ' ' C ' ' A' ' 137' ' ' GLY . 13.4 mm -82.69 -22.12 9.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -37.08 153.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.5 173.33 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 111.117 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.7 p -115.22 165.25 13.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 99.37 159.68 29.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.0 p -75.49 130.48 38.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.832 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.566 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 11.2 t-20 -70.84 118.47 65.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.651 0.739 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 1.98 3.94 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.67 2.246 . . . . 0.0 112.392 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -90.59 116.43 28.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -76.85 -44.19 33.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -49.03 -26.97 2.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 67.9 p -78.82 152.24 77.26 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.558 0.694 . . . . 0.0 111.165 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 146.26 59.48 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.685 2.257 . . . . 0.0 112.363 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.7 t -123.79 148.92 46.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.455 HD11 ' CD1' ' A' ' 122' ' ' LEU . 5.9 mt -118.96 150.64 39.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -112.64 139.92 47.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.576 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -148.6 151.6 35.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.452 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 35.5 mt-10 -119.51 123.11 43.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.412 ' CE2' ' CD2' ' A' ' 152' ' ' LEU . 62.6 m-85 -85.97 115.06 23.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.09 129.15 49.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.566 ' CZ3' HD12 ' A' ' 11' ' ' LEU . 20.7 m95 -124.26 81.55 1.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.5 ' CG ' ' N ' ' A' ' 158' ' ' SER . 43.4 p90 -79.46 -54.47 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.5 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 3.0 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.409 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 1.8 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.822 0.344 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.01 140.36 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.6 tp -103.64 137.49 41.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.464 ' HD2' ' CZ3' ' A' ' 63' ' ' TRP . 16.3 ptt180 -145.41 138.37 26.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.843 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.4 mt -138.4 139.14 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -114.9 137.06 52.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.8 mm -98.59 144.82 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.71 -67.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.6 p -169.56 175.05 5.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.443 ' CB ' HD21 ' A' ' 150' ' ' LEU . . . -139.1 154.41 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.567 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.9 t -130.96 162.37 29.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.567 ' CD2' HG22 ' A' ' 19' ' ' THR . 10.0 m-85 64.44 50.13 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.833 0.349 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -73.96 -56.19 5.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -142.06 172.83 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 pt -141.54 161.11 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -151.38 153.57 35.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.493 HG21 ' CZ2' ' A' ' 60' ' ' TRP . 79.3 t -105.48 137.12 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -110.19 120.15 41.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 p -117.84 161.21 20.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.171 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.78 143.46 3.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.442 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.451 HG23 ' N ' ' A' ' 38' ' ' TYR . 3.9 mp -96.61 137.05 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 111.191 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.455 ' HA ' ' CD1' ' A' ' 44' ' ' LEU . 2.7 m-85 -128.52 150.18 50.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.957 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.537 ' CD2' ' HB3' ' A' ' 76' ' ' ALA . 9.3 t-160 -121.85 99.07 6.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.04 47.23 19.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.74 33.83 81.47 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -146.64 143.69 19.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.68 0.752 . . . . 0.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 150.17 68.27 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.72 2.28 . . . . 0.0 112.365 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.455 ' CD1' ' HA ' ' A' ' 38' ' ' TYR . 7.8 mp -105.69 -39.37 6.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.889 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.0 t -156.28 166.13 34.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.24 124.73 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -61.01 154.09 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' A' ' 64' ' ' LEU . 61.6 t -110.26 137.4 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -119.27 147.91 43.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.5 p -96.18 167.25 11.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -54.15 176.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -105.49 108.98 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -114.26 152.39 45.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.626 0.727 . . . . 0.0 111.128 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 135.65 31.11 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.733 2.289 . . . . 0.0 112.36 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 19.3 p -45.98 -47.26 16.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.2 m -51.27 -30.21 17.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -133.8 87.78 34.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.619 0.723 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.548 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 2.94 3.09 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.681 2.254 . . . . 0.0 112.333 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -58.47 103.84 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.548 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.3 m-90 -90.71 -46.76 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 60' ' ' TRP . 2.9 p30 39.23 46.99 1.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -120.95 135.86 55.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.464 ' CZ3' ' HD2' ' A' ' 12' ' ' ARG . 45.7 m95 -81.35 103.55 11.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.432 ' CD1' HG13 ' A' ' 48' ' ' VAL . 10.4 tp -90.68 121.44 32.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -101.0 133.37 45.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -100.99 131.68 46.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.2 41.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.828 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.451 HD13 ' N ' ' A' ' 69' ' ' TYR . 1.7 pp -112.45 161.89 10.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.585 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -113.54 121.96 45.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -53.42 -54.15 48.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.595 0.712 . . . . 0.0 111.104 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.4 Cg_endo -69.7 3.49 2.71 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.677 2.252 . . . . 0.0 112.396 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.484 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 9.5 t0 -125.22 -4.49 7.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.918 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.1 113.61 29.59 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HG2' ' CB ' ' A' ' 77' ' ' ALA . 54.4 Cg_endo -69.77 132.05 22.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.704 2.27 . . . . 0.0 112.336 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.478 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 11.6 mpt_? -45.46 -42.07 10.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.537 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . . . -56.04 -43.75 78.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.066 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.42 ' CB ' ' HG2' ' A' ' 74' ' ' PRO . . . -55.6 165.02 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.083 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -163.28 173.42 13.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 tp -93.82 138.31 32.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.2 m -136.23 126.4 26.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.16 161.24 33.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 p -166.53 131.9 2.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.8 mt -83.91 144.44 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 62.0 m -147.81 155.04 41.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 t -105.89 150.72 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.93 125.2 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.1 tptp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.929 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.814 0.34 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -130.21 125.92 36.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -103.46 129.21 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.1 t -137.49 123.78 13.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 152.96 69.27 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.673 2.249 . . . . 0.0 112.333 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.0 mt -126.37 -51.13 1.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.41 -177.58 5.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.491 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 67.5 p-90 -164.44 126.04 2.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.94 131.42 6.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.402 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -106.85 129.73 54.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 110.861 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.422 ' CD1' HD21 ' A' ' 120' ' ' LEU . 76.2 mt -119.34 119.27 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 106' ' ' LEU . 3.0 t-20 -73.25 94.57 2.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 105' ' ' ASN . 41.6 mt -35.14 -35.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.478 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 51.3 m-85 -104.39 106.5 17.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.906 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.43 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 42.5 p30 -54.93 -177.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -57.12 -39.19 74.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -86.9 32.14 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.14 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 37.78 54.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.7 m -132.77 116.64 16.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.418 HD22 ' CH2' ' A' ' 156' ' ' TRP . 11.9 mt -44.56 126.62 5.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.541 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 16.3 m -57.51 176.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.9 p -173.83 164.11 4.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.18 149.18 0.2 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.434 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 7.5 ttpt -39.55 158.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.478 ' HG2' ' N ' ' A' ' 119' ' ' ALA . 2.8 ttm -156.62 144.96 19.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.478 ' N ' ' HG2' ' A' ' 118' ' ' MET . . . -140.35 106.96 5.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.083 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.422 HD21 ' CD1' ' A' ' 104' ' ' ILE . 4.1 pp -126.35 163.53 23.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -92.31 158.53 16.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.59 156.08 23.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.566 ' CE3' ' OD1' ' A' ' 142' ' ' ASN . 28.0 m95 -86.57 150.64 51.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.538 0.685 . . . . 0.0 110.924 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 145.92 58.44 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.699 2.266 . . . . 0.0 112.309 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 111.121 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.863 0.364 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.3 tp -84.8 127.53 34.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -104.38 93.53 5.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 110.83 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.414 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.6 Cg_endo -69.74 -17.14 37.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.664 2.243 . . . . 0.0 112.372 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 mm -84.88 -23.15 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.478 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -38.74 151.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.13 163.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.1 p -108.44 151.75 25.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.62 142.84 8.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.5 p -63.11 116.66 5.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.566 ' OD1' ' CE3' ' A' ' 123' ' ' TRP . 32.7 t30 -53.64 130.01 54.8 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.572 0.701 . . . . 0.0 110.93 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -27.03 27.06 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.694 2.263 . . . . 0.0 112.317 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -51.72 144.4 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt -99.53 -37.03 9.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -83.26 39.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.2 p -122.85 156.05 62.67 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.57 0.7 . . . . 0.0 111.127 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 124.65 11.28 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.704 2.269 . . . . 0.0 112.344 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 p -115.92 150.69 36.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.443 HD21 ' CB ' ' A' ' 18' ' ' ALA . 7.4 mt -128.18 135.3 49.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.96 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.411 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 10.1 tt0 -102.49 125.11 49.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.569 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -127.72 169.36 13.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.434 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 26.1 mt-10 -126.4 125.38 42.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.563 ' CE2' HD22 ' A' ' 152' ' ' LEU . 45.0 m-85 -92.1 119.51 31.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -137.39 137.53 38.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.418 ' CH2' HD22 ' A' ' 113' ' ' LEU . 11.6 m95 -127.84 82.45 2.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 158' ' ' SER . 22.0 p90 -85.75 -52.75 5.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.574 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 85.6 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.909 0.385 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.409 ' H ' ' CB ' ' A' ' 158' ' ' SER . . . -120.07 121.85 39.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.435 HD12 ' CZ3' ' A' ' 156' ' ' TRP . 22.2 tp -85.82 144.99 27.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.61 ' NH2' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -135.71 146.93 48.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.402 HG13 ' C ' ' A' ' 12' ' ' ARG . 54.4 mt -145.52 121.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.563 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 73.8 tttt -103.58 131.37 50.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mm -94.07 137.59 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.12 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.23 -72.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.4 p -172.01 172.68 4.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.893 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.15 142.33 48.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.035 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.514 HG22 ' CD2' ' A' ' 20' ' ' TYR . 10.9 t -111.57 136.2 51.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.514 ' CD2' HG22 ' A' ' 19' ' ' THR . 2.6 m-85 65.67 32.94 8.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.076 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.811 0.339 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.424 ' C ' ' HD2' ' A' ' 30' ' ' LYS . 7.4 t70 -115.02 -53.0 2.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.43 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -108.1 155.92 19.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.1 pt -141.55 170.34 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CE2' ' ND1' ' A' ' 96' ' ' HIS . 9.6 p90 -163.96 154.44 15.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.566 HG21 ' CZ2' ' A' ' 60' ' ' TRP . 61.7 t -117.71 137.89 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.434 ' N ' HG13 ' A' ' 33' ' ' VAL . 11.0 ttt180 -112.26 140.78 46.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.8 p -134.4 177.01 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.39 148.78 5.28 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.532 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.0 132.77 40.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 0.0 111.092 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 18.8 m-85 -126.47 150.05 48.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.467 ' CB ' HD11 ' A' ' 44' ' ' LEU . 8.4 t-160 -127.35 101.1 6.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.92 38.16 36.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.63 33.35 58.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -148.2 140.14 14.3 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.678 0.751 . . . . 0.0 110.845 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 149.22 67.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.681 2.254 . . . . 0.0 112.335 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.467 HD11 ' CB ' ' A' ' 39' ' ' HIS . 11.0 mp -102.1 -42.85 5.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 t -147.22 170.72 16.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -47.54 126.85 10.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -61.01 160.15 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.455 HG13 ' CD1' ' A' ' 64' ' ' LEU . 48.5 t -122.57 136.19 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -120.63 146.09 46.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -89.42 171.85 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.116 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -56.56 169.27 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -101.1 110.63 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.526 HG11 ' CD1' ' A' ' 60' ' ' TRP . 1.4 m -112.1 152.13 44.13 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.65 0.738 . . . . 0.0 111.109 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 142.06 47.09 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.698 2.265 . . . . 0.0 112.331 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.7 p -50.63 -42.71 56.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.6 p -60.04 -29.12 68.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -131.36 84.22 57.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.617 0.723 . . . . 0.0 110.921 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 4.27 2.29 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.309 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -61.3 112.06 2.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.566 ' CZ2' HG21 ' A' ' 33' ' ' VAL . 5.0 m-90 -95.46 -65.36 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 55.31 45.51 25.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -120.08 136.54 54.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.568 ' CZ3' ' HD2' ' A' ' 12' ' ' ARG . 71.3 m95 -83.55 98.87 9.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.921 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.455 ' CD1' HG13 ' A' ' 48' ' ' VAL . 11.2 tp -86.95 109.76 19.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -91.22 145.12 24.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -111.08 134.04 52.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.66 50.86 2.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.914 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.416 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.2 pp -117.42 165.7 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.609 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.0 120.36 38.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.1 mp -51.45 -53.8 45.85 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 0.0 111.142 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.609 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.81 3.56 2.73 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.26 . . . . 0.0 112.342 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.491 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 6.0 t70 -124.1 -8.43 7.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.486 ' CD1' ' HB1' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -82.59 110.44 22.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.658 0.742 . . . . 0.0 110.915 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 139.52 40.43 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.661 2.24 . . . . 0.0 112.377 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.529 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 1.8 mpp_? -50.16 -37.8 36.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.81 -48.45 66.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.116 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.486 ' HB1' ' CD1' ' A' ' 73' ' ' LEU . . . -58.83 155.05 13.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -150.23 171.22 17.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.8 tp -94.23 137.62 33.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.1 m -136.54 142.8 43.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.29 156.95 44.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.5 m -156.44 135.54 12.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.0 mt -84.74 137.67 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 54.3 m -130.25 170.11 14.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.5 p -123.71 126.57 46.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.3 p -118.09 120.73 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.163 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.4 tptm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 179.916 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.846 0.355 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -134.83 116.69 15.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.462 ' ND1' ' CE2' ' A' ' 32' ' ' TYR . 11.8 m170 -97.83 130.37 44.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.23 131.76 12.25 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.629 0.728 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 147.32 62.51 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.703 2.269 . . . . 0.0 112.353 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.5 mt -122.13 -56.91 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.88 177.36 7.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.499 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 65.7 p-90 -155.65 123.18 5.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.58 135.24 7.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -114.85 162.37 16.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 88.2 mt -147.12 118.47 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' LEU . 26.0 m-80 -59.21 92.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 105' ' ' ASN . 10.7 mt -36.06 -42.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 97.5 m-85 -104.09 108.42 19.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 44.2 p30 -53.13 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.425 ' CE1' ' HB ' ' A' ' 110' ' ' THR . 34.3 p90 -55.43 -40.39 71.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.425 ' HB ' ' CE1' ' A' ' 109' ' ' TYR . 10.0 t -86.22 33.31 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.5 OUTLIER 37.18 49.9 0.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 89.7 m -130.53 110.45 11.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.548 ' HB3' ' CZ2' ' A' ' 156' ' ' TRP . 36.7 mt -34.78 138.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.5 m -69.86 172.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.2 p -168.94 159.41 9.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.69 145.32 2.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.455 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -43.12 151.15 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.3 ttp -159.48 146.68 16.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.76 122.3 16.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 120' ' ' LEU . 3.9 pp -133.89 158.37 43.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -78.39 158.17 28.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.1 mt -120.35 142.27 49.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.642 ' CE3' ' ND2' ' A' ' 142' ' ' ASN . 6.4 m95 -83.5 142.93 43.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.564 0.697 . . . . 0.0 110.904 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 131.13 20.65 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.235 . . . . 0.0 112.377 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.662 0.744 . . . . 0.0 111.098 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.877 0.37 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.7 tp -96.19 139.83 31.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.408 ' ND2' ' CA ' ' A' ' 137' ' ' GLY . 64.2 t30 -107.04 91.63 6.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.587 0.708 . . . . 0.0 110.923 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.5 Cg_endo -69.73 -37.38 9.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.673 2.249 . . . . 0.0 112.337 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 36.1 mt -73.96 -22.62 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.408 ' CA ' ' ND2' ' A' ' 134' ' ' ASN . . . -40.59 144.7 0.5 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 m -50.43 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.114 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 67.1 p -127.14 165.36 19.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.83 176.49 35.2 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 90.9 p -88.12 149.52 23.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.884 0.373 . . . . 0.0 110.848 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.642 ' ND2' ' CE3' ' A' ' 123' ' ' TRP . 60.5 t-20 -90.57 124.79 61.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.893 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.441 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.73 2.85 3.15 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.661 2.241 . . . . 0.0 112.339 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -85.24 130.92 34.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -89.2 -52.96 4.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -48.55 -24.54 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.882 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.4 p -74.01 151.87 88.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.567 0.698 . . . . 0.0 111.171 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 140.53 43.06 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.692 2.261 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.7 t -123.11 135.5 54.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.4 mt -105.18 139.8 39.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.87 123.68 49.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.552 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -135.44 165.04 26.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.438 ' N ' HD23 ' A' ' 152' ' ' LEU . 51.5 mt-10 -124.25 141.62 51.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.407 ' CE2' HD22 ' A' ' 152' ' ' LEU . 51.1 m-85 -104.58 136.78 43.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.41 ' HB3' ' CG ' ' A' ' 12' ' ' ARG . 1.5 t70 -152.5 147.62 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.548 ' CZ2' ' HB3' ' A' ' 113' ' ' LEU . 7.1 m95 -134.26 89.36 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.61 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 9.3 p90 -87.36 -52.26 5.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.591 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 2.7 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.843 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.6 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.877 0.37 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.93 142.28 47.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 27.4 tp -104.35 142.76 34.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HD2' ' CD1' ' A' ' 157' ' ' PHE . 2.2 ptm85 -148.64 128.15 13.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 mt -129.35 136.38 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 63' ' ' TRP . 67.4 tttt -109.55 125.99 53.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 mm -91.34 141.2 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.61 -74.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.7 p -167.83 178.42 5.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.24 166.89 16.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -135.68 159.09 42.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 41.09 53.51 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.107 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.0 mt . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.854 0.359 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.68 -58.29 2.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -143.81 176.7 9.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -136.63 168.37 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -163.08 152.37 15.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.444 ' CG2' ' CH2' ' A' ' 60' ' ' TRP . 94.9 t -97.92 142.72 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.138 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.41 ' NH2' ' OD1' ' A' ' 47' ' ' ASN . 49.2 ttt85 -119.57 117.33 28.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.7 p -114.69 170.85 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.87 139.11 2.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mp -92.01 138.6 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.145 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.51 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 27.6 m-85 -130.63 164.45 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -133.85 95.29 3.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.845 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.51 -11.97 53.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 135.66 -6.23 4.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -110.45 146.5 34.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 160.26 50.36 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 mp -120.02 -33.81 3.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.8 m -151.63 169.35 22.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -53.37 136.42 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.41 ' OD1' ' NH2' ' A' ' 34' ' ' ARG . 31.8 m120 -74.53 158.01 34.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.3 t -116.82 139.22 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.72 142.39 49.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.5 p -89.29 160.83 16.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -52.24 165.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -93.27 119.92 32.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -120.32 152.14 54.48 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.635 0.731 . . . . 0.0 111.077 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 133.07 24.75 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.7 2.267 . . . . 0.0 112.35 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.7 p -44.09 -48.58 9.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -47.81 -34.34 8.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -134.51 86.88 33.62 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.72 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 3.23 2.92 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.673 2.248 . . . . 0.0 112.328 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -55.22 118.19 4.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.444 ' CH2' ' CG2' ' A' ' 33' ' ' VAL . 2.6 m-90 -101.17 -52.33 3.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 43.83 41.25 3.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -120.82 137.7 54.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.518 ' CD2' ' HB2' ' A' ' 14' ' ' LYS . 59.3 m95 -82.27 109.97 17.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.916 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.5 tp -92.03 120.15 32.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.928 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -97.84 136.26 38.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -107.58 127.29 53.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.34 43.69 0.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.422 HD11 ' C ' ' A' ' 68' ' ' ILE . 2.2 pp -107.32 166.06 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.57 125.29 49.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.589 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -58.77 -53.92 61.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.641 0.734 . . . . 0.0 111.13 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.6 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.9 Cg_endo -69.75 3.04 3.0 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.486 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 6.2 t70 -124.77 -2.32 7.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.69 113.13 53.01 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.665 0.745 . . . . 0.0 110.918 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 132.77 23.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.5 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -46.61 -42.23 15.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.65 -40.88 60.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.139 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.08 168.17 3.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -159.21 173.44 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.409 ' HG ' ' CD2' ' A' ' 81' ' ' LEU . 53.3 tp -95.65 134.8 38.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.3 m -127.18 147.37 50.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.409 ' CD2' ' HG ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -155.55 139.92 16.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 t -145.63 140.82 27.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mt -83.99 124.9 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 67.2 m -124.21 145.23 49.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 p -106.07 128.57 53.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG22 ' NE2' ' A' ' 96' ' ' HIS . 10.4 p -108.57 126.55 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.191 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -128.69 127.96 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.402 ' NE2' HG22 ' A' ' 86' ' ' VAL . 15.3 m170 -107.9 132.89 52.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.5 t -137.42 132.71 17.85 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.605 0.717 . . . . 0.0 110.851 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 153.04 69.3 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.699 2.266 . . . . 0.0 112.354 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.8 mt -128.28 -35.57 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.44 155.63 24.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.51 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 59.4 p-90 -132.21 134.68 45.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.35 121.63 2.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -108.34 133.35 52.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.879 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 105' ' ' ASN . 18.9 mt -118.21 140.38 41.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.442 ' N ' HG22 ' A' ' 104' ' ' ILE . 49.0 m-80 -70.67 85.87 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 105' ' ' ASN . 12.4 mt -34.9 -35.25 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 83.3 m-85 -112.93 123.05 49.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.898 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -51.07 -176.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.56 12.32 3.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 p -130.35 14.21 5.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 70.61 34.38 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.7 m -128.49 109.21 11.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 mt -38.58 149.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.2 m -72.56 178.08 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.143 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.4 p -174.01 156.18 2.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.44 170.11 45.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.427 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 32.5 tttt -71.05 148.7 47.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.733 0.302 . . . . 0.0 110.92 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.7 ttp -156.51 149.76 24.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.47 115.46 10.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.409 ' CD2' HG12 ' A' ' 104' ' ' ILE . 3.6 pp -128.86 155.97 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.03 153.84 28.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.462 ' CD1' HD13 ' A' ' 150' ' ' LEU . 7.7 mt -109.91 158.17 18.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.51 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 13.2 m95 -95.24 139.95 22.22 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 129.02 16.88 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.714 2.276 . . . . 0.0 112.347 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.631 0.729 . . . . 0.0 111.127 179.935 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.906 0.384 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.7 tp -106.16 142.88 35.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -105.41 91.33 4.71 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.51 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.1 Cg_endo -69.72 -43.85 2.45 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.0 112.336 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.0 mt -70.62 -19.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.412 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -41.34 146.15 0.5 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 m -56.02 179.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.15 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.5 p -123.57 179.24 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.37 169.03 44.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.447 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 87.2 p -85.76 131.85 34.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.867 0.365 . . . . 0.0 110.876 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 123' ' ' TRP . 64.8 t-20 -69.27 120.85 79.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.567 0.698 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.4 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.6 Cg_endo -69.74 -19.78 35.78 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.344 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -53.3 132.57 39.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -86.83 -35.03 19.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -84.35 39.69 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.5 p -130.98 156.38 80.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.593 0.711 . . . . 0.0 111.134 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 174.51 9.38 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.701 2.268 . . . . 0.0 112.343 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.5 t -159.7 134.57 7.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.462 HD13 ' CD1' ' A' ' 122' ' ' LEU . 3.3 mt -110.0 143.69 39.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.427 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 6.2 tt0 -111.03 127.7 55.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.518 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -137.79 156.19 48.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -113.89 117.81 32.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.518 ' CE2' HD21 ' A' ' 152' ' ' LEU . 29.3 m-85 -84.74 111.7 19.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.9 155.13 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -137.87 122.28 18.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.93 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 158' ' ' SER . 11.1 p90 -109.73 -44.99 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 10.6 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.867 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.424 ' C ' HD13 ' A' ' 70' ' ' ILE . 1.9 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.872 0.368 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 157' ' ' PHE . . . -98.87 130.94 45.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.083 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.411 HD13 ' CH2' ' A' ' 156' ' ' TRP . 15.8 tp -84.99 134.93 34.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -128.73 133.52 48.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.4 HD13 ' CE1' ' A' ' 66' ' ' TYR . 26.2 mt -139.04 128.74 31.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.197 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.537 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 16.2 tttp -110.25 130.19 55.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.1 mm -95.15 140.03 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.18 -74.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.6 p -167.09 -179.46 4.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.07 166.13 17.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.453 HG22 ' CD2' ' A' ' 20' ' ' TYR . 8.8 t -136.69 141.18 43.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.453 ' CD2' HG22 ' A' ' 19' ' ' THR . 17.0 m-85 60.71 50.1 5.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.142 179.947 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.454 ' CG2' ' HB2' ' A' ' 85' ' ' SER . 4.2 mp . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.813 0.34 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.07 -59.44 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -144.92 159.05 43.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 pt -116.57 179.51 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -173.02 149.23 1.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.526 HG21 ' CZ2' ' A' ' 60' ' ' TRP . 88.0 t -108.57 139.19 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -109.45 133.83 52.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.948 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.1 p -128.07 163.56 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.31 152.83 7.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.39 141.85 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 0.0 111.11 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.437 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 14.4 m-85 -132.55 142.93 49.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.457 ' C ' ' CD2' ' A' ' 39' ' ' HIS . 8.0 t-160 -120.81 94.35 4.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.42 37.16 36.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.66 -23.78 8.4 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -93.05 142.44 25.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.654 0.74 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 165.24 31.64 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.705 2.27 . . . . 0.0 112.356 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.456 HD13 ' N ' ' A' ' 39' ' ' HIS . 10.0 mp -125.77 -37.48 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 39.8 m -148.57 161.91 40.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.68 137.37 9.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -70.43 149.89 46.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.4 t -110.96 133.26 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -115.78 147.41 41.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.444 HG21 ' NE1' ' A' ' 60' ' ' TRP . 13.1 t -95.26 169.19 10.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.91 173.25 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -105.71 124.25 49.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.432 HG11 ' CD1' ' A' ' 60' ' ' TRP . 1.5 m -126.25 152.01 73.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.587 0.708 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 136.93 34.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.346 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.0 p -46.2 -46.15 17.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.3 t -50.33 -33.89 21.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -133.91 86.16 38.78 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.74 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.2 Cg_endo -69.8 4.35 2.26 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.704 2.269 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -58.06 107.29 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.576 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 1.9 m-90 -93.94 -49.82 5.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.5 p30 39.48 43.38 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -112.73 151.02 30.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.537 ' CE3' ' HB2' ' A' ' 14' ' ' LYS . 79.8 m95 -98.57 100.17 11.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.935 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 tp -88.31 118.61 28.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -98.82 145.83 26.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.4 ' CE1' HD13 ' A' ' 13' ' ' ILE . 5.2 m-85 -114.68 135.85 53.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -90.34 52.32 2.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.429 HD11 ' C ' ' A' ' 68' ' ' ILE . 2.4 pp -119.77 169.44 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.586 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -113.58 130.19 56.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -63.96 -52.8 53.93 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.668 0.747 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.9 Cg_endo -69.75 -3.74 12.61 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 8.3 t70 -114.39 -9.11 12.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.46 116.19 50.72 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.545 0.688 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 134.91 29.07 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.683 2.256 . . . . 0.0 112.337 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.574 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 20.7 mmm-85 -47.92 -44.52 29.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.54 -44.87 66.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.138 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.89 161.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -158.7 176.06 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.8 tp -96.71 133.17 41.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.8 m -127.76 133.3 49.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.32 152.1 41.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 96.0 p -157.48 146.49 19.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.7 mt -89.15 147.11 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 61.5 m -149.15 141.62 24.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.454 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 94.7 p -106.46 118.62 37.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.413 HG21 ' NE2' ' A' ' 96' ' ' HIS . 12.4 p -101.44 136.23 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.7 tptm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.796 0.332 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.84 116.43 22.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.446 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 6.4 m170 -95.87 149.71 21.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 t -153.71 120.54 2.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 0.0 110.851 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 144.77 54.93 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.649 2.233 . . . . 0.0 112.335 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.6 mt -115.53 -47.41 2.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.06 169.34 19.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.515 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 64.4 p-90 -147.9 132.89 18.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.9 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.28 120.48 2.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.504 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -100.25 139.37 36.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.76 0.314 . . . . 0.0 110.898 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.9 mt -131.09 120.94 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 106' ' ' LEU . 3.3 t-20 -67.11 95.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.7 mt -34.89 -39.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.574 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 63.6 m-85 -96.7 113.62 25.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -52.22 -176.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.84 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -65.27 -33.25 75.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.952 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -83.53 17.31 2.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 60.35 41.88 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.847 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.1 m -133.75 126.62 31.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.4 mt -47.17 144.57 2.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.562 HG22 ' CE2' ' A' ' 154' ' ' PHE . 34.6 m -76.79 -179.19 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.0 t -172.79 171.48 4.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.21 172.8 7.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 2.2 ttpm? -71.42 151.98 43.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.887 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 29.8 ttp -158.67 148.31 19.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.17 121.44 15.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.099 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.45 160.11 39.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -83.56 151.11 25.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.14 151.03 26.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.515 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 16.3 m95 -80.64 152.61 72.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.534 0.683 . . . . 0.0 110.925 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 168.2 22.32 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 68.6 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.592 0.711 . . . . 0.0 111.126 179.928 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.805 0.336 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.3 tp -88.89 132.99 34.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.438 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 9.6 t-20 -105.71 91.53 5.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.648 0.737 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.437 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.8 Cg_endo -69.76 -27.6 26.28 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.6 mm -80.88 -17.02 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.438 ' CA ' ' OD1' ' A' ' 134' ' ' ASN . . . -43.54 155.07 0.22 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.9 m -71.88 163.21 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.869 0.366 . . . . 0.0 111.126 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.3 p -106.04 157.42 17.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.87 159.97 14.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.525 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.1 p -83.55 108.25 16.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.84 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.506 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 14.3 t-20 -40.07 116.79 1.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.58 0.705 . . . . 0.0 110.841 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -8.41 23.53 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.655 2.237 . . . . 0.0 112.338 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -70.91 151.89 44.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -102.78 -24.53 13.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -85.94 29.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.0 p -124.41 153.03 69.09 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 111.148 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 154.19 68.08 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.722 2.281 . . . . 0.0 112.309 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.1 t -130.9 130.54 43.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.7 mt -109.21 135.95 49.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -105.39 124.78 50.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.514 HD22 ' CZ ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -134.46 159.63 40.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.459 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 54.8 mt-10 -116.77 134.78 54.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.562 ' CE2' HG22 ' A' ' 114' ' ' VAL . 47.7 m-85 -99.96 103.7 15.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -114.27 141.13 47.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.411 ' CH2' HD13 ' A' ' 11' ' ' LEU . 60.0 m95 -125.13 76.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 158' ' ' SER . 9.5 p90 -70.88 -49.05 50.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.68 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 47.2 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.851 0.358 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.31 131.34 55.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.071 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.566 HD11 ' CH2' ' A' ' 156' ' ' TRP . 13.5 tp -93.71 136.24 34.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 157' ' ' PHE . 18.7 ptt180 -142.61 139.37 31.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 14' ' ' LYS . 62.3 mt -136.92 142.25 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HD2' ' CE2' ' A' ' 63' ' ' TRP . 69.3 tttt -118.9 115.37 24.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.0 mm -81.23 145.68 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.49 -72.96 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.1 p -170.53 178.04 3.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.62 142.3 50.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 t -117.86 144.65 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 67.23 47.42 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.789 0.328 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -75.46 -63.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -144.69 -179.8 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 53' ' ' VAL . 12.2 pt -137.56 178.87 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -173.67 138.57 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.571 HG21 ' CZ2' ' A' ' 60' ' ' TRP . 14.9 t -90.08 145.82 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -127.54 120.99 29.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.2 p -117.15 179.45 4.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.25 138.88 2.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.465 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -87.06 150.67 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 111.112 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -140.77 152.64 45.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.419 ' CB ' HD12 ' A' ' 44' ' ' LEU . 10.2 t-160 -127.09 104.17 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.01 51.23 56.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.43 34.79 89.61 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.515 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -142.72 142.67 23.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.691 0.758 . . . . 0.0 110.861 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 149.73 67.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.704 2.27 . . . . 0.0 112.333 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.419 HD12 ' CB ' ' A' ' 39' ' ' HIS . 8.3 mp -114.05 -37.1 4.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.9 m -160.57 170.05 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.805 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -50.46 131.73 24.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -66.74 161.98 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.455 HG13 ' CD1' ' A' ' 64' ' ' LEU . 51.4 t -122.25 139.01 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -126.52 156.5 40.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -93.41 179.82 5.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -66.67 163.92 17.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -82.2 126.46 32.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 1.4 m -137.62 152.05 72.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.647 0.737 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 138.52 38.06 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.73 2.287 . . . . 0.0 112.317 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 23.3 p -49.98 -45.87 52.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.4 t -51.35 -35.72 39.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -130.48 84.77 58.32 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.717 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.588 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.72 3.85 2.51 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.69 2.26 . . . . 0.0 112.366 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -52.63 109.16 0.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.588 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 3.6 m-90 -103.54 -46.89 4.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 60' ' ' TRP . 7.8 p30 35.3 44.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -113.83 147.9 37.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.417 ' CE2' ' HD2' ' A' ' 14' ' ' LYS . 71.2 m95 -88.99 97.16 11.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.455 ' CD1' HG13 ' A' ' 48' ' ' VAL . 11.8 tp -84.62 111.56 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -91.28 132.87 35.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.937 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -99.42 137.41 37.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -88.21 44.26 1.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.855 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 69' ' ' TYR . 2.2 pp -112.5 170.94 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.605 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.14 115.88 25.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.647 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.8 mp -53.38 -51.02 79.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.647 0.737 . . . . 0.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.0 Cg_endo -69.77 2.21 3.75 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.647 2.231 . . . . 0.0 112.382 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.488 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.3 t70 -123.49 -11.17 7.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.426 HD11 ' N ' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -71.84 113.86 23.78 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.631 0.729 . . . . 0.0 110.901 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.426 ' N ' HD11 ' A' ' 73' ' ' LEU . 53.3 Cg_endo -69.74 145.91 58.71 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -41.95 75.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.19 -37.97 70.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -59.85 164.55 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.414 ' CG ' ' O ' ' A' ' 77' ' ' ALA . 50.4 mtt85 -161.34 173.84 14.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 tp -98.3 131.86 44.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 9.5 m -127.65 135.95 50.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 pp -142.83 155.56 44.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 85.2 p -160.16 134.82 7.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.5 mt -81.66 141.45 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 95.7 m -136.88 152.14 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.0 m -111.23 129.11 56.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 p -111.9 130.19 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.1 tptm . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 179.917 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.812 0.339 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -120.94 127.82 52.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -108.43 135.23 50.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.9 t -142.93 127.64 9.83 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.619 0.723 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 146.61 60.67 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.653 2.235 . . . . 0.0 112.332 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.6 mt -119.67 -43.56 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.936 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.1 162.16 41.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.061 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.4 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 66.6 p-90 -143.09 135.67 27.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.06 132.75 5.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 0.9 OUTLIER -111.28 138.18 48.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.792 0.329 . . . . 0.0 110.877 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.459 ' CG1' HD22 ' A' ' 120' ' ' LEU . 78.8 mt -120.6 134.62 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 107' ' ' PHE . 2.5 m120 -73.19 88.1 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 105' ' ' ASN . 12.7 mt -36.26 -33.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 105' ' ' ASN . 57.1 m-85 -110.85 116.46 31.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -50.86 -178.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -64.26 -33.22 75.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.3 t -91.25 30.23 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.151 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.2 t0 49.74 49.21 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 113' ' ' LEU . 45.8 m -136.51 112.82 9.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 112' ' ' THR . 29.6 mt -36.73 148.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.517 HG23 ' CZ ' ' A' ' 154' ' ' PHE . 18.2 m -75.62 -179.83 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.7 p -173.54 155.85 2.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.845 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.35 152.53 6.08 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.454 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -56.17 147.36 20.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 35.9 ttp -156.95 153.09 27.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.27 132.07 37.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.459 HD22 ' CG1' ' A' ' 104' ' ' ILE . 3.9 pp -138.75 154.63 48.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.53 ' ND2' ' HG ' ' A' ' 149' ' ' CYS . 6.0 m120 -77.35 156.82 31.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.1 mt -113.69 153.52 28.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.503 ' CH2' ' OD1' ' A' ' 142' ' ' ASN . 18.7 m95 -89.58 148.79 41.02 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.597 0.713 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 163.67 37.49 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.699 2.266 . . . . 0.0 112.333 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.596 0.712 . . . . 0.0 111.116 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 25.6 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.855 0.359 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.1 tp -97.77 136.03 38.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.47 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 11.2 t-20 -105.34 93.71 7.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.622 0.725 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -30.89 21.45 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.648 2.232 . . . . 0.0 112.373 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 137' ' ' GLY . 12.7 mm -75.19 -25.82 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.488 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -34.76 148.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.473 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.78 173.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 111.077 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 34.1 p -118.09 146.15 44.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.135 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.28 163.19 12.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.508 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.7 p -84.26 118.17 24.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.886 0.374 . . . . 0.0 110.883 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.736 HD22 ' ND2' ' A' ' 144' ' ' ASN . 24.0 t30 -60.89 129.44 90.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 110.913 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 2.03 3.87 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.662 2.241 . . . . 0.0 112.372 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . 0.736 ' ND2' HD22 ' A' ' 142' ' ' ASN . 2.7 m-20 -89.78 117.0 28.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -77.05 -46.18 24.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 147' ' ' THR . 14.8 pt-20 -43.6 -38.66 3.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.405 ' N ' ' HG3' ' A' ' 146' ' ' GLU . 64.6 p -64.25 151.87 89.68 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.606 0.717 . . . . 0.0 111.116 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 132.04 22.59 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.69 2.26 . . . . 0.0 112.375 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.53 ' HG ' ' ND2' ' A' ' 121' ' ' ASN . 1.2 m -113.07 136.99 52.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.4 mt -108.75 137.59 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -105.23 130.75 53.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -135.14 161.53 35.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.401 ' N ' HD22 ' A' ' 152' ' ' LEU . 21.2 mt-10 -116.74 125.06 51.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.517 ' CZ ' HG23 ' A' ' 114' ' ' VAL . 43.1 m-85 -93.41 108.02 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.0 155.82 49.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.566 ' CH2' HD11 ' A' ' 11' ' ' LEU . 6.9 m95 -136.45 105.24 5.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.485 ' CG ' ' N ' ' A' ' 158' ' ' SER . 10.0 p90 -85.17 -44.96 12.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.485 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 4.5 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.893 0.378 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.76 140.13 52.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.064 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.8 tp -104.33 131.51 51.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -139.66 139.12 36.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.475 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 59.3 mt -135.2 128.6 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -102.76 107.14 17.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mm -70.76 143.23 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.37 -72.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.7 p -172.06 179.5 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.25 169.08 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.429 HG22 ' CD2' ' A' ' 20' ' ' TYR . 9.4 t -147.3 144.0 28.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.135 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.429 ' CD2' HG22 ' A' ' 19' ' ' THR . 6.1 m-85 61.78 47.46 6.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.098 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.822 0.344 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.421 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 6.7 t70 -70.52 -62.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 25.1 mmtm -147.36 179.08 7.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 pp -141.86 146.31 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -144.28 163.77 32.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -111.9 140.89 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.09 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.41 ' NH2' ' HB2' ' A' ' 47' ' ' ASN . 14.6 ttt85 -116.27 127.61 54.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.3 p -128.97 168.03 16.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.64 153.22 7.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.481 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.7 mp -96.26 146.78 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 0.0 111.147 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.5 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 32.4 m-85 -139.05 159.4 42.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.41 ' CB ' HD13 ' A' ' 44' ' ' LEU . 7.6 t-160 -139.41 106.44 5.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.39 31.31 46.74 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.96 29.62 60.55 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.533 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -148.67 149.28 30.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.656 0.741 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 158.78 55.75 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.41 HD13 ' CB ' ' A' ' 39' ' ' HIS . 9.4 mp -112.26 -42.16 3.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.3 m -132.61 -69.57 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -173.16 166.49 4.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.41 ' HB2' ' NH2' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -96.91 149.85 21.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.463 HG12 ' CD1' ' A' ' 64' ' ' LEU . 95.9 t -115.04 133.46 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -116.21 156.1 27.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.443 HG22 ' CD1' ' A' ' 60' ' ' TRP . 9.1 t -100.26 165.58 11.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -48.93 178.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.5 mtt85 -108.22 115.73 30.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.56 HG11 ' CD1' ' A' ' 60' ' ' TRP . 1.5 m -120.19 152.3 54.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.582 0.705 . . . . 0.0 111.131 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 139.11 39.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.2 p -47.09 -44.43 21.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m -52.05 -29.41 21.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -134.06 83.97 44.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 0.0 110.904 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.6 Cg_endo -69.78 1.39 4.49 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.672 2.248 . . . . 0.0 112.323 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -60.29 120.27 9.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.576 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 3.2 m-90 -109.52 -47.04 3.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.943 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 60' ' ' TRP . 8.9 p30 34.0 42.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -111.85 144.9 40.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -83.27 110.17 17.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.463 ' CD1' HG12 ' A' ' 48' ' ' VAL . 11.1 tp -94.56 123.07 37.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.924 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -101.63 137.44 39.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -108.92 135.49 50.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -84.25 38.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.433 ' C ' HD12 ' A' ' 68' ' ' ILE . 1.8 pp -110.0 159.57 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.115 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.607 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.12 125.3 53.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.597 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -57.96 -54.06 59.44 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.725 . . . . 0.0 111.165 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.607 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.0 Cg_endo -69.75 2.16 3.78 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.246 . . . . 0.0 112.372 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.487 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.5 t70 -124.84 -1.52 7.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.36 117.05 67.99 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.612 0.72 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 144.62 54.83 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.683 2.255 . . . . 0.0 112.365 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -59.12 -38.39 79.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.4 -26.46 61.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.94 165.53 24.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -159.51 177.28 11.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.0 tp -98.89 148.67 23.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m -143.02 152.49 41.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.89 136.58 14.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.9 p -141.76 133.52 27.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 90.2 mt -80.12 135.72 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 70.9 m -135.72 144.33 45.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.2 p -105.5 125.13 50.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 86' ' ' VAL . 5.8 p -109.94 117.93 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.823 0.344 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -142.53 135.55 28.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.419 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 6.0 m170 -100.25 130.71 46.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.6 m -134.25 127.56 18.99 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.609 0.718 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 150.26 67.94 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.304 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.8 mt -128.48 -52.72 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.64 176.45 8.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.511 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 68.6 p-90 -160.6 146.8 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.09 124.11 1.54 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 27.1 m-20 -104.31 153.12 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.409 HG13 ' C ' ' A' ' 103' ' ' ASN . 55.1 mt -144.9 126.88 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.129 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 106' ' ' LEU . 24.8 m120 -66.5 99.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.0 mt -34.13 -54.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.496 ' CE1' ' HG ' ' A' ' 113' ' ' LEU . 52.3 m-85 -94.88 114.29 26.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -54.64 174.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -48.38 -30.09 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -90.28 28.49 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 44.16 41.88 4.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 55.2 m -127.88 115.58 18.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.496 ' HG ' ' CE1' ' A' ' 107' ' ' PHE . 12.3 mt -43.1 134.4 3.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 m -62.54 173.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.179 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -168.6 161.5 11.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.05 153.78 12.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.45 ' HE3' ' CG ' ' A' ' 151' ' ' GLU . 5.3 tmtt? -63.92 142.9 58.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.748 0.308 . . . . 0.0 110.887 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 37.5 ttp -155.09 154.58 32.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.74 116.11 10.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.103 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.6 pp -123.26 163.75 20.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.933 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -85.23 158.75 20.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.461 HD11 ' CD1' ' A' ' 150' ' ' LEU . 6.0 mt -119.1 155.71 31.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.673 ' CE3' ' ND2' ' A' ' 142' ' ' ASN . 8.3 m95 -90.18 146.42 34.81 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.559 0.695 . . . . 0.0 110.89 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 147.45 62.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.703 2.268 . . . . 0.0 112.305 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.608 0.718 . . . . 0.0 111.118 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.817 0.342 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.0 tp -103.16 125.86 50.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.449 ' CG ' ' O ' ' A' ' 134' ' ' ASN . 11.8 p-10 -106.65 97.29 16.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.732 . . . . 0.0 110.928 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.5 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.8 -30.82 21.47 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.3 mt -70.08 -25.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.093 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.484 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -41.45 153.59 0.11 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.511 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.0 m -59.47 175.3 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.866 0.365 . . . . 0.0 111.161 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 60.7 p -121.37 168.25 11.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.189 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.49 161.93 32.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.9 p -79.6 137.82 37.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.673 ' ND2' ' CE3' ' A' ' 123' ' ' TRP . 34.9 t-20 -75.38 123.96 88.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -14.99 36.8 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.362 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -71.6 140.2 49.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -93.46 -42.32 9.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.37 -35.44 28.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.4 p -66.92 151.3 97.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.572 0.701 . . . . 0.0 111.113 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 148.22 64.3 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.687 2.258 . . . . 0.0 112.358 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 5.5 t -128.07 136.56 51.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.461 ' CD1' HD11 ' A' ' 122' ' ' LEU . 3.5 mt -103.67 -177.09 3.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.45 ' CG ' ' HE3' ' A' ' 117' ' ' LYS . 54.7 tt0 -149.61 122.07 8.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.573 HD23 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -128.38 165.78 19.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.866 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.455 ' N ' HD21 ' A' ' 152' ' ' LEU . 69.0 mt-10 -128.45 119.73 25.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.573 ' CE2' HD23 ' A' ' 152' ' ' LEU . 45.2 m-85 -88.44 129.89 35.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.903 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -148.75 138.89 22.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -129.39 94.26 3.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.586 ' CG ' ' N ' ' A' ' 158' ' ' SER . 16.1 p90 -92.98 -53.3 4.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.586 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 6.3 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.481 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 14.5 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.848 0.356 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.66 150.23 30.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.412 HD11 ' CZ3' ' A' ' 156' ' ' TRP . 12.5 tp -104.48 140.04 38.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.69 ' NE ' ' CE3' ' A' ' 63' ' ' TRP . 2.4 ttt180 -143.72 118.39 9.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.1 mt -120.99 142.51 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.554 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 35.8 tttm -120.59 134.5 55.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.09 144.7 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.15 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.35 -74.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.1 p -162.31 -178.25 6.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.26 149.72 43.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.074 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -123.22 157.88 32.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.123 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 61.25 25.26 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 179.892 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.9 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.792 0.33 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -80.12 -64.62 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -148.23 -179.63 7.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 pt -139.46 171.09 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -164.52 158.9 18.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.518 HG22 ' CZ2' ' A' ' 60' ' ' TRP . 40.9 t -119.86 132.06 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -103.56 122.27 44.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.86 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.0 p -118.6 154.31 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.9 152.4 9.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.499 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 38' ' ' TYR . 2.9 mp -97.41 143.38 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.171 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.561 ' CD1' ' HB3' ' A' ' 135' ' ' PRO . 45.7 m-85 -135.85 152.57 51.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.518 ' CE1' ' HB1' ' A' ' 76' ' ' ALA . 2.7 t-160 -124.5 97.8 5.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.933 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.06 14.38 80.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.34 -25.37 13.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.493 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -88.31 140.72 30.42 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.637 0.732 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 156.33 63.5 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.712 2.275 . . . . 0.0 112.29 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 39' ' ' HIS . 7.8 mp -115.18 -33.19 5.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.1 t -156.31 168.66 26.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.41 126.01 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -59.54 164.99 3.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 64' ' ' LEU . 59.4 t -120.14 134.94 62.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -116.37 139.2 50.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.4 t -89.87 163.12 15.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -51.39 174.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -102.24 135.52 43.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.856 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -137.54 152.17 72.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 0.0 111.121 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 137.27 35.08 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.702 2.268 . . . . 0.0 112.345 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.6 p -46.54 -50.19 17.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.1 p -46.71 -32.49 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -133.21 87.06 39.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.613 0.72 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.478 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.2 Cg_endo -69.72 2.99 3.02 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -58.75 123.48 16.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.518 ' CZ2' HG22 ' A' ' 33' ' ' VAL . 3.4 m-90 -105.74 -63.81 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.4 HD21 ' N ' ' A' ' 61' ' ' ASN . 1.9 m-80 54.24 48.2 21.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -124.93 139.33 53.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.69 ' CE3' ' NE ' ' A' ' 12' ' ' ARG . 80.1 m95 -81.89 112.2 18.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.471 ' CD1' HG11 ' A' ' 48' ' ' VAL . 10.1 tp -98.12 115.6 28.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -95.3 131.05 41.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -100.83 134.26 44.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -81.06 41.29 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.459 ' C ' ' CD1' ' A' ' 68' ' ' ILE . 1.2 pp -115.33 162.83 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.593 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.37 127.41 54.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.565 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -54.2 -55.85 32.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 0.0 111.151 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.593 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.4 Cg_endo -69.81 3.02 3.03 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.707 2.271 . . . . 0.0 112.323 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.484 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.5 t70 -123.48 0.42 8.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.98 113.85 57.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.64 0.733 . . . . 0.0 110.874 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 142.02 46.59 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.673 2.249 . . . . 0.0 112.295 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.555 ' NH1' ' CZ ' ' A' ' 107' ' ' PHE . 78.3 mmt-85 -55.2 -37.83 67.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.518 ' HB1' ' CE1' ' A' ' 39' ' ' HIS . . . -56.57 -32.44 65.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.55 166.79 19.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -161.81 172.01 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.0 tp -95.46 134.2 38.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.3 m -131.26 141.7 50.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.4 pp -147.68 150.5 34.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.3 p -150.93 135.35 17.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.2 mt -84.76 141.5 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.17 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 20.7 m -140.54 150.97 44.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.1 p -113.06 126.15 55.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.551 HG22 ' CD2' ' A' ' 96' ' ' HIS . 8.5 p -104.89 130.44 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 tptp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.9 179.903 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.754 0.312 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -133.16 119.51 20.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.551 ' CD2' HG22 ' A' ' 86' ' ' VAL . 7.9 m170 -103.92 124.59 49.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.823 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.7 t -127.31 128.49 24.05 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.595 0.712 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 147.08 62.03 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.67 2.247 . . . . 0.0 112.356 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.2 mt -120.09 -40.25 2.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.16 175.83 12.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.057 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.51 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 66.7 p-90 -156.79 135.52 11.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.81 134.3 7.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -112.22 133.1 54.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.465 HG12 ' CD2' ' A' ' 120' ' ' LEU . 36.1 mt -122.24 121.0 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -64.27 96.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.4 mt -38.75 -35.65 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.555 ' CZ ' ' NH1' ' A' ' 75' ' ' ARG . 98.9 m-85 -106.12 112.36 25.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -51.09 175.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.445 ' C ' ' CD1' ' A' ' 109' ' ' TYR . 5.0 p90 -59.45 -22.26 61.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -95.76 24.63 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 50.71 39.49 21.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 113' ' ' LEU . 51.2 m -131.5 113.94 14.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 112' ' ' THR . 33.5 mt -38.03 143.52 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.414 HG23 ' CG ' ' A' ' 154' ' ' PHE . 35.7 m -74.3 -177.79 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.5 t -168.23 173.07 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.53 174.01 2.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.422 ' CE ' ' CD ' ' A' ' 151' ' ' GLU . 3.5 ttpm? -73.67 152.3 40.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.925 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.5 ttp -154.39 148.47 25.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.93 116.96 12.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.465 ' CD2' HG12 ' A' ' 104' ' ' ILE . 4.0 pp -129.26 163.79 24.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 147' ' ' THR . 25.2 m-20 -91.05 145.61 24.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.9 mt -98.59 159.74 14.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.51 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 23.4 m95 -87.38 150.79 49.84 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.537 0.684 . . . . 0.0 110.913 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 145.23 56.52 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.355 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 0.0 111.149 179.918 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.4 tp -98.68 136.58 38.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.463 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 7.7 t-20 -106.55 91.51 6.04 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.643 0.735 . . . . 0.0 110.854 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.561 ' HB3' ' CD1' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.77 -41.19 4.47 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.687 2.258 . . . . 0.0 112.311 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.1 mt -75.61 -13.65 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.463 ' CA ' ' OD1' ' A' ' 134' ' ' ASN . . . -44.05 144.44 1.95 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.2 m -54.78 173.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 111.184 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.1 p -118.62 175.57 5.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.192 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.08 154.15 30.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.479 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 86.4 p -78.89 109.85 13.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.916 0.389 . . . . 0.0 110.855 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -44.67 121.88 4.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.609 0.719 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -6.22 18.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -68.84 139.88 55.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -99.65 -9.93 22.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -97.67 14.42 26.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.402 ' O ' ' OD1' ' A' ' 121' ' ' ASN . 59.5 p -112.25 152.55 44.54 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.542 0.686 . . . . 0.0 111.166 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.45 59.99 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.66 2.24 . . . . 0.0 112.344 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 2.0 t -128.95 128.48 43.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.5 mt -100.32 140.32 34.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.422 ' CD ' ' CE ' ' A' ' 117' ' ' LYS . 37.6 tt0 -109.15 120.48 42.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.557 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -128.95 165.91 20.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.436 ' N ' HD21 ' A' ' 152' ' ' LEU . 47.1 mt-10 -120.12 125.99 49.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CG ' HG23 ' A' ' 114' ' ' VAL . 28.5 m-85 -90.77 100.41 13.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.01 141.48 37.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.412 ' CZ3' HD11 ' A' ' 11' ' ' LEU . 74.8 m95 -129.1 69.55 1.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 158' ' ' SER . 7.9 p90 -69.34 -51.09 40.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.636 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 52.5 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 13.2 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.836 0.351 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.08 136.35 54.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.043 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.533 HD11 ' CZ3' ' A' ' 156' ' ' TRP . 24.6 tp -86.67 139.15 31.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.416 ' HD2' ' CE3' ' A' ' 63' ' ' TRP . 10.4 ttp180 -138.39 123.3 18.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.0 mt -134.18 139.27 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.442 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 72.9 tttt -118.37 127.22 53.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -89.17 146.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.44 ' HB2' ' CB ' ' A' ' 151' ' ' GLU . 4.3 mm? -100.85 -72.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 p -168.46 -176.94 3.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.93 141.88 51.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.537 HG21 ' CD2' ' A' ' 20' ' ' TYR . 6.5 t -117.57 134.34 54.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.537 ' CD2' HG21 ' A' ' 19' ' ' THR . 5.8 m-85 72.69 38.75 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.116 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.833 0.349 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -71.14 -52.62 18.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.851 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -145.81 177.44 8.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 pp -146.64 156.94 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -153.47 163.2 40.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.1 t -108.75 140.55 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.158 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -114.77 126.75 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.407 ' CG2' ' HB3' ' A' ' 81' ' ' LEU . 47.0 p -124.73 163.87 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.74 146.24 4.91 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.77 146.01 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 111.166 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.506 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 38.5 m-85 -142.53 157.1 45.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.447 ' C ' ' CD2' ' A' ' 39' ' ' HIS . 6.6 t-160 -129.09 102.84 6.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.89 22.37 70.24 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.29 -37.2 3.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -75.4 137.61 71.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.664 0.745 . . . . 0.0 110.888 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 158.07 58.2 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.0 mp -116.15 -40.08 3.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.3 m -149.76 168.95 22.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -57.35 128.17 35.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -61.65 159.11 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.7 t -114.78 147.5 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.124 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -129.06 156.06 44.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 p -102.64 168.62 9.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -51.92 177.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -107.08 112.62 25.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.536 HG11 ' CD1' ' A' ' 60' ' ' TRP . 1.9 m -118.0 152.83 50.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.606 0.717 . . . . 0.0 111.131 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 135.84 31.39 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.65 2.233 . . . . 0.0 112.331 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.5 p -44.69 -44.37 9.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 93.8 p -48.56 -34.82 12.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -134.18 89.22 28.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.621 0.724 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.58 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.3 Cg_endo -69.82 -0.12 6.5 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.708 2.272 . . . . 0.0 112.297 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -54.09 113.48 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.58 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 3.3 m-90 -104.82 -46.92 4.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.457 ' C ' ' O ' ' A' ' 60' ' ' TRP . 11.8 m-80 33.99 51.58 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -119.94 140.06 51.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.442 ' NE1' ' HD2' ' A' ' 14' ' ' LYS . 76.5 m95 -81.28 108.43 14.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.7 tp -97.66 121.46 39.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -101.33 134.84 43.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -102.34 129.91 48.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.9 42.34 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.877 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 pp -108.91 163.5 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.176 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.602 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.12 126.89 55.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -58.28 -52.41 74.78 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.65 0.738 . . . . 0.0 111.153 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.8 Cg_endo -69.8 -5.56 16.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.348 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.505 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.1 t0 -112.26 -15.79 13.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.41 112.16 12.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.627 0.727 . . . . 0.0 110.92 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 145.17 56.3 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.674 2.249 . . . . 0.0 112.35 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 21.7 mmt180 -53.41 -46.75 69.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . . . -52.52 -41.71 63.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.082 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.82 163.82 2.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.8 ptp85 -160.91 173.92 14.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.6 tp -96.18 144.15 26.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.9 m -134.49 149.45 50.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.879 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -155.76 137.09 13.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.0 p -146.87 154.4 41.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.402 ' CD1' HD13 ' A' ' 150' ' ' LEU . 44.5 mt -104.19 138.81 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.159 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 84.7 m -133.94 155.41 49.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.0 p -106.72 116.1 31.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.891 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.42 127.98 54.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.6 tptt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.948 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.829 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.88 118.94 30.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -103.91 124.65 49.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 17.9 m -131.16 122.96 19.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 140.38 42.43 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.412 ' C ' HG21 ' A' ' 125' ' ' VAL . 16.5 mt -113.9 -36.33 4.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.04 -179.68 6.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.508 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 67.8 p-90 -162.7 127.05 3.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.76 134.16 7.07 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -114.64 129.91 56.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.339 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 87.1 mt -107.57 138.15 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.121 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 106' ' ' LEU . 6.1 m120 -76.58 82.79 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.1 mt -34.43 -38.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.446 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 40.9 m-85 -105.93 120.47 41.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -62.85 170.53 2.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.547 ' CE1' HG21 ' A' ' 110' ' ' THR . 0.2 OUTLIER -51.83 -26.24 9.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.547 HG21 ' CE1' ' A' ' 109' ' ' TYR . 67.9 p -105.23 31.79 4.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 47.01 36.6 4.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 113' ' ' LEU . 97.6 m -115.12 102.52 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 112' ' ' THR . 35.2 mt -34.05 125.13 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.567 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 29.8 m -58.2 176.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.146 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.437 ' HA ' ' CB ' ' A' ' 154' ' ' PHE . 2.2 m -173.42 166.88 4.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.33 132.38 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.471 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.423 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 22.6 ttpt -40.36 149.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.9 ttp -159.71 158.4 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.69 133.47 32.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 pp -143.59 148.74 36.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -76.6 157.94 31.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 mt -118.12 147.71 43.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.581 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 9.1 m95 -81.19 152.7 71.29 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.524 0.678 . . . . 0.0 110.931 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 161.88 44.21 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.708 2.272 . . . . 0.0 112.325 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.412 HG21 ' C ' ' A' ' 99' ' ' LEU . 90.3 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.494 HD23 ' CE1' ' A' ' 38' ' ' TYR . 14.8 tp -88.57 134.14 33.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -105.28 91.42 4.67 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.598 0.713 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.506 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.8 -28.61 24.87 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.252 . . . . 0.0 112.313 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 137' ' ' GLY . 11.5 mm -75.34 -28.48 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.181 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -34.66 151.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.423 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.42 ' N ' ' CZ3' ' A' ' 101' ' ' TRP . 18.6 m -68.63 170.45 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.946 0.403 . . . . 0.0 111.116 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.5 p -111.98 169.17 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.84 159.26 29.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.535 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.5 p -77.5 121.25 23.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.842 0.353 . . . . 0.0 110.858 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.581 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 36.9 t30 -59.14 124.39 74.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -18.45 36.96 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.726 2.284 . . . . 0.0 112.326 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -60.97 139.33 58.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -95.41 -35.36 11.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -83.41 39.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -129.16 156.12 78.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 0.0 111.132 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 130.28 18.98 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.722 2.281 . . . . 0.0 112.294 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 12.1 t -121.29 130.62 53.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.402 HD13 ' CD1' ' A' ' 83' ' ' ILE . 2.9 mt -106.89 151.5 25.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.982 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.44 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -112.86 140.25 47.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.917 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.539 HD23 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -143.13 155.31 44.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.423 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 39.1 mt-10 -119.17 115.98 25.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 114' ' ' VAL . 44.6 m-85 -80.49 109.53 15.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.98 126.34 41.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.533 ' CZ3' HD11 ' A' ' 11' ' ' LEU . 6.3 m95 -123.55 98.38 5.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 158' ' ' SER . 46.9 p90 -98.67 -53.08 3.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.511 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 22.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.843 0.354 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.74 117.68 29.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.454 HD12 ' CZ3' ' A' ' 156' ' ' TRP . 14.7 tp -84.72 131.75 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.521 ' NE ' ' CZ3' ' A' ' 63' ' ' TRP . 23.2 ptt180 -130.1 136.77 49.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.474 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 58.4 mt -134.21 134.9 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -111.41 133.79 53.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.8 mm -93.39 145.93 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.418 ' HB2' ' CB ' ' A' ' 151' ' ' GLU . 4.2 mm? -100.45 -72.4 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.2 p -166.78 -175.36 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.8 148.29 52.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -120.77 133.68 55.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 66.72 41.8 2.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.154 179.893 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.9 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.884 0.373 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -59.78 -66.8 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.844 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -144.33 177.32 8.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.4 173.56 11.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -165.65 170.83 13.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.506 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 92.1 t -119.14 140.51 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.126 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.417 ' N ' HG13 ' A' ' 33' ' ' VAL . 46.5 ttm-85 -115.03 130.82 57.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.4 p -126.71 168.16 14.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.114 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.24 134.22 1.63 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.429 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.99 148.7 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 111.156 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.506 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 19.7 m-85 -140.1 142.75 36.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.7 t-160 -118.64 104.76 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.846 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.36 45.07 82.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.492 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.437 ' CA ' HD12 ' A' ' 136' ' ' ILE . . . 69.14 30.89 71.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.453 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -140.58 144.71 37.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.641 0.734 . . . . 0.0 110.904 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 163.95 36.3 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.696 2.264 . . . . 0.0 112.374 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.429 HD13 ' CB ' ' A' ' 39' ' ' HIS . 9.6 mp -126.2 -40.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.6 p -146.33 177.0 9.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.11 118.06 7.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -50.48 149.07 3.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.454 HG12 ' CD1' ' A' ' 64' ' ' LEU . 61.6 t -111.14 137.23 44.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -118.55 151.29 38.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 79.4 p -100.73 164.37 11.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -49.71 172.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.26 120.24 40.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.526 HG11 ' CD1' ' A' ' 60' ' ' TRP . 1.8 m -122.05 152.12 59.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.568 0.699 . . . . 0.0 111.131 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 136.23 32.34 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.704 2.269 . . . . 0.0 112.306 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.0 p -45.65 -47.55 14.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -47.78 -35.35 9.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -134.72 89.0 26.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.659 0.742 . . . . 0.0 110.911 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.585 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 54.3 Cg_endo -69.73 2.23 3.7 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.65 2.234 . . . . 0.0 112.408 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -54.2 105.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.585 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.9 m-90 -93.18 -49.72 5.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 40.49 45.1 1.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -115.53 138.73 50.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.521 ' CZ3' ' NE ' ' A' ' 12' ' ' ARG . 45.8 m95 -85.76 108.55 18.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.454 ' CD1' HG12 ' A' ' 48' ' ' VAL . 10.3 tp -96.15 117.38 30.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -97.54 126.84 43.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -96.48 122.14 39.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.41 53.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.426 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.3 pp -117.27 167.15 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.609 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.69 119.86 39.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.641 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -58.0 -51.1 84.2 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.654 0.74 . . . . 0.0 111.159 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.75 2.86 3.15 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.697 2.265 . . . . 0.0 112.336 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.487 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.6 t0 -122.46 -11.02 8.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.835 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.413 ' CD1' ' HB2' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -70.62 113.64 20.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.659 0.742 . . . . 0.0 110.92 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 132.97 24.48 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.641 2.228 . . . . 0.0 112.366 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.46 ' NE ' ' OD2' ' A' ' 111' ' ' ASP . 82.8 mmt-85 -43.1 -45.91 5.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.54 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -51.2 -46.92 62.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . . . -53.15 162.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -160.75 175.56 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.858 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.3 tp -94.38 138.22 32.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 84.5 m -139.19 135.63 34.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.03 157.24 45.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 59.5 m -157.99 154.52 27.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.4 mt -97.85 147.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.168 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 86.2 m -142.65 156.61 45.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.1 m -116.07 118.58 33.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 p -102.94 130.07 53.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 179.911 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.775 0.321 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -131.53 130.71 42.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -102.85 132.47 49.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.0 t -132.71 120.85 16.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.632 0.73 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 147.66 63.19 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.693 2.262 . . . . 0.0 112.37 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.6 mt -122.72 -55.04 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.8 -179.82 5.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.424 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 69.3 p-90 -164.36 132.95 3.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.26 136.97 7.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.534 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -115.15 146.44 41.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 110.848 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.42 ' CG1' HD22 ' A' ' 120' ' ' LEU . 95.5 mt -127.29 125.6 66.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 106' ' ' LEU . 16.7 m-80 -64.87 87.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.894 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 105' ' ' ASN . 37.9 mt -33.46 -38.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' ASN . 66.3 m-85 -105.15 110.95 23.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -56.75 177.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -52.08 -40.56 61.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 t -86.57 34.12 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.158 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.46 ' OD2' ' NE ' ' A' ' 75' ' ' ARG . 35.8 t0 38.22 49.49 1.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 113' ' ' LEU . 52.7 m -134.14 111.48 10.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.481 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 58.0 mt -34.19 134.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.569 HG22 ' CE2' ' A' ' 154' ' ' PHE . 31.0 m -65.6 175.55 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.2 p -169.77 165.06 9.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.5 134.6 0.25 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.48 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -42.02 149.31 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.729 0.3 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 45.2 ttp -159.77 159.84 33.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.79 137.27 34.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.103 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.42 HD22 ' CG1' ' A' ' 104' ' ' ILE . 4.3 pp -145.22 155.42 43.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -81.36 152.53 27.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.9 mt -114.87 138.48 50.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.566 ' CH2' ' HD2' ' A' ' 143' ' ' PRO . 12.0 m95 -75.9 149.11 82.63 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.546 0.689 . . . . 0.0 110.953 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 157.12 61.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.685 2.257 . . . . 0.0 112.371 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.1 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 111.086 179.952 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.879 0.371 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.1 tp -93.55 138.85 31.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -107.8 91.29 7.32 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.595 0.712 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.506 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.73 -34.58 14.39 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.338 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.437 HD12 ' CA ' ' A' ' 41' ' ' GLY . 19.1 mm -70.65 -26.46 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.167 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.424 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -39.49 153.62 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.9 m -65.62 166.14 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.935 0.397 . . . . 0.0 111.098 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.0 p -109.41 166.87 10.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.146 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.99 177.79 33.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.2 p -91.79 130.35 37.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.893 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 123' ' ' TRP . 63.8 t-20 -67.17 121.26 77.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.563 0.696 . . . . 0.0 110.885 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.566 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.8 Cg_endo -69.68 -7.23 20.49 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.721 2.281 . . . . 0.0 112.345 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.47 127.19 31.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -78.01 -52.78 8.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -40.61 -41.95 1.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.0 p -62.09 151.66 80.2 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 111.134 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 174.82 8.89 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 0.0 112.384 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 120' ' ' LEU . 4.1 t -150.55 137.92 19.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.855 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.5 mt -110.9 156.48 21.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.418 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . 1.7 mp0 -117.63 138.59 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.568 HD22 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -141.58 158.37 43.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -122.5 120.26 33.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.569 ' CE2' HG22 ' A' ' 114' ' ' VAL . 43.7 m-85 -88.04 119.39 28.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.51 128.5 20.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.481 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 3.9 m95 -123.9 103.48 8.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' CG ' ' N ' ' A' ' 158' ' ' SER . 21.8 p90 -106.46 -49.64 3.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.879 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.494 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 31.4 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.402 ' C ' HD13 ' A' ' 70' ' ' ILE . 1.9 m . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.919 0.39 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.493 ' CB ' ' CB ' ' A' ' 158' ' ' SER . . . -119.71 141.83 49.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.118 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -106.27 137.15 44.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.496 ' NH1' ' N ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER -140.35 163.71 32.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.472 ' CD1' HD22 ' A' ' 79' ' ' LEU . 67.9 mt -154.79 131.75 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -105.88 104.17 13.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.7 mm -73.19 136.58 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.83 -75.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.1 p -168.01 167.8 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.83 164.7 12.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.074 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.489 HG22 ' CD2' ' A' ' 20' ' ' TYR . 10.0 t -142.97 161.14 38.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.489 ' CD2' HG22 ' A' ' 19' ' ' THR . 18.3 m-85 49.79 45.04 25.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.09 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.809 0.338 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.49 -51.62 4.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -146.65 173.49 12.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.17 174.96 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -169.14 148.19 3.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.536 HG22 ' CZ2' ' A' ' 60' ' ' TRP . 55.3 t -100.95 141.44 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.451 ' N ' HG13 ' A' ' 33' ' ' VAL . 29.4 ttt85 -121.11 126.63 50.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.3 p -121.34 176.04 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.67 137.02 2.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.457 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.63 142.78 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.521 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 13.4 m-85 -135.43 164.61 27.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.464 ' CB ' HD12 ' A' ' 44' ' ' LEU . 8.4 t-160 -132.72 100.96 5.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.72 30.56 70.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.526 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.42 -49.57 1.04 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.98 145.31 88.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.652 0.739 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.441 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.76 167.05 25.55 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.345 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.464 HD12 ' CB ' ' A' ' 39' ' ' HIS . 10.9 mp -118.74 -33.24 4.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.6 t -166.02 168.2 15.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -41.91 153.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -92.21 171.85 8.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.459 HG13 ' CG ' ' A' ' 64' ' ' LEU . 57.5 t -125.96 143.61 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -129.65 144.91 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.4 t -94.31 165.09 12.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.168 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -53.39 178.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.8 mtm-85 -104.56 139.02 40.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.8 m -140.68 152.19 65.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.615 0.722 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 135.12 29.73 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.684 2.256 . . . . 0.0 112.356 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 17.4 p -45.96 -47.69 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.1 p -46.43 -37.62 7.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -134.4 88.05 30.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.63 0.728 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.539 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 3.29 2.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.341 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -54.36 110.75 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.539 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.7 m-90 -95.07 -68.53 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 58.25 54.29 5.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -131.18 140.59 49.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -81.61 104.78 12.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.459 ' CG ' HG13 ' A' ' 48' ' ' VAL . 11.2 tp -88.81 111.49 22.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -90.19 127.94 36.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -97.61 134.67 40.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.913 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.46 50.7 1.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.424 HD11 ' C ' ' A' ' 68' ' ' ILE . 2.0 pp -122.92 164.11 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.7 117.34 31.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.633 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.4 mp -54.28 -51.98 72.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.604 0.716 . . . . 0.0 111.146 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.8 Cg_endo -69.79 2.6 3.4 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.696 2.264 . . . . 0.0 112.366 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.492 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.0 t70 -125.72 -9.45 6.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.29 117.44 63.15 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.623 0.725 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 146.06 59.37 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.647 2.231 . . . . 0.0 112.371 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.554 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 62.0 mmt-85 -59.96 -42.2 93.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.405 ' HB1' ' NE2' ' A' ' 39' ' ' HIS . . . -54.42 -31.36 55.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.06 162.0 27.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.2 mtt85 -155.58 175.26 14.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.472 HD22 ' CD1' ' A' ' 13' ' ' ILE . 43.2 tp -98.93 131.41 45.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.6 m -128.55 124.59 36.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.13 158.49 37.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.5 p -156.98 137.73 13.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.404 ' CD1' HD11 ' A' ' 150' ' ' LEU . 33.8 mt -88.24 136.79 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 63.5 m -133.99 141.54 47.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.0 p -105.88 119.75 39.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.565 HG23 ' CD2' ' A' ' 96' ' ' HIS . 6.2 p -101.57 138.17 26.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.911 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.46 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 8.8 mt-10 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.801 0.334 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -125.77 122.96 37.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.565 ' CD2' HG23 ' A' ' 86' ' ' VAL . 7.3 m170 -96.45 140.56 30.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.826 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.9 t -142.31 122.98 8.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 147.01 62.04 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.71 2.273 . . . . 0.0 112.368 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.0 mt -119.2 -56.65 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.16 -178.17 5.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.467 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 61.4 p-90 -160.33 141.89 12.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.923 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.9 125.45 2.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -108.01 117.93 35.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.758 0.314 . . . . 0.0 110.916 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.2 mt -107.63 128.28 62.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 106' ' ' LEU . 1.7 m120 -65.09 94.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.872 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.0 mt -35.84 -43.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.554 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 84.9 m-85 -101.97 119.61 39.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -56.48 -175.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -60.9 -37.71 83.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 t -88.8 32.94 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.19 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 43.81 53.88 5.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 113' ' ' LEU . 98.2 m -137.88 108.43 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.572 ' HB3' ' CZ2' ' A' ' 156' ' ' TRP . 41.4 mt -34.11 135.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.518 HG22 ' CZ ' ' A' ' 154' ' ' PHE . 26.8 m -67.64 172.64 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 154' ' ' PHE . 1.7 m -162.61 169.92 19.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.75 168.37 7.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.443 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 3.4 ttpm? -70.8 149.72 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 18.0 ttp -155.74 148.04 23.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.07 116.6 12.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.42 HD13 ' C ' ' A' ' 120' ' ' LEU . 4.4 pp -130.75 153.05 49.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.409 ' CB ' ' HB2' ' A' ' 142' ' ' ASN . 9.5 m-20 -75.37 147.24 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.4 mt -105.66 155.13 19.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.6 ' CD1' ' OD1' ' A' ' 142' ' ' ASN . 18.7 m95 -84.05 151.33 60.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.613 0.72 . . . . 0.0 110.872 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 152.87 69.23 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.657 2.238 . . . . 0.0 112.305 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 0.0 111.142 179.917 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.6 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.852 0.358 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.0 tp -104.41 119.85 39.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -101.6 97.8 8.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.521 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.9 Cg_endo -69.78 -40.66 5.03 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.373 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 137' ' ' GLY . 42.1 mt -65.16 -27.28 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -37.87 152.38 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.445 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.414 HG22 ' CZ2' ' A' ' 123' ' ' TRP . 14.9 m -56.46 168.07 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.7 p -120.45 154.77 34.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.79 -169.26 12.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.9 p -101.46 141.17 34.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 110.817 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.6 ' OD1' ' CD1' ' A' ' 123' ' ' TRP . 2.6 m120 -68.13 130.94 92.3 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.567 0.699 . . . . 0.0 110.896 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -28.84 25.05 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.696 2.264 . . . . 0.0 112.408 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -79.81 135.71 36.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -80.47 -34.95 35.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -46.85 -54.75 9.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.5 p -47.13 151.56 1.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.57 0.7 . . . . 0.0 111.156 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 168.02 22.88 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 13.1 t -144.88 140.73 28.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.404 HD11 ' CD1' ' A' ' 83' ' ' ILE . 2.3 mt -114.52 139.43 49.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -105.84 118.21 36.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.565 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -124.71 158.08 34.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.443 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 38.7 mt-10 -116.22 142.32 46.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.518 ' CZ ' HG22 ' A' ' 114' ' ' VAL . 45.7 m-85 -106.78 151.14 25.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.496 ' N ' ' NH1' ' A' ' 12' ' ' ARG . 3.8 m-20 -172.79 142.9 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.572 ' CZ2' ' HB3' ' A' ' 113' ' ' LEU . 7.8 m95 -132.21 86.8 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 158' ' ' SER . 28.7 p90 -95.43 -44.59 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.493 ' CB ' ' CB ' ' A' ' 10' ' ' ALA . 2.4 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.413 ' C ' HD13 ' A' ' 70' ' ' ILE . 24.4 p . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.888 0.375 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.17 141.74 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.071 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.474 HD11 ' CZ3' ' A' ' 156' ' ' TRP . 18.8 tp -102.52 140.39 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.408 ' NH2' ' CE3' ' A' ' 63' ' ' TRP . 0.4 OUTLIER -147.35 136.59 22.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.419 HD12 ' CE1' ' A' ' 66' ' ' TYR . 25.5 mt -135.54 145.66 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttt -119.73 119.3 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.2 mm -82.68 138.76 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.06 -73.51 0.58 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.0 p -170.41 176.11 4.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.29 160.4 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.6 t -129.15 158.66 38.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.188 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 42.88 39.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.113 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.3 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.856 0.36 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.68 -64.36 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -145.84 167.47 23.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 pt -127.3 163.72 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -157.15 157.98 35.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG21 ' CE2' ' A' ' 60' ' ' TRP . 98.4 t -104.05 140.13 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.469 ' N ' HG12 ' A' ' 33' ' ' VAL . 31.3 ttm-85 -114.6 116.6 29.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.3 p -119.34 163.6 16.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.27 143.4 3.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.498 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 38' ' ' TYR . 4.2 mp -88.5 148.55 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.511 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 25.3 m-85 -135.47 132.58 37.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -118.94 94.9 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.72 34.66 8.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.96 -26.7 3.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.505 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.25 153.22 62.47 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.634 0.73 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.467 ' O ' ' C ' ' A' ' 44' ' ' LEU . 53.8 Cg_endo -69.77 82.99 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 43' ' ' PRO . 16.4 tp -32.41 -46.54 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.1 m -152.23 177.24 10.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.47 150.89 8.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.83 145.94 25.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.425 HG13 ' CD1' ' A' ' 64' ' ' LEU . 58.8 t -105.54 135.32 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.082 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -113.17 147.15 37.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.9 p -99.74 167.52 10.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -53.76 165.29 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -100.73 116.4 32.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -116.28 152.48 47.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.676 0.75 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 139.01 39.19 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.66 2.24 . . . . 0.0 112.367 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.4 p -42.43 -45.61 4.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.834 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 p -51.12 -37.43 45.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.84 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -125.79 83.5 62.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.646 0.736 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.542 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.73 3.51 2.72 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.378 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.35 128.89 38.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.542 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 10.0 m-90 -106.24 -40.88 5.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 60' ' ' TRP . 2.4 p30 33.76 44.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -117.82 138.55 52.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.408 ' CE3' ' NH2' ' A' ' 12' ' ' ARG . 62.3 m95 -81.82 96.9 7.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.917 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.425 ' CD1' HG13 ' A' ' 48' ' ' VAL . 12.8 tp -85.39 120.37 26.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -98.48 132.58 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.419 ' CE1' HD12 ' A' ' 13' ' ' ILE . 44.7 m-85 -100.41 136.19 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -87.63 44.08 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 69' ' ' TYR . 2.0 pp -112.59 165.57 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.112 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.603 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.58 119.98 37.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.637 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 2.8 mp -56.87 -51.73 79.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.596 0.713 . . . . 0.0 111.144 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.0 Cg_endo -69.75 1.64 4.24 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.36 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 3.5 t70 -125.47 -6.69 6.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -74.6 116.09 50.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.648 0.737 . . . . 0.0 110.926 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.426 ' N ' HD12 ' A' ' 73' ' ' LEU . 53.5 Cg_endo -69.77 139.3 39.84 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.736 2.29 . . . . 0.0 112.309 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -53.07 -36.86 61.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.77 -33.66 73.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.15 165.14 18.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -161.11 172.54 16.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.9 tp -93.79 144.68 25.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.4 m -135.86 149.65 49.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.84 139.42 15.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 96.8 p -148.86 139.19 22.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.5 mt -86.54 138.49 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 72.5 m -139.64 145.17 38.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.5 p -106.86 120.52 42.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.852 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.552 HG23 ' CD2' ' A' ' 96' ' ' HIS . 5.1 p -102.01 130.67 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.09 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.7 tptm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.841 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 36.0 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.777 0.322 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -122.98 116.31 23.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.552 ' CD2' HG23 ' A' ' 86' ' ' VAL . 6.7 m170 -94.02 127.01 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 21.7 t -131.54 123.59 19.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.589 0.709 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.431 ' HD3' ' CD2' ' A' ' 132' ' ' LEU . 53.9 Cg_endo -69.8 147.97 63.81 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.6 mt -122.74 -48.18 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.13 163.09 35.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.108 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.463 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 61.7 p-90 -142.6 138.59 30.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.79 121.05 1.66 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.518 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 34.6 m-20 -101.36 131.44 47.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.1 mt -124.45 121.54 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 106' ' ' LEU . 7.1 m120 -66.76 96.14 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.3 mt -35.0 -39.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -102.45 114.47 28.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -57.48 173.82 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.562 ' CE1' HG22 ' A' ' 110' ' ' THR . 1.1 p90 -58.05 -15.09 8.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.562 HG22 ' CE1' ' A' ' 109' ' ' TYR . 29.9 p -103.46 26.15 8.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 45.87 35.6 2.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 113' ' ' LEU . 93.6 m -125.76 109.3 12.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 112' ' ' THR . 33.7 mt -34.23 139.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.521 HG22 ' CE2' ' A' ' 154' ' ' PHE . 19.3 m -72.84 166.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -161.05 171.98 17.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.38 160.12 2.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -64.16 143.41 57.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 35.2 ttp -153.05 148.71 27.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.77 121.35 15.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.078 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pp -128.84 155.72 44.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -76.26 152.71 36.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.26 157.09 18.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.578 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 15.0 m95 -90.48 152.24 45.1 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.546 0.689 . . . . 0.0 110.946 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 151.26 69.09 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.344 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.941 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.431 ' CD2' ' HD3' ' A' ' 98' ' ' PRO . 43.3 mt . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.808 0.337 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.7 tp -104.12 132.42 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -105.54 91.06 4.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.591 0.71 . . . . 0.0 110.909 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.511 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.2 Cg_endo -69.79 -45.29 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.641 2.227 . . . . 0.0 112.395 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.0 mt -74.25 -23.74 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.449 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -39.83 158.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.472 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.1 m -52.81 172.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.944 0.402 . . . . 0.0 111.102 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.1 p -132.03 161.8 32.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.173 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.52 -179.75 25.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.8 p -90.33 121.29 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 0.0 110.875 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.578 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 29.8 t30 -63.28 126.53 89.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.544 0.688 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 1.49 4.4 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -91.81 113.32 25.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -74.4 -40.16 62.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -49.67 -46.38 49.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.0 p -55.15 152.62 14.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.581 0.705 . . . . 0.0 111.139 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 134.43 27.92 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.673 2.249 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.1 t -113.83 142.54 45.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.7 mt -110.27 146.22 36.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -116.53 123.13 46.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.553 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -130.77 166.23 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -120.26 118.79 31.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.524 ' CE2' HD23 ' A' ' 152' ' ' LEU . 28.8 m-85 -88.96 100.78 13.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.923 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -121.79 154.43 36.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.474 ' CZ3' HD11 ' A' ' 11' ' ' LEU . 20.9 m95 -138.77 105.3 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 158' ' ' SER . 14.8 p90 -90.47 -49.01 6.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.514 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 51.5 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 t -159.24 138.07 10.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.863 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.5 t -37.72 -45.29 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.01 84.71 1.56 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.535 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 7' ' ' GLY . 74.2 m -139.47 173.01 11.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 110.887 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 5' ' ' SER . 55.2 p 34.49 36.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 5' ' ' SER . . . -96.06 63.86 1.22 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 158' ' ' SER . 5.5 t-20 -101.74 151.4 22.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.33 . . . . 0.0 110.937 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.562 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 46.3 m -125.68 -31.63 2.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.26 135.3 55.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.096 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.554 HD12 ' CH2' ' A' ' 156' ' ' TRP . 6.7 tp -97.54 128.92 44.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.412 ' NH2' ' CE3' ' A' ' 63' ' ' TRP . 0.3 OUTLIER -127.35 123.6 36.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.531 HD12 ' CE1' ' A' ' 66' ' ' TYR . 11.3 mt -124.57 137.09 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.175 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -113.96 135.41 54.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 mm -94.78 142.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.136 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.87 -69.19 0.78 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 p -172.3 173.85 4.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.5 161.07 21.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 149' ' ' CYS . 2.1 t -128.34 158.37 38.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 39.47 52.16 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.962 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 t -65.72 158.78 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -83.79 34.31 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 23' ' ' VAL . 32.6 m -103.37 81.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -79.38 -74.66 0.28 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.4 pp -46.09 173.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 55.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -120.29 -32.49 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.8 mt -52.41 135.47 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.128 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.407 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 29.4 t70 -82.85 -55.91 4.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.407 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 25.9 mmtt -146.32 -177.12 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 pt -145.52 170.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 3.7 p90 -158.57 166.23 32.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.422 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 99.0 t -122.27 139.6 48.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.126 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -115.72 121.2 41.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.812 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 57.9 p -118.91 154.16 33.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.08 169.26 41.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.536 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.456 ' C ' ' CD1' ' A' ' 38' ' ' TYR . 4.1 mp -122.98 137.24 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.806 0.336 . . . . 0.0 111.124 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.532 ' CD2' ' HA ' ' A' ' 43' ' ' PRO . 2.9 m-85 -137.03 150.22 47.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.463 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 2.4 t-160 -113.01 99.36 7.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.84 32.55 61.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.478 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.31 -22.45 34.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.58 140.04 29.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.605 0.716 . . . . 0.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 53.8 Cg_endo -69.74 156.09 64.31 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.367 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 39' ' ' HIS . 9.1 mp -120.51 -38.01 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.2 m -154.98 168.21 27.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -51.9 152.65 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -93.94 163.44 13.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.453 HG11 ' CD1' ' A' ' 64' ' ' LEU . 25.4 t -116.73 145.06 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -125.33 141.68 51.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.5 p -85.86 160.66 19.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -52.75 170.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -95.88 115.22 27.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.439 HG13 ' NE1' ' A' ' 60' ' ' TRP . 1.5 m -116.96 152.16 48.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.593 0.711 . . . . 0.0 111.11 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 137.74 36.24 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.35 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 24.6 p -47.85 -44.88 29.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 t -53.16 -31.33 42.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -134.39 84.78 39.87 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.62 0.724 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.447 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.75 3.31 2.84 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.717 2.278 . . . . 0.0 112.37 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -62.81 127.15 29.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.447 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 5.6 m-90 -106.22 -63.46 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 58.67 45.05 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 63' ' ' TRP . 5.5 tp10 -127.55 147.47 50.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.412 ' CE3' ' NH2' ' A' ' 12' ' ' ARG . 77.9 m95 -88.66 117.71 27.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.453 ' CD1' HG11 ' A' ' 48' ' ' VAL . 9.2 tp -101.0 123.25 44.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -99.59 136.63 39.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' CE1' HD12 ' A' ' 13' ' ' ILE . 34.8 m-85 -106.35 138.36 42.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.49 38.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.427 ' C ' HD12 ' A' ' 68' ' ' ILE . 1.8 pp -108.05 161.53 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.588 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.62 124.86 49.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -55.84 -55.27 42.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 0.0 111.173 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.588 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.9 Cg_endo -69.74 2.94 3.07 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 112.346 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.486 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.1 t0 -127.72 1.46 6.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.89 115.71 62.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.643 0.735 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.452 ' HG2' ' CB ' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.78 145.64 57.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.456 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 25.3 mmt85 -59.69 -35.9 75.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . . . -62.73 -32.92 74.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.452 ' CB ' ' HG2' ' A' ' 74' ' ' PRO . . . -68.35 165.0 19.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.093 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -163.09 176.36 10.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.857 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.3 tp -98.97 136.69 38.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.76 132.11 40.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.66 158.62 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.8 p -159.57 135.89 8.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.829 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.7 mt -86.58 136.57 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . 30.3 m -132.53 151.29 51.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 83.6 p -112.97 122.76 48.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 96' ' ' HIS . 8.9 p -106.19 125.85 61.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -151.13 126.35 9.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.28 -174.53 13.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.462 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.4 mtt180 -123.16 160.77 25.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.358 . . . . 0.0 110.859 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -53.36 113.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.97 -26.41 7.65 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.55 158.59 16.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 111.107 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -71.53 170.94 12.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -90.51 168.76 11.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -130.27 122.98 29.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.52 ' CD2' HG21 ' A' ' 86' ' ' VAL . 5.7 m170 -100.95 128.79 46.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.2 t -131.82 129.01 21.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 110.872 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 143.18 49.65 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 0.0 112.282 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.1 mt -118.45 -56.83 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.19 178.68 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.469 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 64.8 p-90 -161.42 144.07 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.96 132.46 4.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.412 ' CB ' HG23 ' A' ' 139' ' ' THR . 6.6 m120 -111.93 120.26 41.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 0.0 110.909 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.7 mt -112.24 127.27 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -68.87 98.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.3 mt -43.15 -34.32 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.456 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 63.3 m-85 -107.9 110.43 22.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -51.65 170.22 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.65 ' CE1' ' CG2' ' A' ' 110' ' ' THR . 0.6 OUTLIER -55.48 -20.25 12.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.984 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.65 ' CG2' ' CE1' ' A' ' 109' ' ' TYR . 41.5 p -102.64 28.46 6.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.113 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 110' ' ' THR . 4.3 p30 46.71 40.34 8.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 113' ' ' LEU . 93.1 m -126.23 109.24 12.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 112' ' ' THR . 34.0 mt -34.2 132.95 0.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.1 m -66.2 163.31 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.5 p -160.42 175.6 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.54 134.9 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.484 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.414 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 5.9 ttpt -43.01 150.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.803 0.335 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 34.8 ttp -158.79 148.72 19.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.7 114.44 9.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.79 160.94 27.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.68 150.23 29.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.5 mt -106.52 153.35 22.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.536 ' CH2' ' OD1' ' A' ' 142' ' ' ASN . 54.7 m95 -85.94 144.81 39.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.514 0.673 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 132.61 23.71 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.646 2.231 . . . . 0.0 112.363 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 m -65.79 150.78 95.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.675 0.75 . . . . 0.0 111.123 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 127' ' ' HIS . 53.5 Cg_endo -69.79 161.22 46.76 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.699 2.266 . . . . 0.0 112.333 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.435 ' C ' ' O ' ' A' ' 126' ' ' PRO . 7.6 m170 -35.25 110.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 36.95 68.4 0.35 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.481 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.61 105.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.318 . . . . 0.0 110.965 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -38.68 -56.04 1.38 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -77.79 -178.57 5.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 40.3 mt -108.34 -44.59 4.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 21.7 tp -106.32 133.05 51.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.914 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -107.08 91.37 6.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.636 0.731 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -17.12 38.01 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.67 2.247 . . . . 0.0 112.381 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 mm -88.89 -20.69 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -41.93 150.75 0.27 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.3 m -66.46 164.2 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.963 0.411 . . . . 0.0 111.086 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.412 HG23 ' CB ' ' A' ' 103' ' ' ASN . 28.4 p -108.15 161.11 15.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.133 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.32 167.51 18.62 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.462 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.6 p -93.5 118.73 31.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 110.885 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.536 ' OD1' ' CH2' ' A' ' 123' ' ' TRP . 31.6 t30 -61.35 123.62 77.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.665 0.745 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -8.73 24.36 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.722 2.282 . . . . 0.0 112.333 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -73.44 138.98 45.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -90.21 -49.5 6.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -44.69 -38.42 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.8 p -63.77 151.24 89.34 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.583 0.706 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 166.4 27.7 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 0.0 112.356 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.402 ' HB3' ' CG2' ' A' ' 19' ' ' THR . 4.2 t -146.1 135.88 23.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.8 mt -113.84 138.49 50.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.967 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.414 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 18.3 tt0 -106.93 132.08 53.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.528 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -134.84 161.74 34.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -116.41 120.84 40.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.517 ' CE2' HD21 ' A' ' 152' ' ' LEU . 25.9 m-85 -90.15 113.94 25.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.63 136.65 46.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.554 ' CH2' HD12 ' A' ' 11' ' ' LEU . 2.7 m95 -134.58 98.96 4.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.564 ' CG ' ' N ' ' A' ' 158' ' ' SER . 15.5 p90 -103.83 -51.76 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.592 ' N ' ' ND2' ' A' ' 8' ' ' ASN . 4.0 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -77.78 148.14 34.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 110.87 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 t -125.13 118.33 25.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.23 53.75 3.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.463 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.3 p -54.44 142.64 26.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.849 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -92.34 95.73 9.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.87 -119.41 6.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.487 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -125.6 151.28 46.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.361 . . . . 0.0 110.863 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.521 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 5.6 m -130.01 -35.86 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.52 147.07 44.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.093 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.2 tp -93.25 130.28 39.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.47 ' HD2' ' CE3' ' A' ' 63' ' ' TRP . 6.2 ttp180 -127.97 127.61 43.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.948 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.449 ' CD1' HD21 ' A' ' 79' ' ' LEU . 51.4 mt -130.75 156.3 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -140.65 128.01 21.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.5 mm -90.29 143.33 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.23 -73.66 0.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 t -162.49 172.17 15.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.23 162.9 17.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' TYR . 9.5 t -130.69 156.08 45.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' THR . 4.9 m-85 35.59 45.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 t -59.84 141.19 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -47.16 -25.54 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 23' ' ' VAL . 28.5 m -53.23 99.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.161 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -94.91 -62.14 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.437 ' H ' ' CD1' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -64.61 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -126.27 14.68 7.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.95 -49.82 27.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -40.43 137.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -79.56 -57.32 3.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -146.15 177.49 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 pt -139.64 173.72 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -165.98 160.57 16.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.529 HG22 ' CZ2' ' A' ' 60' ' ' TRP . 37.6 t -116.74 146.84 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.145 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -119.68 136.14 54.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 63.0 p -130.59 157.65 42.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.11 141.58 3.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -93.59 133.66 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 111.111 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.52 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 17.5 m-85 -127.86 158.69 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.551 ' CD2' ' HB1' ' A' ' 76' ' ' ALA . 12.0 t-160 -134.57 95.43 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.69 32.07 28.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.48 -17.81 46.27 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -96.97 141.8 23.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.625 0.726 . . . . 0.0 110.938 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.477 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.77 160.88 48.08 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.643 2.229 . . . . 0.0 112.358 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mp -119.9 -26.4 5.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.5 p -158.38 168.24 27.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -57.04 131.23 49.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.428 ' ND2' ' OH ' ' A' ' 38' ' ' TYR . 6.4 m120 -64.09 148.52 49.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.15 147.16 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -130.16 145.24 51.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 51' ' ' GLN . 3.2 t -87.59 176.12 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.402 ' N ' ' OG1' ' A' ' 50' ' ' THR . 11.6 pt20 -63.52 167.9 5.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.1 mtm-85 -92.13 140.61 29.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.38 152.12 49.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.662 0.744 . . . . 0.0 111.153 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.67 36.08 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.686 2.257 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.1 p -47.78 -45.75 29.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.4 m -52.3 -28.34 18.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -134.5 87.38 32.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.668 0.747 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.75 3.73 2.6 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.351 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -55.69 134.4 51.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.529 ' CZ2' HG22 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -120.88 -68.45 0.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 53.55 52.72 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -127.56 143.39 51.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.47 ' CE3' ' HD2' ' A' ' 12' ' ' ARG . 90.0 m95 -87.38 104.35 16.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -93.39 120.69 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -95.96 151.95 18.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -118.03 140.21 50.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -84.33 30.29 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 pp -106.63 159.42 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.594 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -110.88 139.97 45.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.967 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.522 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.5 mp -64.64 -58.06 14.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.699 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.594 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.0 Cg_endo -69.73 2.43 3.53 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.679 2.252 . . . . 0.0 112.322 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.477 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.0 t70 -120.67 -0.74 10.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.52 117.13 68.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 138.37 37.49 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.622 2.215 . . . . 0.0 112.344 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -56.45 -26.47 53.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB1' ' CD2' ' A' ' 39' ' ' HIS . . . -70.31 -27.41 64.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.087 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.43 165.52 23.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -157.89 174.13 15.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.449 HD21 ' CD1' ' A' ' 13' ' ' ILE . 33.2 tp -97.01 143.64 27.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.9 m -133.58 154.65 50.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.66 137.84 14.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.42 154.37 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.812 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.9 mt -98.75 128.68 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.193 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 18.6 m -128.52 142.58 51.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.8 p -108.37 130.96 55.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.542 HG23 ' CD2' ' A' ' 96' ' ' HIS . 9.9 p -110.64 129.21 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.115 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -142.64 127.03 17.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.5 167.6 22.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.485 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -114.1 163.93 14.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.871 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -55.03 126.78 26.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.27 6.08 13.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.52 169.27 9.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -83.44 169.37 15.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -98.35 174.01 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -137.52 121.61 17.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.542 ' CD2' HG23 ' A' ' 86' ' ' VAL . 9.1 m170 -97.46 141.46 30.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.7 t -148.6 132.34 8.47 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.582 0.706 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 152.51 69.38 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.24 . . . . 0.0 112.397 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.6 mt -128.48 -47.21 1.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.87 155.47 46.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.112 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -135.68 126.2 26.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.4 130.07 5.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 1.0 OUTLIER -104.6 161.49 14.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 88.6 mt -151.17 118.03 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -64.83 105.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 70.9 mt -44.32 -54.73 5.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.407 ' CE1' ' HG ' ' A' ' 113' ' ' LEU . 65.0 m-85 -94.28 120.34 34.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -56.75 -176.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.09 -0.9 12.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 p -108.86 11.39 26.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.117 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 64.33 48.56 2.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.4 m -147.33 125.64 12.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.432 ' CD2' ' CH2' ' A' ' 156' ' ' TRP . 15.0 mt -45.27 142.12 2.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.487 HG23 ' CZ ' ' A' ' 154' ' ' PHE . 2.4 m -64.24 176.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.4 p -168.51 173.69 7.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.34 139.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.476 ' HD3' ' CG ' ' A' ' 151' ' ' GLU . 0.7 OUTLIER -48.51 146.11 3.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.861 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 32.0 ttp -147.86 152.49 37.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.4 116.68 11.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 pp -128.85 160.41 32.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 147' ' ' THR . 5.4 m120 -87.3 146.95 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 mt -104.63 150.05 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -83.09 151.68 63.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.539 0.685 . . . . 0.0 110.951 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 160.63 48.98 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 0.0 112.365 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.2 t -99.25 118.6 62.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.639 0.733 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 160.63 48.99 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.654 2.236 . . . . 0.0 112.385 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -66.26 124.61 23.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.857 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 130' ' ' GLU . . . 119.16 -60.15 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.527 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 tt -41.06 94.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 110.925 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 128' ' ' GLY . 9.6 pt-20 -91.48 2.28 56.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -81.39 115.83 20.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.827 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 94.3 mt -47.69 -50.46 24.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.6 tp -110.49 145.3 37.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.441 ' ND2' ' CA ' ' A' ' 137' ' ' GLY . 64.2 t30 -119.18 93.87 47.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 110.911 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.52 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.3 Cg_endo -69.83 -47.3 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.716 2.277 . . . . 0.0 112.31 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 137' ' ' GLY . 0.4 OUTLIER -64.36 -30.14 49.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.137 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.441 ' CA ' ' ND2' ' A' ' 134' ' ' ASN . . . -35.14 151.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.468 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.5 m -56.85 176.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.401 . . . . 0.0 111.125 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.2 p -129.48 161.73 29.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.122 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.57 159.17 20.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.0 p -78.18 130.87 36.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.855 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -64.37 119.81 59.63 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.644 0.735 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -7.2 20.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.673 2.249 . . . . 0.0 112.354 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -85.94 145.49 27.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -92.97 -37.15 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.69 -14.67 3.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.485 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 65.0 p -88.85 151.39 47.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.581 0.705 . . . . 0.0 111.154 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 169.39 19.07 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.342 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 t -150.79 137.83 19.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.2 mt -114.42 139.59 49.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.476 ' CG ' ' HD3' ' A' ' 117' ' ' LYS . 5.5 tt0 -107.09 123.17 47.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.506 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -131.08 162.54 29.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -119.15 131.72 55.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 114' ' ' VAL . 24.5 m-85 -95.98 119.74 35.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.822 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.94 137.43 44.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.432 ' CH2' ' CD2' ' A' ' 113' ' ' LEU . 15.9 m95 -130.02 91.24 3.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.958 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.562 ' CG ' ' N ' ' A' ' 158' ' ' SER . 22.3 p90 -96.95 -52.62 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.562 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 30.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 t -164.65 122.09 1.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.364 . . . . 0.0 110.868 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.8 p -150.0 167.28 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.889 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.49 -113.93 1.91 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.467 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t -80.7 84.35 6.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.911 0.386 . . . . 0.0 110.867 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -42.57 165.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.873 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.57 -157.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.509 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -84.63 142.38 29.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 110.848 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.8 p -132.02 -36.81 1.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.45 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . . . -119.55 128.42 53.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.6 tp -97.83 131.66 44.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -139.21 136.57 35.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.1 mt -129.5 135.94 60.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 21.2 tttt -113.59 113.26 24.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.28 143.77 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.35 -73.22 0.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.5 p -170.52 171.0 6.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.94 154.23 25.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.415 HG21 ' CD2' ' A' ' 20' ' ' TYR . 8.1 t -134.64 143.25 47.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CD2' HG21 ' A' ' 19' ' ' THR . 1.6 m-85 63.73 41.29 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.88 151.06 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.143 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -77.11 58.37 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 m -113.86 100.75 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -98.47 -73.49 0.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 pp -56.23 169.03 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 57.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -119.31 -42.77 2.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 mt -39.42 123.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -72.06 -62.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -144.74 177.08 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -137.69 158.12 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -152.37 140.38 20.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 95.8 t -89.82 149.07 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.163 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.405 ' N ' HG13 ' A' ' 33' ' ' VAL . 37.3 ttt85 -131.53 119.35 21.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.4 p -117.04 179.33 4.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.64 140.57 3.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.493 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.7 mp -90.07 142.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.165 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.507 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 22.0 m-85 -137.23 143.68 42.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.563 ' CD2' ' HB1' ' A' ' 76' ' ' ALA . 13.3 t-160 -122.14 99.01 6.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.13 36.58 31.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.44 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.92 35.41 50.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -148.53 140.39 14.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.728 . . . . 0.0 110.88 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 143.45 51.09 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 0.0 112.345 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.3 mp -97.67 -41.83 7.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.8 m -150.36 162.54 40.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -44.02 120.3 2.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -60.52 162.25 6.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.32 147.46 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.163 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -126.86 148.89 49.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.1 t -98.13 163.82 12.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.174 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -49.95 179.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -107.02 127.71 53.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 m -129.95 152.13 79.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.6 0.714 . . . . 0.0 111.161 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 141.55 45.57 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.704 2.269 . . . . 0.0 112.343 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.3 p -50.13 -45.36 52.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.8 p -53.64 -30.85 44.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -134.2 86.3 36.8 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.581 0.705 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.572 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.6 Cg_endo -69.75 3.63 2.66 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.723 2.282 . . . . 0.0 112.322 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.81 135.4 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.572 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -128.93 -56.35 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.5 p30 38.37 37.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -104.29 142.7 34.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.465 ' NE1' ' HD2' ' A' ' 14' ' ' LYS . 45.4 m95 -85.38 104.4 15.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -96.32 121.43 38.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -99.74 141.92 31.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -110.86 128.95 55.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -81.34 47.66 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 69' ' ' TYR . 2.1 pp -114.0 167.25 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.16 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.599 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.55 123.72 46.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.606 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -58.49 -53.2 68.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.634 0.731 . . . . 0.0 111.143 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.82 3.11 2.99 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.268 . . . . 0.0 112.329 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.486 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 3.5 t70 -124.82 -4.42 7.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.01 111.85 30.45 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.94 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 135.9 31.65 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.365 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.47 ' NE ' ' OD1' ' A' ' 111' ' ' ASP . 62.0 mmt-85 -45.27 -43.63 10.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.563 ' HB1' ' CD2' ' A' ' 39' ' ' HIS . . . -50.18 -47.98 54.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.51 160.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 -156.13 173.15 17.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.4 tp -98.62 131.02 45.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -125.98 132.34 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.95 147.05 41.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 88.6 p -155.24 130.32 9.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.6 mt -80.5 131.72 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 55.7 m -123.37 143.38 50.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.7 m -106.98 128.05 54.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.414 ' CG2' ' HB3' ' A' ' 94' ' ' GLU . 6.9 p -109.05 137.71 39.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.169 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -136.05 124.11 22.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -163.36 -164.62 18.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.503 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -125.87 -176.9 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.886 0.374 . . . . 0.0 110.905 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -44.28 -72.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.2 46.04 1.21 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -122.97 172.63 8.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.795 0.331 . . . . 0.0 111.104 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -73.06 146.59 45.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 24.3 mt-10 -106.47 164.3 12.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -124.74 115.33 20.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.949 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.441 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 5.1 m170 -97.07 141.33 30.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.38 124.79 2.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.635 0.731 . . . . 0.0 110.855 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 147.14 61.89 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.706 2.271 . . . . 0.0 112.298 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 mt -113.2 -47.62 3.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.84 156.91 44.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.434 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 67.2 p-90 -137.21 138.91 40.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.07 124.21 3.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.53 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -101.75 129.16 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.892 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.452 ' CD1' HD21 ' A' ' 120' ' ' LEU . 85.0 mt -124.0 126.8 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.076 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 106' ' ' LEU . 8.2 t-20 -73.43 95.24 2.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 105' ' ' ASN . 51.4 mt -35.08 -34.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 105' ' ' ASN . 88.7 m-85 -103.56 112.7 25.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.92 -178.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.829 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 109' ' ' TYR . 1.3 p90 -62.06 -30.53 71.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.947 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.2 t -93.99 33.86 1.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.181 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' OD1' ' NE ' ' A' ' 75' ' ' ARG . 14.5 t0 43.0 44.73 4.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 69.7 m -131.52 109.66 10.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.17 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 112' ' ' THR . 60.3 mt -34.66 140.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.529 HG21 ' CE2' ' A' ' 154' ' ' PHE . 27.6 m -67.66 165.44 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 p -164.94 158.1 16.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.864 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.94 141.05 1.23 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -40.01 149.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.917 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.7 ttp -159.76 148.46 17.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.71 123.36 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.47 ' HB2' ' CB ' ' A' ' 141' ' ' SER . 4.6 pp -135.34 156.55 48.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -77.95 158.72 29.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.852 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.429 HD13 ' CD1' ' A' ' 150' ' ' LEU . 10.3 mt -118.87 158.64 25.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -91.46 152.04 43.23 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.576 0.703 . . . . 0.0 110.909 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 170.37 16.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.346 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.474 ' CG1' ' HD2' ' A' ' 126' ' ' PRO . 98.3 t -109.24 138.49 20.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.548 0.69 . . . . 0.0 111.164 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.474 ' HD2' ' CG1' ' A' ' 125' ' ' VAL . 53.7 Cg_endo -69.76 169.2 19.46 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.323 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 128' ' ' GLY . 11.7 t-160 -42.46 108.84 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.82 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 35.4 73.62 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.452 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.458 ' HB2' ' CG1' ' A' ' 125' ' ' VAL . 56.1 tp -47.65 124.8 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 110.942 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.43 ' HG3' ' N ' ' A' ' 131' ' ' ASP . 13.6 pt-20 -37.66 -50.28 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.43 ' N ' ' HG3' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -115.24 160.26 19.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.03 -60.92 2.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.3 tp -88.64 135.73 33.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -108.06 91.36 7.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.653 0.74 . . . . 0.0 110.897 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.507 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.76 -10.41 28.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.8 mm -95.61 -16.62 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.434 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -41.46 148.17 0.36 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 m -65.3 166.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 66.6 p -108.96 154.67 21.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.139 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.02 135.93 8.27 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.47 ' CB ' ' HB2' ' A' ' 120' ' ' LEU . 88.2 p -51.12 120.41 4.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.377 . . . . 0.0 110.837 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER -50.05 132.15 22.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.644 0.735 . . . . 0.0 110.881 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.0 11.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.688 2.259 . . . . 0.0 112.363 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 146' ' ' GLU . 23.4 t-20 -49.25 143.89 5.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -97.6 -32.49 11.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.447 ' N ' ' OD1' ' A' ' 144' ' ' ASN . 11.9 pt-20 -84.3 34.56 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.5 p -118.26 155.2 51.91 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.516 0.674 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 137.19 34.7 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.308 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 8.3 t -120.69 131.68 54.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.429 ' CD1' HD13 ' A' ' 122' ' ' LEU . 6.4 mt -107.23 140.06 40.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -109.12 123.91 49.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.559 HD23 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -135.08 161.21 35.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -121.18 123.88 43.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 152' ' ' LEU . 25.6 m-85 -91.23 116.13 28.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.61 152.21 51.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.424 ' CZ2' ' HB3' ' A' ' 113' ' ' LEU . 5.3 m95 -137.47 107.97 6.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.497 ' CG ' ' N ' ' A' ' 158' ' ' SER . 16.2 p90 -90.28 -46.65 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.497 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 26.9 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.5 t -64.65 135.69 56.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.874 0.369 . . . . 0.0 110.811 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.4 p -61.4 111.92 1.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.57 -102.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.6 t -159.96 145.83 15.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 0.0 110.874 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.3 p -43.3 130.73 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -47.05 -63.61 3.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -88.99 123.73 33.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.406 ' C ' HD12 ' A' ' 70' ' ' ILE . 5.4 p -128.21 -33.65 2.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.77 126.15 51.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.498 HD12 ' CZ3' ' A' ' 156' ' ' TRP . 12.4 tp -84.15 144.1 29.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -146.95 139.07 24.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.6 mt -141.28 127.65 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.409 ' HB2' ' CD2' ' A' ' 63' ' ' TRP . 25.8 tttp -103.24 120.35 40.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 mm -83.08 145.99 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.06 -73.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.1 p -172.96 169.17 4.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.446 ' CB ' HD21 ' A' ' 150' ' ' LEU . . . -113.97 158.1 21.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.463 HG23 ' CD2' ' A' ' 20' ' ' TYR . 14.6 t -137.04 151.99 49.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.463 ' CD2' HG23 ' A' ' 19' ' ' THR . 9.7 m-85 58.85 32.76 22.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.7 t -63.96 166.5 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.136 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -84.56 38.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 23' ' ' VAL . 18.1 m -93.76 62.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -72.44 -73.38 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 pp -56.79 169.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -120.54 48.58 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -111.01 -40.66 4.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.6 mt -44.76 142.53 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -85.27 -56.38 3.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -148.09 179.69 7.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 55' ' ' CYS . 7.7 pt -139.79 170.15 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.151 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -170.79 150.64 3.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.568 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 9.3 t -102.49 151.94 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -130.86 116.65 18.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.8 p -104.57 170.31 7.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.185 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.98 146.5 4.96 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.47 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 38' ' ' TYR . 3.6 mp -104.12 135.95 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.86 0.362 . . . . 0.0 111.127 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.453 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 35.4 m-85 -129.07 149.18 51.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.467 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.8 t-160 -123.05 98.45 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.74 44.29 39.42 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.446 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.92 29.68 72.47 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.442 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -139.48 140.78 26.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 142.78 48.78 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.712 2.275 . . . . 0.0 112.323 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 39' ' ' HIS . 9.1 mp -110.49 -34.91 6.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 p -152.72 163.09 40.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -47.84 151.49 0.89 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -80.21 140.25 36.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.44 HG11 ' CG ' ' A' ' 64' ' ' LEU . 74.4 t -104.7 132.67 50.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -118.81 161.31 20.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.405 HG22 ' CD1' ' A' ' 60' ' ' TRP . 8.8 t -107.4 160.49 15.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -46.85 154.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.05 136.72 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.413 ' CG2' ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -144.23 152.12 53.4 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.663 0.745 . . . . 0.0 111.086 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 139.89 41.26 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.696 2.264 . . . . 0.0 112.37 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 31' ' ' ILE . 24.9 p -51.03 -44.15 60.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.1 m -53.49 -35.52 60.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -132.53 83.96 52.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.719 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.539 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.79 3.27 2.88 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.688 2.259 . . . . 0.0 112.342 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -49.94 113.15 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.568 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 6.2 m-90 -106.41 -48.83 3.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 60' ' ' TRP . 6.8 m-80 36.61 49.72 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -121.38 146.54 46.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.409 ' CD2' ' HB2' ' A' ' 14' ' ' LYS . 59.5 m95 -87.71 100.05 12.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.44 ' CG ' HG11 ' A' ' 48' ' ' VAL . 12.2 tp -84.39 119.27 24.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -95.07 137.79 33.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -107.75 127.56 53.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.4 50.41 1.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 pp -118.5 163.4 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.57 112.23 22.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.626 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.5 mp -48.68 -52.42 45.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.661 0.743 . . . . 0.0 111.148 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.3 Cg_endo -69.8 2.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.498 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.1 t70 -129.29 1.82 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.6 118.61 71.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.627 0.727 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 136.92 34.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.65 2.233 . . . . 0.0 112.341 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 23.2 mmt85 -54.47 -36.1 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.407 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -59.39 -35.61 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.26 166.25 8.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.106 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -162.18 174.46 12.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.0 tp -94.87 134.35 37.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.0 m -132.28 132.66 43.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.56 155.15 50.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.6 m -157.62 127.42 6.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mt -83.48 140.03 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 63.7 m -136.11 149.68 48.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.9 p -106.6 120.44 41.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 86' ' ' VAL . 7.6 p -102.55 115.43 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.143 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HD2' ' C ' ' A' ' 87' ' ' LYS . 1.4 tmmt? -128.13 132.92 48.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.49 -145.33 5.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.474 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -131.07 136.4 48.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.875 0.369 . . . . 0.0 110.879 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -47.23 129.19 12.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.927 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.58 -41.57 3.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.514 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.98 177.53 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.848 0.356 . . . . 0.0 111.114 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.51 154.1 41.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -115.93 -174.83 2.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -136.07 120.94 18.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.863 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -96.98 135.98 38.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.2 t -137.03 131.94 18.04 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.576 0.703 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 151.93 69.04 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.682 2.255 . . . . 0.0 112.319 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.5 mt -127.82 -53.36 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.923 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.04 164.89 32.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.084 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.532 ' O ' ' CE3' ' A' ' 101' ' ' TRP . 58.9 p-90 -146.94 129.2 15.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.33 129.29 5.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.469 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -106.75 126.84 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 0.0 110.862 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.2 mt -118.51 124.03 72.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.21 96.12 0.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.5 mt -37.92 -45.49 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 67.7 m-85 -94.42 114.81 26.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -48.06 174.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -60.67 -19.03 57.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 t -94.57 12.45 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.131 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 65.97 37.75 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 113' ' ' LEU . 4.5 m -136.77 121.68 18.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.576 ' CD2' ' CH2' ' A' ' 156' ' ' TRP . 23.2 mt -34.69 146.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.505 HG21 ' CG ' ' A' ' 154' ' ' PHE . 23.4 m -75.31 175.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.144 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.6 p -167.15 161.42 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.795 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.1 136.6 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.407 ' HE2' ' CD ' ' A' ' 151' ' ' GLU . 38.7 tttt -42.77 146.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.727 0.298 . . . . 0.0 110.917 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.3 ttp -154.61 148.21 25.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.63 117.17 11.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.126 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.425 ' CD1' ' O ' ' A' ' 121' ' ' ASN . 4.3 pp -129.72 161.88 29.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.425 ' O ' ' CD1' ' A' ' 120' ' ' LEU . 10.8 m120 -82.05 158.48 23.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.5 mt -117.31 144.85 44.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.467 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 49.8 m95 -70.35 152.01 95.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 0.0 110.943 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 170.27 16.9 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 0.0 112.352 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.9 t -109.87 110.01 59.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.656 0.741 . . . . 0.0 111.104 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 161.43 45.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 0.0 112.343 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.699 ' CD2' ' N ' ' A' ' 128' ' ' GLY . 14.7 p-80 -65.64 -52.87 48.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.699 ' N ' ' CD2' ' A' ' 127' ' ' HIS . . . -45.12 -66.92 1.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.447 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 128' ' ' GLY . 12.7 tp -34.63 110.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.896 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -101.37 56.32 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -158.66 150.49 21.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.2 mt -76.97 -49.01 16.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.3 tp -99.32 128.64 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -108.48 91.51 8.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.679 0.752 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.453 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.76 -43.92 2.38 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.711 2.274 . . . . 0.0 112.391 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 137' ' ' GLY . 45.2 mt -65.11 -28.72 45.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -35.01 151.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -60.68 176.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.7 p -122.05 169.11 11.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.112 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.79 166.32 24.28 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 142' ' ' ASN . 6.3 p -88.32 94.19 9.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.628 HD22 ' ND2' ' A' ' 144' ' ' ASN . 10.3 t30 -37.09 133.33 0.71 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.657 0.742 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' ASN . 54.0 Cg_endo -69.66 -48.67 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.361 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.628 ' ND2' HD22 ' A' ' 142' ' ' ASN . 2.3 m-20 -37.12 126.38 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -86.69 -27.22 23.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -60.46 -34.74 74.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.5 p -66.36 151.02 96.58 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.591 0.71 . . . . 0.0 111.168 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 159.48 53.24 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.726 2.284 . . . . 0.0 112.324 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 t -135.51 137.36 42.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.446 HD21 ' CB ' ' A' ' 18' ' ' ALA . 10.4 mt -109.21 138.12 46.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.407 ' CD ' ' HE2' ' A' ' 117' ' ' LYS . 34.7 tt0 -105.67 126.46 52.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.478 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -136.09 159.52 41.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -115.61 123.96 49.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.505 ' CG ' HG21 ' A' ' 114' ' ' VAL . 35.4 m-85 -92.13 118.17 30.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.599 ' C ' ' CD1' ' A' ' 156' ' ' TRP . 1.3 m-20 -143.48 158.23 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.599 ' CD1' ' C ' ' A' ' 155' ' ' ASP . 0.9 OUTLIER -153.16 112.78 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.524 ' CG ' ' N ' ' A' ' 158' ' ' SER . 28.9 p90 -101.28 -53.27 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 1.9 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.889 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.7 p -146.65 122.66 10.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.8 t -115.63 -49.93 2.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.53 -76.16 1.73 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.0 t -112.76 131.83 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.856 0.36 . . . . 0.0 110.851 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.8 p -69.06 -178.48 1.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.828 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.06 -117.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.522 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 10' ' ' ALA . 2.2 t30 -79.18 175.8 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.421 ' C ' HD12 ' A' ' 70' ' ' ILE . 28.1 m -130.17 -43.84 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.522 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . -114.19 139.45 49.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.09 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD11 ' CZ3' ' A' ' 156' ' ' TRP . 6.0 tp -95.89 137.15 35.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.453 ' N ' HD12 ' A' ' 11' ' ' LEU . 9.1 ttp180 -136.71 132.42 34.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.0 mt -138.28 137.31 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.193 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -116.85 128.84 55.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 mm -91.34 140.14 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -98.04 -71.19 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.4 p -171.06 -179.54 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.35 164.57 18.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 t -135.5 150.87 49.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 50.83 52.41 15.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 21.5 t -74.27 165.81 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.4 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.8 t-20 -89.11 36.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 m -101.37 93.05 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.132 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -96.92 -70.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 pp -50.72 168.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.403 ' N ' ' CD ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -120.63 61.88 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -129.41 -33.94 1.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.0 mt -49.62 127.7 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.113 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.54 -64.93 0.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -142.06 179.85 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 53' ' ' VAL . 6.2 pt -136.81 178.25 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 2.3 p90 -172.95 159.55 4.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -118.53 148.98 21.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -124.82 120.69 32.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.8 p -113.7 166.43 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.141 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.74 154.98 8.97 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -102.49 144.73 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.867 0.365 . . . . 0.0 111.13 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.481 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 53.4 m-85 -139.16 153.13 47.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 76' ' ' ALA . 2.8 t-160 -130.18 101.84 5.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.87 24.26 76.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.13 -35.49 4.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.519 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.34 138.93 55.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.718 . . . . 0.0 110.885 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.47 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 53.8 Cg_endo -69.81 165.31 31.46 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.629 2.219 . . . . 0.0 112.328 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mp -122.83 -39.88 2.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.0 p -146.84 161.18 41.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -47.84 155.13 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.73 142.84 29.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.465 ' CG1' HD12 ' A' ' 64' ' ' LEU . 83.5 t -99.78 134.56 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -119.84 140.59 50.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 t -97.82 163.55 12.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -51.12 162.39 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.52 123.01 35.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.448 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 2.3 m -119.6 152.29 53.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 132.79 24.14 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.341 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 4.5 p -44.58 -46.9 10.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -49.75 -34.9 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.883 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -134.72 87.42 31.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.579 0.704 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.583 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.8 Cg_endo -69.77 3.57 2.7 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.681 2.254 . . . . 0.0 112.334 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -54.1 110.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.882 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.583 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.0 m-90 -97.91 -60.58 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 48.07 50.38 16.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -121.58 141.08 51.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -82.95 101.2 10.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.465 HD12 ' CG1' ' A' ' 48' ' ' VAL . 10.0 tp -92.29 114.86 27.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -97.91 139.65 33.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.928 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -105.96 138.66 41.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.8 32.5 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 69' ' ' TYR . 1.9 pp -99.8 164.25 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.26 123.63 47.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.602 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -56.92 -53.8 61.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.6 0.714 . . . . 0.0 111.112 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.79 2.14 3.82 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.641 2.227 . . . . 0.0 112.323 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.499 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 7.0 t0 -124.99 -9.58 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.34 114.46 35.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.697 . . . . 0.0 110.94 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 145.42 57.0 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.692 2.261 . . . . 0.0 112.31 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -57.01 -45.74 82.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.542 ' HB2' ' CE1' ' A' ' 39' ' ' HIS . . . -52.27 -35.53 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' C ' ' HG3' ' A' ' 78' ' ' ARG . . . -65.75 156.32 33.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.419 ' HG3' ' C ' ' A' ' 77' ' ' ALA . 88.0 mtt180 -152.76 172.47 16.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.4 tp -93.74 133.04 37.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.5 m -127.64 134.51 49.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.26 154.72 46.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 99.8 p -158.86 131.33 6.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.431 HG21 ' N ' ' A' ' 84' ' ' CYS . 22.6 mt -80.59 141.98 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.431 ' N ' HG21 ' A' ' 83' ' ' ILE . 87.7 m -135.77 149.16 49.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.9 m -115.02 120.32 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.569 HG21 ' CD2' ' A' ' 96' ' ' HIS . 6.1 p -105.21 137.8 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 tptt -130.03 114.25 15.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.61 -179.78 27.57 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -128.65 -176.64 3.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 0.0 110.879 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.87 -70.76 0.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -111.63 23.31 17.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.488 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -98.48 157.51 16.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 111.081 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.4 pttm -71.05 147.11 48.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.497 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 24.1 mt-10 -103.28 144.87 30.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -120.2 120.29 35.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.569 ' CD2' HG21 ' A' ' 86' ' ' VAL . 5.0 m170 -93.81 145.5 24.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.7 t -152.53 126.34 4.35 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.585 0.707 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 155.0 67.05 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.294 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.4 mt -128.51 -53.09 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.16 152.35 49.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.483 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 64.1 p-90 -134.06 127.37 32.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.48 129.45 6.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -112.53 124.75 53.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.7 mt -119.39 132.5 69.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.181 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -74.84 96.89 3.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.9 mt -36.49 -39.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -99.84 117.36 34.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -57.02 -174.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -76.2 6.39 5.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.95 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.1 p -126.54 18.6 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 58.45 30.05 19.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 94.4 m -117.49 103.52 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 112' ' ' THR . 24.0 mt -34.7 135.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.403 HG21 ' CE2' ' A' ' 154' ' ' PHE . 15.4 m -70.05 157.46 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.6 t -156.15 173.46 16.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.89 142.99 0.18 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.485 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.46 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 9.3 ttpt -44.6 148.75 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 31.8 ttp -159.69 147.86 17.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.73 122.23 16.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.3 155.37 48.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -75.66 152.17 37.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.6 mt -115.81 148.87 39.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.483 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 21.0 m95 -78.38 147.44 72.2 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.553 0.692 . . . . 0.0 110.943 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.44 ' O ' ' NE1' ' A' ' 101' ' ' TRP . 53.0 Cg_endo -69.8 173.57 10.81 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.682 2.255 . . . . 0.0 112.324 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.75 134.04 34.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.581 0.705 . . . . 0.0 111.123 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -165.27 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.703 2.269 . . . . 0.0 112.353 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 127' ' ' HIS . 14.2 p80 -92.83 119.54 32.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.24 85.83 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.507 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 39.8 tp -130.45 100.42 5.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.773 0.321 . . . . 0.0 110.926 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -66.02 -60.94 2.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -53.87 138.71 35.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 25.7 mt -73.82 -48.68 29.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.59 135.66 38.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.958 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -105.84 91.39 5.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.639 0.733 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.481 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.77 -33.28 16.85 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.349 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.41 -20.81 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -42.75 153.86 0.19 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.503 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.3 m -62.95 158.17 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.371 . . . . 0.0 111.129 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 20.0 p -104.19 165.39 11.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.67 169.37 25.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.48 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 142' ' ' ASN . 24.4 p -88.08 102.35 14.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 141' ' ' SER . 56.5 t-20 -34.4 120.48 0.54 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -1.93 9.35 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.709 2.273 . . . . 0.0 112.379 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -85.34 135.02 34.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -85.49 -50.5 7.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -42.82 -52.64 4.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 45.7 p -48.28 150.22 2.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.622 0.725 . . . . 0.0 111.113 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 158.87 55.38 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.656 2.237 . . . . 0.0 112.299 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 7.7 t -135.54 138.39 43.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.1 mt -109.28 142.02 40.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.419 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 9.9 tt0 -110.02 123.54 49.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.521 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -131.06 164.44 25.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.46 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 59.6 mt-10 -123.85 117.69 25.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.403 ' CE2' HG21 ' A' ' 114' ' ' VAL . 31.6 m-85 -82.39 104.35 12.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.844 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -112.35 143.78 42.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.508 ' CZ3' HD11 ' A' ' 11' ' ' LEU . 12.8 m95 -134.67 88.05 2.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 158' ' ' SER . 11.8 p90 -90.05 -41.53 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.466 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 30.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 p -140.06 168.28 20.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.839 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -101.34 -43.37 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.27 -72.4 0.18 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.4 t -43.95 -49.25 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.853 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 t -92.34 98.58 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.85 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.82 44.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.524 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -136.48 163.41 30.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.431 ' H ' ' CB ' ' A' ' 158' ' ' SER . 1.7 m -132.64 -43.37 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.403 ' H ' ' CB ' ' A' ' 158' ' ' SER . . . -120.56 135.09 55.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.554 HD11 ' CH2' ' A' ' 156' ' ' TRP . 12.4 tp -94.42 145.3 24.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.419 ' C ' HG13 ' A' ' 13' ' ' ILE . 27.4 ptt180 -147.53 141.69 26.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.419 HG13 ' C ' ' A' ' 12' ' ' ARG . 21.7 mt -141.13 140.82 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -115.24 136.81 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 16' ' ' LEU . 43.5 mm -98.58 141.69 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.435 ' N ' HG23 ' A' ' 15' ' ' ILE . 4.1 mm? -98.44 -71.99 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.9 p -169.1 172.95 7.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.427 ' CB ' HD21 ' A' ' 150' ' ' LEU . . . -121.53 164.09 17.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.072 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -145.35 156.31 43.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 58.87 35.07 24.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 22' ' ' ASN . 39.7 t -66.93 165.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.466 ' N ' HG13 ' A' ' 21' ' ' VAL . 9.3 m120 -85.57 51.81 2.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.941 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.0 107.09 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -109.71 -74.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 pp -65.33 167.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.462 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -112.77 74.63 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -134.98 -46.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.841 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.4 mt -38.5 123.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -68.26 -61.75 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.892 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -148.18 174.52 11.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -132.49 -179.72 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.098 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -169.74 173.58 6.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.562 HG22 ' CZ2' ' A' ' 60' ' ' TRP . 94.0 t -124.97 146.2 31.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.401 ' NH1' HD11 ' A' ' 132' ' ' LEU . 17.9 ttt180 -129.67 117.31 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.1 p -115.8 175.67 5.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.104 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.44 146.34 4.5 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.516 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.406 ' CG1' HD13 ' A' ' 106' ' ' LEU . 2.3 mp -90.04 140.82 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 111.173 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.556 ' CE1' HD21 ' A' ' 133' ' ' LEU . 37.8 m-85 -137.64 134.04 35.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.541 ' CD2' ' HB2' ' A' ' 76' ' ' ALA . 8.0 t-160 -127.19 105.39 8.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.1 56.16 3.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.489 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.75 37.84 28.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.466 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -154.12 142.71 14.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.678 0.751 . . . . 0.0 110.886 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.472 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 53.3 Cg_endo -69.8 165.96 29.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.654 2.236 . . . . 0.0 112.33 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.6 mp -119.96 -40.25 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 16.2 p -145.94 165.3 29.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -51.06 128.17 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -59.9 143.55 51.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.458 HG12 ' CD1' ' A' ' 64' ' ' LEU . 56.3 t -104.14 133.41 48.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.155 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.31 140.34 49.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -96.58 153.13 18.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -41.72 161.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.1 mtm-85 -89.33 146.09 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.81 152.14 64.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.635 0.731 . . . . 0.0 111.155 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 135.88 31.47 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.719 2.279 . . . . 0.0 112.338 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 8.0 p -46.2 -48.53 17.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -47.76 -36.53 11.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -132.93 87.05 41.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.63 0.728 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.597 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 54.0 Cg_endo -69.74 3.09 2.96 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.68 2.253 . . . . 0.0 112.359 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -57.18 125.82 24.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.832 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.597 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 5.2 m-90 -108.83 -57.42 2.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.937 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 49.28 53.19 13.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -128.23 143.54 51.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -87.64 104.68 16.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.458 ' CD1' HG12 ' A' ' 48' ' ' VAL . 11.6 tp -90.06 121.08 31.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -97.47 136.73 37.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -106.2 129.28 54.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.08 44.25 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.891 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 pp -111.29 164.17 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.119 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.605 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.95 120.07 38.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.616 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -55.61 -52.8 68.97 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.614 0.721 . . . . 0.0 111.153 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.82 2.98 3.07 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.726 2.284 . . . . 0.0 112.325 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.496 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 1.8 t70 -126.08 -7.15 6.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.43 ' C ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -77.99 114.84 45.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.588 0.709 . . . . 0.0 110.917 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.72 139.25 39.9 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.725 2.283 . . . . 0.0 112.331 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.49 ' NE ' ' OD1' ' A' ' 111' ' ' ASP . 74.6 mmt-85 -50.23 -40.39 47.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . . . -54.71 -43.67 72.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.068 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' CB ' HD11 ' A' ' 73' ' ' LEU . . . -53.13 154.22 3.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -151.25 170.75 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.7 tp -93.94 133.23 37.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m -132.73 142.73 49.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 pp -148.71 157.6 43.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.3 p -157.92 131.1 7.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.47 ' CD1' HD11 ' A' ' 150' ' ' LEU . 29.0 mt -85.65 126.22 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 28.6 m -124.22 151.03 44.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 p -107.54 127.7 53.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.411 HG21 ' NE2' ' A' ' 96' ' ' HIS . 2.6 p -105.58 132.53 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -153.16 135.21 14.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.44 174.94 38.05 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.507 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 161.79 17.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -55.92 135.28 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.21 -42.4 3.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.5 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.72 168.54 16.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.834 0.35 . . . . 0.0 111.089 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -82.98 166.5 18.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -88.82 179.01 6.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -138.85 114.5 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 4.5 m170 -94.34 130.62 40.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.9 t -131.94 127.3 21.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.583 0.706 . . . . 0.0 110.887 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 150.4 67.86 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.633 2.222 . . . . 0.0 112.336 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.0 mt -123.87 -50.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.88 179.36 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.514 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 64.6 p-90 -158.22 130.79 7.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.954 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.33 133.43 6.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -115.39 132.55 56.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.771 0.32 . . . . 0.0 110.914 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.31 124.84 73.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 106' ' ' LEU . 4.9 m120 -64.66 89.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 105' ' ' ASN . 16.0 mt -34.66 -40.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -105.25 112.51 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -52.13 173.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -55.33 -35.59 65.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 t -87.78 27.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.49 ' OD1' ' NE ' ' A' ' 75' ' ' ARG . 8.4 t0 47.83 52.46 12.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 97.2 m -139.16 108.71 6.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.133 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.469 ' HB3' ' CZ2' ' A' ' 156' ' ' TRP . 20.3 mt -34.94 133.21 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.527 HG21 ' CE2' ' A' ' 154' ' ' PHE . 26.4 m -63.43 171.71 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.7 m -162.85 175.53 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.04 153.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.496 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.423 ' HE3' ' CG ' ' A' ' 153' ' ' GLU . 20.0 ttmt -58.73 148.07 30.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.76 0.314 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 41.1 ttp -154.67 151.86 29.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.908 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.84 128.5 26.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.117 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 pp -139.87 162.48 35.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -87.52 150.52 23.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 mt -108.17 155.41 20.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.539 ' CH2' ' HD2' ' A' ' 143' ' ' PRO . 7.3 m95 -90.94 141.54 26.72 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.61 0.719 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 136.01 31.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.353 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.0 137.15 72.81 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.619 0.723 . . . . 0.0 111.111 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 159.5 53.22 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 0.0 112.362 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -58.65 -55.5 34.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -44.27 -64.08 2.14 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 128' ' ' GLY . 35.4 tp -33.56 126.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -109.06 -36.58 6.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.54 -175.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.401 HD11 ' NH1' ' A' ' 34' ' ' ARG . 12.1 mt -105.04 -51.53 3.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.556 HD21 ' CE1' ' A' ' 38' ' ' TYR . 9.7 tp -97.38 145.93 25.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -114.38 93.05 30.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.638 0.733 . . . . 0.0 110.857 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.79 -38.68 7.39 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.663 2.242 . . . . 0.0 112.317 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.2 mt -73.02 -20.12 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.405 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -45.67 148.36 1.89 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.3 m -62.35 178.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.141 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 82.4 p -123.79 157.65 33.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.151 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.25 170.91 19.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 p -84.07 128.93 34.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 144' ' ' ASN . 5.9 t-20 -65.6 132.45 94.99 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.672 0.749 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.539 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.79 -50.82 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.689 2.259 . . . . 0.0 112.329 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 69.1 m-80 -39.01 135.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -89.19 -25.95 21.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -85.19 41.39 0.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.8 p -129.55 152.82 80.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.582 0.706 . . . . 0.0 111.145 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 137.15 34.66 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.325 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.37 146.46 48.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.47 HD11 ' CD1' ' A' ' 83' ' ' ILE . 5.7 mt -120.95 156.21 32.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -121.62 120.25 34.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.563 HD22 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -127.43 163.65 23.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.423 ' CG ' ' HE3' ' A' ' 117' ' ' LYS . 49.5 mt-10 -124.59 120.99 33.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.563 ' CE2' HD22 ' A' ' 152' ' ' LEU . 39.2 m-85 -89.31 102.12 14.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -122.6 134.78 54.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.554 ' CH2' HD11 ' A' ' 11' ' ' LEU . 15.7 m95 -120.89 98.01 5.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.597 ' CG ' ' N ' ' A' ' 158' ' ' SER . 12.4 p90 -79.53 -53.38 6.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.597 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 61.6 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -109.06 -52.87 2.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.7 m -77.71 85.51 4.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.887 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.97 70.54 0.1 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.501 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -85.64 109.48 18.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.381 . . . . 0.0 110.848 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.7 p -151.64 138.56 19.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.64 -148.25 4.77 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.518 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -85.09 152.34 23.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.853 0.358 . . . . 0.0 110.923 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 p -125.17 -34.95 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.71 125.19 49.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.564 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 21.0 tp -88.42 142.44 27.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.422 ' HD2' ' CD1' ' A' ' 157' ' ' PHE . 7.7 ptm180 -149.34 127.56 12.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.9 mt -129.52 138.7 53.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.496 ' HD3' ' CE2' ' A' ' 63' ' ' TRP . 3.3 ttpm? -114.02 129.91 56.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mm -89.51 145.34 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.89 -72.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.1 p -169.72 174.8 5.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.99 156.74 34.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.519 HG23 ' CE2' ' A' ' 20' ' ' TYR . 9.8 t -127.1 163.19 24.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.519 ' CE2' HG23 ' A' ' 19' ' ' THR . 7.8 m-85 53.3 30.81 10.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.9 t -53.05 144.77 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -76.87 51.62 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.01 117.0 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -122.41 -51.33 1.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.447 ' H ' ' CD1' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -74.85 172.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.167 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.442 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER -115.43 50.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 87' ' ' LYS . 23.0 t0 -107.11 -59.44 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' A' ' 27' ' ' ASP . 20.2 mt -36.52 132.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.436 ' N ' ' HD3' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -83.34 -52.22 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -147.52 178.6 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.432 ' CG1' ' O ' ' A' ' 53' ' ' VAL . 6.9 pt -138.46 174.83 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -169.51 155.57 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.523 HG21 ' CZ2' ' A' ' 60' ' ' TRP . 58.1 t -111.6 140.28 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -113.42 127.53 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.5 p -123.67 169.73 11.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.54 135.54 1.97 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -81.9 146.51 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.515 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 44.8 m-85 -140.6 162.89 34.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.459 ' CB ' HD11 ' A' ' 44' ' ' LEU . 3.1 t-160 -132.65 94.3 3.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.53 -32.98 4.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.541 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.45 -30.52 0.29 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -91.44 152.64 43.84 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.679 0.752 . . . . 0.0 110.841 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 156.34 63.56 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.737 2.292 . . . . 0.0 112.343 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' N ' HD13 ' A' ' 44' ' ' LEU . 8.9 mp -106.22 -41.39 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.9 m -133.8 -67.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -173.42 171.96 3.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.34 144.51 32.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.461 HG13 ' CD1' ' A' ' 64' ' ' LEU . 43.2 t -110.76 140.24 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -120.73 144.01 48.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.7 p -94.85 159.68 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -49.92 172.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -100.98 131.79 46.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 1.5 m -136.02 152.17 75.07 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.592 0.71 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 140.18 41.93 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.0 p -50.03 -32.77 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 m -63.13 -31.29 72.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -133.32 81.43 55.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.738 . . . . 0.0 110.902 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 3.17 2.91 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.692 2.261 . . . . 0.0 112.343 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -61.42 106.74 0.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.523 ' CZ2' HG21 ' A' ' 33' ' ' VAL . 3.9 m-90 -90.68 -47.24 7.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 39.3 41.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' C ' ' HG3' ' A' ' 14' ' ' LYS . 5.3 tp10 -114.03 135.82 53.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.496 ' CE2' ' HD3' ' A' ' 14' ' ' LYS . 52.7 m95 -83.73 107.88 16.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.461 ' CD1' HG13 ' A' ' 48' ' ' VAL . 10.0 tp -95.2 121.02 36.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.84 140.12 31.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -107.39 125.43 51.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -78.05 45.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.0 164.17 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.59 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.62 124.86 48.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.947 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.559 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -51.89 -55.47 30.09 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.607 0.718 . . . . 0.0 111.134 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.59 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.5 Cg_endo -69.71 2.42 3.52 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.691 2.261 . . . . 0.0 112.401 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.488 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.6 t70 -123.04 -5.69 8.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.422 HD13 ' C ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -83.6 114.7 55.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.633 0.73 . . . . 0.0 110.939 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.413 ' N ' HD13 ' A' ' 73' ' ' LEU . 53.9 Cg_endo -69.7 136.04 32.14 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.694 2.263 . . . . 0.0 112.369 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.433 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -49.75 -44.34 48.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.64 -39.17 61.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.43 157.84 25.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -153.02 177.56 10.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -93.77 139.38 30.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.9 m -129.74 145.94 51.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.87 136.83 14.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.7 m -143.84 139.58 29.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.453 ' CG1' HD12 ' A' ' 150' ' ' LEU . 59.5 mt -88.76 146.84 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.15 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 81.3 m -146.18 153.56 40.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.8 m -114.72 122.3 46.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.65 127.53 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 29' ' ' ASP . 21.9 tptm -141.45 134.14 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.99 -158.52 9.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.511 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 -133.62 -174.57 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -49.25 -74.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -117.1 46.61 1.13 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.51 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -133.99 168.44 18.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 174.32 6.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.81 169.0 8.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -126.98 134.29 50.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -107.71 125.39 51.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.3 t -129.25 125.89 22.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.719 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 152.23 69.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.643 2.229 . . . . 0.0 112.352 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.2 mt -123.91 -49.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.73 174.25 11.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.464 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 68.6 p-90 -151.18 134.33 15.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.918 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.8 133.11 5.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -120.48 130.68 54.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.432 HG12 ' CD2' ' A' ' 120' ' ' LEU . 14.6 mt -114.22 130.55 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 106' ' ' LEU . 40.5 m-20 -67.28 95.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.7 mt -34.81 -43.15 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.433 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 77.8 m-85 -107.24 111.05 23.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 34.6 p30 -52.19 -177.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.876 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -56.49 -37.88 70.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.436 ' O ' ' C ' ' A' ' 111' ' ' ASP . 8.9 t -88.73 34.7 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.138 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 110' ' ' THR . 6.7 m-20 35.62 54.75 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 113' ' ' LEU . 98.1 m -134.28 109.29 8.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.172 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' A' ' 112' ' ' THR . 56.7 mt -34.36 138.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.526 HG22 ' CZ ' ' A' ' 154' ' ' PHE . 12.8 m -68.02 165.49 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 p -159.73 162.86 35.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.1 142.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.424 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 7.8 ttpt -47.21 148.71 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.7 ttp -156.1 151.94 27.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.3 132.56 29.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.432 ' CD2' HG12 ' A' ' 104' ' ' ILE . 3.6 pp -141.16 154.41 45.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.35 152.13 39.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 mt -111.45 141.35 45.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.464 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 23.5 m95 -75.88 152.01 84.55 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.53 0.681 . . . . 0.0 110.925 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 154.0 68.46 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.3 t -89.56 125.69 60.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.628 0.727 . . . . 0.0 111.12 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 133.26 25.11 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.647 2.231 . . . . 0.0 112.335 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -48.37 -28.73 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -89.54 60.92 3.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 42.7 tp -140.93 110.57 6.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.756 0.312 . . . . 0.0 110.955 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -76.29 -47.46 23.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.52 174.55 5.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 mt -98.91 -59.53 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.8 tp -80.42 135.83 36.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -106.11 91.27 5.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.616 0.722 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.515 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.2 Cg_endo -69.73 -44.81 1.88 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.237 . . . . 0.0 112.366 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 137' ' ' GLY . 44.3 mt -67.61 -28.38 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -36.65 149.13 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.502 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -51.73 168.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 111.155 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.454 HG22 ' CZ ' ' A' ' 78' ' ' ARG . 12.7 p -115.14 168.14 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.78 -168.81 30.65 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.451 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.8 p -96.14 148.53 22.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.893 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 142' ' ' ASN . 0.4 OUTLIER -84.45 138.72 38.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.62 0.724 . . . . 0.0 110.88 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -48.2 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.252 . . . . 0.0 112.383 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -40.74 142.14 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -98.2 -31.72 11.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -82.16 40.39 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.0 p -124.21 151.96 66.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.583 0.706 . . . . 0.0 111.115 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 117.23 4.96 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.67 2.247 . . . . 0.0 112.311 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 13.4 t -105.68 137.78 42.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.453 HD12 ' CG1' ' A' ' 83' ' ' ILE . 3.4 mt -105.51 162.18 13.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.424 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 27.5 tt0 -129.81 112.43 13.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.569 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -118.35 162.87 17.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.457 ' N ' HD21 ' A' ' 152' ' ' LEU . 14.9 mt-10 -118.74 119.1 33.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.526 ' CZ ' HG22 ' A' ' 114' ' ' VAL . 50.2 m-85 -87.58 107.46 18.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.26 155.56 48.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.564 ' CZ3' HD13 ' A' ' 11' ' ' LEU . 4.9 m95 -142.48 120.32 11.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.515 ' CG ' ' N ' ' A' ' 158' ' ' SER . 10.1 p90 -110.28 -47.83 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.515 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 8.6 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.7 m -60.31 169.86 1.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.89 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 t -112.38 154.96 24.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.31 152.54 23.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.6 m -91.0 89.66 7.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 m -108.32 122.77 47.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 8' ' ' ASN . . . -145.82 -68.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 7' ' ' GLY . 1.7 p30 -35.61 135.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.905 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -122.83 -13.77 7.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.14 151.21 38.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.086 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.526 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 14.3 tp -110.79 138.95 46.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -148.34 140.07 23.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.466 ' CD1' HD22 ' A' ' 79' ' ' LEU . 85.0 mt -135.93 137.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.159 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttt -110.71 120.81 43.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.6 mm -82.42 141.11 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.26 -72.29 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -172.07 176.79 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.7 163.07 20.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.2 t -134.78 163.39 29.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 39.54 44.6 1.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.447 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 86.9 t -66.51 160.94 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.447 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 2.4 t-20 -82.94 47.19 1.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.5 m -124.09 116.75 48.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -116.63 -43.6 2.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.437 ' H ' ' CD1' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -80.9 -174.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.13 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.26 2.73 10.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.36 -55.63 26.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.3 mt -45.88 129.17 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.418 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 21.5 t0 -72.98 -60.56 2.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.418 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 26.3 mmtp -147.91 166.56 27.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 pt -119.44 169.9 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.505 ' CZ ' ' SG ' ' A' ' 84' ' ' CYS . 6.3 p90 -163.82 144.56 8.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.568 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 63.2 t -103.03 143.92 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.423 ' N ' HG12 ' A' ' 33' ' ' VAL . 52.3 ttm-85 -121.03 122.25 39.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.6 p -116.1 166.91 11.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.73 149.42 6.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.59 134.89 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 111.148 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.463 ' CD2' ' HA ' ' A' ' 43' ' ' PRO . 47.7 m-85 -133.72 158.33 43.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.466 ' C ' ' CD2' ' A' ' 39' ' ' HIS . 6.9 t-160 -131.85 103.37 6.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.858 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.94 17.15 78.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.483 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.5 -35.48 4.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.457 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.33 142.88 59.17 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.668 0.747 . . . . 0.0 110.885 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.463 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.77 166.02 29.02 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.689 2.259 . . . . 0.0 112.338 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 mp -124.89 -41.25 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.0 m -154.39 160.06 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -41.36 151.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -88.82 165.48 14.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.459 HG11 ' CD1' ' A' ' 64' ' ' LEU . 64.2 t -119.96 133.59 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -115.38 138.2 51.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.416 HG23 ' NE1' ' A' ' 60' ' ' TRP . 15.2 t -90.37 159.12 16.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -49.67 174.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -101.89 133.48 46.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -137.36 152.11 72.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.641 0.734 . . . . 0.0 111.164 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 134.23 27.4 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.353 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.6 p -45.48 -44.93 12.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.866 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.8 t -48.66 -40.58 28.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -130.32 86.65 53.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.533 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.3 Cg_endo -69.8 2.97 3.07 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.746 2.297 . . . . 0.0 112.298 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -50.8 109.55 0.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.568 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 1.5 m-90 -99.54 -47.62 5.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 60' ' ' TRP . 3.9 p30 35.25 41.05 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.839 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.12 138.19 50.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -83.05 112.33 19.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.459 ' CD1' HG11 ' A' ' 48' ' ' VAL . 11.1 tp -97.15 119.25 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -93.07 140.13 29.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -112.47 128.71 56.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -82.21 40.5 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.425 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.0 pp -106.93 164.01 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.595 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.0 127.02 53.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -60.01 -54.46 55.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.663 0.744 . . . . 0.0 111.165 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.595 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.74 3.49 2.73 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 0.0 112.355 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.7 t70 -125.46 -7.12 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.417 HD11 ' C ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -82.12 115.72 59.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.608 0.718 . . . . 0.0 110.926 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 132.75 23.96 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.322 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 1.6 mpp_? -47.63 -43.62 26.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.38 58.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.58 167.12 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.1 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -162.21 170.87 18.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.466 HD22 ' CD1' ' A' ' 13' ' ' ILE . 49.3 tp -94.64 133.73 37.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 33.6 m -120.26 150.33 40.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.69 137.17 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 86.5 p -143.61 133.27 23.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.46 ' CG1' HD13 ' A' ' 150' ' ' LEU . 71.7 mt -84.69 140.78 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.505 ' SG ' ' CZ ' ' A' ' 32' ' ' TYR . 1.4 p -151.18 160.24 43.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.3 p -117.23 156.48 27.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.445 HG22 ' CD2' ' A' ' 96' ' ' HIS . 14.8 p -133.77 122.39 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.163 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -126.93 126.73 43.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.22 159.82 29.38 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.515 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 89' ' ' ARG . 6.6 mpt_? -109.5 162.75 14.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.912 0.387 . . . . 0.0 110.88 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -57.14 125.66 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.13 -30.36 4.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.06 167.84 15.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.6 pttm -84.63 151.02 24.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -88.28 156.11 19.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -122.57 126.08 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.445 ' CD2' HG22 ' A' ' 86' ' ' VAL . 7.1 m170 -99.59 134.74 42.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.0 t -135.65 120.31 13.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.611 0.72 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 142.01 46.65 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.664 2.243 . . . . 0.0 112.338 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.8 mt -111.65 -55.65 2.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.02 176.52 8.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.074 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.489 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 61.9 p-90 -152.76 145.09 23.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -151.83 139.78 7.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -117.83 150.3 39.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.784 0.326 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 66.0 mt -138.27 117.91 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 106' ' ' LEU . 12.4 m120 -62.41 96.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.0 mt -35.15 -40.5 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 98.1 m-85 -108.56 115.37 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -55.64 -176.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.475 ' CD1' HG23 ' A' ' 110' ' ' THR . 13.2 p90 -68.41 -4.41 14.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.475 HG23 ' CD1' ' A' ' 109' ' ' TYR . 10.0 p -109.36 22.47 15.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.154 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 110' ' ' THR . 6.0 p-10 46.61 54.43 8.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.3 m -149.9 120.83 7.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.8 mt -40.32 140.81 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.481 HG22 ' CE2' ' A' ' 154' ' ' PHE . 20.3 m -71.3 169.82 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.081 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.6 p -162.86 161.18 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.45 132.73 0.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.415 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 15.6 ttpt -39.63 148.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.738 0.304 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.9 ttp -156.2 149.22 24.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.7 113.66 8.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.89 157.81 29.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -77.67 154.51 32.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.449 ' CD1' HD11 ' A' ' 83' ' ' ILE . 4.4 mt -114.06 134.12 55.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.489 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 10.7 m95 -74.57 147.37 84.63 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.567 0.699 . . . . 0.0 110.935 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 133.93 26.88 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.251 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.7 m -69.28 140.15 90.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 134.27 27.6 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -51.51 151.41 3.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . 86.76 -41.06 3.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 128' ' ' GLY . 34.8 tp -34.73 99.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.774 0.321 . . . . 0.0 110.939 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.63 -22.67 59.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -74.24 174.59 8.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.1 mt -114.14 -43.36 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.7 tp -105.59 131.72 52.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -110.3 91.81 12.35 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.647 0.737 . . . . 0.0 110.902 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.435 ' HB3' ' CD1' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.79 -28.36 25.2 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.656 2.237 . . . . 0.0 112.335 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.2 mm -77.21 -23.58 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.09 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.416 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -36.5 147.77 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.32 174.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 111.159 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 42.2 p -117.28 172.47 7.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.163 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.33 169.63 42.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.529 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.4 p -87.68 135.99 33.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 110.833 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -76.2 122.36 86.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.657 0.742 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -1.33 8.25 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.677 2.252 . . . . 0.0 112.365 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -82.62 129.05 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -84.39 -53.53 5.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -40.6 -35.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.7 p -69.39 151.37 96.85 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 160.1 50.96 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.731 2.287 . . . . 0.0 112.348 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 14.5 t -140.09 136.4 33.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.46 HD13 ' CG1' ' A' ' 83' ' ' ILE . 8.7 mt -106.47 152.18 23.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.411 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 14.8 tt0 -120.71 115.66 23.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.572 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -121.06 159.42 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.958 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.415 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 63.5 mt-10 -116.09 122.55 45.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.481 ' CE2' HG22 ' A' ' 114' ' ' VAL . 28.9 m-85 -90.82 112.53 24.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.553 ' C ' ' CD1' ' A' ' 156' ' ' TRP . 6.6 t0 -132.61 159.07 40.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.553 ' CD1' ' C ' ' A' ' 155' ' ' ASP . 3.6 m95 -152.17 108.18 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.498 ' CG ' ' N ' ' A' ' 158' ' ' SER . 31.5 p90 -102.22 -53.76 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.498 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 16.1 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -156.09 134.38 11.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.361 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -59.74 178.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.09 164.86 12.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 t 64.67 45.26 3.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.855 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -160.17 149.01 17.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.38 63.4 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.526 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -108.67 123.18 48.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.69 -47.13 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.818 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.62 133.62 54.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.566 HD12 ' CZ3' ' A' ' 156' ' ' TRP . 15.8 tp -83.53 126.96 33.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.575 ' NE ' ' CE3' ' A' ' 63' ' ' TRP . 7.0 ttt180 -124.64 120.38 31.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 mt -131.14 141.07 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 34.8 tttt -122.26 128.66 51.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.0 mm -89.76 149.27 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.47 -70.63 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 p -172.45 -176.82 1.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.951 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.61 146.07 50.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 t -120.15 138.09 53.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 67.11 45.25 1.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.934 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 88.4 t -70.52 160.27 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.453 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 28.2 m-20 -76.32 51.27 0.69 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 m -107.85 110.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.13 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -104.68 -61.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.9 pt -87.1 -177.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.414 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 1.0 OUTLIER -121.31 49.28 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.84 -47.36 5.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 29' ' ' ASP . 18.7 mt -41.83 137.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.117 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.456 ' N ' HG22 ' A' ' 28' ' ' ILE . 0.6 OUTLIER -80.52 -57.4 3.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -147.47 -178.7 6.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 53' ' ' VAL . 7.2 pt -139.86 178.02 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 1.2 p90 -173.22 156.61 3.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.562 HG21 ' CZ2' ' A' ' 60' ' ' TRP . 87.3 t -113.75 149.7 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.121 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -122.35 132.78 54.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.1 p -128.52 162.02 28.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.44 143.32 3.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.442 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.72 140.82 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.37 . . . . 0.0 111.136 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.511 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 54.1 m-85 -136.4 145.28 45.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.458 ' CB ' HD13 ' A' ' 44' ' ' LEU . 4.5 t-160 -117.56 94.55 4.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.94 20.95 77.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.15 -26.84 19.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -85.02 141.89 38.11 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.623 0.725 . . . . 0.0 110.85 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 159.87 51.82 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.704 2.269 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.458 HD13 ' CB ' ' A' ' 39' ' ' HIS . 8.9 mp -120.64 -33.54 3.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.94 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.2 m -154.06 165.79 35.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.64 131.29 29.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.815 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -65.65 153.1 42.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.16 140.34 35.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -121.74 137.75 54.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.1 p -83.88 176.35 8.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -63.99 174.7 1.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -102.43 125.98 49.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.428 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 1.4 m -130.28 152.14 79.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.619 0.723 . . . . 0.0 111.101 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 142.28 47.46 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.689 2.259 . . . . 0.0 112.347 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 23.4 p -50.58 -48.16 57.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.8 t -47.34 -38.52 13.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -132.03 87.29 44.63 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.552 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.5 Cg_endo -69.78 3.66 2.65 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.709 2.272 . . . . 0.0 112.312 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -55.64 108.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.562 ' CZ2' HG21 ' A' ' 33' ' ' VAL . 2.3 m-90 -93.56 -52.95 4.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 43.31 49.75 5.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -121.19 138.09 54.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.575 ' CE3' ' NE ' ' A' ' 12' ' ' ARG . 77.8 m95 -84.09 108.39 16.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.9 tp -98.2 122.68 41.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -100.87 145.25 28.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -113.5 131.02 56.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -82.71 47.61 1.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.26 168.13 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -115.07 129.86 56.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.594 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -62.84 -53.63 54.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 111.164 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.1 Cg_endo -69.69 -0.95 7.59 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.362 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.5 t70 -117.64 -13.47 10.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.6 114.97 32.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.556 0.693 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 146.37 59.82 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.637 2.225 . . . . 0.0 112.353 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.445 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 21.1 mmt85 -59.22 -41.84 89.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.64 -31.41 62.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.77 167.35 15.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.097 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -163.23 173.73 13.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.5 tp -95.37 142.8 27.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 83.0 m -129.82 148.52 51.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.32 137.08 14.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 95.3 p -148.92 146.22 27.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.4 mt -93.16 143.37 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.176 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 74.7 m -137.85 145.78 42.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.8 p -109.76 122.56 47.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.443 HG21 ' CD2' ' A' ' 96' ' ' HIS . 12.0 p -105.79 121.63 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -134.64 145.08 48.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.69 174.21 39.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.514 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -102.95 170.55 7.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -65.65 -52.69 49.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.21 -2.27 87.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.46 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -118.21 178.04 4.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -91.71 170.31 10.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 9.9 mt-10 -102.62 161.43 13.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -126.61 119.16 26.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.443 ' CD2' HG21 ' A' ' 86' ' ' VAL . 8.1 m170 -98.77 124.16 43.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.74 123.21 15.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.866 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 143.03 49.42 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.662 2.241 . . . . 0.0 112.351 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.0 mt -107.63 -45.8 3.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.38 178.18 7.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.503 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 70.0 p-90 -154.33 137.89 15.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.03 138.5 7.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.473 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -122.25 140.55 52.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.465 ' CG1' HD22 ' A' ' 120' ' ' LEU . 56.5 mt -120.97 139.69 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.46 ' N ' HG22 ' A' ' 104' ' ' ILE . 77.7 m-20 -76.69 87.91 3.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 105' ' ' ASN . 21.9 mt -34.49 -36.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 59.0 m-85 -109.67 119.34 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -53.1 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.85 6.47 5.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 p -128.76 18.19 6.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.181 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 65.06 29.84 11.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 113' ' ' LEU . 88.2 m -118.68 105.76 11.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 112' ' ' THR . 31.4 mt -36.07 141.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.5 m -70.45 170.35 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.1 m -168.9 164.28 11.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.17 140.72 1.01 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.452 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 38.3 tttt -44.6 149.15 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.783 0.325 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.4 ttp -159.89 154.03 23.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.95 126.67 20.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.465 HD22 ' CG1' ' A' ' 104' ' ' ILE . 4.1 pp -136.15 153.78 51.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -79.25 158.52 27.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.455 ' CD1' HD11 ' A' ' 150' ' ' LEU . 1.9 mt -116.4 148.09 41.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.566 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 8.1 m95 -85.51 150.53 54.22 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.571 0.7 . . . . 0.0 110.944 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 138.82 38.71 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.663 2.242 . . . . 0.0 112.391 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.4 m -64.65 141.93 98.38 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.625 0.726 . . . . 0.0 111.124 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 152.92 69.59 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.697 2.265 . . . . 0.0 112.304 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -52.86 152.0 4.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.42 81.15 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.503 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.4 tp -123.08 111.26 16.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.736 0.303 . . . . 0.0 110.923 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -79.12 -53.36 7.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -59.31 158.66 8.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.7 mt -91.93 -46.54 7.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.8 tp -102.98 139.34 38.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -105.41 91.52 4.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.679 0.752 . . . . 0.0 110.87 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.511 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.9 Cg_endo -69.73 -22.76 31.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.723 2.282 . . . . 0.0 112.366 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.413 ' O ' ' C ' ' A' ' 137' ' ' GLY . 13.4 mm -82.69 -22.12 9.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -37.08 153.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.7 m -69.5 173.33 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 111.117 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.7 p -115.22 165.25 13.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 99.37 159.68 29.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.0 p -75.49 130.48 38.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.832 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.566 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 11.2 t-20 -70.84 118.47 65.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.651 0.739 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 1.98 3.94 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.67 2.246 . . . . 0.0 112.392 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -90.59 116.43 28.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -76.85 -44.19 33.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -49.03 -26.97 2.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 67.9 p -78.82 152.24 77.26 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.558 0.694 . . . . 0.0 111.165 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 146.26 59.48 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.685 2.257 . . . . 0.0 112.363 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.7 t -123.79 148.92 46.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.455 HD11 ' CD1' ' A' ' 122' ' ' LEU . 5.9 mt -118.96 150.64 39.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -112.64 139.92 47.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.576 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -148.6 151.6 35.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.452 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 35.5 mt-10 -119.51 123.11 43.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.412 ' CE2' ' CD2' ' A' ' 152' ' ' LEU . 62.6 m-85 -85.97 115.06 23.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.09 129.15 49.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.566 ' CZ3' HD12 ' A' ' 11' ' ' LEU . 20.7 m95 -124.26 81.55 1.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.5 ' CG ' ' N ' ' A' ' 158' ' ' SER . 43.4 p90 -79.46 -54.47 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.5 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 3.0 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.1 m -119.83 88.78 3.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.873 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m -156.07 146.58 21.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.52 115.8 4.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 t -75.93 144.24 41.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 0.0 110.83 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.7 m -86.65 -54.09 4.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.31 -130.72 3.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -62.76 104.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.951 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.409 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 1.8 m -118.63 -34.52 3.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.01 140.36 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.6 tp -103.64 137.49 41.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.464 ' HD2' ' CZ3' ' A' ' 63' ' ' TRP . 16.3 ptt180 -145.41 138.37 26.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.843 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.4 mt -138.4 139.14 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -114.9 137.06 52.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.8 mm -98.59 144.82 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.71 -67.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.6 p -169.56 175.05 5.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.443 ' CB ' HD21 ' A' ' 150' ' ' LEU . . . -139.1 154.41 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.567 HG22 ' CD2' ' A' ' 20' ' ' TYR . 2.9 t -130.96 162.37 29.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.567 ' CD2' HG22 ' A' ' 19' ' ' THR . 10.0 m-85 64.44 50.13 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.38 163.61 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -84.03 35.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 23' ' ' VAL . 33.5 m -97.61 93.51 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -106.71 -18.05 14.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.427 HD13 ' C ' ' A' ' 25' ' ' ILE . 1.1 pp -104.35 -177.57 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.8 mmm-85 -129.09 60.19 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -126.31 -32.91 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.864 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.0 mt -57.3 118.0 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -73.96 -56.19 5.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -142.06 172.83 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 pt -141.54 161.11 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -151.38 153.57 35.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG21 ' CZ2' ' A' ' 60' ' ' TRP . 79.3 t -105.48 137.12 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -110.19 120.15 41.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 p -117.84 161.21 20.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.171 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.78 143.46 3.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.442 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.451 HG23 ' N ' ' A' ' 38' ' ' TYR . 3.9 mp -96.61 137.05 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 111.191 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.455 ' HA ' ' CD1' ' A' ' 44' ' ' LEU . 2.7 m-85 -128.52 150.18 50.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.957 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.537 ' CD2' ' HB3' ' A' ' 76' ' ' ALA . 9.3 t-160 -121.85 99.07 6.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.04 47.23 19.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.74 33.83 81.47 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -146.64 143.69 19.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.68 0.752 . . . . 0.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 150.17 68.27 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.72 2.28 . . . . 0.0 112.365 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.455 ' CD1' ' HA ' ' A' ' 38' ' ' TYR . 7.8 mp -105.69 -39.37 6.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.889 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.0 t -156.28 166.13 34.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.24 124.73 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -61.01 154.09 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.432 HG13 ' CD1' ' A' ' 64' ' ' LEU . 61.6 t -110.26 137.4 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -119.27 147.91 43.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.5 p -96.18 167.25 11.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -54.15 176.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -105.49 108.98 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -114.26 152.39 45.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.626 0.727 . . . . 0.0 111.128 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 135.65 31.11 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.733 2.289 . . . . 0.0 112.36 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 19.3 p -45.98 -47.26 16.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.2 m -51.27 -30.21 17.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -133.8 87.78 34.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.619 0.723 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.548 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 2.94 3.09 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.681 2.254 . . . . 0.0 112.333 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -58.47 103.84 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.548 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.3 m-90 -90.71 -46.76 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 60' ' ' TRP . 2.9 p30 39.23 46.99 1.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -120.95 135.86 55.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.464 ' CZ3' ' HD2' ' A' ' 12' ' ' ARG . 45.7 m95 -81.35 103.55 11.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.432 ' CD1' HG13 ' A' ' 48' ' ' VAL . 10.4 tp -90.68 121.44 32.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -101.0 133.37 45.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -100.99 131.68 46.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.2 41.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.828 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.451 HD13 ' N ' ' A' ' 69' ' ' TYR . 1.7 pp -112.45 161.89 10.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.585 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -113.54 121.96 45.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -53.42 -54.15 48.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.595 0.712 . . . . 0.0 111.104 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.4 Cg_endo -69.7 3.49 2.71 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.677 2.252 . . . . 0.0 112.396 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.484 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 9.5 t0 -125.22 -4.49 7.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.918 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.1 113.61 29.59 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HG2' ' CB ' ' A' ' 77' ' ' ALA . 54.4 Cg_endo -69.77 132.05 22.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.704 2.27 . . . . 0.0 112.336 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.478 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 11.6 mpt_? -45.46 -42.07 10.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.537 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . . . -56.04 -43.75 78.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.066 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.42 ' CB ' ' HG2' ' A' ' 74' ' ' PRO . . . -55.6 165.02 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.083 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -163.28 173.42 13.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 tp -93.82 138.31 32.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.2 m -136.23 126.4 26.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.16 161.24 33.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 p -166.53 131.9 2.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.8 mt -83.91 144.44 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 62.0 m -147.81 155.04 41.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 t -105.89 150.72 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.93 125.2 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -151.39 134.14 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.49 -137.74 2.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.486 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -149.37 166.94 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -63.11 120.28 11.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.22 -29.18 3.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.475 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.18 160.67 16.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 0.0 111.114 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 169.42 14.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -106.55 -175.53 2.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -130.21 125.92 36.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -103.46 129.21 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.1 t -137.49 123.78 13.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 152.96 69.27 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.673 2.249 . . . . 0.0 112.333 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.0 mt -126.37 -51.13 1.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.41 -177.58 5.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.491 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 67.5 p-90 -164.44 126.04 2.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.94 131.42 6.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.402 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -106.85 129.73 54.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 110.861 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.422 ' CD1' HD21 ' A' ' 120' ' ' LEU . 76.2 mt -119.34 119.27 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 106' ' ' LEU . 3.0 t-20 -73.25 94.57 2.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 105' ' ' ASN . 41.6 mt -35.14 -35.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.478 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 51.3 m-85 -104.39 106.5 17.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.906 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.43 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 42.5 p30 -54.93 -177.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -57.12 -39.19 74.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.0 t -86.9 32.14 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.14 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 37.78 54.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.7 m -132.77 116.64 16.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.418 HD22 ' CH2' ' A' ' 156' ' ' TRP . 11.9 mt -44.56 126.62 5.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.541 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 16.3 m -57.51 176.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.9 p -173.83 164.11 4.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.18 149.18 0.2 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.434 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 7.5 ttpt -39.55 158.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.478 ' HG2' ' N ' ' A' ' 119' ' ' ALA . 2.8 ttm -156.62 144.96 19.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.478 ' N ' ' HG2' ' A' ' 118' ' ' MET . . . -140.35 106.96 5.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.083 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.422 HD21 ' CD1' ' A' ' 104' ' ' ILE . 4.1 pp -126.35 163.53 23.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -92.31 158.53 16.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.0 mt -112.59 156.08 23.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.566 ' CE3' ' OD1' ' A' ' 142' ' ' ASN . 28.0 m95 -86.57 150.64 51.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.538 0.685 . . . . 0.0 110.924 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 145.92 58.44 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.699 2.266 . . . . 0.0 112.309 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.51 126.64 91.67 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -173.86 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.649 2.233 . . . . 0.0 112.314 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -95.05 -35.92 11.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.28 65.85 2.77 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.42 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 19.4 tp -147.64 126.93 13.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.79 0.329 . . . . 0.0 110.905 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -101.17 -47.11 4.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.854 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.94 144.01 54.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.66 -58.64 5.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.3 tp -84.8 127.53 34.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -104.38 93.53 5.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 110.83 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.414 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.6 Cg_endo -69.74 -17.14 37.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.664 2.243 . . . . 0.0 112.372 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 mm -84.88 -23.15 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.478 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -38.74 151.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.13 163.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.1 p -108.44 151.75 25.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.62 142.84 8.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.5 p -63.11 116.66 5.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.566 ' OD1' ' CE3' ' A' ' 123' ' ' TRP . 32.7 t30 -53.64 130.01 54.8 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.572 0.701 . . . . 0.0 110.93 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -27.03 27.06 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.694 2.263 . . . . 0.0 112.317 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -51.72 144.4 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt -99.53 -37.03 9.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -83.26 39.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.2 p -122.85 156.05 62.67 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.57 0.7 . . . . 0.0 111.127 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 124.65 11.28 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.704 2.269 . . . . 0.0 112.344 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 p -115.92 150.69 36.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.443 HD21 ' CB ' ' A' ' 18' ' ' ALA . 7.4 mt -128.18 135.3 49.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.96 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.411 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 10.1 tt0 -102.49 125.11 49.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.569 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -127.72 169.36 13.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.434 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 26.1 mt-10 -126.4 125.38 42.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.563 ' CE2' HD22 ' A' ' 152' ' ' LEU . 45.0 m-85 -92.1 119.51 31.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -137.39 137.53 38.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.418 ' CH2' HD22 ' A' ' 113' ' ' LEU . 11.6 m95 -127.84 82.45 2.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 158' ' ' SER . 22.0 p90 -85.75 -52.75 5.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.574 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 85.6 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m -150.9 121.33 7.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 110.832 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 t -71.83 95.39 1.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.04 116.06 2.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.463 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.9 p -124.96 -53.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.851 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.8 t -98.37 108.66 21.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.23 132.61 21.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.84 122.23 12.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 110.89 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.06 -46.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.409 ' H ' ' CB ' ' A' ' 158' ' ' SER . . . -120.07 121.85 39.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.435 HD12 ' CZ3' ' A' ' 156' ' ' TRP . 22.2 tp -85.82 144.99 27.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.61 ' NH2' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -135.71 146.93 48.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.402 HG13 ' C ' ' A' ' 12' ' ' ARG . 54.4 mt -145.52 121.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.563 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 73.8 tttt -103.58 131.37 50.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mm -94.07 137.59 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.12 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.23 -72.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.4 p -172.01 172.68 4.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.893 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.15 142.33 48.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.035 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.514 HG22 ' CD2' ' A' ' 20' ' ' TYR . 10.9 t -111.57 136.2 51.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.514 ' CD2' HG22 ' A' ' 19' ' ' THR . 2.6 m-85 65.67 32.94 8.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 56.1 t -40.42 161.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.076 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.422 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 3.2 t-20 -84.53 37.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.1 m -78.76 53.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -50.34 -59.46 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.9 pt -76.64 168.71 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.161 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -120.53 40.84 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.817 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -109.84 -31.54 7.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mt -66.86 142.53 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.145 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.424 ' C ' ' HD2' ' A' ' 30' ' ' LYS . 7.4 t70 -115.02 -53.0 2.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.43 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -108.1 155.92 19.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.1 pt -141.55 170.34 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CE2' ' ND1' ' A' ' 96' ' ' HIS . 9.6 p90 -163.96 154.44 15.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.566 HG21 ' CZ2' ' A' ' 60' ' ' TRP . 61.7 t -117.71 137.89 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.434 ' N ' HG13 ' A' ' 33' ' ' VAL . 11.0 ttt180 -112.26 140.78 46.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.8 p -134.4 177.01 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.39 148.78 5.28 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.532 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.0 132.77 40.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 0.0 111.092 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 18.8 m-85 -126.47 150.05 48.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.467 ' CB ' HD11 ' A' ' 44' ' ' LEU . 8.4 t-160 -127.35 101.1 6.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.92 38.16 36.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.63 33.35 58.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -148.2 140.14 14.3 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.678 0.751 . . . . 0.0 110.845 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 149.22 67.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.681 2.254 . . . . 0.0 112.335 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.467 HD11 ' CB ' ' A' ' 39' ' ' HIS . 11.0 mp -102.1 -42.85 5.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 t -147.22 170.72 16.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -47.54 126.85 10.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -61.01 160.15 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.455 HG13 ' CD1' ' A' ' 64' ' ' LEU . 48.5 t -122.57 136.19 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -120.63 146.09 46.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -89.42 171.85 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.116 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -56.56 169.27 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -101.1 110.63 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.526 HG11 ' CD1' ' A' ' 60' ' ' TRP . 1.4 m -112.1 152.13 44.13 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.65 0.738 . . . . 0.0 111.109 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 142.06 47.09 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.698 2.265 . . . . 0.0 112.331 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.7 p -50.63 -42.71 56.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.6 p -60.04 -29.12 68.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -131.36 84.22 57.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.617 0.723 . . . . 0.0 110.921 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 4.27 2.29 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.309 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -61.3 112.06 2.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.566 ' CZ2' HG21 ' A' ' 33' ' ' VAL . 5.0 m-90 -95.46 -65.36 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 55.31 45.51 25.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -120.08 136.54 54.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.568 ' CZ3' ' HD2' ' A' ' 12' ' ' ARG . 71.3 m95 -83.55 98.87 9.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.921 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.455 ' CD1' HG13 ' A' ' 48' ' ' VAL . 11.2 tp -86.95 109.76 19.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -91.22 145.12 24.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -111.08 134.04 52.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.66 50.86 2.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.914 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.416 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.2 pp -117.42 165.7 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.609 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.0 120.36 38.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.1 mp -51.45 -53.8 45.85 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 0.0 111.142 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.609 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.81 3.56 2.73 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.26 . . . . 0.0 112.342 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.491 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 6.0 t70 -124.1 -8.43 7.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.486 ' CD1' ' HB1' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -82.59 110.44 22.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.658 0.742 . . . . 0.0 110.915 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 139.52 40.43 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.661 2.24 . . . . 0.0 112.377 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.529 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 1.8 mpp_? -50.16 -37.8 36.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.81 -48.45 66.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.116 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.486 ' HB1' ' CD1' ' A' ' 73' ' ' LEU . . . -58.83 155.05 13.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -150.23 171.22 17.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.8 tp -94.23 137.62 33.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.1 m -136.54 142.8 43.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.29 156.95 44.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.5 m -156.44 135.54 12.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.0 mt -84.74 137.67 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 54.3 m -130.25 170.11 14.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.5 p -123.71 126.57 46.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.3 p -118.09 120.73 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.163 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -146.01 126.91 14.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.76 -155.69 6.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.5 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -141.93 147.96 37.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.868 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -43.65 119.86 1.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.75 -33.68 3.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.72 160.15 18.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.1 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -72.05 172.13 10.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -104.02 -176.55 3.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -134.83 116.69 15.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.462 ' ND1' ' CE2' ' A' ' 32' ' ' TYR . 11.8 m170 -97.83 130.37 44.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.23 131.76 12.25 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.629 0.728 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 147.32 62.51 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.703 2.269 . . . . 0.0 112.353 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.5 mt -122.13 -56.91 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.88 177.36 7.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.499 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 65.7 p-90 -155.65 123.18 5.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.58 135.24 7.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -114.85 162.37 16.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 88.2 mt -147.12 118.47 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' LEU . 26.0 m-80 -59.21 92.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 105' ' ' ASN . 10.7 mt -36.06 -42.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 97.5 m-85 -104.09 108.42 19.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 44.2 p30 -53.13 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.425 ' CE1' ' HB ' ' A' ' 110' ' ' THR . 34.3 p90 -55.43 -40.39 71.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.425 ' HB ' ' CE1' ' A' ' 109' ' ' TYR . 10.0 t -86.22 33.31 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.5 OUTLIER 37.18 49.9 0.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 89.7 m -130.53 110.45 11.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.548 ' HB3' ' CZ2' ' A' ' 156' ' ' TRP . 36.7 mt -34.78 138.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.5 m -69.86 172.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.2 p -168.94 159.41 9.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.69 145.32 2.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.455 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -43.12 151.15 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.3 ttp -159.48 146.68 16.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.76 122.3 16.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 120' ' ' LEU . 3.9 pp -133.89 158.37 43.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -78.39 158.17 28.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.1 mt -120.35 142.27 49.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.642 ' CE3' ' ND2' ' A' ' 142' ' ' ASN . 6.4 m95 -83.5 142.93 43.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.564 0.697 . . . . 0.0 110.904 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 131.13 20.65 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.235 . . . . 0.0 112.377 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.7 m -65.16 136.65 96.68 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.662 0.744 . . . . 0.0 111.098 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 140.8 43.51 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 0.0 112.347 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -41.49 -43.37 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -84.84 84.57 1.59 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 46.1 tp -147.73 119.02 7.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -94.69 -27.44 15.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -94.9 129.22 42.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 15.6 mt -58.19 -46.95 84.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.978 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.7 tp -96.19 139.83 31.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.408 ' ND2' ' CA ' ' A' ' 137' ' ' GLY . 64.2 t30 -107.04 91.63 6.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.587 0.708 . . . . 0.0 110.923 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.5 Cg_endo -69.73 -37.38 9.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.673 2.249 . . . . 0.0 112.337 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 36.1 mt -73.96 -22.62 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.408 ' CA ' ' ND2' ' A' ' 134' ' ' ASN . . . -40.59 144.7 0.5 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 m -50.43 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.114 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 67.1 p -127.14 165.36 19.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.83 176.49 35.2 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 90.9 p -88.12 149.52 23.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.884 0.373 . . . . 0.0 110.848 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.642 ' ND2' ' CE3' ' A' ' 123' ' ' TRP . 60.5 t-20 -90.57 124.79 61.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.893 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.441 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.73 2.85 3.15 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.661 2.241 . . . . 0.0 112.339 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -85.24 130.92 34.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -89.2 -52.96 4.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -48.55 -24.54 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.882 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.4 p -74.01 151.87 88.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.567 0.698 . . . . 0.0 111.171 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 140.53 43.06 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.692 2.261 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.7 t -123.11 135.5 54.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.4 mt -105.18 139.8 39.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.87 123.68 49.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.552 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -135.44 165.04 26.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.438 ' N ' HD23 ' A' ' 152' ' ' LEU . 51.5 mt-10 -124.25 141.62 51.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.407 ' CE2' HD22 ' A' ' 152' ' ' LEU . 51.1 m-85 -104.58 136.78 43.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.41 ' HB3' ' CG ' ' A' ' 12' ' ' ARG . 1.5 t70 -152.5 147.62 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.548 ' CZ2' ' HB3' ' A' ' 113' ' ' LEU . 7.1 m95 -134.26 89.36 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.61 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 9.3 p90 -87.36 -52.26 5.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.591 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 2.7 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.843 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.0 p -98.48 146.68 25.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 0.0 110.853 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -47.07 170.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.94 50.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.4 p -81.52 157.18 24.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.4 m -111.58 87.96 2.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.01 83.19 0.15 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.458 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -100.0 141.19 33.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.887 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.6 m -122.36 -31.93 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.828 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.93 142.28 47.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 27.4 tp -104.35 142.76 34.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HD2' ' CD1' ' A' ' 157' ' ' PHE . 2.2 ptm85 -148.64 128.15 13.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 mt -129.35 136.38 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 63' ' ' TRP . 67.4 tttt -109.55 125.99 53.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 mm -91.34 141.2 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.61 -74.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.7 p -167.83 178.42 5.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.24 166.89 16.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -135.68 159.09 42.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 41.09 53.51 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HB ' ' CG2' ' A' ' 23' ' ' VAL . 39.0 t -82.84 146.24 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.107 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' VAL . 2.6 t-20 -42.06 -41.68 2.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.467 ' CG2' ' HB ' ' A' ' 21' ' ' VAL . 4.6 m -35.02 110.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.168 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -128.14 -46.24 1.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.842 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.9 pt -75.51 -176.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 33.49 5.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.41 -46.34 7.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.0 mt -52.35 148.1 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.68 -58.29 2.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -143.81 176.7 9.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -136.63 168.37 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -163.08 152.37 15.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.444 ' CG2' ' CH2' ' A' ' 60' ' ' TRP . 94.9 t -97.92 142.72 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.138 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.41 ' NH2' ' OD1' ' A' ' 47' ' ' ASN . 49.2 ttt85 -119.57 117.33 28.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.7 p -114.69 170.85 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.87 139.11 2.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mp -92.01 138.6 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.145 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.51 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 27.6 m-85 -130.63 164.45 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -133.85 95.29 3.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.845 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.51 -11.97 53.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 135.66 -6.23 4.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -110.45 146.5 34.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 160.26 50.36 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.3 mp -120.02 -33.81 3.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.8 m -151.63 169.35 22.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -53.37 136.42 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.41 ' OD1' ' NH2' ' A' ' 34' ' ' ARG . 31.8 m120 -74.53 158.01 34.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.3 t -116.82 139.22 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.72 142.39 49.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.5 p -89.29 160.83 16.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -52.24 165.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -93.27 119.92 32.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -120.32 152.14 54.48 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.635 0.731 . . . . 0.0 111.077 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 133.07 24.75 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.7 2.267 . . . . 0.0 112.35 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.7 p -44.09 -48.58 9.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -47.81 -34.34 8.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -134.51 86.88 33.62 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.72 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 3.23 2.92 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.673 2.248 . . . . 0.0 112.328 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -55.22 118.19 4.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.444 ' CH2' ' CG2' ' A' ' 33' ' ' VAL . 2.6 m-90 -101.17 -52.33 3.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 43.83 41.25 3.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -120.82 137.7 54.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.518 ' CD2' ' HB2' ' A' ' 14' ' ' LYS . 59.3 m95 -82.27 109.97 17.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.916 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.5 tp -92.03 120.15 32.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.928 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -97.84 136.26 38.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -107.58 127.29 53.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.34 43.69 0.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.422 HD11 ' C ' ' A' ' 68' ' ' ILE . 2.2 pp -107.32 166.06 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.57 125.29 49.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.589 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -58.77 -53.92 61.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.641 0.734 . . . . 0.0 111.13 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.6 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.9 Cg_endo -69.75 3.04 3.0 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.486 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 6.2 t70 -124.77 -2.32 7.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.69 113.13 53.01 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.665 0.745 . . . . 0.0 110.918 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 132.77 23.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.5 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -46.61 -42.23 15.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.65 -40.88 60.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.139 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.08 168.17 3.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -159.21 173.44 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.409 ' HG ' ' CD2' ' A' ' 81' ' ' LEU . 53.3 tp -95.65 134.8 38.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.3 m -127.18 147.37 50.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.409 ' CD2' ' HG ' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -155.55 139.92 16.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 t -145.63 140.82 27.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mt -83.99 124.9 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 67.2 m -124.21 145.23 49.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 p -106.07 128.57 53.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG22 ' NE2' ' A' ' 96' ' ' HIS . 10.4 p -108.57 126.55 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.191 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.64 141.09 31.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.58 -153.98 24.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -117.58 178.22 4.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.368 . . . . 0.0 110.888 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -80.93 -68.7 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.19 -24.04 27.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.517 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.65 174.27 5.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.365 . . . . 0.0 111.122 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -83.89 158.49 21.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -101.66 -175.91 2.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -128.69 127.96 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.402 ' NE2' HG22 ' A' ' 86' ' ' VAL . 15.3 m170 -107.9 132.89 52.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.5 t -137.42 132.71 17.85 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.605 0.717 . . . . 0.0 110.851 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 153.04 69.3 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.699 2.266 . . . . 0.0 112.354 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.8 mt -128.28 -35.57 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.44 155.63 24.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.51 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 59.4 p-90 -132.21 134.68 45.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.35 121.63 2.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -108.34 133.35 52.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.879 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 105' ' ' ASN . 18.9 mt -118.21 140.38 41.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.442 ' N ' HG22 ' A' ' 104' ' ' ILE . 49.0 m-80 -70.67 85.87 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 105' ' ' ASN . 12.4 mt -34.9 -35.25 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 83.3 m-85 -112.93 123.05 49.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.898 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -51.07 -176.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.56 12.32 3.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 p -130.35 14.21 5.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 70.61 34.38 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.7 m -128.49 109.21 11.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.3 mt -38.58 149.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.2 m -72.56 178.08 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.143 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.4 p -174.01 156.18 2.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.44 170.11 45.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.427 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 32.5 tttt -71.05 148.7 47.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.733 0.302 . . . . 0.0 110.92 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.7 ttp -156.51 149.76 24.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.47 115.46 10.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.409 ' CD2' HG12 ' A' ' 104' ' ' ILE . 3.6 pp -128.86 155.97 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.03 153.84 28.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.462 ' CD1' HD13 ' A' ' 150' ' ' LEU . 7.7 mt -109.91 158.17 18.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.51 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 13.2 m95 -95.24 139.95 22.22 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 129.02 16.88 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.714 2.276 . . . . 0.0 112.347 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.2 m -71.54 137.45 83.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.631 0.729 . . . . 0.0 111.127 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 159.84 51.96 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.707 2.271 . . . . 0.0 112.349 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -63.2 -39.56 94.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.14 78.81 1.96 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.446 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -145.16 127.34 15.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -91.26 -53.28 4.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.66 153.69 42.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.99 -37.92 25.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.7 tp -106.16 142.88 35.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -105.41 91.33 4.71 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.51 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.1 Cg_endo -69.72 -43.85 2.45 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.0 112.336 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.0 mt -70.62 -19.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.412 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -41.34 146.15 0.5 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.6 m -56.02 179.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.15 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.5 p -123.57 179.24 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.37 169.03 44.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.447 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 87.2 p -85.76 131.85 34.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.867 0.365 . . . . 0.0 110.876 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 123' ' ' TRP . 64.8 t-20 -69.27 120.85 79.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.567 0.698 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.4 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.6 Cg_endo -69.74 -19.78 35.78 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.344 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -53.3 132.57 39.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -86.83 -35.03 19.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -84.35 39.69 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.5 p -130.98 156.38 80.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.593 0.711 . . . . 0.0 111.134 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 174.51 9.38 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.701 2.268 . . . . 0.0 112.343 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.5 t -159.7 134.57 7.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.462 HD13 ' CD1' ' A' ' 122' ' ' LEU . 3.3 mt -110.0 143.69 39.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.427 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 6.2 tt0 -111.03 127.7 55.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.518 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -137.79 156.19 48.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -113.89 117.81 32.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.518 ' CE2' HD21 ' A' ' 152' ' ' LEU . 29.3 m-85 -84.74 111.7 19.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.9 155.13 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 11.1 m95 -137.87 122.28 18.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.93 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.452 ' CG ' ' N ' ' A' ' 158' ' ' SER . 11.1 p90 -109.73 -44.99 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 10.6 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.867 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.7 p -124.04 157.39 34.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.343 . . . . 0.0 110.89 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 t -146.71 143.73 28.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.35 -107.83 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.464 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.8 p -167.39 164.09 15.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 0.0 110.845 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.3 m -101.88 91.13 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.91 -83.49 0.25 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.16 113.72 13.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.868 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.424 ' C ' HD13 ' A' ' 70' ' ' ILE . 1.9 t -134.59 -67.14 0.58 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 157' ' ' PHE . . . -98.87 130.94 45.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.083 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.411 HD13 ' CH2' ' A' ' 156' ' ' TRP . 15.8 tp -84.99 134.93 34.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -128.73 133.52 48.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.4 HD13 ' CE1' ' A' ' 66' ' ' TYR . 26.2 mt -139.04 128.74 31.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.197 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.537 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 16.2 tttp -110.25 130.19 55.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.1 mm -95.15 140.03 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.18 -74.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.6 p -167.09 -179.46 4.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.07 166.13 17.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.453 HG22 ' CD2' ' A' ' 20' ' ' TYR . 8.8 t -136.69 141.18 43.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.453 ' CD2' HG22 ' A' ' 19' ' ' THR . 17.0 m-85 60.71 50.1 5.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 22' ' ' ASN . 65.3 t -74.47 159.01 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.142 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.403 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 1.4 m-20 -79.51 55.15 1.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.903 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.46 83.22 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.471 HD21 ' N ' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -82.33 -64.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.471 ' N ' HD21 ' A' ' 24' ' ' ASN . 2.8 pp -71.35 -177.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.56 79.61 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -132.43 -53.69 0.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.454 ' CG2' ' HB2' ' A' ' 85' ' ' SER . 4.2 mp -39.09 122.71 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.07 -59.44 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -144.92 159.05 43.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.6 pt -116.57 179.51 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -173.02 149.23 1.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.526 HG21 ' CZ2' ' A' ' 60' ' ' TRP . 88.0 t -108.57 139.19 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -109.45 133.83 52.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.948 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.1 p -128.07 163.56 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.31 152.83 7.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.39 141.85 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 0.0 111.11 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.437 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 14.4 m-85 -132.55 142.93 49.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.457 ' C ' ' CD2' ' A' ' 39' ' ' HIS . 8.0 t-160 -120.81 94.35 4.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.42 37.16 36.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.66 -23.78 8.4 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -93.05 142.44 25.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.654 0.74 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 165.24 31.64 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.705 2.27 . . . . 0.0 112.356 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.456 HD13 ' N ' ' A' ' 39' ' ' HIS . 10.0 mp -125.77 -37.48 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 39.8 m -148.57 161.91 40.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.68 137.37 9.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -70.43 149.89 46.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.4 t -110.96 133.26 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -115.78 147.41 41.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.444 HG21 ' NE1' ' A' ' 60' ' ' TRP . 13.1 t -95.26 169.19 10.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.91 173.25 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -105.71 124.25 49.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.432 HG11 ' CD1' ' A' ' 60' ' ' TRP . 1.5 m -126.25 152.01 73.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.587 0.708 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 136.93 34.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.346 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.0 p -46.2 -46.15 17.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.3 t -50.33 -33.89 21.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -133.91 86.16 38.78 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.74 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.2 Cg_endo -69.8 4.35 2.26 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.704 2.269 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -58.06 107.29 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.576 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 1.9 m-90 -93.94 -49.82 5.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.5 p30 39.48 43.38 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -112.73 151.02 30.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.537 ' CE3' ' HB2' ' A' ' 14' ' ' LYS . 79.8 m95 -98.57 100.17 11.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.935 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 tp -88.31 118.61 28.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -98.82 145.83 26.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.4 ' CE1' HD13 ' A' ' 13' ' ' ILE . 5.2 m-85 -114.68 135.85 53.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -90.34 52.32 2.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.429 HD11 ' C ' ' A' ' 68' ' ' ILE . 2.4 pp -119.77 169.44 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.586 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -113.58 130.19 56.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -63.96 -52.8 53.93 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.668 0.747 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.9 Cg_endo -69.75 -3.74 12.61 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 8.3 t70 -114.39 -9.11 12.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.46 116.19 50.72 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.545 0.688 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 134.91 29.07 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.683 2.256 . . . . 0.0 112.337 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.574 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 20.7 mmm-85 -47.92 -44.52 29.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.54 -44.87 66.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.138 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.89 161.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -158.7 176.06 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.8 tp -96.71 133.17 41.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.8 m -127.76 133.3 49.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.32 152.1 41.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 96.0 p -157.48 146.49 19.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.7 mt -89.15 147.11 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 61.5 m -149.15 141.62 24.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.454 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 94.7 p -106.46 118.62 37.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.413 HG21 ' NE2' ' A' ' 96' ' ' HIS . 12.4 p -101.44 136.23 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -140.46 121.82 14.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -119.77 174.91 15.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.489 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.3 mmt-85 -121.91 -175.63 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.866 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.49 104.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 44.49 24.22 0.62 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.489 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -102.52 -179.95 4.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.357 . . . . 0.0 111.08 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.85 158.56 36.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -103.25 160.88 14.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.84 116.43 22.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.446 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 6.4 m170 -95.87 149.71 21.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 t -153.71 120.54 2.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 0.0 110.851 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 144.77 54.93 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.649 2.233 . . . . 0.0 112.335 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.6 mt -115.53 -47.41 2.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.06 169.34 19.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.515 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 64.4 p-90 -147.9 132.89 18.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.9 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.28 120.48 2.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.504 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -100.25 139.37 36.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.76 0.314 . . . . 0.0 110.898 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.9 mt -131.09 120.94 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 106' ' ' LEU . 3.3 t-20 -67.11 95.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.7 mt -34.89 -39.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.574 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 63.6 m-85 -96.7 113.62 25.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -52.22 -176.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.84 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -65.27 -33.25 75.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.952 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -83.53 17.31 2.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 60.35 41.88 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.847 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.1 m -133.75 126.62 31.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 18.4 mt -47.17 144.57 2.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.562 HG22 ' CE2' ' A' ' 154' ' ' PHE . 34.6 m -76.79 -179.19 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.0 t -172.79 171.48 4.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.21 172.8 7.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 2.2 ttpm? -71.42 151.98 43.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.887 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 29.8 ttp -158.67 148.31 19.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.17 121.44 15.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.099 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.45 160.11 39.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -83.56 151.11 25.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.14 151.03 26.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.515 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 16.3 m95 -80.64 152.61 72.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.534 0.683 . . . . 0.0 110.925 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 168.2 22.32 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 68.6 t -86.72 119.99 71.57 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.592 0.711 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 -169.45 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.403 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -97.95 -42.23 7.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.834 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.46 50.22 4.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.479 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 48.5 tp -133.87 106.28 7.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.339 . . . . 0.0 110.91 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -106.46 38.19 2.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -147.09 146.66 30.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mt -62.56 -60.84 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.3 tp -88.89 132.99 34.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.438 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 9.6 t-20 -105.71 91.53 5.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.648 0.737 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.437 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.8 Cg_endo -69.76 -27.6 26.28 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.6 mm -80.88 -17.02 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.438 ' CA ' ' OD1' ' A' ' 134' ' ' ASN . . . -43.54 155.07 0.22 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.9 m -71.88 163.21 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.869 0.366 . . . . 0.0 111.126 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.3 p -106.04 157.42 17.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.87 159.97 14.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.525 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.1 p -83.55 108.25 16.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.84 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.506 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 14.3 t-20 -40.07 116.79 1.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.58 0.705 . . . . 0.0 110.841 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -8.41 23.53 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.655 2.237 . . . . 0.0 112.338 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -70.91 151.89 44.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -102.78 -24.53 13.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -85.94 29.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.0 p -124.41 153.03 69.09 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 111.148 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 154.19 68.08 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.722 2.281 . . . . 0.0 112.309 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.1 t -130.9 130.54 43.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.7 mt -109.21 135.95 49.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -105.39 124.78 50.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.514 HD22 ' CZ ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -134.46 159.63 40.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.459 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 54.8 mt-10 -116.77 134.78 54.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.562 ' CE2' HG22 ' A' ' 114' ' ' VAL . 47.7 m-85 -99.96 103.7 15.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -114.27 141.13 47.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.411 ' CH2' HD13 ' A' ' 11' ' ' LEU . 60.0 m95 -125.13 76.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 158' ' ' SER . 9.5 p90 -70.88 -49.05 50.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.68 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 47.2 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -52.62 139.75 25.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 t -60.51 122.56 14.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.57 90.97 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.5 p -122.42 -47.88 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.36 . . . . 0.0 110.806 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t -50.25 146.67 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.36 -151.06 23.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.491 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -101.67 152.7 20.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.897 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -132.59 -39.22 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.31 131.34 55.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.071 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.566 HD11 ' CH2' ' A' ' 156' ' ' TRP . 13.5 tp -93.71 136.24 34.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 157' ' ' PHE . 18.7 ptt180 -142.61 139.37 31.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 14' ' ' LYS . 62.3 mt -136.92 142.25 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HD2' ' CE2' ' A' ' 63' ' ' TRP . 69.3 tttt -118.9 115.37 24.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.0 mm -81.23 145.68 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.49 -72.96 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.1 p -170.53 178.04 3.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -129.62 142.3 50.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 t -117.86 144.65 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 67.23 47.42 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.464 ' HB ' ' CG2' ' A' ' 23' ' ' VAL . 21.6 t -73.83 140.97 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 23' ' ' VAL . 61.4 t30 -49.1 -35.92 17.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' CG2' ' HB ' ' A' ' 21' ' ' VAL . 9.6 m -34.79 100.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.81 -69.64 0.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 pp -49.56 -179.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.158 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.437 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -130.26 65.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.44 -43.87 0.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 mt -37.88 133.23 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -75.46 -63.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -144.69 -179.8 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 53' ' ' VAL . 12.2 pt -137.56 178.87 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -173.67 138.57 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.571 HG21 ' CZ2' ' A' ' 60' ' ' TRP . 14.9 t -90.08 145.82 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -127.54 120.99 29.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.863 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.2 p -117.15 179.45 4.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.25 138.88 2.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.465 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -87.06 150.67 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 111.112 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -140.77 152.64 45.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.419 ' CB ' HD12 ' A' ' 44' ' ' LEU . 10.2 t-160 -127.09 104.17 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.01 51.23 56.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.43 34.79 89.61 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.515 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -142.72 142.67 23.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.691 0.758 . . . . 0.0 110.861 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 149.73 67.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.704 2.27 . . . . 0.0 112.333 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.419 HD12 ' CB ' ' A' ' 39' ' ' HIS . 8.3 mp -114.05 -37.1 4.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.9 m -160.57 170.05 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.805 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -50.46 131.73 24.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -66.74 161.98 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.455 HG13 ' CD1' ' A' ' 64' ' ' LEU . 51.4 t -122.25 139.01 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -126.52 156.5 40.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -93.41 179.82 5.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -66.67 163.92 17.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -82.2 126.46 32.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 1.4 m -137.62 152.05 72.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.647 0.737 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 138.52 38.06 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.73 2.287 . . . . 0.0 112.317 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 23.3 p -49.98 -45.87 52.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.4 t -51.35 -35.72 39.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -130.48 84.77 58.32 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.717 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.588 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.72 3.85 2.51 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.69 2.26 . . . . 0.0 112.366 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -52.63 109.16 0.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.588 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 3.6 m-90 -103.54 -46.89 4.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 60' ' ' TRP . 7.8 p30 35.3 44.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -113.83 147.9 37.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.417 ' CE2' ' HD2' ' A' ' 14' ' ' LYS . 71.2 m95 -88.99 97.16 11.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.455 ' CD1' HG13 ' A' ' 48' ' ' VAL . 11.8 tp -84.62 111.56 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -91.28 132.87 35.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.937 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -99.42 137.41 37.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -88.21 44.26 1.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.855 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 69' ' ' TYR . 2.2 pp -112.5 170.94 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.605 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.14 115.88 25.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.647 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.8 mp -53.38 -51.02 79.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.647 0.737 . . . . 0.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.0 Cg_endo -69.77 2.21 3.75 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.647 2.231 . . . . 0.0 112.382 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.488 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.3 t70 -123.49 -11.17 7.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.426 HD11 ' N ' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -71.84 113.86 23.78 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.631 0.729 . . . . 0.0 110.901 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.426 ' N ' HD11 ' A' ' 73' ' ' LEU . 53.3 Cg_endo -69.74 145.91 58.71 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -41.95 75.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.19 -37.97 70.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -59.85 164.55 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.414 ' CG ' ' O ' ' A' ' 77' ' ' ALA . 50.4 mtt85 -161.34 173.84 14.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 tp -98.3 131.86 44.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 9.5 m -127.65 135.95 50.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 pp -142.83 155.56 44.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 85.2 p -160.16 134.82 7.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.5 mt -81.66 141.45 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 95.7 m -136.88 152.14 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.0 m -111.23 129.11 56.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 p -111.9 130.19 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -138.72 138.1 37.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.97 171.27 38.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.445 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.55 173.02 6.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.895 0.379 . . . . 0.0 110.857 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -62.99 136.47 57.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.34 -35.52 2.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.506 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.71 166.44 15.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 111.093 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.44 159.23 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -101.85 167.17 10.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -120.94 127.82 52.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -108.43 135.23 50.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.9 t -142.93 127.64 9.83 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.619 0.723 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 146.61 60.67 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.653 2.235 . . . . 0.0 112.332 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.6 mt -119.67 -43.56 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.936 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.1 162.16 41.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.061 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.4 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 66.6 p-90 -143.09 135.67 27.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.06 132.75 5.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 0.9 OUTLIER -111.28 138.18 48.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.792 0.329 . . . . 0.0 110.877 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.459 ' CG1' HD22 ' A' ' 120' ' ' LEU . 78.8 mt -120.6 134.62 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 107' ' ' PHE . 2.5 m120 -73.19 88.1 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 105' ' ' ASN . 12.7 mt -36.26 -33.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 105' ' ' ASN . 57.1 m-85 -110.85 116.46 31.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -50.86 -178.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -64.26 -33.22 75.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.3 t -91.25 30.23 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.151 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.2 t0 49.74 49.21 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 113' ' ' LEU . 45.8 m -136.51 112.82 9.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 112' ' ' THR . 29.6 mt -36.73 148.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.517 HG23 ' CZ ' ' A' ' 154' ' ' PHE . 18.2 m -75.62 -179.83 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.7 p -173.54 155.85 2.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.845 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.35 152.53 6.08 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.454 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -56.17 147.36 20.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 35.9 ttp -156.95 153.09 27.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.92 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.27 132.07 37.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.459 HD22 ' CG1' ' A' ' 104' ' ' ILE . 3.9 pp -138.75 154.63 48.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.53 ' ND2' ' HG ' ' A' ' 149' ' ' CYS . 6.0 m120 -77.35 156.82 31.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.1 mt -113.69 153.52 28.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.503 ' CH2' ' OD1' ' A' ' 142' ' ' ASN . 18.7 m95 -89.58 148.79 41.02 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.597 0.713 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 163.67 37.49 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.699 2.266 . . . . 0.0 112.333 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -98.58 121.03 57.73 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.596 0.712 . . . . 0.0 111.116 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -175.4 1.14 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.717 2.278 . . . . 0.0 112.36 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -90.4 -38.22 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.69 56.82 5.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.477 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 46.2 tp -141.58 120.33 12.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 110.924 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.96 44.62 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -148.65 133.53 18.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 25.6 mt -59.71 -54.55 45.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.1 tp -97.77 136.03 38.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.47 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 11.2 t-20 -105.34 93.71 7.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.622 0.725 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -30.89 21.45 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.648 2.232 . . . . 0.0 112.373 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 137' ' ' GLY . 12.7 mm -75.19 -25.82 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.488 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -34.76 148.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.473 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.78 173.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 111.077 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 34.1 p -118.09 146.15 44.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.135 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.28 163.19 12.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.508 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.7 p -84.26 118.17 24.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.886 0.374 . . . . 0.0 110.883 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.736 HD22 ' ND2' ' A' ' 144' ' ' ASN . 24.0 t30 -60.89 129.44 90.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 110.913 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 2.03 3.87 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.662 2.241 . . . . 0.0 112.372 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.736 ' ND2' HD22 ' A' ' 142' ' ' ASN . 2.7 m-20 -89.78 117.0 28.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -77.05 -46.18 24.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 147' ' ' THR . 14.8 pt-20 -43.6 -38.66 3.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.405 ' N ' ' HG3' ' A' ' 146' ' ' GLU . 64.6 p -64.25 151.87 89.68 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.606 0.717 . . . . 0.0 111.116 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 132.04 22.59 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.69 2.26 . . . . 0.0 112.375 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.53 ' HG ' ' ND2' ' A' ' 121' ' ' ASN . 1.2 m -113.07 136.99 52.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.4 mt -108.75 137.59 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -105.23 130.75 53.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -135.14 161.53 35.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.401 ' N ' HD22 ' A' ' 152' ' ' LEU . 21.2 mt-10 -116.74 125.06 51.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.517 ' CZ ' HG23 ' A' ' 114' ' ' VAL . 43.1 m-85 -93.41 108.02 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.0 155.82 49.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.566 ' CH2' HD11 ' A' ' 11' ' ' LEU . 6.9 m95 -136.45 105.24 5.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.485 ' CG ' ' N ' ' A' ' 158' ' ' SER . 10.0 p90 -85.17 -44.96 12.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.485 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 4.5 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 t -72.78 123.04 22.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.851 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 t -154.54 139.13 16.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.71 -45.16 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.522 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.3 m -107.92 109.63 21.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.878 0.37 . . . . 0.0 110.829 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.2 t -154.67 130.87 10.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -154.02 52.59 0.46 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -128.28 113.62 15.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 110.908 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -126.15 -32.07 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.76 140.13 52.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.064 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.8 tp -104.33 131.51 51.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -139.66 139.12 36.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.475 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 59.3 mt -135.2 128.6 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -102.76 107.14 17.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mm -70.76 143.23 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.37 -72.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.7 p -172.06 179.5 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.25 169.08 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.429 HG22 ' CD2' ' A' ' 20' ' ' TYR . 9.4 t -147.3 144.0 28.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.135 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.429 ' CD2' HG22 ' A' ' 19' ' ' THR . 6.1 m-85 61.78 47.46 6.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.4 ' HB ' ' CG2' ' A' ' 23' ' ' VAL . 38.6 t -87.52 152.89 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.098 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' VAL . 39.5 t30 -48.69 -39.24 23.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' ASN . 11.0 m -36.29 109.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -128.5 -67.27 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.7 pt -63.73 176.54 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.452 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 1.6 mpt_? -111.57 52.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.65 -45.52 3.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 mt -54.19 135.01 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.421 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 6.7 t70 -70.52 -62.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 25.1 mmtm -147.36 179.08 7.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 pp -141.86 146.31 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -144.28 163.77 32.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -111.9 140.89 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.09 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.41 ' NH2' ' HB2' ' A' ' 47' ' ' ASN . 14.6 ttt85 -116.27 127.61 54.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.3 p -128.97 168.03 16.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.64 153.22 7.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.481 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.7 mp -96.26 146.78 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 0.0 111.147 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.5 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 32.4 m-85 -139.05 159.4 42.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.41 ' CB ' HD13 ' A' ' 44' ' ' LEU . 7.6 t-160 -139.41 106.44 5.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.39 31.31 46.74 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.96 29.62 60.55 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.533 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -148.67 149.28 30.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.656 0.741 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 158.78 55.75 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.41 HD13 ' CB ' ' A' ' 39' ' ' HIS . 9.4 mp -112.26 -42.16 3.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.3 m -132.61 -69.57 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -173.16 166.49 4.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.41 ' HB2' ' NH2' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -96.91 149.85 21.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.463 HG12 ' CD1' ' A' ' 64' ' ' LEU . 95.9 t -115.04 133.46 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -116.21 156.1 27.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.443 HG22 ' CD1' ' A' ' 60' ' ' TRP . 9.1 t -100.26 165.58 11.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -48.93 178.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.5 mtt85 -108.22 115.73 30.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.56 HG11 ' CD1' ' A' ' 60' ' ' TRP . 1.5 m -120.19 152.3 54.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.582 0.705 . . . . 0.0 111.131 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 139.11 39.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.2 p -47.09 -44.43 21.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m -52.05 -29.41 21.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -134.06 83.97 44.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 0.0 110.904 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.6 Cg_endo -69.78 1.39 4.49 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.672 2.248 . . . . 0.0 112.323 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -60.29 120.27 9.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.576 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 3.2 m-90 -109.52 -47.04 3.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.943 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 60' ' ' TRP . 8.9 p30 34.0 42.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -111.85 144.9 40.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -83.27 110.17 17.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.463 ' CD1' HG12 ' A' ' 48' ' ' VAL . 11.1 tp -94.56 123.07 37.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.924 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -101.63 137.44 39.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -108.92 135.49 50.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -84.25 38.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.433 ' C ' HD12 ' A' ' 68' ' ' ILE . 1.8 pp -110.0 159.57 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.115 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.607 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.12 125.3 53.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.597 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -57.96 -54.06 59.44 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.725 . . . . 0.0 111.165 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.607 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.0 Cg_endo -69.75 2.16 3.78 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.246 . . . . 0.0 112.372 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.487 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.5 t70 -124.84 -1.52 7.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.36 117.05 67.99 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.612 0.72 . . . . 0.0 110.907 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 144.62 54.83 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.683 2.255 . . . . 0.0 112.365 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -59.12 -38.39 79.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.4 -26.46 61.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.94 165.53 24.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -159.51 177.28 11.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.0 tp -98.89 148.67 23.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m -143.02 152.49 41.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.89 136.58 14.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.9 p -141.76 133.52 27.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 90.2 mt -80.12 135.72 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 70.9 m -135.72 144.33 45.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.2 p -105.5 125.13 50.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 86' ' ' VAL . 5.8 p -109.94 117.93 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.36 151.56 49.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.8 170.25 27.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.401 ' HB2' ' CB ' ' A' ' 92' ' ' ALA . 11.6 mmt180 -101.82 167.98 9.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 110.862 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.9 111.21 1.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.37 -7.27 47.6 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 89' ' ' ARG . . . -100.22 162.15 13.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 111.075 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm -71.84 165.02 24.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.897 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -95.58 178.84 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -142.53 135.55 28.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.419 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 6.0 m170 -100.25 130.71 46.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.6 m -134.25 127.56 18.99 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.609 0.718 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 150.26 67.94 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.304 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.8 mt -128.48 -52.72 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.64 176.45 8.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.511 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 68.6 p-90 -160.6 146.8 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.09 124.11 1.54 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 27.1 m-20 -104.31 153.12 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.409 HG13 ' C ' ' A' ' 103' ' ' ASN . 55.1 mt -144.9 126.88 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.129 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 106' ' ' LEU . 24.8 m120 -66.5 99.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.0 mt -34.13 -54.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.496 ' CE1' ' HG ' ' A' ' 113' ' ' LEU . 52.3 m-85 -94.88 114.29 26.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -54.64 174.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -48.38 -30.09 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -90.28 28.49 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 44.16 41.88 4.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 55.2 m -127.88 115.58 18.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.496 ' HG ' ' CE1' ' A' ' 107' ' ' PHE . 12.3 mt -43.1 134.4 3.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 m -62.54 173.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.179 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -168.6 161.5 11.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.05 153.78 12.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.45 ' HE3' ' CG ' ' A' ' 151' ' ' GLU . 5.3 tmtt? -63.92 142.9 58.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.748 0.308 . . . . 0.0 110.887 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 37.5 ttp -155.09 154.58 32.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.74 116.11 10.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.103 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.6 pp -123.26 163.75 20.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.933 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -85.23 158.75 20.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.461 HD11 ' CD1' ' A' ' 150' ' ' LEU . 6.0 mt -119.1 155.71 31.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.673 ' CE3' ' ND2' ' A' ' 142' ' ' ASN . 8.3 m95 -90.18 146.42 34.81 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.559 0.695 . . . . 0.0 110.89 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 147.45 62.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.703 2.268 . . . . 0.0 112.305 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.74 113.29 18.68 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.608 0.718 . . . . 0.0 111.118 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -178.18 2.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 2.226 . . . . 0.0 112.373 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -83.01 134.61 35.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 109.23 -54.85 0.53 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.49 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 tp -48.74 103.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.934 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -89.92 -46.48 8.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -49.58 143.18 7.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.33 -52.97 50.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.0 tp -103.16 125.86 50.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.449 ' CG ' ' O ' ' A' ' 134' ' ' ASN . 11.8 p-10 -106.65 97.29 16.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.732 . . . . 0.0 110.928 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.5 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.8 -30.82 21.47 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.3 mt -70.08 -25.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.093 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.484 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -41.45 153.59 0.11 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.511 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.0 m -59.47 175.3 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.866 0.365 . . . . 0.0 111.161 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 60.7 p -121.37 168.25 11.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.189 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.49 161.93 32.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.9 p -79.6 137.82 37.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.673 ' ND2' ' CE3' ' A' ' 123' ' ' TRP . 34.9 t-20 -75.38 123.96 88.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -14.99 36.8 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.362 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -71.6 140.2 49.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -93.46 -42.32 9.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.37 -35.44 28.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.4 p -66.92 151.3 97.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.572 0.701 . . . . 0.0 111.113 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 148.22 64.3 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.687 2.258 . . . . 0.0 112.358 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 5.5 t -128.07 136.56 51.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.461 ' CD1' HD11 ' A' ' 122' ' ' LEU . 3.5 mt -103.67 -177.09 3.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.45 ' CG ' ' HE3' ' A' ' 117' ' ' LYS . 54.7 tt0 -149.61 122.07 8.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.573 HD23 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -128.38 165.78 19.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.866 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.455 ' N ' HD21 ' A' ' 152' ' ' LEU . 69.0 mt-10 -128.45 119.73 25.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.573 ' CE2' HD23 ' A' ' 152' ' ' LEU . 45.2 m-85 -88.44 129.89 35.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.903 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -148.75 138.89 22.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -129.39 94.26 3.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.586 ' CG ' ' N ' ' A' ' 158' ' ' SER . 16.1 p90 -92.98 -53.3 4.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.586 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 6.3 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 p -89.09 174.54 7.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.892 0.377 . . . . 0.0 110.871 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.5 p -124.61 167.73 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.38 149.71 5.7 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.539 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.7 p -126.44 157.94 37.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 7' ' ' GLY . 70.6 m -102.97 97.43 7.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 6' ' ' SER . . . 37.93 -99.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.489 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.48 131.04 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.83 0.348 . . . . 0.0 110.877 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.481 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 14.5 m -133.51 -50.95 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.66 150.23 30.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.412 HD11 ' CZ3' ' A' ' 156' ' ' TRP . 12.5 tp -104.48 140.04 38.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.69 ' NE ' ' CE3' ' A' ' 63' ' ' TRP . 2.4 ttt180 -143.72 118.39 9.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.1 mt -120.99 142.51 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.554 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 35.8 tttm -120.59 134.5 55.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.09 144.7 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.15 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.35 -74.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.1 p -162.31 -178.25 6.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -140.26 149.72 43.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.074 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -123.22 157.88 32.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.123 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 61.25 25.26 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 t -54.7 -17.0 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 72.58 34.63 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 m -107.54 85.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.128 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -92.13 -47.29 7.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.9 pt -61.31 -177.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.94 15.64 3.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -76.32 -39.94 52.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.9 mt -52.65 139.18 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -80.12 -64.62 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -148.23 -179.63 7.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.4 pt -139.46 171.09 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -164.52 158.9 18.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG22 ' CZ2' ' A' ' 60' ' ' TRP . 40.9 t -119.86 132.06 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -103.56 122.27 44.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.86 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.0 p -118.6 154.31 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.9 152.4 9.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.499 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 38' ' ' TYR . 2.9 mp -97.41 143.38 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.171 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.561 ' CD1' ' HB3' ' A' ' 135' ' ' PRO . 45.7 m-85 -135.85 152.57 51.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.518 ' CE1' ' HB1' ' A' ' 76' ' ' ALA . 2.7 t-160 -124.5 97.8 5.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.933 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.06 14.38 80.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.34 -25.37 13.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.493 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -88.31 140.72 30.42 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.637 0.732 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 156.33 63.5 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.712 2.275 . . . . 0.0 112.29 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 39' ' ' HIS . 7.8 mp -115.18 -33.19 5.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.1 t -156.31 168.66 26.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.41 126.01 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -59.54 164.99 3.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 64' ' ' LEU . 59.4 t -120.14 134.94 62.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -116.37 139.2 50.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.4 t -89.87 163.12 15.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -51.39 174.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -102.24 135.52 43.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.856 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -137.54 152.17 72.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 0.0 111.121 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 137.27 35.08 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.702 2.268 . . . . 0.0 112.345 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.6 p -46.54 -50.19 17.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.1 p -46.71 -32.49 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -133.21 87.06 39.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.613 0.72 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.478 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.2 Cg_endo -69.72 2.99 3.02 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -58.75 123.48 16.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.518 ' CZ2' HG22 ' A' ' 33' ' ' VAL . 3.4 m-90 -105.74 -63.81 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.4 HD21 ' N ' ' A' ' 61' ' ' ASN . 1.9 m-80 54.24 48.2 21.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -124.93 139.33 53.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.69 ' CE3' ' NE ' ' A' ' 12' ' ' ARG . 80.1 m95 -81.89 112.2 18.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.471 ' CD1' HG11 ' A' ' 48' ' ' VAL . 10.1 tp -98.12 115.6 28.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -95.3 131.05 41.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -100.83 134.26 44.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -81.06 41.29 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.459 ' C ' ' CD1' ' A' ' 68' ' ' ILE . 1.2 pp -115.33 162.83 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.593 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.37 127.41 54.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.565 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -54.2 -55.85 32.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 0.0 111.151 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.593 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.4 Cg_endo -69.81 3.02 3.03 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.707 2.271 . . . . 0.0 112.323 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.484 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.5 t70 -123.48 0.42 8.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.98 113.85 57.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.64 0.733 . . . . 0.0 110.874 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 142.02 46.59 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.673 2.249 . . . . 0.0 112.295 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.555 ' NH1' ' CZ ' ' A' ' 107' ' ' PHE . 78.3 mmt-85 -55.2 -37.83 67.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.518 ' HB1' ' CE1' ' A' ' 39' ' ' HIS . . . -56.57 -32.44 65.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.55 166.79 19.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -161.81 172.01 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.0 tp -95.46 134.2 38.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.3 m -131.26 141.7 50.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.4 pp -147.68 150.5 34.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.3 p -150.93 135.35 17.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.2 mt -84.76 141.5 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.17 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 20.7 m -140.54 150.97 44.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 85.1 p -113.06 126.15 55.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.551 HG22 ' CD2' ' A' ' 96' ' ' HIS . 8.5 p -104.89 130.44 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -149.18 124.18 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.9 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.58 174.76 40.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 89' ' ' ARG . 4.0 mpt_? -109.24 169.24 8.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.959 0.409 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -65.2 146.6 54.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.71 -43.26 2.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.508 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -91.61 164.68 13.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 111.097 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.4 173.03 10.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 -104.57 -176.11 2.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -133.16 119.51 20.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.551 ' CD2' HG22 ' A' ' 86' ' ' VAL . 7.9 m170 -103.92 124.59 49.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.823 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.7 t -127.31 128.49 24.05 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.595 0.712 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 147.08 62.03 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.67 2.247 . . . . 0.0 112.356 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.2 mt -120.09 -40.25 2.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.16 175.83 12.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.057 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.51 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 66.7 p-90 -156.79 135.52 11.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.81 134.3 7.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -112.22 133.1 54.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.465 HG12 ' CD2' ' A' ' 120' ' ' LEU . 36.1 mt -122.24 121.0 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -64.27 96.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.4 mt -38.75 -35.65 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.555 ' CZ ' ' NH1' ' A' ' 75' ' ' ARG . 98.9 m-85 -106.12 112.36 25.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -51.09 175.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.445 ' C ' ' CD1' ' A' ' 109' ' ' TYR . 5.0 p90 -59.45 -22.26 61.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -95.76 24.63 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 50.71 39.49 21.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 113' ' ' LEU . 51.2 m -131.5 113.94 14.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 112' ' ' THR . 33.5 mt -38.03 143.52 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.414 HG23 ' CG ' ' A' ' 154' ' ' PHE . 35.7 m -74.3 -177.79 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.5 t -168.23 173.07 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.53 174.01 2.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.422 ' CE ' ' CD ' ' A' ' 151' ' ' GLU . 3.5 ttpm? -73.67 152.3 40.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.925 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.5 ttp -154.39 148.47 25.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.93 116.96 12.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.465 ' CD2' HG12 ' A' ' 104' ' ' ILE . 4.0 pp -129.26 163.79 24.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 147' ' ' THR . 25.2 m-20 -91.05 145.61 24.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.9 mt -98.59 159.74 14.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.51 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 23.4 m95 -87.38 150.79 49.84 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.537 0.684 . . . . 0.0 110.913 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 145.23 56.52 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.355 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.475 ' CG1' ' HD2' ' A' ' 126' ' ' PRO . 99.2 t -67.79 138.97 93.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.475 ' HD2' ' CG1' ' A' ' 125' ' ' VAL . 53.5 Cg_endo -69.8 -164.8 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 0.0 112.325 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -76.89 120.89 22.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.845 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 40.0 72.69 0.22 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.461 ' CD2' ' O ' ' A' ' 131' ' ' ASP . 56.5 tp -62.21 125.07 22.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.33 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.36 -30.0 33.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.461 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 57.1 m-20 -115.15 114.37 25.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.8 mt -44.19 -46.26 8.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.4 tp -98.68 136.58 38.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.463 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 7.7 t-20 -106.55 91.51 6.04 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.643 0.735 . . . . 0.0 110.854 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.561 ' HB3' ' CD1' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.77 -41.19 4.47 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.687 2.258 . . . . 0.0 112.311 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.1 mt -75.61 -13.65 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.463 ' CA ' ' OD1' ' A' ' 134' ' ' ASN . . . -44.05 144.44 1.95 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.2 m -54.78 173.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 111.184 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.1 p -118.62 175.57 5.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.192 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.08 154.15 30.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.479 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 86.4 p -78.89 109.85 13.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.916 0.389 . . . . 0.0 110.855 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -44.67 121.88 4.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.609 0.719 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -6.22 18.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -68.84 139.88 55.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -99.65 -9.93 22.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -97.67 14.42 26.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.402 ' O ' ' OD1' ' A' ' 121' ' ' ASN . 59.5 p -112.25 152.55 44.54 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.542 0.686 . . . . 0.0 111.166 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.45 59.99 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.66 2.24 . . . . 0.0 112.344 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 2.0 t -128.95 128.48 43.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.5 mt -100.32 140.32 34.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.422 ' CD ' ' CE ' ' A' ' 117' ' ' LYS . 37.6 tt0 -109.15 120.48 42.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.557 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -128.95 165.91 20.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.436 ' N ' HD21 ' A' ' 152' ' ' LEU . 47.1 mt-10 -120.12 125.99 49.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CG ' HG23 ' A' ' 114' ' ' VAL . 28.5 m-85 -90.77 100.41 13.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.01 141.48 37.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.412 ' CZ3' HD11 ' A' ' 11' ' ' LEU . 74.8 m95 -129.1 69.55 1.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 158' ' ' SER . 7.9 p90 -69.34 -51.09 40.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.636 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 52.5 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -74.41 -54.36 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 110.848 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 m -78.24 146.34 34.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.863 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.1 -52.57 0.43 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.1 m -97.56 -47.88 5.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.9 m -107.3 156.37 18.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.53 -63.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.492 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 156' ' ' TRP . 1.3 m120 -46.49 118.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 13.2 m -102.89 -23.54 13.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.838 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.08 136.35 54.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.043 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.533 HD11 ' CZ3' ' A' ' 156' ' ' TRP . 24.6 tp -86.67 139.15 31.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.416 ' HD2' ' CE3' ' A' ' 63' ' ' TRP . 10.4 ttp180 -138.39 123.3 18.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.0 mt -134.18 139.27 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.442 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 72.9 tttt -118.37 127.22 53.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -89.17 146.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.44 ' HB2' ' CB ' ' A' ' 151' ' ' GLU . 4.3 mm? -100.85 -72.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 p -168.46 -176.94 3.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.93 141.88 51.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.537 HG21 ' CD2' ' A' ' 20' ' ' TYR . 6.5 t -117.57 134.34 54.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.537 ' CD2' HG21 ' A' ' 19' ' ' THR . 5.8 m-85 72.69 38.75 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.04 154.01 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -76.16 54.72 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 m -120.52 114.09 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -117.71 -62.19 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 27' ' ' ASP . 43.8 pt -69.1 174.47 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 0.3 OUTLIER -112.83 40.54 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 28' ' ' ILE . 4.1 t0 -92.0 -64.85 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 27' ' ' ASP . 4.7 mp -35.16 123.66 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.167 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -71.14 -52.62 18.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.851 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -145.81 177.44 8.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 pp -146.64 156.94 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -153.47 163.2 40.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.1 t -108.75 140.55 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.158 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -114.77 126.75 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.407 ' CG2' ' HB3' ' A' ' 81' ' ' LEU . 47.0 p -124.73 163.87 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.74 146.24 4.91 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.77 146.01 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 111.166 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.506 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 38.5 m-85 -142.53 157.1 45.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.447 ' C ' ' CD2' ' A' ' 39' ' ' HIS . 6.6 t-160 -129.09 102.84 6.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.89 22.37 70.24 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.29 -37.2 3.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -75.4 137.61 71.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.664 0.745 . . . . 0.0 110.888 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 158.07 58.2 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.0 mp -116.15 -40.08 3.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.3 m -149.76 168.95 22.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -57.35 128.17 35.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -61.65 159.11 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.7 t -114.78 147.5 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.124 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -129.06 156.06 44.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 p -102.64 168.62 9.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -51.92 177.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -107.08 112.62 25.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.536 HG11 ' CD1' ' A' ' 60' ' ' TRP . 1.9 m -118.0 152.83 50.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.606 0.717 . . . . 0.0 111.131 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 135.84 31.39 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.65 2.233 . . . . 0.0 112.331 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.5 p -44.69 -44.37 9.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 93.8 p -48.56 -34.82 12.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -134.18 89.22 28.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.621 0.724 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.58 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.3 Cg_endo -69.82 -0.12 6.5 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.708 2.272 . . . . 0.0 112.297 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -54.09 113.48 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.58 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 3.3 m-90 -104.82 -46.92 4.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.457 ' C ' ' O ' ' A' ' 60' ' ' TRP . 11.8 m-80 33.99 51.58 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -119.94 140.06 51.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.442 ' NE1' ' HD2' ' A' ' 14' ' ' LYS . 76.5 m95 -81.28 108.43 14.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.7 tp -97.66 121.46 39.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -101.33 134.84 43.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -102.34 129.91 48.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.9 42.34 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.877 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 pp -108.91 163.5 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.176 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.602 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.12 126.89 55.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -58.28 -52.41 74.78 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.65 0.738 . . . . 0.0 111.153 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.8 Cg_endo -69.8 -5.56 16.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.348 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.505 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.1 t0 -112.26 -15.79 13.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.41 112.16 12.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.627 0.727 . . . . 0.0 110.92 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 145.17 56.3 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.674 2.249 . . . . 0.0 112.35 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 21.7 mmt180 -53.41 -46.75 69.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . . . -52.52 -41.71 63.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.082 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.82 163.82 2.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.8 ptp85 -160.91 173.92 14.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.6 tp -96.18 144.15 26.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.9 m -134.49 149.45 50.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.879 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -155.76 137.09 13.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.0 p -146.87 154.4 41.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.402 ' CD1' HD13 ' A' ' 150' ' ' LEU . 44.5 mt -104.19 138.81 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.159 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 84.7 m -133.94 155.41 49.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.0 p -106.72 116.1 31.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.891 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.42 127.98 54.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -145.65 136.61 24.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.02 -179.68 38.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -97.04 174.67 6.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.902 0.382 . . . . 0.0 110.851 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -68.91 -59.22 3.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.04 -35.21 91.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.45 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.86 170.77 10.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.905 0.383 . . . . 0.0 111.077 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -84.75 159.14 20.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -99.5 173.37 6.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.88 118.94 30.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -103.91 124.65 49.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 17.9 m -131.16 122.96 19.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 140.38 42.43 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.412 ' C ' HG21 ' A' ' 125' ' ' VAL . 16.5 mt -113.9 -36.33 4.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.04 -179.68 6.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.508 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 67.8 p-90 -162.7 127.05 3.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.76 134.16 7.07 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -114.64 129.91 56.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.339 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 87.1 mt -107.57 138.15 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.121 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 106' ' ' LEU . 6.1 m120 -76.58 82.79 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.1 mt -34.43 -38.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.446 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 40.9 m-85 -105.93 120.47 41.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -62.85 170.53 2.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.547 ' CE1' HG21 ' A' ' 110' ' ' THR . 0.2 OUTLIER -51.83 -26.24 9.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.547 HG21 ' CE1' ' A' ' 109' ' ' TYR . 67.9 p -105.23 31.79 4.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 47.01 36.6 4.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 113' ' ' LEU . 97.6 m -115.12 102.52 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.445 ' C ' ' O ' ' A' ' 112' ' ' THR . 35.2 mt -34.05 125.13 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.567 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 29.8 m -58.2 176.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.146 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.437 ' HA ' ' CB ' ' A' ' 154' ' ' PHE . 2.2 m -173.42 166.88 4.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.33 132.38 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.471 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.423 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 22.6 ttpt -40.36 149.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.9 ttp -159.71 158.4 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.69 133.47 32.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 pp -143.59 148.74 36.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -76.6 157.94 31.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 mt -118.12 147.71 43.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.581 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 9.1 m95 -81.19 152.7 71.29 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.524 0.678 . . . . 0.0 110.931 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 161.88 44.21 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.708 2.272 . . . . 0.0 112.325 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.412 HG21 ' C ' ' A' ' 99' ' ' LEU . 90.3 t -83.64 118.07 70.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -174.03 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.714 2.276 . . . . 0.0 112.324 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -92.35 146.9 23.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.21 -51.43 1.88 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.456 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.2 tp -43.09 112.59 0.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.831 0.348 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -95.32 -46.21 6.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -55.09 135.8 48.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 66.2 mt -57.93 -55.04 40.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.494 HD23 ' CE1' ' A' ' 38' ' ' TYR . 14.8 tp -88.57 134.14 33.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -105.28 91.42 4.67 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.598 0.713 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.506 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.8 -28.61 24.87 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.252 . . . . 0.0 112.313 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 137' ' ' GLY . 11.5 mm -75.34 -28.48 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.181 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -34.66 151.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.423 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.42 ' N ' ' CZ3' ' A' ' 101' ' ' TRP . 18.6 m -68.63 170.45 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.946 0.403 . . . . 0.0 111.116 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.5 p -111.98 169.17 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.84 159.26 29.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.535 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.5 p -77.5 121.25 23.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.842 0.353 . . . . 0.0 110.858 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.581 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 36.9 t30 -59.14 124.39 74.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -18.45 36.96 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.726 2.284 . . . . 0.0 112.326 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -60.97 139.33 58.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -95.41 -35.36 11.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -83.41 39.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -129.16 156.12 78.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 0.0 111.132 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 130.28 18.98 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.722 2.281 . . . . 0.0 112.294 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 12.1 t -121.29 130.62 53.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.402 HD13 ' CD1' ' A' ' 83' ' ' ILE . 2.9 mt -106.89 151.5 25.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.982 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.44 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -112.86 140.25 47.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.917 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.539 HD23 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -143.13 155.31 44.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.423 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 39.1 mt-10 -119.17 115.98 25.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 114' ' ' VAL . 44.6 m-85 -80.49 109.53 15.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.98 126.34 41.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.533 ' CZ3' HD11 ' A' ' 11' ' ' LEU . 6.3 m95 -123.55 98.38 5.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 158' ' ' SER . 46.9 p90 -98.67 -53.08 3.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.511 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 22.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 m -79.17 122.08 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 0.0 110.897 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.8 m -147.37 119.74 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.82 145.12 17.66 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.499 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 t -148.26 168.53 22.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.836 0.35 . . . . 0.0 110.851 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.8 p -101.56 -23.6 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.04 -142.12 13.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.447 ' OD1' ' C ' ' A' ' 158' ' ' SER . 11.7 t30 -106.3 173.62 6.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.43 -41.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.74 117.68 29.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.454 HD12 ' CZ3' ' A' ' 156' ' ' TRP . 14.7 tp -84.72 131.75 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.521 ' NE ' ' CZ3' ' A' ' 63' ' ' TRP . 23.2 ptt180 -130.1 136.77 49.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.474 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 58.4 mt -134.21 134.9 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -111.41 133.79 53.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.8 mm -93.39 145.93 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.418 ' HB2' ' CB ' ' A' ' 151' ' ' GLU . 4.2 mm? -100.45 -72.4 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.2 p -166.78 -175.36 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.8 148.29 52.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -120.77 133.68 55.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 66.72 41.8 2.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.49 140.1 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.154 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 23' ' ' VAL . 59.5 t30 -41.78 -42.2 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 22' ' ' ASN . 15.4 m -35.89 106.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.108 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -95.63 -60.1 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.6 pt -83.88 176.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.169 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -112.55 44.82 1.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.39 -41.45 7.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.822 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.9 mt -49.69 129.1 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -59.78 -66.8 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.844 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -144.33 177.32 8.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.4 173.56 11.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -165.65 170.83 13.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.506 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 92.1 t -119.14 140.51 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.126 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.417 ' N ' HG13 ' A' ' 33' ' ' VAL . 46.5 ttm-85 -115.03 130.82 57.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.4 p -126.71 168.16 14.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.114 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.24 134.22 1.63 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.429 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.99 148.7 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 111.156 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.506 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 19.7 m-85 -140.1 142.75 36.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.7 t-160 -118.64 104.76 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.846 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.36 45.07 82.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.492 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.437 ' CA ' HD12 ' A' ' 136' ' ' ILE . . . 69.14 30.89 71.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.453 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -140.58 144.71 37.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.641 0.734 . . . . 0.0 110.904 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 163.95 36.3 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.696 2.264 . . . . 0.0 112.374 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.429 HD13 ' CB ' ' A' ' 39' ' ' HIS . 9.6 mp -126.2 -40.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.6 p -146.33 177.0 9.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.11 118.06 7.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -50.48 149.07 3.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.454 HG12 ' CD1' ' A' ' 64' ' ' LEU . 61.6 t -111.14 137.23 44.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -118.55 151.29 38.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 79.4 p -100.73 164.37 11.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -49.71 172.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.26 120.24 40.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.526 HG11 ' CD1' ' A' ' 60' ' ' TRP . 1.8 m -122.05 152.12 59.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.568 0.699 . . . . 0.0 111.131 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 136.23 32.34 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.704 2.269 . . . . 0.0 112.306 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.0 p -45.65 -47.55 14.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -47.78 -35.35 9.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -134.72 89.0 26.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.659 0.742 . . . . 0.0 110.911 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.585 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 54.3 Cg_endo -69.73 2.23 3.7 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.65 2.234 . . . . 0.0 112.408 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -54.2 105.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.585 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.9 m-90 -93.18 -49.72 5.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 40.49 45.1 1.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -115.53 138.73 50.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.521 ' CZ3' ' NE ' ' A' ' 12' ' ' ARG . 45.8 m95 -85.76 108.55 18.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.454 ' CD1' HG12 ' A' ' 48' ' ' VAL . 10.3 tp -96.15 117.38 30.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -97.54 126.84 43.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -96.48 122.14 39.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.41 53.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.426 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.3 pp -117.27 167.15 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.609 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.69 119.86 39.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.641 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -58.0 -51.1 84.2 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.654 0.74 . . . . 0.0 111.159 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.75 2.86 3.15 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.697 2.265 . . . . 0.0 112.336 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.487 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.6 t0 -122.46 -11.02 8.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.835 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.413 ' CD1' ' HB2' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -70.62 113.64 20.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.659 0.742 . . . . 0.0 110.92 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 132.97 24.48 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.641 2.228 . . . . 0.0 112.366 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.46 ' NE ' ' OD2' ' A' ' 111' ' ' ASP . 82.8 mmt-85 -43.1 -45.91 5.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.54 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -51.2 -46.92 62.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . . . -53.15 162.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -160.75 175.56 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.858 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.3 tp -94.38 138.22 32.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 84.5 m -139.19 135.63 34.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp -142.03 157.24 45.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 59.5 m -157.99 154.52 27.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.4 mt -97.85 147.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.168 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 86.2 m -142.65 156.61 45.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.1 m -116.07 118.58 33.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 p -102.94 130.07 53.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -148.12 150.75 34.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.3 -172.6 34.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.51 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -104.9 157.97 16.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -59.58 -55.59 32.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.49 -22.33 76.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.549 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -102.21 -179.74 4.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 111.144 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -91.01 157.41 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -100.02 174.19 6.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -131.53 130.71 42.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -102.85 132.47 49.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.0 t -132.71 120.85 16.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.632 0.73 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 147.66 63.19 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.693 2.262 . . . . 0.0 112.37 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.6 mt -122.72 -55.04 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.8 -179.82 5.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.424 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 69.3 p-90 -164.36 132.95 3.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.26 136.97 7.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.534 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -115.15 146.44 41.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 110.848 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.42 ' CG1' HD22 ' A' ' 120' ' ' LEU . 95.5 mt -127.29 125.6 66.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 106' ' ' LEU . 16.7 m-80 -64.87 87.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.894 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 105' ' ' ASN . 37.9 mt -33.46 -38.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' ASN . 66.3 m-85 -105.15 110.95 23.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -56.75 177.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -52.08 -40.56 61.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 t -86.57 34.12 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.158 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.46 ' OD2' ' NE ' ' A' ' 75' ' ' ARG . 35.8 t0 38.22 49.49 1.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 113' ' ' LEU . 52.7 m -134.14 111.48 10.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.481 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 58.0 mt -34.19 134.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.569 HG22 ' CE2' ' A' ' 154' ' ' PHE . 31.0 m -65.6 175.55 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.2 p -169.77 165.06 9.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.5 134.6 0.25 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.48 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -42.02 149.31 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.729 0.3 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 45.2 ttp -159.77 159.84 33.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.79 137.27 34.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.103 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.42 HD22 ' CG1' ' A' ' 104' ' ' ILE . 4.3 pp -145.22 155.42 43.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -81.36 152.53 27.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.9 mt -114.87 138.48 50.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.566 ' CH2' ' HD2' ' A' ' 143' ' ' PRO . 12.0 m95 -75.9 149.11 82.63 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.546 0.689 . . . . 0.0 110.953 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 157.12 61.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.685 2.257 . . . . 0.0 112.371 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.1 t -74.86 128.46 85.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 111.086 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 178.55 4.46 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.645 2.23 . . . . 0.0 112.365 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -83.09 158.89 22.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 49.88 81.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 57.4 tp -150.48 147.19 27.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.743 0.306 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -119.4 -56.54 2.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -51.01 117.02 2.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.3 mt -52.56 -47.79 66.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.1 tp -93.55 138.85 31.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -107.8 91.29 7.32 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.595 0.712 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.506 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.73 -34.58 14.39 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.338 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.437 HD12 ' CA ' ' A' ' 41' ' ' GLY . 19.1 mm -70.65 -26.46 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.167 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.424 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -39.49 153.62 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.9 m -65.62 166.14 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.935 0.397 . . . . 0.0 111.098 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.0 p -109.41 166.87 10.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.146 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.99 177.79 33.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.2 p -91.79 130.35 37.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.893 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 123' ' ' TRP . 63.8 t-20 -67.17 121.26 77.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.563 0.696 . . . . 0.0 110.885 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.566 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.8 Cg_endo -69.68 -7.23 20.49 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.721 2.281 . . . . 0.0 112.345 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.47 127.19 31.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -78.01 -52.78 8.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -40.61 -41.95 1.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.0 p -62.09 151.66 80.2 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 111.134 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 174.82 8.89 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 0.0 112.384 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 120' ' ' LEU . 4.1 t -150.55 137.92 19.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.855 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.5 mt -110.9 156.48 21.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.418 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . 1.7 mp0 -117.63 138.59 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.568 HD22 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -141.58 158.37 43.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -122.5 120.26 33.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.569 ' CE2' HG22 ' A' ' 114' ' ' VAL . 43.7 m-85 -88.04 119.39 28.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.51 128.5 20.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.481 ' CZ3' HD13 ' A' ' 113' ' ' LEU . 3.9 m95 -123.9 103.48 8.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' CG ' ' N ' ' A' ' 158' ' ' SER . 21.8 p90 -106.46 -49.64 3.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.879 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.494 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 31.4 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.0 m -113.68 110.46 20.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 p -86.7 98.4 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.84 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.13 -90.67 1.42 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.518 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m -112.98 131.61 55.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.898 0.38 . . . . 0.0 110.871 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 82.2 p -139.75 139.73 36.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.51 -66.84 0.31 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.47 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -114.1 112.77 23.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.901 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.402 ' C ' HD13 ' A' ' 70' ' ' ILE . 1.9 m -130.17 -33.12 1.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.493 ' CB ' ' CB ' ' A' ' 158' ' ' SER . . . -119.71 141.83 49.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.118 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -106.27 137.15 44.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.496 ' NH1' ' N ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER -140.35 163.71 32.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.472 ' CD1' HD22 ' A' ' 79' ' ' LEU . 67.9 mt -154.79 131.75 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -105.88 104.17 13.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.7 mm -73.19 136.58 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.83 -75.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.1 p -168.01 167.8 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.83 164.7 12.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.074 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.489 HG22 ' CD2' ' A' ' 20' ' ' TYR . 10.0 t -142.97 161.14 38.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.489 ' CD2' HG22 ' A' ' 19' ' ' THR . 18.3 m-85 49.79 45.04 25.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.402 ' CG1' ' H ' ' A' ' 22' ' ' ASN . 3.3 t -80.98 171.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.09 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.402 ' H ' ' CG1' ' A' ' 21' ' ' VAL . 5.2 t-20 -84.46 27.03 0.73 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 23' ' ' VAL . 30.2 m -74.66 64.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -85.72 -73.62 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.863 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 pp -51.96 179.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -132.47 67.47 1.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -133.93 -33.81 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.0 mt -52.02 137.37 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.113 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.49 -51.62 4.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -146.65 173.49 12.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.5 pt -136.17 174.96 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -169.14 148.19 3.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.536 HG22 ' CZ2' ' A' ' 60' ' ' TRP . 55.3 t -100.95 141.44 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.451 ' N ' HG13 ' A' ' 33' ' ' VAL . 29.4 ttt85 -121.11 126.63 50.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.3 p -121.34 176.04 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.67 137.02 2.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.457 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.63 142.78 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.521 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 13.4 m-85 -135.43 164.61 27.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.464 ' CB ' HD12 ' A' ' 44' ' ' LEU . 8.4 t-160 -132.72 100.96 5.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.72 30.56 70.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.526 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.42 -49.57 1.04 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.98 145.31 88.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.652 0.739 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.441 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.76 167.05 25.55 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.345 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.464 HD12 ' CB ' ' A' ' 39' ' ' HIS . 10.9 mp -118.74 -33.24 4.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.6 t -166.02 168.2 15.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -41.91 153.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -92.21 171.85 8.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.459 HG13 ' CG ' ' A' ' 64' ' ' LEU . 57.5 t -125.96 143.61 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -129.65 144.91 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.4 t -94.31 165.09 12.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.168 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -53.39 178.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.8 mtm-85 -104.56 139.02 40.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.8 m -140.68 152.19 65.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.615 0.722 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 135.12 29.73 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.684 2.256 . . . . 0.0 112.356 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 17.4 p -45.96 -47.69 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.1 p -46.43 -37.62 7.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -134.4 88.05 30.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.63 0.728 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.539 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 3.29 2.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.341 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -54.36 110.75 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.539 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.7 m-90 -95.07 -68.53 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 58.25 54.29 5.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -131.18 140.59 49.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -81.61 104.78 12.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.459 ' CG ' HG13 ' A' ' 48' ' ' VAL . 11.2 tp -88.81 111.49 22.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -90.19 127.94 36.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -97.61 134.67 40.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.913 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.46 50.7 1.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.424 HD11 ' C ' ' A' ' 68' ' ' ILE . 2.0 pp -122.92 164.11 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.7 117.34 31.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.633 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.4 mp -54.28 -51.98 72.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.604 0.716 . . . . 0.0 111.146 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.8 Cg_endo -69.79 2.6 3.4 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.696 2.264 . . . . 0.0 112.366 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.492 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.0 t70 -125.72 -9.45 6.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.29 117.44 63.15 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.623 0.725 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 146.06 59.37 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.647 2.231 . . . . 0.0 112.371 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.554 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 62.0 mmt-85 -59.96 -42.2 93.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' HB1' ' NE2' ' A' ' 39' ' ' HIS . . . -54.42 -31.36 55.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.06 162.0 27.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.2 mtt85 -155.58 175.26 14.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.472 HD22 ' CD1' ' A' ' 13' ' ' ILE . 43.2 tp -98.93 131.41 45.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.6 m -128.55 124.59 36.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.13 158.49 37.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.5 p -156.98 137.73 13.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.404 ' CD1' HD11 ' A' ' 150' ' ' LEU . 33.8 mt -88.24 136.79 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 63.5 m -133.99 141.54 47.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.0 p -105.88 119.75 39.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.565 HG23 ' CD2' ' A' ' 96' ' ' HIS . 6.2 p -101.57 138.17 26.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -150.08 137.04 19.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.95 -154.7 12.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -132.9 172.18 12.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.853 0.359 . . . . 0.0 110.83 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -63.43 -60.09 3.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.35 -37.29 79.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.74 172.35 12.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.837 0.351 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -87.3 173.87 8.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.46 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 8.8 mt-10 -104.65 160.04 15.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -125.77 122.96 37.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.565 ' CD2' HG23 ' A' ' 86' ' ' VAL . 7.3 m170 -96.45 140.56 30.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.826 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.9 t -142.31 122.98 8.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 147.01 62.04 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.71 2.273 . . . . 0.0 112.368 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.0 mt -119.2 -56.65 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.16 -178.17 5.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.467 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 61.4 p-90 -160.33 141.89 12.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.923 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.9 125.45 2.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -108.01 117.93 35.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.758 0.314 . . . . 0.0 110.916 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.2 mt -107.63 128.28 62.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 106' ' ' LEU . 1.7 m120 -65.09 94.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.872 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.0 mt -35.84 -43.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.554 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 84.9 m-85 -101.97 119.61 39.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -56.48 -175.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -60.9 -37.71 83.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 t -88.8 32.94 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.19 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 43.81 53.88 5.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 113' ' ' LEU . 98.2 m -137.88 108.43 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.572 ' HB3' ' CZ2' ' A' ' 156' ' ' TRP . 41.4 mt -34.11 135.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.518 HG22 ' CZ ' ' A' ' 154' ' ' PHE . 26.8 m -67.64 172.64 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 154' ' ' PHE . 1.7 m -162.61 169.92 19.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.75 168.37 7.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.443 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 3.4 ttpm? -70.8 149.72 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 18.0 ttp -155.74 148.04 23.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.07 116.6 12.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.42 HD13 ' C ' ' A' ' 120' ' ' LEU . 4.4 pp -130.75 153.05 49.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.409 ' CB ' ' HB2' ' A' ' 142' ' ' ASN . 9.5 m-20 -75.37 147.24 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.4 mt -105.66 155.13 19.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.6 ' CD1' ' OD1' ' A' ' 142' ' ' ASN . 18.7 m95 -84.05 151.33 60.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.613 0.72 . . . . 0.0 110.872 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 152.87 69.23 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.657 2.238 . . . . 0.0 112.305 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.4 t -82.82 124.02 77.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 0.0 111.142 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 139.54 40.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -55.11 -43.66 74.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.851 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.01 65.49 4.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.481 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.7 tp -160.09 136.38 8.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.774 0.321 . . . . 0.0 110.923 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -107.84 -49.58 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -51.05 118.33 3.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.6 mt -56.57 -41.48 76.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.0 tp -104.41 119.85 39.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -101.6 97.8 8.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.521 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.9 Cg_endo -69.78 -40.66 5.03 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.373 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 137' ' ' GLY . 42.1 mt -65.16 -27.28 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -37.87 152.38 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.445 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.414 HG22 ' CZ2' ' A' ' 123' ' ' TRP . 14.9 m -56.46 168.07 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 30.7 p -120.45 154.77 34.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.79 -169.26 12.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.9 p -101.46 141.17 34.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 110.817 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.6 ' OD1' ' CD1' ' A' ' 123' ' ' TRP . 2.6 m120 -68.13 130.94 92.3 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.567 0.699 . . . . 0.0 110.896 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -28.84 25.05 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.696 2.264 . . . . 0.0 112.408 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -79.81 135.71 36.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -80.47 -34.95 35.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -46.85 -54.75 9.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.5 p -47.13 151.56 1.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.57 0.7 . . . . 0.0 111.156 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 168.02 22.88 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 13.1 t -144.88 140.73 28.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.404 HD11 ' CD1' ' A' ' 83' ' ' ILE . 2.3 mt -114.52 139.43 49.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -105.84 118.21 36.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.565 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -124.71 158.08 34.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.443 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 38.7 mt-10 -116.22 142.32 46.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.518 ' CZ ' HG22 ' A' ' 114' ' ' VAL . 45.7 m-85 -106.78 151.14 25.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.496 ' N ' ' NH1' ' A' ' 12' ' ' ARG . 3.8 m-20 -172.79 142.9 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.572 ' CZ2' ' HB3' ' A' ' 113' ' ' LEU . 7.8 m95 -132.21 86.8 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 158' ' ' SER . 28.7 p90 -95.43 -44.59 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.493 ' CB ' ' CB ' ' A' ' 10' ' ' ALA . 2.4 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -117.75 153.54 33.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 110.892 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 t -101.47 -61.87 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.8 113.4 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.456 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.9 t -63.14 -44.81 94.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 110.894 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 t 46.78 36.67 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.21 -41.38 17.62 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -105.35 140.25 38.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 110.87 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.413 ' C ' HD13 ' A' ' 70' ' ' ILE . 24.4 p -129.18 -39.23 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.17 141.74 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.071 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.474 HD11 ' CZ3' ' A' ' 156' ' ' TRP . 18.8 tp -102.52 140.39 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.408 ' NH2' ' CE3' ' A' ' 63' ' ' TRP . 0.4 OUTLIER -147.35 136.59 22.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.419 HD12 ' CE1' ' A' ' 66' ' ' TYR . 25.5 mt -135.54 145.66 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttt -119.73 119.3 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.2 mm -82.68 138.76 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.06 -73.51 0.58 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.0 p -170.41 176.11 4.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.29 160.4 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.6 t -129.15 158.66 38.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.188 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 42.88 39.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.426 HG11 ' N ' ' A' ' 22' ' ' ASN . 59.5 t -66.24 140.8 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 23' ' ' VAL . 15.5 t-20 -48.1 -34.32 9.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 22' ' ' ASN . 12.8 m -34.9 101.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.162 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -117.82 -64.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.41 HD13 ' C ' ' A' ' 25' ' ' ILE . 2.7 pp -48.07 177.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -128.53 62.92 1.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 28' ' ' ILE . 4.2 m-20 -134.74 -50.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.438 ' C ' ' O ' ' A' ' 27' ' ' ASP . 28.3 mt -33.91 136.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.68 -64.36 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -145.84 167.47 23.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 pt -127.3 163.72 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -157.15 157.98 35.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG21 ' CE2' ' A' ' 60' ' ' TRP . 98.4 t -104.05 140.13 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.469 ' N ' HG12 ' A' ' 33' ' ' VAL . 31.3 ttm-85 -114.6 116.6 29.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.3 p -119.34 163.6 16.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.126 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.27 143.4 3.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.498 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 38' ' ' TYR . 4.2 mp -88.5 148.55 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.511 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 25.3 m-85 -135.47 132.58 37.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -118.94 94.9 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.72 34.66 8.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.96 -26.7 3.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.505 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.25 153.22 62.47 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.634 0.73 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.467 ' O ' ' C ' ' A' ' 44' ' ' LEU . 53.8 Cg_endo -69.77 82.99 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 43' ' ' PRO . 16.4 tp -32.41 -46.54 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.1 m -152.23 177.24 10.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.47 150.89 8.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.83 145.94 25.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.425 HG13 ' CD1' ' A' ' 64' ' ' LEU . 58.8 t -105.54 135.32 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.082 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -113.17 147.15 37.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.9 p -99.74 167.52 10.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -53.76 165.29 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -100.73 116.4 32.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -116.28 152.48 47.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.676 0.75 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 139.01 39.19 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.66 2.24 . . . . 0.0 112.367 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.4 p -42.43 -45.61 4.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.834 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 p -51.12 -37.43 45.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.84 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -125.79 83.5 62.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.646 0.736 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.73 3.51 2.72 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.378 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.35 128.89 38.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.542 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 10.0 m-90 -106.24 -40.88 5.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 60' ' ' TRP . 2.4 p30 33.76 44.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -117.82 138.55 52.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.408 ' CE3' ' NH2' ' A' ' 12' ' ' ARG . 62.3 m95 -81.82 96.9 7.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.917 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.425 ' CD1' HG13 ' A' ' 48' ' ' VAL . 12.8 tp -85.39 120.37 26.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -98.48 132.58 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.419 ' CE1' HD12 ' A' ' 13' ' ' ILE . 44.7 m-85 -100.41 136.19 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -87.63 44.08 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 69' ' ' TYR . 2.0 pp -112.59 165.57 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.112 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.603 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.58 119.98 37.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.637 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 2.8 mp -56.87 -51.73 79.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.596 0.713 . . . . 0.0 111.144 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.0 Cg_endo -69.75 1.64 4.24 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.36 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 3.5 t70 -125.47 -6.69 6.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -74.6 116.09 50.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.648 0.737 . . . . 0.0 110.926 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.426 ' N ' HD12 ' A' ' 73' ' ' LEU . 53.5 Cg_endo -69.77 139.3 39.84 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.736 2.29 . . . . 0.0 112.309 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -53.07 -36.86 61.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.77 -33.66 73.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.15 165.14 18.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -161.11 172.54 16.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.9 tp -93.79 144.68 25.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 77.4 m -135.86 149.65 49.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.84 139.42 15.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 96.8 p -148.86 139.19 22.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.5 mt -86.54 138.49 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 72.5 m -139.64 145.17 38.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.5 p -106.86 120.52 42.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.852 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.552 HG23 ' CD2' ' A' ' 96' ' ' HIS . 5.1 p -102.01 130.67 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.09 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -137.95 116.1 11.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -107.14 154.72 16.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.473 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -118.67 168.81 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 110.881 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -67.19 113.03 4.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.56 -23.25 16.86 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -95.74 167.25 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 111.106 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -87.02 168.37 13.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 36.0 mt-10 -75.5 156.09 35.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -122.98 116.31 23.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.552 ' CD2' HG23 ' A' ' 86' ' ' VAL . 6.7 m170 -94.02 127.01 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 21.7 t -131.54 123.59 19.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.589 0.709 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.431 ' HD3' ' CD2' ' A' ' 132' ' ' LEU . 53.9 Cg_endo -69.8 147.97 63.81 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.6 mt -122.74 -48.18 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.13 163.09 35.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.108 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.463 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 61.7 p-90 -142.6 138.59 30.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.79 121.05 1.66 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.518 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 34.6 m-20 -101.36 131.44 47.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.1 mt -124.45 121.54 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 106' ' ' LEU . 7.1 m120 -66.76 96.14 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.3 mt -35.0 -39.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -102.45 114.47 28.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -57.48 173.82 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.562 ' CE1' HG22 ' A' ' 110' ' ' THR . 1.1 p90 -58.05 -15.09 8.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.562 HG22 ' CE1' ' A' ' 109' ' ' TYR . 29.9 p -103.46 26.15 8.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 45.87 35.6 2.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 113' ' ' LEU . 93.6 m -125.76 109.3 12.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 112' ' ' THR . 33.7 mt -34.23 139.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.521 HG22 ' CE2' ' A' ' 154' ' ' PHE . 19.3 m -72.84 166.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -161.05 171.98 17.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.38 160.12 2.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -64.16 143.41 57.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 35.2 ttp -153.05 148.71 27.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.77 121.35 15.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.078 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pp -128.84 155.72 44.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -76.26 152.71 36.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.26 157.09 18.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.578 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 15.0 m95 -90.48 152.24 45.1 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.546 0.689 . . . . 0.0 110.946 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 151.26 69.09 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.344 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 93.4 t -75.18 116.62 56.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 134.41 27.93 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.677 2.251 . . . . 0.0 112.384 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -52.37 151.36 4.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.815 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . 88.86 -47.04 3.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.481 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 128' ' ' GLY . 54.8 tp -37.53 110.87 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -100.58 39.44 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.65 171.65 14.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.431 ' CD2' ' HD3' ' A' ' 98' ' ' PRO . 43.3 mt -103.0 -45.76 4.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.7 tp -104.12 132.42 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -105.54 91.06 4.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.591 0.71 . . . . 0.0 110.909 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.511 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.2 Cg_endo -69.79 -45.29 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.641 2.227 . . . . 0.0 112.395 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.0 mt -74.25 -23.74 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.449 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -39.83 158.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.472 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.1 m -52.81 172.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.944 0.402 . . . . 0.0 111.102 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.1 p -132.03 161.8 32.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.173 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.52 -179.75 25.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.8 p -90.33 121.29 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 0.0 110.875 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.578 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 29.8 t30 -63.28 126.53 89.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.544 0.688 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 1.49 4.4 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -91.81 113.32 25.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -74.4 -40.16 62.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -49.67 -46.38 49.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.0 p -55.15 152.62 14.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.581 0.705 . . . . 0.0 111.139 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 134.43 27.92 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.673 2.249 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.1 t -113.83 142.54 45.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 4.7 mt -110.27 146.22 36.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -116.53 123.13 46.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.553 ' C ' ' CD2' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -130.77 166.23 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -120.26 118.79 31.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.524 ' CE2' HD23 ' A' ' 152' ' ' LEU . 28.8 m-85 -88.96 100.78 13.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.923 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -121.79 154.43 36.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.474 ' CZ3' HD11 ' A' ' 11' ' ' LEU . 20.9 m95 -138.77 105.3 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 158' ' ' SER . 14.8 p90 -90.47 -49.01 6.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.514 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 51.5 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.572 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 46.3 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -120.26 135.3 55.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.096 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.983 HD13 ' CH2' ' A' ' 156' ' ' TRP . 6.7 tp -97.54 128.92 44.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.412 ' NH2' ' CE3' ' A' ' 63' ' ' TRP . 0.3 OUTLIER -127.35 123.6 36.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.687 HD12 ' CE1' ' A' ' 66' ' ' TYR . 11.3 mt -124.57 137.09 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.175 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -113.96 135.41 54.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 mm -94.78 142.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.136 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.87 -69.19 0.78 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 p -172.3 173.85 4.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -120.5 161.07 21.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.07 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' A' ' 149' ' ' CYS . 2.1 t -128.34 158.37 38.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 39.47 52.16 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.962 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.825 0.345 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.401 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 29.4 t70 -82.85 -55.91 4.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 25.9 mmtt -146.32 -177.12 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.536 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.1 pt -145.52 170.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 3.7 p90 -158.57 166.23 32.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.679 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 99.0 t -122.27 139.6 48.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.126 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' HG2' HD22 ' A' ' 133' ' ' LEU . 20.6 ttm180 -115.72 121.2 41.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.812 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 81' ' ' LEU . 57.9 p -118.91 154.16 33.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.406 ' C ' HD12 ' A' ' 37' ' ' ILE . . . -176.08 169.26 41.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.536 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.599 HD13 HG21 ' A' ' 68' ' ' ILE . 4.1 mp -122.98 137.24 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.806 0.336 . . . . 0.0 111.124 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.54 ' HA ' HD13 ' A' ' 44' ' ' LEU . 2.9 m-85 -137.03 150.22 47.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.732 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.4 t-160 -113.01 99.36 7.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.84 32.55 61.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.478 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.31 -22.45 34.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.58 140.04 29.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.605 0.716 . . . . 0.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.485 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 53.8 Cg_endo -69.74 156.09 64.31 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.367 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.6 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.1 mp -120.51 -38.01 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.2 m -154.98 168.21 27.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -51.9 152.65 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -93.94 163.44 13.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.647 HG12 HD11 ' A' ' 64' ' ' LEU . 25.4 t -116.73 145.06 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -125.33 141.68 51.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.5 p -85.86 160.66 19.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -52.75 170.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -95.88 115.22 27.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -116.96 152.16 48.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.593 0.711 . . . . 0.0 111.11 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 137.74 36.24 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.35 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 24.6 p -47.85 -44.88 29.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 t -53.16 -31.33 42.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -134.39 84.78 39.87 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.62 0.724 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.447 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.75 3.31 2.84 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.717 2.278 . . . . 0.0 112.37 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -62.81 127.15 29.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.679 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 5.6 m-90 -106.22 -63.46 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 58.67 45.05 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -127.55 147.47 50.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.412 ' CE3' ' NH2' ' A' ' 12' ' ' ARG . 77.9 m95 -88.66 117.71 27.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.647 HD11 HG12 ' A' ' 48' ' ' VAL . 9.2 tp -101.0 123.25 44.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -99.59 136.63 39.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.687 ' CE1' HD12 ' A' ' 13' ' ' ILE . 34.8 m-85 -106.35 138.36 42.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.49 38.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.599 HG21 HD13 ' A' ' 37' ' ' ILE . 1.8 pp -108.05 161.53 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.605 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.62 124.86 49.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.588 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -55.84 -55.27 42.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 0.0 111.173 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.9 Cg_endo -69.74 2.94 3.07 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 112.346 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.503 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.1 t0 -127.72 1.46 6.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.89 115.71 62.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.643 0.735 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.606 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.78 145.64 57.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.467 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 25.3 mmt85 -59.69 -35.9 75.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.732 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -62.73 -32.92 74.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.606 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -68.35 165.0 19.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.093 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.481 ' O ' HG23 ' A' ' 37' ' ' ILE . 15.3 ptp180 -163.09 176.36 10.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.3 tp -98.97 136.69 38.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.76 132.11 40.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.9 OUTLIER -130.66 158.62 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.8 p -159.57 135.89 8.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.829 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.423 HG12 HD11 ' A' ' 150' ' ' LEU . 34.7 mt -86.58 136.57 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.109 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . 30.3 m -132.53 151.29 51.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.536 ' HA ' HG22 ' A' ' 31' ' ' ILE . 83.6 p -112.97 122.76 48.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.569 HG23 ' CD2' ' A' ' 96' ' ' HIS . 8.9 p -106.19 125.85 61.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.0 tptt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.93 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.842 0.354 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -130.27 122.98 29.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.569 ' CD2' HG23 ' A' ' 86' ' ' VAL . 5.7 m170 -100.95 128.79 46.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.2 t -131.82 129.01 21.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 110.872 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.584 ' HB2' HG11 ' A' ' 125' ' ' VAL . 53.8 Cg_endo -69.84 143.18 49.65 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 0.0 112.282 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.439 ' C ' HG13 ' A' ' 125' ' ' VAL . 11.1 mt -118.45 -56.83 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.19 178.68 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.587 ' HD1' HG12 ' A' ' 125' ' ' VAL . 64.8 p-90 -161.42 144.07 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.96 132.46 4.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -111.93 120.26 41.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 0.0 110.909 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.586 HD11 HD21 ' A' ' 120' ' ' LEU . 73.7 mt -112.24 127.27 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -68.87 98.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.3 mt -43.15 -34.32 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 63.3 m-85 -107.9 110.43 22.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -51.65 170.22 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 1.061 ' CE1' HG23 ' A' ' 110' ' ' THR . 0.6 OUTLIER -55.48 -20.25 12.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.984 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 1.061 HG23 ' CE1' ' A' ' 109' ' ' TYR . 41.5 p -102.64 28.46 6.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.113 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 110' ' ' THR . 4.3 p30 46.71 40.34 8.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 113' ' ' LEU . 93.1 m -126.23 109.24 12.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.838 HD22 ' CH2' ' A' ' 156' ' ' TRP . 34.0 mt -34.2 132.95 0.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.1 m -66.2 163.31 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.5 p -160.42 175.6 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.54 134.9 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.484 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.434 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 5.9 ttpt -43.01 150.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.803 0.335 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.427 ' O ' HD13 ' A' ' 152' ' ' LEU . 34.8 ttp -158.79 148.72 19.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.7 114.44 9.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.586 HD21 HD11 ' A' ' 104' ' ' ILE . 4.1 pp -124.79 160.94 27.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.68 150.23 29.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.428 HD11 HD12 ' A' ' 150' ' ' LEU . 5.5 mt -106.52 153.35 22.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.536 ' CH2' ' OD1' ' A' ' 142' ' ' ASN . 54.7 m95 -85.94 144.81 39.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.514 0.673 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 132.61 23.71 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.646 2.231 . . . . 0.0 112.363 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.587 HG12 ' HD1' ' A' ' 101' ' ' TRP . 21.5 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.675 0.75 . . . . 0.0 111.123 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.468 HD13 ' OH ' ' A' ' 32' ' ' TYR . 40.3 mt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.81 0.338 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.432 HD22 ' HG2' ' A' ' 34' ' ' ARG . 21.7 tp -106.32 133.05 51.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -107.08 91.37 6.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.636 0.731 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -17.12 38.01 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.67 2.247 . . . . 0.0 112.381 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 mm -88.89 -20.69 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -41.93 150.75 0.27 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.3 m -66.46 164.2 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.963 0.411 . . . . 0.0 111.086 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.4 p -108.15 161.11 15.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.133 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.32 167.51 18.62 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.462 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.6 p -93.5 118.73 31.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 110.885 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.536 ' OD1' ' CH2' ' A' ' 123' ' ' TRP . 31.6 t30 -61.35 123.62 77.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.665 0.745 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -8.73 24.36 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.722 2.282 . . . . 0.0 112.333 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -73.44 138.98 45.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -90.21 -49.5 6.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -44.69 -38.42 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.8 p -63.77 151.24 89.34 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.583 0.706 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 166.4 27.7 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 0.0 112.356 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.404 ' HB3' ' CG2' ' A' ' 19' ' ' THR . 4.2 t -146.1 135.88 23.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.475 ' CD2' ' HB2' ' A' ' 18' ' ' ALA . 10.8 mt -113.84 138.49 50.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.967 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.434 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 18.3 tt0 -106.93 132.08 53.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.79 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -134.84 161.74 34.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -116.41 120.84 40.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.644 ' CE2' HD21 ' A' ' 152' ' ' LEU . 25.9 m-85 -90.15 113.94 25.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.63 136.65 46.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.983 ' CH2' HD13 ' A' ' 11' ' ' LEU . 2.7 m95 -134.58 98.96 4.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.564 ' CG ' ' N ' ' A' ' 158' ' ' SER . 15.5 p90 -103.83 -51.76 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.564 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 4.0 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.54 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 5.6 m . . . . . 0 C--O 1.229 0.025 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.888 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -119.52 147.07 44.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.093 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.613 HD13 ' CH2' ' A' ' 156' ' ' TRP . 11.2 tp -93.25 130.28 39.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.572 ' N ' HD12 ' A' ' 11' ' ' LEU . 6.2 ttp180 -127.97 127.61 43.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.948 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.475 HD12 ' CE1' ' A' ' 66' ' ' TYR . 51.4 mt -130.75 156.3 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' N ' HG22 ' A' ' 13' ' ' ILE . 55.7 tttt -140.65 128.01 21.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.5 mm -90.29 143.33 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.68 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.2 mm? -100.23 -73.66 0.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 t -162.49 172.17 15.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.428 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -119.23 162.9 17.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' TYR . 9.5 t -130.69 156.08 45.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' THR . 4.9 m-85 35.59 45.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.863 0.364 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -79.56 -57.32 3.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -146.15 177.49 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.4 pt -139.64 173.72 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -165.98 160.57 16.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.517 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 37.6 t -116.74 146.84 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.145 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -119.68 136.14 54.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.481 HG22 ' HB3' ' A' ' 81' ' ' LEU . 63.0 p -130.59 157.65 42.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.11 141.58 3.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 37' ' ' ILE . 3.4 mp -93.59 133.66 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 111.111 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.549 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 17.5 m-85 -127.86 158.69 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.601 ' HB3' HD11 ' A' ' 44' ' ' LEU . 12.0 t-160 -134.57 95.43 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.69 32.07 28.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.48 -17.81 46.27 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -96.97 141.8 23.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.625 0.726 . . . . 0.0 110.938 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.432 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.77 160.88 48.08 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.643 2.229 . . . . 0.0 112.358 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.601 HD11 ' HB3' ' A' ' 39' ' ' HIS . 10.1 mp -119.9 -26.4 5.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.5 p -158.38 168.24 27.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -57.04 131.23 49.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -64.09 148.52 49.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.479 HG12 HD11 ' A' ' 64' ' ' LEU . 21.3 t -111.15 147.16 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.433 HD21 ' C ' ' A' ' 49' ' ' ASN . 0.4 OUTLIER -130.16 145.24 51.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.452 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 3.2 t -87.59 176.12 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.402 ' N ' ' OG1' ' A' ' 50' ' ' THR . 11.6 pt20 -63.52 167.9 5.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.1 mtm-85 -92.13 140.61 29.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.38 152.12 49.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.662 0.744 . . . . 0.0 111.153 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.67 36.08 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.686 2.257 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.1 p -47.78 -45.75 29.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.4 m -52.3 -28.34 18.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -134.5 87.38 32.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.668 0.747 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.75 3.73 2.6 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.351 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -55.69 134.4 51.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.517 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -120.88 -68.45 0.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.68 ' OD1' HD13 ' A' ' 16' ' ' LEU . 69.0 m-80 53.55 52.72 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -127.56 143.39 51.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.46 ' CE3' ' HD2' ' A' ' 12' ' ' ARG . 90.0 m95 -87.38 104.35 16.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.479 HD11 HG12 ' A' ' 48' ' ' VAL . 10.8 tp -93.39 120.69 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -95.96 151.95 18.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' CE1' HD12 ' A' ' 13' ' ' ILE . 61.8 m-85 -118.03 140.21 50.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -84.33 30.29 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.592 ' C ' HD12 ' A' ' 68' ' ' ILE . 1.3 pp -106.63 159.42 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.608 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -110.88 139.97 45.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.967 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.536 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.5 mp -64.64 -58.06 14.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.699 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.608 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.0 Cg_endo -69.73 2.43 3.53 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.679 2.252 . . . . 0.0 112.322 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.0 t70 -120.67 -0.74 10.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.476 HD21 HG21 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -87.52 117.13 68.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.0 Cg_endo -69.82 138.37 37.49 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.622 2.215 . . . . 0.0 112.344 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -56.45 -26.47 53.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.427 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -70.31 -27.41 64.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.087 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.475 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -78.43 165.52 23.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 37' ' ' ILE . 11.6 ptp180 -157.89 174.13 15.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.465 ' HB2' HD21 ' A' ' 106' ' ' LEU . 33.2 tp -97.01 143.64 27.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.608 ' C ' HD23 ' A' ' 81' ' ' LEU . 81.9 m -133.58 154.65 50.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.608 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -155.66 137.84 14.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.768 ' OG ' HD12 ' A' ' 133' ' ' LEU . 1.0 OUTLIER -139.42 154.37 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.812 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.9 mt -98.75 128.68 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.193 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 18.6 m -128.52 142.58 51.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.676 ' HA ' HG22 ' A' ' 31' ' ' ILE . 29.8 p -108.37 130.96 55.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.788 HG23 ' CD2' ' A' ' 96' ' ' HIS . 9.9 p -110.64 129.21 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.115 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 tptm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.902 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.84 0.352 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -137.52 121.61 17.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.788 ' CD2' HG23 ' A' ' 86' ' ' VAL . 9.1 m170 -97.46 141.46 30.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.7 t -148.6 132.34 8.47 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.582 0.706 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.657 ' O ' HD23 ' A' ' 99' ' ' LEU . 54.0 Cg_endo -69.75 152.51 69.38 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.24 . . . . 0.0 112.397 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 98' ' ' PRO . 6.6 mt -128.48 -47.21 1.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -140.87 155.47 46.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.112 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.76 ' CH2' HG22 ' A' ' 138' ' ' VAL . 62.2 p-90 -135.68 126.2 26.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.4 130.07 5.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.599 ' HB2' HG22 ' A' ' 139' ' ' THR . 1.0 OUTLIER -104.6 161.49 14.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.409 HG13 ' C ' ' A' ' 103' ' ' ASN . 88.6 mt -151.17 118.03 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -64.83 105.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 79' ' ' LEU . 70.9 mt -44.32 -54.73 5.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.406 ' CE1' ' HG ' ' A' ' 113' ' ' LEU . 65.0 m-85 -94.28 120.34 34.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -56.75 -176.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.743 ' CE1' HG23 ' A' ' 110' ' ' THR . 0.3 OUTLIER -72.09 -0.9 12.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.743 HG23 ' CE1' ' A' ' 109' ' ' TYR . 5.0 p -108.86 11.39 26.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.117 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 64.33 48.56 2.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.4 m -147.33 125.64 12.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.982 HD22 ' CH2' ' A' ' 156' ' ' TRP . 15.0 mt -45.27 142.12 2.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 114' ' ' VAL . 2.4 m -64.24 176.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.4 p -168.51 173.69 7.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.34 139.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.476 ' HD3' ' CG ' ' A' ' 151' ' ' GLU . 0.7 OUTLIER -48.51 146.11 3.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.861 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.417 ' O ' HD13 ' A' ' 152' ' ' LEU . 32.0 ttp -147.86 152.49 37.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.407 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.4 116.68 11.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.509 ' C ' HD12 ' A' ' 120' ' ' LEU . 4.5 pp -128.85 160.41 32.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 147' ' ' THR . 5.4 m120 -87.3 146.95 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.492 HD11 HD12 ' A' ' 150' ' ' LEU . 2.8 mt -104.63 150.05 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -83.09 151.68 63.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.539 0.685 . . . . 0.0 110.951 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 160.63 48.98 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 0.0 112.365 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.2 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.639 0.733 . . . . 0.0 111.128 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.845 0.355 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.768 HD12 ' OG ' ' A' ' 82' ' ' SER . 8.6 tp -110.49 145.3 37.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.41 ' HA ' ' HD2' ' A' ' 135' ' ' PRO . 3.5 t-20 -119.18 93.87 47.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 110.911 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.549 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.3 Cg_endo -69.83 -47.3 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.716 2.277 . . . . 0.0 112.31 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.619 ' H ' HD12 ' A' ' 136' ' ' ILE . 0.4 OUTLIER -64.36 -30.14 49.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.137 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.439 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -35.14 151.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.468 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.76 HG22 ' CH2' ' A' ' 101' ' ' TRP . 3.5 m -56.85 176.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.401 . . . . 0.0 111.125 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.599 HG22 ' HB2' ' A' ' 103' ' ' ASN . 41.2 p -129.48 161.73 29.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.122 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.57 159.17 20.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.0 p -78.18 130.87 36.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.855 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.409 ' ND2' HG21 ' A' ' 147' ' ' THR . 13.5 t-20 -64.37 119.81 59.63 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.644 0.735 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -7.2 20.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.673 2.249 . . . . 0.0 112.354 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -85.94 145.49 27.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -92.97 -37.15 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.69 -14.67 3.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.485 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 65.0 p -88.85 151.39 47.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.581 0.705 . . . . 0.0 111.154 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 169.39 19.07 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.342 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 t -150.79 137.83 19.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.492 HD12 HD11 ' A' ' 122' ' ' LEU . 10.2 mt -114.42 139.59 49.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.476 ' CG ' ' HD3' ' A' ' 117' ' ' LYS . 5.5 tt0 -107.09 123.17 47.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.778 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -131.08 162.54 29.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -119.15 131.72 55.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.508 ' CE2' HD21 ' A' ' 152' ' ' LEU . 24.5 m-85 -95.98 119.74 35.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.822 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.94 137.43 44.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.982 ' CH2' HD22 ' A' ' 113' ' ' LEU . 15.9 m95 -130.02 91.24 3.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.958 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.562 ' CG ' ' N ' ' A' ' 158' ' ' SER . 22.3 p90 -96.95 -52.62 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.888 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 30.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.882 0.373 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.55 128.42 53.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.596 HD13 ' CH2' ' A' ' 156' ' ' TRP . 17.6 tp -97.83 131.66 44.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -139.21 136.57 35.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 66' ' ' TYR . 31.1 mt -129.5 135.94 60.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 21.2 tttt -113.59 113.26 24.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.28 143.77 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.35 -73.22 0.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.5 p -170.52 171.0 6.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.94 154.23 25.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.421 HG23 ' CD2' ' A' ' 20' ' ' TYR . 8.1 t -134.64 143.25 47.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.421 ' CD2' HG23 ' A' ' 19' ' ' THR . 1.6 m-85 63.73 41.29 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.143 179.876 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.804 0.335 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -72.06 -62.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -144.74 177.08 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 85' ' ' SER . 4.9 pt -137.69 158.12 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -152.37 140.38 20.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.73 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 95.8 t -89.82 149.07 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.163 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.471 ' O ' HD13 ' A' ' 133' ' ' LEU . 37.3 ttt85 -131.53 119.35 21.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 81' ' ' LEU . 32.4 p -117.04 179.33 4.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.64 140.57 3.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.493 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.7 mp -90.07 142.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.165 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.537 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 22.0 m-85 -137.23 143.68 42.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.425 ' CB ' HD11 ' A' ' 44' ' ' LEU . 13.3 t-160 -122.14 99.01 6.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.13 36.58 31.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.44 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.92 35.41 50.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -148.53 140.39 14.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.728 . . . . 0.0 110.88 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 143.45 51.09 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 0.0 112.345 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 39' ' ' HIS . 11.3 mp -97.67 -41.83 7.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.8 m -150.36 162.54 40.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -44.02 120.3 2.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -60.52 162.25 6.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.552 HG12 HD11 ' A' ' 64' ' ' LEU . 21.2 t -117.32 147.46 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.163 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -126.86 148.89 49.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.459 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 9.1 t -98.13 163.82 12.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.174 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -49.95 179.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -107.02 127.71 53.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 59' ' ' ARG . 1.6 m -129.95 152.13 79.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.6 0.714 . . . . 0.0 111.161 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 141.55 45.57 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.704 2.269 . . . . 0.0 112.343 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.3 p -50.13 -45.36 52.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.8 p -53.64 -30.85 44.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -134.2 86.3 36.8 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.581 0.705 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.572 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.6 Cg_endo -69.75 3.63 2.66 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.723 2.282 . . . . 0.0 112.322 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.432 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -48.81 135.4 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.73 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -128.93 -56.35 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.523 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 0.7 OUTLIER 38.37 37.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -104.29 142.7 34.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.477 ' NE1' ' HD2' ' A' ' 14' ' ' LYS . 45.4 m95 -85.38 104.4 15.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.552 HD11 HG12 ' A' ' 48' ' ' VAL . 10.8 tp -96.32 121.43 38.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -99.74 141.92 31.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.434 ' CE1' HD12 ' A' ' 13' ' ' ILE . 58.4 m-85 -110.86 128.95 55.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -81.34 47.66 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.491 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.1 pp -114.0 167.25 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.16 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.617 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.55 123.72 46.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.621 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -58.49 -53.2 68.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.634 0.731 . . . . 0.0 111.143 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.82 3.11 2.99 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.268 . . . . 0.0 112.329 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.505 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 3.5 t70 -124.82 -4.42 7.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.636 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -82.01 111.85 30.45 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.94 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.498 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.3 Cg_endo -69.75 135.9 31.65 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.365 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.47 ' NE ' ' OD1' ' A' ' 111' ' ' ASP . 62.0 mmt-85 -45.27 -43.63 10.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.18 -47.98 54.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -52.51 160.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 -156.13 173.15 17.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.4 tp -98.62 131.02 45.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -125.98 132.34 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.565 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.4 OUTLIER -138.95 147.05 41.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.423 ' OG ' HD12 ' A' ' 133' ' ' LEU . 88.6 p -155.24 130.32 9.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.536 ' CG1' HD11 ' A' ' 150' ' ' LEU . 72.6 mt -80.5 131.72 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 55.7 m -123.37 143.38 50.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.52 ' HA ' HG22 ' A' ' 31' ' ' ILE . 35.7 m -106.98 128.05 54.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.593 HG23 ' CD2' ' A' ' 96' ' ' HIS . 6.9 p -109.05 137.71 39.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.169 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.936 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.561 ' HB3' HG22 ' A' ' 86' ' ' VAL . 24.3 mt-10 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.825 0.345 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -124.74 115.33 20.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.949 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.593 ' CD2' HG23 ' A' ' 86' ' ' VAL . 5.1 m170 -97.07 141.33 30.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.38 124.79 2.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.635 0.731 . . . . 0.0 110.855 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.549 ' HD3' HD23 ' A' ' 132' ' ' LEU . 53.3 Cg_endo -69.81 147.14 61.89 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.706 2.271 . . . . 0.0 112.298 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.463 ' O ' HG23 ' A' ' 125' ' ' VAL . 21.4 mt -113.2 -47.62 3.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.84 156.91 44.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.449 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 67.2 p-90 -137.21 138.91 40.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.07 124.21 3.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.53 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -101.75 129.16 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.892 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.675 HD11 HD21 ' A' ' 120' ' ' LEU . 85.0 mt -124.0 126.8 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.076 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 106' ' ' LEU . 8.2 t-20 -73.43 95.24 2.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 105' ' ' ASN . 51.4 mt -35.08 -34.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 105' ' ' ASN . 88.7 m-85 -103.56 112.7 25.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.92 -178.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.829 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 109' ' ' TYR . 1.3 p90 -62.06 -30.53 71.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.947 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.402 HG23 ' HB ' ' A' ' 112' ' ' THR . 5.2 t -93.99 33.86 1.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.181 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.47 ' OD1' ' NE ' ' A' ' 75' ' ' ARG . 14.5 t0 43.0 44.73 4.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 69.7 m -131.52 109.66 10.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.17 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.689 HD22 ' CH2' ' A' ' 156' ' ' TRP . 60.3 mt -34.66 140.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.518 HG21 ' CE2' ' A' ' 154' ' ' PHE . 27.6 m -67.66 165.44 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 p -164.94 158.1 16.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.864 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.94 141.05 1.23 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -40.01 149.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.917 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.7 ttp -159.76 148.46 17.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.71 123.36 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.675 HD21 HD11 ' A' ' 104' ' ' ILE . 4.6 pp -135.34 156.55 48.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -77.95 158.72 29.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.852 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.719 HD11 HD12 ' A' ' 150' ' ' LEU . 10.3 mt -118.87 158.64 25.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -91.46 152.04 43.23 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.576 0.703 . . . . 0.0 110.909 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 170.37 16.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.346 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 99' ' ' LEU . 98.3 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.548 0.69 . . . . 0.0 111.164 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.549 HD23 ' HD3' ' A' ' 98' ' ' PRO . 14.1 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.873 0.368 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 34' ' ' ARG . 10.3 tp -88.64 135.73 33.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -108.06 91.36 7.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.653 0.74 . . . . 0.0 110.897 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.76 -10.41 28.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.8 mm -95.61 -16.62 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.449 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -41.46 148.17 0.36 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 m -65.3 166.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 66.6 p -108.96 154.67 21.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.139 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.02 135.93 8.27 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.492 ' CB ' ' HB2' ' A' ' 120' ' ' LEU . 88.2 p -51.12 120.41 4.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.377 . . . . 0.0 110.837 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER -50.05 132.15 22.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.644 0.735 . . . . 0.0 110.881 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.0 11.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.688 2.259 . . . . 0.0 112.363 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 146' ' ' GLU . 23.4 t-20 -49.25 143.89 5.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -97.6 -32.49 11.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.447 ' N ' ' OD1' ' A' ' 144' ' ' ASN . 11.9 pt-20 -84.3 34.56 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.5 p -118.26 155.2 51.91 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.516 0.674 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 137.19 34.7 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.308 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 8.3 t -120.69 131.68 54.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.719 HD12 HD11 ' A' ' 122' ' ' LEU . 6.4 mt -107.23 140.06 40.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -109.12 123.91 49.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.781 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -135.08 161.21 35.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -121.18 123.88 43.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.619 ' CE2' HD21 ' A' ' 152' ' ' LEU . 25.6 m-85 -91.23 116.13 28.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.61 152.21 51.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.689 ' CH2' HD22 ' A' ' 113' ' ' LEU . 5.3 m95 -137.47 107.97 6.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.497 ' CG ' ' N ' ' A' ' 158' ' ' SER . 16.2 p90 -90.28 -46.65 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.497 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 26.9 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -118.77 126.15 51.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.669 HD13 ' CH2' ' A' ' 156' ' ' TRP . 12.4 tp -84.15 144.1 29.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.601 ' H ' HD12 ' A' ' 11' ' ' LEU . 23.5 ptt180 -146.95 139.07 24.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.6 mt -141.28 127.65 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HB2' ' CD2' ' A' ' 63' ' ' TRP . 25.8 tttp -103.24 120.35 40.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 mm -83.08 145.99 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.06 -73.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.1 p -172.96 169.17 4.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.401 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -113.97 158.1 21.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.6 t -137.04 151.99 49.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 58.85 32.76 22.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.136 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.6 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -85.27 -56.38 3.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -148.09 179.69 7.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 55' ' ' CYS . 7.7 pt -139.79 170.15 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.151 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -170.79 150.64 3.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.566 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 9.3 t -102.49 151.94 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -130.86 116.65 18.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.8 p -104.57 170.31 7.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.185 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.98 146.5 4.96 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.47 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 78' ' ' ARG . 3.6 mp -104.12 135.95 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.86 0.362 . . . . 0.0 111.127 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 35.4 m-85 -129.07 149.18 51.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.802 ' CB ' HD11 ' A' ' 44' ' ' LEU . 5.8 t-160 -123.05 98.45 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.74 44.29 39.42 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.446 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.92 29.68 72.47 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.442 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -139.48 140.78 26.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 142.78 48.78 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.712 2.275 . . . . 0.0 112.323 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.802 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.1 mp -110.49 -34.91 6.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 p -152.72 163.09 40.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -47.84 151.49 0.89 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -80.21 140.25 36.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.657 HG12 HD11 ' A' ' 64' ' ' LEU . 74.4 t -104.7 132.67 50.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -118.81 161.31 20.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -107.4 160.49 15.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -46.85 154.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.05 136.72 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.488 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -144.23 152.12 53.4 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.663 0.745 . . . . 0.0 111.086 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 139.89 41.26 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.696 2.264 . . . . 0.0 112.37 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 31' ' ' ILE . 24.9 p -51.03 -44.15 60.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.1 m -53.49 -35.52 60.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -132.53 83.96 52.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.719 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.539 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.79 3.27 2.88 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.688 2.259 . . . . 0.0 112.342 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -49.94 113.15 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.566 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 6.2 m-90 -106.41 -48.83 3.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 60' ' ' TRP . 6.8 m-80 36.61 49.72 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -121.38 146.54 46.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.417 ' CD2' ' HB2' ' A' ' 14' ' ' LYS . 59.5 m95 -87.71 100.05 12.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.657 HD11 HG12 ' A' ' 48' ' ' VAL . 12.2 tp -84.39 119.27 24.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -95.07 137.79 33.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -107.75 127.56 53.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.4 50.41 1.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.1 pp -118.5 163.4 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.616 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.57 112.23 22.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.64 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.5 mp -48.68 -52.42 45.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.661 0.743 . . . . 0.0 111.148 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.3 Cg_endo -69.8 2.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.514 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.1 t70 -129.29 1.82 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.6 118.61 71.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.627 0.727 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.532 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.8 Cg_endo -69.81 136.92 34.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.65 2.233 . . . . 0.0 112.341 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 23.2 mmt85 -54.47 -36.1 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.39 -35.61 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -64.26 166.25 8.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.106 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 37' ' ' ILE . 16.2 ptt180 -162.18 174.46 12.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.0 tp -94.87 134.35 37.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.0 m -132.28 132.66 43.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.56 155.15 50.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.727 ' OG ' HD12 ' A' ' 133' ' ' LEU . 7.6 m -157.62 127.42 6.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mt -83.48 140.03 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 63.7 m -136.11 149.68 48.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.402 ' HA ' HG22 ' A' ' 31' ' ' ILE . 87.9 p -106.6 120.44 41.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 86' ' ' VAL . 7.6 p -102.55 115.43 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.143 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HD2' ' C ' ' A' ' 87' ' ' LYS . 1.4 tmmt? . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.829 0.347 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -136.07 120.94 18.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.863 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.566 ' CD2' HG23 ' A' ' 86' ' ' VAL . 9.4 m170 -96.98 135.98 38.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.2 t -137.03 131.94 18.04 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.576 0.703 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.469 ' HB2' HG11 ' A' ' 125' ' ' VAL . 53.4 Cg_endo -69.79 151.93 69.04 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.682 2.255 . . . . 0.0 112.319 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 98' ' ' PRO . 29.5 mt -127.82 -53.36 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.923 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.04 164.89 32.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.084 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.532 ' O ' ' CE3' ' A' ' 101' ' ' TRP . 58.9 p-90 -146.94 129.2 15.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.53 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -131.33 129.29 5.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.469 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -106.75 126.84 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 0.0 110.862 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.565 HG12 HD21 ' A' ' 120' ' ' LEU . 62.2 mt -118.51 124.03 72.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.21 96.12 0.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.5 mt -37.92 -45.49 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.558 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 67.7 m-85 -94.42 114.81 26.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -48.06 174.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -60.67 -19.03 57.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.476 HG23 ' HB ' ' A' ' 112' ' ' THR . 5.9 t -94.57 12.45 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.131 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 65.97 37.75 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.476 ' HB ' HG23 ' A' ' 110' ' ' THR . 4.5 m -136.77 121.68 18.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.123 HD22 ' CH2' ' A' ' 156' ' ' TRP . 23.2 mt -34.69 146.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.537 HG23 ' CG ' ' A' ' 154' ' ' PHE . 23.4 m -75.31 175.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.144 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.6 p -167.15 161.42 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.795 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.1 136.6 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HE2' ' CD ' ' A' ' 151' ' ' GLU . 38.7 tttt -42.77 146.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.727 0.298 . . . . 0.0 110.917 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.429 ' O ' HD13 ' A' ' 152' ' ' LEU . 17.3 ttp -154.61 148.21 25.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.63 117.17 11.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.126 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.565 HD21 HG12 ' A' ' 104' ' ' ILE . 4.3 pp -129.72 161.88 29.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.552 ' O ' HD12 ' A' ' 120' ' ' LEU . 10.8 m120 -82.05 158.48 23.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.717 HD11 HD12 ' A' ' 150' ' ' LEU . 11.5 mt -117.31 144.85 44.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.592 ' CH2' ' ND2' ' A' ' 142' ' ' ASN . 49.8 m95 -70.35 152.01 95.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 0.0 110.943 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 170.27 16.9 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 0.0 112.352 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 98' ' ' PRO . 76.9 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.656 0.741 . . . . 0.0 111.104 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.2 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.842 0.354 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.727 HD12 ' OG ' ' A' ' 82' ' ' SER . 20.3 tp -99.32 128.64 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -108.48 91.51 8.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.679 0.752 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.76 -43.92 2.38 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.711 2.274 . . . . 0.0 112.391 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 137' ' ' GLY . 45.2 mt -65.11 -28.72 45.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -35.01 151.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -60.68 176.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.7 p -122.05 169.11 11.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.112 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.79 166.32 24.28 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 142' ' ' ASN . 6.3 p -88.32 94.19 9.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.592 ' ND2' ' CH2' ' A' ' 123' ' ' TRP . 3.3 t-20 -37.09 133.33 0.71 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.657 0.742 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' ASN . 54.0 Cg_endo -69.66 -48.67 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.361 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 143' ' ' PRO . 2.3 m-20 -37.12 126.38 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -86.69 -27.22 23.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -60.46 -34.74 74.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.5 p -66.36 151.02 96.58 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.591 0.71 . . . . 0.0 111.168 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 159.48 53.24 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.726 2.284 . . . . 0.0 112.324 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 t -135.51 137.36 42.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 122' ' ' LEU . 10.4 mt -109.21 138.12 46.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.41 ' CD ' ' HE2' ' A' ' 117' ' ' LYS . 34.7 tt0 -105.67 126.46 52.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.759 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -136.09 159.52 41.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -115.61 123.96 49.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.759 ' CE2' HD21 ' A' ' 152' ' ' LEU . 35.4 m-85 -92.13 118.17 30.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.599 ' C ' ' CD1' ' A' ' 156' ' ' TRP . 1.3 m-20 -143.48 158.23 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 1.123 ' CH2' HD22 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -153.16 112.78 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.524 ' CG ' ' N ' ' A' ' 158' ' ' SER . 28.9 p90 -101.28 -53.27 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.579 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 1.9 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.889 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.1 m . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.19 139.45 49.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.09 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 12' ' ' ARG . 6.0 tp -95.89 137.15 35.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 11' ' ' LEU . 9.1 ttp180 -136.71 132.42 34.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.46 HG23 HD23 ' A' ' 152' ' ' LEU . 52.0 mt -138.28 137.31 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.193 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -116.85 128.84 55.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 mm -91.34 140.14 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.426 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.0 mm? -98.04 -71.19 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.4 p -171.06 -179.54 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.35 164.57 18.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 t -135.5 150.87 49.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 50.83 52.41 15.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 179.863 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.0 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.819 0.342 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.54 -64.93 0.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -142.06 179.85 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 85' ' ' SER . 6.2 pt -136.81 178.25 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 2.3 p90 -172.95 159.55 4.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 60.3 t -118.53 148.98 21.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.462 ' O ' HD13 ' A' ' 133' ' ' LEU . 25.6 ttm180 -124.82 120.69 32.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.8 p -113.7 166.43 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.141 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.74 154.98 8.97 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.574 HD13 HG21 ' A' ' 68' ' ' ILE . 3.8 mp -102.49 144.73 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.867 0.365 . . . . 0.0 111.13 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.511 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 53.4 m-85 -139.16 153.13 47.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.657 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 1.3 t-80 -130.18 101.84 5.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.87 24.26 76.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.13 -35.49 4.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.519 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.34 138.93 55.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.718 . . . . 0.0 110.885 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.473 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.8 Cg_endo -69.81 165.31 31.46 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.629 2.219 . . . . 0.0 112.328 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 43' ' ' PRO . 11.0 mp -122.83 -39.88 2.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.0 p -146.84 161.18 41.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -47.84 155.13 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.73 142.84 29.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.653 HG11 ' HG ' ' A' ' 64' ' ' LEU . 83.5 t -99.78 134.56 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -119.84 140.59 50.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 t -97.82 163.55 12.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -51.12 162.39 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.52 123.01 35.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 58' ' ' PRO . 2.3 m -119.6 152.29 53.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 132.79 24.14 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.341 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 4.5 p -44.58 -46.9 10.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -49.75 -34.9 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.883 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -134.72 87.42 31.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.579 0.704 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.583 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.8 Cg_endo -69.77 3.57 2.7 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.681 2.254 . . . . 0.0 112.334 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.435 ' CG ' HD22 ' A' ' 61' ' ' ASN . 30.8 ttp180 -54.1 110.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.882 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.583 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.0 m-90 -97.91 -60.58 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.435 HD22 ' CG ' ' A' ' 59' ' ' ARG . 32.6 m-80 48.07 50.38 16.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -121.58 141.08 51.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -82.95 101.2 10.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.653 ' HG ' HG11 ' A' ' 48' ' ' VAL . 10.0 tp -92.29 114.86 27.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -97.91 139.65 33.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.928 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -105.96 138.66 41.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.8 32.5 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.574 HG21 HD13 ' A' ' 37' ' ' ILE . 1.9 pp -99.8 164.25 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.618 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.26 123.63 47.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.616 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -56.92 -53.8 61.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.6 0.714 . . . . 0.0 111.112 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.79 2.14 3.82 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.641 2.227 . . . . 0.0 112.323 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.516 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 7.0 t0 -124.99 -9.58 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.522 HD13 ' HD2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -75.34 114.46 35.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.697 . . . . 0.0 110.94 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.561 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.78 145.42 57.0 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.692 2.261 . . . . 0.0 112.31 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -57.01 -45.74 82.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.657 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -52.27 -35.53 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -65.75 156.32 33.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.428 ' HG3' ' C ' ' A' ' 77' ' ' ALA . 88.0 mtt180 -152.76 172.47 16.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.4 tp -93.74 133.04 37.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.5 m -127.64 134.51 49.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.26 154.72 46.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.589 ' OG ' HD12 ' A' ' 133' ' ' LEU . 99.8 p -158.86 131.33 6.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.56 HG12 HD11 ' A' ' 150' ' ' LEU . 22.6 mt -80.59 141.98 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 87.7 m -135.77 149.16 49.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.613 ' OG ' HD11 ' A' ' 99' ' ' LEU . 71.9 m -115.02 120.32 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.508 ' CG2' ' HB3' ' A' ' 94' ' ' GLU . 6.1 p -105.21 137.8 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 tptt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.917 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.508 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 24.1 mt-10 . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.803 0.335 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -120.2 120.29 35.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 5.0 m170 -93.81 145.5 24.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.7 t -152.53 126.34 4.35 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.585 0.707 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 155.0 67.05 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.294 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.802 ' O ' HG23 ' A' ' 125' ' ' VAL . 15.4 mt -128.51 -53.09 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.933 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -137.16 152.35 49.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.598 ' CH2' HG22 ' A' ' 138' ' ' VAL . 64.1 p-90 -134.06 127.37 32.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.609 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -129.48 129.45 6.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.453 ' HB3' HG22 ' A' ' 139' ' ' THR . 23.6 m-20 -112.53 124.75 53.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.883 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.653 HG12 HD21 ' A' ' 120' ' ' LEU . 11.7 mt -119.39 132.5 69.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.181 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -74.84 96.89 3.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.9 mt -36.49 -39.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -99.84 117.36 34.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -57.02 -174.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -76.2 6.39 5.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.95 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.1 p -126.54 18.6 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 58.45 30.05 19.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 94.4 m -117.49 103.52 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.543 HD22 ' CH2' ' A' ' 156' ' ' TRP . 24.0 mt -34.7 135.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.4 m -70.05 157.46 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.6 t -156.15 173.46 16.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.89 142.99 0.18 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.485 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 9.3 ttpt -44.6 148.75 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.437 ' O ' HD13 ' A' ' 152' ' ' LEU . 31.8 ttp -159.69 147.86 17.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.421 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.73 122.23 16.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.109 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.653 HD21 HG12 ' A' ' 104' ' ' ILE . 4.4 pp -132.3 155.37 48.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -75.66 152.17 37.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.775 HD11 HD12 ' A' ' 150' ' ' LEU . 10.6 mt -115.81 148.87 39.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.501 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 21.0 m95 -78.38 147.44 72.2 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.553 0.692 . . . . 0.0 110.943 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.44 ' O ' ' NE1' ' A' ' 101' ' ' TRP . 53.0 Cg_endo -69.8 173.57 10.81 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.682 2.255 . . . . 0.0 112.324 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 99' ' ' LEU . 85.4 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.581 0.705 . . . . 0.0 111.123 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.452 HD12 ' NH1' ' A' ' 34' ' ' ARG . 25.7 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.842 0.354 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.589 HD12 ' OG ' ' A' ' 82' ' ' SER . 12.2 tp -96.59 135.66 38.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.958 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -105.84 91.39 5.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.639 0.733 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.511 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.77 -33.28 16.85 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.349 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.41 -20.81 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -42.75 153.86 0.19 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.503 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.598 HG22 ' CH2' ' A' ' 101' ' ' TRP . 6.3 m -62.95 158.17 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.371 . . . . 0.0 111.129 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 103' ' ' ASN . 20.0 p -104.19 165.39 11.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.67 169.37 25.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.48 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 142' ' ' ASN . 24.4 p -88.08 102.35 14.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.55 HD21 HG21 ' A' ' 147' ' ' THR . 56.5 t-20 -34.4 120.48 0.54 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -1.93 9.35 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.709 2.273 . . . . 0.0 112.379 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -85.34 135.02 34.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -85.49 -50.5 7.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -42.82 -52.64 4.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.55 HG21 HD21 ' A' ' 142' ' ' ASN . 45.7 p -48.28 150.22 2.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.622 0.725 . . . . 0.0 111.113 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 158.87 55.38 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.656 2.237 . . . . 0.0 112.299 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 7.7 t -135.54 138.39 43.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.775 HD12 HD11 ' A' ' 122' ' ' LEU . 6.1 mt -109.28 142.02 40.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.436 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 9.9 tt0 -110.02 123.54 49.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.783 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -131.06 164.44 25.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.454 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 59.6 mt-10 -123.85 117.69 25.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.457 ' CE2' HD21 ' A' ' 152' ' ' LEU . 31.6 m-85 -82.39 104.35 12.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.844 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -112.35 143.78 42.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.543 ' CH2' HD22 ' A' ' 113' ' ' LEU . 12.8 m95 -134.67 88.05 2.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 158' ' ' SER . 11.8 p90 -90.05 -41.53 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.466 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 30.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.615 ' N ' ' HG ' ' A' ' 158' ' ' SER . 1.7 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.894 0.378 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' H ' ' CB ' ' A' ' 158' ' ' SER . . . -120.56 135.09 55.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.767 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 12.4 tp -94.42 145.3 24.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.588 ' H ' HD12 ' A' ' 11' ' ' LEU . 27.4 ptt180 -147.53 141.69 26.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.543 HD12 ' CE1' ' A' ' 66' ' ' TYR . 21.7 mt -141.13 140.82 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -115.24 136.81 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mm -98.58 141.69 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.44 -71.99 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.9 p -169.1 172.95 7.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.447 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -121.53 164.09 17.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.072 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -145.35 156.31 43.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 58.87 35.07 24.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.7 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 179.915 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.4 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.829 0.347 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -68.26 -61.75 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.892 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -148.18 174.52 11.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -132.49 -179.72 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.098 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -169.74 173.58 6.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.572 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 94.0 t -124.97 146.2 31.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.798 ' NH1' HD12 ' A' ' 132' ' ' LEU . 17.9 ttt180 -129.67 117.31 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 81' ' ' LEU . 70.1 p -115.8 175.67 5.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.104 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.44 146.34 4.5 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.516 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.51 ' CG2' ' HB1' ' A' ' 77' ' ' ALA . 2.3 mp -90.04 140.82 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 111.173 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.567 ' CD2' ' HB3' ' A' ' 135' ' ' PRO . 37.8 m-85 -137.64 134.04 35.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.558 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -127.19 105.39 8.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.1 56.16 3.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.489 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.75 37.84 28.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.466 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -154.12 142.71 14.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.678 0.751 . . . . 0.0 110.886 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.454 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 53.3 Cg_endo -69.8 165.96 29.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.654 2.236 . . . . 0.0 112.33 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 39' ' ' HIS . 8.6 mp -119.96 -40.25 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 16.2 p -145.94 165.3 29.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -51.06 128.17 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -59.9 143.55 51.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.696 HG12 HD11 ' A' ' 64' ' ' LEU . 56.3 t -104.14 133.41 48.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.155 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -117.31 140.34 49.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -96.58 153.13 18.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -41.72 161.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.1 mtm-85 -89.33 146.09 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -140.81 152.14 64.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.635 0.731 . . . . 0.0 111.155 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 135.88 31.47 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.719 2.279 . . . . 0.0 112.338 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 8.0 p -46.2 -48.53 17.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -47.76 -36.53 11.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -132.93 87.05 41.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.63 0.728 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.597 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 54.0 Cg_endo -69.74 3.09 2.96 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.68 2.253 . . . . 0.0 112.359 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.423 ' CD ' HD21 ' A' ' 61' ' ' ASN . 20.2 ttt85 -57.18 125.82 24.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.832 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.597 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 5.2 m-90 -108.83 -57.42 2.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.937 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.423 HD21 ' CD ' ' A' ' 59' ' ' ARG . 3.4 m-20 49.28 53.19 13.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -128.23 143.54 51.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -87.64 104.68 16.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.696 HD11 HG12 ' A' ' 48' ' ' VAL . 11.6 tp -90.06 121.08 31.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -97.47 136.73 37.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' CE1' HD12 ' A' ' 13' ' ' ILE . 55.3 m-85 -106.2 129.28 54.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.08 44.25 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.891 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 11' ' ' LEU . 2.2 pp -111.29 164.17 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.119 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.623 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.95 120.07 38.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.631 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -55.61 -52.8 68.97 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.614 0.721 . . . . 0.0 111.153 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.82 2.98 3.07 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.726 2.284 . . . . 0.0 112.325 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.513 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 1.8 t70 -126.08 -7.15 6.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.677 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -77.99 114.84 45.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.588 0.709 . . . . 0.0 110.917 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.612 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.2 Cg_endo -69.72 139.25 39.9 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.725 2.283 . . . . 0.0 112.331 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.49 ' NE ' ' OD1' ' A' ' 111' ' ' ASP . 74.6 mmt-85 -50.23 -40.39 47.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.452 ' CB ' ' CE1' ' A' ' 39' ' ' HIS . . . -54.71 -43.67 72.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.068 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.677 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -53.13 154.22 3.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.448 ' HD2' HG21 ' A' ' 139' ' ' THR . 43.6 mtm180 -151.25 170.75 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.7 tp -93.94 133.23 37.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m -132.73 142.73 49.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.636 ' HB3' HG22 ' A' ' 35' ' ' THR . 1.9 pp -148.71 157.6 43.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.3 p -157.92 131.1 7.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 29.0 mt -85.65 126.22 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 28.6 m -124.22 151.03 44.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 p -107.54 127.7 53.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.635 HG23 ' CD2' ' A' ' 96' ' ' HIS . 2.6 p -105.58 132.53 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.0 tptp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HB3' HG22 ' A' ' 86' ' ' VAL . 26.0 mt-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.8 0.334 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -138.85 114.5 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.635 ' CD2' HG23 ' A' ' 86' ' ' VAL . 4.5 m170 -94.34 130.62 40.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.9 t -131.94 127.3 21.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.583 0.706 . . . . 0.0 110.887 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 150.4 67.86 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.633 2.222 . . . . 0.0 112.336 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.0 mt -123.87 -50.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.88 179.36 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.597 ' HD1' HG12 ' A' ' 125' ' ' VAL . 64.6 p-90 -158.22 130.79 7.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.954 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.33 133.43 6.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.44 ' CB ' HG22 ' A' ' 139' ' ' THR . 1.2 m-20 -115.39 132.55 56.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.771 0.32 . . . . 0.0 110.914 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.31 124.84 73.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 106' ' ' LEU . 4.9 m120 -64.66 89.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 105' ' ' ASN . 16.0 mt -34.66 -40.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.433 ' HE2' HD12 ' A' ' 73' ' ' LEU . 94.8 m-85 -105.25 112.51 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -52.13 173.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -55.33 -35.59 65.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 t -87.78 27.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.49 ' OD1' ' NE ' ' A' ' 75' ' ' ARG . 8.4 t0 47.83 52.46 12.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 97.2 m -139.16 108.71 6.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.133 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.961 HD22 ' CH2' ' A' ' 156' ' ' TRP . 20.3 mt -34.94 133.21 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.505 HG23 ' CG ' ' A' ' 154' ' ' PHE . 26.4 m -63.43 171.71 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.7 m -162.85 175.53 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.04 153.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.496 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.444 ' HE3' ' CG ' ' A' ' 153' ' ' GLU . 20.0 ttmt -58.73 148.07 30.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.76 0.314 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.409 ' O ' HD13 ' A' ' 152' ' ' LEU . 41.1 ttp -154.67 151.86 29.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.908 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.84 128.5 26.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.117 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 pp -139.87 162.48 35.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -87.52 150.52 23.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.664 HD11 HD12 ' A' ' 150' ' ' LEU . 2.8 mt -108.17 155.41 20.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.573 ' CH2' ' HD2' ' A' ' 143' ' ' PRO . 7.3 m95 -90.94 141.54 26.72 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.61 0.719 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 136.01 31.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.353 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.597 HG12 ' HD1' ' A' ' 101' ' ' TRP . 3.5 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.619 0.723 . . . . 0.0 111.111 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.798 HD12 ' NH1' ' A' ' 34' ' ' ARG . 12.1 mt . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.843 0.354 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.528 HD23 ' CE1' ' A' ' 38' ' ' TYR . 9.7 tp -97.38 145.93 25.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.427 ' HA ' ' HD2' ' A' ' 135' ' ' PRO . 55.2 t-20 -114.38 93.05 30.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.638 0.733 . . . . 0.0 110.857 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.567 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.79 -38.68 7.39 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.663 2.242 . . . . 0.0 112.317 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.2 mt -73.02 -20.12 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.419 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -45.67 148.36 1.89 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.3 m -62.35 178.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.141 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.448 HG21 ' HD2' ' A' ' 78' ' ' ARG . 82.4 p -123.79 157.65 33.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.151 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.25 170.91 19.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 p -84.07 128.93 34.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 144' ' ' ASN . 5.9 t-20 -65.6 132.45 94.99 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.672 0.749 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.573 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.79 -50.82 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.689 2.259 . . . . 0.0 112.329 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 69.1 m-80 -39.01 135.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -89.19 -25.95 21.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -85.19 41.39 0.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.8 p -129.55 152.82 80.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.582 0.706 . . . . 0.0 111.145 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 137.15 34.66 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.325 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.37 146.46 48.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.664 HD12 HD11 ' A' ' 122' ' ' LEU . 5.7 mt -120.95 156.21 32.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -121.62 120.25 34.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.817 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -127.43 163.65 23.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.444 ' CG ' ' HE3' ' A' ' 117' ' ' LYS . 49.5 mt-10 -124.59 120.99 33.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.643 ' CE2' HD21 ' A' ' 152' ' ' LEU . 39.2 m-85 -89.31 102.12 14.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -122.6 134.78 54.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.961 ' CH2' HD22 ' A' ' 113' ' ' LEU . 15.7 m95 -120.89 98.01 5.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.597 ' CG ' ' N ' ' A' ' 158' ' ' SER . 12.4 p90 -79.53 -53.38 6.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.615 ' HG ' ' N ' ' A' ' 9' ' ' SER . 61.6 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.511 ' N ' ' HG ' ' A' ' 158' ' ' SER . 14.3 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.88 0.371 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.71 125.19 49.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.708 HD13 ' CH2' ' A' ' 156' ' ' TRP . 21.0 tp -88.42 142.44 27.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.466 ' H ' HD12 ' A' ' 11' ' ' LEU . 7.7 ptm180 -149.34 127.56 12.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.9 mt -129.52 138.7 53.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.51 ' HD3' ' CE2' ' A' ' 63' ' ' TRP . 3.3 ttpm? -114.02 129.91 56.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mm -89.51 145.34 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.89 -72.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.1 p -169.72 174.8 5.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.99 156.74 34.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.688 HG23 ' CD2' ' A' ' 20' ' ' TYR . 9.8 t -127.1 163.19 24.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.688 ' CD2' HG23 ' A' ' 19' ' ' THR . 7.8 m-85 53.3 30.81 10.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.126 179.873 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.82 0.343 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' N ' ' HD3' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -83.34 -52.22 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -147.52 178.6 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 85' ' ' SER . 6.9 pt -138.46 174.83 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -169.51 155.57 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.781 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 58.1 t -111.6 140.28 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -113.42 127.53 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.5 p -123.67 169.73 11.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.54 135.54 1.97 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.532 HD12 ' N ' ' A' ' 37' ' ' ILE . 3.4 mp -81.9 146.51 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.544 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 44.8 m-85 -140.6 162.89 34.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.593 ' HB2' HD11 ' A' ' 44' ' ' LEU . 3.1 t-160 -132.65 94.3 3.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.53 -32.98 4.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.541 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.45 -30.52 0.29 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -91.44 152.64 43.84 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.679 0.752 . . . . 0.0 110.841 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 156.34 63.56 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.737 2.292 . . . . 0.0 112.343 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 39' ' ' HIS . 8.9 mp -106.22 -41.39 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.9 m -133.8 -67.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -173.42 171.96 3.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.471 ' OD1' HD22 ' A' ' 133' ' ' LEU . 1.0 OUTLIER -105.34 144.51 32.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.642 HG11 ' HG ' ' A' ' 64' ' ' LEU . 43.2 t -110.76 140.24 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -120.73 144.01 48.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.7 p -94.85 159.68 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -49.92 172.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -100.98 131.79 46.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 1.5 m -136.02 152.17 75.07 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.592 0.71 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 140.18 41.93 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.0 p -50.03 -32.77 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 m -63.13 -31.29 72.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -133.32 81.43 55.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.738 . . . . 0.0 110.902 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 3.17 2.91 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.692 2.261 . . . . 0.0 112.343 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -61.42 106.74 0.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.781 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 3.9 m-90 -90.68 -47.24 7.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 39.3 41.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.439 ' C ' ' HG3' ' A' ' 14' ' ' LYS . 5.3 tp10 -114.03 135.82 53.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.51 ' CE2' ' HD3' ' A' ' 14' ' ' LYS . 52.7 m95 -83.73 107.88 16.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.642 ' HG ' HG11 ' A' ' 48' ' ' VAL . 10.0 tp -95.2 121.02 36.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.84 140.12 31.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -107.39 125.43 51.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -78.05 45.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.477 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.0 pp -113.0 164.17 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.612 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.62 124.86 48.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.947 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.575 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -51.89 -55.47 30.09 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.607 0.718 . . . . 0.0 111.134 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.612 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.5 Cg_endo -69.71 2.42 3.52 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.691 2.261 . . . . 0.0 112.401 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.508 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.6 t70 -123.04 -5.69 8.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -83.6 114.7 55.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.633 0.73 . . . . 0.0 110.939 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.9 Cg_endo -69.7 136.04 32.14 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.694 2.263 . . . . 0.0 112.369 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -49.75 -44.34 48.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.555 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -52.64 -39.17 61.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -64.43 157.84 25.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -153.02 177.56 10.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -93.77 139.38 30.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.598 ' C ' HD23 ' A' ' 81' ' ' LEU . 73.9 m -129.74 145.94 51.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -154.87 136.83 14.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.7 m -143.84 139.58 29.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.76 146.84 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.15 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 81.3 m -146.18 153.56 40.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.483 ' HA ' HG22 ' A' ' 31' ' ' ILE . 24.8 m -114.72 122.3 46.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.65 127.53 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 29' ' ' ASP . 21.9 tptm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -126.98 134.29 50.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -107.71 125.39 51.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.3 t -129.25 125.89 22.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.719 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.469 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.3 Cg_endo -69.79 152.23 69.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.643 2.229 . . . . 0.0 112.352 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 98' ' ' PRO . 14.2 mt -123.91 -49.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.73 174.25 11.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.531 ' CH2' HG22 ' A' ' 138' ' ' VAL . 68.6 p-90 -151.18 134.33 15.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.918 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.8 133.11 5.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -120.48 130.68 54.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.714 HG12 HD21 ' A' ' 120' ' ' LEU . 14.6 mt -114.22 130.55 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 106' ' ' LEU . 40.5 m-20 -67.28 95.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.7 mt -34.81 -43.15 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 77.8 m-85 -107.24 111.05 23.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 34.6 p30 -52.19 -177.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.876 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -56.49 -37.88 70.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.436 ' O ' ' C ' ' A' ' 111' ' ' ASP . 8.9 t -88.73 34.7 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.138 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 110' ' ' THR . 6.7 m-20 35.62 54.75 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 113' ' ' LEU . 98.1 m -134.28 109.29 8.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.172 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.749 HD22 ' CH2' ' A' ' 156' ' ' TRP . 56.7 mt -34.36 138.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 12.8 m -68.02 165.49 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 p -159.73 162.86 35.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.1 142.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.436 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 7.8 ttpt -47.21 148.71 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.441 ' O ' HD13 ' A' ' 152' ' ' LEU . 26.7 ttp -156.1 151.94 27.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.3 132.56 29.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.714 HD21 HG12 ' A' ' 104' ' ' ILE . 3.6 pp -141.16 154.41 45.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.35 152.13 39.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 150' ' ' LEU . 2.5 mt -111.45 141.35 45.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.48 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 23.5 m95 -75.88 152.01 84.55 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.53 0.681 . . . . 0.0 110.925 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 154.0 68.46 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 98' ' ' PRO . 71.3 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.628 0.727 . . . . 0.0 111.12 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.807 0.337 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.471 HD22 ' OD1' ' A' ' 47' ' ' ASN . 7.8 tp -80.42 135.83 36.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -106.11 91.27 5.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.616 0.722 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.544 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.2 Cg_endo -69.73 -44.81 1.88 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.237 . . . . 0.0 112.366 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 137' ' ' GLY . 44.3 mt -67.61 -28.38 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -36.65 149.13 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.502 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.531 HG22 ' CH2' ' A' ' 101' ' ' TRP . 2.4 m -51.73 168.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 111.155 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.7 p -115.14 168.14 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.131 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.78 -168.81 30.65 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.451 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.8 p -96.14 148.53 22.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.893 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 142' ' ' ASN . 0.4 OUTLIER -84.45 138.72 38.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.62 0.724 . . . . 0.0 110.88 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.406 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.72 -48.2 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.252 . . . . 0.0 112.383 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -40.74 142.14 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -98.2 -31.72 11.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -82.16 40.39 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.0 p -124.21 151.96 66.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.583 0.706 . . . . 0.0 111.115 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 117.23 4.96 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.67 2.247 . . . . 0.0 112.311 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 13.4 t -105.68 137.78 42.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 122' ' ' LEU . 3.4 mt -105.51 162.18 13.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.436 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 27.5 tt0 -129.81 112.43 13.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.836 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -118.35 162.87 17.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.457 ' N ' HD22 ' A' ' 152' ' ' LEU . 14.9 mt-10 -118.74 119.1 33.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.727 ' CE2' HD21 ' A' ' 152' ' ' LEU . 50.2 m-85 -87.58 107.46 18.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.26 155.56 48.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.749 ' CH2' HD22 ' A' ' 113' ' ' LEU . 4.9 m95 -142.48 120.32 11.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.515 ' CG ' ' N ' ' A' ' 158' ' ' SER . 10.1 p90 -110.28 -47.83 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.515 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 8.6 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.871 0.367 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.453 ' HB3' ' C ' ' A' ' 158' ' ' SER . . . -119.14 151.21 38.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.086 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.749 HD13 ' CH2' ' A' ' 156' ' ' TRP . 14.3 tp -110.79 138.95 46.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.405 ' H ' HD12 ' A' ' 11' ' ' LEU . 25.8 ptt180 -148.34 140.07 23.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.0 mt -135.93 137.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.159 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttt -110.71 120.81 43.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.6 mm -82.42 141.11 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.26 -72.29 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -172.07 176.79 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.7 163.07 20.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.441 HG23 ' CD2' ' A' ' 20' ' ' TYR . 10.2 t -134.78 163.39 29.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.441 ' CD2' HG23 ' A' ' 19' ' ' THR . 6.3 m-85 39.54 44.6 1.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' A' ' 85' ' ' SER . 17.3 mt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.835 0.35 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.406 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 21.5 t0 -72.98 -60.56 2.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 26.3 mmtp -147.91 166.56 27.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 pt -119.44 169.9 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -163.82 144.56 8.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.621 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 63.2 t -103.03 143.92 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -121.03 122.25 39.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.6 p -116.1 166.91 11.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.73 149.42 6.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.59 134.89 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 111.148 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 135' ' ' PRO . 47.7 m-85 -133.72 158.33 43.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.481 ' HB3' HD11 ' A' ' 44' ' ' LEU . 6.9 t-160 -131.85 103.37 6.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.858 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.94 17.15 78.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.483 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.558 ' HA2' HD13 ' A' ' 136' ' ' ILE . . . 107.5 -35.48 4.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.457 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.33 142.88 59.17 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.668 0.747 . . . . 0.0 110.885 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.527 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.7 Cg_endo -69.77 166.02 29.02 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.689 2.259 . . . . 0.0 112.338 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.527 HD12 ' C ' ' A' ' 43' ' ' PRO . 10.1 mp -124.89 -41.25 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.0 m -154.39 160.06 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -41.36 151.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -88.82 165.48 14.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.59 HG12 HD11 ' A' ' 64' ' ' LEU . 64.2 t -119.96 133.59 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -115.38 138.2 51.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.2 t -90.37 159.12 16.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -49.67 174.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -101.89 133.48 46.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.5 m -137.36 152.11 72.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.641 0.734 . . . . 0.0 111.164 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 134.23 27.4 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.353 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.6 p -45.48 -44.93 12.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.866 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.8 t -48.66 -40.58 28.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -130.32 86.65 53.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.533 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.3 Cg_endo -69.8 2.97 3.07 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.746 2.297 . . . . 0.0 112.298 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -50.8 109.55 0.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.621 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 1.5 m-90 -99.54 -47.62 5.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 61' ' ' ASN . 2.2 p-10 35.25 41.05 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.839 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.12 138.19 50.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -83.05 112.33 19.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.59 HD11 HG12 ' A' ' 48' ' ' VAL . 11.1 tp -97.15 119.25 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -93.07 140.13 29.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -112.47 128.71 56.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -82.21 40.5 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.436 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.0 pp -106.93 164.01 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.614 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.0 127.02 53.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.6 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -60.01 -54.46 55.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.663 0.744 . . . . 0.0 111.165 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.614 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.74 3.49 2.73 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 0.0 112.355 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.494 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.7 t70 -125.46 -7.12 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -82.12 115.72 59.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.608 0.718 . . . . 0.0 110.926 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.6 Cg_endo -69.78 132.75 23.96 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.322 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.491 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 1.6 mpp_? -47.63 -43.62 26.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -51.87 -39.38 58.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.483 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -62.58 167.12 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -162.21 170.87 18.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 tp -94.64 133.73 37.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.621 ' C ' HD23 ' A' ' 81' ' ' LEU . 33.6 m -120.26 150.33 40.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -155.69 137.17 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 133' ' ' LEU . 86.5 p -143.61 133.27 23.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.573 HD11 ' HG ' ' A' ' 150' ' ' LEU . 71.7 mt -84.69 140.78 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.4 p -151.18 160.24 43.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.529 ' HB2' HG21 ' A' ' 28' ' ' ILE . 15.3 p -117.23 156.48 27.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 86' ' ' VAL . 14.8 p -133.77 122.39 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.163 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.0 tptt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.908 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.828 0.347 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -122.57 126.08 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -99.59 134.74 42.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.0 t -135.65 120.31 13.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.611 0.72 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.401 ' HB2' HG11 ' A' ' 125' ' ' VAL . 54.1 Cg_endo -69.79 142.01 46.65 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.664 2.243 . . . . 0.0 112.338 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 83' ' ' ILE . 17.8 mt -111.65 -55.65 2.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.02 176.52 8.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.074 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 61.9 p-90 -152.76 145.09 23.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -151.83 139.78 7.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -117.83 150.3 39.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.784 0.326 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.562 ' CG1' HD21 ' A' ' 120' ' ' LEU . 66.0 mt -138.27 117.91 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 106' ' ' LEU . 12.4 m120 -62.41 96.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.0 mt -35.15 -40.5 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.491 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 98.1 m-85 -108.56 115.37 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -55.64 -176.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.517 ' CD1' HG23 ' A' ' 110' ' ' THR . 13.2 p90 -68.41 -4.41 14.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.517 HG23 ' CD1' ' A' ' 109' ' ' TYR . 10.0 p -109.36 22.47 15.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.154 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 110' ' ' THR . 6.0 p-10 46.61 54.43 8.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.3 m -149.9 120.83 7.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.781 HD22 ' CH2' ' A' ' 156' ' ' TRP . 56.8 mt -40.32 140.81 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.47 HG21 ' CE2' ' A' ' 154' ' ' PHE . 20.3 m -71.3 169.82 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.081 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.6 p -162.86 161.18 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.45 132.73 0.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.422 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 15.6 ttpt -39.63 148.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.738 0.304 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.472 ' O ' HD13 ' A' ' 152' ' ' LEU . 20.9 ttp -156.2 149.22 24.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.407 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.7 113.66 8.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.562 HD21 ' CG1' ' A' ' 104' ' ' ILE . 4.0 pp -120.89 157.81 29.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -77.67 154.51 32.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mt -114.06 134.12 55.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.507 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 10.7 m95 -74.57 147.37 84.63 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.567 0.699 . . . . 0.0 110.935 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 133.93 26.88 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.251 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.463 HG12 ' HD1' ' A' ' 101' ' ' TRP . 4.7 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.1 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.784 0.326 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 82' ' ' SER . 13.7 tp -105.59 131.72 52.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -110.3 91.81 12.35 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.647 0.737 . . . . 0.0 110.902 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.79 -28.36 25.2 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.656 2.237 . . . . 0.0 112.335 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.558 HD13 ' HA2' ' A' ' 41' ' ' GLY . 12.2 mm -77.21 -23.58 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.09 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.427 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -36.5 147.77 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.32 174.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 111.159 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 42.2 p -117.28 172.47 7.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.163 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.33 169.63 42.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.529 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.4 p -87.68 135.99 33.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 110.833 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -76.2 122.36 86.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.657 0.742 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -1.33 8.25 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.677 2.252 . . . . 0.0 112.365 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -82.62 129.05 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -84.39 -53.53 5.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -40.6 -35.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.7 p -69.39 151.37 96.85 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 160.1 50.96 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.731 2.287 . . . . 0.0 112.348 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 14.5 t -140.09 136.4 33.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.573 ' HG ' HD11 ' A' ' 83' ' ' ILE . 8.7 mt -106.47 152.18 23.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.422 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 14.8 tt0 -120.71 115.66 23.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.835 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -121.06 159.42 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.958 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.406 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 63.5 mt-10 -116.09 122.55 45.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.603 ' CE2' HD21 ' A' ' 152' ' ' LEU . 28.9 m-85 -90.82 112.53 24.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.553 ' C ' ' CD1' ' A' ' 156' ' ' TRP . 6.6 t0 -132.61 159.07 40.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.781 ' CH2' HD22 ' A' ' 113' ' ' LEU . 3.6 m95 -152.17 108.18 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.498 ' CG ' ' N ' ' A' ' 158' ' ' SER . 31.5 p90 -102.22 -53.76 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.498 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 16.1 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.465 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.62 133.62 54.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.848 HD13 ' CH2' ' A' ' 156' ' ' TRP . 15.8 tp -83.53 126.96 33.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.575 ' NE ' ' CE3' ' A' ' 63' ' ' TRP . 7.0 ttt180 -124.64 120.38 31.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.419 HD11 HD21 ' A' ' 11' ' ' LEU . 32.4 mt -131.14 141.07 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 34.8 tttt -122.26 128.66 51.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.0 mm -89.76 149.27 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.47 -70.63 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 p -172.45 -176.82 1.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.951 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.61 146.07 50.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 t -120.15 138.09 53.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 67.11 45.25 1.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.934 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.861 0.363 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.52 -57.4 3.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -147.47 -178.7 6.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 53' ' ' VAL . 7.2 pt -139.86 178.02 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 1.2 p90 -173.22 156.61 3.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.57 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 87.3 t -113.75 149.7 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.121 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -122.35 132.78 54.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.1 p -128.52 162.02 28.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.44 143.32 3.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.442 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 37' ' ' ILE . 3.5 mp -86.72 140.82 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.37 . . . . 0.0 111.136 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.539 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 54.1 m-85 -136.4 145.28 45.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.51 ' CB ' HD11 ' A' ' 44' ' ' LEU . 4.5 t-160 -117.56 94.55 4.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.94 20.95 77.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.553 ' HA2' HD13 ' A' ' 136' ' ' ILE . . . 106.15 -26.84 19.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -85.02 141.89 38.11 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.623 0.725 . . . . 0.0 110.85 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 159.87 51.82 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.704 2.269 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.51 HD11 ' CB ' ' A' ' 39' ' ' HIS . 8.9 mp -120.64 -33.54 3.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.94 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.2 m -154.06 165.79 35.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.64 131.29 29.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.815 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -65.65 153.1 42.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.514 HG12 HD11 ' A' ' 64' ' ' LEU . 40.0 t -114.16 140.34 35.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -121.74 137.75 54.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.1 p -83.88 176.35 8.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -63.99 174.7 1.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -102.43 125.98 49.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -130.28 152.14 79.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.619 0.723 . . . . 0.0 111.101 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 142.28 47.46 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.689 2.259 . . . . 0.0 112.347 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 23.4 p -50.58 -48.16 57.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.8 t -47.34 -38.52 13.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -132.03 87.29 44.63 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.552 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.5 Cg_endo -69.78 3.66 2.65 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.709 2.272 . . . . 0.0 112.312 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -55.64 108.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.57 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.3 m-90 -93.56 -52.95 4.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 m120 43.31 49.75 5.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -121.19 138.09 54.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.575 ' CE3' ' NE ' ' A' ' 12' ' ' ARG . 77.8 m95 -84.09 108.39 16.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.514 HD11 HG12 ' A' ' 48' ' ' VAL . 9.9 tp -98.2 122.68 41.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -100.87 145.25 28.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -113.5 131.02 56.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -82.71 47.61 1.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.494 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.1 pp -114.26 168.13 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.611 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -115.07 129.86 56.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.612 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -62.84 -53.63 54.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 111.164 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.1 Cg_endo -69.69 -0.95 7.59 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.362 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.509 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.5 t70 -117.64 -13.47 10.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -71.6 114.97 32.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.556 0.693 . . . . 0.0 110.918 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.56 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.0 Cg_endo -69.79 146.37 59.82 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.637 2.225 . . . . 0.0 112.353 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.454 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 21.1 mmt85 -59.22 -41.84 89.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.45 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -55.64 -31.41 62.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.56 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -68.77 167.35 15.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -163.23 173.73 13.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.5 tp -95.37 142.8 27.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.605 ' C ' HD23 ' A' ' 81' ' ' LEU . 83.0 m -129.82 148.52 51.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -155.32 137.08 14.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.84 ' OG ' HD12 ' A' ' 133' ' ' LEU . 95.3 p -148.92 146.22 27.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.595 ' CG1' HD11 ' A' ' 150' ' ' LEU . 11.4 mt -93.16 143.37 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.176 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 74.7 m -137.85 145.78 42.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.8 p -109.76 122.56 47.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.714 HG23 ' CD2' ' A' ' 96' ' ' HIS . 12.0 p -105.79 121.63 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.7 tttm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.925 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 9.9 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.776 0.322 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -126.61 119.16 26.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.714 ' CD2' HG23 ' A' ' 86' ' ' VAL . 8.1 m170 -98.77 124.16 43.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.74 123.21 15.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.866 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 143.03 49.42 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.662 2.241 . . . . 0.0 112.351 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.0 mt -107.63 -45.8 3.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.38 178.18 7.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.518 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 70.0 p-90 -154.33 137.89 15.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.03 138.5 7.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.473 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -122.25 140.55 52.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.587 HD11 HD21 ' A' ' 120' ' ' LEU . 56.5 mt -120.97 139.69 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 106' ' ' LEU . 77.7 m-20 -76.69 87.91 3.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 105' ' ' ASN . 21.9 mt -34.49 -36.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.454 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 59.0 m-85 -109.67 119.34 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -53.1 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.85 6.47 5.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 p -128.76 18.19 6.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.181 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 65.06 29.84 11.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 113' ' ' LEU . 88.2 m -118.68 105.76 11.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 112' ' ' THR . 31.4 mt -36.07 141.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.5 m -70.45 170.35 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.1 m -168.9 164.28 11.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.17 140.72 1.01 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.446 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 38.3 tttt -44.6 149.15 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.783 0.325 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.4 ttp -159.89 154.03 23.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.691 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.95 126.67 20.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.587 HD21 HD11 ' A' ' 104' ' ' ILE . 4.1 pp -136.15 153.78 51.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -79.25 158.52 27.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.776 HD11 HD12 ' A' ' 150' ' ' LEU . 1.9 mt -116.4 148.09 41.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.566 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 8.1 m95 -85.51 150.53 54.22 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.571 0.7 . . . . 0.0 110.944 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 138.82 38.71 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.663 2.242 . . . . 0.0 112.391 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.625 0.726 . . . . 0.0 111.124 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.867 0.365 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.84 HD12 ' OG ' ' A' ' 82' ' ' SER . 4.8 tp -102.98 139.34 38.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -105.41 91.52 4.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.679 0.752 . . . . 0.0 110.87 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.9 Cg_endo -69.73 -22.76 31.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.723 2.282 . . . . 0.0 112.366 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.553 HD13 ' HA2' ' A' ' 41' ' ' GLY . 13.4 mm -82.69 -22.12 9.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -37.08 153.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.498 HG22 ' CH2' ' A' ' 101' ' ' TRP . 5.7 m -69.5 173.33 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 111.117 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.7 p -115.22 165.25 13.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 99.37 159.68 29.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.0 p -75.49 130.48 38.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.832 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.566 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 11.2 t-20 -70.84 118.47 65.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.651 0.739 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 1.98 3.94 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.67 2.246 . . . . 0.0 112.392 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -90.59 116.43 28.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -76.85 -44.19 33.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -49.03 -26.97 2.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 67.9 p -78.82 152.24 77.26 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.558 0.694 . . . . 0.0 111.165 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 146.26 59.48 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.685 2.257 . . . . 0.0 112.363 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.7 t -123.79 148.92 46.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.776 HD12 HD11 ' A' ' 122' ' ' LEU . 5.9 mt -118.96 150.64 39.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.691 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 5.4 mp0 -112.64 139.92 47.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.727 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -148.6 151.6 35.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.446 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 35.5 mt-10 -119.51 123.11 43.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.727 ' CE2' HD21 ' A' ' 152' ' ' LEU . 62.6 m-85 -85.97 115.06 23.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.09 129.15 49.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.848 ' CH2' HD13 ' A' ' 11' ' ' LEU . 20.7 m95 -124.26 81.55 1.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.5 ' CG ' ' N ' ' A' ' 158' ' ' SER . 43.4 p90 -79.46 -54.47 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.5 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 3.0 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.409 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 1.8 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.822 0.344 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.01 140.36 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.686 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 10.6 tp -103.64 137.49 41.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.563 ' N ' HD12 ' A' ' 11' ' ' LEU . 16.3 ptt180 -145.41 138.37 26.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.843 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.4 mt -138.4 139.14 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 43.8 tttm -114.9 137.06 52.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.8 mm -98.59 144.82 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.71 -67.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.6 p -169.56 175.05 5.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.813 ' HB2' HD23 ' A' ' 150' ' ' LEU . . . -139.1 154.41 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.675 HG23 ' CD2' ' A' ' 20' ' ' TYR . 2.9 t -130.96 162.37 29.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.675 ' CD2' HG23 ' A' ' 19' ' ' THR . 10.0 m-85 64.44 50.13 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.833 0.349 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -73.96 -56.19 5.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -142.06 172.83 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 pt -141.54 161.11 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -151.38 153.57 35.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.745 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 79.3 t -105.48 137.12 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -110.19 120.15 41.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 p -117.84 161.21 20.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.171 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.78 143.46 3.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.442 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.713 HG23 ' O ' ' A' ' 78' ' ' ARG . 3.9 mp -96.61 137.05 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 111.191 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.465 ' HA ' ' CD1' ' A' ' 44' ' ' LEU . 2.7 m-85 -128.52 150.18 50.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.957 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.457 ' C ' ' CD2' ' A' ' 39' ' ' HIS . 9.3 t-160 -121.85 99.07 6.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.04 47.23 19.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.74 33.83 81.47 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -146.64 143.69 19.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.68 0.752 . . . . 0.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 150.17 68.27 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.72 2.28 . . . . 0.0 112.365 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.465 ' CD1' ' HA ' ' A' ' 38' ' ' TYR . 7.8 mp -105.69 -39.37 6.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.889 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.0 t -156.28 166.13 34.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.24 124.73 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -61.01 154.09 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.644 HG12 HD11 ' A' ' 64' ' ' LEU . 61.6 t -110.26 137.4 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -119.27 147.91 43.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.5 p -96.18 167.25 11.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -54.15 176.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -105.49 108.98 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -114.26 152.39 45.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.626 0.727 . . . . 0.0 111.128 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 135.65 31.11 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.733 2.289 . . . . 0.0 112.36 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 19.3 p -45.98 -47.26 16.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.2 m -51.27 -30.21 17.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -133.8 87.78 34.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.619 0.723 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.548 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 2.94 3.09 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.681 2.254 . . . . 0.0 112.333 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -58.47 103.84 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.745 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.3 m-90 -90.71 -46.76 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 61' ' ' ASN . 2.7 p-10 39.23 46.99 1.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -120.95 135.86 55.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.461 ' CE3' ' HD2' ' A' ' 12' ' ' ARG . 45.7 m95 -81.35 103.55 11.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.644 HD11 HG12 ' A' ' 48' ' ' VAL . 10.4 tp -90.68 121.44 32.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -101.0 133.37 45.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -100.99 131.68 46.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.2 41.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.828 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.507 HD13 HD23 ' A' ' 73' ' ' LEU . 1.7 pp -112.45 161.89 10.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.603 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -113.54 121.96 45.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -53.42 -54.15 48.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.595 0.712 . . . . 0.0 111.104 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.4 Cg_endo -69.7 3.49 2.71 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.677 2.252 . . . . 0.0 112.396 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.5 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 9.5 t0 -125.22 -4.49 7.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.918 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.507 HD23 HD13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -76.1 113.61 29.59 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 110.902 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.651 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.4 Cg_endo -69.77 132.05 22.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.704 2.27 . . . . 0.0 112.336 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 11.6 mpt_? -45.46 -42.07 10.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.04 -43.75 78.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.066 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.651 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -55.6 165.02 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.083 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.713 ' O ' HG23 ' A' ' 37' ' ' ILE . 8.2 ptp180 -163.28 173.42 13.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 tp -93.82 138.31 32.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.2 m -136.23 126.4 26.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.16 161.24 33.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 p -166.53 131.9 2.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 99' ' ' LEU . 17.8 mt -83.91 144.44 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 62.0 m -147.81 155.04 41.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 t -105.89 150.72 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 86' ' ' VAL . 8.4 p -135.93 125.2 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.1 tptp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.929 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.814 0.34 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -130.21 125.92 36.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -103.46 129.21 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.1 t -137.49 123.78 13.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.429 ' HB2' HG21 ' A' ' 125' ' ' VAL . 53.7 Cg_endo -69.79 152.96 69.27 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.673 2.249 . . . . 0.0 112.333 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 125' ' ' VAL . 16.0 mt -126.37 -51.13 1.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.409 ' HB2' ' HG3' ' A' ' 148' ' ' PRO . . . -142.41 -177.58 5.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.511 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 67.5 p-90 -164.44 126.04 2.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.475 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -131.94 131.42 6.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.402 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -106.85 129.73 54.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 110.861 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.44 HD11 HD21 ' A' ' 120' ' ' LEU . 76.2 mt -119.34 119.27 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 106' ' ' LEU . 1.6 t30 -73.25 94.57 2.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 105' ' ' ASN . 41.6 mt -35.14 -35.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.488 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 51.3 m-85 -104.39 106.5 17.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.906 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.43 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 42.5 p30 -54.93 -177.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -57.12 -39.19 74.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.424 HG23 ' OG1' ' A' ' 112' ' ' THR . 10.0 t -86.9 32.14 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.14 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 37.78 54.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.424 ' OG1' HG23 ' A' ' 110' ' ' THR . 23.7 m -132.77 116.64 16.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.944 HD22 ' CH2' ' A' ' 156' ' ' TRP . 11.9 mt -44.56 126.62 5.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.604 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 16.3 m -57.51 176.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.9 p -173.83 164.11 4.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.18 149.18 0.2 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 7.5 ttpt -39.55 158.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.485 ' HG2' ' N ' ' A' ' 119' ' ' ALA . 2.8 ttm -156.62 144.96 19.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.485 ' N ' ' HG2' ' A' ' 118' ' ' MET . . . -140.35 106.96 5.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.083 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.477 ' C ' HD12 ' A' ' 120' ' ' LEU . 4.1 pp -126.35 163.53 23.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -92.31 158.53 16.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.511 HD11 HD12 ' A' ' 150' ' ' LEU . 12.0 mt -112.59 156.08 23.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.566 ' CE3' ' OD1' ' A' ' 142' ' ' ASN . 28.0 m95 -86.57 150.64 51.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.538 0.685 . . . . 0.0 110.924 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 145.92 58.44 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.699 2.266 . . . . 0.0 112.309 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 99' ' ' LEU . 94.2 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.863 0.364 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.3 tp -84.8 127.53 34.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -104.38 93.53 5.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 110.83 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.443 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.6 Cg_endo -69.74 -17.14 37.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.664 2.243 . . . . 0.0 112.372 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 mm -84.88 -23.15 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.49 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -38.74 151.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.13 163.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.1 p -108.44 151.75 25.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.62 142.84 8.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.5 p -63.11 116.66 5.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.566 ' OD1' ' CE3' ' A' ' 123' ' ' TRP . 32.7 t30 -53.64 130.01 54.8 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.572 0.701 . . . . 0.0 110.93 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -27.03 27.06 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.694 2.263 . . . . 0.0 112.317 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -51.72 144.4 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt -99.53 -37.03 9.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -83.26 39.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.2 p -122.85 156.05 62.67 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.57 0.7 . . . . 0.0 111.127 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.409 ' HG3' ' HB2' ' A' ' 100' ' ' ALA . 53.3 Cg_endo -69.77 124.65 11.28 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.704 2.269 . . . . 0.0 112.344 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.443 ' SG ' HG22 ' A' ' 19' ' ' THR . 1.4 p -115.92 150.69 36.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.813 HD23 ' HB2' ' A' ' 18' ' ' ALA . 7.4 mt -128.18 135.3 49.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.96 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.424 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 10.1 tt0 -102.49 125.11 49.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.83 ' H ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -127.72 169.36 13.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.441 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 26.1 mt-10 -126.4 125.38 42.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.604 ' CZ ' HG21 ' A' ' 114' ' ' VAL . 45.0 m-85 -92.1 119.51 31.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -137.39 137.53 38.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.944 ' CH2' HD22 ' A' ' 113' ' ' LEU . 11.6 m95 -127.84 82.45 2.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 158' ' ' SER . 22.0 p90 -85.75 -52.75 5.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.574 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 85.6 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.909 0.385 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.737 ' HB3' ' HB2' ' A' ' 158' ' ' SER . . . -120.07 121.85 39.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.753 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 22.2 tp -85.82 144.99 27.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.61 ' NH2' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -135.71 146.93 48.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.541 HD12 ' CE1' ' A' ' 66' ' ' TYR . 54.4 mt -145.52 121.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.581 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 73.8 tttt -103.58 131.37 50.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mm -94.07 137.59 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.12 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.23 -72.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.4 p -172.01 172.68 4.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.893 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.15 142.33 48.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.035 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.457 HG23 ' CD2' ' A' ' 20' ' ' TYR . 10.9 t -111.57 136.2 51.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.457 ' CD2' HG23 ' A' ' 19' ' ' THR . 2.6 m-85 65.67 32.94 8.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.076 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.587 HG21 ' HB2' ' A' ' 85' ' ' SER . 7.7 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.811 0.339 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.45 ' C ' ' HD2' ' A' ' 30' ' ' LYS . 7.4 t70 -115.02 -53.0 2.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HD2' ' C ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -108.1 155.92 19.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.1 pt -141.55 170.34 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CE2' ' ND1' ' A' ' 96' ' ' HIS . 9.6 p90 -163.96 154.44 15.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.726 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 61.7 t -117.71 137.89 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -112.26 140.78 46.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.633 HG22 ' HB3' ' A' ' 81' ' ' LEU . 16.8 p -134.4 177.01 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.39 148.78 5.28 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.532 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.487 HG12 HD11 ' A' ' 106' ' ' LEU . 3.6 mp -97.0 132.77 40.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 0.0 111.092 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.512 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 18.8 m-85 -126.47 150.05 48.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.501 ' CB ' HD11 ' A' ' 44' ' ' LEU . 8.4 t-160 -127.35 101.1 6.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.92 38.16 36.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.63 33.35 58.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -148.2 140.14 14.3 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.678 0.751 . . . . 0.0 110.845 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 149.22 67.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.681 2.254 . . . . 0.0 112.335 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.501 HD11 ' CB ' ' A' ' 39' ' ' HIS . 11.0 mp -102.1 -42.85 5.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 t -147.22 170.72 16.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -47.54 126.85 10.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -61.01 160.15 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.782 HG12 HD11 ' A' ' 64' ' ' LEU . 48.5 t -122.57 136.19 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -120.63 146.09 46.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -89.42 171.85 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.116 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -56.56 169.27 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -101.1 110.63 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.41 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -112.1 152.13 44.13 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.65 0.738 . . . . 0.0 111.109 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 142.06 47.09 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.698 2.265 . . . . 0.0 112.331 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.7 p -50.63 -42.71 56.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.6 p -60.04 -29.12 68.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -131.36 84.22 57.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.617 0.723 . . . . 0.0 110.921 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 4.27 2.29 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.309 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -61.3 112.06 2.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.726 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 5.0 m-90 -95.46 -65.36 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 55.31 45.51 25.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -120.08 136.54 54.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.592 ' CZ3' ' HD2' ' A' ' 12' ' ' ARG . 71.3 m95 -83.55 98.87 9.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.921 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.782 HD11 HG12 ' A' ' 48' ' ' VAL . 11.2 tp -86.95 109.76 19.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -91.22 145.12 24.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.541 ' CE1' HD12 ' A' ' 13' ' ' ILE . 31.8 m-85 -111.08 134.04 52.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.66 50.86 2.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.914 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.44 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.2 pp -117.42 165.7 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.625 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.0 120.36 38.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.1 mp -51.45 -53.8 45.85 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 0.0 111.142 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.625 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.81 3.56 2.73 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.26 . . . . 0.0 112.342 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.511 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 6.0 t70 -124.1 -8.43 7.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -82.59 110.44 22.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.658 0.742 . . . . 0.0 110.915 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.429 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.5 Cg_endo -69.76 139.52 40.43 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.661 2.24 . . . . 0.0 112.377 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.541 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 1.8 mpp_? -50.16 -37.8 36.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.81 -48.45 66.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.116 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -58.83 155.05 13.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -150.23 171.22 17.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.8 tp -94.23 137.62 33.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.1 m -136.54 142.8 43.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.633 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.7 OUTLIER -145.29 156.95 44.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.5 m -156.44 135.54 12.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.463 HG12 HD11 ' A' ' 150' ' ' LEU . 26.0 mt -84.74 137.67 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 54.3 m -130.25 170.11 14.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.587 ' HB2' HG21 ' A' ' 28' ' ' ILE . 49.5 p -123.71 126.57 46.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 86' ' ' VAL . 13.3 p -118.09 120.73 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.163 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.4 tptm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 179.916 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.846 0.355 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -134.83 116.69 15.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.462 ' ND1' ' CE2' ' A' ' 32' ' ' TYR . 11.8 m170 -97.83 130.37 44.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.23 131.76 12.25 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.629 0.728 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 147.32 62.51 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.703 2.269 . . . . 0.0 112.353 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.554 ' O ' HG22 ' A' ' 125' ' ' VAL . 51.5 mt -122.13 -56.91 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.88 177.36 7.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 65.7 p-90 -155.65 123.18 5.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.408 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -135.58 135.24 7.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -114.85 162.37 16.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.561 HD11 HD21 ' A' ' 120' ' ' LEU . 88.2 mt -147.12 118.47 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' LEU . 26.0 m-80 -59.21 92.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.487 HD11 HG12 ' A' ' 37' ' ' ILE . 10.7 mt -36.06 -42.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.541 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 97.5 m-85 -104.09 108.42 19.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 44.2 p30 -53.13 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.437 ' CE1' ' HB ' ' A' ' 110' ' ' THR . 34.3 p90 -55.43 -40.39 71.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.437 ' HB ' ' CE1' ' A' ' 109' ' ' TYR . 10.0 t -86.22 33.31 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.5 OUTLIER 37.18 49.9 0.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 89.7 m -130.53 110.45 11.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.765 HD22 ' CH2' ' A' ' 156' ' ' TRP . 36.7 mt -34.78 138.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.5 m -69.86 172.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.2 p -168.94 159.41 9.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.69 145.32 2.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.455 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -43.12 151.15 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.472 ' O ' HD13 ' A' ' 152' ' ' LEU . 28.3 ttp -159.48 146.68 16.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.76 122.3 16.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.561 HD21 HD11 ' A' ' 104' ' ' ILE . 3.9 pp -133.89 158.37 43.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -78.39 158.17 28.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.829 HD11 HD12 ' A' ' 150' ' ' LEU . 7.1 mt -120.35 142.27 49.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.642 ' CE3' ' ND2' ' A' ' 142' ' ' ASN . 6.4 m95 -83.5 142.93 43.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.564 0.697 . . . . 0.0 110.904 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 131.13 20.65 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.235 . . . . 0.0 112.377 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 99' ' ' LEU . 15.7 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.662 0.744 . . . . 0.0 111.098 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.877 0.37 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.576 HD11 ' HA ' ' A' ' 81' ' ' LEU . 8.7 tp -96.19 139.83 31.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -107.04 91.63 6.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.587 0.708 . . . . 0.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.512 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.5 Cg_endo -69.73 -37.38 9.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.673 2.249 . . . . 0.0 112.337 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 36.1 mt -73.96 -22.62 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -40.59 144.7 0.5 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 138' ' ' VAL . 1.9 m -50.43 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.114 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 67.1 p -127.14 165.36 19.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.83 176.49 35.2 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 90.9 p -88.12 149.52 23.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.884 0.373 . . . . 0.0 110.848 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.642 ' ND2' ' CE3' ' A' ' 123' ' ' TRP . 60.5 t-20 -90.57 124.79 61.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.893 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.465 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.73 2.85 3.15 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.661 2.241 . . . . 0.0 112.339 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -85.24 130.92 34.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -89.2 -52.96 4.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -48.55 -24.54 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.882 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.4 p -74.01 151.87 88.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.567 0.698 . . . . 0.0 111.171 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 140.53 43.06 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.692 2.261 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.7 t -123.11 135.5 54.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.829 HD12 HD11 ' A' ' 122' ' ' LEU . 6.4 mt -105.18 139.8 39.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.87 123.68 49.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.815 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -135.44 165.04 26.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -124.25 141.62 51.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.574 ' CE2' HD21 ' A' ' 152' ' ' LEU . 51.1 m-85 -104.58 136.78 43.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.424 ' HB3' ' CG ' ' A' ' 12' ' ' ARG . 1.5 t70 -152.5 147.62 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.765 ' CH2' HD22 ' A' ' 113' ' ' LEU . 7.1 m95 -134.26 89.36 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.61 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 9.3 p90 -87.36 -52.26 5.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.737 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 2.7 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.843 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.636 ' N ' ' HG ' ' A' ' 158' ' ' SER . 36.6 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.877 0.37 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.93 142.28 47.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.72 HD13 ' CH2' ' A' ' 156' ' ' TRP . 27.4 tp -104.35 142.76 34.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.459 ' HD2' ' CD1' ' A' ' 157' ' ' PHE . 2.2 ptm85 -148.64 128.15 13.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.677 HD12 ' CE1' ' A' ' 66' ' ' TYR . 16.2 mt -129.35 136.38 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.523 ' HB2' ' CD2' ' A' ' 63' ' ' TRP . 67.4 tttt -109.55 125.99 53.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 mm -91.34 141.2 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.456 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.2 mm? -99.61 -74.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.7 p -167.83 178.42 5.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.24 166.89 16.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -135.68 159.09 42.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 41.09 53.51 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.107 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.0 mt . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.854 0.359 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.68 -58.29 2.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -143.81 176.7 9.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.8 pt -136.63 168.37 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -163.08 152.37 15.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.838 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 94.9 t -97.92 142.72 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.138 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.41 ' NH2' ' OD1' ' A' ' 47' ' ' ASN . 49.2 ttt85 -119.57 117.33 28.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 81' ' ' LEU . 27.7 p -114.69 170.85 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.87 139.11 2.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.542 HD13 HG21 ' A' ' 68' ' ' ILE . 3.3 mp -92.01 138.6 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.145 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.538 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 27.6 m-85 -130.63 164.45 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -133.85 95.29 3.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.845 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.51 -11.97 53.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 135.66 -6.23 4.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -110.45 146.5 34.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.466 ' C ' HD12 ' A' ' 44' ' ' LEU . 54.3 Cg_endo -69.73 160.26 50.36 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.466 HD12 ' C ' ' A' ' 43' ' ' PRO . 8.3 mp -120.02 -33.81 3.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.8 m -151.63 169.35 22.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -53.37 136.42 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.41 ' OD1' ' NH2' ' A' ' 34' ' ' ARG . 31.8 m120 -74.53 158.01 34.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.562 HG12 HD11 ' A' ' 64' ' ' LEU . 43.3 t -116.82 139.22 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.72 142.39 49.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.5 p -89.29 160.83 16.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -52.24 165.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -93.27 119.92 32.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.5 m -120.32 152.14 54.48 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.635 0.731 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 133.07 24.75 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.7 2.267 . . . . 0.0 112.35 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.7 p -44.09 -48.58 9.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -47.81 -34.34 8.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -134.51 86.88 33.62 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.72 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HA ' HG21 ' A' ' 53' ' ' VAL . 53.6 Cg_endo -69.81 3.23 2.92 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.673 2.248 . . . . 0.0 112.328 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -55.22 118.19 4.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.838 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.6 m-90 -101.17 -52.33 3.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.456 ' OD1' HD13 ' A' ' 16' ' ' LEU . 76.0 m-20 43.83 41.25 3.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -120.82 137.7 54.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.523 ' CD2' ' HB2' ' A' ' 14' ' ' LYS . 59.3 m95 -82.27 109.97 17.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.916 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.562 HD11 HG12 ' A' ' 48' ' ' VAL . 10.5 tp -92.03 120.15 32.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.928 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -97.84 136.26 38.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.677 ' CE1' HD12 ' A' ' 13' ' ' ILE . 58.8 m-85 -107.58 127.29 53.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.34 43.69 0.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.542 HG21 HD13 ' A' ' 37' ' ' ILE . 2.2 pp -107.32 166.06 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.618 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.57 125.29 49.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.605 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -58.77 -53.92 61.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.641 0.734 . . . . 0.0 111.13 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.9 Cg_endo -69.75 3.04 3.0 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.499 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 6.2 t70 -124.77 -2.32 7.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.487 HD21 HG21 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -87.69 113.13 53.01 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.665 0.745 . . . . 0.0 110.918 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.5 Cg_endo -69.83 132.77 23.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.512 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -46.61 -42.23 15.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.65 -40.88 60.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.139 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -62.08 168.17 3.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -159.21 173.44 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.409 ' HG ' ' CD2' ' A' ' 81' ' ' LEU . 53.3 tp -95.65 134.8 38.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.597 ' C ' HD23 ' A' ' 81' ' ' LEU . 17.3 m -127.18 147.37 50.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.597 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER -155.55 139.92 16.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.667 ' HB3' HD12 ' A' ' 133' ' ' LEU . 5.0 t -145.63 140.82 27.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.662 HG22 HD12 ' A' ' 99' ' ' LEU . 47.0 mt -83.99 124.9 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 67.2 m -124.21 145.23 49.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.478 ' HA ' HG22 ' A' ' 31' ' ' ILE . 6.0 p -106.07 128.57 53.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.49 HG23 ' CD2' ' A' ' 96' ' ' HIS . 10.4 p -108.57 126.55 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.191 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -128.69 127.96 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.49 ' CD2' HG23 ' A' ' 86' ' ' VAL . 15.3 m170 -107.9 132.89 52.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.5 t -137.42 132.71 17.85 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.605 0.717 . . . . 0.0 110.851 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 153.04 69.3 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.699 2.266 . . . . 0.0 112.354 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.662 HD12 HG22 ' A' ' 83' ' ' ILE . 20.8 mt -128.28 -35.57 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.44 155.63 24.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.679 ' HD1' HG12 ' A' ' 125' ' ' VAL . 59.4 p-90 -132.21 134.68 45.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.35 121.63 2.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -108.34 133.35 52.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.879 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.705 HG12 HD21 ' A' ' 120' ' ' LEU . 18.9 mt -118.21 140.38 41.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 107' ' ' PHE . 49.0 m-80 -70.67 85.87 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 105' ' ' ASN . 12.4 mt -34.9 -35.25 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 83.3 m-85 -112.93 123.05 49.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.898 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -51.07 -176.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.56 12.32 3.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 p -130.35 14.21 5.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 70.61 34.38 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.7 m -128.49 109.21 11.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.51 HD22 ' CH2' ' A' ' 156' ' ' TRP . 17.3 mt -38.58 149.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.2 m -72.56 178.08 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.143 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.4 p -174.01 156.18 2.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.44 170.11 45.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 32.5 tttt -71.05 148.7 47.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.733 0.302 . . . . 0.0 110.92 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.7 ttp -156.51 149.76 24.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.47 115.46 10.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.705 HD21 HG12 ' A' ' 104' ' ' ILE . 3.6 pp -128.86 155.97 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.03 153.84 28.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.911 HD11 HD12 ' A' ' 150' ' ' LEU . 7.7 mt -109.91 158.17 18.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.523 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 13.2 m95 -95.24 139.95 22.22 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 129.02 16.88 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.714 2.276 . . . . 0.0 112.347 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.679 HG12 ' HD1' ' A' ' 101' ' ' TRP . 3.2 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.631 0.729 . . . . 0.0 111.127 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.906 0.384 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.667 HD12 ' HB3' ' A' ' 82' ' ' SER . 10.7 tp -106.16 142.88 35.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -105.41 91.33 4.71 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.538 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.1 Cg_endo -69.72 -43.85 2.45 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.0 112.336 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.0 mt -70.62 -19.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.412 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -41.34 146.15 0.5 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.422 ' H ' HG13 ' A' ' 138' ' ' VAL . 1.6 m -56.02 179.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.15 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.5 p -123.57 179.24 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.37 169.03 44.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.447 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 87.2 p -85.76 131.85 34.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.867 0.365 . . . . 0.0 110.876 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 123' ' ' TRP . 64.8 t-20 -69.27 120.85 79.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.567 0.698 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.428 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.6 Cg_endo -69.74 -19.78 35.78 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.344 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -53.3 132.57 39.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -86.83 -35.03 19.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -84.35 39.69 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.5 p -130.98 156.38 80.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.593 0.711 . . . . 0.0 111.134 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 174.51 9.38 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.701 2.268 . . . . 0.0 112.343 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.5 t -159.7 134.57 7.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.911 HD12 HD11 ' A' ' 122' ' ' LEU . 3.3 mt -110.0 143.69 39.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.442 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 6.2 tt0 -111.03 127.7 55.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.704 ' H ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -137.79 156.19 48.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -113.89 117.81 32.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.688 ' CE2' HD21 ' A' ' 152' ' ' LEU . 29.3 m-85 -84.74 111.7 19.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.9 155.13 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.72 ' CH2' HD13 ' A' ' 11' ' ' LEU . 11.1 m95 -137.87 122.28 18.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.93 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.459 ' CD1' ' HD2' ' A' ' 12' ' ' ARG . 11.1 p90 -109.73 -44.99 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.636 ' HG ' ' N ' ' A' ' 9' ' ' SER . 10.6 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.867 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.531 ' N ' HD13 ' A' ' 70' ' ' ILE . 1.9 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.872 0.368 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -98.87 130.94 45.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.083 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.692 HD13 ' CH2' ' A' ' 156' ' ' TRP . 15.8 tp -84.99 134.93 34.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -128.73 133.52 48.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.529 HD12 ' CE1' ' A' ' 66' ' ' TYR . 26.2 mt -139.04 128.74 31.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.197 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.552 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 16.2 tttp -110.25 130.19 55.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.1 mm -95.15 140.03 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.18 -74.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.6 p -167.09 -179.46 4.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.07 166.13 17.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -136.69 141.18 43.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 60.71 50.1 5.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.142 179.947 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.754 HG21 ' HB2' ' A' ' 85' ' ' SER . 4.2 mp . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.813 0.34 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.07 -59.44 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -144.92 159.05 43.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' A' ' 85' ' ' SER . 8.6 pt -116.57 179.51 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -173.02 149.23 1.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.551 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 88.0 t -108.57 139.19 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 47' ' ' ASN . 6.9 tpt180 -109.45 133.83 52.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.1 p -128.07 163.56 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.31 152.83 7.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.492 HG12 HD11 ' A' ' 106' ' ' LEU . 2.7 mp -98.39 141.85 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 0.0 111.11 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.463 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 14.4 m-85 -132.55 142.93 49.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.849 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -120.81 94.35 4.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.42 37.16 36.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.66 -23.78 8.4 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -93.05 142.44 25.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.654 0.74 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.58 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.6 Cg_endo -69.78 165.24 31.64 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.705 2.27 . . . . 0.0 112.356 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.849 HD11 ' HB3' ' A' ' 39' ' ' HIS . 10.0 mp -125.77 -37.48 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 39.8 m -148.57 161.91 40.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.68 137.37 9.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 34' ' ' ARG . 19.6 m120 -70.43 149.89 46.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.591 HG12 HD11 ' A' ' 64' ' ' LEU . 64.4 t -110.96 133.26 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -115.78 147.41 41.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 33' ' ' VAL . 13.1 t -95.26 169.19 10.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.91 173.25 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -105.71 124.25 49.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -126.25 152.01 73.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.587 0.708 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 136.93 34.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.346 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.0 p -46.2 -46.15 17.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.3 t -50.33 -33.89 21.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -133.91 86.16 38.78 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.74 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.2 Cg_endo -69.8 4.35 2.26 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.704 2.269 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -58.06 107.29 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.576 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 1.9 m-90 -93.94 -49.82 5.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 61' ' ' ASN . 3.1 p-10 39.48 43.38 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -112.73 151.02 30.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.552 ' CE3' ' HB2' ' A' ' 14' ' ' LYS . 79.8 m95 -98.57 100.17 11.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.935 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.591 HD11 HG12 ' A' ' 48' ' ' VAL . 11.0 tp -88.31 118.61 28.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -98.82 145.83 26.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CE1' HD12 ' A' ' 13' ' ' ILE . 5.2 m-85 -114.68 135.85 53.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -90.34 52.32 2.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.437 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.4 pp -119.77 169.44 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -113.58 130.19 56.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.627 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -63.96 -52.8 53.93 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.668 0.747 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.9 Cg_endo -69.75 -3.74 12.61 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.51 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 8.3 t70 -114.39 -9.11 12.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -74.46 116.19 50.72 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.545 0.688 . . . . 0.0 110.928 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.78 134.91 29.07 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.683 2.256 . . . . 0.0 112.337 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.586 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 20.7 mmm-85 -47.92 -44.52 29.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.54 -44.87 66.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.138 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.58 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -54.89 161.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -158.7 176.06 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.8 tp -96.71 133.17 41.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.8 m -127.76 133.3 49.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.32 152.1 41.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 96.0 p -157.48 146.49 19.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.7 mt -89.15 147.11 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 61.5 m -149.15 141.62 24.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.754 ' HB2' HG21 ' A' ' 28' ' ' ILE . 94.7 p -106.46 118.62 37.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.597 HG23 ' CD2' ' A' ' 96' ' ' HIS . 12.4 p -101.44 136.23 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.7 tptm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 4.6 mp0 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.796 0.332 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.84 116.43 22.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.597 ' CD2' HG23 ' A' ' 86' ' ' VAL . 6.4 m170 -95.87 149.71 21.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 t -153.71 120.54 2.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 0.0 110.851 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 144.77 54.93 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.649 2.233 . . . . 0.0 112.335 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.677 ' O ' HG23 ' A' ' 125' ' ' VAL . 20.6 mt -115.53 -47.41 2.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -147.06 169.34 19.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.529 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 64.4 p-90 -147.9 132.89 18.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.9 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.28 120.48 2.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.504 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -100.25 139.37 36.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.76 0.314 . . . . 0.0 110.898 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.628 HD11 HD21 ' A' ' 120' ' ' LEU . 54.9 mt -131.09 120.94 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 106' ' ' LEU . 3.3 t-20 -67.11 95.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.492 HD11 HG12 ' A' ' 37' ' ' ILE . 18.7 mt -34.89 -39.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 63.6 m-85 -96.7 113.62 25.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -52.22 -176.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.84 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -65.27 -33.25 75.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.952 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -83.53 17.31 2.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 60.35 41.88 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.847 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.1 m -133.75 126.62 31.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.741 HD22 ' CH2' ' A' ' 156' ' ' TRP . 18.4 mt -47.17 144.57 2.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.79 -179.19 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.0 t -172.79 171.48 4.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.21 172.8 7.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 2.2 ttpm? -71.42 151.98 43.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.887 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 29.8 ttp -158.67 148.31 19.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.17 121.44 15.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.099 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.628 HD21 HD11 ' A' ' 104' ' ' ILE . 2.9 pp -134.45 160.11 39.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -83.56 151.11 25.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.447 ' HB2' ' HB1' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -109.14 151.03 26.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.529 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 16.3 m95 -80.64 152.61 72.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.534 0.683 . . . . 0.0 110.925 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 168.2 22.32 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 99' ' ' LEU . 68.6 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.592 0.711 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.805 0.336 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.3 tp -88.89 132.99 34.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.438 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 9.6 t-20 -105.71 91.53 5.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.648 0.737 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.463 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.8 Cg_endo -69.76 -27.6 26.28 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.6 mm -80.88 -17.02 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.438 ' CA ' ' OD1' ' A' ' 134' ' ' ASN . . . -43.54 155.07 0.22 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.47 HG22 ' CH2' ' A' ' 101' ' ' TRP . 8.9 m -71.88 163.21 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.869 0.366 . . . . 0.0 111.126 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.3 p -106.04 157.42 17.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.87 159.97 14.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.525 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.1 p -83.55 108.25 16.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.84 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.593 ' ND2' HG21 ' A' ' 147' ' ' THR . 14.3 t-20 -40.07 116.79 1.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.58 0.705 . . . . 0.0 110.841 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -8.41 23.53 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.655 2.237 . . . . 0.0 112.338 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -70.91 151.89 44.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -102.78 -24.53 13.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -85.94 29.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.593 HG21 ' ND2' ' A' ' 142' ' ' ASN . 25.0 p -124.41 153.03 69.09 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 111.148 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 154.19 68.08 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.722 2.281 . . . . 0.0 112.309 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.1 t -130.9 130.54 43.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 122' ' ' LEU . 4.7 mt -109.21 135.95 49.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -105.39 124.78 50.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.76 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -134.46 159.63 40.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.459 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 54.8 mt-10 -116.77 134.78 54.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.667 ' CE2' HD21 ' A' ' 152' ' ' LEU . 47.7 m-85 -99.96 103.7 15.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -114.27 141.13 47.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.741 ' CH2' HD22 ' A' ' 113' ' ' LEU . 60.0 m95 -125.13 76.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 158' ' ' SER . 9.5 p90 -70.88 -49.05 50.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.68 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 47.2 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.617 ' N ' ' HG ' ' A' ' 158' ' ' SER . 1.8 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.851 0.358 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.31 131.34 55.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.071 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.59 HD13 ' CH2' ' A' ' 156' ' ' TRP . 13.5 tp -93.71 136.24 34.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 157' ' ' PHE . 18.7 ptt180 -142.61 139.37 31.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.3 mt -136.92 142.25 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HD2' ' CE2' ' A' ' 63' ' ' TRP . 69.3 tttt -118.9 115.37 24.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.0 mm -81.23 145.68 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.49 -72.96 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.1 p -170.53 178.04 3.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -129.62 142.3 50.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 t -117.86 144.65 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 67.23 47.42 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.789 0.328 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -75.46 -63.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -144.69 -179.8 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 85' ' ' SER . 12.2 pt -137.56 178.87 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -173.67 138.57 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.74 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 14.9 t -90.08 145.82 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.439 ' HG2' HD13 ' A' ' 133' ' ' LEU . 19.4 ttt180 -127.54 120.99 29.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.863 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.626 HG22 ' HB3' ' A' ' 81' ' ' LEU . 56.2 p -117.15 179.45 4.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.25 138.88 2.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.465 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.472 HG12 HD11 ' A' ' 106' ' ' LEU . 3.1 mp -87.06 150.67 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 111.112 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.434 ' HA ' HD13 ' A' ' 44' ' ' LEU . 24.3 m-85 -140.77 152.64 45.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.683 ' CB ' HD11 ' A' ' 44' ' ' LEU . 10.2 t-160 -127.09 104.17 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.01 51.23 56.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.43 34.79 89.61 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.515 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -142.72 142.67 23.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.691 0.758 . . . . 0.0 110.861 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 149.73 67.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.704 2.27 . . . . 0.0 112.333 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.683 HD11 ' CB ' ' A' ' 39' ' ' HIS . 8.3 mp -114.05 -37.1 4.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.9 m -160.57 170.05 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.805 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -50.46 131.73 24.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -66.74 161.98 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.701 HG12 HD11 ' A' ' 64' ' ' LEU . 51.4 t -122.25 139.01 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -126.52 156.5 40.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -93.41 179.82 5.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -66.67 163.92 17.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -82.2 126.46 32.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 1.4 m -137.62 152.05 72.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.647 0.737 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 138.52 38.06 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.73 2.287 . . . . 0.0 112.317 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 23.3 p -49.98 -45.87 52.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.4 t -51.35 -35.72 39.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -130.48 84.77 58.32 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.717 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.588 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.72 3.85 2.51 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.69 2.26 . . . . 0.0 112.366 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -52.63 109.16 0.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.74 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 3.6 m-90 -103.54 -46.89 4.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 60' ' ' TRP . 7.8 p30 35.3 44.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -113.83 147.9 37.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.428 ' CE2' ' HD2' ' A' ' 14' ' ' LYS . 71.2 m95 -88.99 97.16 11.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.701 HD11 HG12 ' A' ' 48' ' ' VAL . 11.8 tp -84.62 111.56 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -91.28 132.87 35.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.937 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -99.42 137.41 37.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -88.21 44.26 1.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.855 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.419 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.2 pp -112.5 170.94 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.619 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.14 115.88 25.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.662 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.8 mp -53.38 -51.02 79.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.647 0.737 . . . . 0.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.0 Cg_endo -69.77 2.21 3.75 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.647 2.231 . . . . 0.0 112.382 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.504 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.3 t70 -123.49 -11.17 7.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.574 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -71.84 113.86 23.78 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.631 0.729 . . . . 0.0 110.901 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.3 Cg_endo -69.74 145.91 58.71 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -41.95 75.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -56.19 -37.97 70.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.611 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -59.85 164.55 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.601 ' HD2' HG21 ' A' ' 139' ' ' THR . 50.4 mtt85 -161.34 173.84 14.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 tp -98.3 131.86 44.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 9.5 m -127.65 135.95 50.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.626 ' HB3' HG22 ' A' ' 35' ' ' THR . 2.2 pp -142.83 155.56 44.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.402 ' OG ' HD12 ' A' ' 133' ' ' LEU . 85.2 p -160.16 134.82 7.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.5 mt -81.66 141.45 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 95.7 m -136.88 152.14 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.443 ' HA ' HG22 ' A' ' 31' ' ' ILE . 15.0 m -111.23 129.11 56.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 p -111.9 130.19 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.1 tptm . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 179.917 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.812 0.339 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -120.94 127.82 52.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -108.43 135.23 50.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.9 t -142.93 127.64 9.83 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.619 0.723 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.592 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.1 Cg_endo -69.77 146.61 60.67 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.653 2.235 . . . . 0.0 112.332 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.42 HD11 ' OG ' ' A' ' 85' ' ' SER . 22.6 mt -119.67 -43.56 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.936 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.1 162.16 41.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.061 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.415 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 66.6 p-90 -143.09 135.67 27.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.06 132.75 5.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 0.9 OUTLIER -111.28 138.18 48.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.792 0.329 . . . . 0.0 110.877 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.562 ' CG1' HD21 ' A' ' 120' ' ' LEU . 78.8 mt -120.6 134.62 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 107' ' ' PHE . 2.5 m120 -73.19 88.1 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.472 HD11 HG12 ' A' ' 37' ' ' ILE . 12.7 mt -36.26 -33.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 105' ' ' ASN . 57.1 m-85 -110.85 116.46 31.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -50.86 -178.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -64.26 -33.22 75.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.3 t -91.25 30.23 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.151 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.2 t0 49.74 49.21 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 113' ' ' LEU . 45.8 m -136.51 112.82 9.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.687 HD22 ' CH2' ' A' ' 156' ' ' TRP . 29.6 mt -36.73 148.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.514 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 18.2 m -75.62 -179.83 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.7 p -173.54 155.85 2.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.845 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.35 152.53 6.08 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.454 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -56.17 147.36 20.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.423 ' O ' HD13 ' A' ' 152' ' ' LEU . 35.9 ttp -156.95 153.09 27.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.92 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.27 132.07 37.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 120' ' ' LEU . 3.9 pp -138.75 154.63 48.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -77.35 156.82 31.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.1 mt -113.69 153.52 28.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.503 ' CH2' ' OD1' ' A' ' 142' ' ' ASN . 18.7 m95 -89.58 148.79 41.02 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.597 0.713 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 163.67 37.49 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.699 2.266 . . . . 0.0 112.333 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 98' ' ' PRO . 45.7 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.596 0.712 . . . . 0.0 111.116 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.425 HD12 ' NH1' ' A' ' 34' ' ' ARG . 25.6 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.855 0.359 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.439 HD13 ' HG2' ' A' ' 34' ' ' ARG . 6.1 tp -97.77 136.03 38.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.47 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 11.2 t-20 -105.34 93.71 7.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.622 0.725 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -30.89 21.45 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.648 2.232 . . . . 0.0 112.373 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 137' ' ' GLY . 12.7 mm -75.19 -25.82 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.488 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -34.76 148.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.473 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.78 173.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 111.077 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.601 HG21 ' HD2' ' A' ' 78' ' ' ARG . 34.1 p -118.09 146.15 44.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.28 163.19 12.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.508 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.7 p -84.26 118.17 24.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.886 0.374 . . . . 0.0 110.883 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.503 ' OD1' ' CH2' ' A' ' 123' ' ' TRP . 24.0 t30 -60.89 129.44 90.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 110.913 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 2.03 3.87 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.662 2.241 . . . . 0.0 112.372 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . 0.499 HD21 ' N ' ' A' ' 144' ' ' ASN . 0.9 OUTLIER -89.78 117.0 28.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -77.05 -46.18 24.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 147' ' ' THR . 14.8 pt-20 -43.6 -38.66 3.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.419 ' N ' ' HG3' ' A' ' 146' ' ' GLU . 64.6 p -64.25 151.87 89.68 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.606 0.717 . . . . 0.0 111.116 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 132.04 22.59 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.69 2.26 . . . . 0.0 112.375 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.07 136.99 52.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.941 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.674 ' CD2' ' HB2' ' A' ' 18' ' ' ALA . 8.4 mt -108.75 137.59 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -105.23 130.75 53.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.892 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -135.14 161.53 35.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -116.74 125.06 51.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.892 ' CE2' HD21 ' A' ' 152' ' ' LEU . 43.1 m-85 -93.41 108.02 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.0 155.82 49.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.687 ' CH2' HD22 ' A' ' 113' ' ' LEU . 6.9 m95 -136.45 105.24 5.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.485 ' CG ' ' N ' ' A' ' 158' ' ' SER . 10.0 p90 -85.17 -44.96 12.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.617 ' HG ' ' N ' ' A' ' 9' ' ' SER . 4.5 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.893 0.378 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.76 140.13 52.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.064 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 12' ' ' ARG . 5.8 tp -104.33 131.51 51.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' N ' HD12 ' A' ' 11' ' ' LEU . 32.2 ptt180 -139.66 139.12 36.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.48 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 59.3 mt -135.2 128.6 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -102.76 107.14 17.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mm -70.76 143.23 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.37 -72.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.7 p -172.06 179.5 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.25 169.08 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.4 t -147.3 144.0 28.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.135 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 61.78 47.46 6.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.098 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.822 0.344 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.416 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 6.7 t70 -70.52 -62.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 25.1 mmtm -147.36 179.08 7.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 85' ' ' SER . 1.9 pp -141.86 146.31 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -144.28 163.77 32.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.572 ' H ' HG22 ' A' ' 50' ' ' THR . 60.9 t -111.9 140.89 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.09 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' HG2' HD13 ' A' ' 133' ' ' LEU . 14.6 ttt85 -116.27 127.61 54.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.826 HG22 ' HB3' ' A' ' 81' ' ' LEU . 38.3 p -128.97 168.03 16.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.64 153.22 7.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.481 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.484 HD13 HG21 ' A' ' 68' ' ' ILE . 3.7 mp -96.26 146.78 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 0.0 111.147 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.53 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 32.4 m-85 -139.05 159.4 42.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.425 ' CB ' HD11 ' A' ' 44' ' ' LEU . 7.6 t-160 -139.41 106.44 5.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.39 31.31 46.74 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.96 29.62 60.55 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.533 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -148.67 149.28 30.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.656 0.741 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 158.78 55.75 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.4 mp -112.26 -42.16 3.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.3 m -132.61 -69.57 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -173.16 166.49 4.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.432 ' HB2' ' NH2' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -96.91 149.85 21.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.666 HG12 HD11 ' A' ' 64' ' ' LEU . 95.9 t -115.04 133.46 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -116.21 156.1 27.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 33' ' ' VAL . 9.1 t -100.26 165.58 11.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -48.93 178.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.5 mtt85 -108.22 115.73 30.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -120.19 152.3 54.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.582 0.705 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 139.11 39.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.2 p -47.09 -44.43 21.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m -52.05 -29.41 21.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -134.06 83.97 44.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 0.0 110.904 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.6 Cg_endo -69.78 1.39 4.49 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.672 2.248 . . . . 0.0 112.323 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -60.29 120.27 9.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.576 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 3.2 m-90 -109.52 -47.04 3.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.943 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 60' ' ' TRP . 8.9 p30 34.0 42.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -111.85 144.9 40.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -83.27 110.17 17.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.666 HD11 HG12 ' A' ' 48' ' ' VAL . 11.1 tp -94.56 123.07 37.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.924 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -101.63 137.44 39.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -108.92 135.49 50.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -84.25 38.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.484 HG21 HD13 ' A' ' 37' ' ' ILE . 1.8 pp -110.0 159.57 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.115 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.626 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.12 125.3 53.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -57.96 -54.06 59.44 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.725 . . . . 0.0 111.165 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.0 Cg_endo -69.75 2.16 3.78 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.246 . . . . 0.0 112.372 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.504 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.5 t70 -124.84 -1.52 7.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -85.36 117.05 67.99 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.612 0.72 . . . . 0.0 110.907 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.72 144.62 54.83 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.683 2.255 . . . . 0.0 112.365 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.411 ' HD3' ' CD2' ' A' ' 107' ' ' PHE . 21.5 mmt85 -59.12 -38.39 79.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -57.4 -26.46 61.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -76.94 165.53 24.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -159.51 177.28 11.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 80' ' ' CYS . 43.0 tp -98.89 148.67 23.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.595 ' C ' HD23 ' A' ' 81' ' ' LEU . 61.1 m -143.02 152.49 41.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.826 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.89 136.58 14.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.694 ' OG ' HD12 ' A' ' 133' ' ' LEU . 79.9 p -141.76 133.52 27.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.891 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.503 HG22 HD12 ' A' ' 99' ' ' LEU . 90.2 mt -80.12 135.72 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 70.9 m -135.72 144.33 45.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.483 ' HA ' HG22 ' A' ' 31' ' ' ILE . 6.2 p -105.5 125.13 50.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 86' ' ' VAL . 5.8 p -109.94 117.93 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.823 0.344 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -142.53 135.55 28.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.25 130.71 46.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.6 m -134.25 127.56 18.99 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.609 0.718 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.706 ' HB2' HG21 ' A' ' 125' ' ' VAL . 53.3 Cg_endo -69.77 150.26 67.94 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.304 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.503 HD12 HG22 ' A' ' 83' ' ' ILE . 21.8 mt -128.48 -52.72 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.64 176.45 8.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.549 ' HH2' HG22 ' A' ' 138' ' ' VAL . 68.6 p-90 -160.6 146.8 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.09 124.11 1.54 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 27.1 m-20 -104.31 153.12 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.902 HD11 HD21 ' A' ' 120' ' ' LEU . 55.1 mt -144.9 126.88 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.129 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 106' ' ' LEU . 24.8 m120 -66.5 99.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 37' ' ' ILE . 13.0 mt -34.13 -54.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.493 ' CE1' ' HG ' ' A' ' 113' ' ' LEU . 52.3 m-85 -94.88 114.29 26.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -54.64 174.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -48.38 -30.09 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -90.28 28.49 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 44.16 41.88 4.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 55.2 m -127.88 115.58 18.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.637 HD22 ' CH2' ' A' ' 156' ' ' TRP . 12.3 mt -43.1 134.4 3.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 m -62.54 173.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.179 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -168.6 161.5 11.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.05 153.78 12.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.471 ' HE3' ' CG ' ' A' ' 151' ' ' GLU . 5.3 tmtt? -63.92 142.9 58.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.748 0.308 . . . . 0.0 110.887 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.422 ' O ' HD13 ' A' ' 152' ' ' LEU . 37.5 ttp -155.09 154.58 32.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.74 116.11 10.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.103 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 104' ' ' ILE . 4.6 pp -123.26 163.75 20.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -85.23 158.75 20.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.764 HD11 HD12 ' A' ' 150' ' ' LEU . 6.0 mt -119.1 155.71 31.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.673 ' CE3' ' ND2' ' A' ' 142' ' ' ASN . 8.3 m95 -90.18 146.42 34.81 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.559 0.695 . . . . 0.0 110.89 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 147.45 62.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.703 2.268 . . . . 0.0 112.305 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.706 HG21 ' HB2' ' A' ' 98' ' ' PRO . 48.2 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.608 0.718 . . . . 0.0 111.118 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.817 0.342 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.694 HD12 ' OG ' ' A' ' 82' ' ' SER . 5.0 tp -103.16 125.86 50.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.449 ' CG ' ' O ' ' A' ' 134' ' ' ASN . 11.8 p-10 -106.65 97.29 16.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.732 . . . . 0.0 110.928 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.53 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.8 -30.82 21.47 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.3 mt -70.08 -25.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.093 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.484 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -41.45 153.59 0.11 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.511 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.549 HG22 ' HH2' ' A' ' 101' ' ' TRP . 2.0 m -59.47 175.3 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.866 0.365 . . . . 0.0 111.161 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 60.7 p -121.37 168.25 11.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.189 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.49 161.93 32.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.9 p -79.6 137.82 37.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.673 ' ND2' ' CE3' ' A' ' 123' ' ' TRP . 34.9 t-20 -75.38 123.96 88.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -14.99 36.8 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.362 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -71.6 140.2 49.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -93.46 -42.32 9.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.37 -35.44 28.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.4 p -66.92 151.3 97.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.572 0.701 . . . . 0.0 111.113 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 148.22 64.3 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.687 2.258 . . . . 0.0 112.358 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 5.5 t -128.07 136.56 51.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 122' ' ' LEU . 3.5 mt -103.67 -177.09 3.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.471 ' CG ' ' HE3' ' A' ' 117' ' ' LYS . 54.7 tt0 -149.61 122.07 8.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.8 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -128.38 165.78 19.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.866 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.429 ' N ' HD22 ' A' ' 152' ' ' LEU . 69.0 mt-10 -128.45 119.73 25.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.649 ' CE2' HD21 ' A' ' 152' ' ' LEU . 45.2 m-85 -88.44 129.89 35.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.903 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -148.75 138.89 22.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.637 ' CH2' HD22 ' A' ' 113' ' ' LEU . 7.7 m95 -129.39 94.26 3.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.586 ' CG ' ' N ' ' A' ' 158' ' ' SER . 16.1 p90 -92.98 -53.3 4.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.586 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 6.3 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.496 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 14.5 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.848 0.356 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.66 150.23 30.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.687 HD13 ' CH2' ' A' ' 156' ' ' TRP . 12.5 tp -104.48 140.04 38.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.69 ' NE ' ' CE3' ' A' ' 63' ' ' TRP . 2.4 ttt180 -143.72 118.39 9.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.521 HD12 ' CE1' ' A' ' 66' ' ' TYR . 16.1 mt -120.99 142.51 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.565 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 35.8 tttm -120.59 134.5 55.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.09 144.7 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.15 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.35 -74.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.1 p -162.31 -178.25 6.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -140.26 149.72 43.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.074 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -123.22 157.88 32.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.123 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 61.25 25.26 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 179.892 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.9 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.792 0.33 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -80.12 -64.62 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -148.23 -179.63 7.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.4 pt -139.46 171.09 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -164.52 158.9 18.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.79 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 40.9 t -119.86 132.06 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.687 ' HG2' HD13 ' A' ' 133' ' ' LEU . 19.2 ttm180 -103.56 122.27 44.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.86 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 81' ' ' LEU . 31.0 p -118.6 154.31 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.9 152.4 9.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.499 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.495 HG12 HD11 ' A' ' 106' ' ' LEU . 2.9 mp -97.41 143.38 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.171 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.572 ' CD1' ' HB3' ' A' ' 135' ' ' PRO . 45.7 m-85 -135.85 152.57 51.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.654 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 3.3 t-80 -124.5 97.8 5.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.933 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.06 14.38 80.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.34 -25.37 13.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.493 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -88.31 140.72 30.42 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.637 0.732 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.7 Cg_endo -69.81 156.33 63.5 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.712 2.275 . . . . 0.0 112.29 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.429 HD11 ' CB ' ' A' ' 39' ' ' HIS . 7.8 mp -115.18 -33.19 5.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.1 t -156.31 168.66 26.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.41 126.01 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -59.54 164.99 3.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.67 HG12 HD11 ' A' ' 64' ' ' LEU . 59.4 t -120.14 134.94 62.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -116.37 139.2 50.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.444 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 8.4 t -89.87 163.12 15.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -51.39 174.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -102.24 135.52 43.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.856 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -137.54 152.17 72.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 0.0 111.121 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 137.27 35.08 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.702 2.268 . . . . 0.0 112.345 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.6 p -46.54 -50.19 17.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.1 p -46.71 -32.49 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -133.21 87.06 39.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.613 0.72 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.478 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.2 Cg_endo -69.72 2.99 3.02 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -58.75 123.48 16.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.79 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 3.4 m-90 -105.74 -63.81 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 m120 54.24 48.2 21.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -124.93 139.33 53.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.69 ' CE3' ' NE ' ' A' ' 12' ' ' ARG . 80.1 m95 -81.89 112.2 18.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.67 HD11 HG12 ' A' ' 48' ' ' VAL . 10.1 tp -98.12 115.6 28.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -95.3 131.05 41.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.521 ' CE1' HD12 ' A' ' 13' ' ' ILE . 18.4 m-85 -100.83 134.26 44.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -81.06 41.29 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.682 ' C ' HD12 ' A' ' 68' ' ' ILE . 1.2 pp -115.33 162.83 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.615 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.37 127.41 54.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.578 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -54.2 -55.85 32.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 0.0 111.151 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.615 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.4 Cg_endo -69.81 3.02 3.03 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.707 2.271 . . . . 0.0 112.323 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.502 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.5 t70 -123.48 0.42 8.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -88.98 113.85 57.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.64 0.733 . . . . 0.0 110.874 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.5 Cg_endo -69.81 142.02 46.59 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.673 2.249 . . . . 0.0 112.295 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.555 ' NH1' ' CZ ' ' A' ' 107' ' ' PHE . 78.3 mmt-85 -55.2 -37.83 67.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.654 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -56.57 -32.44 65.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -70.55 166.79 19.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -161.81 172.01 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.0 tp -95.46 134.2 38.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.3 m -131.26 141.7 50.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.406 ' HB3' HG22 ' A' ' 35' ' ' THR . 1.4 pp -147.68 150.5 34.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.466 ' OG ' HD12 ' A' ' 133' ' ' LEU . 79.3 p -150.93 135.35 17.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.2 mt -84.76 141.5 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.17 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 20.7 m -140.54 150.97 44.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.572 ' HA ' HG22 ' A' ' 31' ' ' ILE . 85.1 p -113.06 126.15 55.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.535 HG23 ' CD2' ' A' ' 96' ' ' HIS . 8.5 p -104.89 130.44 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 tptp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.9 179.903 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.754 0.312 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -133.16 119.51 20.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.535 ' CD2' HG23 ' A' ' 86' ' ' VAL . 7.9 m170 -103.92 124.59 49.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.823 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.7 t -127.31 128.49 24.05 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.595 0.712 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.442 ' HB2' HG21 ' A' ' 125' ' ' VAL . 53.5 Cg_endo -69.77 147.08 62.03 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.67 2.247 . . . . 0.0 112.356 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.2 mt -120.09 -40.25 2.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -159.16 175.83 12.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.057 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.527 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 66.7 p-90 -156.79 135.52 11.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.81 134.3 7.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.497 HD21 ' N ' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -112.22 133.1 54.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.666 HG12 HD21 ' A' ' 120' ' ' LEU . 36.1 mt -122.24 121.0 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -64.27 96.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.495 HD11 HG12 ' A' ' 37' ' ' ILE . 20.4 mt -38.75 -35.65 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.555 ' CZ ' ' NH1' ' A' ' 75' ' ' ARG . 98.9 m-85 -106.12 112.36 25.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -51.09 175.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.445 ' C ' ' CD1' ' A' ' 109' ' ' TYR . 5.0 p90 -59.45 -22.26 61.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -95.76 24.63 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 50.71 39.49 21.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 113' ' ' LEU . 51.2 m -131.5 113.94 14.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.423 HD22 ' CH2' ' A' ' 156' ' ' TRP . 33.5 mt -38.03 143.52 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.465 HG21 ' CE2' ' A' ' 154' ' ' PHE . 35.7 m -74.3 -177.79 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.5 t -168.23 173.07 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.53 174.01 2.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.431 ' HE2' ' CD ' ' A' ' 151' ' ' GLU . 3.5 ttpm? -73.67 152.3 40.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.925 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.416 ' O ' HD13 ' A' ' 152' ' ' LEU . 17.5 ttp -154.39 148.47 25.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.93 116.96 12.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.666 HD21 HG12 ' A' ' 104' ' ' ILE . 4.0 pp -129.26 163.79 24.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 147' ' ' THR . 25.2 m-20 -91.05 145.61 24.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.546 ' HB2' ' HB1' ' A' ' 100' ' ' ALA . 2.9 mt -98.59 159.74 14.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.527 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 23.4 m95 -87.38 150.79 49.84 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.537 0.684 . . . . 0.0 110.913 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 145.23 56.52 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.355 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.442 HG21 ' HB2' ' A' ' 98' ' ' PRO . 99.2 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 0.0 111.149 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.687 HD13 ' HG2' ' A' ' 34' ' ' ARG . 16.4 tp -98.68 136.58 38.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.463 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 7.7 t-20 -106.55 91.51 6.04 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.643 0.735 . . . . 0.0 110.854 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.572 ' HB3' ' CD1' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.77 -41.19 4.47 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.687 2.258 . . . . 0.0 112.311 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.1 mt -75.61 -13.65 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.463 ' CA ' ' OD1' ' A' ' 134' ' ' ASN . . . -44.05 144.44 1.95 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.434 HG21 ' CZ2' ' A' ' 123' ' ' TRP . 2.2 m -54.78 173.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 111.184 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.1 p -118.62 175.57 5.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.192 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.08 154.15 30.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.479 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 86.4 p -78.89 109.85 13.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.916 0.389 . . . . 0.0 110.855 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -44.67 121.88 4.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.609 0.719 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -6.22 18.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -68.84 139.88 55.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -99.65 -9.93 22.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -97.67 14.42 26.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.402 ' O ' ' OD1' ' A' ' 121' ' ' ASN . 59.5 p -112.25 152.55 44.54 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.542 0.686 . . . . 0.0 111.166 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.45 59.99 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.66 2.24 . . . . 0.0 112.344 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 2.0 t -128.95 128.48 43.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' A' ' 18' ' ' ALA . 7.5 mt -100.32 140.32 34.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.431 ' CD ' ' HE2' ' A' ' 117' ' ' LYS . 37.6 tt0 -109.15 120.48 42.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.806 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -128.95 165.91 20.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.12 125.99 49.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.471 ' CE2' HD21 ' A' ' 152' ' ' LEU . 28.5 m-85 -90.77 100.41 13.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.01 141.48 37.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.687 ' CH2' HD13 ' A' ' 11' ' ' LEU . 74.8 m95 -129.1 69.55 1.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 158' ' ' SER . 7.9 p90 -69.34 -51.09 40.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.636 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 52.5 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 13.2 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.836 0.351 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -120.08 136.35 54.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.043 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.857 HD13 ' CH2' ' A' ' 156' ' ' TRP . 24.6 tp -86.67 139.15 31.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.412 ' H ' HD12 ' A' ' 11' ' ' LEU . 10.4 ttp180 -138.39 123.3 18.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.0 mt -134.18 139.27 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 72.9 tttt -118.37 127.22 53.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -89.17 146.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 151' ' ' GLU . 4.3 mm? -100.85 -72.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 p -168.46 -176.94 3.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.93 141.88 51.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.424 HG23 ' CD2' ' A' ' 20' ' ' TYR . 6.5 t -117.57 134.34 54.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.424 ' CD2' HG23 ' A' ' 19' ' ' THR . 5.8 m-85 72.69 38.75 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.116 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.833 0.349 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -71.14 -52.62 18.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.851 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -145.81 177.44 8.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.428 HG22 ' HA ' ' A' ' 85' ' ' SER . 2.0 pp -146.64 156.94 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -153.47 163.2 40.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.1 t -108.75 140.55 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.158 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.485 ' HG2' HD13 ' A' ' 133' ' ' LEU . 25.1 ttm180 -114.77 126.75 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.898 HG22 ' HB3' ' A' ' 81' ' ' LEU . 47.0 p -124.73 163.87 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.74 146.24 4.91 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.813 HD13 HG21 ' A' ' 68' ' ' ILE . 3.9 mp -89.77 146.01 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 111.166 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.534 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 38.5 m-85 -142.53 157.1 45.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.467 ' CB ' HD11 ' A' ' 44' ' ' LEU . 6.6 t-160 -129.09 102.84 6.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.89 22.37 70.24 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.29 -37.2 3.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -75.4 137.61 71.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.664 0.745 . . . . 0.0 110.888 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 158.07 58.2 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.467 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.0 mp -116.15 -40.08 3.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.3 m -149.76 168.95 22.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -57.35 128.17 35.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -61.65 159.11 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.54 HG11 ' HG ' ' A' ' 64' ' ' LEU . 58.7 t -114.78 147.5 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -129.06 156.06 44.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 p -102.64 168.62 9.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -51.92 177.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -107.08 112.62 25.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 m -118.0 152.83 50.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.606 0.717 . . . . 0.0 111.131 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 135.84 31.39 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.65 2.233 . . . . 0.0 112.331 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.5 p -44.69 -44.37 9.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 93.8 p -48.56 -34.82 12.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -134.18 89.22 28.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.621 0.724 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.58 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.3 Cg_endo -69.82 -0.12 6.5 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.708 2.272 . . . . 0.0 112.297 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -54.09 113.48 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.58 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 3.3 m-90 -104.82 -46.92 4.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.457 ' C ' ' O ' ' A' ' 60' ' ' TRP . 11.8 m-80 33.99 51.58 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -119.94 140.06 51.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.457 ' NE1' ' HD2' ' A' ' 14' ' ' LYS . 76.5 m95 -81.28 108.43 14.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.54 ' HG ' HG11 ' A' ' 48' ' ' VAL . 9.7 tp -97.66 121.46 39.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -101.33 134.84 43.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -102.34 129.91 48.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.9 42.34 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.877 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.813 HG21 HD13 ' A' ' 37' ' ' ILE . 2.0 pp -108.91 163.5 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.176 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.621 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.12 126.89 55.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.626 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -58.28 -52.41 74.78 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.65 0.738 . . . . 0.0 111.153 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.8 Cg_endo -69.8 -5.56 16.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.348 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.1 t0 -112.26 -15.79 13.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -71.41 112.16 12.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.627 0.727 . . . . 0.0 110.92 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.632 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.77 145.17 56.3 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.674 2.249 . . . . 0.0 112.35 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.457 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 21.7 mmt180 -53.41 -46.75 69.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.52 -41.71 63.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.082 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.632 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -57.82 163.82 2.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.415 ' O ' HG23 ' A' ' 37' ' ' ILE . 3.8 ptp85 -160.91 173.92 14.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.6 tp -96.18 144.15 26.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.611 ' C ' HD23 ' A' ' 81' ' ' LEU . 58.9 m -134.49 149.45 50.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.879 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.898 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.0 OUTLIER -155.76 137.09 13.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.0 p -146.87 154.4 41.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.586 ' CG1' HD11 ' A' ' 150' ' ' LEU . 44.5 mt -104.19 138.81 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.159 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 84.7 m -133.94 155.41 49.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.428 ' HA ' HG22 ' A' ' 31' ' ' ILE . 78.0 p -106.72 116.1 31.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.891 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.42 127.98 54.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.6 tptt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.948 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.829 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.88 118.94 30.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -103.91 124.65 49.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 17.9 m -131.16 122.96 19.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.406 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.4 Cg_endo -69.79 140.38 42.43 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.468 ' C ' HG23 ' A' ' 125' ' ' VAL . 16.5 mt -113.9 -36.33 4.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.04 -179.68 6.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.789 ' HH2' HG22 ' A' ' 138' ' ' VAL . 67.8 p-90 -162.7 127.05 3.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.76 134.16 7.07 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -114.64 129.91 56.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.339 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.484 HG12 HD21 ' A' ' 120' ' ' LEU . 87.1 mt -107.57 138.15 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 106' ' ' LEU . 6.1 m120 -76.58 82.79 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.1 mt -34.43 -38.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.457 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 40.9 m-85 -105.93 120.47 41.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -62.85 170.53 2.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.828 ' CE1' HG23 ' A' ' 110' ' ' THR . 0.2 OUTLIER -51.83 -26.24 9.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.828 HG23 ' CE1' ' A' ' 109' ' ' TYR . 67.9 p -105.23 31.79 4.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 47.01 36.6 4.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 113' ' ' LEU . 97.6 m -115.12 102.52 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.488 HD22 ' CH2' ' A' ' 156' ' ' TRP . 35.2 mt -34.05 125.13 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.479 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 29.8 m -58.2 176.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.146 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.447 ' HA ' ' CB ' ' A' ' 154' ' ' PHE . 2.2 m -173.42 166.88 4.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.33 132.38 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.471 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.417 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 22.6 ttpt -40.36 149.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.9 ttp -159.71 158.4 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.676 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -138.69 133.47 32.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 120' ' ' LEU . 4.5 pp -143.59 148.74 36.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -76.6 157.94 31.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 150' ' ' LEU . 1.2 mt -118.12 147.71 43.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.581 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 9.1 m95 -81.19 152.7 71.29 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.524 0.678 . . . . 0.0 110.931 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 161.88 44.21 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.708 2.272 . . . . 0.0 112.325 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.468 HG23 ' C ' ' A' ' 99' ' ' LEU . 90.3 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.485 HD13 ' HG2' ' A' ' 34' ' ' ARG . 14.8 tp -88.57 134.14 33.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -105.28 91.42 4.67 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.598 0.713 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.534 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.8 -28.61 24.87 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.252 . . . . 0.0 112.313 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 137' ' ' GLY . 11.5 mm -75.34 -28.48 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.181 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -34.66 151.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.423 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.789 HG22 ' HH2' ' A' ' 101' ' ' TRP . 18.6 m -68.63 170.45 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.946 0.403 . . . . 0.0 111.116 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.5 p -111.98 169.17 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.84 159.26 29.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.535 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.5 p -77.5 121.25 23.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.842 0.353 . . . . 0.0 110.858 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.581 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 36.9 t30 -59.14 124.39 74.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -18.45 36.96 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.726 2.284 . . . . 0.0 112.326 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -60.97 139.33 58.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -95.41 -35.36 11.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -83.41 39.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -129.16 156.12 78.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 0.0 111.132 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 130.28 18.98 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.722 2.281 . . . . 0.0 112.294 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 12.1 t -121.29 130.62 53.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.632 HD12 HD11 ' A' ' 122' ' ' LEU . 2.9 mt -106.89 151.5 25.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.982 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.676 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 0.4 OUTLIER -112.86 140.25 47.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.917 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.778 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -143.13 155.31 44.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.417 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 39.1 mt-10 -119.17 115.98 25.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.648 ' CE2' HD21 ' A' ' 152' ' ' LEU . 44.6 m-85 -80.49 109.53 15.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.98 126.34 41.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.857 ' CH2' HD13 ' A' ' 11' ' ' LEU . 6.3 m95 -123.55 98.38 5.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 158' ' ' SER . 46.9 p90 -98.67 -53.08 3.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.797 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 22.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.843 0.354 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.74 117.68 29.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.927 HD13 ' CH2' ' A' ' 156' ' ' TRP . 14.7 tp -84.72 131.75 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.521 ' NE ' ' CZ3' ' A' ' 63' ' ' TRP . 23.2 ptt180 -130.1 136.77 49.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.485 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 58.4 mt -134.21 134.9 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -111.41 133.79 53.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.8 mm -93.39 145.93 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.724 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.2 mm? -100.45 -72.4 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.2 p -166.78 -175.36 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.8 148.29 52.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -120.77 133.68 55.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 66.72 41.8 2.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.154 179.893 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.9 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.884 0.373 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -59.78 -66.8 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.844 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -144.33 177.32 8.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.4 173.56 11.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -165.65 170.83 13.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 92.1 t -119.14 140.51 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.126 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.712 ' HG2' HD13 ' A' ' 133' ' ' LEU . 46.5 ttm-85 -115.03 130.82 57.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.536 HG22 ' HB3' ' A' ' 81' ' ' LEU . 60.4 p -126.71 168.16 14.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.24 134.22 1.63 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.429 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 78' ' ' ARG . 3.8 mp -81.99 148.7 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 111.156 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.533 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 19.7 m-85 -140.1 142.75 36.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.7 t-160 -118.64 104.76 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.846 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.36 45.07 82.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.492 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.14 30.89 71.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.453 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -140.58 144.71 37.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.641 0.734 . . . . 0.0 110.904 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.411 ' O ' HD12 ' A' ' 44' ' ' LEU . 54.1 Cg_endo -69.68 163.95 36.3 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.696 2.264 . . . . 0.0 112.374 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.424 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.6 mp -126.2 -40.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.6 p -146.33 177.0 9.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.11 118.06 7.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -50.48 149.07 3.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.706 HG12 HD11 ' A' ' 64' ' ' LEU . 61.6 t -111.14 137.23 44.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -118.55 151.29 38.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.449 HG22 HD13 ' A' ' 64' ' ' LEU . 79.4 p -100.73 164.37 11.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -49.71 172.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.26 120.24 40.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.8 m -122.05 152.12 59.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.568 0.699 . . . . 0.0 111.131 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 136.23 32.34 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.704 2.269 . . . . 0.0 112.306 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.0 p -45.65 -47.55 14.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -47.78 -35.35 9.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 58.5 m-20 -134.72 89.0 26.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.659 0.742 . . . . 0.0 110.911 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.585 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 54.3 Cg_endo -69.73 2.23 3.7 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.65 2.234 . . . . 0.0 112.408 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -54.2 105.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.585 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.9 m-90 -93.18 -49.72 5.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.724 ' OD1' HD13 ' A' ' 16' ' ' LEU . 62.6 m-20 40.49 45.1 1.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -115.53 138.73 50.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.521 ' CZ3' ' NE ' ' A' ' 12' ' ' ARG . 45.8 m95 -85.76 108.55 18.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.706 HD11 HG12 ' A' ' 48' ' ' VAL . 10.3 tp -96.15 117.38 30.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -97.54 126.84 43.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -96.48 122.14 39.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.41 53.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.442 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.3 pp -117.27 167.15 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.627 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.69 119.86 39.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.659 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -58.0 -51.1 84.2 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.654 0.74 . . . . 0.0 111.159 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.75 2.86 3.15 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.697 2.265 . . . . 0.0 112.336 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.5 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.6 t0 -122.46 -11.02 8.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.835 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -70.62 113.64 20.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.659 0.742 . . . . 0.0 110.92 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.2 Cg_endo -69.74 132.97 24.48 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.641 2.228 . . . . 0.0 112.366 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.46 ' NE ' ' OD2' ' A' ' 111' ' ' ASP . 82.8 mmt-85 -43.1 -45.91 5.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -51.2 -46.92 62.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.538 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -53.15 162.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 37' ' ' ILE . 14.8 ptp180 -160.75 175.56 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.858 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.3 tp -94.38 138.22 32.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 84.5 m -139.19 135.63 34.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.536 ' HB3' HG22 ' A' ' 35' ' ' THR . 1.5 pp -142.03 157.24 45.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.51 ' HB2' HD12 ' A' ' 133' ' ' LEU . 59.5 m -157.99 154.52 27.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.4 mt -97.85 147.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.168 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 86.2 m -142.65 156.61 45.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.1 m -116.07 118.58 33.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 p -102.94 130.07 53.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 179.911 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.775 0.321 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -131.53 130.71 42.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -102.85 132.47 49.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.0 t -132.71 120.85 16.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.632 0.73 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.484 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.0 Cg_endo -69.79 147.66 63.19 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.693 2.262 . . . . 0.0 112.37 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 125' ' ' VAL . 19.6 mt -122.72 -55.04 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.8 -179.82 5.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.435 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 69.3 p-90 -164.36 132.95 3.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA3' HD23 ' A' ' 122' ' ' LEU . . . -143.26 136.97 7.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.534 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -115.15 146.44 41.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 110.848 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.505 HD11 HD21 ' A' ' 120' ' ' LEU . 95.5 mt -127.29 125.6 66.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 106' ' ' LEU . 16.7 m-80 -64.87 87.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.894 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 37' ' ' ILE . 37.9 mt -33.46 -38.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' ASN . 66.3 m-85 -105.15 110.95 23.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -56.75 177.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -52.08 -40.56 61.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.424 HG23 ' HB ' ' A' ' 112' ' ' THR . 4.7 t -86.57 34.12 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.46 ' OD2' ' NE ' ' A' ' 75' ' ' ARG . 35.8 t0 38.22 49.49 1.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 113' ' ' LEU . 52.7 m -134.14 111.48 10.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.69 HD22 ' CH2' ' A' ' 156' ' ' TRP . 58.0 mt -34.19 134.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 154' ' ' PHE . 31.0 m -65.6 175.55 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.2 p -169.77 165.06 9.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.5 134.6 0.25 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.48 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -42.02 149.31 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.729 0.3 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.409 ' O ' HD13 ' A' ' 152' ' ' LEU . 45.2 ttp -159.77 159.84 33.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.65 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.79 137.27 34.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.103 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 104' ' ' ILE . 4.3 pp -145.22 155.42 43.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -81.36 152.53 27.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.898 HD11 HD12 ' A' ' 150' ' ' LEU . 1.9 mt -114.87 138.48 50.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.589 ' CH2' ' HD2' ' A' ' 143' ' ' PRO . 12.0 m95 -75.9 149.11 82.63 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.546 0.689 . . . . 0.0 110.953 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 157.12 61.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.685 2.257 . . . . 0.0 112.371 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 99' ' ' LEU . 87.1 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 111.086 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.879 0.371 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.712 HD13 ' HG2' ' A' ' 34' ' ' ARG . 5.1 tp -93.55 138.85 31.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -107.8 91.29 7.32 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.595 0.712 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.533 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.73 -34.58 14.39 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.338 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.1 mm -70.65 -26.46 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.167 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.435 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -39.49 153.62 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.9 m -65.62 166.14 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.935 0.397 . . . . 0.0 111.098 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.0 p -109.41 166.87 10.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.146 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.99 177.79 33.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.2 p -91.79 130.35 37.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.893 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 123' ' ' TRP . 63.8 t-20 -67.17 121.26 77.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.563 0.696 . . . . 0.0 110.885 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.589 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.8 Cg_endo -69.68 -7.23 20.49 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.721 2.281 . . . . 0.0 112.345 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.47 127.19 31.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -78.01 -52.78 8.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -40.61 -41.95 1.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.0 p -62.09 151.66 80.2 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 111.134 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 174.82 8.89 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 0.0 112.384 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.1 t -150.55 137.92 19.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.898 HD12 HD11 ' A' ' 122' ' ' LEU . 4.5 mt -110.9 156.48 21.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.65 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 1.7 mp0 -117.63 138.59 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.806 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -141.58 158.37 43.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -122.5 120.26 33.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.69 ' CE2' HD21 ' A' ' 152' ' ' LEU . 43.7 m-85 -88.04 119.39 28.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.51 128.5 20.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.927 ' CH2' HD13 ' A' ' 11' ' ' LEU . 3.9 m95 -123.9 103.48 8.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' CG ' ' N ' ' A' ' 158' ' ' SER . 21.8 p90 -106.46 -49.64 3.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.879 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.494 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 31.4 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.919 0.39 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.811 ' HB3' ' CB ' ' A' ' 158' ' ' SER . . . -119.71 141.83 49.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.118 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -106.27 137.15 44.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.503 HH11 ' N ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER -140.35 163.71 32.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.479 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 67.9 mt -154.79 131.75 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -105.88 104.17 13.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.7 mm -73.19 136.58 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.83 -75.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.1 p -168.01 167.8 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.83 164.7 12.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.074 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -142.97 161.14 38.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 49.79 45.04 25.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.09 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.809 0.338 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.49 -51.62 4.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -146.65 173.49 12.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.508 HG22 ' HA ' ' A' ' 85' ' ' SER . 7.5 pt -136.17 174.96 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -169.14 148.19 3.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.662 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 55.3 t -100.95 141.44 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.4 ttt85 -121.11 126.63 50.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 81' ' ' LEU . 30.3 p -121.34 176.04 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.67 137.02 2.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.457 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.537 HG12 HD11 ' A' ' 106' ' ' LEU . 3.5 mp -94.63 142.78 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.553 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 13.4 m-85 -135.43 164.61 27.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.945 ' HB2' HD11 ' A' ' 44' ' ' LEU . 8.4 t-160 -132.72 100.96 5.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.72 30.56 70.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.526 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.42 -49.57 1.04 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.98 145.31 88.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.652 0.739 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 167.05 25.55 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.345 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.945 HD11 ' HB2' ' A' ' 39' ' ' HIS . 10.9 mp -118.74 -33.24 4.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.6 t -166.02 168.2 15.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -41.91 153.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -92.21 171.85 8.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 64' ' ' LEU . 57.5 t -125.96 143.61 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -129.65 144.91 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.426 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 10.4 t -94.31 165.09 12.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.168 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -53.39 178.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.8 mtm-85 -104.56 139.02 40.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.438 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.8 m -140.68 152.19 65.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.615 0.722 . . . . 0.0 111.121 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 135.12 29.73 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.684 2.256 . . . . 0.0 112.356 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 17.4 p -45.96 -47.69 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.1 p -46.43 -37.62 7.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -134.4 88.05 30.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.63 0.728 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.539 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 3.29 2.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.341 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -54.36 110.75 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.662 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.7 m-90 -95.07 -68.53 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.6 m120 58.25 54.29 5.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -131.18 140.59 49.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -81.61 104.78 12.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.546 ' HG ' HG11 ' A' ' 48' ' ' VAL . 11.2 tp -88.81 111.49 22.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -90.19 127.94 36.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -97.61 134.67 40.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.913 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.46 50.7 1.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.436 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.0 pp -122.92 164.11 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.612 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.7 117.34 31.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.646 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.4 mp -54.28 -51.98 72.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.604 0.716 . . . . 0.0 111.146 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.8 Cg_endo -69.79 2.6 3.4 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.696 2.264 . . . . 0.0 112.366 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.508 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.0 t70 -125.72 -9.45 6.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.29 117.44 63.15 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.623 0.725 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.514 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.0 Cg_endo -69.7 146.06 59.37 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.647 2.231 . . . . 0.0 112.371 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.564 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 62.0 mmt-85 -59.96 -42.2 93.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.634 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -54.42 -31.36 55.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.514 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -69.06 162.0 27.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.481 ' HD2' HG21 ' A' ' 139' ' ' THR . 43.2 mtt85 -155.58 175.26 14.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.2 tp -98.93 131.41 45.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.6 m -128.55 124.59 36.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.592 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.7 OUTLIER -128.13 158.49 37.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.5 p -156.98 137.73 13.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.651 HG12 HD11 ' A' ' 150' ' ' LEU . 33.8 mt -88.24 136.79 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 63.5 m -133.99 141.54 47.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.508 ' HA ' HG22 ' A' ' 31' ' ' ILE . 91.0 p -105.88 119.75 39.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.503 HG23 ' CD2' ' A' ' 96' ' ' HIS . 6.2 p -101.57 138.17 26.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.911 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.471 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 8.8 mt-10 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.801 0.334 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -125.77 122.96 37.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.503 ' CD2' HG23 ' A' ' 86' ' ' VAL . 7.3 m170 -96.45 140.56 30.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.826 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.9 t -142.31 122.98 8.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.537 ' HD3' HD23 ' A' ' 132' ' ' LEU . 54.2 Cg_endo -69.74 147.01 62.04 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.71 2.273 . . . . 0.0 112.368 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.677 ' O ' HG23 ' A' ' 125' ' ' VAL . 44.0 mt -119.2 -56.65 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.16 -178.17 5.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.535 ' CH2' HG22 ' A' ' 138' ' ' VAL . 61.4 p-90 -160.33 141.89 12.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.923 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.9 125.45 2.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.445 ' CB ' HG22 ' A' ' 139' ' ' THR . 4.0 m-20 -108.01 117.93 35.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.758 0.314 . . . . 0.0 110.916 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.662 HG12 HD21 ' A' ' 120' ' ' LEU . 54.2 mt -107.63 128.28 62.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 106' ' ' LEU . 1.7 m120 -65.09 94.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.872 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.537 HD11 HG12 ' A' ' 37' ' ' ILE . 13.0 mt -35.84 -43.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 84.9 m-85 -101.97 119.61 39.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -56.48 -175.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -60.9 -37.71 83.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 t -88.8 32.94 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.19 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 43.81 53.88 5.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 113' ' ' LEU . 98.2 m -137.88 108.43 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.776 HD22 ' CH2' ' A' ' 156' ' ' TRP . 41.4 mt -34.11 135.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.442 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 26.8 m -67.64 172.64 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.42 ' HA ' ' CB ' ' A' ' 154' ' ' PHE . 1.7 m -162.61 169.92 19.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.75 168.37 7.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.44 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 3.4 ttpm? -70.8 149.72 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.419 ' O ' HD13 ' A' ' 152' ' ' LEU . 18.0 ttp -155.74 148.04 23.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.07 116.6 12.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.662 HD21 HG12 ' A' ' 104' ' ' ILE . 4.4 pp -130.75 153.05 49.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.431 ' CB ' ' HB2' ' A' ' 142' ' ' ASN . 9.5 m-20 -75.37 147.24 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.833 HD11 HD12 ' A' ' 150' ' ' LEU . 5.4 mt -105.66 155.13 19.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.6 ' CD1' ' OD1' ' A' ' 142' ' ' ASN . 18.7 m95 -84.05 151.33 60.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.613 0.72 . . . . 0.0 110.872 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 152.87 69.23 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.657 2.238 . . . . 0.0 112.305 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 99' ' ' LEU . 71.4 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 0.0 111.142 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.537 HD23 ' HD3' ' A' ' 98' ' ' PRO . 7.6 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.852 0.358 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.0 tp -104.41 119.85 39.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -101.6 97.8 8.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.553 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.9 Cg_endo -69.78 -40.66 5.03 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.373 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 137' ' ' GLY . 42.1 mt -65.16 -27.28 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -37.87 152.38 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.445 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.535 HG22 ' CH2' ' A' ' 101' ' ' TRP . 14.9 m -56.46 168.07 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.481 HG21 ' HD2' ' A' ' 78' ' ' ARG . 30.7 p -120.45 154.77 34.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.79 -169.26 12.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.9 p -101.46 141.17 34.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 110.817 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.6 ' OD1' ' CD1' ' A' ' 123' ' ' TRP . 2.6 m120 -68.13 130.94 92.3 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.567 0.699 . . . . 0.0 110.896 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -28.84 25.05 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.696 2.264 . . . . 0.0 112.408 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -79.81 135.71 36.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -80.47 -34.95 35.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -46.85 -54.75 9.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.5 p -47.13 151.56 1.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.57 0.7 . . . . 0.0 111.156 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 168.02 22.88 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 13.1 t -144.88 140.73 28.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.833 HD12 HD11 ' A' ' 122' ' ' LEU . 2.3 mt -114.52 139.43 49.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -105.84 118.21 36.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.834 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -124.71 158.08 34.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.44 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 38.7 mt-10 -116.22 142.32 46.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.607 ' CE2' HD21 ' A' ' 152' ' ' LEU . 45.7 m-85 -106.78 151.14 25.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.503 ' N ' HH11 ' A' ' 12' ' ' ARG . 3.8 m-20 -172.79 142.9 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.776 ' CH2' HD22 ' A' ' 113' ' ' LEU . 7.8 m95 -132.21 86.8 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 158' ' ' SER . 28.7 p90 -95.43 -44.59 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.811 ' CB ' ' HB3' ' A' ' 10' ' ' ALA . 2.4 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.888 0.375 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.17 141.74 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.071 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.796 HD13 ' CH2' ' A' ' 156' ' ' TRP . 18.8 tp -102.52 140.39 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.461 ' H ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -147.35 136.59 22.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.435 HD12 ' CE1' ' A' ' 66' ' ' TYR . 25.5 mt -135.54 145.66 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttt -119.73 119.3 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.2 mm -82.68 138.76 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.06 -73.51 0.58 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.0 p -170.41 176.11 4.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.29 160.4 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.475 HG23 ' CD2' ' A' ' 20' ' ' TYR . 13.6 t -129.15 158.66 38.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.188 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.475 ' CD2' HG23 ' A' ' 19' ' ' THR . 11.4 m-85 42.88 39.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.113 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.3 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.856 0.36 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.68 -64.36 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -145.84 167.47 23.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 85' ' ' SER . 5.8 pt -127.3 163.72 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -157.15 157.98 35.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.85 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 98.4 t -104.05 140.13 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.412 ' HG2' HD13 ' A' ' 133' ' ' LEU . 31.3 ttm-85 -114.6 116.6 29.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 81' ' ' LEU . 54.3 p -119.34 163.6 16.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.126 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.27 143.4 3.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.498 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.799 HD13 HG21 ' A' ' 68' ' ' ILE . 4.2 mp -88.5 148.55 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.541 ' CD2' ' HB3' ' A' ' 135' ' ' PRO . 25.3 m-85 -135.47 132.58 37.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.575 ' CD2' ' HB3' ' A' ' 76' ' ' ALA . 11.4 t-160 -118.94 94.9 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.72 34.66 8.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.96 -26.7 3.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.505 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.25 153.22 62.47 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.634 0.73 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.467 ' O ' ' C ' ' A' ' 44' ' ' LEU . 53.8 Cg_endo -69.77 82.99 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 43' ' ' PRO . 16.4 tp -32.41 -46.54 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.1 m -152.23 177.24 10.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.47 150.89 8.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.83 145.94 25.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.705 HG12 HD11 ' A' ' 64' ' ' LEU . 58.8 t -105.54 135.32 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.082 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -113.17 147.15 37.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.494 HG22 HD13 ' A' ' 64' ' ' LEU . 80.9 p -99.74 167.52 10.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -53.76 165.29 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -100.73 116.4 32.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -116.28 152.48 47.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.676 0.75 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 139.01 39.19 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.66 2.24 . . . . 0.0 112.367 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.4 p -42.43 -45.61 4.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.834 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 p -51.12 -37.43 45.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.84 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -125.79 83.5 62.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.646 0.736 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.542 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.73 3.51 2.72 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.378 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.35 128.89 38.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.85 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 10.0 m-90 -106.24 -40.88 5.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 61' ' ' ASN . 1.9 p-10 33.76 44.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -117.82 138.55 52.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.408 ' CE3' ' NH2' ' A' ' 12' ' ' ARG . 62.3 m95 -81.82 96.9 7.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.917 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.705 HD11 HG12 ' A' ' 48' ' ' VAL . 12.8 tp -85.39 120.37 26.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -98.48 132.58 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.435 ' CE1' HD12 ' A' ' 13' ' ' ILE . 44.7 m-85 -100.41 136.19 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -87.63 44.08 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.799 HG21 HD13 ' A' ' 37' ' ' ILE . 2.0 pp -112.59 165.57 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.112 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.623 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.58 119.98 37.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.652 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 2.8 mp -56.87 -51.73 79.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.596 0.713 . . . . 0.0 111.144 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.0 Cg_endo -69.75 1.64 4.24 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.36 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.491 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 3.5 t70 -125.47 -6.69 6.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.575 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -74.6 116.09 50.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.648 0.737 . . . . 0.0 110.926 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.586 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.77 139.3 39.84 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.736 2.29 . . . . 0.0 112.309 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -53.07 -36.86 61.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.575 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . . . -60.77 -33.66 73.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -68.15 165.14 18.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 37' ' ' ILE . 10.3 ptt180 -161.11 172.54 16.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.9 tp -93.79 144.68 25.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.609 ' C ' HD23 ' A' ' 81' ' ' LEU . 77.4 m -135.86 149.65 49.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.609 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER -155.84 139.42 15.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.404 ' OG ' HD12 ' A' ' 133' ' ' LEU . 96.8 p -148.86 139.19 22.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.459 ' CG1' HD11 ' A' ' 150' ' ' LEU . 53.5 mt -86.54 138.49 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.124 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 72.5 m -139.64 145.17 38.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.47 ' HA ' HG22 ' A' ' 31' ' ' ILE . 88.5 p -106.86 120.52 42.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.852 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 94' ' ' GLU . 5.1 p -102.01 130.67 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.09 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.7 tptm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.841 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 36.0 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.777 0.322 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -122.98 116.31 23.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.02 127.01 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 21.7 t -131.54 123.59 19.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.589 0.709 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.507 ' HD3' HD23 ' A' ' 132' ' ' LEU . 53.9 Cg_endo -69.8 147.97 63.81 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 125' ' ' VAL . 24.6 mt -122.74 -48.18 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.13 163.09 35.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.108 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.831 ' CH2' HG22 ' A' ' 138' ' ' VAL . 61.7 p-90 -142.6 138.59 30.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.79 121.05 1.66 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.518 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 34.6 m-20 -101.36 131.44 47.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.1 mt -124.45 121.54 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 106' ' ' LEU . 7.1 m120 -66.76 96.14 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.3 mt -35.0 -39.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -102.45 114.47 28.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -57.48 173.82 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.773 ' CE1' HG23 ' A' ' 110' ' ' THR . 1.1 p90 -58.05 -15.09 8.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.773 HG23 ' CE1' ' A' ' 109' ' ' TYR . 29.9 p -103.46 26.15 8.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 45.87 35.6 2.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 113' ' ' LEU . 93.6 m -125.76 109.3 12.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.68 HD22 ' CH2' ' A' ' 156' ' ' TRP . 33.7 mt -34.23 139.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' CG ' ' A' ' 154' ' ' PHE . 19.3 m -72.84 166.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -161.05 171.98 17.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.38 160.12 2.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -64.16 143.41 57.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.432 ' O ' HD13 ' A' ' 152' ' ' LEU . 35.2 ttp -153.05 148.71 27.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.77 121.35 15.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.078 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pp -128.84 155.72 44.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -76.26 152.71 36.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.26 157.09 18.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.578 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 15.0 m95 -90.48 152.24 45.1 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.546 0.689 . . . . 0.0 110.946 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 151.26 69.09 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.344 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 99' ' ' LEU . 93.4 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.507 HD23 ' HD3' ' A' ' 98' ' ' PRO . 43.3 mt . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.808 0.337 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.534 HD23 ' CE1' ' A' ' 38' ' ' TYR . 10.7 tp -104.12 132.42 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -105.54 91.06 4.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.591 0.71 . . . . 0.0 110.909 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.541 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 54.2 Cg_endo -69.79 -45.29 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.641 2.227 . . . . 0.0 112.395 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.0 mt -74.25 -23.74 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.449 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -39.83 158.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.472 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.831 HG22 ' CH2' ' A' ' 101' ' ' TRP . 6.1 m -52.81 172.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.944 0.402 . . . . 0.0 111.102 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.405 HG22 ' CB ' ' A' ' 103' ' ' ASN . 40.1 p -132.03 161.8 32.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.173 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.52 -179.75 25.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.8 p -90.33 121.29 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 0.0 110.875 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.578 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 29.8 t30 -63.28 126.53 89.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.544 0.688 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 1.49 4.4 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -91.81 113.32 25.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -74.4 -40.16 62.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -49.67 -46.38 49.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.0 p -55.15 152.62 14.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.581 0.705 . . . . 0.0 111.139 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 134.43 27.92 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.673 2.249 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.1 t -113.83 142.54 45.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.459 HD11 ' CG1' ' A' ' 83' ' ' ILE . 4.7 mt -110.27 146.22 36.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -116.53 123.13 46.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.807 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -130.77 166.23 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -120.26 118.79 31.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.628 ' CE2' HD21 ' A' ' 152' ' ' LEU . 28.8 m-85 -88.96 100.78 13.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.923 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -121.79 154.43 36.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.796 ' CH2' HD13 ' A' ' 11' ' ' LEU . 20.9 m95 -138.77 105.3 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 158' ' ' SER . 14.8 p90 -90.47 -49.01 6.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.514 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 51.5 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 t -159.24 138.07 10.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.863 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.5 t -37.72 -45.29 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.01 84.71 1.56 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.535 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 7' ' ' GLY . 74.2 m -139.47 173.01 11.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 110.887 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 5' ' ' SER . 55.2 p 34.49 36.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 5' ' ' SER . . . -96.06 63.86 1.22 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.45 ' ND2' ' HB3' ' A' ' 156' ' ' TRP . 29.2 t30 -101.74 151.4 22.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.33 . . . . 0.0 110.937 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.572 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 46.3 m -125.68 -31.63 2.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -120.26 135.3 55.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.096 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.983 HD13 ' CH2' ' A' ' 156' ' ' TRP . 6.7 tp -97.54 128.92 44.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.412 ' NH2' ' CE3' ' A' ' 63' ' ' TRP . 0.3 OUTLIER -127.35 123.6 36.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.687 HD12 ' CE1' ' A' ' 66' ' ' TYR . 11.3 mt -124.57 137.09 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.175 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -113.96 135.41 54.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 mm -94.78 142.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.136 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.87 -69.19 0.78 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 p -172.3 173.85 4.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -120.5 161.07 21.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.07 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' A' ' 149' ' ' CYS . 2.1 t -128.34 158.37 38.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 39.47 52.16 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.962 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 23' ' ' VAL . 11.1 t -65.72 158.78 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.442 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -83.79 34.31 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 23' ' ' VAL . 32.6 m -103.37 81.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -79.38 -74.66 0.28 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.4 pp -46.09 173.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 55.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -120.29 -32.49 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.8 mt -52.41 135.47 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.128 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.401 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 29.4 t70 -82.85 -55.91 4.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 25.9 mmtt -146.32 -177.12 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.536 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.1 pt -145.52 170.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 3.7 p90 -158.57 166.23 32.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.679 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 99.0 t -122.27 139.6 48.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.126 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' HG2' HD22 ' A' ' 133' ' ' LEU . 20.6 ttm180 -115.72 121.2 41.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.812 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 81' ' ' LEU . 57.9 p -118.91 154.16 33.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.406 ' C ' HD12 ' A' ' 37' ' ' ILE . . . -176.08 169.26 41.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.536 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.599 HD13 HG21 ' A' ' 68' ' ' ILE . 4.1 mp -122.98 137.24 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.806 0.336 . . . . 0.0 111.124 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.54 ' HA ' HD13 ' A' ' 44' ' ' LEU . 2.9 m-85 -137.03 150.22 47.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.732 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.4 t-160 -113.01 99.36 7.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.84 32.55 61.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.478 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.31 -22.45 34.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.58 140.04 29.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.605 0.716 . . . . 0.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.485 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 53.8 Cg_endo -69.74 156.09 64.31 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.367 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.6 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.1 mp -120.51 -38.01 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.2 m -154.98 168.21 27.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -51.9 152.65 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -93.94 163.44 13.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.647 HG12 HD11 ' A' ' 64' ' ' LEU . 25.4 t -116.73 145.06 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -125.33 141.68 51.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.5 p -85.86 160.66 19.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -52.75 170.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -95.88 115.22 27.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -116.96 152.16 48.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.593 0.711 . . . . 0.0 111.11 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 137.74 36.24 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.35 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 24.6 p -47.85 -44.88 29.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 t -53.16 -31.33 42.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -134.39 84.78 39.87 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.62 0.724 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.447 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.75 3.31 2.84 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.717 2.278 . . . . 0.0 112.37 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -62.81 127.15 29.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.679 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 5.6 m-90 -106.22 -63.46 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 58.67 45.05 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -127.55 147.47 50.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.412 ' CE3' ' NH2' ' A' ' 12' ' ' ARG . 77.9 m95 -88.66 117.71 27.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.647 HD11 HG12 ' A' ' 48' ' ' VAL . 9.2 tp -101.0 123.25 44.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -99.59 136.63 39.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.687 ' CE1' HD12 ' A' ' 13' ' ' ILE . 34.8 m-85 -106.35 138.36 42.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.49 38.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.599 HG21 HD13 ' A' ' 37' ' ' ILE . 1.8 pp -108.05 161.53 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.605 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.62 124.86 49.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.588 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -55.84 -55.27 42.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 0.0 111.173 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.9 Cg_endo -69.74 2.94 3.07 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 112.346 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.503 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.1 t0 -127.72 1.46 6.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.89 115.71 62.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.643 0.735 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.606 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.78 145.64 57.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.467 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 25.3 mmt85 -59.69 -35.9 75.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.732 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -62.73 -32.92 74.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.606 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -68.35 165.0 19.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.093 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.481 ' O ' HG23 ' A' ' 37' ' ' ILE . 15.3 ptp180 -163.09 176.36 10.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.3 tp -98.97 136.69 38.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.76 132.11 40.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.9 OUTLIER -130.66 158.62 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.8 p -159.57 135.89 8.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.829 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.423 HG12 HD11 ' A' ' 150' ' ' LEU . 34.7 mt -86.58 136.57 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.109 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . 30.3 m -132.53 151.29 51.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.536 ' HA ' HG22 ' A' ' 31' ' ' ILE . 83.6 p -112.97 122.76 48.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.569 HG23 ' CD2' ' A' ' 96' ' ' HIS . 8.9 p -106.19 125.85 61.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -151.13 126.35 9.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.28 -174.53 13.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.462 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.471 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 47.4 mtt180 -123.16 160.77 25.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.358 . . . . 0.0 110.859 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -53.36 113.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.97 -26.41 7.65 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -90.55 158.59 16.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 111.107 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -71.53 170.94 12.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -90.51 168.76 11.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -130.27 122.98 29.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.569 ' CD2' HG23 ' A' ' 86' ' ' VAL . 5.7 m170 -100.95 128.79 46.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.2 t -131.82 129.01 21.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 110.872 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.584 ' HB2' HG11 ' A' ' 125' ' ' VAL . 53.8 Cg_endo -69.84 143.18 49.65 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 0.0 112.282 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.439 ' C ' HG13 ' A' ' 125' ' ' VAL . 11.1 mt -118.45 -56.83 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.19 178.68 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.587 ' HD1' HG12 ' A' ' 125' ' ' VAL . 64.8 p-90 -161.42 144.07 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.96 132.46 4.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -111.93 120.26 41.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 0.0 110.909 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.586 HD11 HD21 ' A' ' 120' ' ' LEU . 73.7 mt -112.24 127.27 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -68.87 98.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.3 mt -43.15 -34.32 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 63.3 m-85 -107.9 110.43 22.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -51.65 170.22 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 1.061 ' CE1' HG23 ' A' ' 110' ' ' THR . 0.6 OUTLIER -55.48 -20.25 12.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.984 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 1.061 HG23 ' CE1' ' A' ' 109' ' ' TYR . 41.5 p -102.64 28.46 6.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.113 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 110' ' ' THR . 4.3 p30 46.71 40.34 8.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 113' ' ' LEU . 93.1 m -126.23 109.24 12.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.838 HD22 ' CH2' ' A' ' 156' ' ' TRP . 34.0 mt -34.2 132.95 0.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.1 m -66.2 163.31 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.5 p -160.42 175.6 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.54 134.9 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.484 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.434 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 5.9 ttpt -43.01 150.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.803 0.335 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.427 ' O ' HD13 ' A' ' 152' ' ' LEU . 34.8 ttp -158.79 148.72 19.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.7 114.44 9.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.586 HD21 HD11 ' A' ' 104' ' ' ILE . 4.1 pp -124.79 160.94 27.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.68 150.23 29.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.428 HD11 HD12 ' A' ' 150' ' ' LEU . 5.5 mt -106.52 153.35 22.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.536 ' CH2' ' OD1' ' A' ' 142' ' ' ASN . 54.7 m95 -85.94 144.81 39.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.514 0.673 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 132.61 23.71 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.646 2.231 . . . . 0.0 112.363 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.587 HG12 ' HD1' ' A' ' 101' ' ' TRP . 21.5 m -65.79 150.78 95.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.675 0.75 . . . . 0.0 111.123 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 127' ' ' HIS . 53.5 Cg_endo -69.79 161.22 46.76 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.699 2.266 . . . . 0.0 112.333 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.435 ' C ' ' O ' ' A' ' 126' ' ' PRO . 7.6 m170 -35.25 110.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 36.95 68.4 0.35 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.481 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.61 105.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.318 . . . . 0.0 110.965 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -38.68 -56.04 1.38 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -77.79 -178.57 5.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.468 HD13 ' OH ' ' A' ' 32' ' ' TYR . 40.3 mt -108.34 -44.59 4.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.432 HD22 ' HG2' ' A' ' 34' ' ' ARG . 21.7 tp -106.32 133.05 51.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -107.08 91.37 6.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.636 0.731 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -17.12 38.01 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.67 2.247 . . . . 0.0 112.381 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 mm -88.89 -20.69 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -41.93 150.75 0.27 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.3 m -66.46 164.2 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.963 0.411 . . . . 0.0 111.086 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.4 p -108.15 161.11 15.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.133 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.32 167.51 18.62 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.462 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.6 p -93.5 118.73 31.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 110.885 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.536 ' OD1' ' CH2' ' A' ' 123' ' ' TRP . 31.6 t30 -61.35 123.62 77.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.665 0.745 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -8.73 24.36 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.722 2.282 . . . . 0.0 112.333 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -73.44 138.98 45.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -90.21 -49.5 6.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -44.69 -38.42 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.8 p -63.77 151.24 89.34 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.583 0.706 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 166.4 27.7 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 0.0 112.356 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.404 ' HB3' ' CG2' ' A' ' 19' ' ' THR . 4.2 t -146.1 135.88 23.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.475 ' CD2' ' HB2' ' A' ' 18' ' ' ALA . 10.8 mt -113.84 138.49 50.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.967 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.434 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 18.3 tt0 -106.93 132.08 53.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.79 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -134.84 161.74 34.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -116.41 120.84 40.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.644 ' CE2' HD21 ' A' ' 152' ' ' LEU . 25.9 m-85 -90.15 113.94 25.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.63 136.65 46.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.983 ' CH2' HD13 ' A' ' 11' ' ' LEU . 2.7 m95 -134.58 98.96 4.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.564 ' CG ' ' N ' ' A' ' 158' ' ' SER . 15.5 p90 -103.83 -51.76 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.564 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 4.0 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -77.78 148.14 34.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 110.87 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 t -125.13 118.33 25.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.23 53.75 3.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.463 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.3 p -54.44 142.64 26.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.849 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -92.34 95.73 9.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.87 -119.41 6.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.487 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -125.6 151.28 46.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.361 . . . . 0.0 110.863 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.54 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 5.6 m -130.01 -35.86 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.888 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -119.52 147.07 44.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.093 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.613 HD13 ' CH2' ' A' ' 156' ' ' TRP . 11.2 tp -93.25 130.28 39.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.572 ' N ' HD12 ' A' ' 11' ' ' LEU . 6.2 ttp180 -127.97 127.61 43.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.948 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.475 HD12 ' CE1' ' A' ' 66' ' ' TYR . 51.4 mt -130.75 156.3 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' N ' HG22 ' A' ' 13' ' ' ILE . 55.7 tttt -140.65 128.01 21.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.5 mm -90.29 143.33 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.68 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.2 mm? -100.23 -73.66 0.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 t -162.49 172.17 15.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.428 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -119.23 162.9 17.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' TYR . 9.5 t -130.69 156.08 45.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' THR . 4.9 m-85 35.59 45.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.841 ' HB ' HG22 ' A' ' 23' ' ' VAL . 8.8 t -59.84 141.19 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -47.16 -25.54 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.841 HG22 ' HB ' ' A' ' 21' ' ' VAL . 28.5 m -53.23 99.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.161 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -94.91 -62.14 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.574 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -64.61 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -126.27 14.68 7.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.95 -49.82 27.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -40.43 137.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -79.56 -57.32 3.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -146.15 177.49 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.4 pt -139.64 173.72 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -165.98 160.57 16.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.517 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 37.6 t -116.74 146.84 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.145 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -119.68 136.14 54.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.481 HG22 ' HB3' ' A' ' 81' ' ' LEU . 63.0 p -130.59 157.65 42.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.11 141.58 3.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 37' ' ' ILE . 3.4 mp -93.59 133.66 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 111.111 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.549 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 17.5 m-85 -127.86 158.69 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.601 ' HB3' HD11 ' A' ' 44' ' ' LEU . 12.0 t-160 -134.57 95.43 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.69 32.07 28.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.48 -17.81 46.27 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -96.97 141.8 23.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.625 0.726 . . . . 0.0 110.938 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.432 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.77 160.88 48.08 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.643 2.229 . . . . 0.0 112.358 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.601 HD11 ' HB3' ' A' ' 39' ' ' HIS . 10.1 mp -119.9 -26.4 5.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.5 p -158.38 168.24 27.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -57.04 131.23 49.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -64.09 148.52 49.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.479 HG12 HD11 ' A' ' 64' ' ' LEU . 21.3 t -111.15 147.16 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.433 HD21 ' C ' ' A' ' 49' ' ' ASN . 0.4 OUTLIER -130.16 145.24 51.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.452 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 3.2 t -87.59 176.12 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.402 ' N ' ' OG1' ' A' ' 50' ' ' THR . 11.6 pt20 -63.52 167.9 5.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.1 mtm-85 -92.13 140.61 29.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.38 152.12 49.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.662 0.744 . . . . 0.0 111.153 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.67 36.08 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.686 2.257 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.1 p -47.78 -45.75 29.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.4 m -52.3 -28.34 18.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -134.5 87.38 32.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.668 0.747 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.75 3.73 2.6 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.351 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -55.69 134.4 51.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.517 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -120.88 -68.45 0.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.68 ' OD1' HD13 ' A' ' 16' ' ' LEU . 69.0 m-80 53.55 52.72 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -127.56 143.39 51.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.46 ' CE3' ' HD2' ' A' ' 12' ' ' ARG . 90.0 m95 -87.38 104.35 16.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.479 HD11 HG12 ' A' ' 48' ' ' VAL . 10.8 tp -93.39 120.69 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -95.96 151.95 18.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' CE1' HD12 ' A' ' 13' ' ' ILE . 61.8 m-85 -118.03 140.21 50.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -84.33 30.29 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.592 ' C ' HD12 ' A' ' 68' ' ' ILE . 1.3 pp -106.63 159.42 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.608 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -110.88 139.97 45.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.967 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.536 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.5 mp -64.64 -58.06 14.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.699 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.608 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.0 Cg_endo -69.73 2.43 3.53 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.679 2.252 . . . . 0.0 112.322 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.0 t70 -120.67 -0.74 10.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.476 HD21 HG21 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -87.52 117.13 68.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.0 Cg_endo -69.82 138.37 37.49 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.622 2.215 . . . . 0.0 112.344 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -56.45 -26.47 53.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.427 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -70.31 -27.41 64.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.087 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.475 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -78.43 165.52 23.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 37' ' ' ILE . 11.6 ptp180 -157.89 174.13 15.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.465 ' HB2' HD21 ' A' ' 106' ' ' LEU . 33.2 tp -97.01 143.64 27.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.608 ' C ' HD23 ' A' ' 81' ' ' LEU . 81.9 m -133.58 154.65 50.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.608 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -155.66 137.84 14.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.768 ' OG ' HD12 ' A' ' 133' ' ' LEU . 1.0 OUTLIER -139.42 154.37 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.812 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.9 mt -98.75 128.68 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.193 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 18.6 m -128.52 142.58 51.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.676 ' HA ' HG22 ' A' ' 31' ' ' ILE . 29.8 p -108.37 130.96 55.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.788 HG23 ' CD2' ' A' ' 96' ' ' HIS . 9.9 p -110.64 129.21 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.115 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -142.64 127.03 17.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.5 167.6 22.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.485 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -114.1 163.93 14.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.871 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -55.03 126.78 26.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.27 6.08 13.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.52 169.27 9.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -83.44 169.37 15.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -98.35 174.01 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -137.52 121.61 17.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.788 ' CD2' HG23 ' A' ' 86' ' ' VAL . 9.1 m170 -97.46 141.46 30.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.7 t -148.6 132.34 8.47 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.582 0.706 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.657 ' O ' HD23 ' A' ' 99' ' ' LEU . 54.0 Cg_endo -69.75 152.51 69.38 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.24 . . . . 0.0 112.397 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 98' ' ' PRO . 6.6 mt -128.48 -47.21 1.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -140.87 155.47 46.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.112 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.76 ' CH2' HG22 ' A' ' 138' ' ' VAL . 62.2 p-90 -135.68 126.2 26.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.4 130.07 5.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.599 ' HB2' HG22 ' A' ' 139' ' ' THR . 1.0 OUTLIER -104.6 161.49 14.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.409 HG13 ' C ' ' A' ' 103' ' ' ASN . 88.6 mt -151.17 118.03 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -64.83 105.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 79' ' ' LEU . 70.9 mt -44.32 -54.73 5.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.406 ' CE1' ' HG ' ' A' ' 113' ' ' LEU . 65.0 m-85 -94.28 120.34 34.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -56.75 -176.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.743 ' CE1' HG23 ' A' ' 110' ' ' THR . 0.3 OUTLIER -72.09 -0.9 12.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.743 HG23 ' CE1' ' A' ' 109' ' ' TYR . 5.0 p -108.86 11.39 26.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.117 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 64.33 48.56 2.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.4 m -147.33 125.64 12.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.982 HD22 ' CH2' ' A' ' 156' ' ' TRP . 15.0 mt -45.27 142.12 2.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 114' ' ' VAL . 2.4 m -64.24 176.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.4 p -168.51 173.69 7.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.34 139.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.476 ' HD3' ' CG ' ' A' ' 151' ' ' GLU . 0.7 OUTLIER -48.51 146.11 3.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.861 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.417 ' O ' HD13 ' A' ' 152' ' ' LEU . 32.0 ttp -147.86 152.49 37.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.407 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.4 116.68 11.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.509 ' C ' HD12 ' A' ' 120' ' ' LEU . 4.5 pp -128.85 160.41 32.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 147' ' ' THR . 5.4 m120 -87.3 146.95 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.492 HD11 HD12 ' A' ' 150' ' ' LEU . 2.8 mt -104.63 150.05 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -83.09 151.68 63.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.539 0.685 . . . . 0.0 110.951 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 160.63 48.98 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 0.0 112.365 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.2 t -99.25 118.6 62.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.639 0.733 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 160.63 48.99 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.654 2.236 . . . . 0.0 112.385 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -66.26 124.61 23.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.857 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 130' ' ' GLU . . . 119.16 -60.15 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.527 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 tt -41.06 94.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 110.925 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 128' ' ' GLY . 9.6 pt-20 -91.48 2.28 56.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -81.39 115.83 20.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.827 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 94.3 mt -47.69 -50.46 24.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.768 HD12 ' OG ' ' A' ' 82' ' ' SER . 8.6 tp -110.49 145.3 37.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.41 ' HA ' ' HD2' ' A' ' 135' ' ' PRO . 3.5 t-20 -119.18 93.87 47.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 110.911 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.549 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.3 Cg_endo -69.83 -47.3 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.716 2.277 . . . . 0.0 112.31 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.619 ' H ' HD12 ' A' ' 136' ' ' ILE . 0.4 OUTLIER -64.36 -30.14 49.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.137 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.439 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -35.14 151.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.468 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.76 HG22 ' CH2' ' A' ' 101' ' ' TRP . 3.5 m -56.85 176.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.401 . . . . 0.0 111.125 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.599 HG22 ' HB2' ' A' ' 103' ' ' ASN . 41.2 p -129.48 161.73 29.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.122 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.57 159.17 20.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.0 p -78.18 130.87 36.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.855 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.409 ' ND2' HG21 ' A' ' 147' ' ' THR . 13.5 t-20 -64.37 119.81 59.63 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.644 0.735 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -7.2 20.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.673 2.249 . . . . 0.0 112.354 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -85.94 145.49 27.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -92.97 -37.15 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.69 -14.67 3.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.485 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 65.0 p -88.85 151.39 47.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.581 0.705 . . . . 0.0 111.154 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 169.39 19.07 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.342 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 t -150.79 137.83 19.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.492 HD12 HD11 ' A' ' 122' ' ' LEU . 10.2 mt -114.42 139.59 49.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.476 ' CG ' ' HD3' ' A' ' 117' ' ' LYS . 5.5 tt0 -107.09 123.17 47.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.778 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -131.08 162.54 29.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -119.15 131.72 55.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.508 ' CE2' HD21 ' A' ' 152' ' ' LEU . 24.5 m-85 -95.98 119.74 35.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.822 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.94 137.43 44.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.982 ' CH2' HD22 ' A' ' 113' ' ' LEU . 15.9 m95 -130.02 91.24 3.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.958 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.562 ' CG ' ' N ' ' A' ' 158' ' ' SER . 22.3 p90 -96.95 -52.62 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.888 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 30.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 t -164.65 122.09 1.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.364 . . . . 0.0 110.868 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.8 p -150.0 167.28 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.889 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.49 -113.93 1.91 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.467 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t -80.7 84.35 6.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.911 0.386 . . . . 0.0 110.867 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -42.57 165.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.873 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.57 -157.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.509 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.518 ' HB2' HG21 ' A' ' 70' ' ' ILE . 49.5 m-80 -84.63 142.38 29.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 110.848 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.8 p -132.02 -36.81 1.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.55 128.42 53.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.596 HD13 ' CH2' ' A' ' 156' ' ' TRP . 17.6 tp -97.83 131.66 44.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -139.21 136.57 35.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 66' ' ' TYR . 31.1 mt -129.5 135.94 60.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 21.2 tttt -113.59 113.26 24.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.28 143.77 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.35 -73.22 0.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.5 p -170.52 171.0 6.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.94 154.23 25.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.421 HG23 ' CD2' ' A' ' 20' ' ' TYR . 8.1 t -134.64 143.25 47.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.421 ' CD2' HG23 ' A' ' 19' ' ' THR . 1.6 m-85 63.73 41.29 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.88 151.06 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.143 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -77.11 58.37 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 m -113.86 100.75 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -98.47 -73.49 0.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.519 HD12 ' H ' ' A' ' 27' ' ' ASP . 2.7 pp -56.23 169.03 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 57.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.519 ' H ' HD12 ' A' ' 25' ' ' ILE . 12.7 t0 -119.31 -42.77 2.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 mt -39.42 123.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -72.06 -62.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -144.74 177.08 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 85' ' ' SER . 4.9 pt -137.69 158.12 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -152.37 140.38 20.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.73 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 95.8 t -89.82 149.07 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.163 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.471 ' O ' HD13 ' A' ' 133' ' ' LEU . 37.3 ttt85 -131.53 119.35 21.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 81' ' ' LEU . 32.4 p -117.04 179.33 4.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.64 140.57 3.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.493 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.7 mp -90.07 142.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.165 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.537 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 22.0 m-85 -137.23 143.68 42.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.425 ' CB ' HD11 ' A' ' 44' ' ' LEU . 13.3 t-160 -122.14 99.01 6.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.13 36.58 31.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.44 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.92 35.41 50.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -148.53 140.39 14.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.728 . . . . 0.0 110.88 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 143.45 51.09 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 0.0 112.345 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 39' ' ' HIS . 11.3 mp -97.67 -41.83 7.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.8 m -150.36 162.54 40.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -44.02 120.3 2.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -60.52 162.25 6.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.552 HG12 HD11 ' A' ' 64' ' ' LEU . 21.2 t -117.32 147.46 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.163 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -126.86 148.89 49.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.459 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 9.1 t -98.13 163.82 12.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.174 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -49.95 179.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -107.02 127.71 53.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 59' ' ' ARG . 1.6 m -129.95 152.13 79.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.6 0.714 . . . . 0.0 111.161 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 141.55 45.57 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.704 2.269 . . . . 0.0 112.343 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.3 p -50.13 -45.36 52.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.8 p -53.64 -30.85 44.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -134.2 86.3 36.8 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.581 0.705 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.572 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.6 Cg_endo -69.75 3.63 2.66 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.723 2.282 . . . . 0.0 112.322 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.432 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -48.81 135.4 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.73 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -128.93 -56.35 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.523 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 0.7 OUTLIER 38.37 37.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -104.29 142.7 34.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.477 ' NE1' ' HD2' ' A' ' 14' ' ' LYS . 45.4 m95 -85.38 104.4 15.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.552 HD11 HG12 ' A' ' 48' ' ' VAL . 10.8 tp -96.32 121.43 38.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -99.74 141.92 31.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.434 ' CE1' HD12 ' A' ' 13' ' ' ILE . 58.4 m-85 -110.86 128.95 55.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -81.34 47.66 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.491 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.1 pp -114.0 167.25 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.16 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.617 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.55 123.72 46.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.621 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -58.49 -53.2 68.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.634 0.731 . . . . 0.0 111.143 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.82 3.11 2.99 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.268 . . . . 0.0 112.329 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.505 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 3.5 t70 -124.82 -4.42 7.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.636 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -82.01 111.85 30.45 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.94 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.498 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.3 Cg_endo -69.75 135.9 31.65 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.365 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.47 ' NE ' ' OD1' ' A' ' 111' ' ' ASP . 62.0 mmt-85 -45.27 -43.63 10.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.18 -47.98 54.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -52.51 160.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 -156.13 173.15 17.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.4 tp -98.62 131.02 45.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -125.98 132.34 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.565 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.4 OUTLIER -138.95 147.05 41.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.423 ' OG ' HD12 ' A' ' 133' ' ' LEU . 88.6 p -155.24 130.32 9.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.536 ' CG1' HD11 ' A' ' 150' ' ' LEU . 72.6 mt -80.5 131.72 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 55.7 m -123.37 143.38 50.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.52 ' HA ' HG22 ' A' ' 31' ' ' ILE . 35.7 m -106.98 128.05 54.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.593 HG23 ' CD2' ' A' ' 96' ' ' HIS . 6.9 p -109.05 137.71 39.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.169 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -136.05 124.11 22.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -163.36 -164.62 18.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.503 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -125.87 -176.9 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.886 0.374 . . . . 0.0 110.905 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -44.28 -72.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.2 46.04 1.21 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -122.97 172.63 8.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.795 0.331 . . . . 0.0 111.104 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -73.06 146.59 45.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.561 ' HB3' HG22 ' A' ' 86' ' ' VAL . 24.3 mt-10 -106.47 164.3 12.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -124.74 115.33 20.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.949 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.593 ' CD2' HG23 ' A' ' 86' ' ' VAL . 5.1 m170 -97.07 141.33 30.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.38 124.79 2.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.635 0.731 . . . . 0.0 110.855 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.549 ' HD3' HD23 ' A' ' 132' ' ' LEU . 53.3 Cg_endo -69.81 147.14 61.89 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.706 2.271 . . . . 0.0 112.298 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.463 ' O ' HG23 ' A' ' 125' ' ' VAL . 21.4 mt -113.2 -47.62 3.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.84 156.91 44.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.449 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 67.2 p-90 -137.21 138.91 40.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.07 124.21 3.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.53 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -101.75 129.16 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.892 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.675 HD11 HD21 ' A' ' 120' ' ' LEU . 85.0 mt -124.0 126.8 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.076 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 106' ' ' LEU . 8.2 t-20 -73.43 95.24 2.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 105' ' ' ASN . 51.4 mt -35.08 -34.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 105' ' ' ASN . 88.7 m-85 -103.56 112.7 25.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.92 -178.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.829 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 109' ' ' TYR . 1.3 p90 -62.06 -30.53 71.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.947 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.402 HG23 ' HB ' ' A' ' 112' ' ' THR . 5.2 t -93.99 33.86 1.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.181 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' OD1' ' NE ' ' A' ' 75' ' ' ARG . 14.5 t0 43.0 44.73 4.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 69.7 m -131.52 109.66 10.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.17 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.689 HD22 ' CH2' ' A' ' 156' ' ' TRP . 60.3 mt -34.66 140.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.518 HG21 ' CE2' ' A' ' 154' ' ' PHE . 27.6 m -67.66 165.44 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 p -164.94 158.1 16.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.864 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.94 141.05 1.23 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -40.01 149.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.917 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.7 ttp -159.76 148.46 17.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.71 123.36 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.675 HD21 HD11 ' A' ' 104' ' ' ILE . 4.6 pp -135.34 156.55 48.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -77.95 158.72 29.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.852 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.719 HD11 HD12 ' A' ' 150' ' ' LEU . 10.3 mt -118.87 158.64 25.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -91.46 152.04 43.23 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.576 0.703 . . . . 0.0 110.909 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 170.37 16.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.346 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.639 HG13 ' HD2' ' A' ' 126' ' ' PRO . 98.3 t -109.24 138.49 20.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.548 0.69 . . . . 0.0 111.164 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.639 ' HD2' HG13 ' A' ' 125' ' ' VAL . 53.7 Cg_endo -69.76 169.2 19.46 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.323 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 128' ' ' GLY . 11.7 t-160 -42.46 108.84 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.82 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 35.4 73.62 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.452 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.482 ' HB2' ' CG1' ' A' ' 125' ' ' VAL . 56.1 tp -47.65 124.8 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 110.942 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 131' ' ' ASP . 13.6 pt-20 -37.66 -50.28 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -115.24 160.26 19.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.549 HD23 ' HD3' ' A' ' 98' ' ' PRO . 14.1 mt -69.03 -60.92 2.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 34' ' ' ARG . 10.3 tp -88.64 135.73 33.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -108.06 91.36 7.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.653 0.74 . . . . 0.0 110.897 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.76 -10.41 28.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.8 mm -95.61 -16.62 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.449 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -41.46 148.17 0.36 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 m -65.3 166.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 66.6 p -108.96 154.67 21.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.139 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.02 135.93 8.27 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.492 ' CB ' ' HB2' ' A' ' 120' ' ' LEU . 88.2 p -51.12 120.41 4.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.377 . . . . 0.0 110.837 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER -50.05 132.15 22.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.644 0.735 . . . . 0.0 110.881 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.0 11.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.688 2.259 . . . . 0.0 112.363 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 146' ' ' GLU . 23.4 t-20 -49.25 143.89 5.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -97.6 -32.49 11.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.447 ' N ' ' OD1' ' A' ' 144' ' ' ASN . 11.9 pt-20 -84.3 34.56 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.5 p -118.26 155.2 51.91 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.516 0.674 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 137.19 34.7 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.308 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 8.3 t -120.69 131.68 54.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.719 HD12 HD11 ' A' ' 122' ' ' LEU . 6.4 mt -107.23 140.06 40.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -109.12 123.91 49.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.781 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -135.08 161.21 35.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -121.18 123.88 43.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.619 ' CE2' HD21 ' A' ' 152' ' ' LEU . 25.6 m-85 -91.23 116.13 28.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.61 152.21 51.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.689 ' CH2' HD22 ' A' ' 113' ' ' LEU . 5.3 m95 -137.47 107.97 6.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.497 ' CG ' ' N ' ' A' ' 158' ' ' SER . 16.2 p90 -90.28 -46.65 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.497 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 26.9 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.5 t -64.65 135.69 56.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.874 0.369 . . . . 0.0 110.811 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.4 p -61.4 111.92 1.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.57 -102.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.6 t -159.96 145.83 15.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 0.0 110.874 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.3 p -43.3 130.73 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -47.05 -63.61 3.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -88.99 123.73 33.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -128.21 -33.65 2.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -118.77 126.15 51.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.669 HD13 ' CH2' ' A' ' 156' ' ' TRP . 12.4 tp -84.15 144.1 29.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.601 ' H ' HD12 ' A' ' 11' ' ' LEU . 23.5 ptt180 -146.95 139.07 24.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.6 mt -141.28 127.65 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HB2' ' CD2' ' A' ' 63' ' ' TRP . 25.8 tttp -103.24 120.35 40.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 mm -83.08 145.99 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.06 -73.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.1 p -172.96 169.17 4.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.401 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -113.97 158.1 21.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.6 t -137.04 151.99 49.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 58.85 32.76 22.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 22' ' ' ASN . 4.7 t -63.96 166.5 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.136 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.518 ' N ' HG12 ' A' ' 21' ' ' VAL . 14.5 t30 -84.56 38.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 23' ' ' VAL . 18.1 m -93.76 62.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -72.44 -73.38 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.52 HD12 ' H ' ' A' ' 27' ' ' ASP . 2.7 pp -56.79 169.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.154 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -120.54 48.58 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' H ' HD12 ' A' ' 25' ' ' ILE . 37.5 m-20 -111.01 -40.66 4.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.6 mt -44.76 142.53 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -85.27 -56.38 3.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -148.09 179.69 7.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 55' ' ' CYS . 7.7 pt -139.79 170.15 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.151 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -170.79 150.64 3.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.566 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 9.3 t -102.49 151.94 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -130.86 116.65 18.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.8 p -104.57 170.31 7.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.185 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.98 146.5 4.96 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.47 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 78' ' ' ARG . 3.6 mp -104.12 135.95 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.86 0.362 . . . . 0.0 111.127 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 35.4 m-85 -129.07 149.18 51.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.802 ' CB ' HD11 ' A' ' 44' ' ' LEU . 5.8 t-160 -123.05 98.45 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.74 44.29 39.42 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.446 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.92 29.68 72.47 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.442 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -139.48 140.78 26.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 142.78 48.78 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.712 2.275 . . . . 0.0 112.323 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.802 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.1 mp -110.49 -34.91 6.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 p -152.72 163.09 40.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -47.84 151.49 0.89 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -80.21 140.25 36.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.657 HG12 HD11 ' A' ' 64' ' ' LEU . 74.4 t -104.7 132.67 50.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -118.81 161.31 20.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -107.4 160.49 15.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -46.85 154.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.05 136.72 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.488 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -144.23 152.12 53.4 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.663 0.745 . . . . 0.0 111.086 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 139.89 41.26 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.696 2.264 . . . . 0.0 112.37 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.518 ' HB2' HG11 ' A' ' 23' ' ' VAL . 24.9 p -51.03 -44.15 60.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.1 m -53.49 -35.52 60.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -132.53 83.96 52.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.719 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.539 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.79 3.27 2.88 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.688 2.259 . . . . 0.0 112.342 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -49.94 113.15 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.566 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 6.2 m-90 -106.41 -48.83 3.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 60' ' ' TRP . 6.8 m-80 36.61 49.72 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -121.38 146.54 46.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.417 ' CD2' ' HB2' ' A' ' 14' ' ' LYS . 59.5 m95 -87.71 100.05 12.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.657 HD11 HG12 ' A' ' 48' ' ' VAL . 12.2 tp -84.39 119.27 24.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -95.07 137.79 33.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -107.75 127.56 53.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.4 50.41 1.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.1 pp -118.5 163.4 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.616 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.57 112.23 22.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.64 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.5 mp -48.68 -52.42 45.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.661 0.743 . . . . 0.0 111.148 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.3 Cg_endo -69.8 2.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.514 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.1 t70 -129.29 1.82 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.6 118.61 71.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.627 0.727 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.532 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.8 Cg_endo -69.81 136.92 34.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.65 2.233 . . . . 0.0 112.341 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 23.2 mmt85 -54.47 -36.1 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.39 -35.61 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -64.26 166.25 8.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.106 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 37' ' ' ILE . 16.2 ptt180 -162.18 174.46 12.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.0 tp -94.87 134.35 37.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.0 m -132.28 132.66 43.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.56 155.15 50.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.727 ' OG ' HD12 ' A' ' 133' ' ' LEU . 7.6 m -157.62 127.42 6.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mt -83.48 140.03 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 63.7 m -136.11 149.68 48.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.402 ' HA ' HG22 ' A' ' 31' ' ' ILE . 87.9 p -106.6 120.44 41.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 86' ' ' VAL . 7.6 p -102.55 115.43 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.143 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HD2' ' C ' ' A' ' 87' ' ' LYS . 1.4 tmmt? -128.13 132.92 48.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.49 -145.33 5.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.474 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -131.07 136.4 48.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.875 0.369 . . . . 0.0 110.879 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -47.23 129.19 12.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.927 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.58 -41.57 3.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.514 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.98 177.53 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.848 0.356 . . . . 0.0 111.114 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.51 154.1 41.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -115.93 -174.83 2.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -136.07 120.94 18.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.863 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.566 ' CD2' HG23 ' A' ' 86' ' ' VAL . 9.4 m170 -96.98 135.98 38.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.2 t -137.03 131.94 18.04 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.576 0.703 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.469 ' HB2' HG11 ' A' ' 125' ' ' VAL . 53.4 Cg_endo -69.79 151.93 69.04 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.682 2.255 . . . . 0.0 112.319 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 98' ' ' PRO . 29.5 mt -127.82 -53.36 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.923 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.04 164.89 32.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.084 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.532 ' O ' ' CE3' ' A' ' 101' ' ' TRP . 58.9 p-90 -146.94 129.2 15.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.53 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -131.33 129.29 5.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.469 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -106.75 126.84 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 0.0 110.862 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.565 HG12 HD21 ' A' ' 120' ' ' LEU . 62.2 mt -118.51 124.03 72.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.21 96.12 0.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.5 mt -37.92 -45.49 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.558 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 67.7 m-85 -94.42 114.81 26.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -48.06 174.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -60.67 -19.03 57.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.476 HG23 ' HB ' ' A' ' 112' ' ' THR . 5.9 t -94.57 12.45 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.131 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 65.97 37.75 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.476 ' HB ' HG23 ' A' ' 110' ' ' THR . 4.5 m -136.77 121.68 18.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.123 HD22 ' CH2' ' A' ' 156' ' ' TRP . 23.2 mt -34.69 146.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.537 HG23 ' CG ' ' A' ' 154' ' ' PHE . 23.4 m -75.31 175.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.144 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.6 p -167.15 161.42 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.795 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.1 136.6 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HE2' ' CD ' ' A' ' 151' ' ' GLU . 38.7 tttt -42.77 146.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.727 0.298 . . . . 0.0 110.917 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.429 ' O ' HD13 ' A' ' 152' ' ' LEU . 17.3 ttp -154.61 148.21 25.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.63 117.17 11.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.126 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.565 HD21 HG12 ' A' ' 104' ' ' ILE . 4.3 pp -129.72 161.88 29.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.552 ' O ' HD12 ' A' ' 120' ' ' LEU . 10.8 m120 -82.05 158.48 23.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.717 HD11 HD12 ' A' ' 150' ' ' LEU . 11.5 mt -117.31 144.85 44.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.592 ' CH2' ' ND2' ' A' ' 142' ' ' ASN . 49.8 m95 -70.35 152.01 95.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 0.0 110.943 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 170.27 16.9 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 0.0 112.352 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 98' ' ' PRO . 76.9 t -109.87 110.01 59.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.656 0.741 . . . . 0.0 111.104 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 161.43 45.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 0.0 112.343 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.531 ' CG ' ' N ' ' A' ' 128' ' ' GLY . 25.3 p80 -65.64 -52.87 48.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.531 ' N ' ' CG ' ' A' ' 127' ' ' HIS . . . -45.12 -66.92 1.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.447 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 128' ' ' GLY . 12.7 tp -34.63 110.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.896 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -101.37 56.32 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -158.66 150.49 21.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.2 mt -76.97 -49.01 16.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.727 HD12 ' OG ' ' A' ' 82' ' ' SER . 20.3 tp -99.32 128.64 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -108.48 91.51 8.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.679 0.752 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.76 -43.92 2.38 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.711 2.274 . . . . 0.0 112.391 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 137' ' ' GLY . 45.2 mt -65.11 -28.72 45.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -35.01 151.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -60.68 176.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.7 p -122.05 169.11 11.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.112 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.79 166.32 24.28 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 142' ' ' ASN . 6.3 p -88.32 94.19 9.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.592 ' ND2' ' CH2' ' A' ' 123' ' ' TRP . 3.3 t-20 -37.09 133.33 0.71 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.657 0.742 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' ASN . 54.0 Cg_endo -69.66 -48.67 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.361 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 143' ' ' PRO . 2.3 m-20 -37.12 126.38 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -86.69 -27.22 23.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -60.46 -34.74 74.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.5 p -66.36 151.02 96.58 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.591 0.71 . . . . 0.0 111.168 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 159.48 53.24 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.726 2.284 . . . . 0.0 112.324 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 t -135.51 137.36 42.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 122' ' ' LEU . 10.4 mt -109.21 138.12 46.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.41 ' CD ' ' HE2' ' A' ' 117' ' ' LYS . 34.7 tt0 -105.67 126.46 52.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.759 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -136.09 159.52 41.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -115.61 123.96 49.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.759 ' CE2' HD21 ' A' ' 152' ' ' LEU . 35.4 m-85 -92.13 118.17 30.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.599 ' C ' ' CD1' ' A' ' 156' ' ' TRP . 1.3 m-20 -143.48 158.23 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 1.123 ' CH2' HD22 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -153.16 112.78 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.524 ' CG ' ' N ' ' A' ' 158' ' ' SER . 28.9 p90 -101.28 -53.27 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.579 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 1.9 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.889 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.7 p -146.65 122.66 10.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.8 t -115.63 -49.93 2.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.53 -76.16 1.73 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.0 t -112.76 131.83 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.856 0.36 . . . . 0.0 110.851 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.8 p -69.06 -178.48 1.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.828 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.06 -117.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.522 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.533 ' ND2' ' HB3' ' A' ' 156' ' ' TRP . 1.6 t-20 -79.18 175.8 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.1 m -130.17 -43.84 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.19 139.45 49.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.09 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 12' ' ' ARG . 6.0 tp -95.89 137.15 35.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 11' ' ' LEU . 9.1 ttp180 -136.71 132.42 34.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.46 HG23 HD23 ' A' ' 152' ' ' LEU . 52.0 mt -138.28 137.31 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.193 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -116.85 128.84 55.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 mm -91.34 140.14 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.426 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.0 mm? -98.04 -71.19 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.4 p -171.06 -179.54 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.35 164.57 18.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 t -135.5 150.87 49.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 50.83 52.41 15.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 22' ' ' ASN . 21.5 t -74.27 165.81 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.585 ' N ' HG12 ' A' ' 21' ' ' VAL . 1.8 t-20 -89.11 36.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 23' ' ' VAL . 21.9 m -101.37 93.05 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.132 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -96.92 -70.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.564 HD11 HG13 ' A' ' 28' ' ' ILE . 2.8 pp -50.72 168.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.403 ' N ' ' CD ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -120.63 61.88 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 25' ' ' ILE . 10.2 t70 -129.41 -33.94 1.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.564 HG13 HD11 ' A' ' 25' ' ' ILE . 24.0 mt -49.62 127.7 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.113 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.54 -64.93 0.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -142.06 179.85 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 85' ' ' SER . 6.2 pt -136.81 178.25 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 2.3 p90 -172.95 159.55 4.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 60.3 t -118.53 148.98 21.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.462 ' O ' HD13 ' A' ' 133' ' ' LEU . 25.6 ttm180 -124.82 120.69 32.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.8 p -113.7 166.43 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.141 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.74 154.98 8.97 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.574 HD13 HG21 ' A' ' 68' ' ' ILE . 3.8 mp -102.49 144.73 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.867 0.365 . . . . 0.0 111.13 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.511 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 53.4 m-85 -139.16 153.13 47.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.657 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 1.3 t-80 -130.18 101.84 5.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.87 24.26 76.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.13 -35.49 4.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.519 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.34 138.93 55.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.718 . . . . 0.0 110.885 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.473 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.8 Cg_endo -69.81 165.31 31.46 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.629 2.219 . . . . 0.0 112.328 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 43' ' ' PRO . 11.0 mp -122.83 -39.88 2.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.0 p -146.84 161.18 41.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -47.84 155.13 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.73 142.84 29.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.653 HG11 ' HG ' ' A' ' 64' ' ' LEU . 83.5 t -99.78 134.56 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -119.84 140.59 50.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 t -97.82 163.55 12.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -51.12 162.39 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.52 123.01 35.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 58' ' ' PRO . 2.3 m -119.6 152.29 53.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 132.79 24.14 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.341 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 4.5 p -44.58 -46.9 10.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -49.75 -34.9 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.883 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -134.72 87.42 31.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.579 0.704 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.583 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.8 Cg_endo -69.77 3.57 2.7 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.681 2.254 . . . . 0.0 112.334 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.435 ' CG ' HD22 ' A' ' 61' ' ' ASN . 30.8 ttp180 -54.1 110.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.882 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.583 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.0 m-90 -97.91 -60.58 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.435 HD22 ' CG ' ' A' ' 59' ' ' ARG . 32.6 m-80 48.07 50.38 16.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -121.58 141.08 51.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -82.95 101.2 10.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.653 ' HG ' HG11 ' A' ' 48' ' ' VAL . 10.0 tp -92.29 114.86 27.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -97.91 139.65 33.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.928 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -105.96 138.66 41.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.8 32.5 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.574 HG21 HD13 ' A' ' 37' ' ' ILE . 1.9 pp -99.8 164.25 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.618 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.26 123.63 47.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.616 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -56.92 -53.8 61.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.6 0.714 . . . . 0.0 111.112 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.79 2.14 3.82 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.641 2.227 . . . . 0.0 112.323 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.516 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 7.0 t0 -124.99 -9.58 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.522 HD13 ' HD2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -75.34 114.46 35.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.697 . . . . 0.0 110.94 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.561 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.78 145.42 57.0 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.692 2.261 . . . . 0.0 112.31 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -57.01 -45.74 82.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.657 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -52.27 -35.53 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -65.75 156.32 33.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.428 ' HG3' ' C ' ' A' ' 77' ' ' ALA . 88.0 mtt180 -152.76 172.47 16.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.4 tp -93.74 133.04 37.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.5 m -127.64 134.51 49.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.26 154.72 46.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.589 ' OG ' HD12 ' A' ' 133' ' ' LEU . 99.8 p -158.86 131.33 6.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.56 HG12 HD11 ' A' ' 150' ' ' LEU . 22.6 mt -80.59 141.98 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 87.7 m -135.77 149.16 49.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.613 ' OG ' HD11 ' A' ' 99' ' ' LEU . 71.9 m -115.02 120.32 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.508 ' CG2' ' HB3' ' A' ' 94' ' ' GLU . 6.1 p -105.21 137.8 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 tptt -130.03 114.25 15.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.61 -179.78 27.57 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 23.7 mmt180 -128.65 -176.64 3.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 0.0 110.879 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.87 -70.76 0.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -111.63 23.31 17.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.488 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -98.48 157.51 16.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 111.081 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.4 pttm -71.05 147.11 48.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.508 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 24.1 mt-10 -103.28 144.87 30.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -120.2 120.29 35.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 5.0 m170 -93.81 145.5 24.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.7 t -152.53 126.34 4.35 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.585 0.707 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 155.0 67.05 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.294 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.802 ' O ' HG23 ' A' ' 125' ' ' VAL . 15.4 mt -128.51 -53.09 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.933 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -137.16 152.35 49.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.598 ' CH2' HG22 ' A' ' 138' ' ' VAL . 64.1 p-90 -134.06 127.37 32.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.609 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -129.48 129.45 6.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.453 ' HB3' HG22 ' A' ' 139' ' ' THR . 23.6 m-20 -112.53 124.75 53.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.883 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.653 HG12 HD21 ' A' ' 120' ' ' LEU . 11.7 mt -119.39 132.5 69.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.181 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -74.84 96.89 3.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.9 mt -36.49 -39.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -99.84 117.36 34.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -57.02 -174.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -76.2 6.39 5.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.95 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.1 p -126.54 18.6 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 58.45 30.05 19.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 94.4 m -117.49 103.52 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.543 HD22 ' CH2' ' A' ' 156' ' ' TRP . 24.0 mt -34.7 135.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.4 m -70.05 157.46 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.6 t -156.15 173.46 16.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.89 142.99 0.18 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.485 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 9.3 ttpt -44.6 148.75 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.437 ' O ' HD13 ' A' ' 152' ' ' LEU . 31.8 ttp -159.69 147.86 17.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.421 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.73 122.23 16.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.109 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.653 HD21 HG12 ' A' ' 104' ' ' ILE . 4.4 pp -132.3 155.37 48.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -75.66 152.17 37.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.775 HD11 HD12 ' A' ' 150' ' ' LEU . 10.6 mt -115.81 148.87 39.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.501 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 21.0 m95 -78.38 147.44 72.2 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.553 0.692 . . . . 0.0 110.943 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.44 ' O ' ' NE1' ' A' ' 101' ' ' TRP . 53.0 Cg_endo -69.8 173.57 10.81 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.682 2.255 . . . . 0.0 112.324 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 99' ' ' LEU . 85.4 t -88.75 134.04 34.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.581 0.705 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 125' ' ' VAL . 53.8 Cg_endo -69.72 -165.27 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.703 2.269 . . . . 0.0 112.353 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 127' ' ' HIS . 14.2 p80 -92.83 119.54 32.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.24 85.83 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.507 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 39.8 tp -130.45 100.42 5.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.773 0.321 . . . . 0.0 110.926 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -66.02 -60.94 2.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -53.87 138.71 35.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.452 HD12 ' NH1' ' A' ' 34' ' ' ARG . 25.7 mt -73.82 -48.68 29.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.589 HD12 ' OG ' ' A' ' 82' ' ' SER . 12.2 tp -96.59 135.66 38.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.958 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -105.84 91.39 5.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.639 0.733 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.511 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.77 -33.28 16.85 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.349 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.41 -20.81 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -42.75 153.86 0.19 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.503 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.598 HG22 ' CH2' ' A' ' 101' ' ' TRP . 6.3 m -62.95 158.17 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.371 . . . . 0.0 111.129 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 103' ' ' ASN . 20.0 p -104.19 165.39 11.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.67 169.37 25.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.48 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 142' ' ' ASN . 24.4 p -88.08 102.35 14.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.55 HD21 HG21 ' A' ' 147' ' ' THR . 56.5 t-20 -34.4 120.48 0.54 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -1.93 9.35 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.709 2.273 . . . . 0.0 112.379 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -85.34 135.02 34.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -85.49 -50.5 7.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -42.82 -52.64 4.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.55 HG21 HD21 ' A' ' 142' ' ' ASN . 45.7 p -48.28 150.22 2.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.622 0.725 . . . . 0.0 111.113 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 158.87 55.38 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.656 2.237 . . . . 0.0 112.299 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 7.7 t -135.54 138.39 43.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.775 HD12 HD11 ' A' ' 122' ' ' LEU . 6.1 mt -109.28 142.02 40.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.436 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 9.9 tt0 -110.02 123.54 49.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.783 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -131.06 164.44 25.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.454 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 59.6 mt-10 -123.85 117.69 25.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.457 ' CE2' HD21 ' A' ' 152' ' ' LEU . 31.6 m-85 -82.39 104.35 12.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.844 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -112.35 143.78 42.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.543 ' CH2' HD22 ' A' ' 113' ' ' LEU . 12.8 m95 -134.67 88.05 2.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 158' ' ' SER . 11.8 p90 -90.05 -41.53 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.466 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 30.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 p -140.06 168.28 20.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.839 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -101.34 -43.37 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.27 -72.4 0.18 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.707 ' HB2' HG23 ' A' ' 112' ' ' THR . 39.4 t -43.95 -49.25 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.853 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 t -92.34 98.58 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.85 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.82 44.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.524 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -136.48 163.41 30.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.475 ' H ' ' CB ' ' A' ' 158' ' ' SER . 1.7 m -132.64 -43.37 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' H ' ' CB ' ' A' ' 158' ' ' SER . . . -120.56 135.09 55.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.767 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 12.4 tp -94.42 145.3 24.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.588 ' H ' HD12 ' A' ' 11' ' ' LEU . 27.4 ptt180 -147.53 141.69 26.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.543 HD12 ' CE1' ' A' ' 66' ' ' TYR . 21.7 mt -141.13 140.82 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -115.24 136.81 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mm -98.58 141.69 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.44 -71.99 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.9 p -169.1 172.95 7.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.447 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -121.53 164.09 17.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.072 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -145.35 156.31 43.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 58.87 35.07 24.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.607 HG12 ' N ' ' A' ' 22' ' ' ASN . 39.7 t -66.93 165.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.607 ' N ' HG12 ' A' ' 21' ' ' VAL . 9.3 m120 -85.57 51.81 2.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.941 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.0 107.09 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -109.71 -74.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.415 ' C ' HD12 ' A' ' 25' ' ' ILE . 2.8 pp -65.33 167.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.458 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -112.77 74.63 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -134.98 -46.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.841 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.4 mt -38.5 123.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -68.26 -61.75 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.892 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -148.18 174.52 11.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -132.49 -179.72 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.098 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -169.74 173.58 6.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.572 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 94.0 t -124.97 146.2 31.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.798 ' NH1' HD12 ' A' ' 132' ' ' LEU . 17.9 ttt180 -129.67 117.31 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 81' ' ' LEU . 70.1 p -115.8 175.67 5.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.104 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.44 146.34 4.5 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.516 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.51 ' CG2' ' HB1' ' A' ' 77' ' ' ALA . 2.3 mp -90.04 140.82 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 111.173 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.567 ' CD2' ' HB3' ' A' ' 135' ' ' PRO . 37.8 m-85 -137.64 134.04 35.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.558 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -127.19 105.39 8.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.1 56.16 3.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.489 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.75 37.84 28.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.466 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -154.12 142.71 14.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.678 0.751 . . . . 0.0 110.886 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.454 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 53.3 Cg_endo -69.8 165.96 29.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.654 2.236 . . . . 0.0 112.33 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 39' ' ' HIS . 8.6 mp -119.96 -40.25 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 16.2 p -145.94 165.3 29.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -51.06 128.17 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -59.9 143.55 51.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.696 HG12 HD11 ' A' ' 64' ' ' LEU . 56.3 t -104.14 133.41 48.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.155 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -117.31 140.34 49.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -96.58 153.13 18.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -41.72 161.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.1 mtm-85 -89.33 146.09 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -140.81 152.14 64.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.635 0.731 . . . . 0.0 111.155 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 135.88 31.47 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.719 2.279 . . . . 0.0 112.338 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 8.0 p -46.2 -48.53 17.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -47.76 -36.53 11.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -132.93 87.05 41.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.63 0.728 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.597 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 54.0 Cg_endo -69.74 3.09 2.96 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.68 2.253 . . . . 0.0 112.359 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.423 ' CD ' HD21 ' A' ' 61' ' ' ASN . 20.2 ttt85 -57.18 125.82 24.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.832 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.597 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 5.2 m-90 -108.83 -57.42 2.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.937 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.423 HD21 ' CD ' ' A' ' 59' ' ' ARG . 3.4 m-20 49.28 53.19 13.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -128.23 143.54 51.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -87.64 104.68 16.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.696 HD11 HG12 ' A' ' 48' ' ' VAL . 11.6 tp -90.06 121.08 31.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -97.47 136.73 37.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' CE1' HD12 ' A' ' 13' ' ' ILE . 55.3 m-85 -106.2 129.28 54.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.08 44.25 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.891 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 11' ' ' LEU . 2.2 pp -111.29 164.17 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.119 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.623 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.95 120.07 38.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.631 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -55.61 -52.8 68.97 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.614 0.721 . . . . 0.0 111.153 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.82 2.98 3.07 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.726 2.284 . . . . 0.0 112.325 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 1.8 t70 -126.08 -7.15 6.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.677 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -77.99 114.84 45.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.588 0.709 . . . . 0.0 110.917 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.612 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.2 Cg_endo -69.72 139.25 39.9 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.725 2.283 . . . . 0.0 112.331 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.49 ' NE ' ' OD1' ' A' ' 111' ' ' ASP . 74.6 mmt-85 -50.23 -40.39 47.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.452 ' CB ' ' CE1' ' A' ' 39' ' ' HIS . . . -54.71 -43.67 72.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.068 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.677 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -53.13 154.22 3.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.448 ' HD2' HG21 ' A' ' 139' ' ' THR . 43.6 mtm180 -151.25 170.75 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.7 tp -93.94 133.23 37.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m -132.73 142.73 49.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.636 ' HB3' HG22 ' A' ' 35' ' ' THR . 1.9 pp -148.71 157.6 43.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.3 p -157.92 131.1 7.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 29.0 mt -85.65 126.22 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 28.6 m -124.22 151.03 44.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 p -107.54 127.7 53.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.635 HG23 ' CD2' ' A' ' 96' ' ' HIS . 2.6 p -105.58 132.53 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -153.16 135.21 14.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.44 174.94 38.05 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.507 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 161.79 17.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -55.92 135.28 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.21 -42.4 3.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.5 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.72 168.54 16.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.834 0.35 . . . . 0.0 111.089 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -82.98 166.5 18.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HB3' HG22 ' A' ' 86' ' ' VAL . 26.0 mt-10 -88.82 179.01 6.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -138.85 114.5 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.635 ' CD2' HG23 ' A' ' 86' ' ' VAL . 4.5 m170 -94.34 130.62 40.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.9 t -131.94 127.3 21.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.583 0.706 . . . . 0.0 110.887 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 150.4 67.86 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.633 2.222 . . . . 0.0 112.336 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.0 mt -123.87 -50.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.88 179.36 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.597 ' HD1' HG12 ' A' ' 125' ' ' VAL . 64.6 p-90 -158.22 130.79 7.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.954 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.33 133.43 6.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.44 ' CB ' HG22 ' A' ' 139' ' ' THR . 1.2 m-20 -115.39 132.55 56.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.771 0.32 . . . . 0.0 110.914 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.31 124.84 73.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 106' ' ' LEU . 4.9 m120 -64.66 89.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 105' ' ' ASN . 16.0 mt -34.66 -40.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.433 ' HE2' HD12 ' A' ' 73' ' ' LEU . 94.8 m-85 -105.25 112.51 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -52.13 173.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -55.33 -35.59 65.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 t -87.78 27.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.49 ' OD1' ' NE ' ' A' ' 75' ' ' ARG . 8.4 t0 47.83 52.46 12.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.707 HG23 ' HB2' ' A' ' 5' ' ' SER . 97.2 m -139.16 108.71 6.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.133 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.961 HD22 ' CH2' ' A' ' 156' ' ' TRP . 20.3 mt -34.94 133.21 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.505 HG23 ' CG ' ' A' ' 154' ' ' PHE . 26.4 m -63.43 171.71 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.7 m -162.85 175.53 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.04 153.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.496 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.444 ' HE3' ' CG ' ' A' ' 153' ' ' GLU . 20.0 ttmt -58.73 148.07 30.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.76 0.314 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.409 ' O ' HD13 ' A' ' 152' ' ' LEU . 41.1 ttp -154.67 151.86 29.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.908 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.84 128.5 26.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.117 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 pp -139.87 162.48 35.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -87.52 150.52 23.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.664 HD11 HD12 ' A' ' 150' ' ' LEU . 2.8 mt -108.17 155.41 20.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.573 ' CH2' ' HD2' ' A' ' 143' ' ' PRO . 7.3 m95 -90.94 141.54 26.72 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.61 0.719 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 136.01 31.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.353 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.597 HG12 ' HD1' ' A' ' 101' ' ' TRP . 3.5 m -75.0 137.15 72.81 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.619 0.723 . . . . 0.0 111.111 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 159.5 53.22 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 0.0 112.362 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -58.65 -55.5 34.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -44.27 -64.08 2.14 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.585 HD23 ' HB ' ' A' ' 125' ' ' VAL . 35.4 tp -33.56 126.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -109.06 -36.58 6.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.54 -175.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.798 HD12 ' NH1' ' A' ' 34' ' ' ARG . 12.1 mt -105.04 -51.53 3.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.528 HD23 ' CE1' ' A' ' 38' ' ' TYR . 9.7 tp -97.38 145.93 25.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.427 ' HA ' ' HD2' ' A' ' 135' ' ' PRO . 55.2 t-20 -114.38 93.05 30.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.638 0.733 . . . . 0.0 110.857 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.567 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.79 -38.68 7.39 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.663 2.242 . . . . 0.0 112.317 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.2 mt -73.02 -20.12 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.419 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -45.67 148.36 1.89 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.3 m -62.35 178.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.141 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.448 HG21 ' HD2' ' A' ' 78' ' ' ARG . 82.4 p -123.79 157.65 33.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.151 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.25 170.91 19.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 p -84.07 128.93 34.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 144' ' ' ASN . 5.9 t-20 -65.6 132.45 94.99 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.672 0.749 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.573 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.79 -50.82 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.689 2.259 . . . . 0.0 112.329 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 69.1 m-80 -39.01 135.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -89.19 -25.95 21.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -85.19 41.39 0.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.8 p -129.55 152.82 80.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.582 0.706 . . . . 0.0 111.145 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 137.15 34.66 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.325 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.37 146.46 48.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.664 HD12 HD11 ' A' ' 122' ' ' LEU . 5.7 mt -120.95 156.21 32.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -121.62 120.25 34.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.817 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -127.43 163.65 23.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.444 ' CG ' ' HE3' ' A' ' 117' ' ' LYS . 49.5 mt-10 -124.59 120.99 33.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.643 ' CE2' HD21 ' A' ' 152' ' ' LEU . 39.2 m-85 -89.31 102.12 14.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -122.6 134.78 54.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.961 ' CH2' HD22 ' A' ' 113' ' ' LEU . 15.7 m95 -120.89 98.01 5.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.597 ' CG ' ' N ' ' A' ' 158' ' ' SER . 12.4 p90 -79.53 -53.38 6.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.597 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 61.6 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -109.06 -52.87 2.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.7 m -77.71 85.51 4.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.887 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.97 70.54 0.1 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.501 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -85.64 109.48 18.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.381 . . . . 0.0 110.848 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.7 p -151.64 138.56 19.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.64 -148.25 4.77 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.518 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.413 ' C ' HD13 ' A' ' 70' ' ' ILE . 28.9 m-80 -85.09 152.34 23.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.853 0.358 . . . . 0.0 110.923 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 p -125.17 -34.95 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.71 125.19 49.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.708 HD13 ' CH2' ' A' ' 156' ' ' TRP . 21.0 tp -88.42 142.44 27.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.466 ' H ' HD12 ' A' ' 11' ' ' LEU . 7.7 ptm180 -149.34 127.56 12.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.9 mt -129.52 138.7 53.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.51 ' HD3' ' CE2' ' A' ' 63' ' ' TRP . 3.3 ttpm? -114.02 129.91 56.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mm -89.51 145.34 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.89 -72.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.1 p -169.72 174.8 5.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.99 156.74 34.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.688 HG23 ' CD2' ' A' ' 20' ' ' TYR . 9.8 t -127.1 163.19 24.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.688 ' CD2' HG23 ' A' ' 19' ' ' THR . 7.8 m-85 53.3 30.81 10.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.9 t -53.05 144.77 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -76.87 51.62 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.01 117.0 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -122.41 -51.33 1.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.739 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -74.85 172.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.167 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.437 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER -115.43 50.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 87' ' ' LYS . 23.0 t0 -107.11 -59.44 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' A' ' 27' ' ' ASP . 20.2 mt -36.52 132.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' N ' ' HD3' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -83.34 -52.22 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -147.52 178.6 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 85' ' ' SER . 6.9 pt -138.46 174.83 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -169.51 155.57 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.781 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 58.1 t -111.6 140.28 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -113.42 127.53 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.5 p -123.67 169.73 11.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.54 135.54 1.97 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.532 HD12 ' N ' ' A' ' 37' ' ' ILE . 3.4 mp -81.9 146.51 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.544 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 44.8 m-85 -140.6 162.89 34.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.593 ' HB2' HD11 ' A' ' 44' ' ' LEU . 3.1 t-160 -132.65 94.3 3.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.53 -32.98 4.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.541 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.45 -30.52 0.29 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -91.44 152.64 43.84 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.679 0.752 . . . . 0.0 110.841 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 156.34 63.56 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.737 2.292 . . . . 0.0 112.343 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 39' ' ' HIS . 8.9 mp -106.22 -41.39 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.9 m -133.8 -67.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -173.42 171.96 3.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.471 ' OD1' HD22 ' A' ' 133' ' ' LEU . 1.0 OUTLIER -105.34 144.51 32.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.642 HG11 ' HG ' ' A' ' 64' ' ' LEU . 43.2 t -110.76 140.24 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -120.73 144.01 48.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.7 p -94.85 159.68 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -49.92 172.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -100.98 131.79 46.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 1.5 m -136.02 152.17 75.07 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.592 0.71 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 140.18 41.93 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.0 p -50.03 -32.77 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 m -63.13 -31.29 72.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -133.32 81.43 55.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.738 . . . . 0.0 110.902 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 3.17 2.91 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.692 2.261 . . . . 0.0 112.343 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -61.42 106.74 0.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.781 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 3.9 m-90 -90.68 -47.24 7.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 39.3 41.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.439 ' C ' ' HG3' ' A' ' 14' ' ' LYS . 5.3 tp10 -114.03 135.82 53.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.51 ' CE2' ' HD3' ' A' ' 14' ' ' LYS . 52.7 m95 -83.73 107.88 16.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.642 ' HG ' HG11 ' A' ' 48' ' ' VAL . 10.0 tp -95.2 121.02 36.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.84 140.12 31.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -107.39 125.43 51.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -78.05 45.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.477 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.0 pp -113.0 164.17 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.612 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.62 124.86 48.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.947 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.575 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -51.89 -55.47 30.09 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.607 0.718 . . . . 0.0 111.134 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.612 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.5 Cg_endo -69.71 2.42 3.52 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.691 2.261 . . . . 0.0 112.401 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.508 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.6 t70 -123.04 -5.69 8.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -83.6 114.7 55.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.633 0.73 . . . . 0.0 110.939 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.9 Cg_endo -69.7 136.04 32.14 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.694 2.263 . . . . 0.0 112.369 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -49.75 -44.34 48.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.555 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -52.64 -39.17 61.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -64.43 157.84 25.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -153.02 177.56 10.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -93.77 139.38 30.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.598 ' C ' HD23 ' A' ' 81' ' ' LEU . 73.9 m -129.74 145.94 51.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -154.87 136.83 14.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.7 m -143.84 139.58 29.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.76 146.84 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.15 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 81.3 m -146.18 153.56 40.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.483 ' HA ' HG22 ' A' ' 31' ' ' ILE . 24.8 m -114.72 122.3 46.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.65 127.53 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 29' ' ' ASP . 21.9 tptm -141.45 134.14 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.99 -158.52 9.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.511 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.514 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 28.6 mtt180 -133.62 -174.57 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -49.25 -74.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -117.1 46.61 1.13 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.51 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -133.99 168.44 18.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 174.32 6.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.81 169.0 8.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -126.98 134.29 50.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -107.71 125.39 51.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.3 t -129.25 125.89 22.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.719 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.469 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.3 Cg_endo -69.79 152.23 69.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.643 2.229 . . . . 0.0 112.352 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 98' ' ' PRO . 14.2 mt -123.91 -49.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.73 174.25 11.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.531 ' CH2' HG22 ' A' ' 138' ' ' VAL . 68.6 p-90 -151.18 134.33 15.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.918 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.8 133.11 5.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -120.48 130.68 54.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.714 HG12 HD21 ' A' ' 120' ' ' LEU . 14.6 mt -114.22 130.55 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 106' ' ' LEU . 40.5 m-20 -67.28 95.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.7 mt -34.81 -43.15 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 77.8 m-85 -107.24 111.05 23.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 34.6 p30 -52.19 -177.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.876 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -56.49 -37.88 70.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.436 ' O ' ' C ' ' A' ' 111' ' ' ASP . 8.9 t -88.73 34.7 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.138 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 110' ' ' THR . 6.7 m-20 35.62 54.75 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 113' ' ' LEU . 98.1 m -134.28 109.29 8.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.172 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.749 HD22 ' CH2' ' A' ' 156' ' ' TRP . 56.7 mt -34.36 138.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 12.8 m -68.02 165.49 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 p -159.73 162.86 35.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.1 142.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.436 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 7.8 ttpt -47.21 148.71 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.441 ' O ' HD13 ' A' ' 152' ' ' LEU . 26.7 ttp -156.1 151.94 27.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.3 132.56 29.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.714 HD21 HG12 ' A' ' 104' ' ' ILE . 3.6 pp -141.16 154.41 45.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.35 152.13 39.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 150' ' ' LEU . 2.5 mt -111.45 141.35 45.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.48 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 23.5 m95 -75.88 152.01 84.55 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.53 0.681 . . . . 0.0 110.925 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 154.0 68.46 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 98' ' ' PRO . 71.3 t -89.56 125.69 60.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.628 0.727 . . . . 0.0 111.12 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 133.26 25.11 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.647 2.231 . . . . 0.0 112.335 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -48.37 -28.73 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -89.54 60.92 3.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.413 ' CD2' HG13 ' A' ' 125' ' ' VAL . 42.7 tp -140.93 110.57 6.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.756 0.312 . . . . 0.0 110.955 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -76.29 -47.46 23.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.52 174.55 5.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 mt -98.91 -59.53 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.471 HD22 ' OD1' ' A' ' 47' ' ' ASN . 7.8 tp -80.42 135.83 36.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -106.11 91.27 5.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.616 0.722 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.544 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.2 Cg_endo -69.73 -44.81 1.88 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.237 . . . . 0.0 112.366 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 137' ' ' GLY . 44.3 mt -67.61 -28.38 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -36.65 149.13 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.502 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.531 HG22 ' CH2' ' A' ' 101' ' ' TRP . 2.4 m -51.73 168.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 111.155 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.7 p -115.14 168.14 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.131 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.78 -168.81 30.65 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.451 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.8 p -96.14 148.53 22.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.893 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 142' ' ' ASN . 0.4 OUTLIER -84.45 138.72 38.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.62 0.724 . . . . 0.0 110.88 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.406 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.72 -48.2 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.252 . . . . 0.0 112.383 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -40.74 142.14 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -98.2 -31.72 11.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -82.16 40.39 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.0 p -124.21 151.96 66.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.583 0.706 . . . . 0.0 111.115 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 117.23 4.96 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.67 2.247 . . . . 0.0 112.311 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 13.4 t -105.68 137.78 42.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 122' ' ' LEU . 3.4 mt -105.51 162.18 13.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.436 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 27.5 tt0 -129.81 112.43 13.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.836 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -118.35 162.87 17.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.457 ' N ' HD22 ' A' ' 152' ' ' LEU . 14.9 mt-10 -118.74 119.1 33.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.727 ' CE2' HD21 ' A' ' 152' ' ' LEU . 50.2 m-85 -87.58 107.46 18.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.26 155.56 48.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.749 ' CH2' HD22 ' A' ' 113' ' ' LEU . 4.9 m95 -142.48 120.32 11.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.515 ' CG ' ' N ' ' A' ' 158' ' ' SER . 10.1 p90 -110.28 -47.83 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.515 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 8.6 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.7 m -60.31 169.86 1.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.89 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 t -112.38 154.96 24.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.31 152.54 23.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.6 m -91.0 89.66 7.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 m -108.32 122.77 47.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 8' ' ' ASN . . . -145.82 -68.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 7' ' ' GLY . 1.7 p30 -35.61 135.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.905 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -122.83 -13.77 7.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.453 ' HB3' ' C ' ' A' ' 158' ' ' SER . . . -119.14 151.21 38.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.086 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.749 HD13 ' CH2' ' A' ' 156' ' ' TRP . 14.3 tp -110.79 138.95 46.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.405 ' H ' HD12 ' A' ' 11' ' ' LEU . 25.8 ptt180 -148.34 140.07 23.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.0 mt -135.93 137.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.159 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttt -110.71 120.81 43.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.6 mm -82.42 141.11 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.26 -72.29 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -172.07 176.79 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.7 163.07 20.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.441 HG23 ' CD2' ' A' ' 20' ' ' TYR . 10.2 t -134.78 163.39 29.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.441 ' CD2' HG23 ' A' ' 19' ' ' THR . 6.3 m-85 39.54 44.6 1.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 22' ' ' ASN . 86.9 t -66.51 160.94 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.569 ' N ' HG12 ' A' ' 21' ' ' VAL . 2.4 t-20 -82.94 47.19 1.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.432 HG22 ' HB ' ' A' ' 21' ' ' VAL . 4.5 m -124.09 116.75 48.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -116.63 -43.6 2.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.745 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -80.9 -174.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.13 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.26 2.73 10.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.36 -55.63 26.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' A' ' 85' ' ' SER . 17.3 mt -45.88 129.17 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.406 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 21.5 t0 -72.98 -60.56 2.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 26.3 mmtp -147.91 166.56 27.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 pt -119.44 169.9 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -163.82 144.56 8.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.621 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 63.2 t -103.03 143.92 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -121.03 122.25 39.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.6 p -116.1 166.91 11.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.73 149.42 6.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.59 134.89 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 111.148 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 135' ' ' PRO . 47.7 m-85 -133.72 158.33 43.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.481 ' HB3' HD11 ' A' ' 44' ' ' LEU . 6.9 t-160 -131.85 103.37 6.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.858 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.94 17.15 78.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.483 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.558 ' HA2' HD13 ' A' ' 136' ' ' ILE . . . 107.5 -35.48 4.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.457 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.33 142.88 59.17 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.668 0.747 . . . . 0.0 110.885 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.527 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.7 Cg_endo -69.77 166.02 29.02 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.689 2.259 . . . . 0.0 112.338 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.527 HD12 ' C ' ' A' ' 43' ' ' PRO . 10.1 mp -124.89 -41.25 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.0 m -154.39 160.06 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -41.36 151.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -88.82 165.48 14.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.59 HG12 HD11 ' A' ' 64' ' ' LEU . 64.2 t -119.96 133.59 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -115.38 138.2 51.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.2 t -90.37 159.12 16.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -49.67 174.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -101.89 133.48 46.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.5 m -137.36 152.11 72.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.641 0.734 . . . . 0.0 111.164 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 134.23 27.4 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.353 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.6 p -45.48 -44.93 12.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.866 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.8 t -48.66 -40.58 28.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -130.32 86.65 53.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.533 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.3 Cg_endo -69.8 2.97 3.07 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.746 2.297 . . . . 0.0 112.298 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -50.8 109.55 0.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.621 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 1.5 m-90 -99.54 -47.62 5.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 61' ' ' ASN . 2.2 p-10 35.25 41.05 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.839 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.12 138.19 50.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -83.05 112.33 19.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.59 HD11 HG12 ' A' ' 48' ' ' VAL . 11.1 tp -97.15 119.25 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -93.07 140.13 29.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -112.47 128.71 56.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -82.21 40.5 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.436 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.0 pp -106.93 164.01 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.614 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.0 127.02 53.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.6 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -60.01 -54.46 55.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.663 0.744 . . . . 0.0 111.165 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.614 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.74 3.49 2.73 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 0.0 112.355 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.494 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.7 t70 -125.46 -7.12 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -82.12 115.72 59.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.608 0.718 . . . . 0.0 110.926 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.6 Cg_endo -69.78 132.75 23.96 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.322 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.491 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 1.6 mpp_? -47.63 -43.62 26.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -51.87 -39.38 58.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -62.58 167.12 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -162.21 170.87 18.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 tp -94.64 133.73 37.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.621 ' C ' HD23 ' A' ' 81' ' ' LEU . 33.6 m -120.26 150.33 40.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -155.69 137.17 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 133' ' ' LEU . 86.5 p -143.61 133.27 23.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.573 HD11 ' HG ' ' A' ' 150' ' ' LEU . 71.7 mt -84.69 140.78 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.4 p -151.18 160.24 43.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.529 ' HB2' HG21 ' A' ' 28' ' ' ILE . 15.3 p -117.23 156.48 27.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 86' ' ' VAL . 14.8 p -133.77 122.39 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.163 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -126.93 126.73 43.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.22 159.82 29.38 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.515 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.442 ' HD2' ' N ' ' A' ' 89' ' ' ARG . 6.6 mpt_? -109.5 162.75 14.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.912 0.387 . . . . 0.0 110.88 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -57.14 125.66 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.13 -30.36 4.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.06 167.84 15.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.6 pttm -84.63 151.02 24.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -88.28 156.11 19.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -122.57 126.08 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -99.59 134.74 42.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.0 t -135.65 120.31 13.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.611 0.72 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.401 ' HB2' HG11 ' A' ' 125' ' ' VAL . 54.1 Cg_endo -69.79 142.01 46.65 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.664 2.243 . . . . 0.0 112.338 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 83' ' ' ILE . 17.8 mt -111.65 -55.65 2.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.02 176.52 8.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.074 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 61.9 p-90 -152.76 145.09 23.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -151.83 139.78 7.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -117.83 150.3 39.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.784 0.326 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.562 ' CG1' HD21 ' A' ' 120' ' ' LEU . 66.0 mt -138.27 117.91 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 106' ' ' LEU . 12.4 m120 -62.41 96.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.0 mt -35.15 -40.5 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.491 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 98.1 m-85 -108.56 115.37 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -55.64 -176.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.517 ' CD1' HG23 ' A' ' 110' ' ' THR . 13.2 p90 -68.41 -4.41 14.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.517 HG23 ' CD1' ' A' ' 109' ' ' TYR . 10.0 p -109.36 22.47 15.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.154 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 110' ' ' THR . 6.0 p-10 46.61 54.43 8.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.3 m -149.9 120.83 7.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.781 HD22 ' CH2' ' A' ' 156' ' ' TRP . 56.8 mt -40.32 140.81 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.47 HG21 ' CE2' ' A' ' 154' ' ' PHE . 20.3 m -71.3 169.82 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.081 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.6 p -162.86 161.18 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.45 132.73 0.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.422 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 15.6 ttpt -39.63 148.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.738 0.304 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.472 ' O ' HD13 ' A' ' 152' ' ' LEU . 20.9 ttp -156.2 149.22 24.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.407 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.7 113.66 8.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.562 HD21 ' CG1' ' A' ' 104' ' ' ILE . 4.0 pp -120.89 157.81 29.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -77.67 154.51 32.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mt -114.06 134.12 55.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.507 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 10.7 m95 -74.57 147.37 84.63 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.567 0.699 . . . . 0.0 110.935 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 133.93 26.88 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.251 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.463 HG12 ' HD1' ' A' ' 101' ' ' TRP . 4.7 m -69.28 140.15 90.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 134.27 27.6 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -51.51 151.41 3.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . 86.76 -41.06 3.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' ' 131' ' ' ASP . 34.8 tp -34.73 99.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.774 0.321 . . . . 0.0 110.939 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.63 -22.67 59.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.585 ' HB2' HD11 ' A' ' 129' ' ' LEU . 70.2 m-20 -74.24 174.59 8.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.1 mt -114.14 -43.36 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 82' ' ' SER . 13.7 tp -105.59 131.72 52.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -110.3 91.81 12.35 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.647 0.737 . . . . 0.0 110.902 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.79 -28.36 25.2 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.656 2.237 . . . . 0.0 112.335 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.558 HD13 ' HA2' ' A' ' 41' ' ' GLY . 12.2 mm -77.21 -23.58 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.09 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.427 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -36.5 147.77 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.32 174.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 111.159 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 42.2 p -117.28 172.47 7.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.163 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.33 169.63 42.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.529 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.4 p -87.68 135.99 33.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 110.833 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -76.2 122.36 86.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.657 0.742 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -1.33 8.25 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.677 2.252 . . . . 0.0 112.365 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -82.62 129.05 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -84.39 -53.53 5.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -40.6 -35.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.7 p -69.39 151.37 96.85 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 160.1 50.96 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.731 2.287 . . . . 0.0 112.348 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 14.5 t -140.09 136.4 33.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.573 ' HG ' HD11 ' A' ' 83' ' ' ILE . 8.7 mt -106.47 152.18 23.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.422 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 14.8 tt0 -120.71 115.66 23.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.835 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -121.06 159.42 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.958 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.406 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 63.5 mt-10 -116.09 122.55 45.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.603 ' CE2' HD21 ' A' ' 152' ' ' LEU . 28.9 m-85 -90.82 112.53 24.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.553 ' C ' ' CD1' ' A' ' 156' ' ' TRP . 6.6 t0 -132.61 159.07 40.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.781 ' CH2' HD22 ' A' ' 113' ' ' LEU . 3.6 m95 -152.17 108.18 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.498 ' CG ' ' N ' ' A' ' 158' ' ' SER . 31.5 p90 -102.22 -53.76 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.498 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 16.1 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -156.09 134.38 11.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.361 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -59.74 178.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.09 164.86 12.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 t 64.67 45.26 3.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.855 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -160.17 149.01 17.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.38 63.4 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.526 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.533 ' OD1' HG21 ' A' ' 70' ' ' ILE . 1.2 p30 -108.67 123.18 48.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.465 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -133.69 -47.13 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.818 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.62 133.62 54.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.848 HD13 ' CH2' ' A' ' 156' ' ' TRP . 15.8 tp -83.53 126.96 33.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.575 ' NE ' ' CE3' ' A' ' 63' ' ' TRP . 7.0 ttt180 -124.64 120.38 31.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.419 HD11 HD21 ' A' ' 11' ' ' LEU . 32.4 mt -131.14 141.07 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 34.8 tttt -122.26 128.66 51.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.0 mm -89.76 149.27 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.47 -70.63 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 p -172.45 -176.82 1.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.951 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.61 146.07 50.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 t -120.15 138.09 53.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 67.11 45.25 1.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.934 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.552 HG12 ' N ' ' A' ' 22' ' ' ASN . 88.4 t -70.52 160.27 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.552 ' N ' HG12 ' A' ' 21' ' ' VAL . 28.2 m-20 -76.32 51.27 0.69 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.424 HG11 ' HB2' ' A' ' 55' ' ' CYS . 2.1 m -107.85 110.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.13 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -104.68 -61.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.9 pt -87.1 -177.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.411 ' HD3' ' N ' ' A' ' 26' ' ' ARG . 1.0 OUTLIER -121.31 49.28 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.84 -47.36 5.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 mt -41.83 137.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.117 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.52 -57.4 3.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -147.47 -178.7 6.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 53' ' ' VAL . 7.2 pt -139.86 178.02 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 1.2 p90 -173.22 156.61 3.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.57 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 87.3 t -113.75 149.7 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.121 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -122.35 132.78 54.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.1 p -128.52 162.02 28.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.44 143.32 3.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.442 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 37' ' ' ILE . 3.5 mp -86.72 140.82 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.37 . . . . 0.0 111.136 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.539 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 54.1 m-85 -136.4 145.28 45.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.51 ' CB ' HD11 ' A' ' 44' ' ' LEU . 4.5 t-160 -117.56 94.55 4.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.94 20.95 77.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.553 ' HA2' HD13 ' A' ' 136' ' ' ILE . . . 106.15 -26.84 19.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -85.02 141.89 38.11 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.623 0.725 . . . . 0.0 110.85 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 159.87 51.82 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.704 2.269 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.51 HD11 ' CB ' ' A' ' 39' ' ' HIS . 8.9 mp -120.64 -33.54 3.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.94 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.2 m -154.06 165.79 35.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.64 131.29 29.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.815 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -65.65 153.1 42.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.514 HG12 HD11 ' A' ' 64' ' ' LEU . 40.0 t -114.16 140.34 35.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -121.74 137.75 54.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.1 p -83.88 176.35 8.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -63.99 174.7 1.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -102.43 125.98 49.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -130.28 152.14 79.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.619 0.723 . . . . 0.0 111.101 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 142.28 47.46 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.689 2.259 . . . . 0.0 112.347 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.424 ' HB2' HG11 ' A' ' 23' ' ' VAL . 23.4 p -50.58 -48.16 57.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.8 t -47.34 -38.52 13.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -132.03 87.29 44.63 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.552 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.5 Cg_endo -69.78 3.66 2.65 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.709 2.272 . . . . 0.0 112.312 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -55.64 108.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.57 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.3 m-90 -93.56 -52.95 4.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.5 m120 43.31 49.75 5.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -121.19 138.09 54.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.575 ' CE3' ' NE ' ' A' ' 12' ' ' ARG . 77.8 m95 -84.09 108.39 16.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.514 HD11 HG12 ' A' ' 48' ' ' VAL . 9.9 tp -98.2 122.68 41.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -100.87 145.25 28.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -113.5 131.02 56.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -82.71 47.61 1.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.494 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.1 pp -114.26 168.13 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.611 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -115.07 129.86 56.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.612 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -62.84 -53.63 54.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 111.164 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.1 Cg_endo -69.69 -0.95 7.59 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.362 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.509 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.5 t70 -117.64 -13.47 10.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -71.6 114.97 32.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.556 0.693 . . . . 0.0 110.918 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.56 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.0 Cg_endo -69.79 146.37 59.82 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.637 2.225 . . . . 0.0 112.353 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.454 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 21.1 mmt85 -59.22 -41.84 89.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.45 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -55.64 -31.41 62.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.56 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -68.77 167.35 15.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -163.23 173.73 13.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.5 tp -95.37 142.8 27.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.605 ' C ' HD23 ' A' ' 81' ' ' LEU . 83.0 m -129.82 148.52 51.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -155.32 137.08 14.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.84 ' OG ' HD12 ' A' ' 133' ' ' LEU . 95.3 p -148.92 146.22 27.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.595 ' CG1' HD11 ' A' ' 150' ' ' LEU . 11.4 mt -93.16 143.37 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.176 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 74.7 m -137.85 145.78 42.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.8 p -109.76 122.56 47.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.714 HG23 ' CD2' ' A' ' 96' ' ' HIS . 12.0 p -105.79 121.63 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -134.64 145.08 48.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.69 174.21 39.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.514 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -102.95 170.55 7.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -65.65 -52.69 49.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.21 -2.27 87.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.46 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -118.21 178.04 4.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -91.71 170.31 10.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 9.9 mt-10 -102.62 161.43 13.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -126.61 119.16 26.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.714 ' CD2' HG23 ' A' ' 86' ' ' VAL . 8.1 m170 -98.77 124.16 43.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.74 123.21 15.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.866 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 143.03 49.42 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.662 2.241 . . . . 0.0 112.351 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.0 mt -107.63 -45.8 3.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.38 178.18 7.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.518 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 70.0 p-90 -154.33 137.89 15.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.03 138.5 7.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.473 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -122.25 140.55 52.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.587 HD11 HD21 ' A' ' 120' ' ' LEU . 56.5 mt -120.97 139.69 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 106' ' ' LEU . 77.7 m-20 -76.69 87.91 3.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 105' ' ' ASN . 21.9 mt -34.49 -36.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.454 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 59.0 m-85 -109.67 119.34 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -53.1 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.85 6.47 5.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 p -128.76 18.19 6.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.181 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 65.06 29.84 11.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 113' ' ' LEU . 88.2 m -118.68 105.76 11.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 112' ' ' THR . 31.4 mt -36.07 141.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.5 m -70.45 170.35 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.1 m -168.9 164.28 11.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.17 140.72 1.01 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.446 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 38.3 tttt -44.6 149.15 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.783 0.325 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.4 ttp -159.89 154.03 23.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.691 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.95 126.67 20.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.587 HD21 HD11 ' A' ' 104' ' ' ILE . 4.1 pp -136.15 153.78 51.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -79.25 158.52 27.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.776 HD11 HD12 ' A' ' 150' ' ' LEU . 1.9 mt -116.4 148.09 41.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.566 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 8.1 m95 -85.51 150.53 54.22 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.571 0.7 . . . . 0.0 110.944 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 138.82 38.71 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.663 2.242 . . . . 0.0 112.391 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.4 m -64.65 141.93 98.38 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.625 0.726 . . . . 0.0 111.124 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 152.92 69.59 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.697 2.265 . . . . 0.0 112.304 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -52.86 152.0 4.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.42 81.15 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.503 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.4 tp -123.08 111.26 16.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.736 0.303 . . . . 0.0 110.923 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -79.12 -53.36 7.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -59.31 158.66 8.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.7 mt -91.93 -46.54 7.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.84 HD12 ' OG ' ' A' ' 82' ' ' SER . 4.8 tp -102.98 139.34 38.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -105.41 91.52 4.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.679 0.752 . . . . 0.0 110.87 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.9 Cg_endo -69.73 -22.76 31.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.723 2.282 . . . . 0.0 112.366 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.553 HD13 ' HA2' ' A' ' 41' ' ' GLY . 13.4 mm -82.69 -22.12 9.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -37.08 153.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.498 HG22 ' CH2' ' A' ' 101' ' ' TRP . 5.7 m -69.5 173.33 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 111.117 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.7 p -115.22 165.25 13.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 99.37 159.68 29.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.0 p -75.49 130.48 38.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.832 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.566 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 11.2 t-20 -70.84 118.47 65.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.651 0.739 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 1.98 3.94 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.67 2.246 . . . . 0.0 112.392 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -90.59 116.43 28.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -76.85 -44.19 33.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -49.03 -26.97 2.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 67.9 p -78.82 152.24 77.26 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.558 0.694 . . . . 0.0 111.165 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 146.26 59.48 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.685 2.257 . . . . 0.0 112.363 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.7 t -123.79 148.92 46.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.776 HD12 HD11 ' A' ' 122' ' ' LEU . 5.9 mt -118.96 150.64 39.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.691 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 5.4 mp0 -112.64 139.92 47.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.727 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -148.6 151.6 35.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.446 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 35.5 mt-10 -119.51 123.11 43.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.727 ' CE2' HD21 ' A' ' 152' ' ' LEU . 62.6 m-85 -85.97 115.06 23.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.09 129.15 49.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.848 ' CH2' HD13 ' A' ' 11' ' ' LEU . 20.7 m95 -124.26 81.55 1.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.5 ' CG ' ' N ' ' A' ' 158' ' ' SER . 43.4 p90 -79.46 -54.47 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.5 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 3.0 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.1 m -119.83 88.78 3.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.873 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m -156.07 146.58 21.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.52 115.8 4.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 t -75.93 144.24 41.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 0.0 110.83 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.7 m -86.65 -54.09 4.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.31 -130.72 3.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -62.76 104.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.951 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.409 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 1.8 m -118.63 -34.52 3.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.01 140.36 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.686 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 10.6 tp -103.64 137.49 41.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.563 ' N ' HD12 ' A' ' 11' ' ' LEU . 16.3 ptt180 -145.41 138.37 26.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.843 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.4 mt -138.4 139.14 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 43.8 tttm -114.9 137.06 52.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.8 mm -98.59 144.82 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.71 -67.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.6 p -169.56 175.05 5.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.813 ' HB2' HD23 ' A' ' 150' ' ' LEU . . . -139.1 154.41 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.675 HG23 ' CD2' ' A' ' 20' ' ' TYR . 2.9 t -130.96 162.37 29.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.675 ' CD2' HG23 ' A' ' 19' ' ' THR . 10.0 m-85 64.44 50.13 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 22' ' ' ASN . 3.9 t -83.38 163.61 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 21' ' ' VAL . 25.1 t30 -84.03 35.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 23' ' ' VAL . 33.5 m -97.61 93.51 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -106.71 -18.05 14.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -104.35 -177.57 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.8 mmm-85 -129.09 60.19 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -126.31 -32.91 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.864 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.0 mt -57.3 118.0 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -73.96 -56.19 5.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -142.06 172.83 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 pt -141.54 161.11 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -151.38 153.57 35.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.745 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 79.3 t -105.48 137.12 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -110.19 120.15 41.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 p -117.84 161.21 20.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.171 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.78 143.46 3.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.442 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.713 HG23 ' O ' ' A' ' 78' ' ' ARG . 3.9 mp -96.61 137.05 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 111.191 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.465 ' HA ' ' CD1' ' A' ' 44' ' ' LEU . 2.7 m-85 -128.52 150.18 50.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.957 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.457 ' C ' ' CD2' ' A' ' 39' ' ' HIS . 9.3 t-160 -121.85 99.07 6.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.04 47.23 19.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.74 33.83 81.47 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -146.64 143.69 19.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.68 0.752 . . . . 0.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 150.17 68.27 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.72 2.28 . . . . 0.0 112.365 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.465 ' CD1' ' HA ' ' A' ' 38' ' ' TYR . 7.8 mp -105.69 -39.37 6.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.889 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.0 t -156.28 166.13 34.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.24 124.73 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -61.01 154.09 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.644 HG12 HD11 ' A' ' 64' ' ' LEU . 61.6 t -110.26 137.4 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -119.27 147.91 43.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.5 p -96.18 167.25 11.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -54.15 176.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -105.49 108.98 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -114.26 152.39 45.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.626 0.727 . . . . 0.0 111.128 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 135.65 31.11 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.733 2.289 . . . . 0.0 112.36 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.41 ' HB2' HG11 ' A' ' 23' ' ' VAL . 19.3 p -45.98 -47.26 16.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.2 m -51.27 -30.21 17.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -133.8 87.78 34.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.619 0.723 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.548 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 2.94 3.09 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.681 2.254 . . . . 0.0 112.333 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -58.47 103.84 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.745 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.3 m-90 -90.71 -46.76 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 61' ' ' ASN . 2.7 p-10 39.23 46.99 1.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -120.95 135.86 55.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.461 ' CE3' ' HD2' ' A' ' 12' ' ' ARG . 45.7 m95 -81.35 103.55 11.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.644 HD11 HG12 ' A' ' 48' ' ' VAL . 10.4 tp -90.68 121.44 32.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -101.0 133.37 45.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -100.99 131.68 46.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.2 41.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.828 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.507 HD13 HD23 ' A' ' 73' ' ' LEU . 1.7 pp -112.45 161.89 10.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.603 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -113.54 121.96 45.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -53.42 -54.15 48.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.595 0.712 . . . . 0.0 111.104 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.4 Cg_endo -69.7 3.49 2.71 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.677 2.252 . . . . 0.0 112.396 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.5 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 9.5 t0 -125.22 -4.49 7.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.918 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.507 HD23 HD13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -76.1 113.61 29.59 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 110.902 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.651 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.4 Cg_endo -69.77 132.05 22.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.704 2.27 . . . . 0.0 112.336 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 11.6 mpt_? -45.46 -42.07 10.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.04 -43.75 78.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.066 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.651 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -55.6 165.02 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.083 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.713 ' O ' HG23 ' A' ' 37' ' ' ILE . 8.2 ptp180 -163.28 173.42 13.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 tp -93.82 138.31 32.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.2 m -136.23 126.4 26.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.16 161.24 33.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 p -166.53 131.9 2.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 99' ' ' LEU . 17.8 mt -83.91 144.44 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 62.0 m -147.81 155.04 41.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 t -105.89 150.72 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 86' ' ' VAL . 8.4 p -135.93 125.2 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -151.39 134.14 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.49 -137.74 2.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.486 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 61.1 mtt180 -149.37 166.94 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -63.11 120.28 11.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.22 -29.18 3.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.475 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -89.18 160.67 16.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 0.0 111.114 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 169.42 14.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -106.55 -175.53 2.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -130.21 125.92 36.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -103.46 129.21 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.1 t -137.49 123.78 13.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.429 ' HB2' HG21 ' A' ' 125' ' ' VAL . 53.7 Cg_endo -69.79 152.96 69.27 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.673 2.249 . . . . 0.0 112.333 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 125' ' ' VAL . 16.0 mt -126.37 -51.13 1.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.409 ' HB2' ' HG3' ' A' ' 148' ' ' PRO . . . -142.41 -177.58 5.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.511 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 67.5 p-90 -164.44 126.04 2.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.475 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -131.94 131.42 6.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.402 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -106.85 129.73 54.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 110.861 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.44 HD11 HD21 ' A' ' 120' ' ' LEU . 76.2 mt -119.34 119.27 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 106' ' ' LEU . 1.6 t30 -73.25 94.57 2.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 105' ' ' ASN . 41.6 mt -35.14 -35.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.488 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 51.3 m-85 -104.39 106.5 17.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.906 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.43 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 42.5 p30 -54.93 -177.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -57.12 -39.19 74.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.424 HG23 ' OG1' ' A' ' 112' ' ' THR . 10.0 t -86.9 32.14 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.14 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 37.78 54.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.424 ' OG1' HG23 ' A' ' 110' ' ' THR . 23.7 m -132.77 116.64 16.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.944 HD22 ' CH2' ' A' ' 156' ' ' TRP . 11.9 mt -44.56 126.62 5.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.604 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 16.3 m -57.51 176.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.9 p -173.83 164.11 4.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.18 149.18 0.2 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 7.5 ttpt -39.55 158.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.485 ' HG2' ' N ' ' A' ' 119' ' ' ALA . 2.8 ttm -156.62 144.96 19.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.485 ' N ' ' HG2' ' A' ' 118' ' ' MET . . . -140.35 106.96 5.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.083 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.477 ' C ' HD12 ' A' ' 120' ' ' LEU . 4.1 pp -126.35 163.53 23.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -92.31 158.53 16.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.511 HD11 HD12 ' A' ' 150' ' ' LEU . 12.0 mt -112.59 156.08 23.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.566 ' CE3' ' OD1' ' A' ' 142' ' ' ASN . 28.0 m95 -86.57 150.64 51.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.538 0.685 . . . . 0.0 110.924 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 145.92 58.44 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.699 2.266 . . . . 0.0 112.309 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 99' ' ' LEU . 94.2 t -71.51 126.64 91.67 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 111.121 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -173.86 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.649 2.233 . . . . 0.0 112.314 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -95.05 -35.92 11.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.28 65.85 2.77 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.42 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.411 HD23 HG13 ' A' ' 125' ' ' VAL . 19.4 tp -147.64 126.93 13.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.79 0.329 . . . . 0.0 110.905 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -101.17 -47.11 4.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.854 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.94 144.01 54.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.66 -58.64 5.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.3 tp -84.8 127.53 34.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -104.38 93.53 5.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 110.83 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.443 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.6 Cg_endo -69.74 -17.14 37.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.664 2.243 . . . . 0.0 112.372 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 mm -84.88 -23.15 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.49 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -38.74 151.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.13 163.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.1 p -108.44 151.75 25.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.62 142.84 8.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.5 p -63.11 116.66 5.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.566 ' OD1' ' CE3' ' A' ' 123' ' ' TRP . 32.7 t30 -53.64 130.01 54.8 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.572 0.701 . . . . 0.0 110.93 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -27.03 27.06 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.694 2.263 . . . . 0.0 112.317 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -51.72 144.4 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt -99.53 -37.03 9.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -83.26 39.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.2 p -122.85 156.05 62.67 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.57 0.7 . . . . 0.0 111.127 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.409 ' HG3' ' HB2' ' A' ' 100' ' ' ALA . 53.3 Cg_endo -69.77 124.65 11.28 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.704 2.269 . . . . 0.0 112.344 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.443 ' SG ' HG22 ' A' ' 19' ' ' THR . 1.4 p -115.92 150.69 36.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.813 HD23 ' HB2' ' A' ' 18' ' ' ALA . 7.4 mt -128.18 135.3 49.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.96 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.424 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 10.1 tt0 -102.49 125.11 49.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.83 ' H ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -127.72 169.36 13.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.441 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 26.1 mt-10 -126.4 125.38 42.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.604 ' CZ ' HG21 ' A' ' 114' ' ' VAL . 45.0 m-85 -92.1 119.51 31.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -137.39 137.53 38.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.944 ' CH2' HD22 ' A' ' 113' ' ' LEU . 11.6 m95 -127.84 82.45 2.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 158' ' ' SER . 22.0 p90 -85.75 -52.75 5.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.574 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 85.6 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m -150.9 121.33 7.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 110.832 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 t -71.83 95.39 1.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.04 116.06 2.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.463 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.9 p -124.96 -53.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.851 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.8 t -98.37 108.66 21.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.23 132.61 21.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.499 ' HB2' HG21 ' A' ' 70' ' ' ILE . 0.8 OUTLIER -57.84 122.23 12.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 110.89 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.06 -46.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.737 ' HB3' ' HB2' ' A' ' 158' ' ' SER . . . -120.07 121.85 39.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.753 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 22.2 tp -85.82 144.99 27.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.61 ' NH2' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -135.71 146.93 48.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.541 HD12 ' CE1' ' A' ' 66' ' ' TYR . 54.4 mt -145.52 121.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.581 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 73.8 tttt -103.58 131.37 50.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mm -94.07 137.59 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.12 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.23 -72.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.4 p -172.01 172.68 4.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.893 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.15 142.33 48.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.035 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.457 HG23 ' CD2' ' A' ' 20' ' ' TYR . 10.9 t -111.57 136.2 51.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.457 ' CD2' HG23 ' A' ' 19' ' ' THR . 2.6 m-85 65.67 32.94 8.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 22' ' ' ASN . 56.1 t -40.42 161.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.076 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' HG12 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -84.53 37.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.438 HG13 ' CG1' ' A' ' 21' ' ' VAL . 21.1 m -78.76 53.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -50.34 -59.46 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 27' ' ' ASP . 3.9 pt -76.64 168.71 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.161 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -120.53 40.84 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.817 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' HB3' HD12 ' A' ' 25' ' ' ILE . 28.3 t70 -109.84 -31.54 7.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.587 HG21 ' HB2' ' A' ' 85' ' ' SER . 7.7 mt -66.86 142.53 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.145 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.45 ' C ' ' HD2' ' A' ' 30' ' ' LYS . 7.4 t70 -115.02 -53.0 2.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HD2' ' C ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -108.1 155.92 19.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.1 pt -141.55 170.34 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CE2' ' ND1' ' A' ' 96' ' ' HIS . 9.6 p90 -163.96 154.44 15.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.726 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 61.7 t -117.71 137.89 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -112.26 140.78 46.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.633 HG22 ' HB3' ' A' ' 81' ' ' LEU . 16.8 p -134.4 177.01 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.39 148.78 5.28 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.532 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.487 HG12 HD11 ' A' ' 106' ' ' LEU . 3.6 mp -97.0 132.77 40.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 0.0 111.092 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.512 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 18.8 m-85 -126.47 150.05 48.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.501 ' CB ' HD11 ' A' ' 44' ' ' LEU . 8.4 t-160 -127.35 101.1 6.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.92 38.16 36.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.63 33.35 58.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -148.2 140.14 14.3 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.678 0.751 . . . . 0.0 110.845 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 149.22 67.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.681 2.254 . . . . 0.0 112.335 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.501 HD11 ' CB ' ' A' ' 39' ' ' HIS . 11.0 mp -102.1 -42.85 5.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 t -147.22 170.72 16.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -47.54 126.85 10.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -61.01 160.15 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.782 HG12 HD11 ' A' ' 64' ' ' LEU . 48.5 t -122.57 136.19 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -120.63 146.09 46.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -89.42 171.85 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.116 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -56.56 169.27 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -101.1 110.63 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.41 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -112.1 152.13 44.13 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.65 0.738 . . . . 0.0 111.109 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 142.06 47.09 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.698 2.265 . . . . 0.0 112.331 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.7 p -50.63 -42.71 56.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.6 p -60.04 -29.12 68.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -131.36 84.22 57.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.617 0.723 . . . . 0.0 110.921 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 4.27 2.29 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.309 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -61.3 112.06 2.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.726 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 5.0 m-90 -95.46 -65.36 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 55.31 45.51 25.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -120.08 136.54 54.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.592 ' CZ3' ' HD2' ' A' ' 12' ' ' ARG . 71.3 m95 -83.55 98.87 9.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.921 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.782 HD11 HG12 ' A' ' 48' ' ' VAL . 11.2 tp -86.95 109.76 19.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -91.22 145.12 24.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.541 ' CE1' HD12 ' A' ' 13' ' ' ILE . 31.8 m-85 -111.08 134.04 52.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.66 50.86 2.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.914 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.44 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.2 pp -117.42 165.7 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.625 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.0 120.36 38.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.1 mp -51.45 -53.8 45.85 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 0.0 111.142 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.625 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.81 3.56 2.73 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.26 . . . . 0.0 112.342 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.511 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 6.0 t70 -124.1 -8.43 7.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -82.59 110.44 22.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.658 0.742 . . . . 0.0 110.915 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.429 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.5 Cg_endo -69.76 139.52 40.43 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.661 2.24 . . . . 0.0 112.377 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.541 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 1.8 mpp_? -50.16 -37.8 36.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.81 -48.45 66.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.116 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -58.83 155.05 13.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -150.23 171.22 17.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.8 tp -94.23 137.62 33.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.1 m -136.54 142.8 43.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.633 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.7 OUTLIER -145.29 156.95 44.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.5 m -156.44 135.54 12.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.463 HG12 HD11 ' A' ' 150' ' ' LEU . 26.0 mt -84.74 137.67 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 54.3 m -130.25 170.11 14.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.587 ' HB2' HG21 ' A' ' 28' ' ' ILE . 49.5 p -123.71 126.57 46.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 86' ' ' VAL . 13.3 p -118.09 120.73 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.163 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -146.01 126.91 14.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.76 -155.69 6.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.5 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -141.93 147.96 37.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.868 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -43.65 119.86 1.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.75 -33.68 3.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.72 160.15 18.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.1 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -72.05 172.13 10.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -104.02 -176.55 3.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -134.83 116.69 15.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.462 ' ND1' ' CE2' ' A' ' 32' ' ' TYR . 11.8 m170 -97.83 130.37 44.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.23 131.76 12.25 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.629 0.728 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 147.32 62.51 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.703 2.269 . . . . 0.0 112.353 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.554 ' O ' HG22 ' A' ' 125' ' ' VAL . 51.5 mt -122.13 -56.91 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.88 177.36 7.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 65.7 p-90 -155.65 123.18 5.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.408 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -135.58 135.24 7.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -114.85 162.37 16.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.561 HD11 HD21 ' A' ' 120' ' ' LEU . 88.2 mt -147.12 118.47 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' LEU . 26.0 m-80 -59.21 92.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.487 HD11 HG12 ' A' ' 37' ' ' ILE . 10.7 mt -36.06 -42.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.541 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 97.5 m-85 -104.09 108.42 19.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 44.2 p30 -53.13 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.437 ' CE1' ' HB ' ' A' ' 110' ' ' THR . 34.3 p90 -55.43 -40.39 71.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.437 ' HB ' ' CE1' ' A' ' 109' ' ' TYR . 10.0 t -86.22 33.31 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.5 OUTLIER 37.18 49.9 0.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 89.7 m -130.53 110.45 11.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.765 HD22 ' CH2' ' A' ' 156' ' ' TRP . 36.7 mt -34.78 138.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.5 m -69.86 172.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.2 p -168.94 159.41 9.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.69 145.32 2.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.455 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -43.12 151.15 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.472 ' O ' HD13 ' A' ' 152' ' ' LEU . 28.3 ttp -159.48 146.68 16.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.76 122.3 16.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.561 HD21 HD11 ' A' ' 104' ' ' ILE . 3.9 pp -133.89 158.37 43.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -78.39 158.17 28.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.829 HD11 HD12 ' A' ' 150' ' ' LEU . 7.1 mt -120.35 142.27 49.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.642 ' CE3' ' ND2' ' A' ' 142' ' ' ASN . 6.4 m95 -83.5 142.93 43.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.564 0.697 . . . . 0.0 110.904 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 131.13 20.65 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.235 . . . . 0.0 112.377 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 99' ' ' LEU . 15.7 m -65.16 136.65 96.68 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.662 0.744 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 140.8 43.51 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 0.0 112.347 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -41.49 -43.37 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -84.84 84.57 1.59 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 46.1 tp -147.73 119.02 7.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -94.69 -27.44 15.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -94.9 129.22 42.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 15.6 mt -58.19 -46.95 84.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.978 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.576 HD11 ' HA ' ' A' ' 81' ' ' LEU . 8.7 tp -96.19 139.83 31.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -107.04 91.63 6.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.587 0.708 . . . . 0.0 110.923 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.512 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.5 Cg_endo -69.73 -37.38 9.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.673 2.249 . . . . 0.0 112.337 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 36.1 mt -73.96 -22.62 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -40.59 144.7 0.5 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 138' ' ' VAL . 1.9 m -50.43 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.114 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 67.1 p -127.14 165.36 19.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.83 176.49 35.2 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 90.9 p -88.12 149.52 23.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.884 0.373 . . . . 0.0 110.848 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.642 ' ND2' ' CE3' ' A' ' 123' ' ' TRP . 60.5 t-20 -90.57 124.79 61.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.893 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.465 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.73 2.85 3.15 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.661 2.241 . . . . 0.0 112.339 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -85.24 130.92 34.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -89.2 -52.96 4.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -48.55 -24.54 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.882 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.4 p -74.01 151.87 88.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.567 0.698 . . . . 0.0 111.171 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 140.53 43.06 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.692 2.261 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.7 t -123.11 135.5 54.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.829 HD12 HD11 ' A' ' 122' ' ' LEU . 6.4 mt -105.18 139.8 39.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.87 123.68 49.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.815 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -135.44 165.04 26.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -124.25 141.62 51.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.574 ' CE2' HD21 ' A' ' 152' ' ' LEU . 51.1 m-85 -104.58 136.78 43.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.424 ' HB3' ' CG ' ' A' ' 12' ' ' ARG . 1.5 t70 -152.5 147.62 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.765 ' CH2' HD22 ' A' ' 113' ' ' LEU . 7.1 m95 -134.26 89.36 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.61 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 9.3 p90 -87.36 -52.26 5.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.737 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 2.7 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.843 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.0 p -98.48 146.68 25.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 0.0 110.853 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -47.07 170.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.94 50.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.4 p -81.52 157.18 24.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.4 m -111.58 87.96 2.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.01 83.19 0.15 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.458 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -100.0 141.19 33.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.887 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.6 m -122.36 -31.93 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.828 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.93 142.28 47.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.72 HD13 ' CH2' ' A' ' 156' ' ' TRP . 27.4 tp -104.35 142.76 34.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' HD2' ' CD1' ' A' ' 157' ' ' PHE . 2.2 ptm85 -148.64 128.15 13.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.677 HD12 ' CE1' ' A' ' 66' ' ' TYR . 16.2 mt -129.35 136.38 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.523 ' HB2' ' CD2' ' A' ' 63' ' ' TRP . 67.4 tttt -109.55 125.99 53.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 mm -91.34 141.2 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.456 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.2 mm? -99.61 -74.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.7 p -167.83 178.42 5.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.24 166.89 16.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -135.68 159.09 42.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 41.09 53.51 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.672 ' HB ' HG22 ' A' ' 23' ' ' VAL . 39.0 t -82.84 146.24 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.107 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' VAL . 2.6 t-20 -42.06 -41.68 2.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.672 HG22 ' HB ' ' A' ' 21' ' ' VAL . 4.6 m -35.02 110.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.168 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -128.14 -46.24 1.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.842 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.533 HD12 ' HB3' ' A' ' 27' ' ' ASP . 32.9 pt -75.51 -176.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 33.49 5.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' HB3' HD12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -94.41 -46.34 7.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.0 mt -52.35 148.1 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.68 -58.29 2.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -143.81 176.7 9.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.8 pt -136.63 168.37 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -163.08 152.37 15.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.838 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 94.9 t -97.92 142.72 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.138 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.41 ' NH2' ' OD1' ' A' ' 47' ' ' ASN . 49.2 ttt85 -119.57 117.33 28.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 81' ' ' LEU . 27.7 p -114.69 170.85 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.87 139.11 2.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.542 HD13 HG21 ' A' ' 68' ' ' ILE . 3.3 mp -92.01 138.6 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.145 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.538 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 27.6 m-85 -130.63 164.45 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -133.85 95.29 3.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.845 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.51 -11.97 53.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 135.66 -6.23 4.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -110.45 146.5 34.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.466 ' C ' HD12 ' A' ' 44' ' ' LEU . 54.3 Cg_endo -69.73 160.26 50.36 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.466 HD12 ' C ' ' A' ' 43' ' ' PRO . 8.3 mp -120.02 -33.81 3.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.8 m -151.63 169.35 22.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -53.37 136.42 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.41 ' OD1' ' NH2' ' A' ' 34' ' ' ARG . 31.8 m120 -74.53 158.01 34.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.562 HG12 HD11 ' A' ' 64' ' ' LEU . 43.3 t -116.82 139.22 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.72 142.39 49.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.5 p -89.29 160.83 16.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -52.24 165.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -93.27 119.92 32.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.5 m -120.32 152.14 54.48 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.635 0.731 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 133.07 24.75 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.7 2.267 . . . . 0.0 112.35 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.7 p -44.09 -48.58 9.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -47.81 -34.34 8.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -134.51 86.88 33.62 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.72 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HA ' HG21 ' A' ' 53' ' ' VAL . 53.6 Cg_endo -69.81 3.23 2.92 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.673 2.248 . . . . 0.0 112.328 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -55.22 118.19 4.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.838 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.6 m-90 -101.17 -52.33 3.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.456 ' OD1' HD13 ' A' ' 16' ' ' LEU . 76.0 m-20 43.83 41.25 3.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -120.82 137.7 54.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.523 ' CD2' ' HB2' ' A' ' 14' ' ' LYS . 59.3 m95 -82.27 109.97 17.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.916 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.562 HD11 HG12 ' A' ' 48' ' ' VAL . 10.5 tp -92.03 120.15 32.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.928 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -97.84 136.26 38.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.677 ' CE1' HD12 ' A' ' 13' ' ' ILE . 58.8 m-85 -107.58 127.29 53.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.34 43.69 0.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.542 HG21 HD13 ' A' ' 37' ' ' ILE . 2.2 pp -107.32 166.06 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.618 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.57 125.29 49.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.605 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -58.77 -53.92 61.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.641 0.734 . . . . 0.0 111.13 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.9 Cg_endo -69.75 3.04 3.0 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.499 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 6.2 t70 -124.77 -2.32 7.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.487 HD21 HG21 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -87.69 113.13 53.01 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.665 0.745 . . . . 0.0 110.918 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.5 Cg_endo -69.83 132.77 23.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.512 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -46.61 -42.23 15.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.65 -40.88 60.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.139 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -62.08 168.17 3.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -159.21 173.44 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.409 ' HG ' ' CD2' ' A' ' 81' ' ' LEU . 53.3 tp -95.65 134.8 38.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.597 ' C ' HD23 ' A' ' 81' ' ' LEU . 17.3 m -127.18 147.37 50.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.597 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER -155.55 139.92 16.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.667 ' HB3' HD12 ' A' ' 133' ' ' LEU . 5.0 t -145.63 140.82 27.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.662 HG22 HD12 ' A' ' 99' ' ' LEU . 47.0 mt -83.99 124.9 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 67.2 m -124.21 145.23 49.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.478 ' HA ' HG22 ' A' ' 31' ' ' ILE . 6.0 p -106.07 128.57 53.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.49 HG23 ' CD2' ' A' ' 96' ' ' HIS . 10.4 p -108.57 126.55 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.191 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.64 141.09 31.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.58 -153.98 24.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -117.58 178.22 4.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.368 . . . . 0.0 110.888 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -80.93 -68.7 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.19 -24.04 27.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.517 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.65 174.27 5.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.365 . . . . 0.0 111.122 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -83.89 158.49 21.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -101.66 -175.91 2.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -128.69 127.96 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.49 ' CD2' HG23 ' A' ' 86' ' ' VAL . 15.3 m170 -107.9 132.89 52.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.5 t -137.42 132.71 17.85 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.605 0.717 . . . . 0.0 110.851 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 153.04 69.3 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.699 2.266 . . . . 0.0 112.354 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.662 HD12 HG22 ' A' ' 83' ' ' ILE . 20.8 mt -128.28 -35.57 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.44 155.63 24.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.679 ' HD1' HG12 ' A' ' 125' ' ' VAL . 59.4 p-90 -132.21 134.68 45.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.35 121.63 2.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -108.34 133.35 52.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.879 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.705 HG12 HD21 ' A' ' 120' ' ' LEU . 18.9 mt -118.21 140.38 41.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 107' ' ' PHE . 49.0 m-80 -70.67 85.87 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 105' ' ' ASN . 12.4 mt -34.9 -35.25 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 83.3 m-85 -112.93 123.05 49.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.898 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -51.07 -176.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.56 12.32 3.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 p -130.35 14.21 5.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 70.61 34.38 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.7 m -128.49 109.21 11.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.51 HD22 ' CH2' ' A' ' 156' ' ' TRP . 17.3 mt -38.58 149.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.2 m -72.56 178.08 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.143 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.4 p -174.01 156.18 2.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.44 170.11 45.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 32.5 tttt -71.05 148.7 47.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.733 0.302 . . . . 0.0 110.92 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.7 ttp -156.51 149.76 24.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.47 115.46 10.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.705 HD21 HG12 ' A' ' 104' ' ' ILE . 3.6 pp -128.86 155.97 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.03 153.84 28.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.911 HD11 HD12 ' A' ' 150' ' ' LEU . 7.7 mt -109.91 158.17 18.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.523 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 13.2 m95 -95.24 139.95 22.22 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 129.02 16.88 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.714 2.276 . . . . 0.0 112.347 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.679 HG12 ' HD1' ' A' ' 101' ' ' TRP . 3.2 m -71.54 137.45 83.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.631 0.729 . . . . 0.0 111.127 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 159.84 51.96 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.707 2.271 . . . . 0.0 112.349 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -63.2 -39.56 94.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.14 78.81 1.96 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.446 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -145.16 127.34 15.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -91.26 -53.28 4.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.66 153.69 42.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.99 -37.92 25.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.667 HD12 ' HB3' ' A' ' 82' ' ' SER . 10.7 tp -106.16 142.88 35.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -105.41 91.33 4.71 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.538 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.1 Cg_endo -69.72 -43.85 2.45 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.0 112.336 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.0 mt -70.62 -19.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.412 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -41.34 146.15 0.5 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.422 ' H ' HG13 ' A' ' 138' ' ' VAL . 1.6 m -56.02 179.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.15 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.5 p -123.57 179.24 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.37 169.03 44.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.447 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 87.2 p -85.76 131.85 34.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.867 0.365 . . . . 0.0 110.876 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 123' ' ' TRP . 64.8 t-20 -69.27 120.85 79.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.567 0.698 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.428 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.6 Cg_endo -69.74 -19.78 35.78 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.344 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -53.3 132.57 39.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -86.83 -35.03 19.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -84.35 39.69 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.5 p -130.98 156.38 80.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.593 0.711 . . . . 0.0 111.134 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 174.51 9.38 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.701 2.268 . . . . 0.0 112.343 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.5 t -159.7 134.57 7.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.911 HD12 HD11 ' A' ' 122' ' ' LEU . 3.3 mt -110.0 143.69 39.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.442 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 6.2 tt0 -111.03 127.7 55.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.704 ' H ' HD13 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -137.79 156.19 48.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -113.89 117.81 32.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.688 ' CE2' HD21 ' A' ' 152' ' ' LEU . 29.3 m-85 -84.74 111.7 19.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.9 155.13 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.72 ' CH2' HD13 ' A' ' 11' ' ' LEU . 11.1 m95 -137.87 122.28 18.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.93 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.459 ' CD1' ' HD2' ' A' ' 12' ' ' ARG . 11.1 p90 -109.73 -44.99 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 10.6 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.867 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.7 p -124.04 157.39 34.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.343 . . . . 0.0 110.89 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 t -146.71 143.73 28.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.35 -107.83 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.464 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.8 p -167.39 164.09 15.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 0.0 110.845 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.3 m -101.88 91.13 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.91 -83.49 0.25 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.562 ' HB2' HG21 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -133.16 113.72 13.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.868 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.531 ' N ' HD13 ' A' ' 70' ' ' ILE . 1.9 t -134.59 -67.14 0.58 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -98.87 130.94 45.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.083 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.692 HD13 ' CH2' ' A' ' 156' ' ' TRP . 15.8 tp -84.99 134.93 34.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -128.73 133.52 48.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.529 HD12 ' CE1' ' A' ' 66' ' ' TYR . 26.2 mt -139.04 128.74 31.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.197 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.552 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 16.2 tttp -110.25 130.19 55.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.1 mm -95.15 140.03 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.18 -74.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.6 p -167.09 -179.46 4.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.07 166.13 17.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -136.69 141.18 43.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 60.71 50.1 5.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 22' ' ' ASN . 65.3 t -74.47 159.01 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.142 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.529 ' N ' HG12 ' A' ' 21' ' ' VAL . 1.4 m-20 -79.51 55.15 1.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.903 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.46 83.22 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -82.33 -64.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.682 HD13 ' OD2' ' A' ' 27' ' ' ASP . 2.8 pp -71.35 -177.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.56 79.61 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.682 ' OD2' HD13 ' A' ' 25' ' ' ILE . 72.3 m-20 -132.43 -53.69 0.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.754 HG21 ' HB2' ' A' ' 85' ' ' SER . 4.2 mp -39.09 122.71 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.07 -59.44 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -144.92 159.05 43.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' A' ' 85' ' ' SER . 8.6 pt -116.57 179.51 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -173.02 149.23 1.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.551 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 88.0 t -108.57 139.19 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 47' ' ' ASN . 6.9 tpt180 -109.45 133.83 52.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.1 p -128.07 163.56 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.31 152.83 7.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.492 HG12 HD11 ' A' ' 106' ' ' LEU . 2.7 mp -98.39 141.85 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 0.0 111.11 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.463 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 14.4 m-85 -132.55 142.93 49.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.849 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -120.81 94.35 4.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.42 37.16 36.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.66 -23.78 8.4 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -93.05 142.44 25.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.654 0.74 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.58 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.6 Cg_endo -69.78 165.24 31.64 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.705 2.27 . . . . 0.0 112.356 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.849 HD11 ' HB3' ' A' ' 39' ' ' HIS . 10.0 mp -125.77 -37.48 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 39.8 m -148.57 161.91 40.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.68 137.37 9.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 34' ' ' ARG . 19.6 m120 -70.43 149.89 46.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.591 HG12 HD11 ' A' ' 64' ' ' LEU . 64.4 t -110.96 133.26 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -115.78 147.41 41.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 33' ' ' VAL . 13.1 t -95.26 169.19 10.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.91 173.25 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -105.71 124.25 49.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -126.25 152.01 73.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.587 0.708 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 136.93 34.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.346 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.0 p -46.2 -46.15 17.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.3 t -50.33 -33.89 21.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -133.91 86.16 38.78 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.74 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.2 Cg_endo -69.8 4.35 2.26 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.704 2.269 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -58.06 107.29 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.576 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 1.9 m-90 -93.94 -49.82 5.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 61' ' ' ASN . 3.1 p-10 39.48 43.38 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -112.73 151.02 30.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.552 ' CE3' ' HB2' ' A' ' 14' ' ' LYS . 79.8 m95 -98.57 100.17 11.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.935 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.591 HD11 HG12 ' A' ' 48' ' ' VAL . 11.0 tp -88.31 118.61 28.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -98.82 145.83 26.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CE1' HD12 ' A' ' 13' ' ' ILE . 5.2 m-85 -114.68 135.85 53.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -90.34 52.32 2.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.437 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.4 pp -119.77 169.44 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -113.58 130.19 56.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.627 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -63.96 -52.8 53.93 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.668 0.747 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.9 Cg_endo -69.75 -3.74 12.61 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.51 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 8.3 t70 -114.39 -9.11 12.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -74.46 116.19 50.72 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.545 0.688 . . . . 0.0 110.928 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.78 134.91 29.07 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.683 2.256 . . . . 0.0 112.337 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.586 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 20.7 mmm-85 -47.92 -44.52 29.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.54 -44.87 66.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.138 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.58 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -54.89 161.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -158.7 176.06 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.8 tp -96.71 133.17 41.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.8 m -127.76 133.3 49.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.32 152.1 41.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 96.0 p -157.48 146.49 19.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.7 mt -89.15 147.11 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 61.5 m -149.15 141.62 24.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.754 ' HB2' HG21 ' A' ' 28' ' ' ILE . 94.7 p -106.46 118.62 37.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.597 HG23 ' CD2' ' A' ' 96' ' ' HIS . 12.4 p -101.44 136.23 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -140.46 121.82 14.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -119.77 174.91 15.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.489 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 3.3 mmt-85 -121.91 -175.63 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.866 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.49 104.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 44.49 24.22 0.62 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.489 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -102.52 -179.95 4.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.357 . . . . 0.0 111.08 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.85 158.56 36.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 4.6 mp0 -103.25 160.88 14.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.84 116.43 22.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.597 ' CD2' HG23 ' A' ' 86' ' ' VAL . 6.4 m170 -95.87 149.71 21.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 t -153.71 120.54 2.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 0.0 110.851 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 144.77 54.93 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.649 2.233 . . . . 0.0 112.335 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.677 ' O ' HG23 ' A' ' 125' ' ' VAL . 20.6 mt -115.53 -47.41 2.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -147.06 169.34 19.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.529 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 64.4 p-90 -147.9 132.89 18.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.9 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.28 120.48 2.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.504 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -100.25 139.37 36.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.76 0.314 . . . . 0.0 110.898 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.628 HD11 HD21 ' A' ' 120' ' ' LEU . 54.9 mt -131.09 120.94 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 106' ' ' LEU . 3.3 t-20 -67.11 95.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.492 HD11 HG12 ' A' ' 37' ' ' ILE . 18.7 mt -34.89 -39.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 63.6 m-85 -96.7 113.62 25.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -52.22 -176.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.84 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -65.27 -33.25 75.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.952 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -83.53 17.31 2.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 60.35 41.88 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.847 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.1 m -133.75 126.62 31.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.741 HD22 ' CH2' ' A' ' 156' ' ' TRP . 18.4 mt -47.17 144.57 2.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.79 -179.19 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.0 t -172.79 171.48 4.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.21 172.8 7.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 2.2 ttpm? -71.42 151.98 43.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.887 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 29.8 ttp -158.67 148.31 19.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.17 121.44 15.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.099 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.628 HD21 HD11 ' A' ' 104' ' ' ILE . 2.9 pp -134.45 160.11 39.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -83.56 151.11 25.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.447 ' HB2' ' HB1' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -109.14 151.03 26.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.529 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 16.3 m95 -80.64 152.61 72.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.534 0.683 . . . . 0.0 110.925 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 168.2 22.32 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 99' ' ' LEU . 68.6 t -86.72 119.99 71.57 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.592 0.711 . . . . 0.0 111.126 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 -169.45 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.403 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -97.95 -42.23 7.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.834 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.46 50.22 4.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.479 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.583 HD23 HG13 ' A' ' 125' ' ' VAL . 48.5 tp -133.87 106.28 7.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.339 . . . . 0.0 110.91 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -106.46 38.19 2.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -147.09 146.66 30.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mt -62.56 -60.84 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.3 tp -88.89 132.99 34.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.438 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 9.6 t-20 -105.71 91.53 5.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.648 0.737 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.463 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.8 Cg_endo -69.76 -27.6 26.28 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.6 mm -80.88 -17.02 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.438 ' CA ' ' OD1' ' A' ' 134' ' ' ASN . . . -43.54 155.07 0.22 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.47 HG22 ' CH2' ' A' ' 101' ' ' TRP . 8.9 m -71.88 163.21 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.869 0.366 . . . . 0.0 111.126 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.3 p -106.04 157.42 17.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.87 159.97 14.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.525 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.1 p -83.55 108.25 16.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.84 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.593 ' ND2' HG21 ' A' ' 147' ' ' THR . 14.3 t-20 -40.07 116.79 1.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.58 0.705 . . . . 0.0 110.841 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -8.41 23.53 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.655 2.237 . . . . 0.0 112.338 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -70.91 151.89 44.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -102.78 -24.53 13.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -85.94 29.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.593 HG21 ' ND2' ' A' ' 142' ' ' ASN . 25.0 p -124.41 153.03 69.09 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 111.148 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 154.19 68.08 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.722 2.281 . . . . 0.0 112.309 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.1 t -130.9 130.54 43.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 122' ' ' LEU . 4.7 mt -109.21 135.95 49.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -105.39 124.78 50.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.76 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -134.46 159.63 40.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.459 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 54.8 mt-10 -116.77 134.78 54.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.667 ' CE2' HD21 ' A' ' 152' ' ' LEU . 47.7 m-85 -99.96 103.7 15.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -114.27 141.13 47.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.741 ' CH2' HD22 ' A' ' 113' ' ' LEU . 60.0 m95 -125.13 76.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 158' ' ' SER . 9.5 p90 -70.88 -49.05 50.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.68 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 47.2 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -52.62 139.75 25.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 t -60.51 122.56 14.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.57 90.97 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.5 p -122.42 -47.88 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.36 . . . . 0.0 110.806 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t -50.25 146.67 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.36 -151.06 23.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.491 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.677 ' HB2' HG21 ' A' ' 70' ' ' ILE . 38.0 m-20 -101.67 152.7 20.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.897 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -132.59 -39.22 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.31 131.34 55.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.071 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.59 HD13 ' CH2' ' A' ' 156' ' ' TRP . 13.5 tp -93.71 136.24 34.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 157' ' ' PHE . 18.7 ptt180 -142.61 139.37 31.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.3 mt -136.92 142.25 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HD2' ' CE2' ' A' ' 63' ' ' TRP . 69.3 tttt -118.9 115.37 24.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.0 mm -81.23 145.68 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.49 -72.96 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.1 p -170.53 178.04 3.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -129.62 142.3 50.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 t -117.86 144.65 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 67.23 47.42 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.705 ' HB ' HG22 ' A' ' 23' ' ' VAL . 21.6 t -73.83 140.97 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 23' ' ' VAL . 61.4 t30 -49.1 -35.92 17.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.705 HG22 ' HB ' ' A' ' 21' ' ' VAL . 9.6 m -34.79 100.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.81 -69.64 0.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.424 ' C ' HD12 ' A' ' 25' ' ' ILE . 2.8 pp -49.56 -179.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.158 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -130.26 65.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.44 -43.87 0.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 mt -37.88 133.23 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -75.46 -63.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -144.69 -179.8 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 85' ' ' SER . 12.2 pt -137.56 178.87 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -173.67 138.57 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.74 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 14.9 t -90.08 145.82 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.439 ' HG2' HD13 ' A' ' 133' ' ' LEU . 19.4 ttt180 -127.54 120.99 29.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.863 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.626 HG22 ' HB3' ' A' ' 81' ' ' LEU . 56.2 p -117.15 179.45 4.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.25 138.88 2.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.465 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.472 HG12 HD11 ' A' ' 106' ' ' LEU . 3.1 mp -87.06 150.67 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 111.112 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.434 ' HA ' HD13 ' A' ' 44' ' ' LEU . 24.3 m-85 -140.77 152.64 45.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.683 ' CB ' HD11 ' A' ' 44' ' ' LEU . 10.2 t-160 -127.09 104.17 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.01 51.23 56.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.43 34.79 89.61 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.515 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -142.72 142.67 23.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.691 0.758 . . . . 0.0 110.861 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 149.73 67.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.704 2.27 . . . . 0.0 112.333 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.683 HD11 ' CB ' ' A' ' 39' ' ' HIS . 8.3 mp -114.05 -37.1 4.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.9 m -160.57 170.05 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.805 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -50.46 131.73 24.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -66.74 161.98 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.701 HG12 HD11 ' A' ' 64' ' ' LEU . 51.4 t -122.25 139.01 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -126.52 156.5 40.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -93.41 179.82 5.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -66.67 163.92 17.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -82.2 126.46 32.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 1.4 m -137.62 152.05 72.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.647 0.737 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 138.52 38.06 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.73 2.287 . . . . 0.0 112.317 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.462 ' HB2' HG11 ' A' ' 23' ' ' VAL . 23.3 p -49.98 -45.87 52.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.4 t -51.35 -35.72 39.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -130.48 84.77 58.32 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.717 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.588 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.72 3.85 2.51 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.69 2.26 . . . . 0.0 112.366 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -52.63 109.16 0.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.74 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 3.6 m-90 -103.54 -46.89 4.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 60' ' ' TRP . 7.8 p30 35.3 44.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -113.83 147.9 37.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.428 ' CE2' ' HD2' ' A' ' 14' ' ' LYS . 71.2 m95 -88.99 97.16 11.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.701 HD11 HG12 ' A' ' 48' ' ' VAL . 11.8 tp -84.62 111.56 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -91.28 132.87 35.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.937 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -99.42 137.41 37.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -88.21 44.26 1.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.855 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.419 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.2 pp -112.5 170.94 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.619 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.14 115.88 25.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.677 HG21 ' HB2' ' A' ' 8' ' ' ASN . 1.8 mp -53.38 -51.02 79.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.647 0.737 . . . . 0.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.0 Cg_endo -69.77 2.21 3.75 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.647 2.231 . . . . 0.0 112.382 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.504 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.3 t70 -123.49 -11.17 7.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.574 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -71.84 113.86 23.78 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.631 0.729 . . . . 0.0 110.901 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.3 Cg_endo -69.74 145.91 58.71 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -41.95 75.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -56.19 -37.97 70.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.611 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -59.85 164.55 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.601 ' HD2' HG21 ' A' ' 139' ' ' THR . 50.4 mtt85 -161.34 173.84 14.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 tp -98.3 131.86 44.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 9.5 m -127.65 135.95 50.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.626 ' HB3' HG22 ' A' ' 35' ' ' THR . 2.2 pp -142.83 155.56 44.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.402 ' OG ' HD12 ' A' ' 133' ' ' LEU . 85.2 p -160.16 134.82 7.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.5 mt -81.66 141.45 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 95.7 m -136.88 152.14 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.443 ' HA ' HG22 ' A' ' 31' ' ' ILE . 15.0 m -111.23 129.11 56.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 p -111.9 130.19 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -138.72 138.1 37.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.97 171.27 38.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.445 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.55 173.02 6.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.895 0.379 . . . . 0.0 110.857 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -62.99 136.47 57.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.34 -35.52 2.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.506 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.71 166.44 15.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 111.093 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.44 159.23 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -101.85 167.17 10.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -120.94 127.82 52.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -108.43 135.23 50.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.9 t -142.93 127.64 9.83 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.619 0.723 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.592 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.1 Cg_endo -69.77 146.61 60.67 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.653 2.235 . . . . 0.0 112.332 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.42 HD11 ' OG ' ' A' ' 85' ' ' SER . 22.6 mt -119.67 -43.56 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.936 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.1 162.16 41.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.061 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.415 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 66.6 p-90 -143.09 135.67 27.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.06 132.75 5.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 0.9 OUTLIER -111.28 138.18 48.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.792 0.329 . . . . 0.0 110.877 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.562 ' CG1' HD21 ' A' ' 120' ' ' LEU . 78.8 mt -120.6 134.62 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 107' ' ' PHE . 2.5 m120 -73.19 88.1 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.472 HD11 HG12 ' A' ' 37' ' ' ILE . 12.7 mt -36.26 -33.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 105' ' ' ASN . 57.1 m-85 -110.85 116.46 31.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -50.86 -178.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -64.26 -33.22 75.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.3 t -91.25 30.23 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.151 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.2 t0 49.74 49.21 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 113' ' ' LEU . 45.8 m -136.51 112.82 9.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.687 HD22 ' CH2' ' A' ' 156' ' ' TRP . 29.6 mt -36.73 148.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.514 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 18.2 m -75.62 -179.83 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.7 p -173.54 155.85 2.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.845 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.35 152.53 6.08 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.454 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -56.17 147.36 20.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.423 ' O ' HD13 ' A' ' 152' ' ' LEU . 35.9 ttp -156.95 153.09 27.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.92 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.27 132.07 37.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.581 HD12 ' O ' ' A' ' 120' ' ' LEU . 3.9 pp -138.75 154.63 48.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -77.35 156.82 31.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.1 mt -113.69 153.52 28.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.503 ' CH2' ' OD1' ' A' ' 142' ' ' ASN . 18.7 m95 -89.58 148.79 41.02 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.597 0.713 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 163.67 37.49 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.699 2.266 . . . . 0.0 112.333 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 98' ' ' PRO . 45.7 t -98.58 121.03 57.73 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.596 0.712 . . . . 0.0 111.116 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -175.4 1.14 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.717 2.278 . . . . 0.0 112.36 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -90.4 -38.22 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.69 56.82 5.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.477 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.515 HD23 HG13 ' A' ' 125' ' ' VAL . 46.2 tp -141.58 120.33 12.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.96 44.62 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -148.65 133.53 18.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.425 HD12 ' NH1' ' A' ' 34' ' ' ARG . 25.6 mt -59.71 -54.55 45.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.439 HD13 ' HG2' ' A' ' 34' ' ' ARG . 6.1 tp -97.77 136.03 38.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.47 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 11.2 t-20 -105.34 93.71 7.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.622 0.725 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -30.89 21.45 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.648 2.232 . . . . 0.0 112.373 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 137' ' ' GLY . 12.7 mm -75.19 -25.82 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.488 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -34.76 148.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.473 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.78 173.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 111.077 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.601 HG21 ' HD2' ' A' ' 78' ' ' ARG . 34.1 p -118.09 146.15 44.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.28 163.19 12.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.508 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.7 p -84.26 118.17 24.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.886 0.374 . . . . 0.0 110.883 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.503 ' OD1' ' CH2' ' A' ' 123' ' ' TRP . 24.0 t30 -60.89 129.44 90.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 110.913 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 2.03 3.87 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.662 2.241 . . . . 0.0 112.372 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.499 HD21 ' N ' ' A' ' 144' ' ' ASN . 0.9 OUTLIER -89.78 117.0 28.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -77.05 -46.18 24.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 147' ' ' THR . 14.8 pt-20 -43.6 -38.66 3.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.419 ' N ' ' HG3' ' A' ' 146' ' ' GLU . 64.6 p -64.25 151.87 89.68 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.606 0.717 . . . . 0.0 111.116 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 132.04 22.59 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.69 2.26 . . . . 0.0 112.375 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.2 m -113.07 136.99 52.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.941 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.674 ' CD2' ' HB2' ' A' ' 18' ' ' ALA . 8.4 mt -108.75 137.59 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -105.23 130.75 53.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.892 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -135.14 161.53 35.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -116.74 125.06 51.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.892 ' CE2' HD21 ' A' ' 152' ' ' LEU . 43.1 m-85 -93.41 108.02 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.0 155.82 49.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.687 ' CH2' HD22 ' A' ' 113' ' ' LEU . 6.9 m95 -136.45 105.24 5.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.485 ' CG ' ' N ' ' A' ' 158' ' ' SER . 10.0 p90 -85.17 -44.96 12.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.485 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 4.5 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 t -72.78 123.04 22.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.851 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 t -154.54 139.13 16.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.71 -45.16 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.522 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.3 m -107.92 109.63 21.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.878 0.37 . . . . 0.0 110.829 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.2 t -154.67 130.87 10.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -154.02 52.59 0.46 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -128.28 113.62 15.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 110.908 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -126.15 -32.07 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.76 140.13 52.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.064 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 12' ' ' ARG . 5.8 tp -104.33 131.51 51.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' N ' HD12 ' A' ' 11' ' ' LEU . 32.2 ptt180 -139.66 139.12 36.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.48 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 59.3 mt -135.2 128.6 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -102.76 107.14 17.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mm -70.76 143.23 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.37 -72.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.7 p -172.06 179.5 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.25 169.08 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.4 t -147.3 144.0 28.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.135 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 61.78 47.46 6.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.687 ' HB ' HG22 ' A' ' 23' ' ' VAL . 38.6 t -87.52 152.89 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.098 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' VAL . 39.5 t30 -48.69 -39.24 23.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.687 HG22 ' HB ' ' A' ' 21' ' ' VAL . 11.0 m -36.29 109.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -128.5 -67.27 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.7 pt -63.73 176.54 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 1.6 mpt_? -111.57 52.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.65 -45.52 3.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 mt -54.19 135.01 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.416 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 6.7 t70 -70.52 -62.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 25.1 mmtm -147.36 179.08 7.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 85' ' ' SER . 1.9 pp -141.86 146.31 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -144.28 163.77 32.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.572 ' H ' HG22 ' A' ' 50' ' ' THR . 60.9 t -111.9 140.89 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.09 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' HG2' HD13 ' A' ' 133' ' ' LEU . 14.6 ttt85 -116.27 127.61 54.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.826 HG22 ' HB3' ' A' ' 81' ' ' LEU . 38.3 p -128.97 168.03 16.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.64 153.22 7.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.481 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.484 HD13 HG21 ' A' ' 68' ' ' ILE . 3.7 mp -96.26 146.78 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 0.0 111.147 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.53 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 32.4 m-85 -139.05 159.4 42.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.425 ' CB ' HD11 ' A' ' 44' ' ' LEU . 7.6 t-160 -139.41 106.44 5.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.39 31.31 46.74 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.96 29.62 60.55 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.533 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -148.67 149.28 30.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.656 0.741 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 158.78 55.75 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.4 mp -112.26 -42.16 3.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.3 m -132.61 -69.57 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -173.16 166.49 4.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.432 ' HB2' ' NH2' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -96.91 149.85 21.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.666 HG12 HD11 ' A' ' 64' ' ' LEU . 95.9 t -115.04 133.46 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -116.21 156.1 27.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 33' ' ' VAL . 9.1 t -100.26 165.58 11.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -48.93 178.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.5 mtt85 -108.22 115.73 30.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -120.19 152.3 54.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.582 0.705 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 139.11 39.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.2 p -47.09 -44.43 21.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m -52.05 -29.41 21.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -134.06 83.97 44.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 0.0 110.904 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.6 Cg_endo -69.78 1.39 4.49 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.672 2.248 . . . . 0.0 112.323 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -60.29 120.27 9.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.576 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 3.2 m-90 -109.52 -47.04 3.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.943 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 60' ' ' TRP . 8.9 p30 34.0 42.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -111.85 144.9 40.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -83.27 110.17 17.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.666 HD11 HG12 ' A' ' 48' ' ' VAL . 11.1 tp -94.56 123.07 37.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.924 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -101.63 137.44 39.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -108.92 135.49 50.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -84.25 38.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.484 HG21 HD13 ' A' ' 37' ' ' ILE . 1.8 pp -110.0 159.57 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.115 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.626 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.12 125.3 53.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -57.96 -54.06 59.44 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.725 . . . . 0.0 111.165 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.0 Cg_endo -69.75 2.16 3.78 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.246 . . . . 0.0 112.372 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.504 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.5 t70 -124.84 -1.52 7.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -85.36 117.05 67.99 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.612 0.72 . . . . 0.0 110.907 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.72 144.62 54.83 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.683 2.255 . . . . 0.0 112.365 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.411 ' HD3' ' CD2' ' A' ' 107' ' ' PHE . 21.5 mmt85 -59.12 -38.39 79.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -57.4 -26.46 61.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -76.94 165.53 24.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -159.51 177.28 11.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 80' ' ' CYS . 43.0 tp -98.89 148.67 23.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.595 ' C ' HD23 ' A' ' 81' ' ' LEU . 61.1 m -143.02 152.49 41.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.826 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.89 136.58 14.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.694 ' OG ' HD12 ' A' ' 133' ' ' LEU . 79.9 p -141.76 133.52 27.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.891 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.503 HG22 HD12 ' A' ' 99' ' ' LEU . 90.2 mt -80.12 135.72 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 70.9 m -135.72 144.33 45.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.483 ' HA ' HG22 ' A' ' 31' ' ' ILE . 6.2 p -105.5 125.13 50.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 86' ' ' VAL . 5.8 p -109.94 117.93 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.36 151.56 49.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.8 170.25 27.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.79 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 11.6 mmt180 -101.82 167.98 9.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 110.862 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.9 111.21 1.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.37 -7.27 47.6 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -100.22 162.15 13.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 111.075 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm -71.84 165.02 24.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.897 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -95.58 178.84 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -142.53 135.55 28.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.25 130.71 46.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.6 m -134.25 127.56 18.99 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.609 0.718 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.706 ' HB2' HG21 ' A' ' 125' ' ' VAL . 53.3 Cg_endo -69.77 150.26 67.94 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.304 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.503 HD12 HG22 ' A' ' 83' ' ' ILE . 21.8 mt -128.48 -52.72 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.64 176.45 8.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.549 ' HH2' HG22 ' A' ' 138' ' ' VAL . 68.6 p-90 -160.6 146.8 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.09 124.11 1.54 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 27.1 m-20 -104.31 153.12 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.902 HD11 HD21 ' A' ' 120' ' ' LEU . 55.1 mt -144.9 126.88 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.129 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 106' ' ' LEU . 24.8 m120 -66.5 99.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 37' ' ' ILE . 13.0 mt -34.13 -54.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.493 ' CE1' ' HG ' ' A' ' 113' ' ' LEU . 52.3 m-85 -94.88 114.29 26.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -54.64 174.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -48.38 -30.09 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -90.28 28.49 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 44.16 41.88 4.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 55.2 m -127.88 115.58 18.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.637 HD22 ' CH2' ' A' ' 156' ' ' TRP . 12.3 mt -43.1 134.4 3.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 m -62.54 173.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.179 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -168.6 161.5 11.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.05 153.78 12.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.471 ' HE3' ' CG ' ' A' ' 151' ' ' GLU . 5.3 tmtt? -63.92 142.9 58.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.748 0.308 . . . . 0.0 110.887 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.422 ' O ' HD13 ' A' ' 152' ' ' LEU . 37.5 ttp -155.09 154.58 32.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.74 116.11 10.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.103 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 104' ' ' ILE . 4.6 pp -123.26 163.75 20.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -85.23 158.75 20.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.764 HD11 HD12 ' A' ' 150' ' ' LEU . 6.0 mt -119.1 155.71 31.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.673 ' CE3' ' ND2' ' A' ' 142' ' ' ASN . 8.3 m95 -90.18 146.42 34.81 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.559 0.695 . . . . 0.0 110.89 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 147.45 62.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.703 2.268 . . . . 0.0 112.305 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.706 HG21 ' HB2' ' A' ' 98' ' ' PRO . 48.2 t -71.74 113.29 18.68 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.608 0.718 . . . . 0.0 111.118 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -178.18 2.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 2.226 . . . . 0.0 112.373 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -83.01 134.61 35.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 109.23 -54.85 0.53 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.49 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.589 HD23 HG13 ' A' ' 125' ' ' VAL . 5.9 tp -48.74 103.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.934 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -89.92 -46.48 8.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -49.58 143.18 7.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.33 -52.97 50.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.694 HD12 ' OG ' ' A' ' 82' ' ' SER . 5.0 tp -103.16 125.86 50.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.541 ' HB3' HD11 ' A' ' 129' ' ' LEU . 11.8 p-10 -106.65 97.29 16.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.732 . . . . 0.0 110.928 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.53 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.8 -30.82 21.47 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.3 mt -70.08 -25.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.093 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.484 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -41.45 153.59 0.11 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.511 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.549 HG22 ' HH2' ' A' ' 101' ' ' TRP . 2.0 m -59.47 175.3 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.866 0.365 . . . . 0.0 111.161 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 60.7 p -121.37 168.25 11.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.189 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.49 161.93 32.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.9 p -79.6 137.82 37.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.673 ' ND2' ' CE3' ' A' ' 123' ' ' TRP . 34.9 t-20 -75.38 123.96 88.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -14.99 36.8 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.362 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -71.6 140.2 49.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -93.46 -42.32 9.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.37 -35.44 28.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.4 p -66.92 151.3 97.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.572 0.701 . . . . 0.0 111.113 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 148.22 64.3 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.687 2.258 . . . . 0.0 112.358 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 5.5 t -128.07 136.56 51.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 122' ' ' LEU . 3.5 mt -103.67 -177.09 3.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.471 ' CG ' ' HE3' ' A' ' 117' ' ' LYS . 54.7 tt0 -149.61 122.07 8.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.8 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -128.38 165.78 19.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.866 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.429 ' N ' HD22 ' A' ' 152' ' ' LEU . 69.0 mt-10 -128.45 119.73 25.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.649 ' CE2' HD21 ' A' ' 152' ' ' LEU . 45.2 m-85 -88.44 129.89 35.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.903 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -148.75 138.89 22.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.637 ' CH2' HD22 ' A' ' 113' ' ' LEU . 7.7 m95 -129.39 94.26 3.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.586 ' CG ' ' N ' ' A' ' 158' ' ' SER . 16.1 p90 -92.98 -53.3 4.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.586 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 6.3 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 p -89.09 174.54 7.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.892 0.377 . . . . 0.0 110.871 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.5 p -124.61 167.73 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.38 149.71 5.7 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.539 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.7 p -126.44 157.94 37.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 7' ' ' GLY . 70.6 m -102.97 97.43 7.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 6' ' ' SER . . . 37.93 -99.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.489 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.48 131.04 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.83 0.348 . . . . 0.0 110.877 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.496 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 14.5 m -133.51 -50.95 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.66 150.23 30.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.687 HD13 ' CH2' ' A' ' 156' ' ' TRP . 12.5 tp -104.48 140.04 38.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.69 ' NE ' ' CE3' ' A' ' 63' ' ' TRP . 2.4 ttt180 -143.72 118.39 9.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.521 HD12 ' CE1' ' A' ' 66' ' ' TYR . 16.1 mt -120.99 142.51 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.565 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 35.8 tttm -120.59 134.5 55.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.09 144.7 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.15 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.35 -74.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.1 p -162.31 -178.25 6.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -140.26 149.72 43.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.074 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -123.22 157.88 32.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.123 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 61.25 25.26 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.722 HG12 HG13 ' A' ' 23' ' ' VAL . 33.7 t -54.7 -17.0 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 72.58 34.63 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.722 HG13 HG12 ' A' ' 21' ' ' VAL . 2.5 m -107.54 85.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.128 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -92.13 -47.29 7.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.9 pt -61.31 -177.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.94 15.64 3.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -76.32 -39.94 52.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.9 mt -52.65 139.18 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -80.12 -64.62 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -148.23 -179.63 7.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.4 pt -139.46 171.09 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -164.52 158.9 18.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.79 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 40.9 t -119.86 132.06 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.687 ' HG2' HD13 ' A' ' 133' ' ' LEU . 19.2 ttm180 -103.56 122.27 44.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.86 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 81' ' ' LEU . 31.0 p -118.6 154.31 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.9 152.4 9.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.499 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.495 HG12 HD11 ' A' ' 106' ' ' LEU . 2.9 mp -97.41 143.38 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.171 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.572 ' CD1' ' HB3' ' A' ' 135' ' ' PRO . 45.7 m-85 -135.85 152.57 51.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.654 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 3.3 t-80 -124.5 97.8 5.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.933 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.06 14.38 80.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.34 -25.37 13.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.493 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -88.31 140.72 30.42 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.637 0.732 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.7 Cg_endo -69.81 156.33 63.5 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.712 2.275 . . . . 0.0 112.29 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.429 HD11 ' CB ' ' A' ' 39' ' ' HIS . 7.8 mp -115.18 -33.19 5.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.1 t -156.31 168.66 26.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.41 126.01 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -59.54 164.99 3.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.67 HG12 HD11 ' A' ' 64' ' ' LEU . 59.4 t -120.14 134.94 62.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -116.37 139.2 50.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.444 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 8.4 t -89.87 163.12 15.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -51.39 174.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -102.24 135.52 43.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.856 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -137.54 152.17 72.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 0.0 111.121 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 137.27 35.08 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.702 2.268 . . . . 0.0 112.345 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.6 p -46.54 -50.19 17.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.1 p -46.71 -32.49 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -133.21 87.06 39.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.613 0.72 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.478 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.2 Cg_endo -69.72 2.99 3.02 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -58.75 123.48 16.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.79 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 3.4 m-90 -105.74 -63.81 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 m120 54.24 48.2 21.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -124.93 139.33 53.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.69 ' CE3' ' NE ' ' A' ' 12' ' ' ARG . 80.1 m95 -81.89 112.2 18.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.67 HD11 HG12 ' A' ' 48' ' ' VAL . 10.1 tp -98.12 115.6 28.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -95.3 131.05 41.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.521 ' CE1' HD12 ' A' ' 13' ' ' ILE . 18.4 m-85 -100.83 134.26 44.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -81.06 41.29 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.682 ' C ' HD12 ' A' ' 68' ' ' ILE . 1.2 pp -115.33 162.83 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.615 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.37 127.41 54.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.578 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -54.2 -55.85 32.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 0.0 111.151 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.615 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.4 Cg_endo -69.81 3.02 3.03 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.707 2.271 . . . . 0.0 112.323 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.502 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.5 t70 -123.48 0.42 8.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -88.98 113.85 57.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.64 0.733 . . . . 0.0 110.874 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.5 Cg_endo -69.81 142.02 46.59 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.673 2.249 . . . . 0.0 112.295 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.555 ' NH1' ' CZ ' ' A' ' 107' ' ' PHE . 78.3 mmt-85 -55.2 -37.83 67.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.654 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -56.57 -32.44 65.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -70.55 166.79 19.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -161.81 172.01 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.0 tp -95.46 134.2 38.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.3 m -131.26 141.7 50.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.406 ' HB3' HG22 ' A' ' 35' ' ' THR . 1.4 pp -147.68 150.5 34.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.466 ' OG ' HD12 ' A' ' 133' ' ' LEU . 79.3 p -150.93 135.35 17.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.2 mt -84.76 141.5 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.17 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 20.7 m -140.54 150.97 44.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.572 ' HA ' HG22 ' A' ' 31' ' ' ILE . 85.1 p -113.06 126.15 55.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.535 HG23 ' CD2' ' A' ' 96' ' ' HIS . 8.5 p -104.89 130.44 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -149.18 124.18 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.9 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.58 174.76 40.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 89' ' ' ARG . 4.0 mpt_? -109.24 169.24 8.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.959 0.409 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -65.2 146.6 54.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.71 -43.26 2.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.508 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -91.61 164.68 13.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 111.097 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.4 173.03 10.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 -104.57 -176.11 2.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -133.16 119.51 20.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.535 ' CD2' HG23 ' A' ' 86' ' ' VAL . 7.9 m170 -103.92 124.59 49.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.823 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.7 t -127.31 128.49 24.05 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.595 0.712 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.442 ' HB2' HG21 ' A' ' 125' ' ' VAL . 53.5 Cg_endo -69.77 147.08 62.03 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.67 2.247 . . . . 0.0 112.356 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.2 mt -120.09 -40.25 2.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -159.16 175.83 12.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.057 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.527 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 66.7 p-90 -156.79 135.52 11.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.81 134.3 7.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.497 HD21 ' N ' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -112.22 133.1 54.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.666 HG12 HD21 ' A' ' 120' ' ' LEU . 36.1 mt -122.24 121.0 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -64.27 96.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.495 HD11 HG12 ' A' ' 37' ' ' ILE . 20.4 mt -38.75 -35.65 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.555 ' CZ ' ' NH1' ' A' ' 75' ' ' ARG . 98.9 m-85 -106.12 112.36 25.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -51.09 175.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.445 ' C ' ' CD1' ' A' ' 109' ' ' TYR . 5.0 p90 -59.45 -22.26 61.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -95.76 24.63 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 50.71 39.49 21.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 113' ' ' LEU . 51.2 m -131.5 113.94 14.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.423 HD22 ' CH2' ' A' ' 156' ' ' TRP . 33.5 mt -38.03 143.52 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.465 HG21 ' CE2' ' A' ' 154' ' ' PHE . 35.7 m -74.3 -177.79 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.5 t -168.23 173.07 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.53 174.01 2.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.431 ' HE2' ' CD ' ' A' ' 151' ' ' GLU . 3.5 ttpm? -73.67 152.3 40.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.925 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.416 ' O ' HD13 ' A' ' 152' ' ' LEU . 17.5 ttp -154.39 148.47 25.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.93 116.96 12.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.666 HD21 HG12 ' A' ' 104' ' ' ILE . 4.0 pp -129.26 163.79 24.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 147' ' ' THR . 25.2 m-20 -91.05 145.61 24.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.546 ' HB2' ' HB1' ' A' ' 100' ' ' ALA . 2.9 mt -98.59 159.74 14.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.527 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 23.4 m95 -87.38 150.79 49.84 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.537 0.684 . . . . 0.0 110.913 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 145.23 56.52 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.355 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.67 HG13 ' HD2' ' A' ' 126' ' ' PRO . 99.2 t -67.79 138.97 93.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.67 ' HD2' HG13 ' A' ' 125' ' ' VAL . 53.5 Cg_endo -69.8 -164.8 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 0.0 112.325 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -76.89 120.89 22.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.845 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 40.0 72.69 0.22 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.671 HD21 ' O ' ' A' ' 131' ' ' ASP . 56.5 tp -62.21 125.07 22.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.33 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.36 -30.0 33.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.671 ' O ' HD21 ' A' ' 129' ' ' LEU . 57.1 m-20 -115.15 114.37 25.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.8 mt -44.19 -46.26 8.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.687 HD13 ' HG2' ' A' ' 34' ' ' ARG . 16.4 tp -98.68 136.58 38.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.463 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 7.7 t-20 -106.55 91.51 6.04 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.643 0.735 . . . . 0.0 110.854 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.572 ' HB3' ' CD1' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.77 -41.19 4.47 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.687 2.258 . . . . 0.0 112.311 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.1 mt -75.61 -13.65 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.463 ' CA ' ' OD1' ' A' ' 134' ' ' ASN . . . -44.05 144.44 1.95 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.434 HG21 ' CZ2' ' A' ' 123' ' ' TRP . 2.2 m -54.78 173.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 111.184 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.1 p -118.62 175.57 5.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.192 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.08 154.15 30.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.479 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 86.4 p -78.89 109.85 13.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.916 0.389 . . . . 0.0 110.855 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -44.67 121.88 4.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.609 0.719 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -6.22 18.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -68.84 139.88 55.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -99.65 -9.93 22.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -97.67 14.42 26.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.402 ' O ' ' OD1' ' A' ' 121' ' ' ASN . 59.5 p -112.25 152.55 44.54 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.542 0.686 . . . . 0.0 111.166 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.45 59.99 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.66 2.24 . . . . 0.0 112.344 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 2.0 t -128.95 128.48 43.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' A' ' 18' ' ' ALA . 7.5 mt -100.32 140.32 34.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.431 ' CD ' ' HE2' ' A' ' 117' ' ' LYS . 37.6 tt0 -109.15 120.48 42.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.806 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -128.95 165.91 20.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.12 125.99 49.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.471 ' CE2' HD21 ' A' ' 152' ' ' LEU . 28.5 m-85 -90.77 100.41 13.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.01 141.48 37.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.687 ' CH2' HD13 ' A' ' 11' ' ' LEU . 74.8 m95 -129.1 69.55 1.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 158' ' ' SER . 7.9 p90 -69.34 -51.09 40.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.636 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 52.5 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -74.41 -54.36 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 110.848 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 m -78.24 146.34 34.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.863 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.1 -52.57 0.43 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.1 m -97.56 -47.88 5.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.9 m -107.3 156.37 18.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.53 -63.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.492 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.441 ' CB ' ' HB3' ' A' ' 156' ' ' TRP . 1.3 m-80 -46.49 118.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 13.2 m -102.89 -23.54 13.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.838 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -120.08 136.35 54.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.043 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.857 HD13 ' CH2' ' A' ' 156' ' ' TRP . 24.6 tp -86.67 139.15 31.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.412 ' H ' HD12 ' A' ' 11' ' ' LEU . 10.4 ttp180 -138.39 123.3 18.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.0 mt -134.18 139.27 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 72.9 tttt -118.37 127.22 53.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -89.17 146.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 151' ' ' GLU . 4.3 mm? -100.85 -72.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 p -168.46 -176.94 3.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.93 141.88 51.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.424 HG23 ' CD2' ' A' ' 20' ' ' TYR . 6.5 t -117.57 134.34 54.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.424 ' CD2' HG23 ' A' ' 19' ' ' THR . 5.8 m-85 72.69 38.75 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.45 ' HB ' HG22 ' A' ' 23' ' ' VAL . 46.2 t -66.04 154.01 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.116 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.426 ' N ' HG12 ' A' ' 21' ' ' VAL . 10.7 m120 -76.16 54.72 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.45 HG22 ' HB ' ' A' ' 21' ' ' VAL . 2.6 m -120.52 114.09 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -117.71 -62.19 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 27' ' ' ASP . 43.8 pt -69.1 174.47 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 0.3 OUTLIER -112.83 40.54 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' HB3' HD12 ' A' ' 25' ' ' ILE . 4.1 t0 -92.0 -64.85 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.667 ' H ' HD12 ' A' ' 28' ' ' ILE . 4.7 mp -35.16 123.66 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.167 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -71.14 -52.62 18.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.851 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -145.81 177.44 8.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.428 HG22 ' HA ' ' A' ' 85' ' ' SER . 2.0 pp -146.64 156.94 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -153.47 163.2 40.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.1 t -108.75 140.55 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.158 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.485 ' HG2' HD13 ' A' ' 133' ' ' LEU . 25.1 ttm180 -114.77 126.75 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.898 HG22 ' HB3' ' A' ' 81' ' ' LEU . 47.0 p -124.73 163.87 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.74 146.24 4.91 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.813 HD13 HG21 ' A' ' 68' ' ' ILE . 3.9 mp -89.77 146.01 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 111.166 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.534 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 38.5 m-85 -142.53 157.1 45.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.467 ' CB ' HD11 ' A' ' 44' ' ' LEU . 6.6 t-160 -129.09 102.84 6.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.89 22.37 70.24 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.29 -37.2 3.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -75.4 137.61 71.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.664 0.745 . . . . 0.0 110.888 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 158.07 58.2 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.467 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.0 mp -116.15 -40.08 3.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.3 m -149.76 168.95 22.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -57.35 128.17 35.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -61.65 159.11 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.54 HG11 ' HG ' ' A' ' 64' ' ' LEU . 58.7 t -114.78 147.5 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -129.06 156.06 44.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 p -102.64 168.62 9.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -51.92 177.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -107.08 112.62 25.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 m -118.0 152.83 50.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.606 0.717 . . . . 0.0 111.131 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 135.84 31.39 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.65 2.233 . . . . 0.0 112.331 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.5 p -44.69 -44.37 9.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 93.8 p -48.56 -34.82 12.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -134.18 89.22 28.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.621 0.724 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.58 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.3 Cg_endo -69.82 -0.12 6.5 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.708 2.272 . . . . 0.0 112.297 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -54.09 113.48 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.58 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 3.3 m-90 -104.82 -46.92 4.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.457 ' C ' ' O ' ' A' ' 60' ' ' TRP . 11.8 m-80 33.99 51.58 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -119.94 140.06 51.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.457 ' NE1' ' HD2' ' A' ' 14' ' ' LYS . 76.5 m95 -81.28 108.43 14.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.54 ' HG ' HG11 ' A' ' 48' ' ' VAL . 9.7 tp -97.66 121.46 39.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -101.33 134.84 43.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -102.34 129.91 48.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.9 42.34 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.877 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.813 HG21 HD13 ' A' ' 37' ' ' ILE . 2.0 pp -108.91 163.5 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.176 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.621 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.12 126.89 55.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.626 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -58.28 -52.41 74.78 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.65 0.738 . . . . 0.0 111.153 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.8 Cg_endo -69.8 -5.56 16.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.348 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.1 t0 -112.26 -15.79 13.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -71.41 112.16 12.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.627 0.727 . . . . 0.0 110.92 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.632 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.77 145.17 56.3 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.674 2.249 . . . . 0.0 112.35 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.457 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 21.7 mmt180 -53.41 -46.75 69.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.52 -41.71 63.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.082 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.632 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -57.82 163.82 2.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.415 ' O ' HG23 ' A' ' 37' ' ' ILE . 3.8 ptp85 -160.91 173.92 14.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.6 tp -96.18 144.15 26.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.611 ' C ' HD23 ' A' ' 81' ' ' LEU . 58.9 m -134.49 149.45 50.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.879 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.898 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.0 OUTLIER -155.76 137.09 13.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.0 p -146.87 154.4 41.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.586 ' CG1' HD11 ' A' ' 150' ' ' LEU . 44.5 mt -104.19 138.81 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.159 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 84.7 m -133.94 155.41 49.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.428 ' HA ' HG22 ' A' ' 31' ' ' ILE . 78.0 p -106.72 116.1 31.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.891 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.42 127.98 54.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -145.65 136.61 24.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.02 -179.68 38.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -97.04 174.67 6.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.902 0.382 . . . . 0.0 110.851 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -68.91 -59.22 3.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.04 -35.21 91.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.45 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.86 170.77 10.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.905 0.383 . . . . 0.0 111.077 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -84.75 159.14 20.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -99.5 173.37 6.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.88 118.94 30.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -103.91 124.65 49.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 17.9 m -131.16 122.96 19.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.406 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.4 Cg_endo -69.79 140.38 42.43 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.468 ' C ' HG23 ' A' ' 125' ' ' VAL . 16.5 mt -113.9 -36.33 4.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.04 -179.68 6.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.789 ' HH2' HG22 ' A' ' 138' ' ' VAL . 67.8 p-90 -162.7 127.05 3.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.76 134.16 7.07 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -114.64 129.91 56.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.339 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.484 HG12 HD21 ' A' ' 120' ' ' LEU . 87.1 mt -107.57 138.15 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 106' ' ' LEU . 6.1 m120 -76.58 82.79 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.1 mt -34.43 -38.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.457 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 40.9 m-85 -105.93 120.47 41.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -62.85 170.53 2.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.828 ' CE1' HG23 ' A' ' 110' ' ' THR . 0.2 OUTLIER -51.83 -26.24 9.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.828 HG23 ' CE1' ' A' ' 109' ' ' TYR . 67.9 p -105.23 31.79 4.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 47.01 36.6 4.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 113' ' ' LEU . 97.6 m -115.12 102.52 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.488 HD22 ' CH2' ' A' ' 156' ' ' TRP . 35.2 mt -34.05 125.13 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.479 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 29.8 m -58.2 176.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.146 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.447 ' HA ' ' CB ' ' A' ' 154' ' ' PHE . 2.2 m -173.42 166.88 4.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.33 132.38 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.471 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.417 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 22.6 ttpt -40.36 149.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.9 ttp -159.71 158.4 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.676 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -138.69 133.47 32.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 120' ' ' LEU . 4.5 pp -143.59 148.74 36.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -76.6 157.94 31.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 150' ' ' LEU . 1.2 mt -118.12 147.71 43.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.581 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 9.1 m95 -81.19 152.7 71.29 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.524 0.678 . . . . 0.0 110.931 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 161.88 44.21 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.708 2.272 . . . . 0.0 112.325 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.468 HG23 ' C ' ' A' ' 99' ' ' LEU . 90.3 t -83.64 118.07 70.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -174.03 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.714 2.276 . . . . 0.0 112.324 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -92.35 146.9 23.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.21 -51.43 1.88 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.456 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.2 tp -43.09 112.59 0.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.831 0.348 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -95.32 -46.21 6.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -55.09 135.8 48.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 66.2 mt -57.93 -55.04 40.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.485 HD13 ' HG2' ' A' ' 34' ' ' ARG . 14.8 tp -88.57 134.14 33.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -105.28 91.42 4.67 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.598 0.713 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.534 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.8 -28.61 24.87 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.252 . . . . 0.0 112.313 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 137' ' ' GLY . 11.5 mm -75.34 -28.48 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.181 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -34.66 151.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.423 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.789 HG22 ' HH2' ' A' ' 101' ' ' TRP . 18.6 m -68.63 170.45 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.946 0.403 . . . . 0.0 111.116 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.5 p -111.98 169.17 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.84 159.26 29.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.535 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.5 p -77.5 121.25 23.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.842 0.353 . . . . 0.0 110.858 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.581 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 36.9 t30 -59.14 124.39 74.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -18.45 36.96 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.726 2.284 . . . . 0.0 112.326 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -60.97 139.33 58.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -95.41 -35.36 11.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -83.41 39.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -129.16 156.12 78.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 0.0 111.132 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 130.28 18.98 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.722 2.281 . . . . 0.0 112.294 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 12.1 t -121.29 130.62 53.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.632 HD12 HD11 ' A' ' 122' ' ' LEU . 2.9 mt -106.89 151.5 25.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.982 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.676 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 0.4 OUTLIER -112.86 140.25 47.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.917 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.778 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -143.13 155.31 44.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.417 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 39.1 mt-10 -119.17 115.98 25.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.648 ' CE2' HD21 ' A' ' 152' ' ' LEU . 44.6 m-85 -80.49 109.53 15.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.98 126.34 41.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.857 ' CH2' HD13 ' A' ' 11' ' ' LEU . 6.3 m95 -123.55 98.38 5.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 158' ' ' SER . 46.9 p90 -98.67 -53.08 3.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.797 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 22.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 m -79.17 122.08 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 0.0 110.897 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.8 m -147.37 119.74 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.82 145.12 17.66 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.499 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 t -148.26 168.53 22.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.836 0.35 . . . . 0.0 110.851 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.8 p -101.56 -23.6 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.04 -142.12 13.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.447 ' OD1' ' C ' ' A' ' 158' ' ' SER . 11.7 t30 -106.3 173.62 6.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.43 -41.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.74 117.68 29.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.927 HD13 ' CH2' ' A' ' 156' ' ' TRP . 14.7 tp -84.72 131.75 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.521 ' NE ' ' CZ3' ' A' ' 63' ' ' TRP . 23.2 ptt180 -130.1 136.77 49.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.485 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 58.4 mt -134.21 134.9 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -111.41 133.79 53.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.8 mm -93.39 145.93 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.724 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.2 mm? -100.45 -72.4 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.2 p -166.78 -175.36 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.8 148.29 52.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -120.77 133.68 55.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 66.72 41.8 2.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.616 ' HB ' HG22 ' A' ' 23' ' ' VAL . 38.3 t -65.49 140.1 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.154 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 23' ' ' VAL . 1.5 t-20 -41.78 -42.2 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 21' ' ' VAL . 15.4 m -35.89 106.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.108 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -95.63 -60.1 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.6 pt -83.88 176.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.169 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -112.55 44.82 1.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.39 -41.45 7.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.822 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.9 mt -49.69 129.1 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -59.78 -66.8 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.844 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -144.33 177.32 8.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.4 173.56 11.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -165.65 170.83 13.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 92.1 t -119.14 140.51 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.126 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.712 ' HG2' HD13 ' A' ' 133' ' ' LEU . 46.5 ttm-85 -115.03 130.82 57.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.536 HG22 ' HB3' ' A' ' 81' ' ' LEU . 60.4 p -126.71 168.16 14.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.24 134.22 1.63 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.429 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 78' ' ' ARG . 3.8 mp -81.99 148.7 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 111.156 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.533 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 19.7 m-85 -140.1 142.75 36.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.7 t-160 -118.64 104.76 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.846 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.36 45.07 82.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.492 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.14 30.89 71.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.453 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -140.58 144.71 37.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.641 0.734 . . . . 0.0 110.904 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.411 ' O ' HD12 ' A' ' 44' ' ' LEU . 54.1 Cg_endo -69.68 163.95 36.3 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.696 2.264 . . . . 0.0 112.374 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.424 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.6 mp -126.2 -40.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.6 p -146.33 177.0 9.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.11 118.06 7.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -50.48 149.07 3.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.706 HG12 HD11 ' A' ' 64' ' ' LEU . 61.6 t -111.14 137.23 44.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -118.55 151.29 38.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.449 HG22 HD13 ' A' ' 64' ' ' LEU . 79.4 p -100.73 164.37 11.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -49.71 172.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.26 120.24 40.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.8 m -122.05 152.12 59.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.568 0.699 . . . . 0.0 111.131 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 136.23 32.34 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.704 2.269 . . . . 0.0 112.306 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.0 p -45.65 -47.55 14.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -47.78 -35.35 9.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 58.5 m-20 -134.72 89.0 26.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.659 0.742 . . . . 0.0 110.911 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.585 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 54.3 Cg_endo -69.73 2.23 3.7 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.65 2.234 . . . . 0.0 112.408 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -54.2 105.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.585 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.9 m-90 -93.18 -49.72 5.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.724 ' OD1' HD13 ' A' ' 16' ' ' LEU . 62.6 m-20 40.49 45.1 1.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -115.53 138.73 50.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.521 ' CZ3' ' NE ' ' A' ' 12' ' ' ARG . 45.8 m95 -85.76 108.55 18.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.706 HD11 HG12 ' A' ' 48' ' ' VAL . 10.3 tp -96.15 117.38 30.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -97.54 126.84 43.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -96.48 122.14 39.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.41 53.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.442 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.3 pp -117.27 167.15 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.627 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.69 119.86 39.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.659 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -58.0 -51.1 84.2 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.654 0.74 . . . . 0.0 111.159 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.75 2.86 3.15 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.697 2.265 . . . . 0.0 112.336 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.5 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.6 t0 -122.46 -11.02 8.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.835 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -70.62 113.64 20.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.659 0.742 . . . . 0.0 110.92 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.2 Cg_endo -69.74 132.97 24.48 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.641 2.228 . . . . 0.0 112.366 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.46 ' NE ' ' OD2' ' A' ' 111' ' ' ASP . 82.8 mmt-85 -43.1 -45.91 5.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -51.2 -46.92 62.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.538 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -53.15 162.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 37' ' ' ILE . 14.8 ptp180 -160.75 175.56 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.858 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.3 tp -94.38 138.22 32.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 84.5 m -139.19 135.63 34.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.536 ' HB3' HG22 ' A' ' 35' ' ' THR . 1.5 pp -142.03 157.24 45.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.51 ' HB2' HD12 ' A' ' 133' ' ' LEU . 59.5 m -157.99 154.52 27.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.4 mt -97.85 147.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.168 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 86.2 m -142.65 156.61 45.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.1 m -116.07 118.58 33.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 p -102.94 130.07 53.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -148.12 150.75 34.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.3 -172.6 34.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.51 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -104.9 157.97 16.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -59.58 -55.59 32.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.49 -22.33 76.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.549 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -102.21 -179.74 4.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 111.144 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -91.01 157.41 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -100.02 174.19 6.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -131.53 130.71 42.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -102.85 132.47 49.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.0 t -132.71 120.85 16.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.632 0.73 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.484 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.0 Cg_endo -69.79 147.66 63.19 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.693 2.262 . . . . 0.0 112.37 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 125' ' ' VAL . 19.6 mt -122.72 -55.04 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.8 -179.82 5.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.435 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 69.3 p-90 -164.36 132.95 3.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA3' HD23 ' A' ' 122' ' ' LEU . . . -143.26 136.97 7.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.534 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -115.15 146.44 41.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 110.848 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.505 HD11 HD21 ' A' ' 120' ' ' LEU . 95.5 mt -127.29 125.6 66.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 106' ' ' LEU . 16.7 m-80 -64.87 87.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.894 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 37' ' ' ILE . 37.9 mt -33.46 -38.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' ASN . 66.3 m-85 -105.15 110.95 23.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -56.75 177.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -52.08 -40.56 61.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.424 HG23 ' HB ' ' A' ' 112' ' ' THR . 4.7 t -86.57 34.12 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.46 ' OD2' ' NE ' ' A' ' 75' ' ' ARG . 35.8 t0 38.22 49.49 1.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 113' ' ' LEU . 52.7 m -134.14 111.48 10.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.69 HD22 ' CH2' ' A' ' 156' ' ' TRP . 58.0 mt -34.19 134.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 154' ' ' PHE . 31.0 m -65.6 175.55 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.2 p -169.77 165.06 9.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.5 134.6 0.25 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.48 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -42.02 149.31 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.729 0.3 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.409 ' O ' HD13 ' A' ' 152' ' ' LEU . 45.2 ttp -159.77 159.84 33.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.65 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.79 137.27 34.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.103 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 104' ' ' ILE . 4.3 pp -145.22 155.42 43.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -81.36 152.53 27.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.898 HD11 HD12 ' A' ' 150' ' ' LEU . 1.9 mt -114.87 138.48 50.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.589 ' CH2' ' HD2' ' A' ' 143' ' ' PRO . 12.0 m95 -75.9 149.11 82.63 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.546 0.689 . . . . 0.0 110.953 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 157.12 61.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.685 2.257 . . . . 0.0 112.371 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 99' ' ' LEU . 87.1 t -74.86 128.46 85.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 111.086 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 178.55 4.46 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.645 2.23 . . . . 0.0 112.365 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -83.09 158.89 22.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 49.88 81.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 57.4 tp -150.48 147.19 27.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.743 0.306 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -119.4 -56.54 2.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -51.01 117.02 2.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.3 mt -52.56 -47.79 66.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.712 HD13 ' HG2' ' A' ' 34' ' ' ARG . 5.1 tp -93.55 138.85 31.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -107.8 91.29 7.32 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.595 0.712 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.533 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.73 -34.58 14.39 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.338 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.1 mm -70.65 -26.46 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.167 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.435 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -39.49 153.62 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.9 m -65.62 166.14 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.935 0.397 . . . . 0.0 111.098 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.0 p -109.41 166.87 10.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.146 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.99 177.79 33.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.2 p -91.79 130.35 37.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.893 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 123' ' ' TRP . 63.8 t-20 -67.17 121.26 77.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.563 0.696 . . . . 0.0 110.885 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.589 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.8 Cg_endo -69.68 -7.23 20.49 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.721 2.281 . . . . 0.0 112.345 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.47 127.19 31.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -78.01 -52.78 8.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -40.61 -41.95 1.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.0 p -62.09 151.66 80.2 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 111.134 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 174.82 8.89 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 0.0 112.384 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.1 t -150.55 137.92 19.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.898 HD12 HD11 ' A' ' 122' ' ' LEU . 4.5 mt -110.9 156.48 21.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.65 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 1.7 mp0 -117.63 138.59 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.806 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -141.58 158.37 43.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -122.5 120.26 33.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.69 ' CE2' HD21 ' A' ' 152' ' ' LEU . 43.7 m-85 -88.04 119.39 28.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.51 128.5 20.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.927 ' CH2' HD13 ' A' ' 11' ' ' LEU . 3.9 m95 -123.9 103.48 8.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' CG ' ' N ' ' A' ' 158' ' ' SER . 21.8 p90 -106.46 -49.64 3.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.879 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.494 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 31.4 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.0 m -113.68 110.46 20.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 p -86.7 98.4 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.84 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.13 -90.67 1.42 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.518 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m -112.98 131.61 55.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.898 0.38 . . . . 0.0 110.871 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 82.2 p -139.75 139.73 36.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.51 -66.84 0.31 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.47 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -114.1 112.77 23.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.901 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -130.17 -33.12 1.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.811 ' HB3' ' CB ' ' A' ' 158' ' ' SER . . . -119.71 141.83 49.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.118 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -106.27 137.15 44.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.503 HH11 ' N ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER -140.35 163.71 32.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.479 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 67.9 mt -154.79 131.75 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -105.88 104.17 13.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.7 mm -73.19 136.58 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.83 -75.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.1 p -168.01 167.8 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.83 164.7 12.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.074 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -142.97 161.14 38.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 49.79 45.04 25.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 22' ' ' ASN . 3.3 t -80.98 171.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.09 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.637 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -84.46 27.03 0.73 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 23' ' ' VAL . 30.2 m -74.66 64.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -85.72 -73.62 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.863 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 pp -51.96 179.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -132.47 67.47 1.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -133.93 -33.81 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.0 mt -52.02 137.37 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.113 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.49 -51.62 4.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -146.65 173.49 12.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.508 HG22 ' HA ' ' A' ' 85' ' ' SER . 7.5 pt -136.17 174.96 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -169.14 148.19 3.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.662 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 55.3 t -100.95 141.44 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.4 ttt85 -121.11 126.63 50.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 81' ' ' LEU . 30.3 p -121.34 176.04 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.67 137.02 2.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.457 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.537 HG12 HD11 ' A' ' 106' ' ' LEU . 3.5 mp -94.63 142.78 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.553 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 13.4 m-85 -135.43 164.61 27.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.945 ' HB2' HD11 ' A' ' 44' ' ' LEU . 8.4 t-160 -132.72 100.96 5.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.72 30.56 70.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.526 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.42 -49.57 1.04 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.98 145.31 88.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.652 0.739 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 167.05 25.55 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.345 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.945 HD11 ' HB2' ' A' ' 39' ' ' HIS . 10.9 mp -118.74 -33.24 4.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.6 t -166.02 168.2 15.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -41.91 153.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -92.21 171.85 8.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 64' ' ' LEU . 57.5 t -125.96 143.61 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -129.65 144.91 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.426 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 10.4 t -94.31 165.09 12.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.168 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -53.39 178.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.8 mtm-85 -104.56 139.02 40.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.438 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.8 m -140.68 152.19 65.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.615 0.722 . . . . 0.0 111.121 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 135.12 29.73 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.684 2.256 . . . . 0.0 112.356 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 17.4 p -45.96 -47.69 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.1 p -46.43 -37.62 7.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -134.4 88.05 30.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.63 0.728 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.539 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 3.29 2.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.341 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -54.36 110.75 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.662 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.7 m-90 -95.07 -68.53 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.6 m120 58.25 54.29 5.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -131.18 140.59 49.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -81.61 104.78 12.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.546 ' HG ' HG11 ' A' ' 48' ' ' VAL . 11.2 tp -88.81 111.49 22.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -90.19 127.94 36.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -97.61 134.67 40.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.913 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.46 50.7 1.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.436 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.0 pp -122.92 164.11 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.612 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.7 117.34 31.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.646 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.4 mp -54.28 -51.98 72.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.604 0.716 . . . . 0.0 111.146 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.8 Cg_endo -69.79 2.6 3.4 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.696 2.264 . . . . 0.0 112.366 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.508 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.0 t70 -125.72 -9.45 6.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.29 117.44 63.15 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.623 0.725 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.514 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.0 Cg_endo -69.7 146.06 59.37 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.647 2.231 . . . . 0.0 112.371 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.564 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 62.0 mmt-85 -59.96 -42.2 93.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.634 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -54.42 -31.36 55.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.514 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -69.06 162.0 27.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.481 ' HD2' HG21 ' A' ' 139' ' ' THR . 43.2 mtt85 -155.58 175.26 14.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.2 tp -98.93 131.41 45.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.6 m -128.55 124.59 36.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.592 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.7 OUTLIER -128.13 158.49 37.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.5 p -156.98 137.73 13.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.651 HG12 HD11 ' A' ' 150' ' ' LEU . 33.8 mt -88.24 136.79 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 63.5 m -133.99 141.54 47.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.508 ' HA ' HG22 ' A' ' 31' ' ' ILE . 91.0 p -105.88 119.75 39.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.503 HG23 ' CD2' ' A' ' 96' ' ' HIS . 6.2 p -101.57 138.17 26.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -150.08 137.04 19.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.95 -154.7 12.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -132.9 172.18 12.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.853 0.359 . . . . 0.0 110.83 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -63.43 -60.09 3.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.35 -37.29 79.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.74 172.35 12.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.837 0.351 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -87.3 173.87 8.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.471 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 8.8 mt-10 -104.65 160.04 15.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -125.77 122.96 37.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.503 ' CD2' HG23 ' A' ' 86' ' ' VAL . 7.3 m170 -96.45 140.56 30.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.826 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.9 t -142.31 122.98 8.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.537 ' HD3' HD23 ' A' ' 132' ' ' LEU . 54.2 Cg_endo -69.74 147.01 62.04 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.71 2.273 . . . . 0.0 112.368 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.677 ' O ' HG23 ' A' ' 125' ' ' VAL . 44.0 mt -119.2 -56.65 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.16 -178.17 5.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.535 ' CH2' HG22 ' A' ' 138' ' ' VAL . 61.4 p-90 -160.33 141.89 12.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.923 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.9 125.45 2.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.445 ' CB ' HG22 ' A' ' 139' ' ' THR . 4.0 m-20 -108.01 117.93 35.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.758 0.314 . . . . 0.0 110.916 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.662 HG12 HD21 ' A' ' 120' ' ' LEU . 54.2 mt -107.63 128.28 62.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 106' ' ' LEU . 1.7 m120 -65.09 94.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.872 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.537 HD11 HG12 ' A' ' 37' ' ' ILE . 13.0 mt -35.84 -43.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 84.9 m-85 -101.97 119.61 39.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -56.48 -175.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -60.9 -37.71 83.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 t -88.8 32.94 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.19 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 43.81 53.88 5.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 113' ' ' LEU . 98.2 m -137.88 108.43 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.776 HD22 ' CH2' ' A' ' 156' ' ' TRP . 41.4 mt -34.11 135.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.442 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 26.8 m -67.64 172.64 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.42 ' HA ' ' CB ' ' A' ' 154' ' ' PHE . 1.7 m -162.61 169.92 19.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.75 168.37 7.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.44 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 3.4 ttpm? -70.8 149.72 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.419 ' O ' HD13 ' A' ' 152' ' ' LEU . 18.0 ttp -155.74 148.04 23.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.07 116.6 12.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.662 HD21 HG12 ' A' ' 104' ' ' ILE . 4.4 pp -130.75 153.05 49.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.431 ' CB ' ' HB2' ' A' ' 142' ' ' ASN . 9.5 m-20 -75.37 147.24 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.833 HD11 HD12 ' A' ' 150' ' ' LEU . 5.4 mt -105.66 155.13 19.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.6 ' CD1' ' OD1' ' A' ' 142' ' ' ASN . 18.7 m95 -84.05 151.33 60.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.613 0.72 . . . . 0.0 110.872 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 152.87 69.23 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.657 2.238 . . . . 0.0 112.305 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 99' ' ' LEU . 71.4 t -82.82 124.02 77.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 0.0 111.142 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 139.54 40.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -55.11 -43.66 74.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.851 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.01 65.49 4.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.481 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.422 HD23 HG13 ' A' ' 125' ' ' VAL . 14.7 tp -160.09 136.38 8.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.774 0.321 . . . . 0.0 110.923 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -107.84 -49.58 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -51.05 118.33 3.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.537 HD23 ' HD3' ' A' ' 98' ' ' PRO . 7.6 mt -56.57 -41.48 76.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.0 tp -104.41 119.85 39.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -101.6 97.8 8.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.553 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.9 Cg_endo -69.78 -40.66 5.03 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.373 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 137' ' ' GLY . 42.1 mt -65.16 -27.28 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -37.87 152.38 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.445 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.535 HG22 ' CH2' ' A' ' 101' ' ' TRP . 14.9 m -56.46 168.07 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.481 HG21 ' HD2' ' A' ' 78' ' ' ARG . 30.7 p -120.45 154.77 34.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.79 -169.26 12.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.9 p -101.46 141.17 34.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 110.817 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.6 ' OD1' ' CD1' ' A' ' 123' ' ' TRP . 2.6 m120 -68.13 130.94 92.3 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.567 0.699 . . . . 0.0 110.896 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -28.84 25.05 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.696 2.264 . . . . 0.0 112.408 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -79.81 135.71 36.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -80.47 -34.95 35.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -46.85 -54.75 9.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.5 p -47.13 151.56 1.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.57 0.7 . . . . 0.0 111.156 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 168.02 22.88 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 13.1 t -144.88 140.73 28.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.833 HD12 HD11 ' A' ' 122' ' ' LEU . 2.3 mt -114.52 139.43 49.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -105.84 118.21 36.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.834 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -124.71 158.08 34.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.44 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 38.7 mt-10 -116.22 142.32 46.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.607 ' CE2' HD21 ' A' ' 152' ' ' LEU . 45.7 m-85 -106.78 151.14 25.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.503 ' N ' HH11 ' A' ' 12' ' ' ARG . 3.8 m-20 -172.79 142.9 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.776 ' CH2' HD22 ' A' ' 113' ' ' LEU . 7.8 m95 -132.21 86.8 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 158' ' ' SER . 28.7 p90 -95.43 -44.59 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.811 ' CB ' ' HB3' ' A' ' 10' ' ' ALA . 2.4 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -117.75 153.54 33.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 110.892 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 t -101.47 -61.87 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.8 113.4 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.456 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.9 t -63.14 -44.81 94.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 110.894 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 t 46.78 36.67 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.21 -41.38 17.62 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.558 ' HB2' HG21 ' A' ' 70' ' ' ILE . 15.9 m120 -105.35 140.25 38.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 110.87 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.4 p -129.18 -39.23 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.17 141.74 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.071 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.796 HD13 ' CH2' ' A' ' 156' ' ' TRP . 18.8 tp -102.52 140.39 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.461 ' H ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -147.35 136.59 22.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.435 HD12 ' CE1' ' A' ' 66' ' ' TYR . 25.5 mt -135.54 145.66 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttt -119.73 119.3 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.2 mm -82.68 138.76 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.06 -73.51 0.58 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.0 p -170.41 176.11 4.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.29 160.4 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.475 HG23 ' CD2' ' A' ' 20' ' ' TYR . 13.6 t -129.15 158.66 38.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.188 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.475 ' CD2' HG23 ' A' ' 19' ' ' THR . 11.4 m-85 42.88 39.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 23' ' ' VAL . 59.5 t -66.24 140.8 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 23' ' ' VAL . 15.5 t-20 -48.1 -34.32 9.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.683 ' H ' HG12 ' A' ' 21' ' ' VAL . 12.8 m -34.9 101.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.162 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -117.82 -64.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 pp -48.07 177.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -128.53 62.92 1.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 28' ' ' ILE . 4.2 m-20 -134.74 -50.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.438 ' C ' ' O ' ' A' ' 27' ' ' ASP . 28.3 mt -33.91 136.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.68 -64.36 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -145.84 167.47 23.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 85' ' ' SER . 5.8 pt -127.3 163.72 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -157.15 157.98 35.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.85 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 98.4 t -104.05 140.13 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.412 ' HG2' HD13 ' A' ' 133' ' ' LEU . 31.3 ttm-85 -114.6 116.6 29.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 81' ' ' LEU . 54.3 p -119.34 163.6 16.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.126 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.27 143.4 3.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.498 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.799 HD13 HG21 ' A' ' 68' ' ' ILE . 4.2 mp -88.5 148.55 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.541 ' CD2' ' HB3' ' A' ' 135' ' ' PRO . 25.3 m-85 -135.47 132.58 37.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.575 ' CD2' ' HB3' ' A' ' 76' ' ' ALA . 11.4 t-160 -118.94 94.9 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.72 34.66 8.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.96 -26.7 3.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.505 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.25 153.22 62.47 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.634 0.73 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.467 ' O ' ' C ' ' A' ' 44' ' ' LEU . 53.8 Cg_endo -69.77 82.99 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 43' ' ' PRO . 16.4 tp -32.41 -46.54 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.1 m -152.23 177.24 10.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.47 150.89 8.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.83 145.94 25.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.705 HG12 HD11 ' A' ' 64' ' ' LEU . 58.8 t -105.54 135.32 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.082 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -113.17 147.15 37.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.494 HG22 HD13 ' A' ' 64' ' ' LEU . 80.9 p -99.74 167.52 10.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -53.76 165.29 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -100.73 116.4 32.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -116.28 152.48 47.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.676 0.75 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 139.01 39.19 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.66 2.24 . . . . 0.0 112.367 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.4 p -42.43 -45.61 4.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.834 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 p -51.12 -37.43 45.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.84 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -125.79 83.5 62.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.646 0.736 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.73 3.51 2.72 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.378 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.35 128.89 38.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.85 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 10.0 m-90 -106.24 -40.88 5.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 61' ' ' ASN . 1.9 p-10 33.76 44.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -117.82 138.55 52.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.408 ' CE3' ' NH2' ' A' ' 12' ' ' ARG . 62.3 m95 -81.82 96.9 7.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.917 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.705 HD11 HG12 ' A' ' 48' ' ' VAL . 12.8 tp -85.39 120.37 26.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -98.48 132.58 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.435 ' CE1' HD12 ' A' ' 13' ' ' ILE . 44.7 m-85 -100.41 136.19 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -87.63 44.08 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.799 HG21 HD13 ' A' ' 37' ' ' ILE . 2.0 pp -112.59 165.57 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.112 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.623 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.58 119.98 37.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.652 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 2.8 mp -56.87 -51.73 79.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.596 0.713 . . . . 0.0 111.144 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.0 Cg_endo -69.75 1.64 4.24 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.36 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.491 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 3.5 t70 -125.47 -6.69 6.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.575 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -74.6 116.09 50.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.648 0.737 . . . . 0.0 110.926 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.586 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.77 139.3 39.84 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.736 2.29 . . . . 0.0 112.309 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -53.07 -36.86 61.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.575 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . . . -60.77 -33.66 73.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -68.15 165.14 18.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 37' ' ' ILE . 10.3 ptt180 -161.11 172.54 16.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.9 tp -93.79 144.68 25.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.609 ' C ' HD23 ' A' ' 81' ' ' LEU . 77.4 m -135.86 149.65 49.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.609 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER -155.84 139.42 15.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.404 ' OG ' HD12 ' A' ' 133' ' ' LEU . 96.8 p -148.86 139.19 22.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.459 ' CG1' HD11 ' A' ' 150' ' ' LEU . 53.5 mt -86.54 138.49 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.124 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 72.5 m -139.64 145.17 38.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.47 ' HA ' HG22 ' A' ' 31' ' ' ILE . 88.5 p -106.86 120.52 42.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.852 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 94' ' ' GLU . 5.1 p -102.01 130.67 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.09 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -137.95 116.1 11.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -107.14 154.72 16.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.473 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -118.67 168.81 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 110.881 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -67.19 113.03 4.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.56 -23.25 16.86 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -95.74 167.25 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 111.106 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -87.02 168.37 13.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 36.0 mt-10 -75.5 156.09 35.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -122.98 116.31 23.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -94.02 127.01 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 21.7 t -131.54 123.59 19.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.589 0.709 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.507 ' HD3' HD23 ' A' ' 132' ' ' LEU . 53.9 Cg_endo -69.8 147.97 63.81 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 125' ' ' VAL . 24.6 mt -122.74 -48.18 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.13 163.09 35.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.108 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.831 ' CH2' HG22 ' A' ' 138' ' ' VAL . 61.7 p-90 -142.6 138.59 30.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.79 121.05 1.66 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.518 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 34.6 m-20 -101.36 131.44 47.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.1 mt -124.45 121.54 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 106' ' ' LEU . 7.1 m120 -66.76 96.14 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.3 mt -35.0 -39.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -102.45 114.47 28.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -57.48 173.82 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.773 ' CE1' HG23 ' A' ' 110' ' ' THR . 1.1 p90 -58.05 -15.09 8.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.773 HG23 ' CE1' ' A' ' 109' ' ' TYR . 29.9 p -103.46 26.15 8.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 45.87 35.6 2.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 113' ' ' LEU . 93.6 m -125.76 109.3 12.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.68 HD22 ' CH2' ' A' ' 156' ' ' TRP . 33.7 mt -34.23 139.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' CG ' ' A' ' 154' ' ' PHE . 19.3 m -72.84 166.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -161.05 171.98 17.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.38 160.12 2.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -64.16 143.41 57.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.432 ' O ' HD13 ' A' ' 152' ' ' LEU . 35.2 ttp -153.05 148.71 27.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.77 121.35 15.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.078 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pp -128.84 155.72 44.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -76.26 152.71 36.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.26 157.09 18.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.578 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 15.0 m95 -90.48 152.24 45.1 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.546 0.689 . . . . 0.0 110.946 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 151.26 69.09 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.344 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 99' ' ' LEU . 93.4 t -75.18 116.62 56.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 134.41 27.93 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.677 2.251 . . . . 0.0 112.384 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -52.37 151.36 4.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.815 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . 88.86 -47.04 3.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.481 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.458 HD23 HG13 ' A' ' 125' ' ' VAL . 54.8 tp -37.53 110.87 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -100.58 39.44 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.65 171.65 14.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.507 HD23 ' HD3' ' A' ' 98' ' ' PRO . 43.3 mt -103.0 -45.76 4.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.534 HD23 ' CE1' ' A' ' 38' ' ' TYR . 10.7 tp -104.12 132.42 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -105.54 91.06 4.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.591 0.71 . . . . 0.0 110.909 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.541 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 54.2 Cg_endo -69.79 -45.29 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.641 2.227 . . . . 0.0 112.395 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.0 mt -74.25 -23.74 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.449 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -39.83 158.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.472 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.831 HG22 ' CH2' ' A' ' 101' ' ' TRP . 6.1 m -52.81 172.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.944 0.402 . . . . 0.0 111.102 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.405 HG22 ' CB ' ' A' ' 103' ' ' ASN . 40.1 p -132.03 161.8 32.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.173 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.52 -179.75 25.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.8 p -90.33 121.29 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 0.0 110.875 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.578 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 29.8 t30 -63.28 126.53 89.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.544 0.688 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 1.49 4.4 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -91.81 113.32 25.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -74.4 -40.16 62.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -49.67 -46.38 49.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.0 p -55.15 152.62 14.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.581 0.705 . . . . 0.0 111.139 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 134.43 27.92 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.673 2.249 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.1 t -113.83 142.54 45.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.459 HD11 ' CG1' ' A' ' 83' ' ' ILE . 4.7 mt -110.27 146.22 36.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -116.53 123.13 46.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.807 ' C ' HD22 ' A' ' 152' ' ' LEU . 0.0 OUTLIER -130.77 166.23 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -120.26 118.79 31.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.628 ' CE2' HD21 ' A' ' 152' ' ' LEU . 28.8 m-85 -88.96 100.78 13.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.923 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -121.79 154.43 36.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.796 ' CH2' HD13 ' A' ' 11' ' ' LEU . 20.9 m95 -138.77 105.3 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 158' ' ' SER . 14.8 p90 -90.47 -49.01 6.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.514 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 51.5 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.572 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 46.3 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.867 0.365 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -120.26 135.3 55.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.096 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.983 HD13 ' CH2' ' A' ' 156' ' ' TRP . 6.7 tp -97.54 128.92 44.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.412 ' NH2' ' CE3' ' A' ' 63' ' ' TRP . 0.3 OUTLIER -127.35 123.6 36.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.687 HD12 ' CE1' ' A' ' 66' ' ' TYR . 11.3 mt -124.57 137.09 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.175 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -113.96 135.41 54.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 mm -94.78 142.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.136 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.87 -69.19 0.78 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 p -172.3 173.85 4.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -120.5 161.07 21.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.07 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' A' ' 149' ' ' CYS . 2.1 t -128.34 158.37 38.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 39.47 52.16 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.962 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.825 0.345 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.401 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 29.4 t70 -82.85 -55.91 4.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 25.9 mmtt -146.32 -177.12 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.536 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.1 pt -145.52 170.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 3.7 p90 -158.57 166.23 32.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.679 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 99.0 t -122.27 139.6 48.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.126 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' HG2' HD22 ' A' ' 133' ' ' LEU . 20.6 ttm180 -115.72 121.2 41.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.812 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 81' ' ' LEU . 57.9 p -118.91 154.16 33.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.406 ' C ' HD12 ' A' ' 37' ' ' ILE . . . -176.08 169.26 41.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.536 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.599 HD13 HG21 ' A' ' 68' ' ' ILE . 4.1 mp -122.98 137.24 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.806 0.336 . . . . 0.0 111.124 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.54 ' HA ' HD13 ' A' ' 44' ' ' LEU . 2.9 m-85 -137.03 150.22 47.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.732 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.4 t-160 -113.01 99.36 7.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.84 32.55 61.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.478 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.31 -22.45 34.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.58 140.04 29.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.605 0.716 . . . . 0.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.485 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 53.8 Cg_endo -69.74 156.09 64.31 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.367 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.6 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.1 mp -120.51 -38.01 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.2 m -154.98 168.21 27.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -51.9 152.65 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -93.94 163.44 13.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.647 HG12 HD11 ' A' ' 64' ' ' LEU . 25.4 t -116.73 145.06 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -125.33 141.68 51.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.5 p -85.86 160.66 19.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -52.75 170.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -95.88 115.22 27.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -116.96 152.16 48.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.593 0.711 . . . . 0.0 111.11 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 137.74 36.24 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.35 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 24.6 p -47.85 -44.88 29.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 t -53.16 -31.33 42.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -134.39 84.78 39.87 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.62 0.724 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.447 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.75 3.31 2.84 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.717 2.278 . . . . 0.0 112.37 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -62.81 127.15 29.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.679 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 5.6 m-90 -106.22 -63.46 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 58.67 45.05 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -127.55 147.47 50.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.412 ' CE3' ' NH2' ' A' ' 12' ' ' ARG . 77.9 m95 -88.66 117.71 27.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.647 HD11 HG12 ' A' ' 48' ' ' VAL . 9.2 tp -101.0 123.25 44.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -99.59 136.63 39.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.687 ' CE1' HD12 ' A' ' 13' ' ' ILE . 34.8 m-85 -106.35 138.36 42.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.49 38.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.599 HG21 HD13 ' A' ' 37' ' ' ILE . 1.8 pp -108.05 161.53 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.605 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.62 124.86 49.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.588 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -55.84 -55.27 42.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 0.0 111.173 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.9 Cg_endo -69.74 2.94 3.07 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 112.346 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.503 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.1 t0 -127.72 1.46 6.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.89 115.71 62.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.643 0.735 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.606 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.78 145.64 57.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.467 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 25.3 mmt85 -59.69 -35.9 75.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.732 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -62.73 -32.92 74.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.606 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -68.35 165.0 19.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.093 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.481 ' O ' HG23 ' A' ' 37' ' ' ILE . 15.3 ptp180 -163.09 176.36 10.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.3 tp -98.97 136.69 38.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.76 132.11 40.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.9 OUTLIER -130.66 158.62 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.8 p -159.57 135.89 8.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.829 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.423 HG12 HD11 ' A' ' 150' ' ' LEU . 34.7 mt -86.58 136.57 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.109 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . 30.3 m -132.53 151.29 51.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.536 ' HA ' HG22 ' A' ' 31' ' ' ILE . 83.6 p -112.97 122.76 48.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.569 HG23 ' CD2' ' A' ' 96' ' ' HIS . 8.9 p -106.19 125.85 61.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.0 tptt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.842 0.354 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -130.27 122.98 29.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.569 ' CD2' HG23 ' A' ' 86' ' ' VAL . 5.7 m170 -100.95 128.79 46.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.2 t -131.82 129.01 21.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 110.872 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.584 ' HB2' HG11 ' A' ' 125' ' ' VAL . 53.8 Cg_endo -69.84 143.18 49.65 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 0.0 112.282 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.439 ' C ' HG13 ' A' ' 125' ' ' VAL . 11.1 mt -118.45 -56.83 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.19 178.68 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.587 ' HD1' HG12 ' A' ' 125' ' ' VAL . 64.8 p-90 -161.42 144.07 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.96 132.46 4.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -111.93 120.26 41.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 0.0 110.909 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.586 HD11 HD21 ' A' ' 120' ' ' LEU . 73.7 mt -112.24 127.27 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -68.87 98.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.3 mt -43.15 -34.32 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 63.3 m-85 -107.9 110.43 22.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -51.65 170.22 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 1.061 ' CE1' HG23 ' A' ' 110' ' ' THR . 0.6 OUTLIER -55.48 -20.25 12.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.984 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 1.061 HG23 ' CE1' ' A' ' 109' ' ' TYR . 41.5 p -102.64 28.46 6.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.113 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 110' ' ' THR . 4.3 p30 46.71 40.34 8.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 113' ' ' LEU . 93.1 m -126.23 109.24 12.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.838 HD22 ' CH2' ' A' ' 156' ' ' TRP . 34.0 mt -34.2 132.95 0.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.1 m -66.2 163.31 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.5 p -160.42 175.6 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.54 134.9 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.484 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.434 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 5.9 ttpt -43.01 150.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.803 0.335 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.427 ' O ' HD13 ' A' ' 152' ' ' LEU . 34.8 ttp -158.79 148.72 19.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.7 114.44 9.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.586 HD21 HD11 ' A' ' 104' ' ' ILE . 4.1 pp -124.79 160.94 27.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.68 150.23 29.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.428 HD11 HD12 ' A' ' 150' ' ' LEU . 5.5 mt -106.52 153.35 22.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.536 ' CH2' ' OD1' ' A' ' 142' ' ' ASN . 54.7 m95 -85.94 144.81 39.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.514 0.673 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 132.61 23.71 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.646 2.231 . . . . 0.0 112.363 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.587 HG12 ' HD1' ' A' ' 101' ' ' TRP . 21.5 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.675 0.75 . . . . 0.0 111.123 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.468 HD13 ' OH ' ' A' ' 32' ' ' TYR . 40.3 mt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.81 0.338 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.432 HD22 ' HG2' ' A' ' 34' ' ' ARG . 21.7 tp -106.32 133.05 51.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -107.08 91.37 6.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.636 0.731 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -17.12 38.01 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.67 2.247 . . . . 0.0 112.381 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 mm -88.89 -20.69 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -41.93 150.75 0.27 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.3 m -66.46 164.2 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.963 0.411 . . . . 0.0 111.086 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.4 p -108.15 161.11 15.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.133 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.32 167.51 18.62 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.462 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.6 p -93.5 118.73 31.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 110.885 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.536 ' OD1' ' CH2' ' A' ' 123' ' ' TRP . 31.6 t30 -61.35 123.62 77.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.665 0.745 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -8.73 24.36 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.722 2.282 . . . . 0.0 112.333 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -73.44 138.98 45.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -90.21 -49.5 6.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -44.69 -38.42 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.8 p -63.77 151.24 89.34 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.583 0.706 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 166.4 27.7 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 0.0 112.356 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.404 ' HB3' ' CG2' ' A' ' 19' ' ' THR . 4.2 t -146.1 135.88 23.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.475 ' CD2' ' HB2' ' A' ' 18' ' ' ALA . 10.8 mt -113.84 138.49 50.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.967 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.434 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 18.3 tt0 -106.93 132.08 53.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.79 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -134.84 161.74 34.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -116.41 120.84 40.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.644 ' CE2' HD21 ' A' ' 152' ' ' LEU . 25.9 m-85 -90.15 113.94 25.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.63 136.65 46.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.983 ' CH2' HD13 ' A' ' 11' ' ' LEU . 2.7 m95 -134.58 98.96 4.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.564 ' CG ' ' N ' ' A' ' 158' ' ' SER . 15.5 p90 -103.83 -51.76 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.564 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 4.0 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.54 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 5.6 m . . . . . 0 C--O 1.229 0.025 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.888 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -119.52 147.07 44.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.093 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.613 HD13 ' CH2' ' A' ' 156' ' ' TRP . 11.2 tp -93.25 130.28 39.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.572 ' N ' HD12 ' A' ' 11' ' ' LEU . 6.2 ttp180 -127.97 127.61 43.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.948 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.475 HD12 ' CE1' ' A' ' 66' ' ' TYR . 51.4 mt -130.75 156.3 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' N ' HG22 ' A' ' 13' ' ' ILE . 55.7 tttt -140.65 128.01 21.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.5 mm -90.29 143.33 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.68 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.2 mm? -100.23 -73.66 0.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 t -162.49 172.17 15.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.428 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -119.23 162.9 17.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' TYR . 9.5 t -130.69 156.08 45.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' THR . 4.9 m-85 35.59 45.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.863 0.364 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -79.56 -57.32 3.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -146.15 177.49 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.4 pt -139.64 173.72 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -165.98 160.57 16.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.517 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 37.6 t -116.74 146.84 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.145 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -119.68 136.14 54.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.481 HG22 ' HB3' ' A' ' 81' ' ' LEU . 63.0 p -130.59 157.65 42.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.11 141.58 3.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.4 mp -93.59 133.66 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 111.111 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.549 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 17.5 m-85 -127.86 158.69 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.601 ' HB3' HD11 ' A' ' 44' ' ' LEU . 12.0 t-160 -134.57 95.43 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.69 32.07 28.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.48 -17.81 46.27 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -96.97 141.8 23.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.625 0.726 . . . . 0.0 110.938 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.432 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.77 160.88 48.08 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.643 2.229 . . . . 0.0 112.358 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.601 HD11 ' HB3' ' A' ' 39' ' ' HIS . 10.1 mp -119.9 -26.4 5.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.5 p -158.38 168.24 27.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -57.04 131.23 49.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.428 ' ND2' ' OH ' ' A' ' 38' ' ' TYR . 6.4 m120 -64.09 148.52 49.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.479 HG12 HD11 ' A' ' 64' ' ' LEU . 21.3 t -111.15 147.16 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -130.16 145.24 51.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.452 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 3.2 t -87.59 176.12 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.402 ' N ' ' OG1' ' A' ' 50' ' ' THR . 11.6 pt20 -63.52 167.9 5.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.1 mtm-85 -92.13 140.61 29.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.38 152.12 49.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.662 0.744 . . . . 0.0 111.153 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.67 36.08 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.686 2.257 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.1 p -47.78 -45.75 29.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.4 m -52.3 -28.34 18.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -134.5 87.38 32.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.668 0.747 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.75 3.73 2.6 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.351 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -55.69 134.4 51.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.517 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -120.88 -68.45 0.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.68 ' OD1' HD13 ' A' ' 16' ' ' LEU . 69.0 m-80 53.55 52.72 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -127.56 143.39 51.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.46 ' CE3' ' HD2' ' A' ' 12' ' ' ARG . 90.0 m95 -87.38 104.35 16.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.479 HD11 HG12 ' A' ' 48' ' ' VAL . 10.8 tp -93.39 120.69 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -95.96 151.95 18.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' CE1' HD12 ' A' ' 13' ' ' ILE . 61.8 m-85 -118.03 140.21 50.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -84.33 30.29 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.592 ' C ' HD12 ' A' ' 68' ' ' ILE . 1.3 pp -106.63 159.42 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.608 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -110.88 139.97 45.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.967 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.536 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.5 mp -64.64 -58.06 14.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.699 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.608 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.0 Cg_endo -69.73 2.43 3.53 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.679 2.252 . . . . 0.0 112.322 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.495 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.0 t70 -120.67 -0.74 10.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.476 HD21 HG21 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -87.52 117.13 68.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.0 Cg_endo -69.82 138.37 37.49 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.622 2.215 . . . . 0.0 112.344 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -56.45 -26.47 53.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.427 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -70.31 -27.41 64.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.087 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.475 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -78.43 165.52 23.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 37' ' ' ILE . 11.6 ptp180 -157.89 174.13 15.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.465 ' HB2' HD21 ' A' ' 106' ' ' LEU . 33.2 tp -97.01 143.64 27.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.608 ' C ' HD23 ' A' ' 81' ' ' LEU . 81.9 m -133.58 154.65 50.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.608 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -155.66 137.84 14.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.768 ' OG ' HD12 ' A' ' 133' ' ' LEU . 1.0 OUTLIER -139.42 154.37 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.812 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.9 mt -98.75 128.68 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.193 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 18.6 m -128.52 142.58 51.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.676 ' HA ' HG22 ' A' ' 31' ' ' ILE . 29.8 p -108.37 130.96 55.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.788 HG23 ' CD2' ' A' ' 96' ' ' HIS . 9.9 p -110.64 129.21 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.115 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 tptm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.902 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.84 0.352 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -137.52 121.61 17.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.788 ' CD2' HG23 ' A' ' 86' ' ' VAL . 9.1 m170 -97.46 141.46 30.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.7 t -148.6 132.34 8.47 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.582 0.706 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.657 ' O ' HD23 ' A' ' 99' ' ' LEU . 54.0 Cg_endo -69.75 152.51 69.38 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.24 . . . . 0.0 112.397 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 98' ' ' PRO . 6.6 mt -128.48 -47.21 1.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -140.87 155.47 46.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.112 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.76 ' CH2' HG22 ' A' ' 138' ' ' VAL . 62.2 p-90 -135.68 126.2 26.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.4 130.07 5.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.599 ' HB2' HG22 ' A' ' 139' ' ' THR . 1.0 OUTLIER -104.6 161.49 14.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.409 HG13 ' C ' ' A' ' 103' ' ' ASN . 88.6 mt -151.17 118.03 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -64.83 105.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 79' ' ' LEU . 70.9 mt -44.32 -54.73 5.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.406 ' CE1' ' HG ' ' A' ' 113' ' ' LEU . 65.0 m-85 -94.28 120.34 34.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -56.75 -176.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.743 ' CE1' HG23 ' A' ' 110' ' ' THR . 0.3 OUTLIER -72.09 -0.9 12.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.743 HG23 ' CE1' ' A' ' 109' ' ' TYR . 5.0 p -108.86 11.39 26.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.117 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 64.33 48.56 2.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.4 m -147.33 125.64 12.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.982 HD22 ' CH2' ' A' ' 156' ' ' TRP . 15.0 mt -45.27 142.12 2.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 114' ' ' VAL . 2.4 m -64.24 176.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.4 p -168.51 173.69 7.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.34 139.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.476 ' HD3' ' CG ' ' A' ' 151' ' ' GLU . 0.7 OUTLIER -48.51 146.11 3.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.861 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.417 ' O ' HD13 ' A' ' 152' ' ' LEU . 32.0 ttp -147.86 152.49 37.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.407 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.4 116.68 11.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.509 ' C ' HD12 ' A' ' 120' ' ' LEU . 4.5 pp -128.85 160.41 32.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 147' ' ' THR . 5.4 m120 -87.3 146.95 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.492 HD11 HD12 ' A' ' 150' ' ' LEU . 2.8 mt -104.63 150.05 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -83.09 151.68 63.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.539 0.685 . . . . 0.0 110.951 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 160.63 48.98 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 0.0 112.365 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.2 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.639 0.733 . . . . 0.0 111.128 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.845 0.355 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.768 HD12 ' OG ' ' A' ' 82' ' ' SER . 8.6 tp -110.49 145.3 37.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.443 ' ND2' ' HA3' ' A' ' 137' ' ' GLY . 64.2 t30 -119.18 93.87 47.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 110.911 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.549 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.3 Cg_endo -69.83 -47.3 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.716 2.277 . . . . 0.0 112.31 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.619 ' H ' HD12 ' A' ' 136' ' ' ILE . 0.4 OUTLIER -64.36 -30.14 49.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.137 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.443 ' HA3' ' ND2' ' A' ' 134' ' ' ASN . . . -35.14 151.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.468 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.76 HG22 ' CH2' ' A' ' 101' ' ' TRP . 3.5 m -56.85 176.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.401 . . . . 0.0 111.125 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.599 HG22 ' HB2' ' A' ' 103' ' ' ASN . 41.2 p -129.48 161.73 29.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.122 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.57 159.17 20.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.0 p -78.18 130.87 36.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.855 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.409 ' ND2' HG21 ' A' ' 147' ' ' THR . 13.5 t-20 -64.37 119.81 59.63 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.644 0.735 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -7.2 20.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.673 2.249 . . . . 0.0 112.354 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -85.94 145.49 27.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -92.97 -37.15 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.69 -14.67 3.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.485 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 65.0 p -88.85 151.39 47.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.581 0.705 . . . . 0.0 111.154 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 169.39 19.07 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.342 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 t -150.79 137.83 19.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.492 HD12 HD11 ' A' ' 122' ' ' LEU . 10.2 mt -114.42 139.59 49.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.476 ' CG ' ' HD3' ' A' ' 117' ' ' LYS . 5.5 tt0 -107.09 123.17 47.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.778 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -131.08 162.54 29.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -119.15 131.72 55.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.508 ' CE2' HD21 ' A' ' 152' ' ' LEU . 24.5 m-85 -95.98 119.74 35.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.822 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.94 137.43 44.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.982 ' CH2' HD22 ' A' ' 113' ' ' LEU . 15.9 m95 -130.02 91.24 3.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.958 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.562 ' CG ' ' N ' ' A' ' 158' ' ' SER . 22.3 p90 -96.95 -52.62 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.888 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 30.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.882 0.373 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.55 128.42 53.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.596 HD13 ' CH2' ' A' ' 156' ' ' TRP . 17.6 tp -97.83 131.66 44.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -139.21 136.57 35.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 66' ' ' TYR . 31.1 mt -129.5 135.94 60.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 21.2 tttt -113.59 113.26 24.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.28 143.77 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.35 -73.22 0.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.5 p -170.52 171.0 6.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.94 154.23 25.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.421 HG23 ' CD2' ' A' ' 20' ' ' TYR . 8.1 t -134.64 143.25 47.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.421 ' CD2' HG23 ' A' ' 19' ' ' THR . 1.6 m-85 63.73 41.29 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.143 179.876 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.804 0.335 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -72.06 -62.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -144.74 177.08 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 85' ' ' SER . 4.9 pt -137.69 158.12 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -152.37 140.38 20.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.73 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 95.8 t -89.82 149.07 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.163 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.471 ' O ' HD13 ' A' ' 133' ' ' LEU . 37.3 ttt85 -131.53 119.35 21.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 81' ' ' LEU . 32.4 p -117.04 179.33 4.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.64 140.57 3.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.493 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.7 mp -90.07 142.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.165 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.537 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 22.0 m-85 -137.23 143.68 42.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.425 ' CB ' HD11 ' A' ' 44' ' ' LEU . 13.3 t-160 -122.14 99.01 6.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.13 36.58 31.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.44 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.92 35.41 50.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -148.53 140.39 14.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.728 . . . . 0.0 110.88 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 143.45 51.09 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 0.0 112.345 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 39' ' ' HIS . 11.3 mp -97.67 -41.83 7.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.8 m -150.36 162.54 40.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -44.02 120.3 2.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -60.52 162.25 6.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.552 HG12 HD11 ' A' ' 64' ' ' LEU . 21.2 t -117.32 147.46 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.163 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -126.86 148.89 49.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.459 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 9.1 t -98.13 163.82 12.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.174 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -49.95 179.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -107.02 127.71 53.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 59' ' ' ARG . 1.6 m -129.95 152.13 79.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.6 0.714 . . . . 0.0 111.161 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 141.55 45.57 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.704 2.269 . . . . 0.0 112.343 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.3 p -50.13 -45.36 52.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.8 p -53.64 -30.85 44.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -134.2 86.3 36.8 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.581 0.705 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.572 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.6 Cg_endo -69.75 3.63 2.66 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.723 2.282 . . . . 0.0 112.322 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.432 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -48.81 135.4 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.73 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -128.93 -56.35 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.5 p30 38.37 37.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -104.29 142.7 34.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.477 ' NE1' ' HD2' ' A' ' 14' ' ' LYS . 45.4 m95 -85.38 104.4 15.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.552 HD11 HG12 ' A' ' 48' ' ' VAL . 10.8 tp -96.32 121.43 38.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -99.74 141.92 31.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.434 ' CE1' HD12 ' A' ' 13' ' ' ILE . 58.4 m-85 -110.86 128.95 55.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -81.34 47.66 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.491 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.1 pp -114.0 167.25 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.16 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.617 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.55 123.72 46.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.621 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -58.49 -53.2 68.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.634 0.731 . . . . 0.0 111.143 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.82 3.11 2.99 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.268 . . . . 0.0 112.329 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.505 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 3.5 t70 -124.82 -4.42 7.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.636 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -82.01 111.85 30.45 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.94 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.498 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.3 Cg_endo -69.75 135.9 31.65 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.365 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.47 ' NE ' ' OD1' ' A' ' 111' ' ' ASP . 62.0 mmt-85 -45.27 -43.63 10.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.18 -47.98 54.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -52.51 160.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 -156.13 173.15 17.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.4 tp -98.62 131.02 45.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -125.98 132.34 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.565 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.4 OUTLIER -138.95 147.05 41.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.423 ' OG ' HD12 ' A' ' 133' ' ' LEU . 88.6 p -155.24 130.32 9.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.536 ' CG1' HD11 ' A' ' 150' ' ' LEU . 72.6 mt -80.5 131.72 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 55.7 m -123.37 143.38 50.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.52 ' HA ' HG22 ' A' ' 31' ' ' ILE . 35.7 m -106.98 128.05 54.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.593 HG23 ' CD2' ' A' ' 96' ' ' HIS . 6.9 p -109.05 137.71 39.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.169 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.936 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.561 ' HB3' HG22 ' A' ' 86' ' ' VAL . 24.3 mt-10 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.825 0.345 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -124.74 115.33 20.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.949 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.593 ' CD2' HG23 ' A' ' 86' ' ' VAL . 5.1 m170 -97.07 141.33 30.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.38 124.79 2.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.635 0.731 . . . . 0.0 110.855 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.549 ' HD3' HD23 ' A' ' 132' ' ' LEU . 53.3 Cg_endo -69.81 147.14 61.89 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.706 2.271 . . . . 0.0 112.298 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.463 ' O ' HG23 ' A' ' 125' ' ' VAL . 21.4 mt -113.2 -47.62 3.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.84 156.91 44.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.449 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 67.2 p-90 -137.21 138.91 40.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.07 124.21 3.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.53 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -101.75 129.16 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.892 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.675 HD11 HD21 ' A' ' 120' ' ' LEU . 85.0 mt -124.0 126.8 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.076 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 106' ' ' LEU . 8.2 t-20 -73.43 95.24 2.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 105' ' ' ASN . 51.4 mt -35.08 -34.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 105' ' ' ASN . 88.7 m-85 -103.56 112.7 25.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.92 -178.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.829 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 109' ' ' TYR . 1.3 p90 -62.06 -30.53 71.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.947 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.402 HG23 ' HB ' ' A' ' 112' ' ' THR . 5.2 t -93.99 33.86 1.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.181 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.47 ' OD1' ' NE ' ' A' ' 75' ' ' ARG . 14.5 t0 43.0 44.73 4.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 69.7 m -131.52 109.66 10.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.17 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.689 HD22 ' CH2' ' A' ' 156' ' ' TRP . 60.3 mt -34.66 140.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.518 HG21 ' CE2' ' A' ' 154' ' ' PHE . 27.6 m -67.66 165.44 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 p -164.94 158.1 16.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.864 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.94 141.05 1.23 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -40.01 149.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.917 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.7 ttp -159.76 148.46 17.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.71 123.36 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.675 HD21 HD11 ' A' ' 104' ' ' ILE . 4.6 pp -135.34 156.55 48.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -77.95 158.72 29.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.852 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.719 HD11 HD12 ' A' ' 150' ' ' LEU . 10.3 mt -118.87 158.64 25.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -91.46 152.04 43.23 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.576 0.703 . . . . 0.0 110.909 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 170.37 16.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.346 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 99' ' ' LEU . 98.3 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 121.548 0.69 . . . . 0.0 111.164 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.549 HD23 ' HD3' ' A' ' 98' ' ' PRO . 14.1 mt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.873 0.368 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 34' ' ' ARG . 10.3 tp -88.64 135.73 33.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -108.06 91.36 7.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.653 0.74 . . . . 0.0 110.897 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.76 -10.41 28.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.8 mm -95.61 -16.62 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.449 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -41.46 148.17 0.36 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 m -65.3 166.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 66.6 p -108.96 154.67 21.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.139 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.02 135.93 8.27 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.492 ' CB ' ' HB2' ' A' ' 120' ' ' LEU . 88.2 p -51.12 120.41 4.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.377 . . . . 0.0 110.837 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER -50.05 132.15 22.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.644 0.735 . . . . 0.0 110.881 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.0 11.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.688 2.259 . . . . 0.0 112.363 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 146' ' ' GLU . 23.4 t-20 -49.25 143.89 5.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -97.6 -32.49 11.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.447 ' N ' ' OD1' ' A' ' 144' ' ' ASN . 11.9 pt-20 -84.3 34.56 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.5 p -118.26 155.2 51.91 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.516 0.674 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 137.19 34.7 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.308 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 8.3 t -120.69 131.68 54.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.719 HD12 HD11 ' A' ' 122' ' ' LEU . 6.4 mt -107.23 140.06 40.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -109.12 123.91 49.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.781 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -135.08 161.21 35.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -121.18 123.88 43.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.619 ' CE2' HD21 ' A' ' 152' ' ' LEU . 25.6 m-85 -91.23 116.13 28.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.61 152.21 51.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.689 ' CH2' HD22 ' A' ' 113' ' ' LEU . 5.3 m95 -137.47 107.97 6.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.497 ' CG ' ' N ' ' A' ' 158' ' ' SER . 16.2 p90 -90.28 -46.65 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.497 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 26.9 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -118.77 126.15 51.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.669 HD13 ' CH2' ' A' ' 156' ' ' TRP . 12.4 tp -84.15 144.1 29.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.601 ' H ' HD12 ' A' ' 11' ' ' LEU . 23.5 ptt180 -146.95 139.07 24.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.6 mt -141.28 127.65 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HB2' ' CD2' ' A' ' 63' ' ' TRP . 25.8 tttp -103.24 120.35 40.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 mm -83.08 145.99 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.06 -73.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.1 p -172.96 169.17 4.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.401 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -113.97 158.1 21.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.6 t -137.04 151.99 49.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 58.85 32.76 22.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.136 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.6 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -85.27 -56.38 3.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -148.09 179.69 7.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 55' ' ' CYS . 7.7 pt -139.79 170.15 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.151 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -170.79 150.64 3.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.566 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 9.3 t -102.49 151.94 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -130.86 116.65 18.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.8 p -104.57 170.31 7.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.185 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.98 146.5 4.96 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.47 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 78' ' ' ARG . 3.6 mp -104.12 135.95 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.86 0.362 . . . . 0.0 111.127 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 35.4 m-85 -129.07 149.18 51.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.802 ' CB ' HD11 ' A' ' 44' ' ' LEU . 5.8 t-160 -123.05 98.45 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.74 44.29 39.42 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.446 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.92 29.68 72.47 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.442 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -139.48 140.78 26.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 142.78 48.78 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.712 2.275 . . . . 0.0 112.323 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.802 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.1 mp -110.49 -34.91 6.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 p -152.72 163.09 40.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -47.84 151.49 0.89 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -80.21 140.25 36.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.657 HG12 HD11 ' A' ' 64' ' ' LEU . 74.4 t -104.7 132.67 50.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -118.81 161.31 20.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -107.4 160.49 15.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -46.85 154.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.05 136.72 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.488 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -144.23 152.12 53.4 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.663 0.745 . . . . 0.0 111.086 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 139.89 41.26 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.696 2.264 . . . . 0.0 112.37 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 31' ' ' ILE . 24.9 p -51.03 -44.15 60.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.1 m -53.49 -35.52 60.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -132.53 83.96 52.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.719 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.539 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.79 3.27 2.88 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.688 2.259 . . . . 0.0 112.342 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -49.94 113.15 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.566 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 6.2 m-90 -106.41 -48.83 3.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 60' ' ' TRP . 6.8 m-80 36.61 49.72 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -121.38 146.54 46.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.417 ' CD2' ' HB2' ' A' ' 14' ' ' LYS . 59.5 m95 -87.71 100.05 12.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.657 HD11 HG12 ' A' ' 48' ' ' VAL . 12.2 tp -84.39 119.27 24.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -95.07 137.79 33.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -107.75 127.56 53.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.4 50.41 1.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.1 pp -118.5 163.4 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.616 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.57 112.23 22.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.64 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.5 mp -48.68 -52.42 45.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.661 0.743 . . . . 0.0 111.148 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.3 Cg_endo -69.8 2.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.514 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.1 t70 -129.29 1.82 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.6 118.61 71.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.627 0.727 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.532 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.8 Cg_endo -69.81 136.92 34.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.65 2.233 . . . . 0.0 112.341 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 23.2 mmt85 -54.47 -36.1 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.39 -35.61 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -64.26 166.25 8.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.106 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 37' ' ' ILE . 16.2 ptt180 -162.18 174.46 12.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.0 tp -94.87 134.35 37.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.0 m -132.28 132.66 43.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.56 155.15 50.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.727 ' OG ' HD12 ' A' ' 133' ' ' LEU . 7.6 m -157.62 127.42 6.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mt -83.48 140.03 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 63.7 m -136.11 149.68 48.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.402 ' HA ' HG22 ' A' ' 31' ' ' ILE . 87.9 p -106.6 120.44 41.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 86' ' ' VAL . 7.6 p -102.55 115.43 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.143 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 87' ' ' LYS . 1.4 tmmt? . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.829 0.347 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -136.07 120.94 18.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.863 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.566 ' CD2' HG23 ' A' ' 86' ' ' VAL . 9.4 m170 -96.98 135.98 38.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.2 t -137.03 131.94 18.04 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.576 0.703 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.469 ' HB2' HG11 ' A' ' 125' ' ' VAL . 53.4 Cg_endo -69.79 151.93 69.04 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.682 2.255 . . . . 0.0 112.319 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 98' ' ' PRO . 29.5 mt -127.82 -53.36 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.923 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.04 164.89 32.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.084 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.532 ' O ' ' CE3' ' A' ' 101' ' ' TRP . 58.9 p-90 -146.94 129.2 15.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.53 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -131.33 129.29 5.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.469 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -106.75 126.84 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 0.0 110.862 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.565 HG12 HD21 ' A' ' 120' ' ' LEU . 62.2 mt -118.51 124.03 72.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.21 96.12 0.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.5 mt -37.92 -45.49 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.558 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 67.7 m-85 -94.42 114.81 26.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -48.06 174.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -60.67 -19.03 57.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.476 HG23 ' HB ' ' A' ' 112' ' ' THR . 5.9 t -94.57 12.45 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.131 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 65.97 37.75 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.476 ' HB ' HG23 ' A' ' 110' ' ' THR . 4.5 m -136.77 121.68 18.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.123 HD22 ' CH2' ' A' ' 156' ' ' TRP . 23.2 mt -34.69 146.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.537 HG23 ' CG ' ' A' ' 154' ' ' PHE . 23.4 m -75.31 175.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.144 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.6 p -167.15 161.42 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.795 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.1 136.6 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HE2' ' CD ' ' A' ' 151' ' ' GLU . 38.7 tttt -42.77 146.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.727 0.298 . . . . 0.0 110.917 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.429 ' O ' HD13 ' A' ' 152' ' ' LEU . 17.3 ttp -154.61 148.21 25.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.63 117.17 11.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.126 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.565 HD21 HG12 ' A' ' 104' ' ' ILE . 4.3 pp -129.72 161.88 29.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.552 ' O ' HD12 ' A' ' 120' ' ' LEU . 10.8 m120 -82.05 158.48 23.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.717 HD11 HD12 ' A' ' 150' ' ' LEU . 11.5 mt -117.31 144.85 44.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.487 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 49.8 m95 -70.35 152.01 95.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 0.0 110.943 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 170.27 16.9 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 0.0 112.352 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 98' ' ' PRO . 76.9 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.656 0.741 . . . . 0.0 111.104 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.2 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.842 0.354 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.727 HD12 ' OG ' ' A' ' 82' ' ' SER . 20.3 tp -99.32 128.64 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -108.48 91.51 8.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.679 0.752 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.76 -43.92 2.38 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.711 2.274 . . . . 0.0 112.391 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 137' ' ' GLY . 45.2 mt -65.11 -28.72 45.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -35.01 151.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -60.68 176.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.7 p -122.05 169.11 11.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.112 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.79 166.32 24.28 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 142' ' ' ASN . 6.3 p -88.32 94.19 9.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.675 HD21 ' ND2' ' A' ' 144' ' ' ASN . 10.3 t30 -37.09 133.33 0.71 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.657 0.742 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' ASN . 54.0 Cg_endo -69.66 -48.67 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.361 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.675 ' ND2' HD21 ' A' ' 142' ' ' ASN . 2.3 m-20 -37.12 126.38 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -86.69 -27.22 23.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -60.46 -34.74 74.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.5 p -66.36 151.02 96.58 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.591 0.71 . . . . 0.0 111.168 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 159.48 53.24 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.726 2.284 . . . . 0.0 112.324 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 t -135.51 137.36 42.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 122' ' ' LEU . 10.4 mt -109.21 138.12 46.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.41 ' CD ' ' HE2' ' A' ' 117' ' ' LYS . 34.7 tt0 -105.67 126.46 52.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.759 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -136.09 159.52 41.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -115.61 123.96 49.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.759 ' CE2' HD21 ' A' ' 152' ' ' LEU . 35.4 m-85 -92.13 118.17 30.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.599 ' C ' ' CD1' ' A' ' 156' ' ' TRP . 1.3 m-20 -143.48 158.23 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 1.123 ' CH2' HD22 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -153.16 112.78 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.524 ' CG ' ' N ' ' A' ' 158' ' ' SER . 28.9 p90 -101.28 -53.27 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.579 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 1.9 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.889 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.1 m . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.19 139.45 49.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.09 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 12' ' ' ARG . 6.0 tp -95.89 137.15 35.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 11' ' ' LEU . 9.1 ttp180 -136.71 132.42 34.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.46 HG23 HD23 ' A' ' 152' ' ' LEU . 52.0 mt -138.28 137.31 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.193 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -116.85 128.84 55.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 mm -91.34 140.14 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.426 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.0 mm? -98.04 -71.19 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.4 p -171.06 -179.54 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.35 164.57 18.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 t -135.5 150.87 49.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 50.83 52.41 15.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 179.863 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.0 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.819 0.342 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.54 -64.93 0.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -142.06 179.85 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 85' ' ' SER . 6.2 pt -136.81 178.25 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 2.3 p90 -172.95 159.55 4.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 60.3 t -118.53 148.98 21.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.462 ' O ' HD13 ' A' ' 133' ' ' LEU . 25.6 ttm180 -124.82 120.69 32.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.8 p -113.7 166.43 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.141 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.74 154.98 8.97 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.574 HD13 HG21 ' A' ' 68' ' ' ILE . 3.8 mp -102.49 144.73 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.867 0.365 . . . . 0.0 111.13 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.511 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 53.4 m-85 -139.16 153.13 47.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.814 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.8 t-160 -130.18 101.84 5.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.87 24.26 76.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.13 -35.49 4.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.519 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.34 138.93 55.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.718 . . . . 0.0 110.885 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.473 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.8 Cg_endo -69.81 165.31 31.46 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.629 2.219 . . . . 0.0 112.328 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 43' ' ' PRO . 11.0 mp -122.83 -39.88 2.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.0 p -146.84 161.18 41.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -47.84 155.13 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.73 142.84 29.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.653 HG11 ' HG ' ' A' ' 64' ' ' LEU . 83.5 t -99.78 134.56 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -119.84 140.59 50.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 t -97.82 163.55 12.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -51.12 162.39 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.52 123.01 35.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 58' ' ' PRO . 2.3 m -119.6 152.29 53.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 132.79 24.14 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.341 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 4.5 p -44.58 -46.9 10.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -49.75 -34.9 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.883 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -134.72 87.42 31.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.579 0.704 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.583 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.8 Cg_endo -69.77 3.57 2.7 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.681 2.254 . . . . 0.0 112.334 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.435 ' CG ' HD22 ' A' ' 61' ' ' ASN . 30.8 ttp180 -54.1 110.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.882 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.583 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.0 m-90 -97.91 -60.58 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.435 HD22 ' CG ' ' A' ' 59' ' ' ARG . 32.6 m-80 48.07 50.38 16.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -121.58 141.08 51.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -82.95 101.2 10.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.653 ' HG ' HG11 ' A' ' 48' ' ' VAL . 10.0 tp -92.29 114.86 27.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -97.91 139.65 33.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.928 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -105.96 138.66 41.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.8 32.5 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.574 HG21 HD13 ' A' ' 37' ' ' ILE . 1.9 pp -99.8 164.25 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.618 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.26 123.63 47.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.616 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -56.92 -53.8 61.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.6 0.714 . . . . 0.0 111.112 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.79 2.14 3.82 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.641 2.227 . . . . 0.0 112.323 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.516 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 7.0 t0 -124.99 -9.58 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.522 HD13 ' HD2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -75.34 114.46 35.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.697 . . . . 0.0 110.94 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.561 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.78 145.42 57.0 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.692 2.261 . . . . 0.0 112.31 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -57.01 -45.74 82.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.814 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -52.27 -35.53 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -65.75 156.32 33.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.428 ' HG3' ' C ' ' A' ' 77' ' ' ALA . 88.0 mtt180 -152.76 172.47 16.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.4 tp -93.74 133.04 37.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.5 m -127.64 134.51 49.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.26 154.72 46.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.589 ' OG ' HD12 ' A' ' 133' ' ' LEU . 99.8 p -158.86 131.33 6.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.56 HG12 HD11 ' A' ' 150' ' ' LEU . 22.6 mt -80.59 141.98 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 87.7 m -135.77 149.16 49.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.613 ' OG ' HD11 ' A' ' 99' ' ' LEU . 71.9 m -115.02 120.32 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.508 ' CG2' ' HB3' ' A' ' 94' ' ' GLU . 6.1 p -105.21 137.8 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 tptt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.917 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.508 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 24.1 mt-10 . . . . . 0 CA--C 1.526 0.05 0 CA-C-O 120.803 0.335 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -120.2 120.29 35.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 5.0 m170 -93.81 145.5 24.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.7 t -152.53 126.34 4.35 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.585 0.707 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 155.0 67.05 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.294 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.802 ' O ' HG23 ' A' ' 125' ' ' VAL . 15.4 mt -128.51 -53.09 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.933 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -137.16 152.35 49.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.598 ' CH2' HG22 ' A' ' 138' ' ' VAL . 64.1 p-90 -134.06 127.37 32.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.609 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -129.48 129.45 6.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.453 ' HB3' HG22 ' A' ' 139' ' ' THR . 23.6 m-20 -112.53 124.75 53.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.883 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.653 HG12 HD21 ' A' ' 120' ' ' LEU . 11.7 mt -119.39 132.5 69.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.181 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -74.84 96.89 3.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.9 mt -36.49 -39.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -99.84 117.36 34.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -57.02 -174.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -76.2 6.39 5.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.95 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.1 p -126.54 18.6 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 58.45 30.05 19.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 94.4 m -117.49 103.52 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.543 HD22 ' CH2' ' A' ' 156' ' ' TRP . 24.0 mt -34.7 135.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.4 m -70.05 157.46 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.6 t -156.15 173.46 16.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.89 142.99 0.18 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.485 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 9.3 ttpt -44.6 148.75 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.437 ' O ' HD13 ' A' ' 152' ' ' LEU . 31.8 ttp -159.69 147.86 17.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.421 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.73 122.23 16.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.109 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.653 HD21 HG12 ' A' ' 104' ' ' ILE . 4.4 pp -132.3 155.37 48.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -75.66 152.17 37.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.775 HD11 HD12 ' A' ' 150' ' ' LEU . 10.6 mt -115.81 148.87 39.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.501 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 21.0 m95 -78.38 147.44 72.2 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.553 0.692 . . . . 0.0 110.943 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.44 ' O ' ' NE1' ' A' ' 101' ' ' TRP . 53.0 Cg_endo -69.8 173.57 10.81 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.682 2.255 . . . . 0.0 112.324 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 99' ' ' LEU . 85.4 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.581 0.705 . . . . 0.0 111.123 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.452 HD12 ' NH1' ' A' ' 34' ' ' ARG . 25.7 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.842 0.354 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.589 HD12 ' OG ' ' A' ' 82' ' ' SER . 12.2 tp -96.59 135.66 38.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.958 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -105.84 91.39 5.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.639 0.733 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.511 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.77 -33.28 16.85 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.349 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.41 -20.81 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -42.75 153.86 0.19 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.503 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.598 HG22 ' CH2' ' A' ' 101' ' ' TRP . 6.3 m -62.95 158.17 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.371 . . . . 0.0 111.129 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 103' ' ' ASN . 20.0 p -104.19 165.39 11.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.67 169.37 25.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.48 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 142' ' ' ASN . 24.4 p -88.08 102.35 14.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.55 HD21 HG21 ' A' ' 147' ' ' THR . 56.5 t-20 -34.4 120.48 0.54 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -1.93 9.35 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.709 2.273 . . . . 0.0 112.379 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -85.34 135.02 34.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -85.49 -50.5 7.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -42.82 -52.64 4.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.55 HG21 HD21 ' A' ' 142' ' ' ASN . 45.7 p -48.28 150.22 2.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.622 0.725 . . . . 0.0 111.113 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 158.87 55.38 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.656 2.237 . . . . 0.0 112.299 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 7.7 t -135.54 138.39 43.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.775 HD12 HD11 ' A' ' 122' ' ' LEU . 6.1 mt -109.28 142.02 40.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.436 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 9.9 tt0 -110.02 123.54 49.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.783 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -131.06 164.44 25.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.454 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 59.6 mt-10 -123.85 117.69 25.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.457 ' CE2' HD21 ' A' ' 152' ' ' LEU . 31.6 m-85 -82.39 104.35 12.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.844 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -112.35 143.78 42.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.543 ' CH2' HD22 ' A' ' 113' ' ' LEU . 12.8 m95 -134.67 88.05 2.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 158' ' ' SER . 11.8 p90 -90.05 -41.53 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.466 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 30.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.615 ' N ' ' HG ' ' A' ' 158' ' ' SER . 1.7 m . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.894 0.378 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' H ' ' CB ' ' A' ' 158' ' ' SER . . . -120.56 135.09 55.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.767 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 12.4 tp -94.42 145.3 24.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.588 ' H ' HD12 ' A' ' 11' ' ' LEU . 27.4 ptt180 -147.53 141.69 26.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.543 HD12 ' CE1' ' A' ' 66' ' ' TYR . 21.7 mt -141.13 140.82 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -115.24 136.81 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mm -98.58 141.69 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.44 -71.99 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.9 p -169.1 172.95 7.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.447 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -121.53 164.09 17.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.072 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -145.35 156.31 43.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 58.87 35.07 24.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.7 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 179.915 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.4 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.829 0.347 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -68.26 -61.75 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.892 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -148.18 174.52 11.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -132.49 -179.72 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.098 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -169.74 173.58 6.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.572 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 94.0 t -124.97 146.2 31.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.798 ' NH1' HD12 ' A' ' 132' ' ' LEU . 17.9 ttt180 -129.67 117.31 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 81' ' ' LEU . 70.1 p -115.8 175.67 5.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.104 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.44 146.34 4.5 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.516 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.51 ' CG2' ' HB1' ' A' ' 77' ' ' ALA . 2.3 mp -90.04 140.82 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 111.173 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.567 ' CD2' ' HB3' ' A' ' 135' ' ' PRO . 37.8 m-85 -137.64 134.04 35.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.558 ' HB3' HD11 ' A' ' 44' ' ' LEU . 8.0 t-160 -127.19 105.39 8.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.1 56.16 3.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.489 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.75 37.84 28.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.466 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -154.12 142.71 14.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.678 0.751 . . . . 0.0 110.886 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.454 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 53.3 Cg_endo -69.8 165.96 29.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.654 2.236 . . . . 0.0 112.33 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 39' ' ' HIS . 8.6 mp -119.96 -40.25 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 16.2 p -145.94 165.3 29.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -51.06 128.17 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -59.9 143.55 51.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.696 HG12 HD11 ' A' ' 64' ' ' LEU . 56.3 t -104.14 133.41 48.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.155 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.31 140.34 49.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -96.58 153.13 18.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -41.72 161.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.1 mtm-85 -89.33 146.09 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -140.81 152.14 64.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.635 0.731 . . . . 0.0 111.155 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 135.88 31.47 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.719 2.279 . . . . 0.0 112.338 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 8.0 p -46.2 -48.53 17.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -47.76 -36.53 11.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -132.93 87.05 41.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.63 0.728 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.597 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 54.0 Cg_endo -69.74 3.09 2.96 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.68 2.253 . . . . 0.0 112.359 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.423 ' CD ' HD21 ' A' ' 61' ' ' ASN . 20.2 ttt85 -57.18 125.82 24.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.832 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.597 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 5.2 m-90 -108.83 -57.42 2.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.937 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.423 HD21 ' CD ' ' A' ' 59' ' ' ARG . 3.4 m-20 49.28 53.19 13.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -128.23 143.54 51.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -87.64 104.68 16.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.696 HD11 HG12 ' A' ' 48' ' ' VAL . 11.6 tp -90.06 121.08 31.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -97.47 136.73 37.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' CE1' HD12 ' A' ' 13' ' ' ILE . 55.3 m-85 -106.2 129.28 54.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.08 44.25 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.891 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 11' ' ' LEU . 2.2 pp -111.29 164.17 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.119 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.623 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.95 120.07 38.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.631 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -55.61 -52.8 68.97 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.614 0.721 . . . . 0.0 111.153 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.82 2.98 3.07 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.726 2.284 . . . . 0.0 112.325 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.513 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 1.8 t70 -126.08 -7.15 6.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.677 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -77.99 114.84 45.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.588 0.709 . . . . 0.0 110.917 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.612 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.2 Cg_endo -69.72 139.25 39.9 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.725 2.283 . . . . 0.0 112.331 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.49 ' NE ' ' OD1' ' A' ' 111' ' ' ASP . 74.6 mmt-85 -50.23 -40.39 47.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -54.71 -43.67 72.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.068 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.677 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -53.13 154.22 3.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.448 ' HD2' HG21 ' A' ' 139' ' ' THR . 43.6 mtm180 -151.25 170.75 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.7 tp -93.94 133.23 37.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m -132.73 142.73 49.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.636 ' HB3' HG22 ' A' ' 35' ' ' THR . 1.9 pp -148.71 157.6 43.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.3 p -157.92 131.1 7.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 29.0 mt -85.65 126.22 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 28.6 m -124.22 151.03 44.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 p -107.54 127.7 53.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.635 HG23 ' CD2' ' A' ' 96' ' ' HIS . 2.6 p -105.58 132.53 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.0 tptp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HB3' HG22 ' A' ' 86' ' ' VAL . 26.0 mt-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.8 0.334 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -138.85 114.5 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.635 ' CD2' HG23 ' A' ' 86' ' ' VAL . 4.5 m170 -94.34 130.62 40.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.9 t -131.94 127.3 21.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.583 0.706 . . . . 0.0 110.887 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 150.4 67.86 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.633 2.222 . . . . 0.0 112.336 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.0 mt -123.87 -50.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.88 179.36 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.597 ' HD1' HG12 ' A' ' 125' ' ' VAL . 64.6 p-90 -158.22 130.79 7.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.954 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.33 133.43 6.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.44 ' CB ' HG22 ' A' ' 139' ' ' THR . 1.2 m-20 -115.39 132.55 56.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.771 0.32 . . . . 0.0 110.914 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.31 124.84 73.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 106' ' ' LEU . 4.9 m120 -64.66 89.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 105' ' ' ASN . 16.0 mt -34.66 -40.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.433 ' HE2' HD12 ' A' ' 73' ' ' LEU . 94.8 m-85 -105.25 112.51 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -52.13 173.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -55.33 -35.59 65.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 t -87.78 27.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.49 ' OD1' ' NE ' ' A' ' 75' ' ' ARG . 8.4 t0 47.83 52.46 12.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 97.2 m -139.16 108.71 6.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.133 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.961 HD22 ' CH2' ' A' ' 156' ' ' TRP . 20.3 mt -34.94 133.21 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.505 HG23 ' CG ' ' A' ' 154' ' ' PHE . 26.4 m -63.43 171.71 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.7 m -162.85 175.53 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.04 153.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.496 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.444 ' HE3' ' CG ' ' A' ' 153' ' ' GLU . 20.0 ttmt -58.73 148.07 30.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.76 0.314 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.409 ' O ' HD13 ' A' ' 152' ' ' LEU . 41.1 ttp -154.67 151.86 29.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.908 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.84 128.5 26.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.117 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 pp -139.87 162.48 35.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -87.52 150.52 23.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.664 HD11 HD12 ' A' ' 150' ' ' LEU . 2.8 mt -108.17 155.41 20.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.573 ' CH2' ' HD2' ' A' ' 143' ' ' PRO . 7.3 m95 -90.94 141.54 26.72 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.61 0.719 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 136.01 31.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.353 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.597 HG12 ' HD1' ' A' ' 101' ' ' TRP . 3.5 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 121.619 0.723 . . . . 0.0 111.111 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.798 HD12 ' NH1' ' A' ' 34' ' ' ARG . 12.1 mt . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.843 0.354 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.528 HD23 ' CE1' ' A' ' 38' ' ' TYR . 9.7 tp -97.38 145.93 25.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.427 ' HA ' ' HD2' ' A' ' 135' ' ' PRO . 55.2 t-20 -114.38 93.05 30.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.638 0.733 . . . . 0.0 110.857 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.567 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.79 -38.68 7.39 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.663 2.242 . . . . 0.0 112.317 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.2 mt -73.02 -20.12 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.419 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -45.67 148.36 1.89 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.3 m -62.35 178.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.141 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.448 HG21 ' HD2' ' A' ' 78' ' ' ARG . 82.4 p -123.79 157.65 33.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.151 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.25 170.91 19.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 p -84.07 128.93 34.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 144' ' ' ASN . 5.9 t-20 -65.6 132.45 94.99 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.672 0.749 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.573 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.79 -50.82 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.689 2.259 . . . . 0.0 112.329 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 69.1 m-80 -39.01 135.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -89.19 -25.95 21.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -85.19 41.39 0.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.8 p -129.55 152.82 80.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.582 0.706 . . . . 0.0 111.145 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 137.15 34.66 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.325 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.37 146.46 48.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.664 HD12 HD11 ' A' ' 122' ' ' LEU . 5.7 mt -120.95 156.21 32.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -121.62 120.25 34.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.817 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -127.43 163.65 23.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.444 ' CG ' ' HE3' ' A' ' 117' ' ' LYS . 49.5 mt-10 -124.59 120.99 33.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.643 ' CE2' HD21 ' A' ' 152' ' ' LEU . 39.2 m-85 -89.31 102.12 14.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -122.6 134.78 54.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.961 ' CH2' HD22 ' A' ' 113' ' ' LEU . 15.7 m95 -120.89 98.01 5.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.597 ' CG ' ' N ' ' A' ' 158' ' ' SER . 12.4 p90 -79.53 -53.38 6.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.615 ' HG ' ' N ' ' A' ' 9' ' ' SER . 61.6 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.511 ' N ' ' HG ' ' A' ' 158' ' ' SER . 14.3 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.88 0.371 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.71 125.19 49.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.708 HD13 ' CH2' ' A' ' 156' ' ' TRP . 21.0 tp -88.42 142.44 27.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.466 ' H ' HD12 ' A' ' 11' ' ' LEU . 7.7 ptm180 -149.34 127.56 12.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.9 mt -129.52 138.7 53.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.51 ' HD3' ' CE2' ' A' ' 63' ' ' TRP . 3.3 ttpm? -114.02 129.91 56.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mm -89.51 145.34 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.89 -72.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.1 p -169.72 174.8 5.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.99 156.74 34.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.688 HG23 ' CD2' ' A' ' 20' ' ' TYR . 9.8 t -127.1 163.19 24.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.688 ' CD2' HG23 ' A' ' 19' ' ' THR . 7.8 m-85 53.3 30.81 10.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.126 179.873 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.82 0.343 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' N ' ' HD3' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -83.34 -52.22 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -147.52 178.6 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 85' ' ' SER . 6.9 pt -138.46 174.83 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -169.51 155.57 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.781 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 58.1 t -111.6 140.28 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -113.42 127.53 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.5 p -123.67 169.73 11.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.54 135.54 1.97 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.4 mp -81.9 146.51 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.544 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 44.8 m-85 -140.6 162.89 34.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.593 ' HB2' HD11 ' A' ' 44' ' ' LEU . 3.1 t-160 -132.65 94.3 3.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.53 -32.98 4.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.541 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.45 -30.52 0.29 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -91.44 152.64 43.84 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.679 0.752 . . . . 0.0 110.841 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 156.34 63.56 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.737 2.292 . . . . 0.0 112.343 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 39' ' ' HIS . 8.9 mp -106.22 -41.39 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.9 m -133.8 -67.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -173.42 171.96 3.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.471 ' OD1' HD22 ' A' ' 133' ' ' LEU . 1.0 OUTLIER -105.34 144.51 32.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.642 HG11 ' HG ' ' A' ' 64' ' ' LEU . 43.2 t -110.76 140.24 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -120.73 144.01 48.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.7 p -94.85 159.68 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -49.92 172.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -100.98 131.79 46.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 1.5 m -136.02 152.17 75.07 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.592 0.71 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 140.18 41.93 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.0 p -50.03 -32.77 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 m -63.13 -31.29 72.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -133.32 81.43 55.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.738 . . . . 0.0 110.902 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 3.17 2.91 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.692 2.261 . . . . 0.0 112.343 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -61.42 106.74 0.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.781 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 3.9 m-90 -90.68 -47.24 7.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 39.3 41.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.439 ' C ' ' HG3' ' A' ' 14' ' ' LYS . 5.3 tp10 -114.03 135.82 53.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.51 ' CE2' ' HD3' ' A' ' 14' ' ' LYS . 52.7 m95 -83.73 107.88 16.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.642 ' HG ' HG11 ' A' ' 48' ' ' VAL . 10.0 tp -95.2 121.02 36.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.84 140.12 31.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -107.39 125.43 51.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -78.05 45.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.477 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.0 pp -113.0 164.17 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.612 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.62 124.86 48.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.947 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.575 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -51.89 -55.47 30.09 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.607 0.718 . . . . 0.0 111.134 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.612 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.5 Cg_endo -69.71 2.42 3.52 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.691 2.261 . . . . 0.0 112.401 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.508 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.6 t70 -123.04 -5.69 8.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -83.6 114.7 55.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.633 0.73 . . . . 0.0 110.939 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.9 Cg_endo -69.7 136.04 32.14 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.694 2.263 . . . . 0.0 112.369 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -49.75 -44.34 48.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.555 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -52.64 -39.17 61.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -64.43 157.84 25.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -153.02 177.56 10.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -93.77 139.38 30.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.598 ' C ' HD23 ' A' ' 81' ' ' LEU . 73.9 m -129.74 145.94 51.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -154.87 136.83 14.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.7 m -143.84 139.58 29.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.76 146.84 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.15 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 81.3 m -146.18 153.56 40.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.483 ' HA ' HG22 ' A' ' 31' ' ' ILE . 24.8 m -114.72 122.3 46.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.65 127.53 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 29' ' ' ASP . 21.9 tptm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -126.98 134.29 50.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -107.71 125.39 51.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.3 t -129.25 125.89 22.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.719 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.469 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.3 Cg_endo -69.79 152.23 69.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.643 2.229 . . . . 0.0 112.352 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 98' ' ' PRO . 14.2 mt -123.91 -49.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.73 174.25 11.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.531 ' CH2' HG22 ' A' ' 138' ' ' VAL . 68.6 p-90 -151.18 134.33 15.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.918 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.8 133.11 5.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -120.48 130.68 54.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.714 HG12 HD21 ' A' ' 120' ' ' LEU . 14.6 mt -114.22 130.55 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 106' ' ' LEU . 40.5 m-20 -67.28 95.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.7 mt -34.81 -43.15 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 77.8 m-85 -107.24 111.05 23.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 108' ' ' ASP . 34.6 p30 -52.19 -177.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.876 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -56.49 -37.88 70.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.436 ' O ' ' C ' ' A' ' 111' ' ' ASP . 8.9 t -88.73 34.7 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.138 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 110' ' ' THR . 6.7 m-20 35.62 54.75 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 113' ' ' LEU . 98.1 m -134.28 109.29 8.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.172 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.749 HD22 ' CH2' ' A' ' 156' ' ' TRP . 56.7 mt -34.36 138.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 12.8 m -68.02 165.49 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 p -159.73 162.86 35.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.1 142.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.436 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 7.8 ttpt -47.21 148.71 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.441 ' O ' HD13 ' A' ' 152' ' ' LEU . 26.7 ttp -156.1 151.94 27.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.3 132.56 29.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.714 HD21 HG12 ' A' ' 104' ' ' ILE . 3.6 pp -141.16 154.41 45.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.35 152.13 39.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 150' ' ' LEU . 2.5 mt -111.45 141.35 45.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.48 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 23.5 m95 -75.88 152.01 84.55 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.53 0.681 . . . . 0.0 110.925 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 154.0 68.46 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 98' ' ' PRO . 71.3 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.628 0.727 . . . . 0.0 111.12 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.807 0.337 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.471 HD22 ' OD1' ' A' ' 47' ' ' ASN . 7.8 tp -80.42 135.83 36.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -106.11 91.27 5.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.616 0.722 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.544 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.2 Cg_endo -69.73 -44.81 1.88 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.237 . . . . 0.0 112.366 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 137' ' ' GLY . 44.3 mt -67.61 -28.38 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -36.65 149.13 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.502 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.531 HG22 ' CH2' ' A' ' 101' ' ' TRP . 2.4 m -51.73 168.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 111.155 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.7 p -115.14 168.14 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.131 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.78 -168.81 30.65 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.451 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.8 p -96.14 148.53 22.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.893 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.451 ' OD1' ' C ' ' A' ' 142' ' ' ASN . 0.4 OUTLIER -84.45 138.72 38.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.62 0.724 . . . . 0.0 110.88 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.406 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.72 -48.2 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.252 . . . . 0.0 112.383 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -40.74 142.14 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -98.2 -31.72 11.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -82.16 40.39 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.0 p -124.21 151.96 66.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.583 0.706 . . . . 0.0 111.115 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 117.23 4.96 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.67 2.247 . . . . 0.0 112.311 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 13.4 t -105.68 137.78 42.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 122' ' ' LEU . 3.4 mt -105.51 162.18 13.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.436 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 27.5 tt0 -129.81 112.43 13.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.836 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -118.35 162.87 17.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.457 ' N ' HD22 ' A' ' 152' ' ' LEU . 14.9 mt-10 -118.74 119.1 33.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.727 ' CE2' HD21 ' A' ' 152' ' ' LEU . 50.2 m-85 -87.58 107.46 18.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.26 155.56 48.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.749 ' CH2' HD22 ' A' ' 113' ' ' LEU . 4.9 m95 -142.48 120.32 11.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.515 ' CG ' ' N ' ' A' ' 158' ' ' SER . 10.1 p90 -110.28 -47.83 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.515 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 8.6 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.871 0.367 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.453 ' HB3' ' C ' ' A' ' 158' ' ' SER . . . -119.14 151.21 38.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.086 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.749 HD13 ' CH2' ' A' ' 156' ' ' TRP . 14.3 tp -110.79 138.95 46.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.405 ' H ' HD12 ' A' ' 11' ' ' LEU . 25.8 ptt180 -148.34 140.07 23.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.0 mt -135.93 137.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.159 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttt -110.71 120.81 43.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.6 mm -82.42 141.11 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.26 -72.29 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -172.07 176.79 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.7 163.07 20.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.441 HG23 ' CD2' ' A' ' 20' ' ' TYR . 10.2 t -134.78 163.39 29.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.441 ' CD2' HG23 ' A' ' 19' ' ' THR . 6.3 m-85 39.54 44.6 1.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.9 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' A' ' 85' ' ' SER . 17.3 mt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.835 0.35 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.406 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 21.5 t0 -72.98 -60.56 2.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 26.3 mmtp -147.91 166.56 27.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 pt -119.44 169.9 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -163.82 144.56 8.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.621 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 63.2 t -103.03 143.92 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -121.03 122.25 39.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.6 p -116.1 166.91 11.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.73 149.42 6.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.59 134.89 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 111.148 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 135' ' ' PRO . 47.7 m-85 -133.72 158.33 43.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.481 ' HB3' HD11 ' A' ' 44' ' ' LEU . 6.9 t-160 -131.85 103.37 6.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.858 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.94 17.15 78.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.483 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.558 ' HA2' HD13 ' A' ' 136' ' ' ILE . . . 107.5 -35.48 4.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.457 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.33 142.88 59.17 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.668 0.747 . . . . 0.0 110.885 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.527 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.7 Cg_endo -69.77 166.02 29.02 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.689 2.259 . . . . 0.0 112.338 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.527 HD12 ' C ' ' A' ' 43' ' ' PRO . 10.1 mp -124.89 -41.25 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.0 m -154.39 160.06 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -41.36 151.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -88.82 165.48 14.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.59 HG12 HD11 ' A' ' 64' ' ' LEU . 64.2 t -119.96 133.59 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -115.38 138.2 51.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.2 t -90.37 159.12 16.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -49.67 174.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -101.89 133.48 46.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.5 m -137.36 152.11 72.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.641 0.734 . . . . 0.0 111.164 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 134.23 27.4 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.353 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.6 p -45.48 -44.93 12.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.866 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.8 t -48.66 -40.58 28.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -130.32 86.65 53.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.533 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.3 Cg_endo -69.8 2.97 3.07 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.746 2.297 . . . . 0.0 112.298 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -50.8 109.55 0.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.621 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 1.5 m-90 -99.54 -47.62 5.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 60' ' ' TRP . 3.9 p30 35.25 41.05 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.839 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.12 138.19 50.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -83.05 112.33 19.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.59 HD11 HG12 ' A' ' 48' ' ' VAL . 11.1 tp -97.15 119.25 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -93.07 140.13 29.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -112.47 128.71 56.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -82.21 40.5 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.436 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.0 pp -106.93 164.01 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.614 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.0 127.02 53.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.6 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -60.01 -54.46 55.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.663 0.744 . . . . 0.0 111.165 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.614 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.74 3.49 2.73 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 0.0 112.355 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.494 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.7 t70 -125.46 -7.12 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -82.12 115.72 59.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.608 0.718 . . . . 0.0 110.926 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.6 Cg_endo -69.78 132.75 23.96 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.322 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.491 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 1.6 mpp_? -47.63 -43.62 26.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -51.87 -39.38 58.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.483 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -62.58 167.12 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -162.21 170.87 18.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 tp -94.64 133.73 37.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.621 ' C ' HD23 ' A' ' 81' ' ' LEU . 33.6 m -120.26 150.33 40.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -155.69 137.17 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 133' ' ' LEU . 86.5 p -143.61 133.27 23.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.573 HD11 ' HG ' ' A' ' 150' ' ' LEU . 71.7 mt -84.69 140.78 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.4 p -151.18 160.24 43.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.529 ' HB2' HG21 ' A' ' 28' ' ' ILE . 15.3 p -117.23 156.48 27.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 86' ' ' VAL . 14.8 p -133.77 122.39 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.163 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.0 tptt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.908 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.828 0.347 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -122.57 126.08 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -99.59 134.74 42.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.0 t -135.65 120.31 13.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.611 0.72 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.401 ' HB2' HG11 ' A' ' 125' ' ' VAL . 54.1 Cg_endo -69.79 142.01 46.65 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.664 2.243 . . . . 0.0 112.338 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 83' ' ' ILE . 17.8 mt -111.65 -55.65 2.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.02 176.52 8.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.074 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 61.9 p-90 -152.76 145.09 23.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -151.83 139.78 7.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -117.83 150.3 39.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.784 0.326 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.562 ' CG1' HD21 ' A' ' 120' ' ' LEU . 66.0 mt -138.27 117.91 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 106' ' ' LEU . 12.4 m120 -62.41 96.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.0 mt -35.15 -40.5 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.491 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 98.1 m-85 -108.56 115.37 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -55.64 -176.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.517 ' CD1' HG23 ' A' ' 110' ' ' THR . 13.2 p90 -68.41 -4.41 14.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.517 HG23 ' CD1' ' A' ' 109' ' ' TYR . 10.0 p -109.36 22.47 15.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.154 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 110' ' ' THR . 6.0 p-10 46.61 54.43 8.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.3 m -149.9 120.83 7.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.781 HD22 ' CH2' ' A' ' 156' ' ' TRP . 56.8 mt -40.32 140.81 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.47 HG21 ' CE2' ' A' ' 154' ' ' PHE . 20.3 m -71.3 169.82 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.081 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.6 p -162.86 161.18 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.45 132.73 0.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.422 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 15.6 ttpt -39.63 148.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.738 0.304 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.472 ' O ' HD13 ' A' ' 152' ' ' LEU . 20.9 ttp -156.2 149.22 24.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.407 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.7 113.66 8.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.562 HD21 ' CG1' ' A' ' 104' ' ' ILE . 4.0 pp -120.89 157.81 29.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -77.67 154.51 32.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mt -114.06 134.12 55.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.507 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 10.7 m95 -74.57 147.37 84.63 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.567 0.699 . . . . 0.0 110.935 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 133.93 26.88 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.251 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.463 HG12 ' HD1' ' A' ' 101' ' ' TRP . 4.7 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.1 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.784 0.326 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 82' ' ' SER . 13.7 tp -105.59 131.72 52.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -110.3 91.81 12.35 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.647 0.737 . . . . 0.0 110.902 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.79 -28.36 25.2 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.656 2.237 . . . . 0.0 112.335 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.558 HD13 ' HA2' ' A' ' 41' ' ' GLY . 12.2 mm -77.21 -23.58 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.09 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.427 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -36.5 147.77 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.32 174.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 111.159 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 42.2 p -117.28 172.47 7.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.163 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.33 169.63 42.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.529 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.4 p -87.68 135.99 33.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 110.833 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -76.2 122.36 86.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.657 0.742 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -1.33 8.25 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.677 2.252 . . . . 0.0 112.365 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -82.62 129.05 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -84.39 -53.53 5.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -40.6 -35.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.7 p -69.39 151.37 96.85 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 160.1 50.96 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.731 2.287 . . . . 0.0 112.348 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 14.5 t -140.09 136.4 33.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.573 ' HG ' HD11 ' A' ' 83' ' ' ILE . 8.7 mt -106.47 152.18 23.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.422 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 14.8 tt0 -120.71 115.66 23.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.835 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -121.06 159.42 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.958 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.406 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 63.5 mt-10 -116.09 122.55 45.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.603 ' CE2' HD21 ' A' ' 152' ' ' LEU . 28.9 m-85 -90.82 112.53 24.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.553 ' C ' ' CD1' ' A' ' 156' ' ' TRP . 6.6 t0 -132.61 159.07 40.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.781 ' CH2' HD22 ' A' ' 113' ' ' LEU . 3.6 m95 -152.17 108.18 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.498 ' CG ' ' N ' ' A' ' 158' ' ' SER . 31.5 p90 -102.22 -53.76 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.498 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 16.1 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.465 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.62 133.62 54.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.848 HD13 ' CH2' ' A' ' 156' ' ' TRP . 15.8 tp -83.53 126.96 33.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.575 ' NE ' ' CE3' ' A' ' 63' ' ' TRP . 7.0 ttt180 -124.64 120.38 31.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.419 HD11 HD21 ' A' ' 11' ' ' LEU . 32.4 mt -131.14 141.07 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 34.8 tttt -122.26 128.66 51.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.0 mm -89.76 149.27 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.47 -70.63 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 p -172.45 -176.82 1.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.951 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.61 146.07 50.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 t -120.15 138.09 53.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 67.11 45.25 1.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.934 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.92 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.861 0.363 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.52 -57.4 3.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -147.47 -178.7 6.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 53' ' ' VAL . 7.2 pt -139.86 178.02 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 1.2 p90 -173.22 156.61 3.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.57 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 87.3 t -113.75 149.7 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.121 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -122.35 132.78 54.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.1 p -128.52 162.02 28.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.44 143.32 3.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.442 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.5 mp -86.72 140.82 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.37 . . . . 0.0 111.136 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.539 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 54.1 m-85 -136.4 145.28 45.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.51 ' CB ' HD11 ' A' ' 44' ' ' LEU . 4.5 t-160 -117.56 94.55 4.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.94 20.95 77.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.553 ' HA2' HD13 ' A' ' 136' ' ' ILE . . . 106.15 -26.84 19.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -85.02 141.89 38.11 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.623 0.725 . . . . 0.0 110.85 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 159.87 51.82 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.704 2.269 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.51 HD11 ' CB ' ' A' ' 39' ' ' HIS . 8.9 mp -120.64 -33.54 3.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.94 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.2 m -154.06 165.79 35.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.64 131.29 29.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.815 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -65.65 153.1 42.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.514 HG12 HD11 ' A' ' 64' ' ' LEU . 40.0 t -114.16 140.34 35.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -121.74 137.75 54.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.1 p -83.88 176.35 8.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -63.99 174.7 1.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -102.43 125.98 49.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -130.28 152.14 79.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.619 0.723 . . . . 0.0 111.101 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 142.28 47.46 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.689 2.259 . . . . 0.0 112.347 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 23.4 p -50.58 -48.16 57.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.8 t -47.34 -38.52 13.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -132.03 87.29 44.63 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.552 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.5 Cg_endo -69.78 3.66 2.65 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.709 2.272 . . . . 0.0 112.312 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -55.64 108.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.57 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.3 m-90 -93.56 -52.95 4.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 43.31 49.75 5.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -121.19 138.09 54.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.575 ' CE3' ' NE ' ' A' ' 12' ' ' ARG . 77.8 m95 -84.09 108.39 16.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.514 HD11 HG12 ' A' ' 48' ' ' VAL . 9.9 tp -98.2 122.68 41.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -100.87 145.25 28.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -113.5 131.02 56.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -82.71 47.61 1.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.494 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.1 pp -114.26 168.13 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.611 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -115.07 129.86 56.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.612 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -62.84 -53.63 54.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 111.164 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.1 Cg_endo -69.69 -0.95 7.59 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.362 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.509 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.5 t70 -117.64 -13.47 10.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -71.6 114.97 32.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.556 0.693 . . . . 0.0 110.918 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.56 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.0 Cg_endo -69.79 146.37 59.82 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.637 2.225 . . . . 0.0 112.353 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.454 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 21.1 mmt85 -59.22 -41.84 89.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.45 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -55.64 -31.41 62.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.56 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -68.77 167.35 15.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -163.23 173.73 13.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.5 tp -95.37 142.8 27.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.605 ' C ' HD23 ' A' ' 81' ' ' LEU . 83.0 m -129.82 148.52 51.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -155.32 137.08 14.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.84 ' OG ' HD12 ' A' ' 133' ' ' LEU . 95.3 p -148.92 146.22 27.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.595 ' CG1' HD11 ' A' ' 150' ' ' LEU . 11.4 mt -93.16 143.37 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.176 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 74.7 m -137.85 145.78 42.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.8 p -109.76 122.56 47.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.714 HG23 ' CD2' ' A' ' 96' ' ' HIS . 12.0 p -105.79 121.63 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.7 tttm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.925 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 9.9 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.776 0.322 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -126.61 119.16 26.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.714 ' CD2' HG23 ' A' ' 86' ' ' VAL . 8.1 m170 -98.77 124.16 43.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.74 123.21 15.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.866 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 143.03 49.42 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.662 2.241 . . . . 0.0 112.351 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.0 mt -107.63 -45.8 3.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.38 178.18 7.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.518 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 70.0 p-90 -154.33 137.89 15.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.03 138.5 7.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.473 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -122.25 140.55 52.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.587 HD11 HD21 ' A' ' 120' ' ' LEU . 56.5 mt -120.97 139.69 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 106' ' ' LEU . 77.7 m-20 -76.69 87.91 3.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 105' ' ' ASN . 21.9 mt -34.49 -36.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.454 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 59.0 m-85 -109.67 119.34 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -53.1 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.85 6.47 5.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 p -128.76 18.19 6.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.181 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 65.06 29.84 11.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 113' ' ' LEU . 88.2 m -118.68 105.76 11.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 112' ' ' THR . 31.4 mt -36.07 141.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.5 m -70.45 170.35 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.1 m -168.9 164.28 11.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.17 140.72 1.01 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.446 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 38.3 tttt -44.6 149.15 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.783 0.325 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.4 ttp -159.89 154.03 23.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.691 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.95 126.67 20.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.587 HD21 HD11 ' A' ' 104' ' ' ILE . 4.1 pp -136.15 153.78 51.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -79.25 158.52 27.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.776 HD11 HD12 ' A' ' 150' ' ' LEU . 1.9 mt -116.4 148.09 41.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.566 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 8.1 m95 -85.51 150.53 54.22 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.571 0.7 . . . . 0.0 110.944 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 138.82 38.71 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.663 2.242 . . . . 0.0 112.391 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.625 0.726 . . . . 0.0 111.124 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.867 0.365 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.84 HD12 ' OG ' ' A' ' 82' ' ' SER . 4.8 tp -102.98 139.34 38.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -105.41 91.52 4.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.679 0.752 . . . . 0.0 110.87 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.9 Cg_endo -69.73 -22.76 31.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.723 2.282 . . . . 0.0 112.366 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.553 HD13 ' HA2' ' A' ' 41' ' ' GLY . 13.4 mm -82.69 -22.12 9.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -37.08 153.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.498 HG22 ' CH2' ' A' ' 101' ' ' TRP . 5.7 m -69.5 173.33 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 111.117 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.7 p -115.22 165.25 13.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 99.37 159.68 29.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.0 p -75.49 130.48 38.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.832 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.566 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 11.2 t-20 -70.84 118.47 65.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.651 0.739 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 1.98 3.94 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.67 2.246 . . . . 0.0 112.392 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -90.59 116.43 28.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -76.85 -44.19 33.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -49.03 -26.97 2.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 67.9 p -78.82 152.24 77.26 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.558 0.694 . . . . 0.0 111.165 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 146.26 59.48 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.685 2.257 . . . . 0.0 112.363 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.7 t -123.79 148.92 46.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.776 HD12 HD11 ' A' ' 122' ' ' LEU . 5.9 mt -118.96 150.64 39.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.691 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 5.4 mp0 -112.64 139.92 47.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.727 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -148.6 151.6 35.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.446 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 35.5 mt-10 -119.51 123.11 43.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.727 ' CE2' HD21 ' A' ' 152' ' ' LEU . 62.6 m-85 -85.97 115.06 23.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.09 129.15 49.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.848 ' CH2' HD13 ' A' ' 11' ' ' LEU . 20.7 m95 -124.26 81.55 1.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.5 ' CG ' ' N ' ' A' ' 158' ' ' SER . 43.4 p90 -79.46 -54.47 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.5 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 3.0 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.409 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 1.8 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.822 0.344 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.01 140.36 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.686 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 10.6 tp -103.64 137.49 41.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.563 ' N ' HD12 ' A' ' 11' ' ' LEU . 16.3 ptt180 -145.41 138.37 26.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.843 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.4 mt -138.4 139.14 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 43.8 tttm -114.9 137.06 52.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.8 mm -98.59 144.82 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.71 -67.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.6 p -169.56 175.05 5.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.813 ' HB2' HD23 ' A' ' 150' ' ' LEU . . . -139.1 154.41 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.675 HG23 ' CD2' ' A' ' 20' ' ' TYR . 2.9 t -130.96 162.37 29.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.675 ' CD2' HG23 ' A' ' 19' ' ' THR . 10.0 m-85 64.44 50.13 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.833 0.349 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -73.96 -56.19 5.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -142.06 172.83 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 pt -141.54 161.11 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -151.38 153.57 35.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.745 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 79.3 t -105.48 137.12 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -110.19 120.15 41.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 p -117.84 161.21 20.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.171 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.78 143.46 3.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.442 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.713 HG23 ' O ' ' A' ' 78' ' ' ARG . 3.9 mp -96.61 137.05 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 111.191 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.465 ' HA ' ' CD1' ' A' ' 44' ' ' LEU . 2.7 m-85 -128.52 150.18 50.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.957 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.457 ' C ' ' CD2' ' A' ' 39' ' ' HIS . 9.3 t-160 -121.85 99.07 6.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.04 47.23 19.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.74 33.83 81.47 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -146.64 143.69 19.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.68 0.752 . . . . 0.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 150.17 68.27 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.72 2.28 . . . . 0.0 112.365 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.465 ' CD1' ' HA ' ' A' ' 38' ' ' TYR . 7.8 mp -105.69 -39.37 6.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.889 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.0 t -156.28 166.13 34.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.24 124.73 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -61.01 154.09 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.644 HG12 HD11 ' A' ' 64' ' ' LEU . 61.6 t -110.26 137.4 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -119.27 147.91 43.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.5 p -96.18 167.25 11.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -54.15 176.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -105.49 108.98 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -114.26 152.39 45.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.626 0.727 . . . . 0.0 111.128 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 135.65 31.11 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.733 2.289 . . . . 0.0 112.36 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 19.3 p -45.98 -47.26 16.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.2 m -51.27 -30.21 17.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -133.8 87.78 34.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.619 0.723 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.548 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 2.94 3.09 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.681 2.254 . . . . 0.0 112.333 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -58.47 103.84 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.745 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.3 m-90 -90.71 -46.76 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 60' ' ' TRP . 2.9 p30 39.23 46.99 1.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -120.95 135.86 55.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.461 ' CE3' ' HD2' ' A' ' 12' ' ' ARG . 45.7 m95 -81.35 103.55 11.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.644 HD11 HG12 ' A' ' 48' ' ' VAL . 10.4 tp -90.68 121.44 32.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -101.0 133.37 45.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -100.99 131.68 46.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.2 41.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.828 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.507 HD13 HD23 ' A' ' 73' ' ' LEU . 1.7 pp -112.45 161.89 10.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.603 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -113.54 121.96 45.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -53.42 -54.15 48.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.595 0.712 . . . . 0.0 111.104 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.4 Cg_endo -69.7 3.49 2.71 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.677 2.252 . . . . 0.0 112.396 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.5 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 9.5 t0 -125.22 -4.49 7.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.918 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.507 HD23 HD13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -76.1 113.61 29.59 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 110.902 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.651 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.4 Cg_endo -69.77 132.05 22.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.704 2.27 . . . . 0.0 112.336 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 11.6 mpt_? -45.46 -42.07 10.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.04 -43.75 78.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.066 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.651 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -55.6 165.02 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.083 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.713 ' O ' HG23 ' A' ' 37' ' ' ILE . 8.2 ptp180 -163.28 173.42 13.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 tp -93.82 138.31 32.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.2 m -136.23 126.4 26.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.16 161.24 33.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 p -166.53 131.9 2.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 99' ' ' LEU . 17.8 mt -83.91 144.44 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 62.0 m -147.81 155.04 41.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 t -105.89 150.72 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 86' ' ' VAL . 8.4 p -135.93 125.2 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.1 tptp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.929 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.814 0.34 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -130.21 125.92 36.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -103.46 129.21 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.1 t -137.49 123.78 13.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.429 ' HB2' HG21 ' A' ' 125' ' ' VAL . 53.7 Cg_endo -69.79 152.96 69.27 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.673 2.249 . . . . 0.0 112.333 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 125' ' ' VAL . 16.0 mt -126.37 -51.13 1.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.409 ' HB2' ' HG3' ' A' ' 148' ' ' PRO . . . -142.41 -177.58 5.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.511 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 67.5 p-90 -164.44 126.04 2.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.475 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -131.94 131.42 6.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.402 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -106.85 129.73 54.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 110.861 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.44 HD11 HD21 ' A' ' 120' ' ' LEU . 76.2 mt -119.34 119.27 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 106' ' ' LEU . 3.0 t-20 -73.25 94.57 2.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 105' ' ' ASN . 41.6 mt -35.14 -35.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.488 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 51.3 m-85 -104.39 106.5 17.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.906 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 108' ' ' ASP . 42.5 p30 -54.93 -177.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -57.12 -39.19 74.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.424 HG23 ' OG1' ' A' ' 112' ' ' THR . 10.0 t -86.9 32.14 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.14 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 37.78 54.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.424 ' OG1' HG23 ' A' ' 110' ' ' THR . 23.7 m -132.77 116.64 16.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.944 HD22 ' CH2' ' A' ' 156' ' ' TRP . 11.9 mt -44.56 126.62 5.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.604 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 16.3 m -57.51 176.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.9 p -173.83 164.11 4.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.18 149.18 0.2 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 7.5 ttpt -39.55 158.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.485 ' HG2' ' N ' ' A' ' 119' ' ' ALA . 2.8 ttm -156.62 144.96 19.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.485 ' N ' ' HG2' ' A' ' 118' ' ' MET . . . -140.35 106.96 5.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.083 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.477 ' C ' HD12 ' A' ' 120' ' ' LEU . 4.1 pp -126.35 163.53 23.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -92.31 158.53 16.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.511 HD11 HD12 ' A' ' 150' ' ' LEU . 12.0 mt -112.59 156.08 23.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.566 ' CE3' ' OD1' ' A' ' 142' ' ' ASN . 28.0 m95 -86.57 150.64 51.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.538 0.685 . . . . 0.0 110.924 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 145.92 58.44 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.699 2.266 . . . . 0.0 112.309 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 99' ' ' LEU . 94.2 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 111.121 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.863 0.364 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.3 tp -84.8 127.53 34.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -104.38 93.53 5.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 110.83 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.443 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.6 Cg_endo -69.74 -17.14 37.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.664 2.243 . . . . 0.0 112.372 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 mm -84.88 -23.15 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.49 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -38.74 151.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.13 163.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.1 p -108.44 151.75 25.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.62 142.84 8.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.5 p -63.11 116.66 5.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.566 ' OD1' ' CE3' ' A' ' 123' ' ' TRP . 32.7 t30 -53.64 130.01 54.8 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.572 0.701 . . . . 0.0 110.93 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -27.03 27.06 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.694 2.263 . . . . 0.0 112.317 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -51.72 144.4 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt -99.53 -37.03 9.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -83.26 39.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.2 p -122.85 156.05 62.67 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.57 0.7 . . . . 0.0 111.127 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.409 ' HG3' ' HB2' ' A' ' 100' ' ' ALA . 53.3 Cg_endo -69.77 124.65 11.28 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.704 2.269 . . . . 0.0 112.344 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.443 ' SG ' HG22 ' A' ' 19' ' ' THR . 1.4 p -115.92 150.69 36.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.813 HD23 ' HB2' ' A' ' 18' ' ' ALA . 7.4 mt -128.18 135.3 49.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.96 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.424 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 10.1 tt0 -102.49 125.11 49.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.83 HD13 ' H ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -127.72 169.36 13.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.441 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 26.1 mt-10 -126.4 125.38 42.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.604 ' CZ ' HG21 ' A' ' 114' ' ' VAL . 45.0 m-85 -92.1 119.51 31.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -137.39 137.53 38.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.944 ' CH2' HD22 ' A' ' 113' ' ' LEU . 11.6 m95 -127.84 82.45 2.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 158' ' ' SER . 22.0 p90 -85.75 -52.75 5.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.574 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 85.6 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.909 0.385 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.737 ' HB3' ' HB2' ' A' ' 158' ' ' SER . . . -120.07 121.85 39.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.753 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 22.2 tp -85.82 144.99 27.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.61 ' NH2' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -135.71 146.93 48.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.541 HD12 ' CE1' ' A' ' 66' ' ' TYR . 54.4 mt -145.52 121.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.581 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 73.8 tttt -103.58 131.37 50.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mm -94.07 137.59 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.12 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.23 -72.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.4 p -172.01 172.68 4.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.893 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.15 142.33 48.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.035 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.457 HG23 ' CD2' ' A' ' 20' ' ' TYR . 10.9 t -111.57 136.2 51.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.457 ' CD2' HG23 ' A' ' 19' ' ' THR . 2.6 m-85 65.67 32.94 8.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.076 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.587 HG21 ' HB2' ' A' ' 85' ' ' SER . 7.7 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.811 0.339 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.45 ' C ' ' HD2' ' A' ' 30' ' ' LYS . 7.4 t70 -115.02 -53.0 2.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HD2' ' C ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -108.1 155.92 19.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.1 pt -141.55 170.34 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CE2' ' ND1' ' A' ' 96' ' ' HIS . 9.6 p90 -163.96 154.44 15.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.726 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 61.7 t -117.71 137.89 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -112.26 140.78 46.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.633 HG22 ' HB3' ' A' ' 81' ' ' LEU . 16.8 p -134.4 177.01 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.39 148.78 5.28 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.532 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.487 HG12 HD11 ' A' ' 106' ' ' LEU . 3.6 mp -97.0 132.77 40.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 0.0 111.092 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.512 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 18.8 m-85 -126.47 150.05 48.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.501 ' CB ' HD11 ' A' ' 44' ' ' LEU . 8.4 t-160 -127.35 101.1 6.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.92 38.16 36.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.63 33.35 58.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -148.2 140.14 14.3 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.678 0.751 . . . . 0.0 110.845 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 149.22 67.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.681 2.254 . . . . 0.0 112.335 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.501 HD11 ' CB ' ' A' ' 39' ' ' HIS . 11.0 mp -102.1 -42.85 5.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 t -147.22 170.72 16.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -47.54 126.85 10.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -61.01 160.15 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.782 HG12 HD11 ' A' ' 64' ' ' LEU . 48.5 t -122.57 136.19 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -120.63 146.09 46.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -89.42 171.85 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.116 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -56.56 169.27 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -101.1 110.63 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.41 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -112.1 152.13 44.13 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.65 0.738 . . . . 0.0 111.109 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 142.06 47.09 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.698 2.265 . . . . 0.0 112.331 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.7 p -50.63 -42.71 56.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.6 p -60.04 -29.12 68.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -131.36 84.22 57.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.617 0.723 . . . . 0.0 110.921 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 4.27 2.29 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.309 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -61.3 112.06 2.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.726 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 5.0 m-90 -95.46 -65.36 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 55.31 45.51 25.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -120.08 136.54 54.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.592 ' CZ3' ' HD2' ' A' ' 12' ' ' ARG . 71.3 m95 -83.55 98.87 9.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.921 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.782 HD11 HG12 ' A' ' 48' ' ' VAL . 11.2 tp -86.95 109.76 19.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -91.22 145.12 24.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.541 ' CE1' HD12 ' A' ' 13' ' ' ILE . 31.8 m-85 -111.08 134.04 52.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.66 50.86 2.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.914 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.44 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.2 pp -117.42 165.7 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.625 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.0 120.36 38.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.1 mp -51.45 -53.8 45.85 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 0.0 111.142 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.625 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.81 3.56 2.73 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.26 . . . . 0.0 112.342 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.511 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 6.0 t70 -124.1 -8.43 7.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -82.59 110.44 22.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.658 0.742 . . . . 0.0 110.915 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.429 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.5 Cg_endo -69.76 139.52 40.43 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.661 2.24 . . . . 0.0 112.377 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.541 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 1.8 mpp_? -50.16 -37.8 36.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.81 -48.45 66.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.116 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -58.83 155.05 13.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -150.23 171.22 17.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.8 tp -94.23 137.62 33.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.1 m -136.54 142.8 43.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.633 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.7 OUTLIER -145.29 156.95 44.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.5 m -156.44 135.54 12.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.463 HG12 HD11 ' A' ' 150' ' ' LEU . 26.0 mt -84.74 137.67 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 54.3 m -130.25 170.11 14.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.587 ' HB2' HG21 ' A' ' 28' ' ' ILE . 49.5 p -123.71 126.57 46.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 86' ' ' VAL . 13.3 p -118.09 120.73 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.163 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.4 tptm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 179.916 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.846 0.355 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -134.83 116.69 15.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.462 ' ND1' ' CE2' ' A' ' 32' ' ' TYR . 11.8 m170 -97.83 130.37 44.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.23 131.76 12.25 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.629 0.728 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 147.32 62.51 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.703 2.269 . . . . 0.0 112.353 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.554 ' O ' HG22 ' A' ' 125' ' ' VAL . 51.5 mt -122.13 -56.91 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.88 177.36 7.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 65.7 p-90 -155.65 123.18 5.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.408 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -135.58 135.24 7.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -114.85 162.37 16.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.561 HD11 HD21 ' A' ' 120' ' ' LEU . 88.2 mt -147.12 118.47 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' LEU . 26.0 m-80 -59.21 92.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.487 HD11 HG12 ' A' ' 37' ' ' ILE . 10.7 mt -36.06 -42.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.541 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 97.5 m-85 -104.09 108.42 19.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 108' ' ' ASP . 44.2 p30 -53.13 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.437 ' CE1' ' HB ' ' A' ' 110' ' ' THR . 34.3 p90 -55.43 -40.39 71.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.437 ' HB ' ' CE1' ' A' ' 109' ' ' TYR . 10.0 t -86.22 33.31 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.5 OUTLIER 37.18 49.9 0.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 89.7 m -130.53 110.45 11.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.765 HD22 ' CH2' ' A' ' 156' ' ' TRP . 36.7 mt -34.78 138.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.5 m -69.86 172.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.2 p -168.94 159.41 9.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.69 145.32 2.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.455 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -43.12 151.15 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.472 ' O ' HD13 ' A' ' 152' ' ' LEU . 28.3 ttp -159.48 146.68 16.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.76 122.3 16.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.561 HD21 HD11 ' A' ' 104' ' ' ILE . 3.9 pp -133.89 158.37 43.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -78.39 158.17 28.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.829 HD11 HD12 ' A' ' 150' ' ' LEU . 7.1 mt -120.35 142.27 49.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.642 ' CE3' ' ND2' ' A' ' 142' ' ' ASN . 6.4 m95 -83.5 142.93 43.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.564 0.697 . . . . 0.0 110.904 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 131.13 20.65 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.235 . . . . 0.0 112.377 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 99' ' ' LEU . 15.7 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.662 0.744 . . . . 0.0 111.098 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.877 0.37 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.576 HD11 ' HA ' ' A' ' 81' ' ' LEU . 8.7 tp -96.19 139.83 31.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.408 ' ND2' ' CA ' ' A' ' 137' ' ' GLY . 64.2 t30 -107.04 91.63 6.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.587 0.708 . . . . 0.0 110.923 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.512 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.5 Cg_endo -69.73 -37.38 9.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.673 2.249 . . . . 0.0 112.337 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 36.1 mt -73.96 -22.62 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.408 ' CA ' ' ND2' ' A' ' 134' ' ' ASN . . . -40.59 144.7 0.5 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 138' ' ' VAL . 1.9 m -50.43 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.114 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 67.1 p -127.14 165.36 19.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.83 176.49 35.2 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 90.9 p -88.12 149.52 23.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.884 0.373 . . . . 0.0 110.848 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.642 ' ND2' ' CE3' ' A' ' 123' ' ' TRP . 60.5 t-20 -90.57 124.79 61.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.893 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.465 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.73 2.85 3.15 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.661 2.241 . . . . 0.0 112.339 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -85.24 130.92 34.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -89.2 -52.96 4.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -48.55 -24.54 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.882 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.4 p -74.01 151.87 88.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.567 0.698 . . . . 0.0 111.171 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 140.53 43.06 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.692 2.261 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.7 t -123.11 135.5 54.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.829 HD12 HD11 ' A' ' 122' ' ' LEU . 6.4 mt -105.18 139.8 39.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.87 123.68 49.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.815 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -135.44 165.04 26.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -124.25 141.62 51.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.574 ' CE2' HD21 ' A' ' 152' ' ' LEU . 51.1 m-85 -104.58 136.78 43.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.424 ' HB3' ' CG ' ' A' ' 12' ' ' ARG . 1.5 t70 -152.5 147.62 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.765 ' CH2' HD22 ' A' ' 113' ' ' LEU . 7.1 m95 -134.26 89.36 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.61 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 9.3 p90 -87.36 -52.26 5.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.737 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 2.7 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.843 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.636 ' N ' ' HG ' ' A' ' 158' ' ' SER . 36.6 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.877 0.37 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.93 142.28 47.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.72 HD13 ' CH2' ' A' ' 156' ' ' TRP . 27.4 tp -104.35 142.76 34.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.459 ' HD2' ' CD1' ' A' ' 157' ' ' PHE . 2.2 ptm85 -148.64 128.15 13.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.677 HD12 ' CE1' ' A' ' 66' ' ' TYR . 16.2 mt -129.35 136.38 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.523 ' HB2' ' CD2' ' A' ' 63' ' ' TRP . 67.4 tttt -109.55 125.99 53.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 mm -91.34 141.2 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.456 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.2 mm? -99.61 -74.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.7 p -167.83 178.42 5.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.24 166.89 16.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -135.68 159.09 42.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 41.09 53.51 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.0 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.107 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.0 mt . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.854 0.359 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.68 -58.29 2.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -143.81 176.7 9.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.8 pt -136.63 168.37 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -163.08 152.37 15.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.838 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 94.9 t -97.92 142.72 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.138 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.41 ' NH2' ' OD1' ' A' ' 47' ' ' ASN . 49.2 ttt85 -119.57 117.33 28.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 81' ' ' LEU . 27.7 p -114.69 170.85 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.87 139.11 2.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.542 HD13 HG21 ' A' ' 68' ' ' ILE . 3.3 mp -92.01 138.6 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.145 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.538 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 27.6 m-85 -130.63 164.45 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -133.85 95.29 3.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.845 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.51 -11.97 53.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 135.66 -6.23 4.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -110.45 146.5 34.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.466 ' C ' HD12 ' A' ' 44' ' ' LEU . 54.3 Cg_endo -69.73 160.26 50.36 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.466 HD12 ' C ' ' A' ' 43' ' ' PRO . 8.3 mp -120.02 -33.81 3.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.8 m -151.63 169.35 22.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -53.37 136.42 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.41 ' OD1' ' NH2' ' A' ' 34' ' ' ARG . 31.8 m120 -74.53 158.01 34.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.562 HG12 HD11 ' A' ' 64' ' ' LEU . 43.3 t -116.82 139.22 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.72 142.39 49.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.5 p -89.29 160.83 16.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -52.24 165.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -93.27 119.92 32.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.5 m -120.32 152.14 54.48 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.635 0.731 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 133.07 24.75 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.7 2.267 . . . . 0.0 112.35 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.7 p -44.09 -48.58 9.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -47.81 -34.34 8.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -134.51 86.88 33.62 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.72 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HA ' HG21 ' A' ' 53' ' ' VAL . 53.6 Cg_endo -69.81 3.23 2.92 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.673 2.248 . . . . 0.0 112.328 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -55.22 118.19 4.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.838 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.6 m-90 -101.17 -52.33 3.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.456 ' OD1' HD13 ' A' ' 16' ' ' LEU . 76.0 m-20 43.83 41.25 3.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -120.82 137.7 54.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.523 ' CD2' ' HB2' ' A' ' 14' ' ' LYS . 59.3 m95 -82.27 109.97 17.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.916 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.562 HD11 HG12 ' A' ' 48' ' ' VAL . 10.5 tp -92.03 120.15 32.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.928 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -97.84 136.26 38.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.677 ' CE1' HD12 ' A' ' 13' ' ' ILE . 58.8 m-85 -107.58 127.29 53.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.34 43.69 0.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.542 HG21 HD13 ' A' ' 37' ' ' ILE . 2.2 pp -107.32 166.06 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.618 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.57 125.29 49.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.605 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -58.77 -53.92 61.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.641 0.734 . . . . 0.0 111.13 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.9 Cg_endo -69.75 3.04 3.0 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.499 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 6.2 t70 -124.77 -2.32 7.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.487 HD21 HG21 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -87.69 113.13 53.01 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.665 0.745 . . . . 0.0 110.918 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.5 Cg_endo -69.83 132.77 23.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.512 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -46.61 -42.23 15.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.65 -40.88 60.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.139 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -62.08 168.17 3.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -159.21 173.44 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.409 ' HG ' ' CD2' ' A' ' 81' ' ' LEU . 53.3 tp -95.65 134.8 38.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.597 ' C ' HD23 ' A' ' 81' ' ' LEU . 17.3 m -127.18 147.37 50.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.597 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER -155.55 139.92 16.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.667 ' HB3' HD12 ' A' ' 133' ' ' LEU . 5.0 t -145.63 140.82 27.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.662 HG22 HD12 ' A' ' 99' ' ' LEU . 47.0 mt -83.99 124.9 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 67.2 m -124.21 145.23 49.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.478 ' HA ' HG22 ' A' ' 31' ' ' ILE . 6.0 p -106.07 128.57 53.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.49 HG23 ' CD2' ' A' ' 96' ' ' HIS . 10.4 p -108.57 126.55 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.191 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.829 0.347 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -128.69 127.96 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.49 ' CD2' HG23 ' A' ' 86' ' ' VAL . 15.3 m170 -107.9 132.89 52.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.5 t -137.42 132.71 17.85 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.605 0.717 . . . . 0.0 110.851 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 153.04 69.3 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.699 2.266 . . . . 0.0 112.354 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.662 HD12 HG22 ' A' ' 83' ' ' ILE . 20.8 mt -128.28 -35.57 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.44 155.63 24.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.679 ' HD1' HG12 ' A' ' 125' ' ' VAL . 59.4 p-90 -132.21 134.68 45.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.35 121.63 2.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -108.34 133.35 52.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.879 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.705 HG12 HD21 ' A' ' 120' ' ' LEU . 18.9 mt -118.21 140.38 41.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 107' ' ' PHE . 49.0 m-80 -70.67 85.87 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 105' ' ' ASN . 12.4 mt -34.9 -35.25 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 83.3 m-85 -112.93 123.05 49.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.898 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -51.07 -176.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.56 12.32 3.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 p -130.35 14.21 5.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 70.61 34.38 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.7 m -128.49 109.21 11.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.51 HD22 ' CH2' ' A' ' 156' ' ' TRP . 17.3 mt -38.58 149.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.2 m -72.56 178.08 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.143 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.4 p -174.01 156.18 2.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.44 170.11 45.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 32.5 tttt -71.05 148.7 47.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.733 0.302 . . . . 0.0 110.92 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.7 ttp -156.51 149.76 24.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.47 115.46 10.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.705 HD21 HG12 ' A' ' 104' ' ' ILE . 3.6 pp -128.86 155.97 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.03 153.84 28.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.911 HD11 HD12 ' A' ' 150' ' ' LEU . 7.7 mt -109.91 158.17 18.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.523 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 13.2 m95 -95.24 139.95 22.22 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 129.02 16.88 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.714 2.276 . . . . 0.0 112.347 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.679 HG12 ' HD1' ' A' ' 101' ' ' TRP . 3.2 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.631 0.729 . . . . 0.0 111.127 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.906 0.384 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.667 HD12 ' HB3' ' A' ' 82' ' ' SER . 10.7 tp -106.16 142.88 35.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -105.41 91.33 4.71 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.538 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.1 Cg_endo -69.72 -43.85 2.45 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.0 112.336 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.0 mt -70.62 -19.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.412 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -41.34 146.15 0.5 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.422 ' H ' HG13 ' A' ' 138' ' ' VAL . 1.6 m -56.02 179.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.15 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.5 p -123.57 179.24 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.37 169.03 44.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.447 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 87.2 p -85.76 131.85 34.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.867 0.365 . . . . 0.0 110.876 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 123' ' ' TRP . 64.8 t-20 -69.27 120.85 79.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.567 0.698 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.428 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.6 Cg_endo -69.74 -19.78 35.78 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.344 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -53.3 132.57 39.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -86.83 -35.03 19.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -84.35 39.69 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.5 p -130.98 156.38 80.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.593 0.711 . . . . 0.0 111.134 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 174.51 9.38 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.701 2.268 . . . . 0.0 112.343 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.5 t -159.7 134.57 7.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.911 HD12 HD11 ' A' ' 122' ' ' LEU . 3.3 mt -110.0 143.69 39.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.442 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 6.2 tt0 -111.03 127.7 55.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.704 HD13 ' H ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -137.79 156.19 48.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -113.89 117.81 32.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.688 ' CE2' HD21 ' A' ' 152' ' ' LEU . 29.3 m-85 -84.74 111.7 19.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.9 155.13 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.72 ' CH2' HD13 ' A' ' 11' ' ' LEU . 11.1 m95 -137.87 122.28 18.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.93 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.459 ' CD1' ' HD2' ' A' ' 12' ' ' ARG . 11.1 p90 -109.73 -44.99 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.636 ' HG ' ' N ' ' A' ' 9' ' ' SER . 10.6 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.867 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.531 ' N ' HD13 ' A' ' 70' ' ' ILE . 1.9 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.872 0.368 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -98.87 130.94 45.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.083 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.692 HD13 ' CH2' ' A' ' 156' ' ' TRP . 15.8 tp -84.99 134.93 34.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -128.73 133.52 48.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.529 HD12 ' CE1' ' A' ' 66' ' ' TYR . 26.2 mt -139.04 128.74 31.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.197 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.552 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 16.2 tttp -110.25 130.19 55.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.1 mm -95.15 140.03 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.18 -74.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.6 p -167.09 -179.46 4.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.07 166.13 17.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -136.69 141.18 43.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 60.71 50.1 5.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.142 179.947 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.754 HG21 ' HB2' ' A' ' 85' ' ' SER . 4.2 mp . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.813 0.34 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.07 -59.44 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -144.92 159.05 43.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' A' ' 85' ' ' SER . 8.6 pt -116.57 179.51 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -173.02 149.23 1.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.551 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 88.0 t -108.57 139.19 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 47' ' ' ASN . 6.9 tpt180 -109.45 133.83 52.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.1 p -128.07 163.56 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.31 152.83 7.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.492 HG12 HD11 ' A' ' 106' ' ' LEU . 2.7 mp -98.39 141.85 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 0.0 111.11 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.463 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 14.4 m-85 -132.55 142.93 49.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.849 ' HB3' HD11 ' A' ' 44' ' ' LEU . 8.0 t-160 -120.81 94.35 4.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.42 37.16 36.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.66 -23.78 8.4 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -93.05 142.44 25.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.654 0.74 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.58 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.6 Cg_endo -69.78 165.24 31.64 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.705 2.27 . . . . 0.0 112.356 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.849 HD11 ' HB3' ' A' ' 39' ' ' HIS . 10.0 mp -125.77 -37.48 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 39.8 m -148.57 161.91 40.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.68 137.37 9.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 34' ' ' ARG . 19.6 m120 -70.43 149.89 46.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.591 HG12 HD11 ' A' ' 64' ' ' LEU . 64.4 t -110.96 133.26 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -115.78 147.41 41.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 33' ' ' VAL . 13.1 t -95.26 169.19 10.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.91 173.25 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -105.71 124.25 49.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -126.25 152.01 73.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.587 0.708 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 136.93 34.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.346 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.0 p -46.2 -46.15 17.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.3 t -50.33 -33.89 21.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -133.91 86.16 38.78 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.74 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.2 Cg_endo -69.8 4.35 2.26 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.704 2.269 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -58.06 107.29 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.576 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 1.9 m-90 -93.94 -49.82 5.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.5 p30 39.48 43.38 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -112.73 151.02 30.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.552 ' CE3' ' HB2' ' A' ' 14' ' ' LYS . 79.8 m95 -98.57 100.17 11.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.935 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.591 HD11 HG12 ' A' ' 48' ' ' VAL . 11.0 tp -88.31 118.61 28.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -98.82 145.83 26.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CE1' HD12 ' A' ' 13' ' ' ILE . 5.2 m-85 -114.68 135.85 53.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -90.34 52.32 2.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.437 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.4 pp -119.77 169.44 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -113.58 130.19 56.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.627 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -63.96 -52.8 53.93 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.668 0.747 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.9 Cg_endo -69.75 -3.74 12.61 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.51 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 8.3 t70 -114.39 -9.11 12.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -74.46 116.19 50.72 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.545 0.688 . . . . 0.0 110.928 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.78 134.91 29.07 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.683 2.256 . . . . 0.0 112.337 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.586 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 20.7 mmm-85 -47.92 -44.52 29.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.54 -44.87 66.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.138 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.58 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -54.89 161.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -158.7 176.06 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.8 tp -96.71 133.17 41.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.8 m -127.76 133.3 49.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.32 152.1 41.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 96.0 p -157.48 146.49 19.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.7 mt -89.15 147.11 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 61.5 m -149.15 141.62 24.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.754 ' HB2' HG21 ' A' ' 28' ' ' ILE . 94.7 p -106.46 118.62 37.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.597 HG23 ' CD2' ' A' ' 96' ' ' HIS . 12.4 p -101.44 136.23 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.7 tptm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 4.6 mp0 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.796 0.332 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.84 116.43 22.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.597 ' CD2' HG23 ' A' ' 86' ' ' VAL . 6.4 m170 -95.87 149.71 21.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 t -153.71 120.54 2.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 0.0 110.851 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 144.77 54.93 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.649 2.233 . . . . 0.0 112.335 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.677 ' O ' HG23 ' A' ' 125' ' ' VAL . 20.6 mt -115.53 -47.41 2.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -147.06 169.34 19.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.529 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 64.4 p-90 -147.9 132.89 18.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.9 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.28 120.48 2.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.504 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -100.25 139.37 36.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.76 0.314 . . . . 0.0 110.898 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.628 HD11 HD21 ' A' ' 120' ' ' LEU . 54.9 mt -131.09 120.94 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 106' ' ' LEU . 3.3 t-20 -67.11 95.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.492 HD11 HG12 ' A' ' 37' ' ' ILE . 18.7 mt -34.89 -39.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 63.6 m-85 -96.7 113.62 25.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -52.22 -176.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.84 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -65.27 -33.25 75.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.952 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -83.53 17.31 2.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 60.35 41.88 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.847 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.1 m -133.75 126.62 31.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.741 HD22 ' CH2' ' A' ' 156' ' ' TRP . 18.4 mt -47.17 144.57 2.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.79 -179.19 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.0 t -172.79 171.48 4.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.21 172.8 7.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 2.2 ttpm? -71.42 151.98 43.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.887 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 29.8 ttp -158.67 148.31 19.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.17 121.44 15.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.099 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.628 HD21 HD11 ' A' ' 104' ' ' ILE . 2.9 pp -134.45 160.11 39.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -83.56 151.11 25.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.447 ' HB2' ' HB1' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -109.14 151.03 26.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.529 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 16.3 m95 -80.64 152.61 72.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.534 0.683 . . . . 0.0 110.925 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 168.2 22.32 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 99' ' ' LEU . 68.6 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.592 0.711 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.805 0.336 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.3 tp -88.89 132.99 34.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.438 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 9.6 t-20 -105.71 91.53 5.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.648 0.737 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.463 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.8 Cg_endo -69.76 -27.6 26.28 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.6 mm -80.88 -17.02 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.438 ' CA ' ' OD1' ' A' ' 134' ' ' ASN . . . -43.54 155.07 0.22 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.47 HG22 ' CH2' ' A' ' 101' ' ' TRP . 8.9 m -71.88 163.21 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.869 0.366 . . . . 0.0 111.126 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.3 p -106.04 157.42 17.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.87 159.97 14.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.525 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.1 p -83.55 108.25 16.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.84 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.593 ' ND2' HG21 ' A' ' 147' ' ' THR . 14.3 t-20 -40.07 116.79 1.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.58 0.705 . . . . 0.0 110.841 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -8.41 23.53 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.655 2.237 . . . . 0.0 112.338 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -70.91 151.89 44.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -102.78 -24.53 13.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -85.94 29.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.593 HG21 ' ND2' ' A' ' 142' ' ' ASN . 25.0 p -124.41 153.03 69.09 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 111.148 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 154.19 68.08 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.722 2.281 . . . . 0.0 112.309 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.1 t -130.9 130.54 43.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 122' ' ' LEU . 4.7 mt -109.21 135.95 49.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -105.39 124.78 50.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.76 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -134.46 159.63 40.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.459 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 54.8 mt-10 -116.77 134.78 54.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.667 ' CE2' HD21 ' A' ' 152' ' ' LEU . 47.7 m-85 -99.96 103.7 15.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -114.27 141.13 47.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.741 ' CH2' HD22 ' A' ' 113' ' ' LEU . 60.0 m95 -125.13 76.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 158' ' ' SER . 9.5 p90 -70.88 -49.05 50.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.68 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 47.2 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.617 ' N ' ' HG ' ' A' ' 158' ' ' SER . 1.8 m . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.851 0.358 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.31 131.34 55.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.071 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.59 HD13 ' CH2' ' A' ' 156' ' ' TRP . 13.5 tp -93.71 136.24 34.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 157' ' ' PHE . 18.7 ptt180 -142.61 139.37 31.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.3 mt -136.92 142.25 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HD2' ' CE2' ' A' ' 63' ' ' TRP . 69.3 tttt -118.9 115.37 24.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.0 mm -81.23 145.68 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.49 -72.96 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.1 p -170.53 178.04 3.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -129.62 142.3 50.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 t -117.86 144.65 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 67.23 47.42 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 mt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.789 0.328 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -75.46 -63.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -144.69 -179.8 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 85' ' ' SER . 12.2 pt -137.56 178.87 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -173.67 138.57 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.74 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 14.9 t -90.08 145.82 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.439 ' HG2' HD13 ' A' ' 133' ' ' LEU . 19.4 ttt180 -127.54 120.99 29.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.863 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.626 HG22 ' HB3' ' A' ' 81' ' ' LEU . 56.2 p -117.15 179.45 4.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.25 138.88 2.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.465 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.472 HG12 HD11 ' A' ' 106' ' ' LEU . 3.1 mp -87.06 150.67 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 111.112 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.434 ' HA ' HD13 ' A' ' 44' ' ' LEU . 24.3 m-85 -140.77 152.64 45.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.683 ' CB ' HD11 ' A' ' 44' ' ' LEU . 10.2 t-160 -127.09 104.17 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.01 51.23 56.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.43 34.79 89.61 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.515 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -142.72 142.67 23.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.691 0.758 . . . . 0.0 110.861 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 149.73 67.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.704 2.27 . . . . 0.0 112.333 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.683 HD11 ' CB ' ' A' ' 39' ' ' HIS . 8.3 mp -114.05 -37.1 4.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.9 m -160.57 170.05 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.805 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -50.46 131.73 24.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -66.74 161.98 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.701 HG12 HD11 ' A' ' 64' ' ' LEU . 51.4 t -122.25 139.01 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -126.52 156.5 40.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -93.41 179.82 5.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -66.67 163.92 17.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -82.2 126.46 32.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 1.4 m -137.62 152.05 72.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.647 0.737 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 138.52 38.06 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.73 2.287 . . . . 0.0 112.317 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 23.3 p -49.98 -45.87 52.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.4 t -51.35 -35.72 39.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -130.48 84.77 58.32 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.717 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.588 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.72 3.85 2.51 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.69 2.26 . . . . 0.0 112.366 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -52.63 109.16 0.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.74 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 3.6 m-90 -103.54 -46.89 4.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 60' ' ' TRP . 7.8 p30 35.3 44.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -113.83 147.9 37.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.428 ' CE2' ' HD2' ' A' ' 14' ' ' LYS . 71.2 m95 -88.99 97.16 11.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.701 HD11 HG12 ' A' ' 48' ' ' VAL . 11.8 tp -84.62 111.56 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -91.28 132.87 35.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.937 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -99.42 137.41 37.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -88.21 44.26 1.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.855 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.419 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.2 pp -112.5 170.94 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.619 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.14 115.88 25.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.662 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.8 mp -53.38 -51.02 79.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.647 0.737 . . . . 0.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.0 Cg_endo -69.77 2.21 3.75 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.647 2.231 . . . . 0.0 112.382 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.504 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.3 t70 -123.49 -11.17 7.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.574 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -71.84 113.86 23.78 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.631 0.729 . . . . 0.0 110.901 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.3 Cg_endo -69.74 145.91 58.71 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -41.95 75.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -56.19 -37.97 70.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.611 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -59.85 164.55 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.601 ' HD2' HG21 ' A' ' 139' ' ' THR . 50.4 mtt85 -161.34 173.84 14.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 tp -98.3 131.86 44.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 9.5 m -127.65 135.95 50.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.626 ' HB3' HG22 ' A' ' 35' ' ' THR . 2.2 pp -142.83 155.56 44.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.402 ' OG ' HD12 ' A' ' 133' ' ' LEU . 85.2 p -160.16 134.82 7.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.5 mt -81.66 141.45 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 95.7 m -136.88 152.14 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.443 ' HA ' HG22 ' A' ' 31' ' ' ILE . 15.0 m -111.23 129.11 56.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 p -111.9 130.19 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.1 tptm . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 179.917 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.812 0.339 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -120.94 127.82 52.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -108.43 135.23 50.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.9 t -142.93 127.64 9.83 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.619 0.723 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.592 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.1 Cg_endo -69.77 146.61 60.67 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.653 2.235 . . . . 0.0 112.332 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.42 HD11 ' OG ' ' A' ' 85' ' ' SER . 22.6 mt -119.67 -43.56 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.936 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.1 162.16 41.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.061 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.415 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 66.6 p-90 -143.09 135.67 27.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.06 132.75 5.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 0.9 OUTLIER -111.28 138.18 48.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.792 0.329 . . . . 0.0 110.877 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.562 ' CG1' HD21 ' A' ' 120' ' ' LEU . 78.8 mt -120.6 134.62 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 107' ' ' PHE . 2.5 m120 -73.19 88.1 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.472 HD11 HG12 ' A' ' 37' ' ' ILE . 12.7 mt -36.26 -33.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 105' ' ' ASN . 57.1 m-85 -110.85 116.46 31.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -50.86 -178.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -64.26 -33.22 75.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.3 t -91.25 30.23 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.151 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.2 t0 49.74 49.21 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 113' ' ' LEU . 45.8 m -136.51 112.82 9.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.687 HD22 ' CH2' ' A' ' 156' ' ' TRP . 29.6 mt -36.73 148.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.514 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 18.2 m -75.62 -179.83 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.7 p -173.54 155.85 2.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.845 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.35 152.53 6.08 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.454 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -56.17 147.36 20.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.423 ' O ' HD13 ' A' ' 152' ' ' LEU . 35.9 ttp -156.95 153.09 27.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.92 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.27 132.07 37.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.581 ' O ' HD12 ' A' ' 120' ' ' LEU . 3.9 pp -138.75 154.63 48.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.502 ' ND2' ' SG ' ' A' ' 149' ' ' CYS . 6.0 m120 -77.35 156.82 31.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.1 mt -113.69 153.52 28.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.503 ' CH2' ' OD1' ' A' ' 142' ' ' ASN . 18.7 m95 -89.58 148.79 41.02 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.597 0.713 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 163.67 37.49 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.699 2.266 . . . . 0.0 112.333 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 98' ' ' PRO . 45.7 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.596 0.712 . . . . 0.0 111.116 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.425 HD12 ' NH1' ' A' ' 34' ' ' ARG . 25.6 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.855 0.359 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.439 HD13 ' HG2' ' A' ' 34' ' ' ARG . 6.1 tp -97.77 136.03 38.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.47 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 11.2 t-20 -105.34 93.71 7.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.622 0.725 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -30.89 21.45 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.648 2.232 . . . . 0.0 112.373 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 137' ' ' GLY . 12.7 mm -75.19 -25.82 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.488 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -34.76 148.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.473 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.78 173.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 111.077 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.601 HG21 ' HD2' ' A' ' 78' ' ' ARG . 34.1 p -118.09 146.15 44.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.28 163.19 12.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.508 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.7 p -84.26 118.17 24.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.886 0.374 . . . . 0.0 110.883 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.776 HD21 ' ND2' ' A' ' 144' ' ' ASN . 24.0 t30 -60.89 129.44 90.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 110.913 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 2.03 3.87 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.662 2.241 . . . . 0.0 112.372 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . 0.776 ' ND2' HD21 ' A' ' 142' ' ' ASN . 2.7 m-20 -89.78 117.0 28.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -77.05 -46.18 24.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 147' ' ' THR . 14.8 pt-20 -43.6 -38.66 3.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.419 ' N ' ' HG3' ' A' ' 146' ' ' GLU . 64.6 p -64.25 151.87 89.68 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.606 0.717 . . . . 0.0 111.116 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 132.04 22.59 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.69 2.26 . . . . 0.0 112.375 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.502 ' SG ' ' ND2' ' A' ' 121' ' ' ASN . 1.2 m -113.07 136.99 52.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.674 ' CD2' ' HB2' ' A' ' 18' ' ' ALA . 8.4 mt -108.75 137.59 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -105.23 130.75 53.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.892 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -135.14 161.53 35.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -116.74 125.06 51.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.892 ' CE2' HD21 ' A' ' 152' ' ' LEU . 43.1 m-85 -93.41 108.02 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.0 155.82 49.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.687 ' CH2' HD22 ' A' ' 113' ' ' LEU . 6.9 m95 -136.45 105.24 5.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.485 ' CG ' ' N ' ' A' ' 158' ' ' SER . 10.0 p90 -85.17 -44.96 12.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.617 ' HG ' ' N ' ' A' ' 9' ' ' SER . 4.5 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.893 0.378 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.76 140.13 52.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.064 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 12' ' ' ARG . 5.8 tp -104.33 131.51 51.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' N ' HD12 ' A' ' 11' ' ' LEU . 32.2 ptt180 -139.66 139.12 36.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.48 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 59.3 mt -135.2 128.6 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -102.76 107.14 17.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mm -70.76 143.23 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.37 -72.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.7 p -172.06 179.5 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.25 169.08 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.4 t -147.3 144.0 28.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.135 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 61.78 47.46 6.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.098 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.822 0.344 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.416 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 6.7 t70 -70.52 -62.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 25.1 mmtm -147.36 179.08 7.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 85' ' ' SER . 1.9 pp -141.86 146.31 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -144.28 163.77 32.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.572 ' H ' HG22 ' A' ' 50' ' ' THR . 60.9 t -111.9 140.89 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.09 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.477 ' HG2' HD13 ' A' ' 133' ' ' LEU . 14.6 ttt85 -116.27 127.61 54.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.826 HG22 ' HB3' ' A' ' 81' ' ' LEU . 38.3 p -128.97 168.03 16.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.64 153.22 7.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.481 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.484 HD13 HG21 ' A' ' 68' ' ' ILE . 3.7 mp -96.26 146.78 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 0.0 111.147 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.53 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 32.4 m-85 -139.05 159.4 42.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.425 ' CB ' HD11 ' A' ' 44' ' ' LEU . 7.6 t-160 -139.41 106.44 5.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.39 31.31 46.74 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.96 29.62 60.55 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.533 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -148.67 149.28 30.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.656 0.741 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 158.78 55.75 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.4 mp -112.26 -42.16 3.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.3 m -132.61 -69.57 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -173.16 166.49 4.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.432 ' HB2' ' NH2' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -96.91 149.85 21.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.666 HG12 HD11 ' A' ' 64' ' ' LEU . 95.9 t -115.04 133.46 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -116.21 156.1 27.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 33' ' ' VAL . 9.1 t -100.26 165.58 11.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -48.93 178.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.5 mtt85 -108.22 115.73 30.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -120.19 152.3 54.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.582 0.705 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 139.11 39.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.2 p -47.09 -44.43 21.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m -52.05 -29.41 21.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -134.06 83.97 44.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 0.0 110.904 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.6 Cg_endo -69.78 1.39 4.49 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.672 2.248 . . . . 0.0 112.323 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -60.29 120.27 9.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.576 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 3.2 m-90 -109.52 -47.04 3.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.943 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 60' ' ' TRP . 8.9 p30 34.0 42.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -111.85 144.9 40.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -83.27 110.17 17.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.666 HD11 HG12 ' A' ' 48' ' ' VAL . 11.1 tp -94.56 123.07 37.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.924 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -101.63 137.44 39.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -108.92 135.49 50.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -84.25 38.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.484 HG21 HD13 ' A' ' 37' ' ' ILE . 1.8 pp -110.0 159.57 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.115 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.626 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.12 125.3 53.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -57.96 -54.06 59.44 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.725 . . . . 0.0 111.165 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.0 Cg_endo -69.75 2.16 3.78 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.246 . . . . 0.0 112.372 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.504 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.5 t70 -124.84 -1.52 7.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -85.36 117.05 67.99 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.612 0.72 . . . . 0.0 110.907 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.72 144.62 54.83 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.683 2.255 . . . . 0.0 112.365 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.411 ' HD3' ' CD2' ' A' ' 107' ' ' PHE . 21.5 mmt85 -59.12 -38.39 79.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -57.4 -26.46 61.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -76.94 165.53 24.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -159.51 177.28 11.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 80' ' ' CYS . 43.0 tp -98.89 148.67 23.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.595 ' C ' HD23 ' A' ' 81' ' ' LEU . 61.1 m -143.02 152.49 41.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.826 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.89 136.58 14.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.694 ' OG ' HD12 ' A' ' 133' ' ' LEU . 79.9 p -141.76 133.52 27.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.891 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.503 HG22 HD12 ' A' ' 99' ' ' LEU . 90.2 mt -80.12 135.72 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 70.9 m -135.72 144.33 45.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.483 ' HA ' HG22 ' A' ' 31' ' ' ILE . 6.2 p -105.5 125.13 50.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 86' ' ' VAL . 5.8 p -109.94 117.93 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.823 0.344 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -142.53 135.55 28.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.584 ' CD2' HG23 ' A' ' 86' ' ' VAL . 6.0 m170 -100.25 130.71 46.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.6 m -134.25 127.56 18.99 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.609 0.718 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.706 ' HB2' HG21 ' A' ' 125' ' ' VAL . 53.3 Cg_endo -69.77 150.26 67.94 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.304 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.503 HD12 HG22 ' A' ' 83' ' ' ILE . 21.8 mt -128.48 -52.72 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.64 176.45 8.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.549 ' HH2' HG22 ' A' ' 138' ' ' VAL . 68.6 p-90 -160.6 146.8 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.09 124.11 1.54 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 27.1 m-20 -104.31 153.12 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.902 HD11 HD21 ' A' ' 120' ' ' LEU . 55.1 mt -144.9 126.88 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.129 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 106' ' ' LEU . 24.8 m120 -66.5 99.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 37' ' ' ILE . 13.0 mt -34.13 -54.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.493 ' CE1' ' HG ' ' A' ' 113' ' ' LEU . 52.3 m-85 -94.88 114.29 26.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -54.64 174.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -48.38 -30.09 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -90.28 28.49 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 44.16 41.88 4.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 55.2 m -127.88 115.58 18.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.637 HD22 ' CH2' ' A' ' 156' ' ' TRP . 12.3 mt -43.1 134.4 3.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 m -62.54 173.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.179 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -168.6 161.5 11.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.05 153.78 12.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.471 ' HE3' ' CG ' ' A' ' 151' ' ' GLU . 5.3 tmtt? -63.92 142.9 58.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.748 0.308 . . . . 0.0 110.887 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.422 ' O ' HD13 ' A' ' 152' ' ' LEU . 37.5 ttp -155.09 154.58 32.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.74 116.11 10.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.103 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 104' ' ' ILE . 4.6 pp -123.26 163.75 20.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -85.23 158.75 20.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.764 HD11 HD12 ' A' ' 150' ' ' LEU . 6.0 mt -119.1 155.71 31.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.673 ' CE3' ' ND2' ' A' ' 142' ' ' ASN . 8.3 m95 -90.18 146.42 34.81 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.559 0.695 . . . . 0.0 110.89 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 147.45 62.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.703 2.268 . . . . 0.0 112.305 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.706 HG21 ' HB2' ' A' ' 98' ' ' PRO . 48.2 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.608 0.718 . . . . 0.0 111.118 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.817 0.342 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.694 HD12 ' OG ' ' A' ' 82' ' ' SER . 5.0 tp -103.16 125.86 50.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.449 ' CG ' ' O ' ' A' ' 134' ' ' ASN . 11.8 p-10 -106.65 97.29 16.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.732 . . . . 0.0 110.928 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.53 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.8 -30.82 21.47 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.3 mt -70.08 -25.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.093 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.484 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -41.45 153.59 0.11 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.511 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.549 HG22 ' HH2' ' A' ' 101' ' ' TRP . 2.0 m -59.47 175.3 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.866 0.365 . . . . 0.0 111.161 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 60.7 p -121.37 168.25 11.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.189 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.49 161.93 32.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.9 p -79.6 137.82 37.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.673 ' ND2' ' CE3' ' A' ' 123' ' ' TRP . 34.9 t-20 -75.38 123.96 88.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -14.99 36.8 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.362 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -71.6 140.2 49.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -93.46 -42.32 9.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.37 -35.44 28.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.4 p -66.92 151.3 97.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.572 0.701 . . . . 0.0 111.113 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 148.22 64.3 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.687 2.258 . . . . 0.0 112.358 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 5.5 t -128.07 136.56 51.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 122' ' ' LEU . 3.5 mt -103.67 -177.09 3.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.471 ' CG ' ' HE3' ' A' ' 117' ' ' LYS . 54.7 tt0 -149.61 122.07 8.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.8 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -128.38 165.78 19.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.866 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.429 ' N ' HD22 ' A' ' 152' ' ' LEU . 69.0 mt-10 -128.45 119.73 25.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.649 ' CE2' HD21 ' A' ' 152' ' ' LEU . 45.2 m-85 -88.44 129.89 35.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.903 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -148.75 138.89 22.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.637 ' CH2' HD22 ' A' ' 113' ' ' LEU . 7.7 m95 -129.39 94.26 3.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.586 ' CG ' ' N ' ' A' ' 158' ' ' SER . 16.1 p90 -92.98 -53.3 4.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.586 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 6.3 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.496 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 14.5 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.848 0.356 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.66 150.23 30.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.687 HD13 ' CH2' ' A' ' 156' ' ' TRP . 12.5 tp -104.48 140.04 38.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.69 ' NE ' ' CE3' ' A' ' 63' ' ' TRP . 2.4 ttt180 -143.72 118.39 9.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.521 HD12 ' CE1' ' A' ' 66' ' ' TYR . 16.1 mt -120.99 142.51 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.565 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 35.8 tttm -120.59 134.5 55.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.09 144.7 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.15 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.35 -74.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.1 p -162.31 -178.25 6.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -140.26 149.72 43.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.074 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -123.22 157.88 32.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.123 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 61.25 25.26 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 179.892 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.9 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.792 0.33 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -80.12 -64.62 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -148.23 -179.63 7.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.4 pt -139.46 171.09 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -164.52 158.9 18.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.79 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 40.9 t -119.86 132.06 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.687 ' HG2' HD13 ' A' ' 133' ' ' LEU . 19.2 ttm180 -103.56 122.27 44.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.86 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 81' ' ' LEU . 31.0 p -118.6 154.31 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.9 152.4 9.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.499 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.495 HG12 HD11 ' A' ' 106' ' ' LEU . 2.9 mp -97.41 143.38 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.171 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.572 ' CD1' ' HB3' ' A' ' 135' ' ' PRO . 45.7 m-85 -135.85 152.57 51.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.848 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.7 t-160 -124.5 97.8 5.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.933 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.06 14.38 80.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.34 -25.37 13.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.493 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -88.31 140.72 30.42 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.637 0.732 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.7 Cg_endo -69.81 156.33 63.5 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.712 2.275 . . . . 0.0 112.29 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.429 HD11 ' CB ' ' A' ' 39' ' ' HIS . 7.8 mp -115.18 -33.19 5.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.1 t -156.31 168.66 26.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.41 126.01 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -59.54 164.99 3.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.67 HG12 HD11 ' A' ' 64' ' ' LEU . 59.4 t -120.14 134.94 62.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -116.37 139.2 50.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.444 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 8.4 t -89.87 163.12 15.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -51.39 174.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -102.24 135.52 43.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.856 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -137.54 152.17 72.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 0.0 111.121 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 137.27 35.08 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.702 2.268 . . . . 0.0 112.345 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.6 p -46.54 -50.19 17.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.1 p -46.71 -32.49 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -133.21 87.06 39.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.613 0.72 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.478 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.2 Cg_endo -69.72 2.99 3.02 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -58.75 123.48 16.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.79 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 3.4 m-90 -105.74 -63.81 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 54.24 48.2 21.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -124.93 139.33 53.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.69 ' CE3' ' NE ' ' A' ' 12' ' ' ARG . 80.1 m95 -81.89 112.2 18.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.67 HD11 HG12 ' A' ' 48' ' ' VAL . 10.1 tp -98.12 115.6 28.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -95.3 131.05 41.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.521 ' CE1' HD12 ' A' ' 13' ' ' ILE . 18.4 m-85 -100.83 134.26 44.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -81.06 41.29 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.682 ' C ' HD12 ' A' ' 68' ' ' ILE . 1.2 pp -115.33 162.83 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.615 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.37 127.41 54.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.578 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -54.2 -55.85 32.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 0.0 111.151 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.615 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.4 Cg_endo -69.81 3.02 3.03 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.707 2.271 . . . . 0.0 112.323 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.502 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.5 t70 -123.48 0.42 8.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -88.98 113.85 57.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.64 0.733 . . . . 0.0 110.874 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.5 Cg_endo -69.81 142.02 46.59 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.673 2.249 . . . . 0.0 112.295 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.555 ' NH1' ' CZ ' ' A' ' 107' ' ' PHE . 78.3 mmt-85 -55.2 -37.83 67.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.848 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -56.57 -32.44 65.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -70.55 166.79 19.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -161.81 172.01 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.0 tp -95.46 134.2 38.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.3 m -131.26 141.7 50.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.406 ' HB3' HG22 ' A' ' 35' ' ' THR . 1.4 pp -147.68 150.5 34.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.466 ' OG ' HD12 ' A' ' 133' ' ' LEU . 79.3 p -150.93 135.35 17.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.2 mt -84.76 141.5 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.17 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 20.7 m -140.54 150.97 44.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.572 ' HA ' HG22 ' A' ' 31' ' ' ILE . 85.1 p -113.06 126.15 55.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.535 HG23 ' CD2' ' A' ' 96' ' ' HIS . 8.5 p -104.89 130.44 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 tptp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.9 179.903 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.754 0.312 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -133.16 119.51 20.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.535 ' CD2' HG23 ' A' ' 86' ' ' VAL . 7.9 m170 -103.92 124.59 49.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.823 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.7 t -127.31 128.49 24.05 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.595 0.712 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.442 ' HB2' HG21 ' A' ' 125' ' ' VAL . 53.5 Cg_endo -69.77 147.08 62.03 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.67 2.247 . . . . 0.0 112.356 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.2 mt -120.09 -40.25 2.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -159.16 175.83 12.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.057 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.527 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 66.7 p-90 -156.79 135.52 11.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.81 134.3 7.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -112.22 133.1 54.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.666 HG12 HD21 ' A' ' 120' ' ' LEU . 36.1 mt -122.24 121.0 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -64.27 96.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.495 HD11 HG12 ' A' ' 37' ' ' ILE . 20.4 mt -38.75 -35.65 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.555 ' CZ ' ' NH1' ' A' ' 75' ' ' ARG . 98.9 m-85 -106.12 112.36 25.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -51.09 175.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' A' ' 109' ' ' TYR . 5.0 p90 -59.45 -22.26 61.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -95.76 24.63 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 50.71 39.49 21.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 113' ' ' LEU . 51.2 m -131.5 113.94 14.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.423 HD22 ' CH2' ' A' ' 156' ' ' TRP . 33.5 mt -38.03 143.52 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.465 HG21 ' CE2' ' A' ' 154' ' ' PHE . 35.7 m -74.3 -177.79 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.5 t -168.23 173.07 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.53 174.01 2.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.431 ' HE2' ' CD ' ' A' ' 151' ' ' GLU . 3.5 ttpm? -73.67 152.3 40.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.925 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.416 ' O ' HD13 ' A' ' 152' ' ' LEU . 17.5 ttp -154.39 148.47 25.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.93 116.96 12.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.666 HD21 HG12 ' A' ' 104' ' ' ILE . 4.0 pp -129.26 163.79 24.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 147' ' ' THR . 25.2 m-20 -91.05 145.61 24.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.546 ' HB2' ' HB1' ' A' ' 100' ' ' ALA . 2.9 mt -98.59 159.74 14.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.527 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 23.4 m95 -87.38 150.79 49.84 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.537 0.684 . . . . 0.0 110.913 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 145.23 56.52 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.355 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.442 HG21 ' HB2' ' A' ' 98' ' ' PRO . 99.2 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 0.0 111.149 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.836 0.35 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.687 HD13 ' HG2' ' A' ' 34' ' ' ARG . 16.4 tp -98.68 136.58 38.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.463 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 7.7 t-20 -106.55 91.51 6.04 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.643 0.735 . . . . 0.0 110.854 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.572 ' HB3' ' CD1' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.77 -41.19 4.47 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.687 2.258 . . . . 0.0 112.311 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.1 mt -75.61 -13.65 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.463 ' CA ' ' OD1' ' A' ' 134' ' ' ASN . . . -44.05 144.44 1.95 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.434 HG21 ' CZ2' ' A' ' 123' ' ' TRP . 2.2 m -54.78 173.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 111.184 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.1 p -118.62 175.57 5.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.192 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.08 154.15 30.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.479 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 86.4 p -78.89 109.85 13.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.916 0.389 . . . . 0.0 110.855 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -44.67 121.88 4.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.609 0.719 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -6.22 18.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -68.84 139.88 55.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -99.65 -9.93 22.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -97.67 14.42 26.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.402 ' O ' ' OD1' ' A' ' 121' ' ' ASN . 59.5 p -112.25 152.55 44.54 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.542 0.686 . . . . 0.0 111.166 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.45 59.99 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.66 2.24 . . . . 0.0 112.344 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 2.0 t -128.95 128.48 43.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' A' ' 18' ' ' ALA . 7.5 mt -100.32 140.32 34.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.431 ' CD ' ' HE2' ' A' ' 117' ' ' LYS . 37.6 tt0 -109.15 120.48 42.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.806 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -128.95 165.91 20.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.12 125.99 49.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.471 ' CE2' HD21 ' A' ' 152' ' ' LEU . 28.5 m-85 -90.77 100.41 13.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.01 141.48 37.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.687 ' CH2' HD13 ' A' ' 11' ' ' LEU . 74.8 m95 -129.1 69.55 1.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 158' ' ' SER . 7.9 p90 -69.34 -51.09 40.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.636 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 52.5 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 13.2 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.836 0.351 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -120.08 136.35 54.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.043 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.857 HD13 ' CH2' ' A' ' 156' ' ' TRP . 24.6 tp -86.67 139.15 31.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.412 ' H ' HD12 ' A' ' 11' ' ' LEU . 10.4 ttp180 -138.39 123.3 18.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.0 mt -134.18 139.27 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 72.9 tttt -118.37 127.22 53.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -89.17 146.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 151' ' ' GLU . 4.3 mm? -100.85 -72.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 p -168.46 -176.94 3.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.93 141.88 51.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.424 HG23 ' CD2' ' A' ' 20' ' ' TYR . 6.5 t -117.57 134.34 54.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.424 ' CD2' HG23 ' A' ' 19' ' ' THR . 5.8 m-85 72.69 38.75 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.116 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.833 0.349 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -71.14 -52.62 18.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.851 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -145.81 177.44 8.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.428 HG22 ' HA ' ' A' ' 85' ' ' SER . 2.0 pp -146.64 156.94 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -153.47 163.2 40.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.1 t -108.75 140.55 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.158 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.485 ' HG2' HD13 ' A' ' 133' ' ' LEU . 25.1 ttm180 -114.77 126.75 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.898 HG22 ' HB3' ' A' ' 81' ' ' LEU . 47.0 p -124.73 163.87 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.74 146.24 4.91 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.813 HD13 HG21 ' A' ' 68' ' ' ILE . 3.9 mp -89.77 146.01 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 111.166 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.534 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 38.5 m-85 -142.53 157.1 45.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.467 ' CB ' HD11 ' A' ' 44' ' ' LEU . 6.6 t-160 -129.09 102.84 6.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.89 22.37 70.24 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.29 -37.2 3.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -75.4 137.61 71.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.664 0.745 . . . . 0.0 110.888 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 158.07 58.2 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.467 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.0 mp -116.15 -40.08 3.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.3 m -149.76 168.95 22.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -57.35 128.17 35.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -61.65 159.11 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.54 HG11 ' HG ' ' A' ' 64' ' ' LEU . 58.7 t -114.78 147.5 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -129.06 156.06 44.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 p -102.64 168.62 9.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -51.92 177.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -107.08 112.62 25.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 m -118.0 152.83 50.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.606 0.717 . . . . 0.0 111.131 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 135.84 31.39 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.65 2.233 . . . . 0.0 112.331 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.5 p -44.69 -44.37 9.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 93.8 p -48.56 -34.82 12.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -134.18 89.22 28.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.621 0.724 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.58 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.3 Cg_endo -69.82 -0.12 6.5 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.708 2.272 . . . . 0.0 112.297 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -54.09 113.48 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.58 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 3.3 m-90 -104.82 -46.92 4.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.457 ' C ' ' O ' ' A' ' 60' ' ' TRP . 11.8 m-80 33.99 51.58 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -119.94 140.06 51.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.457 ' NE1' ' HD2' ' A' ' 14' ' ' LYS . 76.5 m95 -81.28 108.43 14.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.54 ' HG ' HG11 ' A' ' 48' ' ' VAL . 9.7 tp -97.66 121.46 39.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -101.33 134.84 43.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -102.34 129.91 48.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.9 42.34 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.877 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.813 HG21 HD13 ' A' ' 37' ' ' ILE . 2.0 pp -108.91 163.5 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.176 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.621 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.12 126.89 55.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.626 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -58.28 -52.41 74.78 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.65 0.738 . . . . 0.0 111.153 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.8 Cg_endo -69.8 -5.56 16.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.348 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.1 t0 -112.26 -15.79 13.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -71.41 112.16 12.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.627 0.727 . . . . 0.0 110.92 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.632 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.77 145.17 56.3 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.674 2.249 . . . . 0.0 112.35 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.457 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 21.7 mmt180 -53.41 -46.75 69.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.52 -41.71 63.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.082 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.632 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -57.82 163.82 2.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.415 ' O ' HG23 ' A' ' 37' ' ' ILE . 3.8 ptp85 -160.91 173.92 14.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.6 tp -96.18 144.15 26.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.611 ' C ' HD23 ' A' ' 81' ' ' LEU . 58.9 m -134.49 149.45 50.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.879 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.898 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.0 OUTLIER -155.76 137.09 13.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.0 p -146.87 154.4 41.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.586 ' CG1' HD11 ' A' ' 150' ' ' LEU . 44.5 mt -104.19 138.81 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.159 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 84.7 m -133.94 155.41 49.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.428 ' HA ' HG22 ' A' ' 31' ' ' ILE . 78.0 p -106.72 116.1 31.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.891 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.42 127.98 54.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.6 tptt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.948 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.829 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.88 118.94 30.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -103.91 124.65 49.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 17.9 m -131.16 122.96 19.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.406 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.4 Cg_endo -69.79 140.38 42.43 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.468 ' C ' HG23 ' A' ' 125' ' ' VAL . 16.5 mt -113.9 -36.33 4.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.04 -179.68 6.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.789 ' HH2' HG22 ' A' ' 138' ' ' VAL . 67.8 p-90 -162.7 127.05 3.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.76 134.16 7.07 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -114.64 129.91 56.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.339 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.484 HG12 HD21 ' A' ' 120' ' ' LEU . 87.1 mt -107.57 138.15 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 106' ' ' LEU . 6.1 m120 -76.58 82.79 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.1 mt -34.43 -38.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.457 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 40.9 m-85 -105.93 120.47 41.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -62.85 170.53 2.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.828 ' CE1' HG23 ' A' ' 110' ' ' THR . 0.2 OUTLIER -51.83 -26.24 9.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.828 HG23 ' CE1' ' A' ' 109' ' ' TYR . 67.9 p -105.23 31.79 4.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 47.01 36.6 4.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 113' ' ' LEU . 97.6 m -115.12 102.52 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.488 HD22 ' CH2' ' A' ' 156' ' ' TRP . 35.2 mt -34.05 125.13 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.479 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 29.8 m -58.2 176.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.146 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.447 ' HA ' ' CB ' ' A' ' 154' ' ' PHE . 2.2 m -173.42 166.88 4.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.33 132.38 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.471 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.417 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 22.6 ttpt -40.36 149.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.9 ttp -159.71 158.4 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.676 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -138.69 133.47 32.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.5 pp -143.59 148.74 36.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -76.6 157.94 31.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 150' ' ' LEU . 1.2 mt -118.12 147.71 43.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.581 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 9.1 m95 -81.19 152.7 71.29 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.524 0.678 . . . . 0.0 110.931 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 161.88 44.21 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.708 2.272 . . . . 0.0 112.325 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.468 HG23 ' C ' ' A' ' 99' ' ' LEU . 90.3 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.485 HD13 ' HG2' ' A' ' 34' ' ' ARG . 14.8 tp -88.57 134.14 33.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -105.28 91.42 4.67 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.598 0.713 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.534 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.8 -28.61 24.87 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.252 . . . . 0.0 112.313 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 137' ' ' GLY . 11.5 mm -75.34 -28.48 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.181 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -34.66 151.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.423 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.789 HG22 ' HH2' ' A' ' 101' ' ' TRP . 18.6 m -68.63 170.45 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.946 0.403 . . . . 0.0 111.116 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.5 p -111.98 169.17 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.84 159.26 29.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.535 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.5 p -77.5 121.25 23.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.842 0.353 . . . . 0.0 110.858 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.581 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 36.9 t30 -59.14 124.39 74.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -18.45 36.96 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.726 2.284 . . . . 0.0 112.326 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -60.97 139.33 58.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -95.41 -35.36 11.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -83.41 39.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -129.16 156.12 78.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 0.0 111.132 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 130.28 18.98 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.722 2.281 . . . . 0.0 112.294 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 12.1 t -121.29 130.62 53.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.632 HD12 HD11 ' A' ' 122' ' ' LEU . 2.9 mt -106.89 151.5 25.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.982 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.676 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 0.4 OUTLIER -112.86 140.25 47.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.917 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.778 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -143.13 155.31 44.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.417 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 39.1 mt-10 -119.17 115.98 25.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.648 ' CE2' HD21 ' A' ' 152' ' ' LEU . 44.6 m-85 -80.49 109.53 15.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.98 126.34 41.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.857 ' CH2' HD13 ' A' ' 11' ' ' LEU . 6.3 m95 -123.55 98.38 5.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 158' ' ' SER . 46.9 p90 -98.67 -53.08 3.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.797 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 22.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.843 0.354 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.74 117.68 29.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.927 HD13 ' CH2' ' A' ' 156' ' ' TRP . 14.7 tp -84.72 131.75 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.521 ' NE ' ' CZ3' ' A' ' 63' ' ' TRP . 23.2 ptt180 -130.1 136.77 49.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.485 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 58.4 mt -134.21 134.9 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -111.41 133.79 53.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.8 mm -93.39 145.93 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.724 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.2 mm? -100.45 -72.4 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.2 p -166.78 -175.36 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.8 148.29 52.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -120.77 133.68 55.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 66.72 41.8 2.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.154 179.893 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.9 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.884 0.373 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -59.78 -66.8 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.844 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -144.33 177.32 8.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.4 173.56 11.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -165.65 170.83 13.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 92.1 t -119.14 140.51 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.126 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.712 ' HG2' HD13 ' A' ' 133' ' ' LEU . 46.5 ttm-85 -115.03 130.82 57.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.536 HG22 ' HB3' ' A' ' 81' ' ' LEU . 60.4 p -126.71 168.16 14.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.24 134.22 1.63 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.429 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 78' ' ' ARG . 3.8 mp -81.99 148.7 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 111.156 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.533 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 19.7 m-85 -140.1 142.75 36.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.7 t-160 -118.64 104.76 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.846 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.36 45.07 82.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.492 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.14 30.89 71.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.453 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -140.58 144.71 37.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.641 0.734 . . . . 0.0 110.904 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.411 ' O ' HD12 ' A' ' 44' ' ' LEU . 54.1 Cg_endo -69.68 163.95 36.3 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.696 2.264 . . . . 0.0 112.374 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.424 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.6 mp -126.2 -40.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.6 p -146.33 177.0 9.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.11 118.06 7.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -50.48 149.07 3.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.706 HG12 HD11 ' A' ' 64' ' ' LEU . 61.6 t -111.14 137.23 44.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -118.55 151.29 38.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.449 HG22 HD13 ' A' ' 64' ' ' LEU . 79.4 p -100.73 164.37 11.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -49.71 172.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.26 120.24 40.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.8 m -122.05 152.12 59.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.568 0.699 . . . . 0.0 111.131 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 136.23 32.34 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.704 2.269 . . . . 0.0 112.306 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.0 p -45.65 -47.55 14.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -47.78 -35.35 9.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 58.5 m-20 -134.72 89.0 26.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.659 0.742 . . . . 0.0 110.911 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.585 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 54.3 Cg_endo -69.73 2.23 3.7 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.65 2.234 . . . . 0.0 112.408 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -54.2 105.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.585 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.9 m-90 -93.18 -49.72 5.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.724 ' OD1' HD13 ' A' ' 16' ' ' LEU . 62.6 m-20 40.49 45.1 1.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -115.53 138.73 50.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.521 ' CZ3' ' NE ' ' A' ' 12' ' ' ARG . 45.8 m95 -85.76 108.55 18.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.706 HD11 HG12 ' A' ' 48' ' ' VAL . 10.3 tp -96.15 117.38 30.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -97.54 126.84 43.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -96.48 122.14 39.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.41 53.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.442 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.3 pp -117.27 167.15 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.627 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.69 119.86 39.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.659 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -58.0 -51.1 84.2 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.654 0.74 . . . . 0.0 111.159 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.75 2.86 3.15 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.697 2.265 . . . . 0.0 112.336 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.5 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.6 t0 -122.46 -11.02 8.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.835 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -70.62 113.64 20.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.659 0.742 . . . . 0.0 110.92 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.2 Cg_endo -69.74 132.97 24.48 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.641 2.228 . . . . 0.0 112.366 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.46 ' NE ' ' OD2' ' A' ' 111' ' ' ASP . 82.8 mmt-85 -43.1 -45.91 5.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -51.2 -46.92 62.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.538 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -53.15 162.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 37' ' ' ILE . 14.8 ptp180 -160.75 175.56 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.858 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.3 tp -94.38 138.22 32.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 84.5 m -139.19 135.63 34.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.536 ' HB3' HG22 ' A' ' 35' ' ' THR . 1.5 pp -142.03 157.24 45.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.51 ' HB2' HD12 ' A' ' 133' ' ' LEU . 59.5 m -157.99 154.52 27.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.4 mt -97.85 147.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.168 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 86.2 m -142.65 156.61 45.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.1 m -116.07 118.58 33.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 p -102.94 130.07 53.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 179.911 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.775 0.321 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -131.53 130.71 42.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -102.85 132.47 49.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.0 t -132.71 120.85 16.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.632 0.73 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.484 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.0 Cg_endo -69.79 147.66 63.19 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.693 2.262 . . . . 0.0 112.37 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 125' ' ' VAL . 19.6 mt -122.72 -55.04 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.8 -179.82 5.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.435 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 69.3 p-90 -164.36 132.95 3.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA3' HD23 ' A' ' 122' ' ' LEU . . . -143.26 136.97 7.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.534 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -115.15 146.44 41.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 110.848 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.505 HD11 HD21 ' A' ' 120' ' ' LEU . 95.5 mt -127.29 125.6 66.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 106' ' ' LEU . 16.7 m-80 -64.87 87.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.894 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 37' ' ' ILE . 37.9 mt -33.46 -38.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' ASN . 66.3 m-85 -105.15 110.95 23.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -56.75 177.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -52.08 -40.56 61.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.424 HG23 ' HB ' ' A' ' 112' ' ' THR . 4.7 t -86.57 34.12 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.46 ' OD2' ' NE ' ' A' ' 75' ' ' ARG . 35.8 t0 38.22 49.49 1.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 113' ' ' LEU . 52.7 m -134.14 111.48 10.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.69 HD22 ' CH2' ' A' ' 156' ' ' TRP . 58.0 mt -34.19 134.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 154' ' ' PHE . 31.0 m -65.6 175.55 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.2 p -169.77 165.06 9.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.5 134.6 0.25 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.48 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -42.02 149.31 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.729 0.3 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.409 ' O ' HD13 ' A' ' 152' ' ' LEU . 45.2 ttp -159.77 159.84 33.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.65 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.79 137.27 34.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.103 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 104' ' ' ILE . 4.3 pp -145.22 155.42 43.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -81.36 152.53 27.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.898 HD11 HD12 ' A' ' 150' ' ' LEU . 1.9 mt -114.87 138.48 50.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.589 ' CH2' ' HD2' ' A' ' 143' ' ' PRO . 12.0 m95 -75.9 149.11 82.63 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.546 0.689 . . . . 0.0 110.953 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 157.12 61.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.685 2.257 . . . . 0.0 112.371 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 99' ' ' LEU . 87.1 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 111.086 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.879 0.371 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.712 HD13 ' HG2' ' A' ' 34' ' ' ARG . 5.1 tp -93.55 138.85 31.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -107.8 91.29 7.32 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.595 0.712 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.533 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.73 -34.58 14.39 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.338 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.1 mm -70.65 -26.46 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.167 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.435 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -39.49 153.62 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.9 m -65.62 166.14 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.935 0.397 . . . . 0.0 111.098 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.0 p -109.41 166.87 10.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.146 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.99 177.79 33.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.2 p -91.79 130.35 37.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.893 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 123' ' ' TRP . 63.8 t-20 -67.17 121.26 77.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.563 0.696 . . . . 0.0 110.885 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.589 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.8 Cg_endo -69.68 -7.23 20.49 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.721 2.281 . . . . 0.0 112.345 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.47 127.19 31.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -78.01 -52.78 8.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -40.61 -41.95 1.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.0 p -62.09 151.66 80.2 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 111.134 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 174.82 8.89 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 0.0 112.384 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.1 t -150.55 137.92 19.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.898 HD12 HD11 ' A' ' 122' ' ' LEU . 4.5 mt -110.9 156.48 21.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.65 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 1.7 mp0 -117.63 138.59 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.806 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -141.58 158.37 43.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -122.5 120.26 33.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.69 ' CE2' HD21 ' A' ' 152' ' ' LEU . 43.7 m-85 -88.04 119.39 28.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.51 128.5 20.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.927 ' CH2' HD13 ' A' ' 11' ' ' LEU . 3.9 m95 -123.9 103.48 8.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' CG ' ' N ' ' A' ' 158' ' ' SER . 21.8 p90 -106.46 -49.64 3.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.879 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.494 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 31.4 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.919 0.39 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.811 ' HB3' ' CB ' ' A' ' 158' ' ' SER . . . -119.71 141.83 49.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.118 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -106.27 137.15 44.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.503 HH11 ' N ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER -140.35 163.71 32.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.479 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 67.9 mt -154.79 131.75 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -105.88 104.17 13.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.7 mm -73.19 136.58 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.83 -75.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.1 p -168.01 167.8 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.83 164.7 12.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.074 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -142.97 161.14 38.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 49.79 45.04 25.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.09 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.809 0.338 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.49 -51.62 4.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -146.65 173.49 12.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.508 HG22 ' HA ' ' A' ' 85' ' ' SER . 7.5 pt -136.17 174.96 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -169.14 148.19 3.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.662 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 55.3 t -100.95 141.44 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.4 ttt85 -121.11 126.63 50.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 81' ' ' LEU . 30.3 p -121.34 176.04 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.67 137.02 2.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.457 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.537 HG12 HD11 ' A' ' 106' ' ' LEU . 3.5 mp -94.63 142.78 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.553 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 13.4 m-85 -135.43 164.61 27.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.945 ' HB2' HD11 ' A' ' 44' ' ' LEU . 8.4 t-160 -132.72 100.96 5.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.72 30.56 70.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.526 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.42 -49.57 1.04 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.98 145.31 88.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.652 0.739 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 167.05 25.55 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.345 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.945 HD11 ' HB2' ' A' ' 39' ' ' HIS . 10.9 mp -118.74 -33.24 4.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.6 t -166.02 168.2 15.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -41.91 153.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -92.21 171.85 8.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 64' ' ' LEU . 57.5 t -125.96 143.61 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -129.65 144.91 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.426 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 10.4 t -94.31 165.09 12.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.168 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -53.39 178.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.8 mtm-85 -104.56 139.02 40.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.438 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.8 m -140.68 152.19 65.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.615 0.722 . . . . 0.0 111.121 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 135.12 29.73 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.684 2.256 . . . . 0.0 112.356 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 17.4 p -45.96 -47.69 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.1 p -46.43 -37.62 7.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -134.4 88.05 30.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.63 0.728 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.539 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 3.29 2.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.341 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -54.36 110.75 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.662 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.7 m-90 -95.07 -68.53 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 58.25 54.29 5.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -131.18 140.59 49.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -81.61 104.78 12.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.546 ' HG ' HG11 ' A' ' 48' ' ' VAL . 11.2 tp -88.81 111.49 22.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -90.19 127.94 36.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -97.61 134.67 40.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.913 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.46 50.7 1.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.436 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.0 pp -122.92 164.11 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.612 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.7 117.34 31.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.646 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.4 mp -54.28 -51.98 72.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.604 0.716 . . . . 0.0 111.146 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.8 Cg_endo -69.79 2.6 3.4 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.696 2.264 . . . . 0.0 112.366 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.508 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.0 t70 -125.72 -9.45 6.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.29 117.44 63.15 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.623 0.725 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.514 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.0 Cg_endo -69.7 146.06 59.37 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.647 2.231 . . . . 0.0 112.371 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.564 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 62.0 mmt-85 -59.96 -42.2 93.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.634 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -54.42 -31.36 55.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.514 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -69.06 162.0 27.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.481 ' HD2' HG21 ' A' ' 139' ' ' THR . 43.2 mtt85 -155.58 175.26 14.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.2 tp -98.93 131.41 45.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.6 m -128.55 124.59 36.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.592 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.7 OUTLIER -128.13 158.49 37.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.5 p -156.98 137.73 13.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.651 HG12 HD11 ' A' ' 150' ' ' LEU . 33.8 mt -88.24 136.79 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 63.5 m -133.99 141.54 47.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.508 ' HA ' HG22 ' A' ' 31' ' ' ILE . 91.0 p -105.88 119.75 39.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.503 HG23 ' CD2' ' A' ' 96' ' ' HIS . 6.2 p -101.57 138.17 26.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.911 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.471 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 8.8 mt-10 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.801 0.334 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -125.77 122.96 37.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.503 ' CD2' HG23 ' A' ' 86' ' ' VAL . 7.3 m170 -96.45 140.56 30.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.826 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.9 t -142.31 122.98 8.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.537 ' HD3' HD23 ' A' ' 132' ' ' LEU . 54.2 Cg_endo -69.74 147.01 62.04 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.71 2.273 . . . . 0.0 112.368 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.677 ' O ' HG23 ' A' ' 125' ' ' VAL . 44.0 mt -119.2 -56.65 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.16 -178.17 5.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.535 ' CH2' HG22 ' A' ' 138' ' ' VAL . 61.4 p-90 -160.33 141.89 12.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.923 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.9 125.45 2.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.445 ' CB ' HG22 ' A' ' 139' ' ' THR . 4.0 m-20 -108.01 117.93 35.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.758 0.314 . . . . 0.0 110.916 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.662 HG12 HD21 ' A' ' 120' ' ' LEU . 54.2 mt -107.63 128.28 62.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 106' ' ' LEU . 1.7 m120 -65.09 94.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.872 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.537 HD11 HG12 ' A' ' 37' ' ' ILE . 13.0 mt -35.84 -43.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 84.9 m-85 -101.97 119.61 39.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -56.48 -175.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -60.9 -37.71 83.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 t -88.8 32.94 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.19 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 43.81 53.88 5.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 113' ' ' LEU . 98.2 m -137.88 108.43 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.776 HD22 ' CH2' ' A' ' 156' ' ' TRP . 41.4 mt -34.11 135.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.442 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 26.8 m -67.64 172.64 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.42 ' HA ' ' CB ' ' A' ' 154' ' ' PHE . 1.7 m -162.61 169.92 19.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.75 168.37 7.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.44 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 3.4 ttpm? -70.8 149.72 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.419 ' O ' HD13 ' A' ' 152' ' ' LEU . 18.0 ttp -155.74 148.04 23.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.07 116.6 12.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.662 HD21 HG12 ' A' ' 104' ' ' ILE . 4.4 pp -130.75 153.05 49.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.431 ' CB ' ' HB2' ' A' ' 142' ' ' ASN . 9.5 m-20 -75.37 147.24 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.833 HD11 HD12 ' A' ' 150' ' ' LEU . 5.4 mt -105.66 155.13 19.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.6 ' CD1' ' OD1' ' A' ' 142' ' ' ASN . 18.7 m95 -84.05 151.33 60.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.613 0.72 . . . . 0.0 110.872 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 152.87 69.23 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.657 2.238 . . . . 0.0 112.305 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 99' ' ' LEU . 71.4 t . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 0.0 111.142 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.537 HD23 ' HD3' ' A' ' 98' ' ' PRO . 7.6 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.852 0.358 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.0 tp -104.41 119.85 39.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -101.6 97.8 8.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.553 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.9 Cg_endo -69.78 -40.66 5.03 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.373 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 137' ' ' GLY . 42.1 mt -65.16 -27.28 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -37.87 152.38 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.445 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.535 HG22 ' CH2' ' A' ' 101' ' ' TRP . 14.9 m -56.46 168.07 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.481 HG21 ' HD2' ' A' ' 78' ' ' ARG . 30.7 p -120.45 154.77 34.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.79 -169.26 12.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.9 p -101.46 141.17 34.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 110.817 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.6 ' OD1' ' CD1' ' A' ' 123' ' ' TRP . 2.6 m120 -68.13 130.94 92.3 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.567 0.699 . . . . 0.0 110.896 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -28.84 25.05 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.696 2.264 . . . . 0.0 112.408 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -79.81 135.71 36.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -80.47 -34.95 35.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -46.85 -54.75 9.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.5 p -47.13 151.56 1.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.57 0.7 . . . . 0.0 111.156 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 168.02 22.88 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 13.1 t -144.88 140.73 28.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.833 HD12 HD11 ' A' ' 122' ' ' LEU . 2.3 mt -114.52 139.43 49.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -105.84 118.21 36.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.834 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -124.71 158.08 34.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.44 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 38.7 mt-10 -116.22 142.32 46.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.607 ' CE2' HD21 ' A' ' 152' ' ' LEU . 45.7 m-85 -106.78 151.14 25.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.503 ' N ' HH11 ' A' ' 12' ' ' ARG . 3.8 m-20 -172.79 142.9 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.776 ' CH2' HD22 ' A' ' 113' ' ' LEU . 7.8 m95 -132.21 86.8 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 158' ' ' SER . 28.7 p90 -95.43 -44.59 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.811 ' CB ' ' HB3' ' A' ' 10' ' ' ALA . 2.4 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.888 0.375 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.17 141.74 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.071 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.796 HD13 ' CH2' ' A' ' 156' ' ' TRP . 18.8 tp -102.52 140.39 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.461 ' H ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -147.35 136.59 22.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.435 HD12 ' CE1' ' A' ' 66' ' ' TYR . 25.5 mt -135.54 145.66 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttt -119.73 119.3 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.2 mm -82.68 138.76 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.06 -73.51 0.58 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.0 p -170.41 176.11 4.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.29 160.4 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.475 HG23 ' CD2' ' A' ' 20' ' ' TYR . 13.6 t -129.15 158.66 38.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.188 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.475 ' CD2' HG23 ' A' ' 19' ' ' THR . 11.4 m-85 42.88 39.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.5 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.113 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.3 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.856 0.36 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.68 -64.36 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -145.84 167.47 23.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 85' ' ' SER . 5.8 pt -127.3 163.72 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -157.15 157.98 35.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.85 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 98.4 t -104.05 140.13 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.412 ' HG2' HD13 ' A' ' 133' ' ' LEU . 31.3 ttm-85 -114.6 116.6 29.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 81' ' ' LEU . 54.3 p -119.34 163.6 16.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.126 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.27 143.4 3.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.498 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.799 HD13 HG21 ' A' ' 68' ' ' ILE . 4.2 mp -88.5 148.55 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.541 ' CD2' ' HB3' ' A' ' 135' ' ' PRO . 25.3 m-85 -135.47 132.58 37.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.575 ' CD2' ' HB3' ' A' ' 76' ' ' ALA . 11.4 t-160 -118.94 94.9 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.72 34.66 8.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.96 -26.7 3.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.505 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.25 153.22 62.47 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.634 0.73 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.467 ' O ' ' C ' ' A' ' 44' ' ' LEU . 53.8 Cg_endo -69.77 82.99 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 43' ' ' PRO . 16.4 tp -32.41 -46.54 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.1 m -152.23 177.24 10.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.47 150.89 8.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.83 145.94 25.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.705 HG12 HD11 ' A' ' 64' ' ' LEU . 58.8 t -105.54 135.32 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.082 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -113.17 147.15 37.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.494 HG22 HD13 ' A' ' 64' ' ' LEU . 80.9 p -99.74 167.52 10.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -53.76 165.29 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -100.73 116.4 32.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -116.28 152.48 47.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.676 0.75 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 139.01 39.19 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.66 2.24 . . . . 0.0 112.367 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.4 p -42.43 -45.61 4.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.834 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 p -51.12 -37.43 45.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.84 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -125.79 83.5 62.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.646 0.736 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.542 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.73 3.51 2.72 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.378 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.35 128.89 38.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.85 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 10.0 m-90 -106.24 -40.88 5.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 60' ' ' TRP . 2.4 p30 33.76 44.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -117.82 138.55 52.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.408 ' CE3' ' NH2' ' A' ' 12' ' ' ARG . 62.3 m95 -81.82 96.9 7.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.917 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.705 HD11 HG12 ' A' ' 48' ' ' VAL . 12.8 tp -85.39 120.37 26.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -98.48 132.58 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.435 ' CE1' HD12 ' A' ' 13' ' ' ILE . 44.7 m-85 -100.41 136.19 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -87.63 44.08 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.799 HG21 HD13 ' A' ' 37' ' ' ILE . 2.0 pp -112.59 165.57 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.112 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.623 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.58 119.98 37.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.652 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 2.8 mp -56.87 -51.73 79.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.596 0.713 . . . . 0.0 111.144 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.0 Cg_endo -69.75 1.64 4.24 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.36 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.491 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 3.5 t70 -125.47 -6.69 6.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.575 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -74.6 116.09 50.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.648 0.737 . . . . 0.0 110.926 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.586 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.77 139.3 39.84 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.736 2.29 . . . . 0.0 112.309 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -53.07 -36.86 61.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.575 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . . . -60.77 -33.66 73.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -68.15 165.14 18.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 37' ' ' ILE . 10.3 ptt180 -161.11 172.54 16.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.9 tp -93.79 144.68 25.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.609 ' C ' HD23 ' A' ' 81' ' ' LEU . 77.4 m -135.86 149.65 49.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.609 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER -155.84 139.42 15.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.404 ' OG ' HD12 ' A' ' 133' ' ' LEU . 96.8 p -148.86 139.19 22.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.459 ' CG1' HD11 ' A' ' 150' ' ' LEU . 53.5 mt -86.54 138.49 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.124 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 72.5 m -139.64 145.17 38.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.47 ' HA ' HG22 ' A' ' 31' ' ' ILE . 88.5 p -106.86 120.52 42.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.852 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.505 HG23 ' CD2' ' A' ' 96' ' ' HIS . 5.1 p -102.01 130.67 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.09 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.7 tptm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.841 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 36.0 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.777 0.322 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -122.98 116.31 23.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.505 ' CD2' HG23 ' A' ' 86' ' ' VAL . 6.7 m170 -94.02 127.01 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 21.7 t -131.54 123.59 19.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.589 0.709 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.507 ' HD3' HD23 ' A' ' 132' ' ' LEU . 53.9 Cg_endo -69.8 147.97 63.81 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 125' ' ' VAL . 24.6 mt -122.74 -48.18 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.13 163.09 35.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.108 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.831 ' CH2' HG22 ' A' ' 138' ' ' VAL . 61.7 p-90 -142.6 138.59 30.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.79 121.05 1.66 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.518 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 34.6 m-20 -101.36 131.44 47.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.1 mt -124.45 121.54 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 106' ' ' LEU . 7.1 m120 -66.76 96.14 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.3 mt -35.0 -39.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -102.45 114.47 28.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -57.48 173.82 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.773 ' CE1' HG23 ' A' ' 110' ' ' THR . 1.1 p90 -58.05 -15.09 8.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.773 HG23 ' CE1' ' A' ' 109' ' ' TYR . 29.9 p -103.46 26.15 8.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 45.87 35.6 2.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 113' ' ' LEU . 93.6 m -125.76 109.3 12.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.68 HD22 ' CH2' ' A' ' 156' ' ' TRP . 33.7 mt -34.23 139.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' CG ' ' A' ' 154' ' ' PHE . 19.3 m -72.84 166.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -161.05 171.98 17.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.38 160.12 2.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -64.16 143.41 57.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.432 ' O ' HD13 ' A' ' 152' ' ' LEU . 35.2 ttp -153.05 148.71 27.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.77 121.35 15.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.078 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pp -128.84 155.72 44.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -76.26 152.71 36.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.26 157.09 18.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.578 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 15.0 m95 -90.48 152.24 45.1 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.546 0.689 . . . . 0.0 110.946 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 151.26 69.09 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.344 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 99' ' ' LEU . 93.4 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.507 HD23 ' HD3' ' A' ' 98' ' ' PRO . 43.3 mt . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.808 0.337 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.534 HD23 ' CE1' ' A' ' 38' ' ' TYR . 10.7 tp -104.12 132.42 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -105.54 91.06 4.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.591 0.71 . . . . 0.0 110.909 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.541 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 54.2 Cg_endo -69.79 -45.29 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.641 2.227 . . . . 0.0 112.395 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.0 mt -74.25 -23.74 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.449 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -39.83 158.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.472 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.831 HG22 ' CH2' ' A' ' 101' ' ' TRP . 6.1 m -52.81 172.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.944 0.402 . . . . 0.0 111.102 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.405 HG22 ' CB ' ' A' ' 103' ' ' ASN . 40.1 p -132.03 161.8 32.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.173 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.52 -179.75 25.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.8 p -90.33 121.29 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 0.0 110.875 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.578 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 29.8 t30 -63.28 126.53 89.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.544 0.688 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 1.49 4.4 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -91.81 113.32 25.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -74.4 -40.16 62.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -49.67 -46.38 49.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.0 p -55.15 152.62 14.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.581 0.705 . . . . 0.0 111.139 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 134.43 27.92 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.673 2.249 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.1 t -113.83 142.54 45.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.459 HD11 ' CG1' ' A' ' 83' ' ' ILE . 4.7 mt -110.27 146.22 36.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -116.53 123.13 46.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.807 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -130.77 166.23 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -120.26 118.79 31.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.628 ' CE2' HD21 ' A' ' 152' ' ' LEU . 28.8 m-85 -88.96 100.78 13.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.923 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -121.79 154.43 36.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.796 ' CH2' HD13 ' A' ' 11' ' ' LEU . 20.9 m95 -138.77 105.3 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 158' ' ' SER . 14.8 p90 -90.47 -49.01 6.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.514 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 51.5 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 t -159.24 138.07 10.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 0.0 110.863 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.5 t -37.72 -45.29 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.01 84.71 1.56 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.535 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 7' ' ' GLY . 74.2 m -139.47 173.01 11.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.859 0.362 . . . . 0.0 110.887 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 5' ' ' SER . 55.2 p 34.49 36.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 5' ' ' SER . . . -96.06 63.86 1.22 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.592 ' ND2' ' N ' ' A' ' 158' ' ' SER . 5.5 t-20 -101.74 151.4 22.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.33 . . . . 0.0 110.937 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.572 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 46.3 m -125.68 -31.63 2.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -120.26 135.3 55.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.096 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.983 HD13 ' CH2' ' A' ' 156' ' ' TRP . 6.7 tp -97.54 128.92 44.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.412 ' NH2' ' CE3' ' A' ' 63' ' ' TRP . 0.3 OUTLIER -127.35 123.6 36.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.908 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.687 HD12 ' CE1' ' A' ' 66' ' ' TYR . 11.3 mt -124.57 137.09 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.175 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -113.96 135.41 54.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.4 mm -94.78 142.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.136 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.87 -69.19 0.78 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.3 p -172.3 173.85 4.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -120.5 161.07 21.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.07 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' A' ' 149' ' ' CYS . 2.1 t -128.34 158.37 38.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 39.47 52.16 2.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.962 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 23' ' ' VAL . 11.1 t -65.72 158.78 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.132 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.442 ' N ' HG12 ' A' ' 21' ' ' VAL . 3.2 t-20 -83.79 34.31 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 23' ' ' VAL . 32.6 m -103.37 81.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -79.38 -74.66 0.28 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.4 pp -46.09 173.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.133 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 55.35 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.818 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -120.29 -32.49 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.8 mt -52.41 135.47 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.128 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.401 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 29.4 t70 -82.85 -55.91 4.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 25.9 mmtt -146.32 -177.12 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.536 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.1 pt -145.52 170.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 3.7 p90 -158.57 166.23 32.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.679 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 99.0 t -122.27 139.6 48.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.126 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' HG2' HD22 ' A' ' 133' ' ' LEU . 20.6 ttm180 -115.72 121.2 41.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.812 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 81' ' ' LEU . 57.9 p -118.91 154.16 33.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.406 ' C ' HD12 ' A' ' 37' ' ' ILE . . . -176.08 169.26 41.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.536 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.599 HD13 HG21 ' A' ' 68' ' ' ILE . 4.1 mp -122.98 137.24 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.806 0.336 . . . . 0.0 111.124 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.54 ' HA ' HD13 ' A' ' 44' ' ' LEU . 2.9 m-85 -137.03 150.22 47.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.732 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.4 t-160 -113.01 99.36 7.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.84 32.55 61.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.478 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.31 -22.45 34.89 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.458 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -88.58 140.04 29.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.605 0.716 . . . . 0.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.485 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 53.8 Cg_endo -69.74 156.09 64.31 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.367 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.6 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.1 mp -120.51 -38.01 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.2 m -154.98 168.21 27.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -51.9 152.65 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -93.94 163.44 13.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.647 HG12 HD11 ' A' ' 64' ' ' LEU . 25.4 t -116.73 145.06 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.154 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -125.33 141.68 51.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.5 p -85.86 160.66 19.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.156 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -52.75 170.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -95.88 115.22 27.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -116.96 152.16 48.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.593 0.711 . . . . 0.0 111.11 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 137.74 36.24 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.679 2.253 . . . . 0.0 112.35 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 24.6 p -47.85 -44.88 29.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 t -53.16 -31.33 42.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.868 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -134.39 84.78 39.87 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.62 0.724 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.447 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.75 3.31 2.84 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.717 2.278 . . . . 0.0 112.37 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -62.81 127.15 29.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.679 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 5.6 m-90 -106.22 -63.46 1.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 58.67 45.05 16.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -127.55 147.47 50.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.412 ' CE3' ' NH2' ' A' ' 12' ' ' ARG . 77.9 m95 -88.66 117.71 27.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.647 HD11 HG12 ' A' ' 48' ' ' VAL . 9.2 tp -101.0 123.25 44.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -99.59 136.63 39.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.687 ' CE1' HD12 ' A' ' 13' ' ' ILE . 34.8 m-85 -106.35 138.36 42.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.49 38.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.895 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.599 HG21 HD13 ' A' ' 37' ' ' ILE . 1.8 pp -108.05 161.53 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.605 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.62 124.86 49.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.588 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -55.84 -55.27 42.89 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.603 0.716 . . . . 0.0 111.173 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.9 Cg_endo -69.74 2.94 3.07 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.734 2.289 . . . . 0.0 112.346 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.503 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.1 t0 -127.72 1.46 6.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.89 115.71 62.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.643 0.735 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.606 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.78 145.64 57.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 0.0 112.347 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.467 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 25.3 mmt85 -59.69 -35.9 75.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.732 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -62.73 -32.92 74.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.606 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -68.35 165.0 19.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.093 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.481 ' O ' HG23 ' A' ' 37' ' ' ILE . 15.3 ptp180 -163.09 176.36 10.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.3 tp -98.97 136.69 38.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -133.76 132.11 40.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.9 OUTLIER -130.66 158.62 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.8 p -159.57 135.89 8.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.829 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.423 HG12 HD11 ' A' ' 150' ' ' LEU . 34.7 mt -86.58 136.57 22.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.109 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . 30.3 m -132.53 151.29 51.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.536 ' HA ' HG22 ' A' ' 31' ' ' ILE . 83.6 p -112.97 122.76 48.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.569 HG23 ' CD2' ' A' ' 96' ' ' HIS . 8.9 p -106.19 125.85 61.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.122 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -151.13 126.35 9.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.28 -174.53 13.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.462 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.471 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 47.4 mtt180 -123.16 160.77 25.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.853 0.358 . . . . 0.0 110.859 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -53.36 113.38 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.97 -26.41 7.65 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -90.55 158.59 16.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.845 0.355 . . . . 0.0 111.107 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 mtmm -71.53 170.94 12.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -90.51 168.76 11.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -130.27 122.98 29.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.569 ' CD2' HG23 ' A' ' 86' ' ' VAL . 5.7 m170 -100.95 128.79 46.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.2 t -131.82 129.01 21.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 110.872 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.584 ' HB2' HG11 ' A' ' 125' ' ' VAL . 53.8 Cg_endo -69.84 143.18 49.65 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 0.0 112.282 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.439 ' C ' HG13 ' A' ' 125' ' ' VAL . 11.1 mt -118.45 -56.83 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.19 178.68 6.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.587 ' HD1' HG12 ' A' ' 125' ' ' VAL . 64.8 p-90 -161.42 144.07 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.96 132.46 4.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -111.93 120.26 41.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.773 0.32 . . . . 0.0 110.909 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.586 HD11 HD21 ' A' ' 120' ' ' LEU . 73.7 mt -112.24 127.27 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -68.87 98.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.856 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.3 mt -43.15 -34.32 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 63.3 m-85 -107.9 110.43 22.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -51.65 170.22 0.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 1.061 ' CE1' HG23 ' A' ' 110' ' ' THR . 0.6 OUTLIER -55.48 -20.25 12.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.984 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 1.061 HG23 ' CE1' ' A' ' 109' ' ' TYR . 41.5 p -102.64 28.46 6.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.113 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 110' ' ' THR . 4.3 p30 46.71 40.34 8.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 113' ' ' LEU . 93.1 m -126.23 109.24 12.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.838 HD22 ' CH2' ' A' ' 156' ' ' TRP . 34.0 mt -34.2 132.95 0.24 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.1 m -66.2 163.31 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.5 p -160.42 175.6 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.54 134.9 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.484 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.434 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 5.9 ttpt -43.01 150.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.803 0.335 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.427 ' O ' HD13 ' A' ' 152' ' ' LEU . 34.8 ttp -158.79 148.72 19.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.7 114.44 9.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.088 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.586 HD21 HD11 ' A' ' 104' ' ' ILE . 4.1 pp -124.79 160.94 27.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.68 150.23 29.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.428 HD11 HD12 ' A' ' 150' ' ' LEU . 5.5 mt -106.52 153.35 22.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.536 ' CH2' ' OD1' ' A' ' 142' ' ' ASN . 54.7 m95 -85.94 144.81 39.77 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.514 0.673 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 132.61 23.71 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.646 2.231 . . . . 0.0 112.363 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.587 HG12 ' HD1' ' A' ' 101' ' ' TRP . 21.5 m -65.79 150.78 95.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.675 0.75 . . . . 0.0 111.123 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 127' ' ' HIS . 53.5 Cg_endo -69.79 161.22 46.76 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.699 2.266 . . . . 0.0 112.333 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.435 ' C ' ' O ' ' A' ' 126' ' ' PRO . 7.6 m170 -35.25 110.38 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 36.95 68.4 0.35 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.481 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.61 105.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.318 . . . . 0.0 110.965 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -38.68 -56.04 1.38 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -77.79 -178.57 5.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.468 HD13 ' OH ' ' A' ' 32' ' ' TYR . 40.3 mt -108.34 -44.59 4.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.432 HD22 ' HG2' ' A' ' 34' ' ' ARG . 21.7 tp -106.32 133.05 51.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -107.08 91.37 6.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.636 0.731 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -17.12 38.01 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.67 2.247 . . . . 0.0 112.381 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 mm -88.89 -20.69 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -41.93 150.75 0.27 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.3 m -66.46 164.2 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.963 0.411 . . . . 0.0 111.086 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.4 p -108.15 161.11 15.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.133 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.32 167.51 18.62 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.462 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.6 p -93.5 118.73 31.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.815 0.34 . . . . 0.0 110.885 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.536 ' OD1' ' CH2' ' A' ' 123' ' ' TRP . 31.6 t30 -61.35 123.62 77.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.665 0.745 . . . . 0.0 110.882 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -8.73 24.36 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.722 2.282 . . . . 0.0 112.333 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -73.44 138.98 45.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -90.21 -49.5 6.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -44.69 -38.42 4.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.8 p -63.77 151.24 89.34 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.583 0.706 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 166.4 27.7 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.639 2.226 . . . . 0.0 112.356 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.404 ' HB3' ' CG2' ' A' ' 19' ' ' THR . 4.2 t -146.1 135.88 23.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.475 ' CD2' ' HB2' ' A' ' 18' ' ' ALA . 10.8 mt -113.84 138.49 50.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.967 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.434 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 18.3 tt0 -106.93 132.08 53.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.79 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -134.84 161.74 34.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.874 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -116.41 120.84 40.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.644 ' CE2' HD21 ' A' ' 152' ' ' LEU . 25.9 m-85 -90.15 113.94 25.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.63 136.65 46.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.983 ' CH2' HD13 ' A' ' 11' ' ' LEU . 2.7 m95 -134.58 98.96 4.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.564 ' CG ' ' N ' ' A' ' 158' ' ' SER . 15.5 p90 -103.83 -51.76 3.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.877 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.592 ' N ' ' ND2' ' A' ' 8' ' ' ASN . 4.0 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -77.78 148.14 34.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 0.0 110.87 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 t -125.13 118.33 25.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.23 53.75 3.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.463 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.3 p -54.44 142.64 26.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.849 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -92.34 95.73 9.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.87 -119.41 6.32 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.487 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -125.6 151.28 46.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.361 . . . . 0.0 110.863 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.54 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 5.6 m -130.01 -35.86 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.888 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -119.52 147.07 44.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.093 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.613 HD13 ' CH2' ' A' ' 156' ' ' TRP . 11.2 tp -93.25 130.28 39.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.572 ' N ' HD12 ' A' ' 11' ' ' LEU . 6.2 ttp180 -127.97 127.61 43.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.948 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.475 HD12 ' CE1' ' A' ' 66' ' ' TYR . 51.4 mt -130.75 156.3 42.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' N ' HG22 ' A' ' 13' ' ' ILE . 55.7 tttt -140.65 128.01 21.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.842 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.5 mm -90.29 143.33 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.68 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.2 mm? -100.23 -73.66 0.63 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.1 t -162.49 172.17 15.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.428 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -119.23 162.9 17.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' TYR . 9.5 t -130.69 156.08 45.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.415 ' C ' ' O ' ' A' ' 19' ' ' THR . 4.9 m-85 35.59 45.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.841 ' HB ' HG22 ' A' ' 23' ' ' VAL . 8.8 t -59.84 141.19 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -47.16 -25.54 0.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.841 HG22 ' HB ' ' A' ' 21' ' ' VAL . 28.5 m -53.23 99.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.161 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -94.91 -62.14 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.574 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -64.61 -174.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -126.27 14.68 7.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.95 -49.82 27.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.2 mt -40.43 137.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.128 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -79.56 -57.32 3.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -146.15 177.49 8.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.4 pt -139.64 173.72 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -165.98 160.57 16.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.517 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 37.6 t -116.74 146.84 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.145 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -119.68 136.14 54.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.481 HG22 ' HB3' ' A' ' 81' ' ' LEU . 63.0 p -130.59 157.65 42.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.11 141.58 3.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.4 mp -93.59 133.66 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.834 0.349 . . . . 0.0 111.111 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.549 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 17.5 m-85 -127.86 158.69 37.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.601 ' HB3' HD11 ' A' ' 44' ' ' LEU . 12.0 t-160 -134.57 95.43 3.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.69 32.07 28.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.48 -17.81 46.27 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -96.97 141.8 23.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.625 0.726 . . . . 0.0 110.938 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.432 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.77 160.88 48.08 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.643 2.229 . . . . 0.0 112.358 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.601 HD11 ' HB3' ' A' ' 39' ' ' HIS . 10.1 mp -119.9 -26.4 5.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 17.5 p -158.38 168.24 27.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -57.04 131.23 49.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.428 ' ND2' ' OH ' ' A' ' 38' ' ' TYR . 6.4 m120 -64.09 148.52 49.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.479 HG12 HD11 ' A' ' 64' ' ' LEU . 21.3 t -111.15 147.16 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -130.16 145.24 51.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.452 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 3.2 t -87.59 176.12 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.402 ' N ' ' OG1' ' A' ' 50' ' ' THR . 11.6 pt20 -63.52 167.9 5.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.1 mtm-85 -92.13 140.61 29.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.38 152.12 49.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.662 0.744 . . . . 0.0 111.153 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.67 36.08 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.686 2.257 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.1 p -47.78 -45.75 29.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.4 m -52.3 -28.34 18.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -134.5 87.38 32.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.668 0.747 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.75 3.73 2.6 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.351 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -55.69 134.4 51.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.517 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -120.88 -68.45 0.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.68 ' OD1' HD13 ' A' ' 16' ' ' LEU . 69.0 m-80 53.55 52.72 12.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -127.56 143.39 51.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.46 ' CE3' ' HD2' ' A' ' 12' ' ' ARG . 90.0 m95 -87.38 104.35 16.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.479 HD11 HG12 ' A' ' 48' ' ' VAL . 10.8 tp -93.39 120.69 33.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -95.96 151.95 18.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' CE1' HD12 ' A' ' 13' ' ' ILE . 61.8 m-85 -118.03 140.21 50.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -84.33 30.29 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.592 ' C ' HD12 ' A' ' 68' ' ' ILE . 1.3 pp -106.63 159.42 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.608 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -110.88 139.97 45.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.967 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.536 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.5 mp -64.64 -58.06 14.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.567 0.699 . . . . 0.0 111.166 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.608 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.0 Cg_endo -69.73 2.43 3.53 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.679 2.252 . . . . 0.0 112.322 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.495 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.0 t70 -120.67 -0.74 10.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.476 HD21 HG21 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -87.52 117.13 68.14 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.603 0.716 . . . . 0.0 110.903 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.0 Cg_endo -69.82 138.37 37.49 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.622 2.215 . . . . 0.0 112.344 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -56.45 -26.47 53.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.427 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -70.31 -27.41 64.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.087 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.475 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -78.43 165.52 23.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.085 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 37' ' ' ILE . 11.6 ptp180 -157.89 174.13 15.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.465 ' HB2' HD21 ' A' ' 106' ' ' LEU . 33.2 tp -97.01 143.64 27.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.608 ' C ' HD23 ' A' ' 81' ' ' LEU . 81.9 m -133.58 154.65 50.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.608 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -155.66 137.84 14.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.768 ' OG ' HD12 ' A' ' 133' ' ' LEU . 1.0 OUTLIER -139.42 154.37 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.812 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.9 mt -98.75 128.68 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.193 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 18.6 m -128.52 142.58 51.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.676 ' HA ' HG22 ' A' ' 31' ' ' ILE . 29.8 p -108.37 130.96 55.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.834 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.788 HG23 ' CD2' ' A' ' 96' ' ' HIS . 9.9 p -110.64 129.21 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.115 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -142.64 127.03 17.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -131.5 167.6 22.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.485 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -114.1 163.93 14.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.871 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -55.03 126.78 26.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.27 6.08 13.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.486 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.52 169.27 9.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -83.44 169.37 15.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -98.35 174.01 6.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.884 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -137.52 121.61 17.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.788 ' CD2' HG23 ' A' ' 86' ' ' VAL . 9.1 m170 -97.46 141.46 30.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 5.7 t -148.6 132.34 8.47 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.582 0.706 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.657 ' O ' HD23 ' A' ' 99' ' ' LEU . 54.0 Cg_endo -69.75 152.51 69.38 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.24 . . . . 0.0 112.397 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 98' ' ' PRO . 6.6 mt -128.48 -47.21 1.3 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -140.87 155.47 46.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.112 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.76 ' CH2' HG22 ' A' ' 138' ' ' VAL . 62.2 p-90 -135.68 126.2 26.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.4 130.07 5.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.48 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.599 ' HB2' HG22 ' A' ' 139' ' ' THR . 1.0 OUTLIER -104.6 161.49 14.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.409 HG13 ' C ' ' A' ' 103' ' ' ASN . 88.6 mt -151.17 118.03 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -64.83 105.56 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 79' ' ' LEU . 70.9 mt -44.32 -54.73 5.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.406 ' CE1' ' HG ' ' A' ' 113' ' ' LEU . 65.0 m-85 -94.28 120.34 34.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -56.75 -176.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.743 ' CE1' HG23 ' A' ' 110' ' ' THR . 0.3 OUTLIER -72.09 -0.9 12.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.743 HG23 ' CE1' ' A' ' 109' ' ' TYR . 5.0 p -108.86 11.39 26.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.117 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 64.33 48.56 2.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.4 m -147.33 125.64 12.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.113 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.982 HD22 ' CH2' ' A' ' 156' ' ' TRP . 15.0 mt -45.27 142.12 2.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 114' ' ' VAL . 2.4 m -64.24 176.0 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.4 p -168.51 173.69 7.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.34 139.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.476 ' HD3' ' CG ' ' A' ' 151' ' ' GLU . 0.7 OUTLIER -48.51 146.11 3.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.861 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.417 ' O ' HD13 ' A' ' 152' ' ' LEU . 32.0 ttp -147.86 152.49 37.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.407 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.4 116.68 11.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.509 ' C ' HD12 ' A' ' 120' ' ' LEU . 4.5 pp -128.85 160.41 32.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 147' ' ' THR . 5.4 m120 -87.3 146.95 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.492 HD11 HD12 ' A' ' 150' ' ' LEU . 2.8 mt -104.63 150.05 25.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.95 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -83.09 151.68 63.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.539 0.685 . . . . 0.0 110.951 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 160.63 48.98 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.675 2.25 . . . . 0.0 112.365 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.2 t -99.25 118.6 62.21 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.639 0.733 . . . . 0.0 111.128 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 160.63 48.99 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.654 2.236 . . . . 0.0 112.385 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -66.26 124.61 23.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.857 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 130' ' ' GLU . . . 119.16 -60.15 0.5 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.527 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 tt -41.06 94.69 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 110.925 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 128' ' ' GLY . 9.6 pt-20 -91.48 2.28 56.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -81.39 115.83 20.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.827 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 94.3 mt -47.69 -50.46 24.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.768 HD12 ' OG ' ' A' ' 82' ' ' SER . 8.6 tp -110.49 145.3 37.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.443 ' ND2' ' HA3' ' A' ' 137' ' ' GLY . 64.2 t30 -119.18 93.87 47.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 110.911 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.549 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.3 Cg_endo -69.83 -47.3 0.94 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.716 2.277 . . . . 0.0 112.31 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.619 ' H ' HD12 ' A' ' 136' ' ' ILE . 0.4 OUTLIER -64.36 -30.14 49.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.137 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.443 ' HA3' ' ND2' ' A' ' 134' ' ' ASN . . . -35.14 151.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.468 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.76 HG22 ' CH2' ' A' ' 101' ' ' TRP . 3.5 m -56.85 176.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.401 . . . . 0.0 111.125 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.599 HG22 ' HB2' ' A' ' 103' ' ' ASN . 41.2 p -129.48 161.73 29.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.122 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.57 159.17 20.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.535 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 89.0 p -78.18 130.87 36.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.855 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.409 ' ND2' HG21 ' A' ' 147' ' ' THR . 13.5 t-20 -64.37 119.81 59.63 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.644 0.735 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -7.2 20.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.673 2.249 . . . . 0.0 112.354 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -85.94 145.49 27.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -92.97 -37.15 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.69 -14.67 3.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.485 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 65.0 p -88.85 151.39 47.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.581 0.705 . . . . 0.0 111.154 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 169.39 19.07 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.342 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 t -150.79 137.83 19.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.492 HD12 HD11 ' A' ' 122' ' ' LEU . 10.2 mt -114.42 139.59 49.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.476 ' CG ' ' HD3' ' A' ' 117' ' ' LYS . 5.5 tt0 -107.09 123.17 47.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.778 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -131.08 162.54 29.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -119.15 131.72 55.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.508 ' CE2' HD21 ' A' ' 152' ' ' LEU . 24.5 m-85 -95.98 119.74 35.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.822 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.94 137.43 44.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.883 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.982 ' CH2' HD22 ' A' ' 113' ' ' LEU . 15.9 m95 -130.02 91.24 3.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.958 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.562 ' CG ' ' N ' ' A' ' 158' ' ' SER . 22.3 p90 -96.95 -52.62 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.888 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 30.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.7 t -164.65 122.09 1.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.364 . . . . 0.0 110.868 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.8 p -150.0 167.28 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.889 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.49 -113.93 1.91 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.467 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t -80.7 84.35 6.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.911 0.386 . . . . 0.0 110.867 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 t -42.57 165.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.873 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.57 -157.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.509 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.518 ' HB2' HG21 ' A' ' 70' ' ' ILE . 28.4 m120 -84.63 142.38 29.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.844 0.354 . . . . 0.0 110.848 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.8 p -132.02 -36.81 1.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.55 128.42 53.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.131 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.596 HD13 ' CH2' ' A' ' 156' ' ' TRP . 17.6 tp -97.83 131.66 44.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -139.21 136.57 35.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.434 HD12 ' CE1' ' A' ' 66' ' ' TYR . 31.1 mt -129.5 135.94 60.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 21.2 tttt -113.59 113.26 24.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.28 143.77 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.35 -73.22 0.61 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.5 p -170.52 171.0 6.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.94 154.23 25.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.421 HG23 ' CD2' ' A' ' 20' ' ' TYR . 8.1 t -134.64 143.25 47.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.421 ' CD2' HG23 ' A' ' 19' ' ' THR . 1.6 m-85 63.73 41.29 7.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.88 151.06 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.143 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -77.11 58.37 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 m -113.86 100.75 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -98.47 -73.49 0.62 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.519 HD12 ' H ' ' A' ' 27' ' ' ASP . 2.7 pp -56.23 169.03 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.49 57.93 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.519 ' H ' HD12 ' A' ' 25' ' ' ILE . 12.7 t0 -119.31 -42.77 2.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.7 mt -39.42 123.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -72.06 -62.78 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -144.74 177.08 8.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 85' ' ' SER . 4.9 pt -137.69 158.12 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -152.37 140.38 20.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.73 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 95.8 t -89.82 149.07 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.163 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.471 ' O ' HD13 ' A' ' 133' ' ' LEU . 37.3 ttt85 -131.53 119.35 21.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 81' ' ' LEU . 32.4 p -117.04 179.33 4.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.64 140.57 3.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.493 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.7 mp -90.07 142.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.165 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.537 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 22.0 m-85 -137.23 143.68 42.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.425 ' CB ' HD11 ' A' ' 44' ' ' LEU . 13.3 t-160 -122.14 99.01 6.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.13 36.58 31.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.44 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.92 35.41 50.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -148.53 140.39 14.4 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.63 0.728 . . . . 0.0 110.88 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 143.45 51.09 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 0.0 112.345 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 39' ' ' HIS . 11.3 mp -97.67 -41.83 7.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.8 m -150.36 162.54 40.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.847 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -44.02 120.3 2.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -60.52 162.25 6.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.552 HG12 HD11 ' A' ' 64' ' ' LEU . 21.2 t -117.32 147.46 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.163 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -126.86 148.89 49.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.459 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 9.1 t -98.13 163.82 12.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.174 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -49.95 179.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -107.02 127.71 53.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 59' ' ' ARG . 1.6 m -129.95 152.13 79.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.6 0.714 . . . . 0.0 111.161 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 141.55 45.57 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.704 2.269 . . . . 0.0 112.343 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.3 p -50.13 -45.36 52.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.8 p -53.64 -30.85 44.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -134.2 86.3 36.8 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.581 0.705 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.572 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.6 Cg_endo -69.75 3.63 2.66 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.723 2.282 . . . . 0.0 112.322 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.432 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -48.81 135.4 15.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.856 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.73 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -128.93 -56.35 1.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.5 p30 38.37 37.93 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -104.29 142.7 34.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.477 ' NE1' ' HD2' ' A' ' 14' ' ' LYS . 45.4 m95 -85.38 104.4 15.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.552 HD11 HG12 ' A' ' 48' ' ' VAL . 10.8 tp -96.32 121.43 38.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -99.74 141.92 31.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.434 ' CE1' HD12 ' A' ' 13' ' ' ILE . 58.4 m-85 -110.86 128.95 55.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -81.34 47.66 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.491 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.1 pp -114.0 167.25 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.16 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.617 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.55 123.72 46.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.621 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -58.49 -53.2 68.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.634 0.731 . . . . 0.0 111.143 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.82 3.11 2.99 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.268 . . . . 0.0 112.329 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.505 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 3.5 t70 -124.82 -4.42 7.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.836 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.636 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -82.01 111.85 30.45 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.616 0.722 . . . . 0.0 110.94 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.498 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.3 Cg_endo -69.75 135.9 31.65 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.365 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.47 ' NE ' ' OD1' ' A' ' 111' ' ' ASP . 62.0 mmt-85 -45.27 -43.63 10.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.18 -47.98 54.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.636 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -52.51 160.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 -156.13 173.15 17.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.4 tp -98.62 131.02 45.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.8 m -125.98 132.34 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.565 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.4 OUTLIER -138.95 147.05 41.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.423 ' OG ' HD12 ' A' ' 133' ' ' LEU . 88.6 p -155.24 130.32 9.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.536 ' CG1' HD11 ' A' ' 150' ' ' LEU . 72.6 mt -80.5 131.72 33.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 55.7 m -123.37 143.38 50.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.52 ' HA ' HG22 ' A' ' 31' ' ' ILE . 35.7 m -106.98 128.05 54.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.593 HG23 ' CD2' ' A' ' 96' ' ' HIS . 6.9 p -109.05 137.71 39.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.169 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -136.05 124.11 22.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -163.36 -164.62 18.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.503 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -125.87 -176.9 3.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.886 0.374 . . . . 0.0 110.905 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -44.28 -72.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.2 46.04 1.21 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.5 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -122.97 172.63 8.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.795 0.331 . . . . 0.0 111.104 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -73.06 146.59 45.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.561 ' HB3' HG22 ' A' ' 86' ' ' VAL . 24.3 mt-10 -106.47 164.3 12.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -124.74 115.33 20.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.949 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.593 ' CD2' HG23 ' A' ' 86' ' ' VAL . 5.1 m170 -97.07 141.33 30.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.38 124.79 2.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.635 0.731 . . . . 0.0 110.855 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.549 ' HD3' HD23 ' A' ' 132' ' ' LEU . 53.3 Cg_endo -69.81 147.14 61.89 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.706 2.271 . . . . 0.0 112.298 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.463 ' O ' HG23 ' A' ' 125' ' ' VAL . 21.4 mt -113.2 -47.62 3.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.84 156.91 44.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.138 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.449 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 67.2 p-90 -137.21 138.91 40.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.07 124.21 3.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.53 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -101.75 129.16 47.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.892 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.675 HD11 HD21 ' A' ' 120' ' ' LEU . 85.0 mt -124.0 126.8 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.076 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 106' ' ' LEU . 8.2 t-20 -73.43 95.24 2.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 105' ' ' ASN . 51.4 mt -35.08 -34.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 105' ' ' ASN . 88.7 m-85 -103.56 112.7 25.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -52.92 -178.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.829 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 109' ' ' TYR . 1.3 p90 -62.06 -30.53 71.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.947 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.402 HG23 ' HB ' ' A' ' 112' ' ' THR . 5.2 t -93.99 33.86 1.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.181 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' OD1' ' NE ' ' A' ' 75' ' ' ARG . 14.5 t0 43.0 44.73 4.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.87 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 69.7 m -131.52 109.66 10.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.17 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.689 HD22 ' CH2' ' A' ' 156' ' ' TRP . 60.3 mt -34.66 140.06 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.951 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.518 HG21 ' CE2' ' A' ' 154' ' ' PHE . 27.6 m -67.66 165.44 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 p -164.94 158.1 16.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.864 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.94 141.05 1.23 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -40.01 149.86 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.917 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.7 ttp -159.76 148.46 17.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.71 123.36 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.675 HD21 HD11 ' A' ' 104' ' ' ILE . 4.6 pp -135.34 156.55 48.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -77.95 158.72 29.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.852 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.719 HD11 HD12 ' A' ' 150' ' ' LEU . 10.3 mt -118.87 158.64 25.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -91.46 152.04 43.23 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.576 0.703 . . . . 0.0 110.909 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 170.37 16.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 0.0 112.346 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.639 HG13 ' HD2' ' A' ' 126' ' ' PRO . 98.3 t -109.24 138.49 20.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.548 0.69 . . . . 0.0 111.164 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.639 ' HD2' HG13 ' A' ' 125' ' ' VAL . 53.7 Cg_endo -69.76 169.2 19.46 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.323 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 128' ' ' GLY . 11.7 t-160 -42.46 108.84 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.82 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 127' ' ' HIS . . . 35.4 73.62 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.452 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.482 ' HB2' ' CG1' ' A' ' 125' ' ' VAL . 56.1 tp -47.65 124.8 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 110.942 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 131' ' ' ASP . 13.6 pt-20 -37.66 -50.28 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -115.24 160.26 19.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.847 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.549 HD23 ' HD3' ' A' ' 98' ' ' PRO . 14.1 mt -69.03 -60.92 2.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 34' ' ' ARG . 10.3 tp -88.64 135.73 33.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -108.06 91.36 7.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.653 0.74 . . . . 0.0 110.897 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.76 -10.41 28.49 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.8 mm -95.61 -16.62 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.449 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -41.46 148.17 0.36 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 m -65.3 166.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 66.6 p -108.96 154.67 21.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.139 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.02 135.93 8.27 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.492 ' CB ' ' HB2' ' A' ' 120' ' ' LEU . 88.2 p -51.12 120.41 4.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.893 0.377 . . . . 0.0 110.837 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 144' ' ' ASN . 0.7 OUTLIER -50.05 132.15 22.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.644 0.735 . . . . 0.0 110.881 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.0 11.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.688 2.259 . . . . 0.0 112.363 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 146' ' ' GLU . 23.4 t-20 -49.25 143.89 5.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -97.6 -32.49 11.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.447 ' N ' ' OD1' ' A' ' 144' ' ' ASN . 11.9 pt-20 -84.3 34.56 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.5 p -118.26 155.2 51.91 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.516 0.674 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 137.19 34.7 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.693 2.262 . . . . 0.0 112.308 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 8.3 t -120.69 131.68 54.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.719 HD12 HD11 ' A' ' 122' ' ' LEU . 6.4 mt -107.23 140.06 40.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -109.12 123.91 49.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.781 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -135.08 161.21 35.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -121.18 123.88 43.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.619 ' CE2' HD21 ' A' ' 152' ' ' LEU . 25.6 m-85 -91.23 116.13 28.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.61 152.21 51.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.848 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.689 ' CH2' HD22 ' A' ' 113' ' ' LEU . 5.3 m95 -137.47 107.97 6.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.497 ' CG ' ' N ' ' A' ' 158' ' ' SER . 16.2 p90 -90.28 -46.65 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.497 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 26.9 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.5 t -64.65 135.69 56.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.874 0.369 . . . . 0.0 110.811 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.4 p -61.4 111.92 1.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.57 -102.1 0.16 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.6 t -159.96 145.83 15.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 0.0 110.874 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.3 p -43.3 130.73 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -47.05 -63.61 3.16 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -88.99 123.73 33.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -128.21 -33.65 2.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -118.77 126.15 51.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.669 HD13 ' CH2' ' A' ' 156' ' ' TRP . 12.4 tp -84.15 144.1 29.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.601 ' H ' HD12 ' A' ' 11' ' ' LEU . 23.5 ptt180 -146.95 139.07 24.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.6 mt -141.28 127.65 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HB2' ' CD2' ' A' ' 63' ' ' TRP . 25.8 tttp -103.24 120.35 40.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 mm -83.08 145.99 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.06 -73.0 0.67 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.1 p -172.96 169.17 4.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.401 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -113.97 158.1 21.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.6 t -137.04 151.99 49.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 58.85 32.76 22.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 22' ' ' ASN . 4.7 t -63.96 166.5 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.136 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.518 ' N ' HG12 ' A' ' 21' ' ' VAL . 14.5 t30 -84.56 38.69 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 23' ' ' VAL . 18.1 m -93.76 62.42 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -72.44 -73.38 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.52 HD12 ' H ' ' A' ' 27' ' ' ASP . 2.7 pp -56.79 169.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.154 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.1 mmm-85 -120.54 48.58 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' H ' HD12 ' A' ' 25' ' ' ILE . 37.5 m-20 -111.01 -40.66 4.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.6 mt -44.76 142.53 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -85.27 -56.38 3.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -148.09 179.69 7.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 55' ' ' CYS . 7.7 pt -139.79 170.15 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.151 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -170.79 150.64 3.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.566 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 9.3 t -102.49 151.94 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.174 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -130.86 116.65 18.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 48.8 p -104.57 170.31 7.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.185 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.98 146.5 4.96 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.47 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 78' ' ' ARG . 3.6 mp -104.12 135.95 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.86 0.362 . . . . 0.0 111.127 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 35.4 m-85 -129.07 149.18 51.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.802 ' CB ' HD11 ' A' ' 44' ' ' LEU . 5.8 t-160 -123.05 98.45 5.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.74 44.29 39.42 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.446 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.92 29.68 72.47 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.442 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -139.48 140.78 26.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 0.0 110.861 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 142.78 48.78 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.712 2.275 . . . . 0.0 112.323 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.802 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.1 mp -110.49 -34.91 6.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 p -152.72 163.09 40.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -47.84 151.49 0.89 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -80.21 140.25 36.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.657 HG12 HD11 ' A' ' 64' ' ' LEU . 74.4 t -104.7 132.67 50.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -118.81 161.31 20.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.8 t -107.4 160.49 15.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -46.85 154.49 0.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.05 136.72 37.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.488 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -144.23 152.12 53.4 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.663 0.745 . . . . 0.0 111.086 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 139.89 41.26 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.696 2.264 . . . . 0.0 112.37 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.518 ' HB2' HG11 ' A' ' 23' ' ' VAL . 24.9 p -51.03 -44.15 60.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.1 m -53.49 -35.52 60.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -132.53 83.96 52.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.719 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.539 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.79 3.27 2.88 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.688 2.259 . . . . 0.0 112.342 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.4 ttp180 -49.94 113.15 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.566 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 6.2 m-90 -106.41 -48.83 3.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 60' ' ' TRP . 6.8 m-80 36.61 49.72 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -121.38 146.54 46.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.417 ' CD2' ' HB2' ' A' ' 14' ' ' LYS . 59.5 m95 -87.71 100.05 12.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.657 HD11 HG12 ' A' ' 48' ' ' VAL . 12.2 tp -84.39 119.27 24.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -95.07 137.79 33.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -107.75 127.56 53.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -79.4 50.41 1.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.1 pp -118.5 163.4 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.616 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.57 112.23 22.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.64 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.5 mp -48.68 -52.42 45.15 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.661 0.743 . . . . 0.0 111.148 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.3 Cg_endo -69.8 2.84 3.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.514 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.1 t70 -129.29 1.82 5.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.6 118.61 71.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.627 0.727 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.532 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.8 Cg_endo -69.81 136.92 34.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.65 2.233 . . . . 0.0 112.341 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 23.2 mmt85 -54.47 -36.1 63.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.39 -35.61 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.075 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -64.26 166.25 8.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.106 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 37' ' ' ILE . 16.2 ptt180 -162.18 174.46 12.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.0 tp -94.87 134.35 37.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 58.0 m -132.28 132.66 43.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.56 155.15 50.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.727 ' OG ' HD12 ' A' ' 133' ' ' LEU . 7.6 m -157.62 127.42 6.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 mt -83.48 140.03 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 63.7 m -136.11 149.68 48.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.402 ' HA ' HG22 ' A' ' 31' ' ' ILE . 87.9 p -106.6 120.44 41.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.826 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 86' ' ' VAL . 7.6 p -102.55 115.43 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.143 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 87' ' ' LYS . 1.4 tmmt? -128.13 132.92 48.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.49 -145.33 5.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.474 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.6 mtt180 -131.07 136.4 48.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.875 0.369 . . . . 0.0 110.879 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -47.23 129.19 12.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.927 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.58 -41.57 3.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.514 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.98 177.53 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.848 0.356 . . . . 0.0 111.114 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.51 154.1 41.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -115.93 -174.83 2.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -136.07 120.94 18.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.863 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.566 ' CD2' HG23 ' A' ' 86' ' ' VAL . 9.4 m170 -96.98 135.98 38.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.2 t -137.03 131.94 18.04 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.576 0.703 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.469 ' HB2' HG11 ' A' ' 125' ' ' VAL . 53.4 Cg_endo -69.79 151.93 69.04 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.682 2.255 . . . . 0.0 112.319 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 98' ' ' PRO . 29.5 mt -127.82 -53.36 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.923 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.04 164.89 32.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.084 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.532 ' O ' ' CE3' ' A' ' 101' ' ' TRP . 58.9 p-90 -146.94 129.2 15.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.53 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -131.33 129.29 5.66 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.469 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -106.75 126.84 52.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.816 0.341 . . . . 0.0 110.862 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.565 HG12 HD21 ' A' ' 120' ' ' LEU . 62.2 mt -118.51 124.03 72.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -66.21 96.12 0.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.5 mt -37.92 -45.49 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.558 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 67.7 m-85 -94.42 114.81 26.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -48.06 174.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -60.67 -19.03 57.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.476 HG23 ' HB ' ' A' ' 112' ' ' THR . 5.9 t -94.57 12.45 27.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.131 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 65.97 37.75 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.476 ' HB ' HG23 ' A' ' 110' ' ' THR . 4.5 m -136.77 121.68 18.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.164 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.123 HD22 ' CH2' ' A' ' 156' ' ' TRP . 23.2 mt -34.69 146.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.537 HG23 ' CG ' ' A' ' 154' ' ' PHE . 23.4 m -75.31 175.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.144 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.6 p -167.15 161.42 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.795 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.1 136.6 0.64 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HE2' ' CD ' ' A' ' 151' ' ' GLU . 38.7 tttt -42.77 146.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.727 0.298 . . . . 0.0 110.917 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.429 ' O ' HD13 ' A' ' 152' ' ' LEU . 17.3 ttp -154.61 148.21 25.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.63 117.17 11.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.126 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.565 HD21 HG12 ' A' ' 104' ' ' ILE . 4.3 pp -129.72 161.88 29.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.934 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.552 ' O ' HD12 ' A' ' 120' ' ' LEU . 10.8 m120 -82.05 158.48 23.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.717 HD11 HD12 ' A' ' 150' ' ' LEU . 11.5 mt -117.31 144.85 44.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.487 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 49.8 m95 -70.35 152.01 95.63 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 0.0 110.943 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 170.27 16.9 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 0.0 112.352 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 98' ' ' PRO . 76.9 t -109.87 110.01 59.2 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.656 0.741 . . . . 0.0 111.104 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 161.43 45.96 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 0.0 112.343 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.699 ' CD2' ' N ' ' A' ' 128' ' ' GLY . 14.7 p-80 -65.64 -52.87 48.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.858 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.699 ' N ' ' CD2' ' A' ' 127' ' ' HIS . . . -45.12 -66.92 1.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.447 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 128' ' ' GLY . 12.7 tp -34.63 110.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 110.896 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -101.37 56.32 0.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -158.66 150.49 21.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 53.2 mt -76.97 -49.01 16.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.727 HD12 ' OG ' ' A' ' 82' ' ' SER . 20.3 tp -99.32 128.64 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -108.48 91.51 8.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.679 0.752 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.484 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.76 -43.92 2.38 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.711 2.274 . . . . 0.0 112.391 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 137' ' ' GLY . 45.2 mt -65.11 -28.72 45.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -35.01 151.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -60.68 176.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 0.0 111.15 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.7 p -122.05 169.11 11.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.112 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 104.79 166.32 24.28 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 142' ' ' ASN . 6.3 p -88.32 94.19 9.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.675 HD21 ' ND2' ' A' ' 144' ' ' ASN . 10.3 t30 -37.09 133.33 0.71 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.657 0.742 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' ASN . 54.0 Cg_endo -69.66 -48.67 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.717 2.278 . . . . 0.0 112.361 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.675 ' ND2' HD21 ' A' ' 142' ' ' ASN . 2.3 m-20 -37.12 126.38 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -86.69 -27.22 23.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -60.46 -34.74 74.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.5 p -66.36 151.02 96.58 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.591 0.71 . . . . 0.0 111.168 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 159.48 53.24 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.726 2.284 . . . . 0.0 112.324 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 t -135.51 137.36 42.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.835 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 122' ' ' LEU . 10.4 mt -109.21 138.12 46.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.41 ' CD ' ' HE2' ' A' ' 117' ' ' LYS . 34.7 tt0 -105.67 126.46 52.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.759 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -136.09 159.52 41.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.948 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -115.61 123.96 49.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.759 ' CE2' HD21 ' A' ' 152' ' ' LEU . 35.4 m-85 -92.13 118.17 30.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.599 ' C ' ' CD1' ' A' ' 156' ' ' TRP . 1.3 m-20 -143.48 158.23 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 1.123 ' CH2' HD22 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -153.16 112.78 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.524 ' CG ' ' N ' ' A' ' 158' ' ' SER . 28.9 p90 -101.28 -53.27 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.579 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 1.9 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.889 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.7 p -146.65 122.66 10.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.8 t -115.63 -49.93 2.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.53 -76.16 1.73 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.0 t -112.76 131.83 55.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.856 0.36 . . . . 0.0 110.851 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.8 p -69.06 -178.48 1.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.828 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.06 -117.84 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.522 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 10' ' ' ALA . 2.2 t30 -79.18 175.8 10.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.1 m -130.17 -43.84 1.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.522 ' O ' ' ND2' ' A' ' 8' ' ' ASN . . . -114.19 139.45 49.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.09 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 12' ' ' ARG . 6.0 tp -95.89 137.15 35.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.607 ' N ' HD12 ' A' ' 11' ' ' LEU . 9.1 ttp180 -136.71 132.42 34.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.46 HG23 HD23 ' A' ' 152' ' ' LEU . 52.0 mt -138.28 137.31 44.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.193 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -116.85 128.84 55.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 mm -91.34 140.14 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.426 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.0 mm? -98.04 -71.19 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.4 p -171.06 -179.54 2.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -123.35 164.57 18.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.2 t -135.5 150.87 49.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 50.83 52.41 15.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 22' ' ' ASN . 21.5 t -74.27 165.81 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.585 ' N ' HG12 ' A' ' 21' ' ' VAL . 1.8 t-20 -89.11 36.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 23' ' ' VAL . 21.9 m -101.37 93.05 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.132 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -96.92 -70.7 0.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.564 HD11 HG13 ' A' ' 28' ' ' ILE . 2.8 pp -50.72 168.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.403 ' CD ' ' N ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -120.63 61.88 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 25' ' ' ILE . 10.2 t70 -129.41 -33.94 1.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.564 HG13 HD11 ' A' ' 25' ' ' ILE . 24.0 mt -49.62 127.7 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.113 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.54 -64.93 0.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -142.06 179.85 6.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 85' ' ' SER . 6.2 pt -136.81 178.25 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 2.3 p90 -172.95 159.55 4.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 60.3 t -118.53 148.98 21.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.462 ' O ' HD13 ' A' ' 133' ' ' LEU . 25.6 ttm180 -124.82 120.69 32.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.8 p -113.7 166.43 11.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.141 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.74 154.98 8.97 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.574 HD13 HG21 ' A' ' 68' ' ' ILE . 3.8 mp -102.49 144.73 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.867 0.365 . . . . 0.0 111.13 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.511 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 53.4 m-85 -139.16 153.13 47.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.814 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.8 t-160 -130.18 101.84 5.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.876 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.87 24.26 76.86 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.13 -35.49 4.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.519 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -79.34 138.93 55.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.607 0.718 . . . . 0.0 110.885 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.473 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.8 Cg_endo -69.81 165.31 31.46 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.629 2.219 . . . . 0.0 112.328 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 43' ' ' PRO . 11.0 mp -122.83 -39.88 2.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.0 p -146.84 161.18 41.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -47.84 155.13 0.44 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -84.73 142.84 29.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.653 HG11 ' HG ' ' A' ' 64' ' ' LEU . 83.5 t -99.78 134.56 38.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -119.84 140.59 50.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 t -97.82 163.55 12.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -51.12 162.39 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.52 123.01 35.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 58' ' ' PRO . 2.3 m -119.6 152.29 53.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 0.0 111.142 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 132.79 24.14 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.341 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 4.5 p -44.58 -46.9 10.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 m -49.75 -34.9 20.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.883 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -134.72 87.42 31.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.579 0.704 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.583 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.8 Cg_endo -69.77 3.57 2.7 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.681 2.254 . . . . 0.0 112.334 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.435 ' CG ' HD22 ' A' ' 61' ' ' ASN . 30.8 ttp180 -54.1 110.98 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.882 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.583 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.0 m-90 -97.91 -60.58 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.435 HD22 ' CG ' ' A' ' 59' ' ' ARG . 32.6 m-80 48.07 50.38 16.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -121.58 141.08 51.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -82.95 101.2 10.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.653 ' HG ' HG11 ' A' ' 48' ' ' VAL . 10.0 tp -92.29 114.86 27.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -97.91 139.65 33.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.928 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -105.96 138.66 41.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -83.8 32.5 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.574 HG21 HD13 ' A' ' 37' ' ' ILE . 1.9 pp -99.8 164.25 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.618 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.26 123.63 47.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.616 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -56.92 -53.8 61.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.6 0.714 . . . . 0.0 111.112 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.79 2.14 3.82 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.641 2.227 . . . . 0.0 112.323 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.516 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 7.0 t0 -124.99 -9.58 7.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.522 HD13 ' HD2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -75.34 114.46 35.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.697 . . . . 0.0 110.94 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.561 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.78 145.42 57.0 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.692 2.261 . . . . 0.0 112.31 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -57.01 -45.74 82.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.814 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -52.27 -35.53 50.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -65.75 156.32 33.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.428 ' HG3' ' C ' ' A' ' 77' ' ' ALA . 88.0 mtt180 -152.76 172.47 16.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.4 tp -93.74 133.04 37.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.5 m -127.64 134.51 49.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.26 154.72 46.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.589 ' OG ' HD12 ' A' ' 133' ' ' LEU . 99.8 p -158.86 131.33 6.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.56 HG12 HD11 ' A' ' 150' ' ' LEU . 22.6 mt -80.59 141.98 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 87.7 m -135.77 149.16 49.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.613 ' OG ' HD11 ' A' ' 99' ' ' LEU . 71.9 m -115.02 120.32 39.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.508 ' CG2' ' HB3' ' A' ' 94' ' ' GLU . 6.1 p -105.21 137.8 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 tptt -130.03 114.25 15.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.61 -179.78 27.57 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 23.7 mmt180 -128.65 -176.64 3.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.864 0.364 . . . . 0.0 110.879 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.87 -70.76 0.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.863 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -111.63 23.31 17.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.488 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -98.48 157.51 16.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.852 0.358 . . . . 0.0 111.081 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.4 pttm -71.05 147.11 48.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.508 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 24.1 mt-10 -103.28 144.87 30.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -120.2 120.29 35.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 5.0 m170 -93.81 145.5 24.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.7 t -152.53 126.34 4.35 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.585 0.707 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 155.0 67.05 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.294 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.802 ' O ' HG23 ' A' ' 125' ' ' VAL . 15.4 mt -128.51 -53.09 1.26 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.933 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.46 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -137.16 152.35 49.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.598 ' CH2' HG22 ' A' ' 138' ' ' VAL . 64.1 p-90 -134.06 127.37 32.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.913 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.609 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -129.48 129.45 6.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.499 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.453 ' HB3' HG22 ' A' ' 139' ' ' THR . 23.6 m-20 -112.53 124.75 53.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.883 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.653 HG12 HD21 ' A' ' 120' ' ' LEU . 11.7 mt -119.39 132.5 69.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.181 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -74.84 96.89 3.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.9 mt -36.49 -39.99 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -99.84 117.36 34.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.92 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -57.02 -174.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -76.2 6.39 5.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.95 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 31.1 p -126.54 18.6 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 58.45 30.05 19.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 94.4 m -117.49 103.52 10.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.543 HD22 ' CH2' ' A' ' 156' ' ' TRP . 24.0 mt -34.7 135.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.4 m -70.05 157.46 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.6 t -156.15 173.46 16.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.89 142.99 0.18 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.485 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 9.3 ttpt -44.6 148.75 0.46 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.801 0.334 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.437 ' O ' HD13 ' A' ' 152' ' ' LEU . 31.8 ttp -159.69 147.86 17.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.421 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.73 122.23 16.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.109 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.653 HD21 HG12 ' A' ' 104' ' ' ILE . 4.4 pp -132.3 155.37 48.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -75.66 152.17 37.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.882 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.775 HD11 HD12 ' A' ' 150' ' ' LEU . 10.6 mt -115.81 148.87 39.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.501 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 21.0 m95 -78.38 147.44 72.2 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.553 0.692 . . . . 0.0 110.943 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.44 ' O ' ' NE1' ' A' ' 101' ' ' TRP . 53.0 Cg_endo -69.8 173.57 10.81 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.682 2.255 . . . . 0.0 112.324 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 99' ' ' LEU . 85.4 t -88.75 134.04 34.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.581 0.705 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 125' ' ' VAL . 53.8 Cg_endo -69.72 -165.27 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.703 2.269 . . . . 0.0 112.353 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 127' ' ' HIS . 14.2 p80 -92.83 119.54 32.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.86 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.24 85.83 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.507 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 39.8 tp -130.45 100.42 5.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.773 0.321 . . . . 0.0 110.926 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -66.02 -60.94 2.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -53.87 138.71 35.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.452 HD12 ' NH1' ' A' ' 34' ' ' ARG . 25.7 mt -73.82 -48.68 29.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.589 HD12 ' OG ' ' A' ' 82' ' ' SER . 12.2 tp -96.59 135.66 38.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.958 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -105.84 91.39 5.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.639 0.733 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.511 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.77 -33.28 16.85 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.673 2.249 . . . . 0.0 112.349 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.41 -20.81 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -42.75 153.86 0.19 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.503 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.598 HG22 ' CH2' ' A' ' 101' ' ' TRP . 6.3 m -62.95 158.17 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.371 . . . . 0.0 111.129 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.453 HG22 ' HB3' ' A' ' 103' ' ' ASN . 20.0 p -104.19 165.39 11.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.67 169.37 25.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.48 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 142' ' ' ASN . 24.4 p -88.08 102.35 14.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.859 0.361 . . . . 0.0 110.893 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.55 HD21 HG21 ' A' ' 147' ' ' THR . 56.5 t-20 -34.4 120.48 0.54 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.618 0.723 . . . . 0.0 110.873 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -1.93 9.35 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.709 2.273 . . . . 0.0 112.379 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -85.34 135.02 34.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt -85.49 -50.5 7.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -42.82 -52.64 4.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.55 HG21 HD21 ' A' ' 142' ' ' ASN . 45.7 p -48.28 150.22 2.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.622 0.725 . . . . 0.0 111.113 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 158.87 55.38 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.656 2.237 . . . . 0.0 112.299 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 7.7 t -135.54 138.39 43.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.775 HD12 HD11 ' A' ' 122' ' ' LEU . 6.1 mt -109.28 142.02 40.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.436 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 9.9 tt0 -110.02 123.54 49.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.783 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -131.06 164.44 25.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.454 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 59.6 mt-10 -123.85 117.69 25.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.457 ' CE2' HD21 ' A' ' 152' ' ' LEU . 31.6 m-85 -82.39 104.35 12.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.844 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -112.35 143.78 42.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.543 ' CH2' HD22 ' A' ' 113' ' ' LEU . 12.8 m95 -134.67 88.05 2.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.977 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 158' ' ' SER . 11.8 p90 -90.05 -41.53 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.82 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.468 ' HB2' ' ND2' ' A' ' 8' ' ' ASN . 30.4 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 p -140.06 168.28 20.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.839 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -101.34 -43.37 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.865 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.27 -72.4 0.18 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.707 ' HB2' HG23 ' A' ' 112' ' ' THR . 39.4 t -43.95 -49.25 8.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.853 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 t -92.34 98.58 11.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.85 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.82 44.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.524 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -136.48 163.41 30.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.882 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.475 ' H ' ' CB ' ' A' ' 158' ' ' SER . 1.7 m -132.64 -43.37 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' H ' ' CB ' ' A' ' 158' ' ' SER . . . -120.56 135.09 55.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.767 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 12.4 tp -94.42 145.3 24.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.588 ' H ' HD12 ' A' ' 11' ' ' LEU . 27.4 ptt180 -147.53 141.69 26.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.543 HD12 ' CE1' ' A' ' 66' ' ' TYR . 21.7 mt -141.13 140.82 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -115.24 136.81 52.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mm -98.58 141.69 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.44 -71.99 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.9 p -169.1 172.95 7.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.447 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -121.53 164.09 17.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.072 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -145.35 156.31 43.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.156 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 58.87 35.07 24.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.607 HG12 ' N ' ' A' ' 22' ' ' ASN . 39.7 t -66.93 165.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.153 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.607 ' N ' HG12 ' A' ' 21' ' ' VAL . 9.3 m120 -85.57 51.81 2.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.941 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.0 107.09 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -109.71 -74.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.415 ' C ' HD12 ' A' ' 25' ' ' ILE . 2.8 pp -65.33 167.79 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.458 ' N ' ' HD3' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -112.77 74.63 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -134.98 -46.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.841 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.4 mt -38.5 123.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -68.26 -61.75 1.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.892 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -148.18 174.52 11.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -132.49 -179.72 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.098 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -169.74 173.58 6.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.572 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 94.0 t -124.97 146.2 31.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.798 ' NH1' HD12 ' A' ' 132' ' ' LEU . 17.9 ttt180 -129.67 117.31 20.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 81' ' ' LEU . 70.1 p -115.8 175.67 5.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.104 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.44 146.34 4.5 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.516 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.51 ' CG2' ' HB1' ' A' ' 77' ' ' ALA . 2.3 mp -90.04 140.82 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 111.173 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.567 ' CD2' ' HB3' ' A' ' 135' ' ' PRO . 37.8 m-85 -137.64 134.04 35.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.558 ' HB3' HD11 ' A' ' 44' ' ' LEU . 8.0 t-160 -127.19 105.39 8.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.868 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.1 56.16 3.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.489 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.75 37.84 28.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.466 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -154.12 142.71 14.48 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.678 0.751 . . . . 0.0 110.886 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.454 ' HB3' ' CE2' ' A' ' 38' ' ' TYR . 53.3 Cg_endo -69.8 165.96 29.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.654 2.236 . . . . 0.0 112.33 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 39' ' ' HIS . 8.6 mp -119.96 -40.25 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 16.2 p -145.94 165.3 29.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -51.06 128.17 20.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -59.9 143.55 51.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.696 HG12 HD11 ' A' ' 64' ' ' LEU . 56.3 t -104.14 133.41 48.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.155 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.31 140.34 49.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.8 t -96.58 153.13 18.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -41.72 161.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 68.1 mtm-85 -89.33 146.09 24.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -140.81 152.14 64.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.635 0.731 . . . . 0.0 111.155 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 135.88 31.47 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.719 2.279 . . . . 0.0 112.338 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 8.0 p -46.2 -48.53 17.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -47.76 -36.53 11.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -132.93 87.05 41.39 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.63 0.728 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.597 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 54.0 Cg_endo -69.74 3.09 2.96 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.68 2.253 . . . . 0.0 112.359 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.423 ' CD ' HD21 ' A' ' 61' ' ' ASN . 20.2 ttt85 -57.18 125.82 24.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.832 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.597 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 5.2 m-90 -108.83 -57.42 2.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.937 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.423 HD21 ' CD ' ' A' ' 59' ' ' ARG . 3.4 m-20 49.28 53.19 13.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -128.23 143.54 51.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -87.64 104.68 16.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.696 HD11 HG12 ' A' ' 48' ' ' VAL . 11.6 tp -90.06 121.08 31.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -97.47 136.73 37.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' CE1' HD12 ' A' ' 13' ' ' ILE . 55.3 m-85 -106.2 129.28 54.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.08 44.25 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.891 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 11' ' ' LEU . 2.2 pp -111.29 164.17 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.119 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.623 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.95 120.07 38.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.631 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -55.61 -52.8 68.97 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.614 0.721 . . . . 0.0 111.153 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.82 2.98 3.07 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.726 2.284 . . . . 0.0 112.325 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 1.8 t70 -126.08 -7.15 6.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.677 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -77.99 114.84 45.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.588 0.709 . . . . 0.0 110.917 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.612 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.2 Cg_endo -69.72 139.25 39.9 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.725 2.283 . . . . 0.0 112.331 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.49 ' NE ' ' OD1' ' A' ' 111' ' ' ASP . 74.6 mmt-85 -50.23 -40.39 47.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -54.71 -43.67 72.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.068 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.677 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -53.13 154.22 3.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.448 ' HD2' HG21 ' A' ' 139' ' ' THR . 43.6 mtm180 -151.25 170.75 18.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.7 tp -93.94 133.23 37.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 61.1 m -132.73 142.73 49.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.636 ' HB3' HG22 ' A' ' 35' ' ' THR . 1.9 pp -148.71 157.6 43.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.3 p -157.92 131.1 7.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 29.0 mt -85.65 126.22 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.151 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 28.6 m -124.22 151.03 44.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.0 p -107.54 127.7 53.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.635 HG23 ' CD2' ' A' ' 96' ' ' HIS . 2.6 p -105.58 132.53 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.0 tptp -153.16 135.21 14.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.44 174.94 38.05 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.507 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 161.79 17.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.7 mmmt -55.92 135.28 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.21 -42.4 3.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.5 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.72 168.54 16.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.834 0.35 . . . . 0.0 111.089 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -82.98 166.5 18.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HB3' HG22 ' A' ' 86' ' ' VAL . 26.0 mt-10 -88.82 179.01 6.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -138.85 114.5 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.859 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.635 ' CD2' HG23 ' A' ' 86' ' ' VAL . 4.5 m170 -94.34 130.62 40.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.9 t -131.94 127.3 21.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.583 0.706 . . . . 0.0 110.887 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 150.4 67.86 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.633 2.222 . . . . 0.0 112.336 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.0 mt -123.87 -50.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.88 179.36 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.597 ' HD1' HG12 ' A' ' 125' ' ' VAL . 64.6 p-90 -158.22 130.79 7.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.954 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.33 133.43 6.57 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.44 ' CB ' HG22 ' A' ' 139' ' ' THR . 1.2 m-20 -115.39 132.55 56.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.771 0.32 . . . . 0.0 110.914 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.31 124.84 73.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.15 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 106' ' ' LEU . 4.9 m120 -64.66 89.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 105' ' ' ASN . 16.0 mt -34.66 -40.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.433 ' HE2' HD12 ' A' ' 73' ' ' LEU . 94.8 m-85 -105.25 112.51 25.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -52.13 173.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -55.33 -35.59 65.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.2 t -87.78 27.55 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.49 ' OD1' ' NE ' ' A' ' 75' ' ' ARG . 8.4 t0 47.83 52.46 12.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.707 HG23 ' HB2' ' A' ' 5' ' ' SER . 97.2 m -139.16 108.71 6.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.133 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.961 HD22 ' CH2' ' A' ' 156' ' ' TRP . 20.3 mt -34.94 133.21 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.505 HG23 ' CG ' ' A' ' 154' ' ' PHE . 26.4 m -63.43 171.71 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.7 m -162.85 175.53 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.04 153.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.496 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.444 ' HE3' ' CG ' ' A' ' 153' ' ' GLU . 20.0 ttmt -58.73 148.07 30.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.76 0.314 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.409 ' O ' HD13 ' A' ' 152' ' ' LEU . 41.1 ttp -154.67 151.86 29.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.908 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.84 128.5 26.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.117 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 pp -139.87 162.48 35.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -87.52 150.52 23.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.664 HD11 HD12 ' A' ' 150' ' ' LEU . 2.8 mt -108.17 155.41 20.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.573 ' CH2' ' HD2' ' A' ' 143' ' ' PRO . 7.3 m95 -90.94 141.54 26.72 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.61 0.719 . . . . 0.0 110.881 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 136.01 31.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.353 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.597 HG12 ' HD1' ' A' ' 101' ' ' TRP . 3.5 m -75.0 137.15 72.81 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.619 0.723 . . . . 0.0 111.111 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 159.5 53.22 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 0.0 112.362 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -58.65 -55.5 34.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . -44.27 -64.08 2.14 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.536 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.585 HD23 ' HB ' ' A' ' 125' ' ' VAL . 35.4 tp -33.56 126.67 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -109.06 -36.58 6.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.54 -175.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.798 HD12 ' NH1' ' A' ' 34' ' ' ARG . 12.1 mt -105.04 -51.53 3.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.528 HD23 ' CE1' ' A' ' 38' ' ' TYR . 9.7 tp -97.38 145.93 25.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.427 ' HA ' ' HD2' ' A' ' 135' ' ' PRO . 55.2 t-20 -114.38 93.05 30.13 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.638 0.733 . . . . 0.0 110.857 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.567 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.79 -38.68 7.39 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.663 2.242 . . . . 0.0 112.317 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.2 mt -73.02 -20.12 18.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.419 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -45.67 148.36 1.89 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.3 m -62.35 178.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.92 0.39 . . . . 0.0 111.141 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.448 HG21 ' HD2' ' A' ' 78' ' ' ARG . 82.4 p -123.79 157.65 33.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.151 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 111.25 170.91 19.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.473 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 p -84.07 128.93 34.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 144' ' ' ASN . 5.9 t-20 -65.6 132.45 94.99 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.672 0.749 . . . . 0.0 110.892 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.573 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.79 -50.82 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.689 2.259 . . . . 0.0 112.329 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 142' ' ' ASN . 69.1 m-80 -39.01 135.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -89.19 -25.95 21.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -85.19 41.39 0.88 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.8 p -129.55 152.82 80.31 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.582 0.706 . . . . 0.0 111.145 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 137.15 34.66 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.325 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -124.37 146.46 48.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.664 HD12 HD11 ' A' ' 122' ' ' LEU . 5.7 mt -120.95 156.21 32.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -121.62 120.25 34.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.911 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.817 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -127.43 163.65 23.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.95 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.444 ' CG ' ' HE3' ' A' ' 117' ' ' LYS . 49.5 mt-10 -124.59 120.99 33.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.643 ' CE2' HD21 ' A' ' 152' ' ' LEU . 39.2 m-85 -89.31 102.12 14.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -122.6 134.78 54.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.961 ' CH2' HD22 ' A' ' 113' ' ' LEU . 15.7 m95 -120.89 98.01 5.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.597 ' CG ' ' N ' ' A' ' 158' ' ' SER . 12.4 p90 -79.53 -53.38 6.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.85 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.597 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 61.6 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -109.06 -52.87 2.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.931 0.396 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.7 m -77.71 85.51 4.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.887 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.97 70.54 0.1 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.501 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 t -85.64 109.48 18.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.381 . . . . 0.0 110.848 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.7 p -151.64 138.56 19.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.64 -148.25 4.77 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.518 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.413 ' C ' HD13 ' A' ' 70' ' ' ILE . 28.9 m-80 -85.09 152.34 23.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.853 0.358 . . . . 0.0 110.923 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 p -125.17 -34.95 2.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.71 125.19 49.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.108 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.708 HD13 ' CH2' ' A' ' 156' ' ' TRP . 21.0 tp -88.42 142.44 27.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.936 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.466 ' H ' HD12 ' A' ' 11' ' ' LEU . 7.7 ptm180 -149.34 127.56 12.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.9 mt -129.52 138.7 53.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.51 ' HD3' ' CE2' ' A' ' 63' ' ' TRP . 3.3 ttpm? -114.02 129.91 56.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.5 mm -89.51 145.34 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.89 -72.23 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.1 p -169.72 174.8 5.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.99 156.74 34.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.128 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.688 HG23 ' CD2' ' A' ' 20' ' ' TYR . 9.8 t -127.1 163.19 24.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.688 ' CD2' HG23 ' A' ' 19' ' ' THR . 7.8 m-85 53.3 30.81 10.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.906 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.9 t -53.05 144.77 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.126 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -76.87 51.62 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.01 117.0 54.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -122.41 -51.33 1.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.739 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -74.85 172.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.167 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.437 ' N ' ' HD3' ' A' ' 26' ' ' ARG . 0.4 OUTLIER -115.43 50.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' OD1' ' NZ ' ' A' ' 87' ' ' LYS . 23.0 t0 -107.11 -59.44 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' A' ' 27' ' ' ASP . 20.2 mt -36.52 132.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' N ' ' HD3' ' A' ' 87' ' ' LYS . 0.5 OUTLIER -83.34 -52.22 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.857 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -147.52 178.6 8.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 85' ' ' SER . 6.9 pt -138.46 174.83 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.097 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -169.51 155.57 6.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.781 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 58.1 t -111.6 140.28 31.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -113.42 127.53 56.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.883 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.5 p -123.67 169.73 11.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.54 135.54 1.97 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.4 mp -81.9 146.51 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.544 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 44.8 m-85 -140.6 162.89 34.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.593 ' HB2' HD11 ' A' ' 44' ' ' LEU . 3.1 t-160 -132.65 94.3 3.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.53 -32.98 4.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.541 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 162.45 -30.52 0.29 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -91.44 152.64 43.84 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.679 0.752 . . . . 0.0 110.841 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 156.34 63.56 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.737 2.292 . . . . 0.0 112.343 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' A' ' 39' ' ' HIS . 8.9 mp -106.22 -41.39 5.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.9 m -133.8 -67.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -173.42 171.96 3.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.471 ' OD1' HD22 ' A' ' 133' ' ' LEU . 1.0 OUTLIER -105.34 144.51 32.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.642 HG11 ' HG ' ' A' ' 64' ' ' LEU . 43.2 t -110.76 140.24 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.114 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -120.73 144.01 48.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.7 p -94.85 159.68 14.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -49.92 172.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.936 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -100.98 131.79 46.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 1.5 m -136.02 152.17 75.07 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.592 0.71 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 140.18 41.93 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.0 p -50.03 -32.77 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 m -63.13 -31.29 72.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -133.32 81.43 55.64 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.738 . . . . 0.0 110.902 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 3.17 2.91 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.692 2.261 . . . . 0.0 112.343 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -61.42 106.74 0.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.781 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 3.9 m-90 -90.68 -47.24 7.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 39.3 41.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.439 ' C ' ' HG3' ' A' ' 14' ' ' LYS . 5.3 tp10 -114.03 135.82 53.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.51 ' CE2' ' HD3' ' A' ' 14' ' ' LYS . 52.7 m95 -83.73 107.88 16.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.642 ' HG ' HG11 ' A' ' 48' ' ' VAL . 10.0 tp -95.2 121.02 36.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.84 140.12 31.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -107.39 125.43 51.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -78.05 45.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.477 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.0 pp -113.0 164.17 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.612 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.62 124.86 48.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.947 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.575 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -51.89 -55.47 30.09 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.607 0.718 . . . . 0.0 111.134 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.612 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.5 Cg_endo -69.71 2.42 3.52 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.691 2.261 . . . . 0.0 112.401 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.508 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.6 t70 -123.04 -5.69 8.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.862 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' A' ' 74' ' ' PRO . 0.2 OUTLIER -83.6 114.7 55.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.633 0.73 . . . . 0.0 110.939 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.9 Cg_endo -69.7 136.04 32.14 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.694 2.263 . . . . 0.0 112.369 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -49.75 -44.34 48.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.555 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -52.64 -39.17 61.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -64.43 157.84 25.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.094 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -153.02 177.56 10.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.4 tp -93.77 139.38 30.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.598 ' C ' HD23 ' A' ' 81' ' ' LEU . 73.9 m -129.74 145.94 51.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.598 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -154.87 136.83 14.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.7 m -143.84 139.58 29.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.5 mt -88.76 146.84 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.15 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 81.3 m -146.18 153.56 40.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.483 ' HA ' HG22 ' A' ' 31' ' ' ILE . 24.8 m -114.72 122.3 46.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -103.65 127.53 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 29' ' ' ASP . 21.9 tptm -141.45 134.14 28.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.99 -158.52 9.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.511 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.514 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 28.6 mtt180 -133.62 -174.57 3.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -49.25 -74.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -117.1 46.61 1.13 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.51 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -133.99 168.44 18.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 174.32 6.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.81 169.0 8.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -126.98 134.29 50.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.868 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -107.71 125.39 51.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.3 t -129.25 125.89 22.79 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.719 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.469 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.3 Cg_endo -69.79 152.23 69.08 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.643 2.229 . . . . 0.0 112.352 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 98' ' ' PRO . 14.2 mt -123.91 -49.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.941 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.73 174.25 11.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.531 ' CH2' HG22 ' A' ' 138' ' ' VAL . 68.6 p-90 -151.18 134.33 15.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.918 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.8 133.11 5.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.511 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -120.48 130.68 54.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 110.908 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.714 HG12 HD21 ' A' ' 120' ' ' LEU . 14.6 mt -114.22 130.55 68.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.176 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 106' ' ' LEU . 40.5 m-20 -67.28 95.79 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 105' ' ' ASN . 13.7 mt -34.81 -43.15 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 77.8 m-85 -107.24 111.05 23.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 108' ' ' ASP . 34.6 p30 -52.19 -177.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.876 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -56.49 -37.88 70.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.436 ' O ' ' C ' ' A' ' 111' ' ' ASP . 8.9 t -88.73 34.7 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.138 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 110' ' ' THR . 6.7 m-20 35.62 54.75 0.88 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 113' ' ' LEU . 98.1 m -134.28 109.29 8.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.172 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.749 HD22 ' CH2' ' A' ' 156' ' ' TRP . 56.7 mt -34.36 138.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 12.8 m -68.02 165.49 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 37.9 p -159.73 162.86 35.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.1 142.61 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.436 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 7.8 ttpt -47.21 148.71 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.441 ' O ' HD13 ' A' ' 152' ' ' LEU . 26.7 ttp -156.1 151.94 27.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.3 132.56 29.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.714 HD21 HG12 ' A' ' 104' ' ' ILE . 3.6 pp -141.16 154.41 45.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.35 152.13 39.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.638 HD11 HD12 ' A' ' 150' ' ' LEU . 2.5 mt -111.45 141.35 45.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.48 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 23.5 m95 -75.88 152.01 84.55 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.53 0.681 . . . . 0.0 110.925 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 154.0 68.46 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.337 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 98' ' ' PRO . 71.3 t -89.56 125.69 60.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.628 0.727 . . . . 0.0 111.12 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 133.26 25.11 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.647 2.231 . . . . 0.0 112.335 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -48.37 -28.73 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -89.54 60.92 3.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.413 ' CD2' HG13 ' A' ' 125' ' ' VAL . 42.7 tp -140.93 110.57 6.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.756 0.312 . . . . 0.0 110.955 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -76.29 -47.46 23.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -70.52 174.55 5.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 mt -98.91 -59.53 1.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.471 HD22 ' OD1' ' A' ' 47' ' ' ASN . 7.8 tp -80.42 135.83 36.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -106.11 91.27 5.34 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.616 0.722 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.544 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.2 Cg_endo -69.73 -44.81 1.88 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.237 . . . . 0.0 112.366 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 137' ' ' GLY . 44.3 mt -67.61 -28.38 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -36.65 149.13 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.502 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.531 HG22 ' CH2' ' A' ' 101' ' ' TRP . 2.4 m -51.73 168.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.897 0.38 . . . . 0.0 111.155 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.7 p -115.14 168.14 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.131 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 92.78 -168.81 30.65 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.451 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.8 p -96.14 148.53 22.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.382 . . . . 0.0 110.893 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.451 ' OD1' ' C ' ' A' ' 142' ' ' ASN . 0.4 OUTLIER -84.45 138.72 38.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.62 0.724 . . . . 0.0 110.88 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.406 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.72 -48.2 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.679 2.252 . . . . 0.0 112.383 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -40.74 142.14 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -98.2 -31.72 11.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -82.16 40.39 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.0 p -124.21 151.96 66.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.583 0.706 . . . . 0.0 111.115 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 117.23 4.96 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.67 2.247 . . . . 0.0 112.311 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 13.4 t -105.68 137.78 42.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 122' ' ' LEU . 3.4 mt -105.51 162.18 13.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.436 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 27.5 tt0 -129.81 112.43 13.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.836 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -118.35 162.87 17.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.457 ' N ' HD22 ' A' ' 152' ' ' LEU . 14.9 mt-10 -118.74 119.1 33.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.727 ' CE2' HD21 ' A' ' 152' ' ' LEU . 50.2 m-85 -87.58 107.46 18.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.26 155.56 48.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.749 ' CH2' HD22 ' A' ' 113' ' ' LEU . 4.9 m95 -142.48 120.32 11.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.515 ' CG ' ' N ' ' A' ' 158' ' ' SER . 10.1 p90 -110.28 -47.83 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.515 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 8.6 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.7 m -60.31 169.86 1.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 0.0 110.89 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 t -112.38 154.96 24.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.31 152.54 23.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.6 m -91.0 89.66 7.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 m -108.32 122.77 47.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.862 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 8' ' ' ASN . . . -145.82 -68.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 7' ' ' GLY . 1.7 p30 -35.61 135.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.905 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -122.83 -13.77 7.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.453 ' HB3' ' C ' ' A' ' 158' ' ' SER . . . -119.14 151.21 38.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.086 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.749 HD13 ' CH2' ' A' ' 156' ' ' TRP . 14.3 tp -110.79 138.95 46.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.405 ' H ' HD12 ' A' ' 11' ' ' LEU . 25.8 ptt180 -148.34 140.07 23.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.0 mt -135.93 137.78 48.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.159 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttt -110.71 120.81 43.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.6 mm -82.42 141.11 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.26 -72.29 0.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.6 p -172.07 176.79 3.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.7 163.07 20.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.087 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.441 HG23 ' CD2' ' A' ' 20' ' ' TYR . 10.2 t -134.78 163.39 29.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.441 ' CD2' HG23 ' A' ' 19' ' ' THR . 6.3 m-85 39.54 44.6 1.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.94 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 22' ' ' ASN . 86.9 t -66.51 160.94 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.569 ' N ' HG12 ' A' ' 21' ' ' VAL . 2.4 t-20 -82.94 47.19 1.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.432 HG22 ' HB ' ' A' ' 21' ' ' VAL . 4.5 m -124.09 116.75 48.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -116.63 -43.6 2.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.745 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -80.9 -174.61 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.13 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.26 2.73 10.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.36 -55.63 26.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' A' ' 85' ' ' SER . 17.3 mt -45.88 129.17 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.1 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.406 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 21.5 t0 -72.98 -60.56 2.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 26.3 mmtp -147.91 166.56 27.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.8 pt -119.44 169.9 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -163.82 144.56 8.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.621 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 63.2 t -103.03 143.92 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.3 ttm-85 -121.03 122.25 39.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.6 p -116.1 166.91 11.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.73 149.42 6.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.48 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.59 134.89 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 111.148 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 135' ' ' PRO . 47.7 m-85 -133.72 158.33 43.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.481 ' HB3' HD11 ' A' ' 44' ' ' LEU . 6.9 t-160 -131.85 103.37 6.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.858 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.94 17.15 78.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.483 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.558 ' HA2' HD13 ' A' ' 136' ' ' ILE . . . 107.5 -35.48 4.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.457 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.33 142.88 59.17 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.668 0.747 . . . . 0.0 110.885 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.527 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.7 Cg_endo -69.77 166.02 29.02 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.689 2.259 . . . . 0.0 112.338 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.527 HD12 ' C ' ' A' ' 43' ' ' PRO . 10.1 mp -124.89 -41.25 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.0 m -154.39 160.06 41.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.903 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -41.36 151.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -88.82 165.48 14.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.59 HG12 HD11 ' A' ' 64' ' ' LEU . 64.2 t -119.96 133.59 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.155 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -115.38 138.2 51.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.2 t -90.37 159.12 16.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -49.67 174.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -101.89 133.48 46.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.5 m -137.36 152.11 72.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.641 0.734 . . . . 0.0 111.164 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 134.23 27.4 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.706 2.271 . . . . 0.0 112.353 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.6 p -45.48 -44.93 12.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.866 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.8 t -48.66 -40.58 28.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -130.32 86.65 53.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.533 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.3 Cg_endo -69.8 2.97 3.07 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.746 2.297 . . . . 0.0 112.298 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -50.8 109.55 0.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.621 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 1.5 m-90 -99.54 -47.62 5.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 60' ' ' TRP . 3.9 p30 35.25 41.05 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.839 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -114.12 138.19 50.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -83.05 112.33 19.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.59 HD11 HG12 ' A' ' 48' ' ' VAL . 11.1 tp -97.15 119.25 35.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -93.07 140.13 29.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -112.47 128.71 56.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -82.21 40.5 0.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.436 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.0 pp -106.93 164.01 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.614 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -117.0 127.02 53.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.6 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.3 mp -60.01 -54.46 55.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.663 0.744 . . . . 0.0 111.165 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.614 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.74 3.49 2.73 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.657 2.238 . . . . 0.0 112.355 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.494 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.7 t70 -125.46 -7.12 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -82.12 115.72 59.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.608 0.718 . . . . 0.0 110.926 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.6 Cg_endo -69.78 132.75 23.96 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 2.269 . . . . 0.0 112.322 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.491 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 1.6 mpp_? -47.63 -43.62 26.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.403 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -51.87 -39.38 58.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -62.58 167.12 4.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.1 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -162.21 170.87 18.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.3 tp -94.64 133.73 37.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.621 ' C ' HD23 ' A' ' 81' ' ' LEU . 33.6 m -120.26 150.33 40.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -155.69 137.17 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.601 ' OG ' HD12 ' A' ' 133' ' ' LEU . 86.5 p -143.61 133.27 23.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.573 HD11 ' HG ' ' A' ' 150' ' ' LEU . 71.7 mt -84.69 140.78 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.4 p -151.18 160.24 43.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.529 ' HB2' HG21 ' A' ' 28' ' ' ILE . 15.3 p -117.23 156.48 27.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 86' ' ' VAL . 14.8 p -133.77 122.39 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.163 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -126.93 126.73 43.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.22 159.82 29.38 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.515 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' A' ' 89' ' ' ARG . 6.6 mpt_? -109.5 162.75 14.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.912 0.387 . . . . 0.0 110.88 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -57.14 125.66 23.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.885 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.13 -30.36 4.01 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.06 167.84 15.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.1 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.6 pttm -84.63 151.02 24.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -88.28 156.11 19.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -122.57 126.08 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -99.59 134.74 42.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.0 t -135.65 120.31 13.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.611 0.72 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.401 ' HB2' HG11 ' A' ' 125' ' ' VAL . 54.1 Cg_endo -69.79 142.01 46.65 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.664 2.243 . . . . 0.0 112.338 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.57 HD12 HG22 ' A' ' 83' ' ' ILE . 17.8 mt -111.65 -55.65 2.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.881 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.02 176.52 8.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.074 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 61.9 p-90 -152.76 145.09 23.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.891 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -151.83 139.78 7.33 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -117.83 150.3 39.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.784 0.326 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.562 ' CG1' HD21 ' A' ' 120' ' ' LEU . 66.0 mt -138.27 117.91 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 106' ' ' LEU . 12.4 m120 -62.41 96.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.861 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.0 mt -35.15 -40.5 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.491 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 98.1 m-85 -108.56 115.37 29.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -55.64 -176.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.517 ' CD1' HG23 ' A' ' 110' ' ' THR . 13.2 p90 -68.41 -4.41 14.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.517 HG23 ' CD1' ' A' ' 109' ' ' TYR . 10.0 p -109.36 22.47 15.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.154 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 110' ' ' THR . 6.0 p-10 46.61 54.43 8.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.3 m -149.9 120.83 7.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.781 HD22 ' CH2' ' A' ' 156' ' ' TRP . 56.8 mt -40.32 140.81 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.47 HG21 ' CE2' ' A' ' 154' ' ' PHE . 20.3 m -71.3 169.82 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.081 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.6 p -162.86 161.18 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.45 132.73 0.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.497 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.422 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 15.6 ttpt -39.63 148.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.738 0.304 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.472 ' O ' HD13 ' A' ' 152' ' ' LEU . 20.9 ttp -156.2 149.22 24.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.407 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.7 113.66 8.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.562 HD21 ' CG1' ' A' ' 104' ' ' ILE . 4.0 pp -120.89 157.81 29.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -77.67 154.51 32.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mt -114.06 134.12 55.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.507 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 10.7 m95 -74.57 147.37 84.63 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.567 0.699 . . . . 0.0 110.935 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 133.93 26.88 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.251 . . . . 0.0 112.361 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.463 HG12 ' HD1' ' A' ' 101' ' ' TRP . 4.7 m -69.28 140.15 90.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 134.27 27.6 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -51.51 151.41 3.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . 86.76 -41.06 3.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.585 HD11 ' HB2' ' A' ' 131' ' ' ASP . 34.8 tp -34.73 99.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.774 0.321 . . . . 0.0 110.939 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -73.63 -22.67 59.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.585 ' HB2' HD11 ' A' ' 129' ' ' LEU . 70.2 m-20 -74.24 174.59 8.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.1 mt -114.14 -43.36 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.601 HD12 ' OG ' ' A' ' 82' ' ' SER . 13.7 tp -105.59 131.72 52.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -110.3 91.81 12.35 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.647 0.737 . . . . 0.0 110.902 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 38' ' ' TYR . 53.7 Cg_endo -69.79 -28.36 25.2 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.656 2.237 . . . . 0.0 112.335 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.558 HD13 ' HA2' ' A' ' 41' ' ' GLY . 12.2 mm -77.21 -23.58 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.09 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.427 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -36.5 147.77 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.471 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.32 174.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 111.159 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 42.2 p -117.28 172.47 7.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.163 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.33 169.63 42.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.529 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.4 p -87.68 135.99 33.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.917 0.389 . . . . 0.0 110.833 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -76.2 122.36 86.68 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.657 0.742 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -1.33 8.25 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.677 2.252 . . . . 0.0 112.365 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -82.62 129.05 34.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -84.39 -53.53 5.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -40.6 -35.59 0.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.7 p -69.39 151.37 96.85 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.592 0.71 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 160.1 50.96 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.731 2.287 . . . . 0.0 112.348 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 14.5 t -140.09 136.4 33.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.573 ' HG ' HD11 ' A' ' 83' ' ' ILE . 8.7 mt -106.47 152.18 23.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.422 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 14.8 tt0 -120.71 115.66 23.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.835 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -121.06 159.42 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.958 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.406 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 63.5 mt-10 -116.09 122.55 45.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.603 ' CE2' HD21 ' A' ' 152' ' ' LEU . 28.9 m-85 -90.82 112.53 24.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.553 ' C ' ' CD1' ' A' ' 156' ' ' TRP . 6.6 t0 -132.61 159.07 40.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.781 ' CH2' HD22 ' A' ' 113' ' ' LEU . 3.6 m95 -152.17 108.18 3.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.498 ' CG ' ' N ' ' A' ' 158' ' ' SER . 31.5 p90 -102.22 -53.76 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.498 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 16.1 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -156.09 134.38 11.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.361 . . . . 0.0 110.836 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -59.74 178.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.09 164.86 12.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 t 64.67 45.26 3.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 0.0 110.855 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -160.17 149.01 17.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.38 63.4 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.526 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.533 ' OD1' HG21 ' A' ' 70' ' ' ILE . 1.2 p30 -108.67 123.18 48.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.465 ' N ' HD13 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -133.69 -47.13 0.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.818 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.62 133.62 54.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.848 HD13 ' CH2' ' A' ' 156' ' ' TRP . 15.8 tp -83.53 126.96 33.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.575 ' NE ' ' CE3' ' A' ' 63' ' ' TRP . 7.0 ttt180 -124.64 120.38 31.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.419 HD11 HD21 ' A' ' 11' ' ' LEU . 32.4 mt -131.14 141.07 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.159 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 34.8 tttt -122.26 128.66 51.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.0 mm -89.76 149.27 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.159 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.47 -70.63 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.4 p -172.45 -176.82 1.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.951 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.61 146.07 50.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 t -120.15 138.09 53.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.18 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 67.11 45.25 1.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.934 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.552 HG12 ' N ' ' A' ' 22' ' ' ASN . 88.4 t -70.52 160.27 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.552 ' N ' HG12 ' A' ' 21' ' ' VAL . 28.2 m-20 -76.32 51.27 0.69 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.424 HG11 ' HB2' ' A' ' 55' ' ' CYS . 2.1 m -107.85 110.44 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.13 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -104.68 -61.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.9 pt -87.1 -177.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.411 ' N ' ' HD3' ' A' ' 26' ' ' ARG . 1.0 OUTLIER -121.31 49.28 1.53 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.84 -47.36 5.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 mt -41.83 137.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.117 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.52 -57.4 3.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.882 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -147.47 -178.7 6.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' A' ' 53' ' ' VAL . 7.2 pt -139.86 178.02 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 1.2 p90 -173.22 156.61 3.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.57 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 87.3 t -113.75 149.7 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.121 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -122.35 132.78 54.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.1 p -128.52 162.02 28.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.121 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.44 143.32 3.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.442 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 37' ' ' ILE . 3.5 mp -86.72 140.82 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.37 . . . . 0.0 111.136 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.539 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 54.1 m-85 -136.4 145.28 45.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.51 ' CB ' HD11 ' A' ' 44' ' ' LEU . 4.5 t-160 -117.56 94.55 4.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.94 20.95 77.28 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.553 ' HA2' HD13 ' A' ' 136' ' ' ILE . . . 106.15 -26.84 19.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -85.02 141.89 38.11 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.623 0.725 . . . . 0.0 110.85 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 159.87 51.82 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.704 2.269 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.51 HD11 ' CB ' ' A' ' 39' ' ' HIS . 8.9 mp -120.64 -33.54 3.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.94 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.2 m -154.06 165.79 35.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.955 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.64 131.29 29.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.815 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -65.65 153.1 42.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.514 HG12 HD11 ' A' ' 64' ' ' LEU . 40.0 t -114.16 140.34 35.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -121.74 137.75 54.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.1 p -83.88 176.35 8.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -63.99 174.7 1.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.8 mtm180 -102.43 125.98 49.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.833 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -130.28 152.14 79.68 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.619 0.723 . . . . 0.0 111.101 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 142.28 47.46 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.689 2.259 . . . . 0.0 112.347 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.424 ' HB2' HG11 ' A' ' 23' ' ' VAL . 23.4 p -50.58 -48.16 57.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.8 t -47.34 -38.52 13.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -132.03 87.29 44.63 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.552 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.5 Cg_endo -69.78 3.66 2.65 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.709 2.272 . . . . 0.0 112.312 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -55.64 108.35 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.57 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.3 m-90 -93.56 -52.95 4.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 43.31 49.75 5.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -121.19 138.09 54.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.575 ' CE3' ' NE ' ' A' ' 12' ' ' ARG . 77.8 m95 -84.09 108.39 16.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.514 HD11 HG12 ' A' ' 48' ' ' VAL . 9.9 tp -98.2 122.68 41.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -100.87 145.25 28.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -113.5 131.02 56.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -82.71 47.61 1.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.494 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.1 pp -114.26 168.13 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.611 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -115.07 129.86 56.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.612 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -62.84 -53.63 54.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 111.164 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.1 Cg_endo -69.69 -0.95 7.59 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 0.0 112.362 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.509 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.5 t70 -117.64 -13.47 10.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -71.6 114.97 32.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.556 0.693 . . . . 0.0 110.918 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.56 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.0 Cg_endo -69.79 146.37 59.82 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.637 2.225 . . . . 0.0 112.353 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.454 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 21.1 mmt85 -59.22 -41.84 89.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.45 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -55.64 -31.41 62.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.56 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -68.77 167.35 15.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.097 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -163.23 173.73 13.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.5 tp -95.37 142.8 27.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.605 ' C ' HD23 ' A' ' 81' ' ' LEU . 83.0 m -129.82 148.52 51.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -155.32 137.08 14.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.84 ' OG ' HD12 ' A' ' 133' ' ' LEU . 95.3 p -148.92 146.22 27.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.595 ' CG1' HD11 ' A' ' 150' ' ' LEU . 11.4 mt -93.16 143.37 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.176 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 74.7 m -137.85 145.78 42.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.871 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.8 p -109.76 122.56 47.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.714 HG23 ' CD2' ' A' ' 96' ' ' HIS . 12.0 p -105.79 121.63 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -134.64 145.08 48.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 172.69 174.21 39.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.514 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -102.95 170.55 7.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -65.65 -52.69 49.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.21 -2.27 87.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.46 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -118.21 178.04 4.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -91.71 170.31 10.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 9.9 mt-10 -102.62 161.43 13.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -126.61 119.16 26.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.714 ' CD2' HG23 ' A' ' 86' ' ' VAL . 8.1 m170 -98.77 124.16 43.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.74 123.21 15.99 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.866 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 143.03 49.42 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.662 2.241 . . . . 0.0 112.351 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.0 mt -107.63 -45.8 3.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.38 178.18 7.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.518 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 70.0 p-90 -154.33 137.89 15.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.03 138.5 7.79 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.473 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -122.25 140.55 52.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.587 HD11 HD21 ' A' ' 120' ' ' LEU . 56.5 mt -120.97 139.69 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 106' ' ' LEU . 77.7 m-20 -76.69 87.91 3.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 105' ' ' ASN . 21.9 mt -34.49 -36.01 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.454 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 59.0 m-85 -109.67 119.34 39.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -53.1 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.85 6.47 5.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 p -128.76 18.19 6.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.181 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 65.06 29.84 11.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 113' ' ' LEU . 88.2 m -118.68 105.76 11.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 112' ' ' THR . 31.4 mt -36.07 141.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.5 m -70.45 170.35 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.1 m -168.9 164.28 11.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.17 140.72 1.01 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.446 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 38.3 tttt -44.6 149.15 0.42 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.783 0.325 . . . . 0.0 110.915 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.4 ttp -159.89 154.03 23.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.691 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.95 126.67 20.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.587 HD21 HD11 ' A' ' 104' ' ' ILE . 4.1 pp -136.15 153.78 51.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -79.25 158.52 27.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.776 HD11 HD12 ' A' ' 150' ' ' LEU . 1.9 mt -116.4 148.09 41.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.566 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 8.1 m95 -85.51 150.53 54.22 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.571 0.7 . . . . 0.0 110.944 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 138.82 38.71 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.663 2.242 . . . . 0.0 112.391 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.4 m -64.65 141.93 98.38 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.625 0.726 . . . . 0.0 111.124 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 152.92 69.59 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.697 2.265 . . . . 0.0 112.304 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -52.86 152.0 4.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.42 81.15 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.503 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.4 tp -123.08 111.26 16.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.736 0.303 . . . . 0.0 110.923 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -79.12 -53.36 7.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -59.31 158.66 8.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.7 mt -91.93 -46.54 7.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.84 HD12 ' OG ' ' A' ' 82' ' ' SER . 4.8 tp -102.98 139.34 38.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -105.41 91.52 4.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.679 0.752 . . . . 0.0 110.87 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.9 Cg_endo -69.73 -22.76 31.75 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.723 2.282 . . . . 0.0 112.366 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.553 HD13 ' HA2' ' A' ' 41' ' ' GLY . 13.4 mm -82.69 -22.12 9.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.413 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -37.08 153.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.498 HG22 ' CH2' ' A' ' 101' ' ' TRP . 5.7 m -69.5 173.33 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.914 0.388 . . . . 0.0 111.117 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.7 p -115.22 165.25 13.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 99.37 159.68 29.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 57.0 p -75.49 130.48 38.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.957 0.408 . . . . 0.0 110.832 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.566 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 11.2 t-20 -70.84 118.47 65.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.651 0.739 . . . . 0.0 110.914 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 1.98 3.94 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.67 2.246 . . . . 0.0 112.392 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -90.59 116.43 28.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -76.85 -44.19 33.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -49.03 -26.97 2.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 67.9 p -78.82 152.24 77.26 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.558 0.694 . . . . 0.0 111.165 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 146.26 59.48 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.685 2.257 . . . . 0.0 112.363 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.7 t -123.79 148.92 46.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.776 HD12 HD11 ' A' ' 122' ' ' LEU . 5.9 mt -118.96 150.64 39.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.906 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.691 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 5.4 mp0 -112.64 139.92 47.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.727 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -148.6 151.6 35.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.446 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 35.5 mt-10 -119.51 123.11 43.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.727 ' CE2' HD21 ' A' ' 152' ' ' LEU . 62.6 m-85 -85.97 115.06 23.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.09 129.15 49.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.848 ' CH2' HD13 ' A' ' 11' ' ' LEU . 20.7 m95 -124.26 81.55 1.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.5 ' CG ' ' N ' ' A' ' 158' ' ' SER . 43.4 p90 -79.46 -54.47 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.5 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 3.0 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.1 m -119.83 88.78 3.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.873 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m -156.07 146.58 21.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.839 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.52 115.8 4.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 t -75.93 144.24 41.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 0.0 110.83 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.7 m -86.65 -54.09 4.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.899 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 146.31 -130.72 3.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.476 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -62.76 104.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.951 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.409 ' O ' ' CD1' ' A' ' 69' ' ' TYR . 1.8 m -118.63 -34.52 3.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.01 140.36 49.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.122 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.686 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 10.6 tp -103.64 137.49 41.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.563 ' N ' HD12 ' A' ' 11' ' ' LEU . 16.3 ptt180 -145.41 138.37 26.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.843 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.4 mt -138.4 139.14 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 43.8 tttm -114.9 137.06 52.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.8 mm -98.59 144.82 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.71 -67.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.6 p -169.56 175.05 5.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.813 ' HB2' HD23 ' A' ' 150' ' ' LEU . . . -139.1 154.41 48.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.101 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.675 HG23 ' CD2' ' A' ' 20' ' ' TYR . 2.9 t -130.96 162.37 29.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.675 ' CD2' HG23 ' A' ' 19' ' ' THR . 10.0 m-85 64.44 50.13 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 22' ' ' ASN . 3.9 t -83.38 163.61 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 21' ' ' VAL . 25.1 t30 -84.03 35.51 0.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.854 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 23' ' ' VAL . 33.5 m -97.61 93.51 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -106.71 -18.05 14.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -104.35 -177.57 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.8 mmm-85 -129.09 60.19 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -126.31 -32.91 2.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.864 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.0 mt -57.3 118.0 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -73.96 -56.19 5.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -142.06 172.83 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 pt -141.54 161.11 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -151.38 153.57 35.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.745 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 79.3 t -105.48 137.12 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -110.19 120.15 41.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.2 p -117.84 161.21 20.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.171 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.78 143.46 3.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.442 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.713 HG23 ' O ' ' A' ' 78' ' ' ARG . 3.9 mp -96.61 137.05 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 111.191 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.465 ' HA ' ' CD1' ' A' ' 44' ' ' LEU . 2.7 m-85 -128.52 150.18 50.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.957 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.457 ' C ' ' CD2' ' A' ' 39' ' ' HIS . 9.3 t-160 -121.85 99.07 6.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.04 47.23 19.44 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.74 33.83 81.47 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -146.64 143.69 19.18 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.68 0.752 . . . . 0.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 150.17 68.27 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.72 2.28 . . . . 0.0 112.365 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.465 ' CD1' ' HA ' ' A' ' 38' ' ' TYR . 7.8 mp -105.69 -39.37 6.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.889 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 6.0 t -156.28 166.13 34.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.24 124.73 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -61.01 154.09 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.644 HG12 HD11 ' A' ' 64' ' ' LEU . 61.6 t -110.26 137.4 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -119.27 147.91 43.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.5 p -96.18 167.25 11.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -54.15 176.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -105.49 108.98 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -114.26 152.39 45.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.626 0.727 . . . . 0.0 111.128 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 135.65 31.11 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.733 2.289 . . . . 0.0 112.36 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.41 ' HB2' HG11 ' A' ' 23' ' ' VAL . 19.3 p -45.98 -47.26 16.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.888 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.2 m -51.27 -30.21 17.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -133.8 87.78 34.78 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.619 0.723 . . . . 0.0 110.883 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.548 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 2.94 3.09 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.681 2.254 . . . . 0.0 112.333 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -58.47 103.84 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.745 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.3 m-90 -90.71 -46.76 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 60' ' ' TRP . 2.9 p30 39.23 46.99 1.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -120.95 135.86 55.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.461 ' CE3' ' HD2' ' A' ' 12' ' ' ARG . 45.7 m95 -81.35 103.55 11.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.644 HD11 HG12 ' A' ' 48' ' ' VAL . 10.4 tp -90.68 121.44 32.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -101.0 133.37 45.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -100.99 131.68 46.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.2 41.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.828 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.507 HD13 HD23 ' A' ' 73' ' ' LEU . 1.7 pp -112.45 161.89 10.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.603 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -113.54 121.96 45.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -53.42 -54.15 48.56 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.595 0.712 . . . . 0.0 111.104 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.4 Cg_endo -69.7 3.49 2.71 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.677 2.252 . . . . 0.0 112.396 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.5 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 9.5 t0 -125.22 -4.49 7.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.918 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.507 HD23 HD13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -76.1 113.61 29.59 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.622 0.725 . . . . 0.0 110.902 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.651 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.4 Cg_endo -69.77 132.05 22.5 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.704 2.27 . . . . 0.0 112.336 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 11.6 mpt_? -45.46 -42.07 10.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.04 -43.75 78.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.066 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.651 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -55.6 165.02 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.083 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.713 ' O ' HG23 ' A' ' 37' ' ' ILE . 8.2 ptp180 -163.28 173.42 13.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.835 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 tp -93.82 138.31 32.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.2 m -136.23 126.4 26.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.16 161.24 33.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 p -166.53 131.9 2.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 99' ' ' LEU . 17.8 mt -83.91 144.44 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 62.0 m -147.81 155.04 41.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 t -105.89 150.72 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 86' ' ' VAL . 8.4 p -135.93 125.2 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -151.39 134.14 15.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.49 -137.74 2.68 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.486 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 61.1 mtt180 -149.37 166.94 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -63.11 120.28 11.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.22 -29.18 3.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.475 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -89.18 160.67 16.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 0.0 111.114 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 169.42 14.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -106.55 -175.53 2.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -130.21 125.92 36.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -103.46 129.21 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.1 t -137.49 123.78 13.27 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.429 ' HB2' HG21 ' A' ' 125' ' ' VAL . 53.7 Cg_endo -69.79 152.96 69.27 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.673 2.249 . . . . 0.0 112.333 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 125' ' ' VAL . 16.0 mt -126.37 -51.13 1.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.409 ' HB2' ' HG3' ' A' ' 148' ' ' PRO . . . -142.41 -177.58 5.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.511 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 67.5 p-90 -164.44 126.04 2.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.899 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.475 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -131.94 131.42 6.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.402 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -106.85 129.73 54.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 0.0 110.861 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.44 HD11 HD21 ' A' ' 120' ' ' LEU . 76.2 mt -119.34 119.27 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 106' ' ' LEU . 3.0 t-20 -73.25 94.57 2.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 105' ' ' ASN . 41.6 mt -35.14 -35.78 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.488 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 51.3 m-85 -104.39 106.5 17.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.906 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 108' ' ' ASP . 42.5 p30 -54.93 -177.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -57.12 -39.19 74.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.424 HG23 ' OG1' ' A' ' 112' ' ' THR . 10.0 t -86.9 32.14 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.14 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 37.78 54.01 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.424 ' OG1' HG23 ' A' ' 110' ' ' THR . 23.7 m -132.77 116.64 16.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.944 HD22 ' CH2' ' A' ' 156' ' ' TRP . 11.9 mt -44.56 126.62 5.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.604 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 16.3 m -57.51 176.56 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.9 p -173.83 164.11 4.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.18 149.18 0.2 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.472 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 7.5 ttpt -39.55 158.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.485 ' HG2' ' N ' ' A' ' 119' ' ' ALA . 2.8 ttm -156.62 144.96 19.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.485 ' N ' ' HG2' ' A' ' 118' ' ' MET . . . -140.35 106.96 5.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.083 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.477 ' C ' HD12 ' A' ' 120' ' ' LEU . 4.1 pp -126.35 163.53 23.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -92.31 158.53 16.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.511 HD11 HD12 ' A' ' 150' ' ' LEU . 12.0 mt -112.59 156.08 23.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.566 ' CE3' ' OD1' ' A' ' 142' ' ' ASN . 28.0 m95 -86.57 150.64 51.57 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.538 0.685 . . . . 0.0 110.924 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 145.92 58.44 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.699 2.266 . . . . 0.0 112.309 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 99' ' ' LEU . 94.2 t -71.51 126.64 91.67 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.639 0.733 . . . . 0.0 111.121 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -173.86 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.649 2.233 . . . . 0.0 112.314 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -95.05 -35.92 11.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.28 65.85 2.77 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.42 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.411 HD23 HG13 ' A' ' 125' ' ' VAL . 19.4 tp -147.64 126.93 13.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.79 0.329 . . . . 0.0 110.905 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -101.17 -47.11 4.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.854 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.94 144.01 54.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.66 -58.64 5.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.3 tp -84.8 127.53 34.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -104.38 93.53 5.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.614 0.721 . . . . 0.0 110.83 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.443 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.6 Cg_endo -69.74 -17.14 37.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.664 2.243 . . . . 0.0 112.372 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 mm -84.88 -23.15 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.156 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.49 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -38.74 151.85 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 m -64.13 163.82 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.1 p -108.44 151.75 25.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.164 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.62 142.84 8.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 72.5 p -63.11 116.66 5.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.566 ' OD1' ' CE3' ' A' ' 123' ' ' TRP . 32.7 t30 -53.64 130.01 54.8 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.572 0.701 . . . . 0.0 110.93 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -27.03 27.06 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.694 2.263 . . . . 0.0 112.317 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -51.72 144.4 11.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.7 mmtt -99.53 -37.03 9.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -83.26 39.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.2 p -122.85 156.05 62.67 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.57 0.7 . . . . 0.0 111.127 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.409 ' HG3' ' HB2' ' A' ' 100' ' ' ALA . 53.3 Cg_endo -69.77 124.65 11.28 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.704 2.269 . . . . 0.0 112.344 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.443 ' SG ' HG22 ' A' ' 19' ' ' THR . 1.4 p -115.92 150.69 36.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.813 HD23 ' HB2' ' A' ' 18' ' ' ALA . 7.4 mt -128.18 135.3 49.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.96 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.424 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 10.1 tt0 -102.49 125.11 49.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.83 HD13 ' H ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -127.72 169.36 13.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.441 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 26.1 mt-10 -126.4 125.38 42.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.604 ' CZ ' HG21 ' A' ' 114' ' ' VAL . 45.0 m-85 -92.1 119.51 31.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -137.39 137.53 38.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.944 ' CH2' HD22 ' A' ' 113' ' ' LEU . 11.6 m95 -127.84 82.45 2.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.574 ' CG ' ' N ' ' A' ' 158' ' ' SER . 22.0 p90 -85.75 -52.75 5.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.574 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 85.6 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m -150.9 121.33 7.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 110.832 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 t -71.83 95.39 1.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.04 116.06 2.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.463 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.9 p -124.96 -53.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.851 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.8 t -98.37 108.66 21.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.23 132.61 21.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.499 ' HB2' HG21 ' A' ' 70' ' ' ILE . 0.8 OUTLIER -57.84 122.23 12.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.368 . . . . 0.0 110.89 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.06 -46.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.737 ' HB3' ' HB2' ' A' ' 158' ' ' SER . . . -120.07 121.85 39.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.753 HD13 ' CZ3' ' A' ' 156' ' ' TRP . 22.2 tp -85.82 144.99 27.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.61 ' NH2' ' CD1' ' A' ' 157' ' ' PHE . 0.1 OUTLIER -135.71 146.93 48.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.541 HD12 ' CE1' ' A' ' 66' ' ' TYR . 54.4 mt -145.52 121.26 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.581 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 73.8 tttt -103.58 131.37 50.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 mm -94.07 137.59 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.12 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.23 -72.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.4 p -172.01 172.68 4.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.893 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.15 142.33 48.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.035 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.457 HG23 ' CD2' ' A' ' 20' ' ' TYR . 10.9 t -111.57 136.2 51.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.167 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.457 ' CD2' HG23 ' A' ' 19' ' ' THR . 2.6 m-85 65.67 32.94 8.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 22' ' ' ASN . 56.1 t -40.42 161.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.076 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.562 ' N ' HG12 ' A' ' 21' ' ' VAL . 3.2 t-20 -84.53 37.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.438 HG13 ' CG1' ' A' ' 21' ' ' VAL . 21.1 m -78.76 53.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -50.34 -59.46 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 27' ' ' ASP . 3.9 pt -76.64 168.71 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.161 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -120.53 40.84 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.817 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' HB3' HD12 ' A' ' 25' ' ' ILE . 28.3 t70 -109.84 -31.54 7.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.587 HG21 ' HB2' ' A' ' 85' ' ' SER . 7.7 mt -66.86 142.53 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.145 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.45 ' C ' ' HD2' ' A' ' 30' ' ' LYS . 7.4 t70 -115.02 -53.0 2.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HD2' ' C ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -108.1 155.92 19.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.1 pt -141.55 170.34 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CE2' ' ND1' ' A' ' 96' ' ' HIS . 9.6 p90 -163.96 154.44 15.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.726 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 61.7 t -117.71 137.89 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -112.26 140.78 46.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.633 HG22 ' HB3' ' A' ' 81' ' ' LEU . 16.8 p -134.4 177.01 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 158.39 148.78 5.28 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.532 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.487 HG12 HD11 ' A' ' 106' ' ' LEU . 3.6 mp -97.0 132.77 40.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 0.0 111.092 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.512 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 18.8 m-85 -126.47 150.05 48.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.501 ' CB ' HD11 ' A' ' 44' ' ' LEU . 8.4 t-160 -127.35 101.1 6.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.92 38.16 36.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.63 33.35 58.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.508 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -148.2 140.14 14.3 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.678 0.751 . . . . 0.0 110.845 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 149.22 67.03 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.681 2.254 . . . . 0.0 112.335 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.501 HD11 ' CB ' ' A' ' 39' ' ' HIS . 11.0 mp -102.1 -42.85 5.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 t -147.22 170.72 16.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -47.54 126.85 10.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -61.01 160.15 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.782 HG12 HD11 ' A' ' 64' ' ' LEU . 48.5 t -122.57 136.19 60.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -120.63 146.09 46.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -89.42 171.85 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.116 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -56.56 169.27 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -101.1 110.63 22.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.41 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.4 m -112.1 152.13 44.13 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.65 0.738 . . . . 0.0 111.109 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 142.06 47.09 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.698 2.265 . . . . 0.0 112.331 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.7 p -50.63 -42.71 56.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.6 p -60.04 -29.12 68.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -131.36 84.22 57.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.617 0.723 . . . . 0.0 110.921 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 4.27 2.29 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.677 2.251 . . . . 0.0 112.309 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -61.3 112.06 2.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.726 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 5.0 m-90 -95.46 -65.36 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.916 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 55.31 45.51 25.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -120.08 136.54 54.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.592 ' CZ3' ' HD2' ' A' ' 12' ' ' ARG . 71.3 m95 -83.55 98.87 9.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.921 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.782 HD11 HG12 ' A' ' 48' ' ' VAL . 11.2 tp -86.95 109.76 19.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -91.22 145.12 24.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.541 ' CE1' HD12 ' A' ' 13' ' ' ILE . 31.8 m-85 -111.08 134.04 52.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.66 50.86 2.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.914 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.44 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.2 pp -117.42 165.7 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.625 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.0 120.36 38.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.1 mp -51.45 -53.8 45.85 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.646 0.736 . . . . 0.0 111.142 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.625 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.5 Cg_endo -69.81 3.56 2.73 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.26 . . . . 0.0 112.342 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.511 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 6.0 t70 -124.1 -8.43 7.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -82.59 110.44 22.16 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.658 0.742 . . . . 0.0 110.915 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.429 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.5 Cg_endo -69.76 139.52 40.43 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.661 2.24 . . . . 0.0 112.377 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.541 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 1.8 mpp_? -50.16 -37.8 36.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.81 -48.45 66.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.116 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -58.83 155.05 13.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -150.23 171.22 17.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.8 tp -94.23 137.62 33.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.1 m -136.54 142.8 43.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.633 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.7 OUTLIER -145.29 156.95 44.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.5 m -156.44 135.54 12.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.463 HG12 HD11 ' A' ' 150' ' ' LEU . 26.0 mt -84.74 137.67 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 54.3 m -130.25 170.11 14.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.587 ' HB2' HG21 ' A' ' 28' ' ' ILE . 49.5 p -123.71 126.57 46.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 86' ' ' VAL . 13.3 p -118.09 120.73 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.163 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -146.01 126.91 14.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.76 -155.69 6.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.5 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -141.93 147.96 37.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.868 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -43.65 119.86 1.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.75 -33.68 3.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.487 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.72 160.15 18.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.1 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -72.05 172.13 10.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -104.02 -176.55 3.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -134.83 116.69 15.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.909 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.462 ' ND1' ' CE2' ' A' ' 32' ' ' TYR . 11.8 m170 -97.83 130.37 44.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.87 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.23 131.76 12.25 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.629 0.728 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 147.32 62.51 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.703 2.269 . . . . 0.0 112.353 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.554 ' O ' HG22 ' A' ' 125' ' ' VAL . 51.5 mt -122.13 -56.91 1.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.88 177.36 7.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.507 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 65.7 p-90 -155.65 123.18 5.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.408 ' HA3' HD22 ' A' ' 122' ' ' LEU . . . -135.58 135.24 7.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -114.85 162.37 16.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.333 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.561 HD11 HD21 ' A' ' 120' ' ' LEU . 88.2 mt -147.12 118.47 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' LEU . 26.0 m-80 -59.21 92.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.487 HD11 HG12 ' A' ' 37' ' ' ILE . 10.7 mt -36.06 -42.68 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.541 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 97.5 m-85 -104.09 108.42 19.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 108' ' ' ASP . 44.2 p30 -53.13 -176.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.437 ' CE1' ' HB ' ' A' ' 110' ' ' THR . 34.3 p90 -55.43 -40.39 71.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.437 ' HB ' ' CE1' ' A' ' 109' ' ' TYR . 10.0 t -86.22 33.31 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.167 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.5 OUTLIER 37.18 49.9 0.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 89.7 m -130.53 110.45 11.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.765 HD22 ' CH2' ' A' ' 156' ' ' TRP . 36.7 mt -34.78 138.21 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.5 m -69.86 172.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.2 p -168.94 159.41 9.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.69 145.32 2.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.455 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -43.12 151.15 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.472 ' O ' HD13 ' A' ' 152' ' ' LEU . 28.3 ttp -159.48 146.68 16.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.76 122.3 16.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.561 HD21 HD11 ' A' ' 104' ' ' ILE . 3.9 pp -133.89 158.37 43.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -78.39 158.17 28.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.829 HD11 HD12 ' A' ' 150' ' ' LEU . 7.1 mt -120.35 142.27 49.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.642 ' CE3' ' ND2' ' A' ' 142' ' ' ASN . 6.4 m95 -83.5 142.93 43.58 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.564 0.697 . . . . 0.0 110.904 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 131.13 20.65 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.235 . . . . 0.0 112.377 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 99' ' ' LEU . 15.7 m -65.16 136.65 96.68 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.662 0.744 . . . . 0.0 111.098 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 140.8 43.51 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 0.0 112.347 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -41.49 -43.37 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -84.84 84.57 1.59 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 46.1 tp -147.73 119.02 7.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -94.69 -27.44 15.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.931 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -94.9 129.22 42.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 15.6 mt -58.19 -46.95 84.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.978 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.576 HD11 ' HA ' ' A' ' 81' ' ' LEU . 8.7 tp -96.19 139.83 31.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.408 ' ND2' ' CA ' ' A' ' 137' ' ' GLY . 64.2 t30 -107.04 91.63 6.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.587 0.708 . . . . 0.0 110.923 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.512 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.5 Cg_endo -69.73 -37.38 9.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.673 2.249 . . . . 0.0 112.337 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 36.1 mt -73.96 -22.62 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.408 ' CA ' ' ND2' ' A' ' 134' ' ' ASN . . . -40.59 144.7 0.5 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.414 ' H ' HG13 ' A' ' 138' ' ' VAL . 1.9 m -50.43 -178.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.114 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 67.1 p -127.14 165.36 19.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.83 176.49 35.2 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 90.9 p -88.12 149.52 23.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.884 0.373 . . . . 0.0 110.848 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.642 ' ND2' ' CE3' ' A' ' 123' ' ' TRP . 60.5 t-20 -90.57 124.79 61.6 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.663 0.744 . . . . 0.0 110.893 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.465 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.9 Cg_endo -69.73 2.85 3.15 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.661 2.241 . . . . 0.0 112.339 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -85.24 130.92 34.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -89.2 -52.96 4.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -48.55 -24.54 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.882 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.4 p -74.01 151.87 88.51 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.567 0.698 . . . . 0.0 111.171 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 140.53 43.06 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.692 2.261 . . . . 0.0 112.364 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.7 t -123.11 135.5 54.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.829 HD12 HD11 ' A' ' 122' ' ' LEU . 6.4 mt -105.18 139.8 39.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.87 123.68 49.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.815 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -135.44 165.04 26.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -124.25 141.62 51.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.574 ' CE2' HD21 ' A' ' 152' ' ' LEU . 51.1 m-85 -104.58 136.78 43.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.424 ' HB3' ' CG ' ' A' ' 12' ' ' ARG . 1.5 t70 -152.5 147.62 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.765 ' CH2' HD22 ' A' ' 113' ' ' LEU . 7.1 m95 -134.26 89.36 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.61 ' CD1' ' NH2' ' A' ' 12' ' ' ARG . 9.3 p90 -87.36 -52.26 5.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.737 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 2.7 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.843 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.0 p -98.48 146.68 25.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.38 . . . . 0.0 110.853 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -47.07 170.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.94 50.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.4 p -81.52 157.18 24.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.4 m -111.58 87.96 2.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.01 83.19 0.15 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.458 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -100.0 141.19 33.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.887 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.6 m -122.36 -31.93 3.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.828 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -116.93 142.28 47.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.72 HD13 ' CH2' ' A' ' 156' ' ' TRP . 27.4 tp -104.35 142.76 34.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.919 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.459 ' HD2' ' CD1' ' A' ' 157' ' ' PHE . 2.2 ptm85 -148.64 128.15 13.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.677 HD12 ' CE1' ' A' ' 66' ' ' TYR . 16.2 mt -129.35 136.38 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.157 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.523 ' HB2' ' CD2' ' A' ' 63' ' ' TRP . 67.4 tttt -109.55 125.99 53.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.0 mm -91.34 141.2 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.456 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.2 mm? -99.61 -74.07 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.7 p -167.83 178.42 5.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.24 166.89 16.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -135.68 159.09 42.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 41.09 53.51 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.672 ' HB ' HG22 ' A' ' 23' ' ' VAL . 39.0 t -82.84 146.24 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.107 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.417 ' O ' ' C ' ' A' ' 23' ' ' VAL . 2.6 t-20 -42.06 -41.68 2.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.672 HG22 ' HB ' ' A' ' 21' ' ' VAL . 4.6 m -35.02 110.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.168 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -128.14 -46.24 1.37 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.842 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.533 HD12 ' HB3' ' A' ' 27' ' ' ASP . 32.9 pt -75.51 -176.91 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 33.49 5.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.533 ' HB3' HD12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -94.41 -46.34 7.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.0 mt -52.35 148.1 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.68 -58.29 2.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mmtm -143.81 176.7 9.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.8 pt -136.63 168.37 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -163.08 152.37 15.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.838 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 94.9 t -97.92 142.72 14.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.138 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.41 ' NH2' ' OD1' ' A' ' 47' ' ' ASN . 49.2 ttt85 -119.57 117.33 28.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.586 HG22 ' HB3' ' A' ' 81' ' ' LEU . 27.7 p -114.69 170.85 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.87 139.11 2.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.542 HD13 HG21 ' A' ' 68' ' ' ILE . 3.3 mp -92.01 138.6 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.145 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.538 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 27.6 m-85 -130.63 164.45 24.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -133.85 95.29 3.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.845 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.51 -11.97 53.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.449 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 135.66 -6.23 4.15 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -110.45 146.5 34.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.648 0.737 . . . . 0.0 110.881 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.466 ' C ' HD12 ' A' ' 44' ' ' LEU . 54.3 Cg_endo -69.73 160.26 50.36 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.686 2.257 . . . . 0.0 112.348 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.466 HD12 ' C ' ' A' ' 43' ' ' PRO . 8.3 mp -120.02 -33.81 3.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.8 m -151.63 169.35 22.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -53.37 136.42 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.41 ' OD1' ' NH2' ' A' ' 34' ' ' ARG . 31.8 m120 -74.53 158.01 34.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.562 HG12 HD11 ' A' ' 64' ' ' LEU . 43.3 t -116.82 139.22 44.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.72 142.39 49.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.931 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.5 p -89.29 160.83 16.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -52.24 165.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -93.27 119.92 32.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.808 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.5 m -120.32 152.14 54.48 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.635 0.731 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 133.07 24.75 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.7 2.267 . . . . 0.0 112.35 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.7 p -44.09 -48.58 9.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.2 m -47.81 -34.34 8.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -134.51 86.88 33.62 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.72 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HA ' HG21 ' A' ' 53' ' ' VAL . 53.6 Cg_endo -69.81 3.23 2.92 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.673 2.248 . . . . 0.0 112.328 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -55.22 118.19 4.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.838 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.6 m-90 -101.17 -52.33 3.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.456 ' OD1' HD13 ' A' ' 16' ' ' LEU . 76.0 m-20 43.83 41.25 3.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -120.82 137.7 54.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.523 ' CD2' ' HB2' ' A' ' 14' ' ' LYS . 59.3 m95 -82.27 109.97 17.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.916 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.562 HD11 HG12 ' A' ' 48' ' ' VAL . 10.5 tp -92.03 120.15 32.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.928 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -97.84 136.26 38.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.677 ' CE1' HD12 ' A' ' 13' ' ' ILE . 58.8 m-85 -107.58 127.29 53.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.923 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.34 43.69 0.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.542 HG21 HD13 ' A' ' 37' ' ' ILE . 2.2 pp -107.32 166.06 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.11 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.618 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.57 125.29 49.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.605 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -58.77 -53.92 61.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.641 0.734 . . . . 0.0 111.13 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.9 Cg_endo -69.75 3.04 3.0 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.687 2.258 . . . . 0.0 112.355 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.499 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 6.2 t70 -124.77 -2.32 7.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.487 HD21 HG21 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -87.69 113.13 53.01 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.665 0.745 . . . . 0.0 110.918 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.43 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.5 Cg_endo -69.83 132.77 23.91 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.512 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -46.61 -42.23 15.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.65 -40.88 60.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.139 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -62.08 168.17 3.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 -159.21 173.44 16.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.409 ' HG ' ' CD2' ' A' ' 81' ' ' LEU . 53.3 tp -95.65 134.8 38.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.597 ' C ' HD23 ' A' ' 81' ' ' LEU . 17.3 m -127.18 147.37 50.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.597 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER -155.55 139.92 16.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.667 ' HB3' HD12 ' A' ' 133' ' ' LEU . 5.0 t -145.63 140.82 27.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.846 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.662 HG22 HD12 ' A' ' 99' ' ' LEU . 47.0 mt -83.99 124.9 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 67.2 m -124.21 145.23 49.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.478 ' HA ' HG22 ' A' ' 31' ' ' ILE . 6.0 p -106.07 128.57 53.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.49 HG23 ' CD2' ' A' ' 96' ' ' HIS . 10.4 p -108.57 126.55 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.191 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.64 141.09 31.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.58 -153.98 24.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -117.58 178.22 4.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.368 . . . . 0.0 110.888 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -80.93 -68.7 0.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -54.19 -24.04 27.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.517 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.65 174.27 5.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.365 . . . . 0.0 111.122 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -83.89 158.49 21.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.926 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -101.66 -175.91 2.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -128.69 127.96 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.49 ' CD2' HG23 ' A' ' 86' ' ' VAL . 15.3 m170 -107.9 132.89 52.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.5 t -137.42 132.71 17.85 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.605 0.717 . . . . 0.0 110.851 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 153.04 69.3 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.699 2.266 . . . . 0.0 112.354 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.662 HD12 HG22 ' A' ' 83' ' ' ILE . 20.8 mt -128.28 -35.57 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -160.44 155.63 24.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.133 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.679 ' HD1' HG12 ' A' ' 125' ' ' VAL . 59.4 p-90 -132.21 134.68 45.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.35 121.63 2.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -108.34 133.35 52.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.789 0.328 . . . . 0.0 110.879 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.705 HG12 HD21 ' A' ' 120' ' ' LEU . 18.9 mt -118.21 140.38 41.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 107' ' ' PHE . 49.0 m-80 -70.67 85.87 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 105' ' ' ASN . 12.4 mt -34.9 -35.25 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 83.3 m-85 -112.93 123.05 49.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.898 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -51.07 -176.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.56 12.32 3.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 p -130.35 14.21 5.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.148 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 70.61 34.38 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.7 m -128.49 109.21 11.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.51 HD22 ' CH2' ' A' ' 156' ' ' TRP . 17.3 mt -38.58 149.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.2 m -72.56 178.08 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.143 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 72.4 p -174.01 156.18 2.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.44 170.11 45.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.442 ' HE3' ' CD ' ' A' ' 151' ' ' GLU . 32.5 tttt -71.05 148.7 47.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.733 0.302 . . . . 0.0 110.92 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 27.7 ttp -156.51 149.76 24.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.884 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.47 115.46 10.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.705 HD21 HG12 ' A' ' 104' ' ' ILE . 3.6 pp -128.86 155.97 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.03 153.84 28.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.911 HD11 HD12 ' A' ' 150' ' ' LEU . 7.7 mt -109.91 158.17 18.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.523 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 13.2 m95 -95.24 139.95 22.22 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 0.0 110.919 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 129.02 16.88 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.714 2.276 . . . . 0.0 112.347 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.679 HG12 ' HD1' ' A' ' 101' ' ' TRP . 3.2 m -71.54 137.45 83.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.631 0.729 . . . . 0.0 111.127 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 159.84 51.96 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.707 2.271 . . . . 0.0 112.349 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -63.2 -39.56 94.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.842 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -85.14 78.81 1.96 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.446 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -145.16 127.34 15.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.778 0.323 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -91.26 -53.28 4.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.66 153.69 42.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.865 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.99 -37.92 25.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.927 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.667 HD12 ' HB3' ' A' ' 82' ' ' SER . 10.7 tp -106.16 142.88 35.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -105.41 91.33 4.71 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.866 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.538 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.1 Cg_endo -69.72 -43.85 2.45 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.0 112.336 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.0 mt -70.62 -19.25 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.412 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -41.34 146.15 0.5 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.422 ' H ' HG13 ' A' ' 138' ' ' VAL . 1.6 m -56.02 179.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 111.15 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.5 p -123.57 179.24 4.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.37 169.03 44.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.447 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 87.2 p -85.76 131.85 34.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.867 0.365 . . . . 0.0 110.876 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.402 ' HA ' ' CZ2' ' A' ' 123' ' ' TRP . 64.8 t-20 -69.27 120.85 79.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.567 0.698 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.428 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.6 Cg_endo -69.74 -19.78 35.78 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.344 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -53.3 132.57 39.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -86.83 -35.03 19.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -84.35 39.69 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.5 p -130.98 156.38 80.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.593 0.711 . . . . 0.0 111.134 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 174.51 9.38 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.701 2.268 . . . . 0.0 112.343 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.5 t -159.7 134.57 7.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.911 HD12 HD11 ' A' ' 122' ' ' LEU . 3.3 mt -110.0 143.69 39.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.442 ' CD ' ' HE3' ' A' ' 117' ' ' LYS . 6.2 tt0 -111.03 127.7 55.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.704 HD13 ' H ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -137.79 156.19 48.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -113.89 117.81 32.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.688 ' CE2' HD21 ' A' ' 152' ' ' LEU . 29.3 m-85 -84.74 111.7 19.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.9 155.13 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.894 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.72 ' CH2' HD13 ' A' ' 11' ' ' LEU . 11.1 m95 -137.87 122.28 18.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.93 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.459 ' CD1' ' HD2' ' A' ' 12' ' ' ARG . 11.1 p90 -109.73 -44.99 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.452 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 10.6 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.867 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.7 p -124.04 157.39 34.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.343 . . . . 0.0 110.89 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 t -146.71 143.73 28.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.35 -107.83 2.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.464 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.8 p -167.39 164.09 15.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 0.0 110.845 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.3 m -101.88 91.13 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.91 -83.49 0.25 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.562 ' HB2' HG21 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -133.16 113.72 13.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.868 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.531 ' N ' HD13 ' A' ' 70' ' ' ILE . 1.9 t -134.59 -67.14 0.58 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . . . -98.87 130.94 45.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.083 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.692 HD13 ' CH2' ' A' ' 156' ' ' TRP . 15.8 tp -84.99 134.93 34.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -128.73 133.52 48.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.529 HD12 ' CE1' ' A' ' 66' ' ' TYR . 26.2 mt -139.04 128.74 31.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.197 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.552 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 16.2 tttp -110.25 130.19 55.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.1 mm -95.15 140.03 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.18 -74.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.6 p -167.09 -179.46 4.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.879 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -126.07 166.13 17.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.8 t -136.69 141.18 43.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 60.71 50.1 5.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.912 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 22' ' ' ASN . 65.3 t -74.47 159.01 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.142 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.529 ' N ' HG12 ' A' ' 21' ' ' VAL . 1.4 m-20 -79.51 55.15 1.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.903 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.46 83.22 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -82.33 -64.54 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.682 HD13 ' OD2' ' A' ' 27' ' ' ASP . 2.8 pp -71.35 -177.18 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.176 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.56 79.61 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.682 ' OD2' HD13 ' A' ' 25' ' ' ILE . 72.3 m-20 -132.43 -53.69 0.95 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.754 HG21 ' HB2' ' A' ' 85' ' ' SER . 4.2 mp -39.09 122.71 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.07 -59.44 3.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -144.92 159.05 43.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.489 HG22 ' HA ' ' A' ' 85' ' ' SER . 8.6 pt -116.57 179.51 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.123 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -173.02 149.23 1.83 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.551 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 88.0 t -108.57 139.19 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 47' ' ' ASN . 6.9 tpt180 -109.45 133.83 52.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 18.1 p -128.07 163.56 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.31 152.83 7.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.492 HG12 HD11 ' A' ' 106' ' ' LEU . 2.7 mp -98.39 141.85 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.349 . . . . 0.0 111.11 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.463 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 14.4 m-85 -132.55 142.93 49.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.849 ' HB3' HD11 ' A' ' 44' ' ' LEU . 8.0 t-160 -120.81 94.35 4.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.42 37.16 36.75 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.66 -23.78 8.4 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.481 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -93.05 142.44 25.37 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.654 0.74 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.58 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.6 Cg_endo -69.78 165.24 31.64 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.705 2.27 . . . . 0.0 112.356 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.849 HD11 ' HB3' ' A' ' 39' ' ' HIS . 10.0 mp -125.77 -37.48 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 39.8 m -148.57 161.91 40.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -47.68 137.37 9.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 34' ' ' ARG . 19.6 m120 -70.43 149.89 46.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.591 HG12 HD11 ' A' ' 64' ' ' LEU . 64.4 t -110.96 133.26 57.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -115.78 147.41 41.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 33' ' ' VAL . 13.1 t -95.26 169.19 10.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.91 173.25 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -105.71 124.25 49.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -126.25 152.01 73.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.587 0.708 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 136.93 34.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 0.0 112.346 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.0 p -46.2 -46.15 17.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.3 t -50.33 -33.89 21.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -133.91 86.16 38.78 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.655 0.74 . . . . 0.0 110.89 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.2 Cg_endo -69.8 4.35 2.26 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.704 2.269 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -58.06 107.29 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.576 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 1.9 m-90 -93.94 -49.82 5.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.5 p30 39.48 43.38 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -112.73 151.02 30.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.552 ' CE3' ' HB2' ' A' ' 14' ' ' LYS . 79.8 m95 -98.57 100.17 11.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.935 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.591 HD11 HG12 ' A' ' 48' ' ' VAL . 11.0 tp -88.31 118.61 28.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -98.82 145.83 26.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CE1' HD12 ' A' ' 13' ' ' ILE . 5.2 m-85 -114.68 135.85 53.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -90.34 52.32 2.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.437 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.4 pp -119.77 169.44 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.6 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -113.58 130.19 56.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.627 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -63.96 -52.8 53.93 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.668 0.747 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.9 Cg_endo -69.75 -3.74 12.61 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.686 2.257 . . . . 0.0 112.32 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.51 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 8.3 t70 -114.39 -9.11 12.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.916 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -74.46 116.19 50.72 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.545 0.688 . . . . 0.0 110.928 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.78 134.91 29.07 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.683 2.256 . . . . 0.0 112.337 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.586 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 20.7 mmm-85 -47.92 -44.52 29.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.54 -44.87 66.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.138 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.58 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -54.89 161.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -158.7 176.06 12.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.8 tp -96.71 133.17 41.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 64.8 m -127.76 133.3 49.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.32 152.1 41.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 96.0 p -157.48 146.49 19.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 63.7 mt -89.15 147.11 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.103 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 61.5 m -149.15 141.62 24.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.754 ' HB2' HG21 ' A' ' 28' ' ' ILE . 94.7 p -106.46 118.62 37.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.597 HG23 ' CD2' ' A' ' 96' ' ' HIS . 12.4 p -101.44 136.23 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -140.46 121.82 14.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -119.77 174.91 15.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.489 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 3.3 mmt-85 -121.91 -175.63 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.866 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.49 104.49 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 44.49 24.22 0.62 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.489 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.46 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -102.52 -179.95 4.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.357 . . . . 0.0 111.08 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.85 158.56 36.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.857 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 4.6 mp0 -103.25 160.88 14.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -123.84 116.43 22.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.597 ' CD2' HG23 ' A' ' 86' ' ' VAL . 6.4 m170 -95.87 149.71 21.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 t -153.71 120.54 2.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 0.0 110.851 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 144.77 54.93 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.649 2.233 . . . . 0.0 112.335 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.677 ' O ' HG23 ' A' ' 125' ' ' VAL . 20.6 mt -115.53 -47.41 2.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -147.06 169.34 19.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.529 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 64.4 p-90 -147.9 132.89 18.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.9 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.28 120.48 2.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.504 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -100.25 139.37 36.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.76 0.314 . . . . 0.0 110.898 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.628 HD11 HD21 ' A' ' 120' ' ' LEU . 54.9 mt -131.09 120.94 48.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 106' ' ' LEU . 3.3 t-20 -67.11 95.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.492 HD11 HG12 ' A' ' 37' ' ' ILE . 18.7 mt -34.89 -39.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 63.6 m-85 -96.7 113.62 25.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -52.22 -176.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.84 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -65.27 -33.25 75.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.952 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.8 t -83.53 17.31 2.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.147 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 60.35 41.88 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.847 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.1 m -133.75 126.62 31.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.182 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.741 HD22 ' CH2' ' A' ' 156' ' ' TRP . 18.4 mt -47.17 144.57 2.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.79 -179.19 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.0 t -172.79 171.48 4.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.887 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.21 172.8 7.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 2.2 ttpm? -71.42 151.98 43.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.887 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 29.8 ttp -158.67 148.31 19.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.17 121.44 15.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.099 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.628 HD21 HD11 ' A' ' 104' ' ' ILE . 2.9 pp -134.45 160.11 39.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -83.56 151.11 25.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.447 ' HB2' ' HB1' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -109.14 151.03 26.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.529 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 16.3 m95 -80.64 152.61 72.7 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.534 0.683 . . . . 0.0 110.925 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 168.2 22.32 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 99' ' ' LEU . 68.6 t -86.72 119.99 71.57 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.592 0.711 . . . . 0.0 111.126 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 -169.45 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.672 2.248 . . . . 0.0 112.403 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -97.95 -42.23 7.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.834 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.46 50.22 4.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.479 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.583 HD23 HG13 ' A' ' 125' ' ' VAL . 48.5 tp -133.87 106.28 7.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.339 . . . . 0.0 110.91 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -106.46 38.19 2.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -147.09 146.66 30.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.5 mt -62.56 -60.84 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.3 tp -88.89 132.99 34.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.438 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 9.6 t-20 -105.71 91.53 5.21 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.648 0.737 . . . . 0.0 110.889 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.463 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.8 Cg_endo -69.76 -27.6 26.28 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.6 mm -80.88 -17.02 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.438 ' CA ' ' OD1' ' A' ' 134' ' ' ASN . . . -43.54 155.07 0.22 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.47 HG22 ' CH2' ' A' ' 101' ' ' TRP . 8.9 m -71.88 163.21 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.869 0.366 . . . . 0.0 111.126 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.3 p -106.04 157.42 17.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.87 159.97 14.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.525 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 8.1 p -83.55 108.25 16.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.84 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.593 ' ND2' HG21 ' A' ' 147' ' ' THR . 14.3 t-20 -40.07 116.79 1.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.58 0.705 . . . . 0.0 110.841 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -8.41 23.53 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.655 2.237 . . . . 0.0 112.338 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -70.91 151.89 44.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -102.78 -24.53 13.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -85.94 29.64 0.71 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.593 HG21 ' ND2' ' A' ' 142' ' ' ASN . 25.0 p -124.41 153.03 69.09 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 111.148 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 154.19 68.08 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.722 2.281 . . . . 0.0 112.309 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.1 t -130.9 130.54 43.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 122' ' ' LEU . 4.7 mt -109.21 135.95 49.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -105.39 124.78 50.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.76 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -134.46 159.63 40.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.459 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 54.8 mt-10 -116.77 134.78 54.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.667 ' CE2' HD21 ' A' ' 152' ' ' LEU . 47.7 m-85 -99.96 103.7 15.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -114.27 141.13 47.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.741 ' CH2' HD22 ' A' ' 113' ' ' LEU . 60.0 m95 -125.13 76.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.909 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 158' ' ' SER . 9.5 p90 -70.88 -49.05 50.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.68 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 47.2 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -52.62 139.75 25.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.9 t -60.51 122.56 14.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.848 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.57 90.97 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.5 p -122.42 -47.88 2.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.36 . . . . 0.0 110.806 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 t -50.25 146.67 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.36 -151.06 23.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.491 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.677 ' HB2' HG21 ' A' ' 70' ' ' ILE . 38.0 m-20 -101.67 152.7 20.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 110.897 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 m -132.59 -39.22 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.31 131.34 55.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.071 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.59 HD13 ' CH2' ' A' ' 156' ' ' TRP . 13.5 tp -93.71 136.24 34.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 157' ' ' PHE . 18.7 ptt180 -142.61 139.37 31.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.3 mt -136.92 142.25 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HD2' ' CE2' ' A' ' 63' ' ' TRP . 69.3 tttt -118.9 115.37 24.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.0 mm -81.23 145.68 8.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.49 -72.96 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.1 p -170.53 178.04 3.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -129.62 142.3 50.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 t -117.86 144.65 45.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.163 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 67.23 47.42 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.705 ' HB ' HG22 ' A' ' 23' ' ' VAL . 21.6 t -73.83 140.97 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 23' ' ' VAL . 61.4 t30 -49.1 -35.92 17.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.705 HG22 ' HB ' ' A' ' 21' ' ' VAL . 9.6 m -34.79 100.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.81 -69.64 0.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.424 ' C ' HD12 ' A' ' 25' ' ' ILE . 2.8 pp -49.56 -179.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.158 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -130.26 65.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -133.44 -43.87 0.84 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 mt -37.88 133.23 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -75.46 -63.33 1.31 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -144.69 -179.8 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.891 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 85' ' ' SER . 12.2 pt -137.56 178.87 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -173.67 138.57 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.74 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 14.9 t -90.08 145.82 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.439 ' HG2' HD13 ' A' ' 133' ' ' LEU . 19.4 ttt180 -127.54 120.99 29.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.863 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.626 HG22 ' HB3' ' A' ' 81' ' ' LEU . 56.2 p -117.15 179.45 4.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.148 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.25 138.88 2.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.465 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.472 HG12 HD11 ' A' ' 106' ' ' LEU . 3.1 mp -87.06 150.67 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 111.112 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.434 ' HA ' HD13 ' A' ' 44' ' ' LEU . 24.3 m-85 -140.77 152.64 45.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.683 ' CB ' HD11 ' A' ' 44' ' ' LEU . 10.2 t-160 -127.09 104.17 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.01 51.23 56.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.493 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.43 34.79 89.61 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.515 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -142.72 142.67 23.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.691 0.758 . . . . 0.0 110.861 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 149.73 67.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.704 2.27 . . . . 0.0 112.333 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.683 HD11 ' CB ' ' A' ' 39' ' ' HIS . 8.3 mp -114.05 -37.1 4.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.9 m -160.57 170.05 21.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.805 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -50.46 131.73 24.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.9 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -66.74 161.98 22.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.701 HG12 HD11 ' A' ' 64' ' ' LEU . 51.4 t -122.25 139.01 50.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.144 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -126.52 156.5 40.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -93.41 179.82 5.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.164 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -66.67 163.92 17.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -82.2 126.46 32.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 1.4 m -137.62 152.05 72.04 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.647 0.737 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 138.52 38.06 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.73 2.287 . . . . 0.0 112.317 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.462 ' HB2' HG11 ' A' ' 23' ' ' VAL . 23.3 p -49.98 -45.87 52.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.4 t -51.35 -35.72 39.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -130.48 84.77 58.32 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.717 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.588 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.72 3.85 2.51 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.69 2.26 . . . . 0.0 112.366 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -52.63 109.16 0.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.74 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 3.6 m-90 -103.54 -46.89 4.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 60' ' ' TRP . 7.8 p30 35.3 44.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -113.83 147.9 37.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.428 ' CE2' ' HD2' ' A' ' 14' ' ' LYS . 71.2 m95 -88.99 97.16 11.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.701 HD11 HG12 ' A' ' 48' ' ' VAL . 11.8 tp -84.62 111.56 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -91.28 132.87 35.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.937 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -99.42 137.41 37.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -88.21 44.26 1.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.855 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.419 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.2 pp -112.5 170.94 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.124 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.619 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -118.14 115.88 25.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.677 HG21 ' HB2' ' A' ' 8' ' ' ASN . 1.8 mp -53.38 -51.02 79.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.647 0.737 . . . . 0.0 111.173 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.0 Cg_endo -69.77 2.21 3.75 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.647 2.231 . . . . 0.0 112.382 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.504 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.3 t70 -123.49 -11.17 7.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.894 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.574 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -71.84 113.86 23.78 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.631 0.729 . . . . 0.0 110.901 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.3 Cg_endo -69.74 145.91 58.71 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.92 -41.95 75.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.412 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -56.19 -37.97 70.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.611 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -59.85 164.55 3.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.601 ' HD2' HG21 ' A' ' 139' ' ' THR . 50.4 mtt85 -161.34 173.84 14.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 tp -98.3 131.86 44.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 9.5 m -127.65 135.95 50.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.626 ' HB3' HG22 ' A' ' 35' ' ' THR . 2.2 pp -142.83 155.56 44.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.402 ' OG ' HD12 ' A' ' 133' ' ' LEU . 85.2 p -160.16 134.82 7.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.5 mt -81.66 141.45 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 95.7 m -136.88 152.14 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.443 ' HA ' HG22 ' A' ' 31' ' ' ILE . 15.0 m -111.23 129.11 56.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 p -111.9 130.19 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -138.72 138.1 37.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.906 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.97 171.27 38.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.445 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.55 173.02 6.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.895 0.379 . . . . 0.0 110.857 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -62.99 136.47 57.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.34 -35.52 2.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.506 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.71 166.44 15.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 111.093 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.44 159.23 20.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -101.85 167.17 10.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -120.94 127.82 52.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -108.43 135.23 50.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.9 t -142.93 127.64 9.83 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.619 0.723 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.592 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.1 Cg_endo -69.77 146.61 60.67 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.653 2.235 . . . . 0.0 112.332 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.42 HD11 ' OG ' ' A' ' 85' ' ' SER . 22.6 mt -119.67 -43.56 2.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.936 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.1 162.16 41.53 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.061 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.415 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 66.6 p-90 -143.09 135.67 27.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.06 132.75 5.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 0.9 OUTLIER -111.28 138.18 48.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.792 0.329 . . . . 0.0 110.877 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.562 ' CG1' HD21 ' A' ' 120' ' ' LEU . 78.8 mt -120.6 134.62 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 107' ' ' PHE . 2.5 m120 -73.19 88.1 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.472 HD11 HG12 ' A' ' 37' ' ' ILE . 12.7 mt -36.26 -33.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 105' ' ' ASN . 57.1 m-85 -110.85 116.46 31.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -50.86 -178.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -64.26 -33.22 75.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.3 t -91.25 30.23 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.151 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.2 t0 49.74 49.21 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 113' ' ' LEU . 45.8 m -136.51 112.82 9.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.687 HD22 ' CH2' ' A' ' 156' ' ' TRP . 29.6 mt -36.73 148.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.514 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 18.2 m -75.62 -179.83 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.7 p -173.54 155.85 2.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.845 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.35 152.53 6.08 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.454 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -56.17 147.36 20.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.778 0.323 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.423 ' O ' HD13 ' A' ' 152' ' ' LEU . 35.9 ttp -156.95 153.09 27.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.92 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -135.27 132.07 37.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.581 ' O ' HD12 ' A' ' 120' ' ' LEU . 3.9 pp -138.75 154.63 48.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.502 ' ND2' ' SG ' ' A' ' 149' ' ' CYS . 6.0 m120 -77.35 156.82 31.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.1 mt -113.69 153.52 28.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.503 ' CH2' ' OD1' ' A' ' 142' ' ' ASN . 18.7 m95 -89.58 148.79 41.02 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.597 0.713 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 163.67 37.49 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.699 2.266 . . . . 0.0 112.333 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.592 HG21 ' HB2' ' A' ' 98' ' ' PRO . 45.7 t -98.58 121.03 57.73 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.596 0.712 . . . . 0.0 111.116 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -175.4 1.14 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.717 2.278 . . . . 0.0 112.36 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -90.4 -38.22 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.69 56.82 5.05 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.477 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.515 HD23 HG13 ' A' ' 125' ' ' VAL . 46.2 tp -141.58 120.33 12.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.96 44.62 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -148.65 133.53 18.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.425 HD12 ' NH1' ' A' ' 34' ' ' ARG . 25.6 mt -59.71 -54.55 45.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.937 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.439 HD13 ' HG2' ' A' ' 34' ' ' ARG . 6.1 tp -97.77 136.03 38.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.47 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 11.2 t-20 -105.34 93.71 7.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.622 0.725 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -30.89 21.45 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.648 2.232 . . . . 0.0 112.373 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.432 ' O ' ' C ' ' A' ' 137' ' ' GLY . 12.7 mm -75.19 -25.82 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.488 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -34.76 148.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.473 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.78 173.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 111.077 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.601 HG21 ' HD2' ' A' ' 78' ' ' ARG . 34.1 p -118.09 146.15 44.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 118.28 163.19 12.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.508 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.7 p -84.26 118.17 24.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.886 0.374 . . . . 0.0 110.883 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.776 HD21 ' ND2' ' A' ' 144' ' ' ASN . 24.0 t30 -60.89 129.44 90.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.615 0.721 . . . . 0.0 110.913 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 2.03 3.87 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.662 2.241 . . . . 0.0 112.372 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.776 ' ND2' HD21 ' A' ' 142' ' ' ASN . 2.7 m-20 -89.78 117.0 28.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -77.05 -46.18 24.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 147' ' ' THR . 14.8 pt-20 -43.6 -38.66 3.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.419 ' N ' ' HG3' ' A' ' 146' ' ' GLU . 64.6 p -64.25 151.87 89.68 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.606 0.717 . . . . 0.0 111.116 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 132.04 22.59 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.69 2.26 . . . . 0.0 112.375 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.502 ' SG ' ' ND2' ' A' ' 121' ' ' ASN . 1.2 m -113.07 136.99 52.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.941 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.674 ' CD2' ' HB2' ' A' ' 18' ' ' ALA . 8.4 mt -108.75 137.59 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -105.23 130.75 53.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.892 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -135.14 161.53 35.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -116.74 125.06 51.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.892 ' CE2' HD21 ' A' ' 152' ' ' LEU . 43.1 m-85 -93.41 108.02 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.0 155.82 49.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.687 ' CH2' HD22 ' A' ' 113' ' ' LEU . 6.9 m95 -136.45 105.24 5.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.485 ' CG ' ' N ' ' A' ' 158' ' ' SER . 10.0 p90 -85.17 -44.96 12.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.485 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 4.5 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 t -72.78 123.04 22.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 110.851 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 t -154.54 139.13 16.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.71 -45.16 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.522 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.3 m -107.92 109.63 21.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.878 0.37 . . . . 0.0 110.829 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.2 t -154.67 130.87 10.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -154.02 52.59 0.46 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.484 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -128.28 113.62 15.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.328 . . . . 0.0 110.908 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -126.15 -32.07 2.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.76 140.13 52.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.064 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 12' ' ' ARG . 5.8 tp -104.33 131.51 51.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' N ' HD12 ' A' ' 11' ' ' LEU . 32.2 ptt180 -139.66 139.12 36.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.48 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 59.3 mt -135.2 128.6 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -102.76 107.14 17.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.5 mm -70.76 143.23 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -96.37 -72.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.7 p -172.06 179.5 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.25 169.08 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.4 t -147.3 144.0 28.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.135 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 61.78 47.46 6.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.687 ' HB ' HG22 ' A' ' 23' ' ' VAL . 38.6 t -87.52 152.89 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.098 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 23' ' ' VAL . 39.5 t30 -48.69 -39.24 23.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.687 HG22 ' HB ' ' A' ' 21' ' ' VAL . 11.0 m -36.29 109.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -128.5 -67.27 0.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.7 pt -63.73 176.54 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 1.6 mpt_? -111.57 52.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.65 -45.52 3.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 mt -54.19 135.01 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.416 ' C ' ' HG2' ' A' ' 30' ' ' LYS . 6.7 t70 -70.52 -62.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 29' ' ' ASP . 25.1 mmtm -147.36 179.08 7.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.483 HG22 ' HA ' ' A' ' 85' ' ' SER . 1.9 pp -141.86 146.31 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -144.28 163.77 32.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.572 ' H ' HG22 ' A' ' 50' ' ' THR . 60.9 t -111.9 140.89 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.09 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.477 ' HG2' HD13 ' A' ' 133' ' ' LEU . 14.6 ttt85 -116.27 127.61 54.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.826 HG22 ' HB3' ' A' ' 81' ' ' LEU . 38.3 p -128.97 168.03 16.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 163.64 153.22 7.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.481 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.484 HD13 HG21 ' A' ' 68' ' ' ILE . 3.7 mp -96.26 146.78 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.81 0.338 . . . . 0.0 111.147 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.53 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 32.4 m-85 -139.05 159.4 42.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.425 ' CB ' HD11 ' A' ' 44' ' ' LEU . 7.6 t-160 -139.41 106.44 5.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.39 31.31 46.74 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.96 29.62 60.55 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.533 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -148.67 149.28 30.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.656 0.741 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 158.78 55.75 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.425 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.4 mp -112.26 -42.16 3.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.3 m -132.61 -69.57 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.88 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -173.16 166.49 4.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.432 ' HB2' ' NH2' ' A' ' 34' ' ' ARG . 0.8 OUTLIER -96.91 149.85 21.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.666 HG12 HD11 ' A' ' 64' ' ' LEU . 95.9 t -115.04 133.46 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -116.21 156.1 27.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.572 HG22 ' H ' ' A' ' 33' ' ' VAL . 9.1 t -100.26 165.58 11.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.13 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -48.93 178.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.5 mtt85 -108.22 115.73 30.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -120.19 152.3 54.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.582 0.705 . . . . 0.0 111.131 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 139.11 39.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.696 2.264 . . . . 0.0 112.359 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 26.2 p -47.09 -44.43 21.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.3 m -52.05 -29.41 21.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -134.06 83.97 44.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.614 0.721 . . . . 0.0 110.904 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.6 Cg_endo -69.78 1.39 4.49 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.672 2.248 . . . . 0.0 112.323 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -60.29 120.27 9.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.576 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 3.2 m-90 -109.52 -47.04 3.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.943 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 60' ' ' TRP . 8.9 p30 34.0 42.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -111.85 144.9 40.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -83.27 110.17 17.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.666 HD11 HG12 ' A' ' 48' ' ' VAL . 11.1 tp -94.56 123.07 37.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.924 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -101.63 137.44 39.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -108.92 135.49 50.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -84.25 38.31 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.484 HG21 HD13 ' A' ' 37' ' ' ILE . 1.8 pp -110.0 159.57 9.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.115 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.626 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.12 125.3 53.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -57.96 -54.06 59.44 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.624 0.725 . . . . 0.0 111.165 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 54.0 Cg_endo -69.75 2.16 3.78 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.67 2.246 . . . . 0.0 112.372 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.504 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 5.5 t70 -124.84 -1.52 7.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -85.36 117.05 67.99 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.612 0.72 . . . . 0.0 110.907 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.72 144.62 54.83 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.683 2.255 . . . . 0.0 112.365 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.411 ' HD3' ' CD2' ' A' ' 107' ' ' PHE . 21.5 mmt85 -59.12 -38.39 79.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -57.4 -26.46 61.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -76.94 165.53 24.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.14 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.1 ptp85 -159.51 177.28 11.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 80' ' ' CYS . 43.0 tp -98.89 148.67 23.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.595 ' C ' HD23 ' A' ' 81' ' ' LEU . 61.1 m -143.02 152.49 41.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.826 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.89 136.58 14.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.694 ' OG ' HD12 ' A' ' 133' ' ' LEU . 79.9 p -141.76 133.52 27.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.891 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.503 HG22 HD12 ' A' ' 99' ' ' LEU . 90.2 mt -80.12 135.72 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 70.9 m -135.72 144.33 45.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.483 ' HA ' HG22 ' A' ' 31' ' ' ILE . 6.2 p -105.5 125.13 50.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.871 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 86' ' ' VAL . 5.8 p -109.94 117.93 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.36 151.56 49.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.8 170.25 27.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.79 ' HB2' ' HB3' ' A' ' 92' ' ' ALA . 11.6 mmt180 -101.82 167.98 9.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 110.862 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.9 111.21 1.21 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.37 -7.27 47.6 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 89' ' ' ARG . . . -100.22 162.15 13.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 111.075 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm -71.84 165.02 24.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.897 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -95.58 178.84 5.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -142.53 135.55 28.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.584 ' CD2' HG23 ' A' ' 86' ' ' VAL . 6.0 m170 -100.25 130.71 46.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.6 m -134.25 127.56 18.99 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.609 0.718 . . . . 0.0 110.909 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.706 ' HB2' HG21 ' A' ' 125' ' ' VAL . 53.3 Cg_endo -69.77 150.26 67.94 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 0.0 112.304 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.503 HD12 HG22 ' A' ' 83' ' ' ILE . 21.8 mt -128.48 -52.72 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.64 176.45 8.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.139 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.549 ' HH2' HG22 ' A' ' 138' ' ' VAL . 68.6 p-90 -160.6 146.8 15.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.09 124.11 1.54 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 27.1 m-20 -104.31 153.12 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.847 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.902 HD11 HD21 ' A' ' 120' ' ' LEU . 55.1 mt -144.9 126.88 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.129 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.455 ' O ' ' C ' ' A' ' 106' ' ' LEU . 24.8 m120 -66.5 99.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 37' ' ' ILE . 13.0 mt -34.13 -54.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.493 ' CE1' ' HG ' ' A' ' 113' ' ' LEU . 52.3 m-85 -94.88 114.29 26.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -54.64 174.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -48.38 -30.09 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.859 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -90.28 28.49 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 44.16 41.88 4.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 55.2 m -127.88 115.58 18.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.144 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.637 HD22 ' CH2' ' A' ' 156' ' ' TRP . 12.3 mt -43.1 134.4 3.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.913 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 m -62.54 173.23 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.179 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -168.6 161.5 11.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.05 153.78 12.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.471 ' HE3' ' CG ' ' A' ' 151' ' ' GLU . 5.3 tmtt? -63.92 142.9 58.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.748 0.308 . . . . 0.0 110.887 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.422 ' O ' HD13 ' A' ' 152' ' ' LEU . 37.5 ttp -155.09 154.58 32.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.74 116.11 10.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.103 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 104' ' ' ILE . 4.6 pp -123.26 163.75 20.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -85.23 158.75 20.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.764 HD11 HD12 ' A' ' 150' ' ' LEU . 6.0 mt -119.1 155.71 31.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.673 ' CE3' ' ND2' ' A' ' 142' ' ' ASN . 8.3 m95 -90.18 146.42 34.81 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.559 0.695 . . . . 0.0 110.89 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 147.45 62.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.703 2.268 . . . . 0.0 112.305 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.706 HG21 ' HB2' ' A' ' 98' ' ' PRO . 48.2 t -71.74 113.29 18.68 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.608 0.718 . . . . 0.0 111.118 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -178.18 2.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 2.226 . . . . 0.0 112.373 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -83.01 134.61 35.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 109.23 -54.85 0.53 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.49 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.589 HD23 HG13 ' A' ' 125' ' ' VAL . 5.9 tp -48.74 103.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.934 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -89.92 -46.48 8.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -49.58 143.18 7.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.33 -52.97 50.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.926 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.694 HD12 ' OG ' ' A' ' 82' ' ' SER . 5.0 tp -103.16 125.86 50.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.541 ' HB3' HD11 ' A' ' 129' ' ' LEU . 11.8 p-10 -106.65 97.29 16.49 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.732 . . . . 0.0 110.928 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.53 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.8 -30.82 21.47 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.3 mt -70.08 -25.49 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.093 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.484 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -41.45 153.59 0.11 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.511 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.549 HG22 ' HH2' ' A' ' 101' ' ' TRP . 2.0 m -59.47 175.3 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.866 0.365 . . . . 0.0 111.161 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 60.7 p -121.37 168.25 11.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.189 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.49 161.93 32.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.9 p -79.6 137.82 37.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.673 ' ND2' ' CE3' ' A' ' 123' ' ' TRP . 34.9 t-20 -75.38 123.96 88.87 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -14.99 36.8 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.362 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -71.6 140.2 49.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -93.46 -42.32 9.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -50.37 -35.44 28.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.4 p -66.92 151.3 97.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.572 0.701 . . . . 0.0 111.113 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 148.22 64.3 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.687 2.258 . . . . 0.0 112.358 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 5.5 t -128.07 136.56 51.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.764 HD12 HD11 ' A' ' 122' ' ' LEU . 3.5 mt -103.67 -177.09 3.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.471 ' CG ' ' HE3' ' A' ' 117' ' ' LYS . 54.7 tt0 -149.61 122.07 8.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.8 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -128.38 165.78 19.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.866 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.429 ' N ' HD22 ' A' ' 152' ' ' LEU . 69.0 mt-10 -128.45 119.73 25.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.649 ' CE2' HD21 ' A' ' 152' ' ' LEU . 45.2 m-85 -88.44 129.89 35.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.903 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -148.75 138.89 22.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.637 ' CH2' HD22 ' A' ' 113' ' ' LEU . 7.7 m95 -129.39 94.26 3.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.95 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.586 ' CG ' ' N ' ' A' ' 158' ' ' SER . 16.1 p90 -92.98 -53.3 4.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.586 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 6.3 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.0 p -89.09 174.54 7.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.892 0.377 . . . . 0.0 110.871 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.5 p -124.61 167.73 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.852 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.38 149.71 5.7 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.539 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.7 p -126.44 157.94 37.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 7' ' ' GLY . 70.6 m -102.97 97.43 7.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 6' ' ' SER . . . 37.93 -99.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.489 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.48 131.04 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.83 0.348 . . . . 0.0 110.877 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.496 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 14.5 m -133.51 -50.95 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.66 150.23 30.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.161 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.687 HD13 ' CH2' ' A' ' 156' ' ' TRP . 12.5 tp -104.48 140.04 38.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.955 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.69 ' NE ' ' CE3' ' A' ' 63' ' ' TRP . 2.4 ttt180 -143.72 118.39 9.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.521 HD12 ' CE1' ' A' ' 66' ' ' TYR . 16.1 mt -120.99 142.51 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.565 ' HB2' ' CE3' ' A' ' 63' ' ' TRP . 35.8 tttm -120.59 134.5 55.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.09 144.7 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.15 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.35 -74.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.1 p -162.31 -178.25 6.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.515 ' HB2' ' CD2' ' A' ' 150' ' ' LEU . . . -140.26 149.72 43.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.074 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -123.22 157.88 32.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.123 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 61.25 25.26 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.722 HG12 HG13 ' A' ' 23' ' ' VAL . 33.7 t -54.7 -17.0 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.112 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 72.58 34.63 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.722 HG13 HG12 ' A' ' 21' ' ' VAL . 2.5 m -107.54 85.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.128 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -92.13 -47.29 7.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.9 pt -61.31 -177.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.94 15.64 3.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -76.32 -39.94 52.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.9 mt -52.65 139.18 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -80.12 -64.62 1.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.908 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -148.23 -179.63 7.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' A' ' 85' ' ' SER . 3.4 pt -139.46 171.09 14.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -164.52 158.9 18.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.79 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 40.9 t -119.86 132.06 70.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.083 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.687 ' HG2' HD13 ' A' ' 133' ' ' LEU . 19.2 ttm180 -103.56 122.27 44.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.86 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 81' ' ' LEU . 31.0 p -118.6 154.31 32.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.167 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.9 152.4 9.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.499 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.495 HG12 HD11 ' A' ' 106' ' ' LEU . 2.9 mp -97.41 143.38 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.845 0.355 . . . . 0.0 111.171 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.572 ' CD1' ' HB3' ' A' ' 135' ' ' PRO . 45.7 m-85 -135.85 152.57 51.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.848 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.7 t-160 -124.5 97.8 5.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.933 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.06 14.38 80.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.501 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.34 -25.37 13.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.493 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -88.31 140.72 30.42 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.637 0.732 . . . . 0.0 110.881 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' C ' HD12 ' A' ' 44' ' ' LEU . 53.7 Cg_endo -69.81 156.33 63.5 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.712 2.275 . . . . 0.0 112.29 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.429 HD11 ' CB ' ' A' ' 39' ' ' HIS . 7.8 mp -115.18 -33.19 5.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.1 t -156.31 168.66 26.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.41 126.01 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -59.54 164.99 3.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.67 HG12 HD11 ' A' ' 64' ' ' LEU . 59.4 t -120.14 134.94 62.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.122 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -116.37 139.2 50.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.444 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 8.4 t -89.87 163.12 15.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.172 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -51.39 174.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -102.24 135.52 43.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.856 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 m -137.54 152.17 72.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 0.0 111.121 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 137.27 35.08 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.702 2.268 . . . . 0.0 112.345 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.6 p -46.54 -50.19 17.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.1 p -46.71 -32.49 3.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -133.21 87.06 39.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.613 0.72 . . . . 0.0 110.882 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.478 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.2 Cg_endo -69.72 2.99 3.02 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.683 2.255 . . . . 0.0 112.35 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -58.75 123.48 16.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.79 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 3.4 m-90 -105.74 -63.81 1.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 54.24 48.2 21.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -124.93 139.33 53.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.69 ' CE3' ' NE ' ' A' ' 12' ' ' ARG . 80.1 m95 -81.89 112.2 18.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.67 HD11 HG12 ' A' ' 48' ' ' VAL . 10.1 tp -98.12 115.6 28.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -95.3 131.05 41.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.521 ' CE1' HD12 ' A' ' 13' ' ' ILE . 18.4 m-85 -100.83 134.26 44.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -81.06 41.29 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.682 ' C ' HD12 ' A' ' 68' ' ' ILE . 1.2 pp -115.33 162.83 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.615 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.37 127.41 54.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.578 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.2 mp -54.2 -55.85 32.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.631 0.729 . . . . 0.0 111.151 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.615 ' HG2' ' CD2' ' A' ' 69' ' ' TYR . 53.4 Cg_endo -69.81 3.02 3.03 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.707 2.271 . . . . 0.0 112.323 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.502 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 4.5 t70 -123.48 0.42 8.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -88.98 113.85 57.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.64 0.733 . . . . 0.0 110.874 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HD2' HD13 ' A' ' 73' ' ' LEU . 53.5 Cg_endo -69.81 142.02 46.59 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.673 2.249 . . . . 0.0 112.295 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.555 ' NH1' ' CZ ' ' A' ' 107' ' ' PHE . 78.3 mmt-85 -55.2 -37.83 67.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.848 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -56.57 -32.44 65.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . . . -70.55 166.79 19.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -161.81 172.01 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.0 tp -95.46 134.2 38.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.3 m -131.26 141.7 50.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.406 ' HB3' HG22 ' A' ' 35' ' ' THR . 1.4 pp -147.68 150.5 34.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.892 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.466 ' OG ' HD12 ' A' ' 133' ' ' LEU . 79.3 p -150.93 135.35 17.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.2 mt -84.76 141.5 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.17 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 20.7 m -140.54 150.97 44.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.572 ' HA ' HG22 ' A' ' 31' ' ' ILE . 85.1 p -113.06 126.15 55.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.535 HG23 ' CD2' ' A' ' 96' ' ' HIS . 8.5 p -104.89 130.44 55.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.13 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -149.18 124.18 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.9 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.58 174.76 40.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.483 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.435 ' N ' ' HD2' ' A' ' 89' ' ' ARG . 4.0 mpt_? -109.24 169.24 8.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.959 0.409 . . . . 0.0 110.854 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -65.2 146.6 54.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.71 -43.26 2.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.508 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -91.61 164.68 13.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 111.097 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.4 173.03 10.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 -104.57 -176.11 2.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -133.16 119.51 20.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.535 ' CD2' HG23 ' A' ' 86' ' ' VAL . 7.9 m170 -103.92 124.59 49.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.823 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.7 t -127.31 128.49 24.05 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.595 0.712 . . . . 0.0 110.877 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.442 ' HB2' HG21 ' A' ' 125' ' ' VAL . 53.5 Cg_endo -69.77 147.08 62.03 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.67 2.247 . . . . 0.0 112.356 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.2 mt -120.09 -40.25 2.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -159.16 175.83 12.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.057 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.527 ' CE2' ' HB2' ' A' ' 123' ' ' TRP . 66.7 p-90 -156.79 135.52 11.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.81 134.3 7.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -112.22 133.1 54.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.666 HG12 HD21 ' A' ' 120' ' ' LEU . 36.1 mt -122.24 121.0 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -64.27 96.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.495 HD11 HG12 ' A' ' 37' ' ' ILE . 20.4 mt -38.75 -35.65 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.926 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.555 ' CZ ' ' NH1' ' A' ' 75' ' ' ARG . 98.9 m-85 -106.12 112.36 25.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -51.09 175.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' A' ' 109' ' ' TYR . 5.0 p90 -59.45 -22.26 61.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.1 t -95.76 24.63 5.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 50.71 39.49 21.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.864 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 113' ' ' LEU . 51.2 m -131.5 113.94 14.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.423 HD22 ' CH2' ' A' ' 156' ' ' TRP . 33.5 mt -38.03 143.52 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.465 HG21 ' CE2' ' A' ' 154' ' ' PHE . 35.7 m -74.3 -177.79 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.5 t -168.23 173.07 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.53 174.01 2.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.431 ' HE2' ' CD ' ' A' ' 151' ' ' GLU . 3.5 ttpm? -73.67 152.3 40.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.739 0.304 . . . . 0.0 110.925 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.416 ' O ' HD13 ' A' ' 152' ' ' LEU . 17.5 ttp -154.39 148.47 25.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -137.93 116.96 12.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.077 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.666 HD21 HG12 ' A' ' 104' ' ' ILE . 4.0 pp -129.26 163.79 24.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 147' ' ' THR . 25.2 m-20 -91.05 145.61 24.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.546 ' HB2' ' HB1' ' A' ' 100' ' ' ALA . 2.9 mt -98.59 159.74 14.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.527 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 23.4 m95 -87.38 150.79 49.84 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.537 0.684 . . . . 0.0 110.913 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 145.23 56.52 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.673 2.249 . . . . 0.0 112.355 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.67 HG13 ' HD2' ' A' ' 126' ' ' PRO . 99.2 t -67.79 138.97 93.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.618 0.723 . . . . 0.0 111.149 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.67 ' HD2' HG13 ' A' ' 125' ' ' VAL . 53.5 Cg_endo -69.8 -164.8 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 0.0 112.325 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -76.89 120.89 22.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.845 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 40.0 72.69 0.22 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.671 HD21 ' O ' ' A' ' 131' ' ' ASP . 56.5 tp -62.21 125.07 22.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.33 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.36 -30.0 33.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.671 ' O ' HD21 ' A' ' 129' ' ' LEU . 57.1 m-20 -115.15 114.37 25.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 43.8 mt -44.19 -46.26 8.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.687 HD13 ' HG2' ' A' ' 34' ' ' ARG . 16.4 tp -98.68 136.58 38.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.463 ' OD1' ' CA ' ' A' ' 137' ' ' GLY . 7.7 t-20 -106.55 91.51 6.04 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.643 0.735 . . . . 0.0 110.854 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.572 ' HB3' ' CD1' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.77 -41.19 4.47 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.687 2.258 . . . . 0.0 112.311 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.1 mt -75.61 -13.65 15.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.463 ' CA ' ' OD1' ' A' ' 134' ' ' ASN . . . -44.05 144.44 1.95 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.434 HG21 ' CZ2' ' A' ' 123' ' ' TRP . 2.2 m -54.78 173.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 111.184 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.1 p -118.62 175.57 5.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.192 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.08 154.15 30.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.479 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 86.4 p -78.89 109.85 13.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.916 0.389 . . . . 0.0 110.855 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -44.67 121.88 4.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.609 0.719 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -6.22 18.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -68.84 139.88 55.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -99.65 -9.93 22.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -97.67 14.42 26.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.402 ' O ' ' OD1' ' A' ' 121' ' ' ASN . 59.5 p -112.25 152.55 44.54 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.542 0.686 . . . . 0.0 111.166 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 146.45 59.99 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.66 2.24 . . . . 0.0 112.344 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 2.0 t -128.95 128.48 43.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.515 ' CD2' ' HB2' ' A' ' 18' ' ' ALA . 7.5 mt -100.32 140.32 34.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.431 ' CD ' ' HE2' ' A' ' 117' ' ' LYS . 37.6 tt0 -109.15 120.48 42.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.806 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -128.95 165.91 20.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.12 125.99 49.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.471 ' CE2' HD21 ' A' ' 152' ' ' LEU . 28.5 m-85 -90.77 100.41 13.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.01 141.48 37.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.853 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.687 ' CH2' HD13 ' A' ' 11' ' ' LEU . 74.8 m95 -129.1 69.55 1.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.908 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 158' ' ' SER . 7.9 p90 -69.34 -51.09 40.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.636 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 52.5 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.812 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -74.41 -54.36 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 110.848 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.3 m -78.24 146.34 34.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.863 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.1 -52.57 0.43 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.1 m -97.56 -47.88 5.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.9 m -107.3 156.37 18.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.53 -63.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.492 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 156' ' ' TRP . 1.3 m120 -46.49 118.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.573 ' HB3' ' CE1' ' A' ' 69' ' ' TYR . 13.2 m -102.89 -23.54 13.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.838 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 158' ' ' SER . . . -120.08 136.35 54.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.043 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.857 HD13 ' CH2' ' A' ' 156' ' ' TRP . 24.6 tp -86.67 139.15 31.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.412 ' H ' HD12 ' A' ' 11' ' ' LEU . 10.4 ttp180 -138.39 123.3 18.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.0 mt -134.18 139.27 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.119 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HD2' ' NE1' ' A' ' 63' ' ' TRP . 72.9 tttt -118.37 127.22 53.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.3 mm -89.17 146.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 151' ' ' GLU . 4.3 mm? -100.85 -72.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 p -168.46 -176.94 3.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -127.93 141.88 51.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.424 HG23 ' CD2' ' A' ' 20' ' ' TYR . 6.5 t -117.57 134.34 54.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.424 ' CD2' HG23 ' A' ' 19' ' ' THR . 5.8 m-85 72.69 38.75 0.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.45 ' HB ' HG22 ' A' ' 23' ' ' VAL . 46.2 t -66.04 154.01 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.116 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.426 ' N ' HG12 ' A' ' 21' ' ' VAL . 9.3 m-80 -76.16 54.72 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.45 HG22 ' HB ' ' A' ' 21' ' ' VAL . 2.6 m -120.52 114.09 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -117.71 -62.19 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 27' ' ' ASP . 43.8 pt -69.1 174.47 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 0.3 OUTLIER -112.83 40.54 2.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' HB3' HD12 ' A' ' 25' ' ' ILE . 4.1 t0 -92.0 -64.85 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.667 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.7 mp -35.16 123.66 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.167 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -71.14 -52.62 18.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.851 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.1 mmtm -145.81 177.44 8.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.428 HG22 ' HA ' ' A' ' 85' ' ' SER . 2.0 pp -146.64 156.94 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -153.47 163.2 40.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 92.1 t -108.75 140.55 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.158 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.485 ' HG2' HD13 ' A' ' 133' ' ' LEU . 25.1 ttm180 -114.77 126.75 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.898 HG22 ' HB3' ' A' ' 81' ' ' LEU . 47.0 p -124.73 163.87 21.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.139 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.74 146.24 4.91 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.813 HD13 HG21 ' A' ' 68' ' ' ILE . 3.9 mp -89.77 146.01 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 111.166 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.534 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 38.5 m-85 -142.53 157.1 45.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.467 ' CB ' HD11 ' A' ' 44' ' ' LEU . 6.6 t-160 -129.09 102.84 6.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.89 22.37 70.24 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.475 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.29 -37.2 3.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -75.4 137.61 71.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.664 0.745 . . . . 0.0 110.888 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 158.07 58.2 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.467 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.0 mp -116.15 -40.08 3.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.946 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.3 m -149.76 168.95 22.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -57.35 128.17 35.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -61.65 159.11 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.54 HG11 ' HG ' ' A' ' 64' ' ' LEU . 58.7 t -114.78 147.5 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -129.06 156.06 44.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.876 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 p -102.64 168.62 9.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.133 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -51.92 177.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -107.08 112.62 25.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 m -118.0 152.83 50.81 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.606 0.717 . . . . 0.0 111.131 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 135.84 31.39 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.65 2.233 . . . . 0.0 112.331 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.5 p -44.69 -44.37 9.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 93.8 p -48.56 -34.82 12.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -134.18 89.22 28.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.621 0.724 . . . . 0.0 110.857 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.58 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.3 Cg_endo -69.82 -0.12 6.5 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.708 2.272 . . . . 0.0 112.297 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -54.09 113.48 1.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.58 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 3.3 m-90 -104.82 -46.92 4.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.457 ' C ' ' O ' ' A' ' 60' ' ' TRP . 11.8 m-80 33.99 51.58 0.41 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -119.94 140.06 51.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.457 ' NE1' ' HD2' ' A' ' 14' ' ' LYS . 76.5 m95 -81.28 108.43 14.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.54 ' HG ' HG11 ' A' ' 48' ' ' VAL . 9.7 tp -97.66 121.46 39.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -101.33 134.84 43.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -102.34 129.91 48.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.9 42.34 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.877 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.813 HG21 HD13 ' A' ' 37' ' ' ILE . 2.0 pp -108.91 163.5 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.176 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.621 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -114.12 126.89 55.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.933 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.626 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -58.28 -52.41 74.78 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.65 0.738 . . . . 0.0 111.153 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.8 Cg_endo -69.8 -5.56 16.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.682 2.255 . . . . 0.0 112.348 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.1 t0 -112.26 -15.79 13.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -71.41 112.16 12.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.627 0.727 . . . . 0.0 110.92 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.632 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.77 145.17 56.3 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.674 2.249 . . . . 0.0 112.35 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.457 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 21.7 mmt180 -53.41 -46.75 69.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.52 -41.71 63.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.082 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.632 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -57.82 163.82 2.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.415 ' O ' HG23 ' A' ' 37' ' ' ILE . 3.8 ptp85 -160.91 173.92 14.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.6 tp -96.18 144.15 26.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.611 ' C ' HD23 ' A' ' 81' ' ' LEU . 58.9 m -134.49 149.45 50.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.879 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.898 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.0 OUTLIER -155.76 137.09 13.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.0 p -146.87 154.4 41.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.586 ' CG1' HD11 ' A' ' 150' ' ' LEU . 44.5 mt -104.19 138.81 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.159 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 84.7 m -133.94 155.41 49.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.428 ' HA ' HG22 ' A' ' 31' ' ' ILE . 78.0 p -106.72 116.1 31.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.891 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.42 127.98 54.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.6 tptt -145.65 136.61 24.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.02 -179.68 38.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.6 mtm180 -97.04 174.67 6.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.902 0.382 . . . . 0.0 110.851 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -68.91 -59.22 3.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.04 -35.21 91.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.45 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -88.86 170.77 10.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.905 0.383 . . . . 0.0 111.077 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -84.75 159.14 20.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -99.5 173.37 6.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.88 118.94 30.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -103.91 124.65 49.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 17.9 m -131.16 122.96 19.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.623 0.725 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.406 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.4 Cg_endo -69.79 140.38 42.43 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.468 ' C ' HG23 ' A' ' 125' ' ' VAL . 16.5 mt -113.9 -36.33 4.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.04 -179.68 6.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.13 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.789 ' HH2' HG22 ' A' ' 138' ' ' VAL . 67.8 p-90 -162.7 127.05 3.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.76 134.16 7.07 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -114.64 129.91 56.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.813 0.339 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.484 HG12 HD21 ' A' ' 120' ' ' LEU . 87.1 mt -107.57 138.15 35.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 106' ' ' LEU . 6.1 m120 -76.58 82.79 3.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.446 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.1 mt -34.43 -38.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.457 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 40.9 m-85 -105.93 120.47 41.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -62.85 170.53 2.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.828 ' CE1' HG23 ' A' ' 110' ' ' THR . 0.2 OUTLIER -51.83 -26.24 9.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.905 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.828 HG23 ' CE1' ' A' ' 109' ' ' TYR . 67.9 p -105.23 31.79 4.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 47.01 36.6 4.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 113' ' ' LEU . 97.6 m -115.12 102.52 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.488 HD22 ' CH2' ' A' ' 156' ' ' TRP . 35.2 mt -34.05 125.13 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.479 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 29.8 m -58.2 176.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.146 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.447 ' HA ' ' CB ' ' A' ' 154' ' ' PHE . 2.2 m -173.42 166.88 4.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.33 132.38 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.471 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.417 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 22.6 ttpt -40.36 149.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.9 ttp -159.71 158.4 31.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.676 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -138.69 133.47 32.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 120' ' ' LEU . 4.5 pp -143.59 148.74 36.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -76.6 157.94 31.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 150' ' ' LEU . 1.2 mt -118.12 147.71 43.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.581 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 9.1 m95 -81.19 152.7 71.29 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.524 0.678 . . . . 0.0 110.931 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 161.88 44.21 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.708 2.272 . . . . 0.0 112.325 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.468 HG23 ' C ' ' A' ' 99' ' ' LEU . 90.3 t -83.64 118.07 70.42 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -174.03 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.714 2.276 . . . . 0.0 112.324 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -92.35 146.9 23.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.21 -51.43 1.88 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.456 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.2 tp -43.09 112.59 0.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.831 0.348 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -95.32 -46.21 6.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.868 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -55.09 135.8 48.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 66.2 mt -57.93 -55.04 40.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.485 HD13 ' HG2' ' A' ' 34' ' ' ARG . 14.8 tp -88.57 134.14 33.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -105.28 91.42 4.67 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.598 0.713 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.534 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.4 Cg_endo -69.8 -28.61 24.87 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.252 . . . . 0.0 112.313 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 137' ' ' GLY . 11.5 mm -75.34 -28.48 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.181 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -34.66 151.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.423 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.789 HG22 ' HH2' ' A' ' 101' ' ' TRP . 18.6 m -68.63 170.45 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.946 0.403 . . . . 0.0 111.116 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 40.5 p -111.98 169.17 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.84 159.26 29.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.535 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.5 p -77.5 121.25 23.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.842 0.353 . . . . 0.0 110.858 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.581 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 36.9 t30 -59.14 124.39 74.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -18.45 36.96 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.726 2.284 . . . . 0.0 112.326 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -60.97 139.33 58.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -95.41 -35.36 11.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -83.41 39.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.0 p -129.16 156.12 78.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 0.0 111.132 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 130.28 18.98 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.722 2.281 . . . . 0.0 112.294 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 12.1 t -121.29 130.62 53.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.632 HD12 HD11 ' A' ' 122' ' ' LEU . 2.9 mt -106.89 151.5 25.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.982 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.676 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 0.4 OUTLIER -112.86 140.25 47.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.917 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.778 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -143.13 155.31 44.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.958 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.417 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 39.1 mt-10 -119.17 115.98 25.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.648 ' CE2' HD21 ' A' ' 152' ' ' LEU . 44.6 m-85 -80.49 109.53 15.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -127.98 126.34 41.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.857 ' CH2' HD13 ' A' ' 11' ' ' LEU . 6.3 m95 -123.55 98.38 5.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.94 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 158' ' ' SER . 46.9 p90 -98.67 -53.08 3.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.797 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 22.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 m -79.17 122.08 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 0.0 110.897 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.8 m -147.37 119.74 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.871 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.82 145.12 17.66 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.499 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 t -148.26 168.53 22.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.836 0.35 . . . . 0.0 110.851 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.8 p -101.56 -23.6 14.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.04 -142.12 13.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.48 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.447 ' OD1' ' C ' ' A' ' 158' ' ' SER . 11.7 t30 -106.3 173.62 6.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.43 -41.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.74 117.68 29.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.927 HD13 ' CH2' ' A' ' 156' ' ' TRP . 14.7 tp -84.72 131.75 34.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.521 ' NE ' ' CZ3' ' A' ' 63' ' ' TRP . 23.2 ptt180 -130.1 136.77 49.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.485 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 58.4 mt -134.21 134.9 54.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -111.41 133.79 53.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.8 mm -93.39 145.93 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.724 HD13 ' OD1' ' A' ' 61' ' ' ASN . 4.2 mm? -100.45 -72.4 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.2 p -166.78 -175.36 3.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -131.8 148.29 52.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.109 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.1 t -120.77 133.68 55.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 66.72 41.8 2.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.616 ' HB ' HG22 ' A' ' 23' ' ' VAL . 38.3 t -65.49 140.1 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.154 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.578 HD22 HD22 ' A' ' 99' ' ' LEU . 59.5 t30 -41.78 -42.2 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.887 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 21' ' ' VAL . 15.4 m -35.89 106.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.108 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -95.63 -60.1 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.6 pt -83.88 176.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.169 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -112.55 44.82 1.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.39 -41.45 7.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.822 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.9 mt -49.69 129.1 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -59.78 -66.8 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.844 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -144.33 177.32 8.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.1 pt -139.4 173.56 11.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -165.65 170.83 13.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 92.1 t -119.14 140.51 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.126 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.712 ' HG2' HD13 ' A' ' 133' ' ' LEU . 46.5 ttm-85 -115.03 130.82 57.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.536 HG22 ' HB3' ' A' ' 81' ' ' LEU . 60.4 p -126.71 168.16 14.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.114 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.24 134.22 1.63 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.429 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 78' ' ' ARG . 3.8 mp -81.99 148.7 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 111.156 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.533 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 19.7 m-85 -140.1 142.75 36.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.926 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 76' ' ' ALA . 2.7 t-160 -118.64 104.76 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.846 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.36 45.07 82.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.492 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.14 30.89 71.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.453 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -140.58 144.71 37.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.641 0.734 . . . . 0.0 110.904 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.411 ' O ' HD12 ' A' ' 44' ' ' LEU . 54.1 Cg_endo -69.68 163.95 36.3 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.696 2.264 . . . . 0.0 112.374 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.424 HD11 ' CB ' ' A' ' 39' ' ' HIS . 9.6 mp -126.2 -40.54 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.907 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 19.6 p -146.33 177.0 9.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.11 118.06 7.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -50.48 149.07 3.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.706 HG12 HD11 ' A' ' 64' ' ' LEU . 61.6 t -111.14 137.23 44.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -118.55 151.29 38.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.449 HG22 HD13 ' A' ' 64' ' ' LEU . 79.4 p -100.73 164.37 11.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -49.71 172.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.26 120.24 40.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.8 m -122.05 152.12 59.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.568 0.699 . . . . 0.0 111.131 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 136.23 32.34 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.704 2.269 . . . . 0.0 112.306 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 27.0 p -45.65 -47.55 14.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -47.78 -35.35 9.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 58.5 m-20 -134.72 89.0 26.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.659 0.742 . . . . 0.0 110.911 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.585 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 54.3 Cg_endo -69.73 2.23 3.7 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.65 2.234 . . . . 0.0 112.408 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -54.2 105.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.585 ' CE3' ' O ' ' A' ' 58' ' ' PRO . 2.9 m-90 -93.18 -49.72 5.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.935 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.724 ' OD1' HD13 ' A' ' 16' ' ' LEU . 62.6 m-20 40.49 45.1 1.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -115.53 138.73 50.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.521 ' CZ3' ' NE ' ' A' ' 12' ' ' ARG . 45.8 m95 -85.76 108.55 18.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.706 HD11 HG12 ' A' ' 48' ' ' VAL . 10.3 tp -96.15 117.38 30.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -97.54 126.84 43.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -96.48 122.14 39.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.41 53.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.442 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.3 pp -117.27 167.15 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.627 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.69 119.86 39.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.659 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.7 mp -58.0 -51.1 84.2 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.654 0.74 . . . . 0.0 111.159 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.5 Cg_endo -69.75 2.86 3.15 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.697 2.265 . . . . 0.0 112.336 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.5 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 12.6 t0 -122.46 -11.02 8.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.835 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.4 OUTLIER -70.62 113.64 20.1 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.659 0.742 . . . . 0.0 110.92 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.2 Cg_endo -69.74 132.97 24.48 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.641 2.228 . . . . 0.0 112.366 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.46 ' NE ' ' OD2' ' A' ' 111' ' ' ASP . 82.8 mmt-85 -43.1 -45.91 5.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 39' ' ' HIS . . . -51.2 -46.92 62.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.538 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -53.15 162.78 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 37' ' ' ILE . 14.8 ptp180 -160.75 175.56 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.858 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.3 tp -94.38 138.22 32.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 84.5 m -139.19 135.63 34.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.536 ' HB3' HG22 ' A' ' 35' ' ' THR . 1.5 pp -142.03 157.24 45.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.51 ' HB2' HD12 ' A' ' 133' ' ' LEU . 59.5 m -157.99 154.52 27.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.4 mt -97.85 147.14 6.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.168 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 86.2 m -142.65 156.61 45.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 63.1 m -116.07 118.58 33.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 p -102.94 130.07 53.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -148.12 150.75 34.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.889 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.3 -172.6 34.75 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.51 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -104.9 157.97 16.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.855 0.36 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -59.58 -55.59 32.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.49 -22.33 76.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.549 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -102.21 -179.74 4.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 0.0 111.144 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -91.01 157.41 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -100.02 174.19 6.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -131.53 130.71 42.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -102.85 132.47 49.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 8.0 t -132.71 120.85 16.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.632 0.73 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.484 ' HB2' HG21 ' A' ' 125' ' ' VAL . 54.0 Cg_endo -69.79 147.66 63.19 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.693 2.262 . . . . 0.0 112.37 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 125' ' ' VAL . 19.6 mt -122.72 -55.04 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.8 -179.82 5.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.435 ' CZ3' ' HA3' ' A' ' 137' ' ' GLY . 69.3 p-90 -164.36 132.95 3.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.952 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.415 ' HA3' HD23 ' A' ' 122' ' ' LEU . . . -143.26 136.97 7.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.534 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 20.8 m-20 -115.15 146.44 41.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.831 0.348 . . . . 0.0 110.848 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.505 HD11 HD21 ' A' ' 120' ' ' LEU . 95.5 mt -127.29 125.6 66.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.453 ' O ' ' C ' ' A' ' 106' ' ' LEU . 16.7 m-80 -64.87 87.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.894 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 37' ' ' ILE . 37.9 mt -33.46 -38.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.896 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 105' ' ' ASN . 66.3 m-85 -105.15 110.95 23.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -56.75 177.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -52.08 -40.56 61.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.424 HG23 ' HB ' ' A' ' 112' ' ' THR . 4.7 t -86.57 34.12 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.158 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.46 ' OD2' ' NE ' ' A' ' 75' ' ' ARG . 35.8 t0 38.22 49.49 1.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.441 ' O ' ' C ' ' A' ' 113' ' ' LEU . 52.7 m -134.14 111.48 10.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.69 HD22 ' CH2' ' A' ' 156' ' ' TRP . 58.0 mt -34.19 134.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 154' ' ' PHE . 31.0 m -65.6 175.55 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.2 p -169.77 165.06 9.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.5 134.6 0.25 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.48 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -42.02 149.31 0.15 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.729 0.3 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.409 ' O ' HD13 ' A' ' 152' ' ' LEU . 45.2 ttp -159.77 159.84 33.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.65 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . . . -139.79 137.27 34.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.103 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 104' ' ' ILE . 4.3 pp -145.22 155.42 43.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -81.36 152.53 27.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.898 HD11 HD12 ' A' ' 150' ' ' LEU . 1.9 mt -114.87 138.48 50.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.589 ' CH2' ' HD2' ' A' ' 143' ' ' PRO . 12.0 m95 -75.9 149.11 82.63 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.546 0.689 . . . . 0.0 110.953 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 157.12 61.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.685 2.257 . . . . 0.0 112.371 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 99' ' ' LEU . 87.1 t -74.86 128.46 85.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 111.086 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 178.55 4.46 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.645 2.23 . . . . 0.0 112.365 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -83.09 158.89 22.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 49.88 81.43 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 57.4 tp -150.48 147.19 27.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.743 0.306 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -119.4 -56.54 2.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -51.01 117.02 2.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 24.3 mt -52.56 -47.79 66.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.712 HD13 ' HG2' ' A' ' 34' ' ' ARG . 5.1 tp -93.55 138.85 31.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -107.8 91.29 7.32 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.595 0.712 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.533 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 54.0 Cg_endo -69.73 -34.58 14.39 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.68 2.253 . . . . 0.0 112.338 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.1 mm -70.65 -26.46 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.167 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.435 ' HA3' ' CZ3' ' A' ' 101' ' ' TRP . . . -39.49 153.62 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.9 m -65.62 166.14 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.935 0.397 . . . . 0.0 111.098 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.0 p -109.41 166.87 10.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.146 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.99 177.79 33.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.511 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.2 p -91.79 130.35 37.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.867 0.365 . . . . 0.0 110.893 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 123' ' ' TRP . 63.8 t-20 -67.17 121.26 77.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.563 0.696 . . . . 0.0 110.885 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.589 ' HD2' ' CH2' ' A' ' 123' ' ' TRP . 53.8 Cg_endo -69.68 -7.23 20.49 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.721 2.281 . . . . 0.0 112.345 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -79.47 127.19 31.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -78.01 -52.78 8.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -40.61 -41.95 1.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.0 p -62.09 151.66 80.2 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.576 0.703 . . . . 0.0 111.134 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 174.82 8.89 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 0.0 112.384 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.1 t -150.55 137.92 19.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.898 HD12 HD11 ' A' ' 122' ' ' LEU . 4.5 mt -110.9 156.48 21.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.65 ' HG3' ' HB2' ' A' ' 119' ' ' ALA . 1.7 mp0 -117.63 138.59 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.806 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -141.58 158.37 43.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -122.5 120.26 33.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.69 ' CE2' HD21 ' A' ' 152' ' ' LEU . 43.7 m-85 -88.04 119.39 28.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.51 128.5 20.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.857 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.927 ' CH2' HD13 ' A' ' 11' ' ' LEU . 3.9 m95 -123.9 103.48 8.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' CG ' ' N ' ' A' ' 158' ' ' SER . 21.8 p90 -106.46 -49.64 3.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.879 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.494 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 31.4 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.855 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.0 m -113.68 110.46 20.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 p -86.7 98.4 11.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.84 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.13 -90.67 1.42 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.518 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m -112.98 131.61 55.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.898 0.38 . . . . 0.0 110.871 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 82.2 p -139.75 139.73 36.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.51 -66.84 0.31 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.47 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -114.1 112.77 23.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.901 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -130.17 -33.12 1.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.811 ' HB3' ' CB ' ' A' ' 158' ' ' SER . . . -119.71 141.83 49.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.118 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -106.27 137.15 44.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.503 HH11 ' N ' ' A' ' 155' ' ' ASP . 0.0 OUTLIER -140.35 163.71 32.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.479 ' CG2' ' HB2' ' A' ' 152' ' ' LEU . 67.9 mt -154.79 131.75 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -105.88 104.17 13.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.7 mm -73.19 136.58 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.83 -75.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.1 p -168.01 167.8 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.83 164.7 12.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.074 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -142.97 161.14 38.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.114 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 49.79 45.04 25.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 22' ' ' ASN . 3.3 t -80.98 171.3 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.09 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.637 ' H ' HG12 ' A' ' 21' ' ' VAL . 5.2 t-20 -84.46 27.03 0.73 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 23' ' ' VAL . 30.2 m -74.66 64.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.13 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -85.72 -73.62 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.863 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 pp -51.96 179.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -132.47 67.47 1.53 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -133.93 -33.81 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.0 mt -52.02 137.37 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.113 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.49 -51.62 4.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -146.65 173.49 12.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.508 HG22 ' HA ' ' A' ' 85' ' ' SER . 7.5 pt -136.17 174.96 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.155 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -169.14 148.19 3.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.662 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 55.3 t -100.95 141.44 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.4 ttt85 -121.11 126.63 50.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 81' ' ' LEU . 30.3 p -121.34 176.04 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.67 137.02 2.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.457 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.537 HG12 HD11 ' A' ' 106' ' ' LEU . 3.5 mp -94.63 142.78 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.553 ' CG ' ' HB3' ' A' ' 135' ' ' PRO . 13.4 m-85 -135.43 164.61 27.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.945 ' HB2' HD11 ' A' ' 44' ' ' LEU . 8.4 t-160 -132.72 100.96 5.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.72 30.56 70.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.526 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.42 -49.57 1.04 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.98 145.31 88.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.652 0.739 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 167.05 25.55 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.345 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.945 HD11 ' HB2' ' A' ' 39' ' ' HIS . 10.9 mp -118.74 -33.24 4.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.6 t -166.02 168.2 15.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -41.91 153.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -92.21 171.85 8.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 64' ' ' LEU . 57.5 t -125.96 143.61 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -129.65 144.91 51.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.426 ' CG2' ' H ' ' A' ' 33' ' ' VAL . 10.4 t -94.31 165.09 12.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.168 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -53.39 178.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.8 mtm-85 -104.56 139.02 40.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.438 HG21 ' HA ' ' A' ' 58' ' ' PRO . 1.8 m -140.68 152.19 65.31 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.615 0.722 . . . . 0.0 111.121 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 135.12 29.73 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.684 2.256 . . . . 0.0 112.356 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 17.4 p -45.96 -47.69 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.1 p -46.43 -37.62 7.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -134.4 88.05 30.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.63 0.728 . . . . 0.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.539 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.7 Cg_endo -69.77 3.29 2.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.674 2.249 . . . . 0.0 112.341 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -54.36 110.75 0.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.662 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 2.7 m-90 -95.07 -68.53 0.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 58.25 54.29 5.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -131.18 140.59 49.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -81.61 104.78 12.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.546 ' HG ' HG11 ' A' ' 48' ' ' VAL . 11.2 tp -88.81 111.49 22.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -90.19 127.94 36.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -97.61 134.67 40.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.913 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -83.46 50.7 1.83 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.436 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.0 pp -122.92 164.11 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.137 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.612 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -112.7 117.34 31.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.646 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 1.4 mp -54.28 -51.98 72.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.604 0.716 . . . . 0.0 111.146 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 53.8 Cg_endo -69.79 2.6 3.4 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.696 2.264 . . . . 0.0 112.366 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.508 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 2.0 t70 -125.72 -9.45 6.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.29 117.44 63.15 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.623 0.725 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.514 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 54.0 Cg_endo -69.7 146.06 59.37 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.647 2.231 . . . . 0.0 112.371 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.564 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 62.0 mmt-85 -59.96 -42.2 93.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.839 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.634 ' HB3' ' NE2' ' A' ' 39' ' ' HIS . . . -54.42 -31.36 55.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.514 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -69.06 162.0 27.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.481 ' HD2' HG21 ' A' ' 139' ' ' THR . 43.2 mtt85 -155.58 175.26 14.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.2 tp -98.93 131.41 45.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.6 m -128.55 124.59 36.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.592 ' HB3' HG22 ' A' ' 35' ' ' THR . 0.7 OUTLIER -128.13 158.49 37.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.5 p -156.98 137.73 13.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.651 HG12 HD11 ' A' ' 150' ' ' LEU . 33.8 mt -88.24 136.79 22.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 63.5 m -133.99 141.54 47.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.508 ' HA ' HG22 ' A' ' 31' ' ' ILE . 91.0 p -105.88 119.75 39.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.503 HG23 ' CD2' ' A' ' 96' ' ' HIS . 6.2 p -101.57 138.17 26.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -150.08 137.04 19.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.95 -154.7 12.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.495 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -132.9 172.18 12.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.853 0.359 . . . . 0.0 110.83 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -63.43 -60.09 3.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.35 -37.29 79.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.74 172.35 12.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.837 0.351 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -87.3 173.87 8.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.471 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 8.8 mt-10 -104.65 160.04 15.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -125.77 122.96 37.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.503 ' CD2' HG23 ' A' ' 86' ' ' VAL . 7.3 m170 -96.45 140.56 30.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.826 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 2.9 t -142.31 122.98 8.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.537 ' HD3' HD23 ' A' ' 132' ' ' LEU . 54.2 Cg_endo -69.74 147.01 62.04 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.71 2.273 . . . . 0.0 112.368 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.677 ' O ' HG23 ' A' ' 125' ' ' VAL . 44.0 mt -119.2 -56.65 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.16 -178.17 5.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.535 ' CH2' HG22 ' A' ' 138' ' ' VAL . 61.4 p-90 -160.33 141.89 12.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.923 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.9 125.45 2.83 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.445 ' CB ' HG22 ' A' ' 139' ' ' THR . 4.0 m-20 -108.01 117.93 35.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.758 0.314 . . . . 0.0 110.916 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.662 HG12 HD21 ' A' ' 120' ' ' LEU . 54.2 mt -107.63 128.28 62.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.109 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 106' ' ' LEU . 1.7 m120 -65.09 94.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.872 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.537 HD11 HG12 ' A' ' 37' ' ' ILE . 13.0 mt -35.84 -43.08 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 75' ' ' ARG . 84.9 m-85 -101.97 119.61 39.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -56.48 -175.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -60.9 -37.71 83.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.0 t -88.8 32.94 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.19 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 43.81 53.88 5.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 113' ' ' LEU . 98.2 m -137.88 108.43 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.138 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.776 HD22 ' CH2' ' A' ' 156' ' ' TRP . 41.4 mt -34.11 135.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.442 HG21 ' CZ ' ' A' ' 154' ' ' PHE . 26.8 m -67.64 172.64 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.42 ' HA ' ' CB ' ' A' ' 154' ' ' PHE . 1.7 m -162.61 169.92 19.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.75 168.37 7.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.509 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.44 ' HG3' ' CG ' ' A' ' 153' ' ' GLU . 3.4 ttpm? -70.8 149.72 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.419 ' O ' HD13 ' A' ' 152' ' ' LEU . 18.0 ttp -155.74 148.04 23.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -138.07 116.6 12.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.662 HD21 HG12 ' A' ' 104' ' ' ILE . 4.4 pp -130.75 153.05 49.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.931 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.431 ' CB ' ' HB2' ' A' ' 142' ' ' ASN . 9.5 m-20 -75.37 147.24 40.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.833 HD11 HD12 ' A' ' 150' ' ' LEU . 5.4 mt -105.66 155.13 19.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.6 ' CD1' ' OD1' ' A' ' 142' ' ' ASN . 18.7 m95 -84.05 151.33 60.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.613 0.72 . . . . 0.0 110.872 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 152.87 69.23 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.657 2.238 . . . . 0.0 112.305 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 99' ' ' LEU . 71.4 t -82.82 124.02 77.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.598 0.713 . . . . 0.0 111.142 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 139.54 40.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -55.11 -43.66 74.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.851 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.01 65.49 4.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.481 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.422 HD23 HG13 ' A' ' 125' ' ' VAL . 14.7 tp -160.09 136.38 8.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.774 0.321 . . . . 0.0 110.923 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -107.84 -49.58 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -51.05 118.33 3.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.537 HD23 ' HD3' ' A' ' 98' ' ' PRO . 7.6 mt -56.57 -41.48 76.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.0 tp -104.41 119.85 39.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -101.6 97.8 8.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 110.899 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.553 ' HB3' ' CG ' ' A' ' 38' ' ' TYR . 53.9 Cg_endo -69.78 -40.66 5.03 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.373 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 137' ' ' GLY . 42.1 mt -65.16 -27.28 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 136' ' ' ILE . . . -37.87 152.38 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.445 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.535 HG22 ' CH2' ' A' ' 101' ' ' TRP . 14.9 m -56.46 168.07 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.481 HG21 ' HD2' ' A' ' 78' ' ' ARG . 30.7 p -120.45 154.77 34.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.117 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.79 -169.26 12.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.9 p -101.46 141.17 34.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.876 0.37 . . . . 0.0 110.817 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.6 ' OD1' ' CD1' ' A' ' 123' ' ' TRP . 2.6 m120 -68.13 130.94 92.3 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.567 0.699 . . . . 0.0 110.896 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -28.84 25.05 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.696 2.264 . . . . 0.0 112.408 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -79.81 135.71 36.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -80.47 -34.95 35.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -46.85 -54.75 9.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 43.5 p -47.13 151.56 1.19 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.57 0.7 . . . . 0.0 111.156 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 168.02 22.88 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.653 2.235 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 13.1 t -144.88 140.73 28.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.833 HD12 HD11 ' A' ' 122' ' ' LEU . 2.3 mt -114.52 139.43 49.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -105.84 118.21 36.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.834 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -124.71 158.08 34.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.44 ' CG ' ' HG3' ' A' ' 117' ' ' LYS . 38.7 mt-10 -116.22 142.32 46.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.607 ' CE2' HD21 ' A' ' 152' ' ' LEU . 45.7 m-85 -106.78 151.14 25.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.887 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.503 ' N ' HH11 ' A' ' 12' ' ' ARG . 3.8 m-20 -172.79 142.9 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.776 ' CH2' HD22 ' A' ' 113' ' ' LEU . 7.8 m95 -132.21 86.8 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 158' ' ' SER . 28.7 p90 -95.43 -44.59 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.811 ' CB ' ' HB3' ' A' ' 10' ' ' ALA . 2.4 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.818 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -117.75 153.54 33.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 110.892 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.1 t -101.47 -61.87 1.32 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.8 113.4 0.82 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.456 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.9 t -63.14 -44.81 94.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 110.894 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 t 46.78 36.67 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.21 -41.38 17.62 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.558 ' HB2' HG21 ' A' ' 70' ' ' ILE . 15.9 m120 -105.35 140.25 38.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 110.87 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.4 p -129.18 -39.23 1.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.17 141.74 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.071 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.796 HD13 ' CH2' ' A' ' 156' ' ' TRP . 18.8 tp -102.52 140.39 36.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.461 ' H ' HD12 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -147.35 136.59 22.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.435 HD12 ' CE1' ' A' ' 66' ' ' TYR . 25.5 mt -135.54 145.66 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 tttt -119.73 119.3 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.2 mm -82.68 138.76 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.06 -73.51 0.58 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.0 p -170.41 176.11 4.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.29 160.4 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.475 HG23 ' CD2' ' A' ' 20' ' ' TYR . 13.6 t -129.15 158.66 38.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.188 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.475 ' CD2' HG23 ' A' ' 19' ' ' THR . 11.4 m-85 42.88 39.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 23' ' ' VAL . 59.5 t -66.24 140.8 18.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 23' ' ' VAL . 15.5 t-20 -48.1 -34.32 9.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.683 ' H ' HG12 ' A' ' 21' ' ' VAL . 12.8 m -34.9 101.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.162 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -117.82 -64.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 pp -48.07 177.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -128.53 62.92 1.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 28' ' ' ILE . 4.2 m-20 -134.74 -50.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.438 ' C ' ' O ' ' A' ' 27' ' ' ASP . 28.3 mt -33.91 136.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.68 -64.36 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -145.84 167.47 23.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 85' ' ' SER . 5.8 pt -127.3 163.72 29.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -157.15 157.98 35.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.85 HG23 ' CZ2' ' A' ' 60' ' ' TRP . 98.4 t -104.05 140.13 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.412 ' HG2' HD13 ' A' ' 133' ' ' LEU . 31.3 ttm-85 -114.6 116.6 29.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 81' ' ' LEU . 54.3 p -119.34 163.6 16.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.126 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.27 143.4 3.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.498 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.799 HD13 HG21 ' A' ' 68' ' ' ILE . 4.2 mp -88.5 148.55 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.154 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.541 ' CD2' ' HB3' ' A' ' 135' ' ' PRO . 25.3 m-85 -135.47 132.58 37.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.575 ' CD2' ' HB3' ' A' ' 76' ' ' ALA . 11.4 t-160 -118.94 94.9 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.72 34.66 8.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.96 -26.7 3.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.505 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.25 153.22 62.47 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.634 0.73 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.467 ' O ' ' C ' ' A' ' 44' ' ' LEU . 53.8 Cg_endo -69.77 82.99 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.694 2.263 . . . . 0.0 112.344 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 43' ' ' PRO . 16.4 tp -32.41 -46.54 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.1 m -152.23 177.24 10.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.47 150.89 8.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.83 145.94 25.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.705 HG12 HD11 ' A' ' 64' ' ' LEU . 58.8 t -105.54 135.32 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.082 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -113.17 147.15 37.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.494 HG22 HD13 ' A' ' 64' ' ' LEU . 80.9 p -99.74 167.52 10.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -53.76 165.29 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.906 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -100.73 116.4 32.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -116.28 152.48 47.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.676 0.75 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 139.01 39.19 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.66 2.24 . . . . 0.0 112.367 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 22.4 p -42.43 -45.61 4.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.834 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 p -51.12 -37.43 45.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.84 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -125.79 83.5 62.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.646 0.736 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' O ' ' CE3' ' A' ' 60' ' ' TRP . 53.9 Cg_endo -69.73 3.51 2.72 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.378 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.35 128.89 38.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.85 ' CZ2' HG23 ' A' ' 33' ' ' VAL . 10.0 m-90 -106.24 -40.88 5.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.449 ' C ' ' O ' ' A' ' 60' ' ' TRP . 2.4 p30 33.76 44.57 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -117.82 138.55 52.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.408 ' CE3' ' NH2' ' A' ' 12' ' ' ARG . 62.3 m95 -81.82 96.9 7.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.917 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.705 HD11 HG12 ' A' ' 48' ' ' VAL . 12.8 tp -85.39 120.37 26.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.895 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -98.48 132.58 43.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.435 ' CE1' HD12 ' A' ' 13' ' ' ILE . 44.7 m-85 -100.41 136.19 40.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.945 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -87.63 44.08 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.799 HG21 HD13 ' A' ' 37' ' ' ILE . 2.0 pp -112.59 165.57 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.112 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.623 ' CD2' ' HG2' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -116.58 119.98 37.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.652 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 2.8 mp -56.87 -51.73 79.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.596 0.713 . . . . 0.0 111.144 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 70' ' ' ILE . 54.0 Cg_endo -69.75 1.64 4.24 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.36 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.491 ' CB ' ' HB3' ' A' ' 69' ' ' TYR . 3.5 t70 -125.47 -6.69 6.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.575 ' CD1' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -74.6 116.09 50.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.648 0.737 . . . . 0.0 110.926 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.586 ' HG2' ' HB2' ' A' ' 77' ' ' ALA . 53.5 Cg_endo -69.77 139.3 39.84 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.736 2.29 . . . . 0.0 112.309 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -53.07 -36.86 61.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.575 ' HB3' ' CD2' ' A' ' 39' ' ' HIS . . . -60.77 -33.66 73.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.586 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . . . -68.15 165.14 18.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.135 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 37' ' ' ILE . 10.3 ptt180 -161.11 172.54 16.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.9 tp -93.79 144.68 25.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.609 ' C ' HD23 ' A' ' 81' ' ' LEU . 77.4 m -135.86 149.65 49.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.609 HD23 ' C ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER -155.84 139.42 15.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.404 ' OG ' HD12 ' A' ' 133' ' ' LEU . 96.8 p -148.86 139.19 22.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.459 ' CG1' HD11 ' A' ' 150' ' ' LEU . 53.5 mt -86.54 138.49 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.124 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 72.5 m -139.64 145.17 38.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.47 ' HA ' HG22 ' A' ' 31' ' ' ILE . 88.5 p -106.86 120.52 42.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.852 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.505 HG23 ' CD2' ' A' ' 96' ' ' HIS . 5.1 p -102.01 130.67 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.09 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -137.95 116.1 11.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -107.14 154.72 16.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.473 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.2 mmt180 -118.67 168.81 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.348 . . . . 0.0 110.881 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -67.19 113.03 4.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.56 -23.25 16.86 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.501 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -95.74 167.25 11.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.886 0.374 . . . . 0.0 111.106 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -87.02 168.37 13.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HB3' ' CG2' ' A' ' 86' ' ' VAL . 36.0 mt-10 -75.5 156.09 35.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -122.98 116.31 23.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.505 ' CD2' HG23 ' A' ' 86' ' ' VAL . 6.7 m170 -94.02 127.01 39.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 21.7 t -131.54 123.59 19.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.589 0.709 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.507 ' HD3' HD23 ' A' ' 132' ' ' LEU . 53.9 Cg_endo -69.8 147.97 63.81 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.63 2.22 . . . . 0.0 112.367 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 125' ' ' VAL . 24.6 mt -122.74 -48.18 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.13 163.09 35.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.108 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.831 ' CH2' HG22 ' A' ' 138' ' ' VAL . 61.7 p-90 -142.6 138.59 30.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.79 121.05 1.66 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.518 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 137' ' ' GLY . 34.6 m-20 -101.36 131.44 47.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.782 0.325 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.1 mt -124.45 121.54 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 106' ' ' LEU . 7.1 m120 -66.76 96.14 0.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 105' ' ' ASN . 18.3 mt -35.0 -39.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -102.45 114.47 28.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -57.48 173.82 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.773 ' CE1' HG23 ' A' ' 110' ' ' THR . 1.1 p90 -58.05 -15.09 8.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.773 HG23 ' CE1' ' A' ' 109' ' ' TYR . 29.9 p -103.46 26.15 8.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.143 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 45.87 35.6 2.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 113' ' ' LEU . 93.6 m -125.76 109.3 12.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.68 HD22 ' CH2' ' A' ' 156' ' ' TRP . 33.7 mt -34.23 139.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.475 HG23 ' CG ' ' A' ' 154' ' ' PHE . 19.3 m -72.84 166.63 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.8 m -161.05 171.98 17.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.38 160.12 2.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -64.16 143.41 57.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.774 0.321 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.432 ' O ' HD13 ' A' ' 152' ' ' LEU . 35.2 ttp -153.05 148.71 27.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -139.77 121.35 15.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.078 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pp -128.84 155.72 44.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -76.26 152.71 36.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.26 157.09 18.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.578 ' CZ3' ' OD1' ' A' ' 142' ' ' ASN . 15.0 m95 -90.48 152.24 45.1 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.546 0.689 . . . . 0.0 110.946 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 151.26 69.09 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.344 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 99' ' ' LEU . 93.4 t -75.18 116.62 56.11 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.599 0.714 . . . . 0.0 111.132 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 134.41 27.93 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.677 2.251 . . . . 0.0 112.384 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -52.37 151.36 4.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.815 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 129' ' ' LEU . . . 88.86 -47.04 3.36 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.481 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.458 HD23 HG13 ' A' ' 125' ' ' VAL . 54.8 tp -37.53 110.87 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -100.58 39.44 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.851 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.65 171.65 14.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.507 HD23 ' HD3' ' A' ' 98' ' ' PRO . 43.3 mt -103.0 -45.76 4.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.534 HD23 ' CE1' ' A' ' 38' ' ' TYR . 10.7 tp -104.12 132.42 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -105.54 91.06 4.57 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.591 0.71 . . . . 0.0 110.909 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.541 ' HB3' ' CD2' ' A' ' 38' ' ' TYR . 54.2 Cg_endo -69.79 -45.29 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.641 2.227 . . . . 0.0 112.395 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 17.0 mt -74.25 -23.74 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.449 ' O ' ' ND2' ' A' ' 103' ' ' ASN . . . -39.83 158.49 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.472 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.831 HG22 ' CH2' ' A' ' 101' ' ' TRP . 6.1 m -52.81 172.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.944 0.402 . . . . 0.0 111.102 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.405 HG22 ' CB ' ' A' ' 103' ' ' ASN . 40.1 p -132.03 161.8 32.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.173 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 103.52 -179.75 25.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.8 p -90.33 121.29 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 0.0 110.875 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.578 ' OD1' ' CZ3' ' A' ' 123' ' ' TRP . 29.8 t30 -63.28 126.53 89.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.544 0.688 . . . . 0.0 110.886 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 1.49 4.4 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -91.81 113.32 25.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -74.4 -40.16 62.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -49.67 -46.38 49.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.0 p -55.15 152.62 14.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.581 0.705 . . . . 0.0 111.139 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 134.43 27.92 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.673 2.249 . . . . 0.0 112.326 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 4.1 t -113.83 142.54 45.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.459 HD11 ' CG1' ' A' ' 83' ' ' ILE . 4.7 mt -110.27 146.22 36.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -116.53 123.13 46.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.807 HD22 ' C ' ' A' ' 152' ' ' LEU . 0.0 OUTLIER -130.77 166.23 21.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.918 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -120.26 118.79 31.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.628 ' CE2' HD21 ' A' ' 152' ' ' LEU . 28.8 m-85 -88.96 100.78 13.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.923 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -121.79 154.43 36.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.796 ' CH2' HD13 ' A' ' 11' ' ' LEU . 20.9 m95 -138.77 105.3 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 158' ' ' SER . 14.8 p90 -90.47 -49.01 6.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.514 ' N ' ' CG ' ' A' ' 157' ' ' PHE . 51.5 p . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 -179.811 . . . . . . . . 1 1 . 1 stop_ save_